"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,DE,D1,DE 3368477 D1,138-322-245-754-692,1987-01-29,1987,DE 3368477 T,1983-08-10,US 40854182 A;;US 8301235 W,1982-08-16,IMPEDANCE COMPARATOR FOR SENSING A READ-ONLY MEMORY,,NCR CO,DOTY JAMES,"NCR INTERNATIONAL, INC. (N.D.GES.D.STAATES DELAWAR (1999-05-27);;AT&T GLOBAL INFORMATION SOLUTIONS INTERNATIONAL IN (1996-01-11);;NCR INTERNATIONAL INC., DAYTON, OHIO, US (1992-11-12)",https://lens.org/138-322-245-754-692,Granted Patent,no,0,0,7,8,0,G11C11/56;;G11C11/5692;;G11C2211/5645;;H03K5/2481;;H03K5/2481;;G11C11/56;;G11C2211/5645;;G11C11/5692,G11C17/00;;G11C11/56;;G11C16/04;;G11C16/06;;G11C17/18;;H03K5/24,,0,0,,,,EXPIRED
2,US,B1,US 6825804 B1,007-594-365-247-600,2004-11-30,2004,US 61646703 A,2003-07-09,US 61646703 A,2003-07-09,Interference-aided navigation with cyclic jammer cancellation,"
    An interference-aided signal acquisition and tracking system includes a vehicle, an interference detector, a noise canceller, and a signal processor. The vehicle has at least two receivers configured to detect external signals and the at least two receivers have an output dependent on attitude of the vehicle. The interference detector measures the output of at least one of the at least two receivers. The noise canceller combines the output of the at least two receivers. The signal processor extracts a desired signal from the output of the noise canceller. The output of the interference detector is used to control the noise canceller as to reject unwanted signals and enhance performance of the signal processor in extracting the desired signal. 
",ROCKWELL COLLINS INC,DOTY JAMES H,ROCKWELL COLLINS INC (2003-07-09),https://lens.org/007-594-365-247-600,Granted Patent,yes,9,28,1,1,0,F41G7/346;;F41G7/36;;G01S3/20;;G01S19/18;;G01S19/21;;H04K3/22;;H04K2203/22;;F41G7/36;;G01S3/20;;F41G7/346;;H04K3/22;;G01S19/18;;G01S19/21;;H04K2203/22,G01S19/26;;G01S19/21;;H04B7/185,342/357.12,1,0,,,"Co-pending Patent Application No. 10/123,928, entitled, ""Interference-Aided Navigation For Rotating Vehicles"".",EXPIRED
3,US,A1,US 2002/0079806 A1,000-710-276-488-358,2002-06-27,2002,US 74722900 A,2000-12-22,US 74722900 A,2000-12-22,Apparatus and method for terminating crosswires on a tension focus mask,"
   An apparatus and method for terminating crosswires on a tension focus mask. The apparatus includes a busbar support rail aligned with a busbar attached by a set of spacers and busbar support clips, a termination assembly and a set of termination spring clips. The method includes aligning the busbar support rail with the busbar, attaching busbar support clips to the busbar, affixing spacers to a side of the busbar and then placing a termination strip along the side of the spacer. After all the elements have been aligned, crosswires are drawn across the top of the busbar and attached to the termination strip. An electrical adhesive is applied over the busbar top and allowed to cure. After the electrical adhesive cures, the crosswires between the busbar and the termination strip are cut so as to provide electrical isolation. 
",DOTY JAMES EDWARD,DOTY JAMES EDWARD,THOMSON LICENSING S.A (2001-03-28),https://lens.org/000-710-276-488-358,Patent Application,yes,0,0,2,2,0,H01J9/142;;H01J29/07;;H01J9/142;;H01J29/07,H01J9/14;;H01J29/07,313/402,0,0,,,,EXPIRED
4,IT,A0,IT 8421288 A0,000-292-387-418-871,1984-06-07,1984,IT 2128884 A,1984-06-07,IT 2128884 A,1984-06-07,SONDA OTTICA PER CARTOGRAFIA.,,SPECTRON DEV LAB INC,DOTY JAMES L,,https://lens.org/000-292-387-418-871,Patent Application,no,0,0,3,3,0,,G01C/,,0,0,,,,EXPIRED
5,US,B1,US 9488732 B1,017-671-424-762-24X,2016-11-08,2016,US 201313949399 A,2013-07-24,US 201313949399 A,2013-07-24,GPS optimization for limited data,"A satellite navigation signal receiver connected to a legacy satellite navigation system receives a plurality of satellite signals. The receiver selects a subset of the plurality of signals and uses all available data from all of the signals to correct any errors in the subset of signals or otherwise increase the precision of the subset of signals. Alternatively, the receiver uses all of the available data in the plurality of signals to simulate idealized satellite signals that the legacy satellite navigation system uses to derive a location.",ROCKWELL COLLINS INC,DOTY JAMES H,ROCKWELL COLLINS INC (2013-07-24),https://lens.org/017-671-424-762-24X,Granted Patent,yes,5,1,1,1,0,G01S19/26;;G01S19/41;;G01S19/258;;G01S19/41;;G01S19/26,G01S19/25,,0,0,,,,ACTIVE
6,US,A,US 1129179 A,084-630-756-387-596,1915-02-23,1915,US 1913/0781337 A,1913-07-26,US 1913/0781337 A,1913-07-26,FENDER FOR VEHICLES.,,DOTY JAMES M,DOTY JAMES M,,https://lens.org/084-630-756-387-596,Granted Patent,no,0,0,1,1,0,B60R21/34;;B60R21/34,,,0,0,,,,EXPIRED
7,US,A,US 3443771 A,084-265-554-556-758,1969-05-13,1969,US 3443771D A,1967-09-18,US 66842667 A,1967-09-18,SUTURE WINDING CARD,,SMITHKLINE CORP,DOTY JAMES E,SMITHKLINE BECKMAN CORPORATION (1982-03-04),https://lens.org/084-265-554-556-758,Granted Patent,no,4,8,1,1,0,B65H75/06;;B65H2701/3918;;B65H75/06;;B65H2701/3918,B65H75/06,242/85.1,0,0,,,,EXPIRED
8,US,A,US 5841537 A,182-319-166-425-282,1998-11-24,1998,US 90947997 A,1997-08-11,US 90947997 A,1997-08-11,Synthesized attitude and heading inertial reference,An inertial reference system for determining the attitude and rate of change of attitude of a vehicle such as an aircraft is disclosed. Redundancy of the inertial reference system may be accomplished by replacement of one of the fiber optic gyroscopes of an otherwise dual fiber optic gyros installation with a low-cost reference IMU. Failure detection and isolation of a fiber optic gyroscope system may be accomplished with a low-cost reference IMU rather than with an additional fiber optic gyroscope. The information provided by the eliminated fiber optic gyroscope is synthesized from the output of the remaining fiber optic gyroscope and the output of the low-cost reference IMU.,ROCKWELL INTERNATIONAL CORP,DOTY JAMES H,ROCKWELL COLLINS INC (1998-02-13),https://lens.org/182-319-166-425-282,Granted Patent,yes,4,48,1,1,0,G01C19/72;;G01C21/166;;G01C19/72;;G01C21/166,G01C19/72;;G01C21/16,356/350;;701/221,0,0,,,,EXPIRED
9,GB,A,GB 2158228 A,177-622-761-322-73X,1985-11-06,1985,GB 8411592 A,1984-05-05,GB 8411592 A,1984-05-05,Astigmatic non-contact optical probe,"An optical probe, having particular application in contour mapping and small distance gauging, includes a light generation and projection means 14, 17 which projects a light beam 16 through crossed cylindrical lenses 18, 20 to induce astigmatism in the beam. The astigmatic beam is then directed onto a target surface 30 to be mapped. The back-scattered radiation 32 reflected from the target surface is collected by a collection means 34 and focused onto a photodetector 36. The shape of the image projected onto the photodetector is dependent upon the distance between the probe and surface. By observing the output of the detector the distance between the probe end surface may be measured, or maintained constant, and a contour map generated using known mapping techniques. In an alternative embodiment, astigmatism is induced in the reflected beam, instead of in the incident beam. <IMAGE>",SPECTRON DEV LAB INC,DOTY JAMES L,,https://lens.org/177-622-761-322-73X,Patent Application,no,2,16,7,7,0,G01B11/026;;G01B11/24;;G02B13/08,G01B11/02;;G01B11/24;;G02B13/08,G1A AA2           EXX;;G1A AA3           EXX;;G1A AD1           EXX;;G1A AD11          EXX;;G1A AEXX          EXX;;G1A AG1           EXX;;G1A AG2           EXX;;G1A AG7           EXX;;G1A AG8           EXX;;G1A AP15          EXX;;G1A AP17          EXX;;G1A AP6           EXX;;G1A AR7           EXX;;G1A AS11          EXX;;G1A AS4           EXX;;G1A AS5           EXX;;G1A AT14          EXX;;G1A AT26          EXX;;G1A AT3           EXX;;G3N NCB1B         CB1B;;G3N NGF1B         GF1B;;H4D DLRG          LRG;;H4D D715          L;;H4D D715          LRG;;H4D D747          L;;H4D D747          LRG;;H4D D748          L;;H4D D748          LRG;;H4D D757          L;;H4D D757          LRG;;H4D D775          L;;H4D D775          LRG;;H4D D78X          L;;H4D D78X          LRG;;H4D D782          L;;H4D D782          LRG;;H4D D783          L;;H4D D783          LRG;;U1S S1839;;U1S S2016;;U1S S2101;;U1S S2102;;U1S S2117;;U1S S2145;;U1S S2148,0,0,,,,DISCONTINUED
10,US,A,US 5606415 A,095-968-721-308-787,1997-02-25,1997,US 31224294 A,1994-09-23,US 31224294 A,1994-09-23,Fiber optic gyro with reduced readout reflection coupling characteristics,"A FOG design is disclosed that eliminates the need for spatially averaging the output of a readout optical fiber by using a short coherence length light source and decorrelating the orthogonal fiber modes in the birefringent readout optical fiber prior to them being received by the photodetector. The orientation of the optical output of the readout optical fiber with respect to the photodetector is at an angle other than normal incidence, which is designed to reduce the reflections from the photodetector back into the readout optical fiber. The coherence length of the source and the length and birefringence of the readout optical fiber are selected so that there is a complete decorrelation of the polarization states of the light as they pass through the readout optical fiber.",ROCKWELL INTERNATIONAL CORP,DOTY JAMES H,ROCKWELL INTERNATIONAL CORPORATION (1994-09-23),https://lens.org/095-968-721-308-787,Granted Patent,yes,6,10,1,1,0,G01C19/721;;G01C19/721,G01B9/02;;G01C19/72,356/350;;250/227.24,0,0,,,,EXPIRED
11,US,A,US 4439010 A,171-890-795-373-116,1984-03-27,1984,US 36431782 A,1982-04-01,US 36431782 A,1982-04-01,Apparatus for combining optical images,"An apparatus for combining optical images which is particularly suited for use in integrated circuit lead wire gang bonding systems is disclosed. The apparatus includes an objective lens to gather and focus light rays reflected from an object, such as a microelectronic device. A beamsplitter provides first and second images of the object which are inverted with respect to one another. The images are directed onto mirrowed prism surfaces, such that only selected portions of the first and second images actually strike each prism face. That portion of each image which does strike the respective prism face is reflected upward and combined to form one resulting image. Viewing means are provided to view the resultant image.",SPECTRON DEV LAB INC,DOTY JAMES L,SPECTRON DEVELOPMENT LABORATORIES INC. A CORP. OF CA (1982-03-22),https://lens.org/171-890-795-373-116,Granted Patent,yes,3,28,1,1,0,G02B27/1066;;G02B27/1066;;G02B27/143;;G02B27/143;;G02B27/144;;G02B27/144,G02B27/10,G2J JBSX1         JBSX1,0,0,,,,EXPIRED
12,US,A,US 4936306 A,078-541-199-452-348,1990-06-26,1990,US 80237185 A,1985-11-27,US 80237185 A;;US 70225185 A,1985-02-15,Device and method for monitoring evoked potentials and electroencephalograms,"Device and method for monitoring evoked potentials and/or electroencephalograms including a novel unipolar spiral coil electrode. The unipolar electrode includes a user holder member formed of non-conductive material and having an outside surface adapted to be grasped by the physician's fingers. A spiral coil formed of a conductive material and having a pointed or beveled tip extends forward from the user holder member. The coil is directly attached to the user holder member such that when the user holder member is grasped by the physician's fingers, pressed against the patient's skin and rotated, the tip pierces the patient's skin and the spiral coil is twisted through the epidermis to a distance sufficient to secure the user holder member to the patient but not great enough to pierce the underlying bone. To assist in manipulating the user holder member, the user holder member on its outer surface includes a friction increasing device such as a pair of projecting ears, a knurled surface, or a knob. An electrically conducting wire connects to the holder member, and thus the spiral coil, either through a permanent or a removable connection, and exits preferably rearwardly from the holder member. The wire has an opposite connector end adapted to be connected to a device for monitoring the electrical activity of the brain.",DOTY JAMES R,DOTY JAMES R,,https://lens.org/078-541-199-452-348,Granted Patent,yes,25,81,1,1,0,A61B5/377;;A61B5/377;;A61B5/291;;A61B5/291,A61B5/0478;;A61B5/0484,128/642;;128/731,0,0,,,,EXPIRED
13,US,A,US 865087 A,065-525-903-714-726,1907-09-03,1907,US 1907/0365012 A,1907-03-28,US 1907/0365012 A,1907-03-28,CAR-MOVER.,,DOTY JAMES R,DOTY JAMES R,,https://lens.org/065-525-903-714-726,Granted Patent,no,0,0,1,1,0,B61J3/10;;B61J3/10,,,0,0,,,,EXPIRED
14,US,A,US 4599086 A,101-040-745-764-565,1986-07-08,1986,US 74241085 A,1985-06-07,US 74241085 A,1985-06-07,Spine stabilization device and method,"A spinal stabilization device positionable between separated but neighboring vertebral bodies to stabilize a spinal column which has been rendered unstable by disease. The device includes a vertebral body prosthesis containing at least one pair of oppositely disposed anchoring pins which are advanced out of the prosthesis into the abutting vertebral bodies to secure the prosthesis to and between them. On its anterior side the prosthesis has an opening communicating with the pins inside the prosthesis. A wrench is inserted into the opening until it engages the pair of pins, and then the wrench is rotated to advance the pins into the abutting vertebral bodies. Detent pins bias the anchoring pins against the wrench and lock the anchoring pins in place when in their fully extended anchoring positions. Spacer members can be attached to the ends of the prosthesis thereby elongating it to accommodate separations between neighboring vertebral bodies of varying dimensions.",DOTY JAMES R,DOTY JAMES R,,https://lens.org/101-040-745-764-565,Granted Patent,yes,11,1133,1,1,0,A61B17/70;;A61B17/7059;;A61B17/8061;;A61F2/44;;A61F2002/30433;;A61F2002/30492;;A61F2002/30505;;A61F2002/30523;;A61F2002/30578;;A61F2002/30579;;A61F2002/30841;;A61F2220/0025;;A61F2220/0041;;A61F2/44;;A61B17/8061;;A61F2002/30841;;A61F2002/30523;;A61F2002/30578;;A61F2002/30579;;A61F2220/0025;;A61B17/70;;A61B17/7059;;A61F2002/30492;;A61F2002/30433;;A61F2220/0041;;A61F2002/30505,A61B17/70;;A61B17/80;;A61F2/00;;A61F2/30;;A61F2/44,A5R RFB           RX7;;A5R RX7           RX7,0,0,,,,EXPIRED
15,FR,A1,FR 2564602 A1,167-516-335-580-160,1985-11-22,1985,FR 8407874 A,1984-05-21,GB 8411592 A,1984-05-05,CAPTEUR OPTIQUE ASTIGMATE SANS CONTACT,"<P>UN CAPTEUR OPTIQUE AMELIORE DONT UNE APPLICATION PARTICULIERE EST LE DESSIN DES CONTOURS ET LA MESURE DES FAIBLES DISTANCES, EST DECRIT. LE CAPTEUR COMPORTE UN MOYEN DE PRODUCTION DE LUMIERE ET DE PROJECTION QUI PROJETTE UN FAISCEAU LUMINEUX A TRAVERS DES LENTILLES CYLINDRIQUES CROISEES DE FACON A PROVOQUER ARTIFICIELLEMENT DE L'ASTIGMATISME. LE FAISCEAU ASTIGMATE EST ENSUITE DIRIGE SUR LA SURFACE D'UNE CIBLE A DESSINER. LE RAYONNEMENT DISPERSE VERS L'ARRIERE REFLECHI PAR LA SURFACE DE LA CIBLE, EST COLLECTE PAR UN MOYEN COLLECTEUR ET FOCALISE SUR UN PHOTODETECTEUR. LA FORME DE L'IMAGE PROJETEE SUR LE PHOTODETECTEUR DEPEND DE LA DISTANCE ENTRE LE CAPTEUR ET LA SURFACE. EN OBSERVANT LA SORTIE DU DETECTEUR, ON PEUT MESURER LA DISTANCE QUI SEPARE LE CAPTEUR ET LA SURFACE OU ON PEUT LA MAINTENIR CONSTANTE, CE QUI PERMET D'OBTENIR UN DESSIN DES CONTOURS EN UTILISANT DES TECHNIQUES DE REPRODUCTION CONNUES.</P>",SPECTRON DEV LAB,DOTY JAMES L,,https://lens.org/167-516-335-580-160,Patent Application,no,2,2,7,7,0,G01B11/026;;G01B11/24;;G02B13/08,G01B11/02;;G01B11/24;;G02B13/08,,0,0,,,,DISCONTINUED
16,IT,B,IT 1176280 B,145-358-466-648-71X,1987-08-18,1987,IT 2128884 A,1984-06-07,IT 2128884 A,1984-06-07,Astigmatic non-contact optical probe,"A light generation source (e.g. laser or LED) (14) and a collimating lens project a beam (16) through crossed cylindrical lenses (18,20) to induce astigmatism in the beam. The astigmatic beam is then directed onto a target surface (30) to be mapped via a beam splitter (28). The back-scattered radiation (32) reflected from the target surface is collected by an imaging lens (34) and focused onto a photodetector (36). The photodetector comprises quadrant sensors. The shape of the image projected onto the photodetector is dependent upon the distance between the probe and surface. By observing the output of the detector the distance between the probe and surface may be measured, or maintained constant.",SPECTRON DEV LAB INC,DOTY JAMES L,,https://lens.org/145-358-466-648-71X,Granted Patent,no,0,0,3,3,0,,G01C/,,0,0,,,,EXPIRED
17,CH,A5,CH 658312 A5,040-520-698-924-758,1986-10-31,1986,CH 251784 A,1984-05-22,GB 8411592 A,1984-05-05,SONDE OPTIQUE ASTIGMATIQUE SANS CONTACT.,,SPECTRON DEV LAB INC,DOTY JAMES L,,https://lens.org/040-520-698-924-758,Granted Patent,no,0,0,7,7,0,G01B11/026;;G01B11/24;;G02B13/08,G01B11/02;;G01B11/24;;G02B13/08,,0,0,,,,EXPIRED
18,US,B2,US 6501213 B2,038-909-024-671-655,2002-12-31,2002,US 74722900 A,2000-12-22,US 74722900 A,2000-12-22,Apparatus and method for terminating crosswires on a tension focus mask,"
    An apparatus and method for terminating crosswires on a tension focus mask. The apparatus includes a busbar support rail aligned with a busbar attached by a set of spacers and busbar support clips, a termination assembly and a set of termination spring clips. The method includes aligning the busbar support rail with the busbar, attaching busbar support clips to the busbar, affixing spacers to a side of the busbar and then placing a termination strip along the side of the spacer. After all the elements have been aligned, crosswires are drawn across the top of the busbar and attached to the termination strip. An electrical adhesive is applied over the busbar top and allowed to cure. After the electrical adhesive cures, the crosswires between the busbar and the termination strip are cut so as to provide electrical isolation. 
",THOMSON LICENSING SA,DOTY JAMES EDWARD,THOMSON LICENSING S.A (2001-03-28),https://lens.org/038-909-024-671-655,Granted Patent,yes,3,1,2,2,0,H01J9/142;;H01J29/07;;H01J9/142;;H01J29/07,H01J9/14;;H01J29/07,313/402;;313/407;;445/30,0,0,,,,EXPIRED
19,US,B1,US 6592070 B1,099-940-692-019-02X,2003-07-15,2003,US 12392802 A,2002-04-17,US 12392802 A,2002-04-17,Interference-aided navigation system for rotating vehicles,"
    An interference-aided navigation system for a rotating vehicle provides rotation angle estimates using interference or jamming signals. An antenna receives interference signals and desired navigation signals. A RF processing function connected to the antenna processes the received interference signals and the desired navigation signals into IF signals. An A/D converter connected to the RF processing function digitizes the interference signals and desired navigation signals and to provide a digitized IF signal. A tracking filter tracks amplitude variations of the interference signals and provides the rotation angle estimate signal of the rotating vehicle. 
",ROCKWELL COLLINS INC,DOTY JAMES H,ROCKWELL COLLINS INC (2002-04-17),https://lens.org/099-940-692-019-02X,Granted Patent,yes,14,7,1,1,0,F42B15/01;;F42B15/01;;F41G7/305;;F41G7/305,F41G7/30;;F42B15/01;;G01S19/47,244/3.23;;244/3.1;;244/3.15;;244/3.19;;701/207;;701/213;;342/357.01;;342/357.06,3,0,,,"Co-filed patent application entitled ""Interference-Aided Navigation With Temporal Beam Forming In Rotating Vehicles"" filed on an even date, inventor J. Doty.;;Co-pending patent application entitled ""Spinning-Vehicle Navigation Using Apparent Modulation Of Navigational Signals"" filed on Jun. 12, 2001, Application No. 09/879,392, inventors J. Doty and G. McGraw.;;Co-pending patent application entitled ""Low Cost Interference Reduction System For GPS Receivers"" filed on Dec. 5, 2001, Application No. 10/005,237, inventor Thomas V. DeWulf.",EXPIRED
20,US,A,US 5252823 A,029-453-860-831-598,1993-10-12,1993,US 95243192 A,1992-09-28,US 95243192 A,1992-09-28,Combined light source and readout for fiber-optic sensors with reduced back-reflections,"A combined angle-faceted, superluminescent diode and readout photodetector with an optical fiber coupled at one end of the superluminescent diode and the readout photodetector coupled at the other end wherein no fiber-optic couplers are used to couple the optical fiber with the readout photodetector.",ROCKWELL INTERNATIONAL CORP,DOTY JAMES H,ROCKWELL INTERNATIONAL CORPORATION (1992-09-28),https://lens.org/029-453-860-831-598,Granted Patent,yes,5,6,1,1,0,G01C19/721;;G02B6/4207;;G02B6/4207;;G01C19/721,G01C19/72;;G02B6/42,H1K KED           ED,0,0,,,,EXPIRED
21,US,B1,US 6587078 B1,146-261-379-343-438,2003-07-01,2003,US 12394702 A,2002-04-17,US 12394702 A,2002-04-17,Interference-aided navigation with temporal beam forming in rotating vehicles,"
    An interference-aided signal acquisition and tracking system with temporal beam forming for a rotating vehicle enhances signal to noise ratio using interference or jamming signals. An antenna receives interference signals and desired navigation signals. A RF processing function connected to the antenna processes the received interference signals and the desired navigation signals into IF signals. An A/D converter connected to the RF processing function digitizes the interference signals and desired navigation signals and provides a digitized IF signal. A tracking filter tracks amplitude variations of the interference signals and provides a rotation angle estimate signal of the rotating vehicle. A signal modulation function connected to the tracking filter and the A/D converter varies gain of the IF signal to enhance the signal to noise ratio. 
",ROCKWELL COLLINS INC,DOTY JAMES H,ROCKWELL COLLINS INC (2002-04-17),https://lens.org/146-261-379-343-438,Granted Patent,yes,6,9,1,1,0,F41G7/305;;F41G7/305;;F42B15/01;;F42B15/01;;G01S19/21;;G01S19/21;;G01S3/06;;G01S3/06,F41G7/30;;F42B15/01;;G01S1/00;;G01S3/06,342/383;;244/3.1;;244/3.23,3,0,,,"Co-filed patent application Docket No. 02CR169/KE entitled ""Interference-Aided Navigation System For Rotating Vehicles"" filed on an even date, inventor J. Doty.;;Co-pending patent application Docket No. 00CR163/KE entitled ""Spinning-Vehicle Navigation Using Apparent Modulation Of Navigational Signals"" filed on Jun. 12, 2001, Application No. 09/879,392, inventors J. Doty and G. McGraw.;;Co-pending patent application Docket No. 01CR040/KE entitled ""Low Cost Interference Reduction System For GPS Receivers"" filed on Dec. 5, 2001, Application No. 10/005,237, inventor Thomas V. DeWulf.",EXPIRED
22,US,A,US 3550717 A,081-164-786-695-923,1970-12-29,1970,US 3550717D A,1968-09-09,US 75826468 A,1968-09-09,AUTOMOTIVE SAFETY DEVICES,,GULF OIL CORP,DOTY JAMES FRANKLIN JR,CHEVRON U.S.A. INC (1985-07-01);;CHEVRON RESEARCH COMPANY (1986-07-21),https://lens.org/081-164-786-695-923,Granted Patent,no,0,30,1,1,0,B60K28/14;;B60R25/04;;Y10T137/0753;;Y10T137/7069;;Y10T137/0753;;Y10T137/7069;;B60K28/14;;B60R25/04,B60K28/14;;B60R25/04,180/103,0,0,,,,EXPIRED
23,CA,A,CA 1246160 A,180-697-881-575-170,1988-12-06,1988,CA 550086 A,1987-10-23,US 92486786 A,1986-10-30,DRIVE CIRCUIT WITH LIMITED SIGNAL TRANSITION RATE FOR RFI REDUCTION,"RCA 83,456 An amplifier applies turn-on bias to the gate electrode of an output field-effect transistor in response to a first level of an input signal applied to the amplifier. A switched power source supplies operating current to the amplifier for developing the turn-on bias when the amplifier input signal is at the first level. A feedback-controlled bypass circuit diverts a portion of the operating current from the amplifier during an initial turn on period and gradually reduces the magnitude of the diverted operating current as the output transistor turns on thereby producing a ""soft"" turn-on of the output transistor so as to minimize a potential for creating radio frequency interference in nearby RFI sensitive devices such as the tuner in a television or radio receiver. Complementary circuits include dual current supply and diversion circuits providing controlled rise and fall times for complementary field-effect output transistors.",RCA CORP,DOTY JAMES H II,,https://lens.org/180-697-881-575-170,Granted Patent,no,0,0,2,2,0,G11C7/22;;G11C7/22;;G11C8/18;;G11C8/18;;H03K19/00361;;H03K19/00361,G11C7/22;;G11C8/18;;H03K19/003,328-202,0,0,,,,EXPIRED
24,EP,A1,EP 0116088 A1,163-881-278-445-113,1984-08-22,1984,EP 83902850 A,1983-08-10,US 40854182 A,1982-08-16,IMPEDANCE COMPARATOR FOR SENSING A READ-ONLY MEMORY.,"Un circuit de détection permet de déterminer l'amplitude d'une impédance inconnue (26) en comparant les niveaux de tension générés dans une succession de circuits à miroir de courant (21). Le circuit de détection décrit est connecté à un réseau de mémoire morte comprenant des dispositifs TEC (26) (transistor à effet de champ) ayant des structures de canaux sélectionnés à partir de 2n structures possibles de canaux différents correspondant à 2n impédances possibles pour représenter n bits différents de données par cellule de mémoire morte. Lorsqu'il est adressé, le TEC de mémoire morte (26) est couplé à un TEC de référence à miroir de courant dont les électrodes de porte et de drain connectées en commun sont en outre couplées à une succession de 2n-1 TECs à miroir de courant (29, 31, 32). Chacun des TECs à miroir de courant (29, 31, 32) est connecté en série conductive avec une impédance incrémentiellement différente (37, 38, 39), la valeur de chaque impédance se trouvant sensiblement à mi-chemin entre les 2n impédances potentielles possibles dans le TEC de cellule de la mémoire morte (26). Les tensions sur les TECs à miroir de courant (29, 31, 32) sont comparées individuellement à la tension sur le TEC de référence à miroir de courant (28) pour générer une représentation à format numérique des grandeurs relatives, une telle représentation étant décodée dans un circuit logique (24) pour produire n bits de données.",NCR CO,DOTY JAMES HARRISON II,"AT&T GLOBAL INFORMATION SOLUTIONS INTERNATIONAL IN (1996-08-01);;NCR INTERNATIONAL, INC;HYUNDAI ELECTRONICS AMERICA (1998-06-02);;NCR INTERNATIONAL INC. TE DAYTON, OHIO, VER. ST. V (1993-12-01)",https://lens.org/163-881-278-445-113,Patent Application,yes,0,0,7,8,0,G11C11/56;;G11C11/5692;;G11C2211/5645;;H03K5/2481;;H03K5/2481;;G11C11/56;;G11C2211/5645;;G11C11/5692,G11C17/00;;G11C11/56;;G11C16/04;;G11C16/06;;G11C17/18;;H03K5/24,,0,0,,,,EXPIRED
25,WO,A1,WO 1984/000840 A1,064-714-861-433-083,1984-03-01,1984,US 8301235 W,1983-08-10,US 40854182 A,1982-08-16,IMPEDANCE COMPARATOR FOR SENSING A READ-ONLY MEMORY,"A sensing circuit for determining the amplitude of an unknown impedance (26) by comparing the voltage levels generated in a succession of current mirror circuits (21). As described, the sensing circuit is connected to a ROM array including FET devices (26) having channel structures selected from 2n possible different channel structures, corresponding to 2n possible impedances, to represent n different bits of data per ROM cell. When addressed, the selected ROM FET (26) is coupled to a current mirror reference FET, whose commonly connected gate and drain electrodes are further coupled to a succession of 2n-1 current mirror FETs (29, 31, 32). Each of the current mirror FETs (29, 31, 32) is connected in conductive series with an incrementally different impedance (37, 38, 39), the value of each impedance lying substantially midway between the 2n potential impedances possible in the ROM cell FET (26). The voltages on the current mirror FETs (29, 31, 32) are individually compared to the voltage on the current mirror reference FET (28) to generate a digital format representation of the relative magnitudes, such representation being decoded in a logic circuit (24) to provide n data bits.",NCR CO,DOTY JAMES HARRISON II,,https://lens.org/064-714-861-433-083,Patent Application,yes,5,3,7,8,0,G11C11/56;;G11C11/5692;;G11C2211/5645;;H03K5/2481;;H03K5/2481;;G11C11/56;;G11C2211/5645;;G11C11/5692,G11C11/56;;G11C17/00;;G11C16/04;;G11C16/06;;G11C17/18;;H03K5/24,H3X X20           X20;;H3X X3B           X20,1,0,,,"VLSI Digest of Papers: Compcon Spring 1981, published in 1981, M. STARK: ""Two bits per Cell ROM"", see pages 209-212 and particularly page 210 to page 211, left-hand column, seventh line from below; figures 2 to 4",PATENTED
26,US,A,US 4739193 A,167-481-397-885-931,1988-04-19,1988,US 92486786 A,1986-10-30,US 92486786 A,1986-10-30,Drive circuit with limited signal transition rate for RFI reduction,"An amplifier applies turn-on bias to the gate electrode of an output field-effect transistor in response to a first level of an input signal applied to the amplifier. A switched power source supplies operating current to the amplifier for developing the turn-on bias when the amplifier input signal is at the first level. A feedback-controlled bypass circuit diverts a portion of the operating current from the amplifier during an initial turn-on period and gradually reduces the magnitude of the diverted operating current as the output transistor turns on thereby producing a ""soft"" turn-on of the output transistor so as to minimize a potential for creating radio frequency interference in nearby RFI sensitive devices such as the tuner in a television or radio receiver. Complementary circuits include dual current supply and diversion circuits providing controlled rise and fall times for complementary field-effect output transistors.",RCA CORP,DOTY II JAMES H,RCA CORPORATION A CORP. OF DE (1986-12-09);;RCA LICENSING CORPORATION TWO INDEPENDENCE WAY PRINCETON NJ 08540 A CORP. OF DE (1987-12-08),https://lens.org/167-481-397-885-931,Granted Patent,yes,9,31,2,2,0,G11C7/22;;G11C7/22;;G11C8/18;;G11C8/18;;H03K19/00361;;H03K19/00361,G11C7/22;;G11C8/18;;H03K19/003,307/443;;307/451;;307/475;;307/363;;307/263,0,0,,,,EXPIRED
27,EP,B1,EP 0116088 B1,105-461-505-754-625,1986-12-17,1986,EP 83902850 A,1983-08-10,US 40854182 A,1982-08-16,IMPEDANCE COMPARATOR FOR SENSING A READ-ONLY MEMORY,,NCR CORPORATION,"DOTY, JAMES, HARRISON, II","AT&T GLOBAL INFORMATION SOLUTIONS INTERNATIONAL IN (1996-08-01);;NCR INTERNATIONAL, INC;HYUNDAI ELECTRONICS AMERICA (1998-06-02);;NCR INTERNATIONAL INC. TE DAYTON, OHIO, VER. ST. V (1993-12-01)",https://lens.org/105-461-505-754-625,Granted Patent,yes,0,0,7,8,0,G11C11/56;;G11C11/5692;;G11C2211/5645;;H03K5/2481;;H03K5/2481;;G11C11/56;;G11C2211/5645;;G11C11/5692,G11C17/00;;G11C11/56;;G11C16/04;;G11C16/06;;G11C17/18;;H03K5/24,,0,0,,,,EXPIRED
28,KR,B1,KR 960002499 B1,077-651-204-779-128,1996-02-17,1996,KR 870012086 A,1987-10-30,US 92486886 A,1986-10-30,START-STOP OSCILLATION HAVING FIXED STARTING PHASE & MINIMIZED QUIESCENT POWER DISSIPATION,,RCA LICENSING CORP,DOTY JAMES H N,,https://lens.org/077-651-204-779-128,Granted Patent,no,0,0,11,11,0,H03K3/80;;H03K3/80;;H04N5/44;;H03L7/24;;H03L7/24,H03B5/06;;H03B5/12;;H03K3/80;;H03L7/24,,0,0,,,,EXPIRED
29,US,A,US 4488065 A,154-091-883-660-716,1984-12-11,1984,US 40854182 A,1982-08-16,US 40854182 A,1982-08-16,Sensing and logic for multiple bit per cell ROM,"A sensing circuit for determining the amplitude of an unknown impedance by comparing the voltage levels generated in a succession of current mirror circuits. In one form, the present circuit is connected to a ROM array comprised of FET devices having the potential of 2.sup.n different channel structures, impedances, to represent n different bits of data. When addressed, the selected ROM FET is coupled to a current mirror reference FET, whose commonly connected gate and drain electrodes are further coupled to a succession of 2.sup.n -1 current mirror FETs. Each of the current mirror FETs is connected in conductive series with an incrementally different impedance, the value of each impedance lying substantially midway between the 2.sup.n potential impedances possible in the ROM cell FET. The voltages on the current mirror FETs are individually compared to the voltage on the current mirror reference FET to generate a digital format representation of the relative magnitudes. The n data bits in the addressed ROM cell are then decoded by digital logic blocks.",NCR CO,DOTY II JAMES H,MAGNACHIP SEMICONDUCTOR LTD (2004-10-04);;HYNIX SEMICONDUCTOR AMERICA INC (2001-04-12);;NCR CORORATION A CORP. OF MD (1982-08-10);;SYMBIOS INC (1995-08-18);;HYNIX SEMICONDUCTOR INC (2004-09-20),https://lens.org/154-091-883-660-716,Granted Patent,yes,5,9,7,8,0,G11C11/56;;G11C11/5692;;G11C2211/5645;;H03K5/2481;;H03K5/2481;;G11C11/56;;G11C2211/5645;;G11C11/5692,G11C11/56;;G11C16/04;;G11C17/00;;G11C16/06;;G11C17/18;;H03K5/24,307/350;;307/360;;307/363;;X324 57R,6,2,121-397-752-942-785;;008-961-813-604-527,10.1109/jssc.1979.1051317;;10.1109/jssc.1980.1051498,"R. E. Myrick, (Mostek Corp.), Multi Bit Read Only Memory Cell Sensing Circuit , International Publication No. WO82/02276, Jul. 8, 1982.;;M. Stark, Two Bits Per Cell ROM , 1981 IEEE, pp. 209 212.;;I. A. Young, A High Performance All Enchancement NMOS Operational Amplifier , IEEE J. Solid State Circuits, vol. SC 14, No. 6, pp. 1070 1077, Dec. 1979.;;Y. P. Tsividis, D. L. Fraser, and J. E. Dziak, A Process Insensitive High Performance NMOS Operational Amplifier, IEEE J. Solid State Circuits, vol. SC 15, No. 6, pp. 921 928, Dec. 1980.;;John G. Posa, Four State Cell Doubles ROM Bit Capacity , Electronics, Oct. 9, 1980.;;J. Robert Lineback, Four State Cell Called Density Key , Electronics, Jun. 30, 1982.",EXPIRED
30,US,B1,US 10302450 B1,083-476-787-721-80X,2019-05-28,2019,US 201715627317 A,2017-06-19,US 201715627317 A,2017-06-19,Methods and systems for high accuracy and integrity estimation of flight critical aircraft states,"A system includes a first solution engine, second solution engine, output voter engine, and output modification engine. The first solution engine receives first sensor data associated with a first error rate, and determines at least one first flight parameter based on the first sensor data. The second solution engine receives the first sensor data and second sensor data associated with a second error rate, and determines at least one second flight parameter based on the first and second sensor data. The output voter engine determines a difference between the flight parameters, compares the difference to a first threshold, and generates an output including the at least one first flight parameter or the at least one second flight parameter. The output modification engine receives the output from the output voter engine, modifies a rate of change of the output to be less than a second threshold, and transmits the modified output.",ROCKWELL COLLINS INC,DOTY JAMES H;;GAVRILETS VLADISLAV,ROCKWELL COLLINS INC (2017-06-15),https://lens.org/083-476-787-721-80X,Granted Patent,yes,6,6,1,1,0,G01C23/00;;B64D43/00;;B64D31/06;;G01C23/00;;B64C39/024,G01C23/00;;B64C39/02;;B64D43/02,,0,0,,,,ACTIVE
31,US,A1,US 2005/0143803 A1,144-156-691-581-02X,2005-06-30,2005,US 99334104 A,2004-11-19,US 99334104 A;;US 53279703 P,2003-12-24,Protective sheath for drug coated stent,"The present invention provides a system for packaging a drug coated stent, including a transport package body including an arcuate catheter guide and a catheter. The catheter has a drug coated stent disposed thereon to be received in the catheter guide. A sheath including at least one reduced thickness region therein to increase flexibility of the sheath is disposed on the catheter, which encloses the drug coated stent.",MEDTRONIC VASCULAR INC,WATSON JAMES R;;DOTY DAVID,MEDTRONIC VASCULAR INC (2004-11-18),https://lens.org/144-156-691-581-02X,Patent Application,yes,13,31,1,1,0,A61F2/0095;;A61F2002/9583;;A61F2/0095;;A61F2002/9583,A61F2/00;;A61F2/06,623/1.11,0,0,,,,DISCONTINUED
32,DE,A1,DE 10235998 A1,010-741-271-329-950,2004-02-19,2004,DE 10235998 A,2002-08-06,DE 10235998 A,2002-08-06,"Suction device, especially combustion engine induction system, has induction pipe pulse switching units with controllers that produce high pressure charging pulses by opening/closing switching units.",The device has an induction pipe associated with each combustion chamber that opens at one end into an air inlet (41) associated with a combustion chamber and has an air inlet opening of an induction plenum chamber (20) at the other end. Each induction pipe has a pulse switching unit (32') with an associated controller (32'') that can produce a high pressure charging pulse by opening and closing the pulse switching unit.,ALTMANN OTTO;;SOLVAY ADVANCED POLYMERS LLC,ALTMANN OTTO;;DOTY JAMES K,,https://lens.org/010-741-271-329-950,Patent Application,no,0,2,3,3,0,F02B27/0215;;F02B27/0257;;F02B29/083;;F02B31/06;;F02D9/16;;F02M26/03;;F02M26/08;;F02M26/16;;F02M26/42;;F02M35/04;;F02M35/1255;;F02M35/14;;Y02T10/12,F02B27/02;;F02B29/08;;F02B31/06;;F02D9/16;;F02M25/07;;F02M35/04;;F02M35/14,,0,0,,,,DISCONTINUED
33,WO,A1,WO 2004/015254 A1,151-131-881-958-070,2004-02-19,2004,EP 0308185 W,2003-07-24,DE 10235998 A,2002-08-06,"ASPIRATOR, WHICH USES PULSED CHARGING, FOR INTERNAL COMBUSTION ENGINES","The invention relates to an aspirator, in particular an air aspirator for an internal combustion engine. The cylinder heads of the combustion chambers of the internal combustion engine are provided with air inlets. Each respective end of the intake pipes of the inventive aspirator is in contact with the air inlets, the other respective ends of the intake pipes (30) opening into an aspiration plenum (20) of the aspirator by means of air intake openings. In addition, each intake pipe has a pulse switching unit (32'), which creates high-pressure air charging pulses by rapidly opening and closing by means of a control device (32'), said pulses being fed to the combustion chambers.",SOLVAY ADVANCED POLYMERS LLC;;ALTMANN OTTO;;DOTY JAMES K,ALTMANN OTTO;;DOTY JAMES K,,https://lens.org/151-131-881-958-070,Patent Application,yes,4,0,3,3,0,F02B27/0215;;F02B27/0257;;F02B29/083;;F02B31/06;;F02D9/16;;F02M26/03;;F02M26/08;;F02M26/16;;F02M26/42;;F02M35/04;;F02M35/1255;;F02M35/14;;Y02T10/12,F02B27/02;;F02B29/08;;F02B31/06;;F02D9/16;;F02M25/07;;F02M35/04;;F02M35/14,,4,0,,,"PATENT ABSTRACTS OF JAPAN vol. 006, no. 210 (M - 166) 22 October 1982 (1982-10-22);;PATENT ABSTRACTS OF JAPAN vol. 009, no. 333 (M - 443) 27 December 1985 (1985-12-27);;PATENT ABSTRACTS OF JAPAN vol. 010, no. 189 (M - 494) 3 July 1986 (1986-07-03);;PATENT ABSTRACTS OF JAPAN vol. 010, no. 286 (M - 521) 27 September 1986 (1986-09-27)",PENDING
34,US,A1,US 2007/0231666 A1,005-966-070-076-682,2007-10-04,2007,US 23614805 A,2005-09-27,US 23614805 A;;US 61365904 P,2004-09-28,Fuel cell interconnect,"Provided, in one embodiment, is a fuel cell interconnect comprising: a first primary conduit located at the periphery of the interconnect; a second primary conduit located at the periphery of the interconnect; a fuel cell distribution plate located at the top or bottom of the interconnect adapted to interface with a fuel cell and comprising: (i) an internal distribution conduit through the fuel cell distribution plate, and (ii) two or more second distribution conduits through the fuel cell distribution plate located peripheral to the internal distribution conduit but interior to the primary conduits, the internal and second distribution conduits adapted to convey fluid from one to the other along the top or bottom, as relevant, of the interconnect; and one or more manifold plates comprising a conduit from the first primary conduit to the internal distribution conduit and a conduit from the second primary conduit to two or more said second distribution conduits.",WANG CONGHUA;;DOTY JAMES E,WANG CONGHUA;;DOTY JAMES E,SARNOFF CORPORATION (2005-09-27),https://lens.org/005-966-070-076-682,Patent Application,yes,11,14,1,1,0,H01M8/0228;;H01M8/0228;;H01M8/0206;;H01M8/0206;;H01M8/0215;;H01M8/0215;;H01M8/0247;;H01M8/0247;;H01M8/0625;;H01M8/0625;;H01M8/0637;;H01M8/0637;;H01M8/2432;;H01M8/2432;;H01M8/2483;;H01M8/2483;;Y02E60/50;;Y02E60/50,H01M8/24,429/38,0,0,,,,DISCONTINUED
35,AU,A1,AU 2003/255285 A1,010-483-337-344-071,2004-02-25,2004,AU 2003/255285 A,2003-07-24,DE 10235998 A;;EP 0308185 W,2002-08-06,"ASPIRATOR, WHICH USES PULSED CHARGING, FOR INTERNAL COMBUSTION ENGINES",,ALTMANN OTTO;;SOLVAY ADVANCED POLYMERS LLC,ALTMANN OTTO;;DOTY JAMES K,,https://lens.org/010-483-337-344-071,Patent Application,no,0,0,3,3,0,F02B27/0215;;F02B27/0257;;F02B29/083;;F02B31/06;;F02D9/16;;F02M26/03;;F02M26/08;;F02M26/16;;F02M26/42;;F02M35/04;;F02M35/1255;;F02M35/14;;Y02T10/12,F02B27/02;;F02B29/08;;F02B31/06;;F02D9/16;;F02M25/07;;F02M35/04;;F02M35/14,,0,0,,,,DISCONTINUED
36,FR,A,FR 651827 A,029-634-162-350-108,1929-02-28,1929,FR 651827D A,1928-03-27,US 17938827 A,1927-03-29,Perfectionnements apportés au décapage des métaux,,,GRAVELL JAMES HARVEY;;DOTY ALFRED,,https://lens.org/029-634-162-350-108,Granted Patent,no,0,0,4,4,0,C23G1/04;;C23G1/04,C23G1/04,,0,0,,,,EXPIRED
37,GB,A,GB 2269979 A,015-411-173-466-265,1994-03-02,1994,GB 9321158 A,1992-04-22,US 68998591 A;;US 9203306 W,1991-04-23,Dual-spring retractor,"A dual spring seat-belt retractor system with a tension-ease system (68) operable to provide one (12) of two springs continuously maintaining a retractive force on the belt (18) to maintain the belt against the wearer in the tension-ease mode, which tension-ease system is automatically initiated at the cessation of belt protraction with a slight retraction to engage latch means (76) that renders one of the springs ineffective to provide a reduced belt tension. A lost motion connection between the belt reel and the latch means permits limited belt movement by the user while maintaining the reduced tension until a predetermined retraction occurs. <IMAGE>",TAKATA INC,ZYGUTIS JAMES L;;DOTY GERALD ARTHUR,,https://lens.org/015-411-173-466-265,Patent Application,no,11,3,8,8,0,B60R22/44;;B60R22/44;;B60R2022/4426;;B60R2022/4426,B60R22/44,A3V VRG           NONE;;B7B BVRG          BVRG,0,0,,,,EXPIRED
38,DE,A1,DE 3248000 A1,089-674-272-680-805,1983-07-07,1983,DE 3248000 A,1982-12-24,US 33578081 A,1981-12-30,Method for the pretreatment of plastic substrates for electroless metallisation,"A method for the pretreatment of plastic substrates for electroless metallisation is disclosed, specifically a method of the type which includes the steps of etching the substrate and activating the etched substrate. The improvement comprises the step of acceleration of the activated substrate using an improved aqueous accelerator solution which contains a water-soluble compatible oxidant in an amount effective for increasing the activity of the accelerator solution. The improved accelerator solution inhibits the metallisation of resist coatings and electroplating mounts and can be used in a versatile manner.",OCCIDENTAL CHEM CO,DOTY WARREN RUSSELL;;KINNEY TIMOTHY JAMES,OMI INTERNATIONAL CORP. (EINE GESELLSCHAFT N.D.GES (1985-06-20),https://lens.org/089-674-272-680-805,Patent Application,no,3,5,4,5,0,C23C18/28;;H05K3/181;;H05K3/38,C23C18/28;;C23C18/30;;H05K3/18;;H05K3/38,,0,0,,,,EXPIRED
39,US,A1,US 2006/0220950 A1,154-236-289-115-787,2006-10-05,2006,US 9886205 A,2005-04-04,US 9886205 A,2005-04-04,Sparse numerical array feed for compact antenna and RCS ranges,"Systems and methods enable numerically creating a flat field in a compact radar range with a curved reflector, and without use of a separate phased array of elements, at frequencies lower than those that are possible with currently known, reflector-only compact radar ranges. A compact radar range is calibrated to enable weighting factors to be computed. The weighting factors may be computed by performing an optimization algorithm. The weighting factors are used to weight separate target signals sequentially returned from a target zone such that, when combined, a numerically composite measurement has a substantially constant magnitude across the target zone.",BOEING CO,MORGAN DOUGLAS P;;DOTY JAMES D,BOEING COMPANY THE (2005-04-05),https://lens.org/154-236-289-115-787,Patent Application,yes,9,17,5,5,0,G01R29/105;;G01R29/08;;G01R29/0892;;G01R29/105;;G01R29/105,G01S7/40,342/165;;342/173;;342/194,0,0,,,,INACTIVE
40,CA,A1,CA 2035269 A1,148-991-054-095-111,1991-08-10,1991,CA 2035269 A,1991-01-30,US 47759590 A,1990-02-09,DUAL MODE SEAT BELT RETRACTOR,"An inertia retractor may be provided with an automatic locking mode by the addition of an assembly mounted as an attachment to sidewall of the inertia retractor. The assembly allows the retractor to be used as an inertia retractor until the belt is pulled to a predetermined extent whereupon a belt coil sensor senses this predetermined belt extraction and operates an actuator to shift a pawl into locking engagement with the ratchet wheels and thereby into the automatic locking mode. When the belt rewinds, the belt coil sensor deactivates the ALR mechanism by latching the pawl actuator thereby allowing an inertia member to again operate the pawl to the locking position upon a deceleration of sufficient magnitude.",OCCUPANT SAFETY SYSTEMS INC,ZYGUTIS JAMES L;;DOTY GERALD A,,https://lens.org/148-991-054-095-111,Patent Application,no,0,0,2,2,0,B60R22/415;;B60R22/415,B60R22/415,D124200435   M,0,0,,,,DISCONTINUED
41,KR,B1,KR 0166376 B1,024-929-723-080-926,1999-02-01,1999,KR 910002811 A,1991-02-21,US 48449990 A,1990-02-22,SAFETY BELT RETRACTOR,"안전 밸트 견인기는 밸트 파지기 또는 제동기구를 가지며 이 제동기구는 밸트 파지 위치 및 비작동 위치 사이에서 이동가능하다. 제동기구는 제동 접촉부를 포함하고 이 접촉부는 좌석밸트 끈이 한표면과 결합하여 끈의 반대측 표면을 고 마찰 계수를 가지는 압축가능한 탄성중합체 패드와 단단하게 마찰 결합하도록 힘을 가한다. 죄석 밸트의 섬유들은 압축 가능한 패드안으로 압축되며 그 패드가 섬유들 사이의 틈세기들로 비어져 나온다.패드에 의한 파지 작용은 견인 하중을 실제로, 에컨대 약 십퍼센트(10%)정도 증가시킨다.",OCCUPANT SAFETY SYSTEM INC,ZYGUTIS JAMES L;;DOTY GERALD ARTHUR,,https://lens.org/024-929-723-080-926,Granted Patent,no,0,0,8,8,0,B60R22/42;;B60R22/00;;B60R22/42,B60R22/42,,0,0,,,,EXPIRED
42,WO,A1,WO 2023/147064 A1,112-454-469-825-948,2023-08-03,2023,US 2023/0011754 W,2023-01-27,US 202263304108 P,2022-01-28,BONE FIXATION SYSTEM AND DEVICE,A bone fixation device configured to fix one or more bone segments is provided.,FORMA MEDICAL INC,DAVISON ANDREW;;GAULT JAMES;;DOTY JESSE,,https://lens.org/112-454-469-825-948,Patent Application,yes,6,0,2,2,0,A61B17/1717;;A61B17/1775;;A61B17/1796;;A61B17/7291;;A61B17/848;;A61B17/8605;;A61B17/864;;A61B17/8645;;A61B17/8685;;A61B17/8897;;A61B17/90;;A61B17/56;;A61B17/7035;;A61B2017/564,A61B17/17;;A61B17/72;;A61B17/90,,0,0,,,,PENDING
43,CA,A1,CA 2158061 A1,131-467-548-134-186,1994-09-15,1994,CA 2158061 A,1994-03-14,US 3085393 A;;US 9402705 W,1993-03-12,CRESCENT GRADIENT COILS,"A high-conductivity ceramic coil form with an internal water jacket is used to simplify water cooling for 3-axis MRI gradient coil configuration on a single cylindrical coilform. Crescent-shaped, axially aligned coils are symmetrically employed on either side of the axial symmetry plane to increase transversely the region of field linearity. These crescent coils may be used in conjunction with Golay-type coils for improved switching efficiency. Lead-filled copper tubing may be used to reduce acoustic noise from pulsed coils in high external magnetic fields.",DOTY SCIENT INC,DOTY F DAVID;;WILCHER JAMES K,,https://lens.org/131-467-548-134-186,Patent Application,no,0,0,10,10,0,G01R33/385;;G01R33/3854;;G01R33/3856;;G01R33/3854;;G01R33/385;;G01R33/3856,G01R33/385,,0,0,,,,EXPIRED
44,US,A,US 5886548 A,133-016-792-873-706,1999-03-23,1999,US 60890696 A,1996-02-29,US 60890696 A;;US 3085393 A,1993-03-12,Crescent gradient coils,"A high-conductivity ceramic coil form with an internal water jacket is used to simplify water cooling for 3-axis MRI gradient coil configurations on a single cylindrical coilform. Crescent-shaped, axially aligned coils are symmetrically employed on either side of the axial symmetry plane to increase transversely the region of field linearity. These crescent coils may be used in conjunction with Golay-type coils for improved switching efficiency. Lead-filled copper tubing may be used to reduce acoustic noise from pulsed coils in high external magnetic fields.",DOTY SCIENT INC,DOTY F DAVID;;WILCHER JAMES K,,https://lens.org/133-016-792-873-706,Granted Patent,yes,53,19,10,10,0,G01R33/385;;G01R33/3854;;G01R33/3856;;G01R33/3854;;G01R33/385;;G01R33/3856,G01R33/385,324/318,7,5,014-149-893-456-543;;041-771-174-719-000;;075-382-980-562-364;;141-448-826-831-803;;039-341-740-425-356,10.1002/mrm.1910210107;;1943678;;10.1016/0730-725x(82)90232-6;;10.1016/0022-2364(86)90205-2;;10.1016/0022-2364(87)90283-6;;1925560;;10.1126/science.1925560,"E.C. Wong et al., Magnetic Resonance in Medicine, vol. 21, 1 Sep. 1991, pp. 39 48.;;V. Bangert et al., Journal of Physics E: Scientific Instuments, vol. 15, 1 Feb. 1982, pp. 235 239.;;J.P. Boehmer et al., Journal of Magnetic Resonance, vol. 83, 1 Jun. 1989, pp. 152 159.;;Y. Bangert and P. Mansfield, J. Physics E 15 , Magnetic Field Gradient Coils for NMR Imaging, 235 (1982).;;P. Mansfield and B. Chapman, J. Magnetic Resonance 66 , Active Magnetic Screening of Gradient Coils in NMR Imaging, 573 576 (Feb. 1986).;;P. Mansfield and B. Chapman, J. Magnetic Resonance 72 , Multishield Active Magnetic Screening of Coil Structures in NMR, 211 (1987).;;M.K. Stehling, R. Turner, P. Mansfield, Science 254 , Echo Planar Imaging: Magnetic Resonance Imaging in a Fraction of a Second, 43 (1991).",EXPIRED
45,WO,A1,WO 1994/020862 A1,138-221-995-378-240,1994-09-15,1994,US 9402705 W,1994-03-14,US 3085393 A,1993-03-12,CRESCENT GRADIENT COILS,"A high-conductivity ceramic coil form with an internal water jacket is used to simplify water cooling for 3-axis MRI gradient coil configurations on a single cylindrical coilform. Crescent-shaped, axially aligned coils are symmetrically employed on either side of the axial symmetry plane to increase transversely the region of field linearity. These crescent coils may be used in conjunction with Golay-type coils for improved switching efficiency. Lead-filled copper tubing may be used to reduce acoustic noise from pulsed coils in high external magnetic fields.",DOTY SCIENT INC,DOTY F DAVID;;WILCHER JAMES K,,https://lens.org/138-221-995-378-240,Patent Application,yes,5,10,10,10,0,G01R33/385;;G01R33/3854;;G01R33/3856;;G01R33/3854;;G01R33/385;;G01R33/3856,G01R33/385,,3,3,014-149-893-456-543;;087-967-381-119-140;;055-671-423-257-901,10.1002/mrm.1910210107;;1943678;;10.1088/0022-3735/15/2/018;;10.1016/0022-2364(89)90299-0,"E.C. WONG ET AL.: ""COIL OPTIMIZATION FOR MRI BY CONJUGATE GRADIENT DESCENT"", MAGNETIC RESONANCE IN MEDICINE., vol. 21, no. 1, 1 September 1991 (1991-09-01), DULUTH,MN US, pages 39 - 48;;V. BANGERT ET AL.: ""MAGNETIC FIELD GRADIENT COILS FOR NMR IMAGING"", JOURNAL OF PHYSICS E. SCIENTIFIC INSTRUMENTS, vol. 15, no. 2, 1 February 1982 (1982-02-01), BRISTOL GB, pages 235 - 239;;J.P. BOEHMER ET AL.: ""THE CONE COIL, AN RF GRADIENT COIL FOR SPATIAL ENCODING ALONG THE B0 AXIS IN ROTATING-FRAME IMAGING EXPERIMENTS"", JOURNAL OF MAGNETIC RESONANCE., vol. 83, no. 1, 1 June 1989 (1989-06-01), ORLANDO, MN US, pages 152 - 159",PATENTED
46,DE,T1,DE 4291012 T1,012-713-721-026-434,1994-04-28,1994,DE 4291012 T,1992-04-22,US 9203306 W;;US 68998591 A,1991-04-23,Rückholer mit zwei Federn,,TAKATA INC,ZYGUTIS JAMES L;;DOTY GERALD ARTHUR,,https://lens.org/012-713-721-026-434,Patent Application,no,0,0,8,8,0,B60R22/44;;B60R22/44;;B60R2022/4426;;B60R2022/4426,B60R22/44,,0,0,,,,DISCONTINUED
47,AU,A,AU 1992/020039 A,147-058-644-487-110,1992-11-17,1992,AU 1992/020039 A,1992-04-22,US 68998591 A,1991-04-23,DUAL-SPRING RETRACTOR,,TAKATA INC.,JAMES L ZYGUTIS;;GERALD ARTHUR DOTY,,https://lens.org/147-058-644-487-110,Patent Application,no,0,0,8,8,0,B60R22/44;;B60R22/44;;B60R2022/4426;;B60R2022/4426,B60R22/44,,0,0,,,,PENDING
48,US,A,US 5554929 A,169-664-484-003-700,1996-09-10,1996,US 3085393 A,1993-03-12,US 3085393 A,1993-03-12,Crescent gradient coils,"A high-conductivity ceramic coil form with an internal water jacket is used to simplify water cooling for 3-axis MRI gradient coil configurations on a single cylindrical coilform. Crescent-shaped, axially aligned coils are symmetrically employed on either side of the axial symmetry plane to increase transversely the region of field linearity. These crescent coils may be used in conjunction with Golay-type coils for improved switching efficiency. Lead-filled copper tubing may be used to reduce acoustic noise from pulsed coils in high external magnetic fields.",DOTY SCIENT INC,DOTY F DAVID;;WILCHER JAMES K,DOTY SCIENTIFIC INC (1993-09-15),https://lens.org/169-664-484-003-700,Granted Patent,yes,43,32,10,10,0,G01R33/385;;G01R33/3854;;G01R33/3856;;G01R33/3854;;G01R33/385;;G01R33/3856,G01R33/385,324/318,7,5,041-771-174-719-000;;075-382-980-562-364;;141-448-826-831-803;;039-341-740-425-356;;014-149-893-456-543,10.1016/0730-725x(82)90232-6;;10.1016/0022-2364(86)90205-2;;10.1016/0022-2364(87)90283-6;;1925560;;10.1126/science.1925560;;10.1002/mrm.1910210107;;1943678,"Y. Bangert and P. Mansfield, J. Physics E 15, Magnetic Field Gradient Coils for NMR Imaging, 235 (1982).;;P. Mansfield and B. Chapman, J. Magnetic Resonance 66, Active Magnetic Screening of Gradient Coils in NMR Imaging, 573 576 (Feb. 1986).;;P. Mansfield and B. Chapman, J. Magnetic Resonance 72, Multishield Active Magnetic Screening of Coil Structures in NMR, 211 (1987).;;M. K. Stehling, R. Turner, P. Mansfield, Science 254, Echo Planar Imaging: Magnetic Resonance Imaging in a Fraction of a Second, 43 (1991).;;E. C. Wong et al., Magnetic Resonance in Medicine, vol. 21, 1 Sep. 1991, pp. 39 48.;;V. Bangert et al., Journal of Physics E. Scientific Instuments, vol. 15, 1 Feb. 1982, pp. 235 239.;;J. P. Boehmer et al., Journal of Magnetic Resonance, vol. 83, 1 Jun. 1989, pp. 152 159.",EXPIRED
49,US,A1,US 2017/0192999 A1,056-705-085-440-533,2017-07-06,2017,US 201614989008 A,2016-01-06,US 201614989008 A,2016-01-06,COMPRESSION AND OPTIMIZATION OF A SPECIFIED SCHEMA THAT PERFORMS ANALYTICS ON DATA WITHIN DATA SYSTEMS,"A system optimizes performance of analytics and includes at least one processor. The system analyzes a specification of an analytic produced in accordance with a schema, where the specification indicates a set of conditions for members of a population to determine the analytic. The system compresses the specification by modifying constructs within the specification to produce a compressed specification of a reduced size and complying with the schema, where modifying the constructs within the specification includes removing duplicate portions, combining logical conditions, and removing portions with unused data. The system further performs the analytic based on the compressed specification. Embodiments further include a method and computer program product for optimizing performance of analytics in substantially the same manner as the system.",IBM,BAIERA JAMES C;;DOTY JILL R,MERATIVE US L.P (2022-06-30);;INTERNATIONAL BUSINESS MACHINES CORPORATION (2016-01-05),https://lens.org/056-705-085-440-533,Patent Application,yes,0,1,2,2,0,G16H10/60;;G06F16/1744;;G06F16/81;;G06F16/1748;;G16H10/60;;G06F16/1744;;G06F16/81;;G06F16/1748,G06F19/00;;G06F17/30,,0,0,,,,ACTIVE
50,DE,A1,DE 1501247 A1,067-896-404-950-869,1970-01-29,1970,DE 1501247 A,1966-08-01,US 47768165 A,1965-08-06,Gekuehlter Ausstellungs- oder Schaukasten,,EMHART CORP,HENRY BRENNAN JAMES;;DOTY MACMASTER MALCOLM,,https://lens.org/067-896-404-950-869,Patent Application,no,0,4,2,2,0,A47F3/0447;;A47F3/0447;;A47F2003/046;;A47F2003/046,A47F3/04,,0,0,,,,DISCONTINUED
51,US,A,US 4802266 A,127-820-432-320-649,1989-02-07,1989,US 4595487 A,1987-05-01,US 4595487 A,1987-05-01,Seat belt buckle,"A seat belt buckle having a buckle frame and a pivotal latching member mounted therein includes an improved actuating system which locks the latching member and which assists in ejecting a tongue plate from the frame when the latch mechanism is in its open position. The actuating system includes a stirrup-like linkage including a cylindrical ejector member joined at each end to a pair of pivotally mounted arms. A locking cylinder also extends between the arms. A generally U-shaped retainer includes flat plate-like walls which are pinned to the pair of arms. The ejector member making up the central portion of the stirrup is mounted for sliding reciprocation in a slider member which is attached thereto with a snap-lock action. The slider member includes a sliding tail which reciprocates back and forth in the buckle frame. The actuating mechanism made up of the retainer member, stirrup-shaped linkage, and slider reduces friction and provides improved rigidity in the linkage which eliminates jamming of the mechanism throughout its range of motion.",GATEWAY INDUSTRIES,DOTY GERALD A;;ZYGUTIS JAMES L,OCCUPANT SAFETY SYSTEMS INC. A DE. CORP (1989-05-31);;GATEWAY INDUSTRIES INC. 19900 GOVERNORS HIGHWAY OLYMPIA FIELDS IL 60416 A CORP OF DE (1987-06-26),https://lens.org/127-820-432-320-649,Granted Patent,yes,9,21,1,1,0,A44B11/2523;;A44B11/2523;;Y10T24/45644;;Y10T24/45644;;Y10T24/45665;;Y10T24/45665,A44B11/25,24/637;;24/641,0,0,,,,EXPIRED
52,AU,A,AU 1994/064459 A,147-613-191-014-272,1994-09-26,1994,AU 1994/064459 A,1994-03-14,US 3085393 A;;US 9402705 W,1993-03-12,Crescent gradient coils,,DOTY SCIENT INC,DOTY F DAVID;;WILCHER JAMES K,,https://lens.org/147-613-191-014-272,Patent Application,no,0,0,10,10,0,G01R33/385;;G01R33/3854;;G01R33/3856;;G01R33/3854;;G01R33/385;;G01R33/3856,G01R33/385,,0,0,,,,PENDING
53,AU,A,AU 1975/084782 A,192-137-285-830-294,1977-03-17,1977,AU 1975/084782 A,1975-09-12,US 55742375 A,1975-03-11,TREATING POLYMERIC SUBSTRATES PRIOR TO PLATING,,OXY METAL IND CORPORATION,DOTY WARREN RUSSELL;;KINNEY TIMOTHY JAMES,,https://lens.org/192-137-285-830-294,Patent Application,no,0,0,13,13,0,C23C18/28;;H05K3/181;;H05K3/381;;C23C18/28;;H05K3/181;;H05K3/381,C23C18/22;;C23C18/24;;C23C18/28;;H05K3/18;;H05K3/38,,0,0,,,,EXPIRED
54,US,B1,US 9222799 B1,046-947-488-478-105,2015-12-29,2015,US 201213566302 A,2012-08-03,US 201213566302 A,2012-08-03,Navigation data validation systems and methods,"Present novel and non-trivial systems and methods for validating navigation data are disclosed. A processor receives navigation data from an external source such as a global positioning system (“GPS”); receives navigation data from a second source comprised of multiple sources; determines the validity of the GPS navigation data; and alerts the pilot if validity of the data falls outside a limit. In an embodiment related to lateral information (i.e., geographic position) data, the second navigation data is comprised of both GPS data and data provided from an internal source. In an embodiment related to altitude information data, the second navigation data is comprised of both GPS data and data provided by multiple internal sources.",BELL DOUGLAS A;;DOTY JAMES H;;ROCKWELL COLLINS INC,BELL DOUGLAS A;;DOTY JAMES H,ROCKWELL COLLINS INC (2012-08-03),https://lens.org/046-947-488-478-105,Granted Patent,yes,6,13,1,1,0,G01S19/15;;G01C21/1652;;G01C21/188;;G01C23/00;;G01S19/15;;G01C21/188;;G01C21/1652,G01C23/00;;G01C21/16;;G05D1/00;;G05D3/00;;G06F7/00;;G06F7/70;;G06F17/00;;G06F19/00;;G06G7/00;;G06G7/76,,2,0,,,"U.S. Appl. No. 12/892,546, filed Sep. 28, 2010, Bell et al.;;U.S. Appl. No. 13/193,788, filed Jul. 29, 2011, McCusker.",ACTIVE
55,US,B1,US 10459085 B1,123-627-710-480-264,2019-10-29,2019,US 201615344077 A,2016-11-04,US 201615344077 A,2016-11-04,System and method for validating GPS altitude for low visibility approaches,"A system and related method for validating satellite-based navigation data determines an estimated altitude or position solution based on GPS altitude or position data adjusted with inertial altitude or position data integrated with barometric altitude data corrected for air temperature and latitude. The system may include a vertical monitor for validating the GPS altitude data by comparing the weighted, limited, and integrated estimated altitude solution to the GPS altitude data. The integrated altitude solution may compensate for vertical speed offset. The system may provide secondary altitude monitoring by comparing radar altimeter data to local object data to verify obstacle clearance height. The system may include a lateral monitor for validating GPS lateral position data based on weighting and limiting of altitude sources controlled by a height above threshold estimate from the vertical monitor. Validity information may be presented to the pilot or autopilot.",ROCKWELL COLLINS INC,BELL DOUGLAS A;;DOTY JAMES H,ROCKWELL COLLINS INC (2016-10-31),https://lens.org/123-627-710-480-264,Granted Patent,yes,12,11,1,1,0,G01S19/396;;G01S19/15;;G01S13/882;;G01S19/20;;G01S19/40;;G01S19/53,G01S19/20;;G01S19/40;;G01S19/53,,2,0,,,"Federal Aviation Administration, U.S. Department of Transportation, Criteria for Approval of Category I and Category II Weather Minima for Approach, Advisory Circular, AC 120-29A, Aug. 12, 2002, 273 pages.;;NovaLynx Corporation, Fortin Type Mercurial Barometer Instruction Manual, Models 230-7410, 230-7411, 230-7415, 230-7420, 230-7421, © 1988-2006 NovaLynx Corporation, 17 pages.",ACTIVE
56,DE,D1,DE 69101985 D1,021-650-547-910-97X,1994-06-23,1994,DE 69101985 T,1991-02-12,US 48449990 A,1990-02-22,Sicherheitsgurtaufroller.,,OCCUPANT SAFETY SYSTEMS INC,ZYGUTIS JAMES L;;DOTY GERALD ARTHUR,,https://lens.org/021-650-547-910-97X,Granted Patent,no,0,0,8,8,0,B60R22/42;;B60R22/00;;B60R22/42,B60R22/42,,0,0,,,,EXPIRED
57,GB,B,GB 2424959 B,074-514-493-379-859,2007-05-02,2007,GB 0605404 A,2006-03-16,US 9886205 A,2005-04-04,Sparse numerical array feed for compact antenna and RCS ranges,,BOEING CO,MORGAN DOUGLAS P;;DOTY JAMES D,,https://lens.org/074-514-493-379-859,Granted Patent,no,4,0,5,5,0,G01R29/105;;G01R29/08;;G01R29/0892;;G01R29/105;;G01R29/105,G01R29/08,G1U UR2908        29/08,0,0,,,,INACTIVE
58,GB,B,GB 2269979 B,090-303-083-214-672,1995-04-19,1995,GB 9321158 A,1992-04-22,US 68998591 A;;US 9203306 W,1991-04-23,Safety-belt retractor systems,,TAKATA INC,ZYGUTIS JAMES L;;DOTY GERALD ARTHUR,,https://lens.org/090-303-083-214-672,Granted Patent,no,11,0,8,8,0,B60R22/44;;B60R22/44;;B60R2022/4426;;B60R2022/4426,B60R22/44,A3V VRG           VRG,0,0,,,,EXPIRED
59,US,B2,US 9996543 B2,131-445-857-762-840,2018-06-12,2018,US 201614989008 A,2016-01-06,US 201614989008 A,2016-01-06,Compression and optimization of a specified schema that performs analytics on data within data systems,"A system optimizes performance of analytics and includes at least one processor. The system analyzes a specification of an analytic produced in accordance with a schema, where the specification indicates a set of conditions for members of a population to determine the analytic. The system compresses the specification by modifying constructs within the specification to produce a compressed specification of a reduced size and complying with the schema, where modifying the constructs within the specification includes removing duplicate portions, combining logical conditions, and removing portions with unused data. The system further performs the analytic based on the compressed specification. Embodiments further include a method and computer program product for optimizing performance of analytics in substantially the same manner as the system.",IBM,BAIERA JAMES C;;DOTY JILL R,MERATIVE US L.P (2022-06-30);;INTERNATIONAL BUSINESS MACHINES CORPORATION (2016-01-05),https://lens.org/131-445-857-762-840,Granted Patent,yes,34,0,2,2,0,G16H10/60;;G06F16/1744;;G06F16/81;;G06F16/1748;;G16H10/60;;G06F16/1744;;G06F16/81;;G06F16/1748,G06F17/30,,3,2,023-418-841-474-933;;077-018-075-507-842,10.1007/11827252_5;;10.1109/jstsp.2015.2403800,"Groppe et al., “Satisfiability-Test, Rewriting and Refinement of Users' XPath Queries According to XML Schema Definitions”, ADBIS 2006, LNCS 4152, pp. 22-38, 2006. (Year: 2006).;;“The Explorys Platform”, IBM Watson Health, Solution Brief, Produced in the United States of America, Nov. 2015, 4 pages.;;Krishnan et al.; “A universal parallel two-pass MDL context tree compression algorithm.” (2014). IEEE Journal of Selected Topics in Signal Processing, vol. 9, No. 4, Jun. 2015, pp. 741-748.",ACTIVE
60,US,B1,US 9325550 B1,177-470-639-806-466,2016-04-26,2016,US 201514708809 A,2015-05-11,US 201514708809 A,2015-05-11,"Frequency-domain windowing for precision position, navigation, and timing (PNT) estimation","Systems and methods for mitigating multipath effects on precision PNT estimation are disclosed. Frequency-domain windowing techniques are disclosed and utilized to mitigate multipath effects on precision PNT estimation for systems employing coherent communication signals. More specifically, to mitigate multipath effects an input signal, the input signal may be channelized into a plurality of carrier-specific signals, and each carrier-specific signal may be correlated against a reference signal to produce a corresponding carrier-specific correlation result. A window function may be applied to the carrier-specific correlation results for the plurality of carriers to produce a set of carrier-specific weighted correlation results. The set of carrier-specific weighted correlation results may be integrated to produce an integrated correlation output, which may then be utilized to facilitate PNT estimation.",CHÁVEZ CARLOS J;;DOTY JAMES H;;ROCKWELL COLLINS INC,CHÁVEZ CARLOS J;;DOTY JAMES H,ROCKWELL COLLINS INC (2015-05-06),https://lens.org/177-470-639-806-466,Granted Patent,yes,1,3,1,1,0,H04L27/2278;;G01S5/0218;;H04L27/2278;;G01S5/0218,H04L27/227;;G01S5/02;;H04W24/02;;H04W24/08,,0,0,,,,ACTIVE
61,US,A,US 5024391 A,196-044-016-879-308,1991-06-18,1991,US 48449990 A,1990-02-22,US 48449990 A;;US 34144089 A,1989-04-21,Retractor with auxiliary braking mechanism,"A safety belt retractor which has a belt gripping or braking mechanism that is movable between a belt gripping position and an inactive position. The braking mechanism includes a brake shoe which engages one side of the seat belt webbing and forces the opposite side of the webbing into tight frictional engagement with a compressible elastomeric pad having a high coefficient of friction. The filaments of the seat belt are compressed into the compressible pad and the pad protrudes into interstices between the filaments. This gripping action by the pad increases the pull load by a substantial amount, for example, about ten percent (10%).",OCCUPANT SAFETY SYSTEMS INC,ZYGUTIS JAMES L;;DOTY GERALD A,OCCUPANT SAFETY SYSTEMS INC (1990-02-20),https://lens.org/196-044-016-879-308,Granted Patent,yes,4,4,8,8,0,B60R22/42;;B60R22/00;;B60R22/42,B60R22/42,242/107.2;;X24210740 A;;280/806,0,0,,,,EXPIRED
62,DE,A1,DE 1501248 A1,093-910-938-063-747,1970-02-12,1970,DE 1501248 A,1966-08-01,US 47773065 A,1965-08-06,Gekuehlte Schau- oder Vorfuehrkaesten,,EMHART CORP,HENRY BRENNAN JAMES;;DOTY MACMASTER MALCOLM,,https://lens.org/093-910-938-063-747,Patent Application,no,0,7,2,2,0,A47F3/0447;;A47F3/0447,A47F3/04,,0,0,,,,DISCONTINUED
63,US,A,US 5037038 A,033-642-680-373-267,1991-08-06,1991,US 47759590 A,1990-02-09,US 47759590 A,1990-02-09,Dual mode seat belt retractor,"An inertia retractor may be provided with an automatic locking mode by the addition of an assembly mounted as an attachment to sidewall of the inertia retractor. The assembly allows the retractor to be used as an inertia retractor until the belt is pulled to a predetermined extent whereupon a belt coil sensor senses this predetermined belt extraction and operates an actuator to shift a pawl into locking engagement with the ratchet wheels and thereby into the automatic locking mode. When the belt rewinds, the belt coil sensor deactivates the ALR mechanism by latching the pawl actuator thereby allowing an inertia member to again operate the pawl to the locking position upon a deceleration of sufficient magnitude.",OCCUPANT SAFETY SYSTEMS INC,ZYGUTIS JAMES L;;DOTY GERALD A,OCCUPANT SAFETY SYSTEMS INC (1990-02-09),https://lens.org/033-642-680-373-267,Granted Patent,yes,8,7,2,2,0,B60R22/415;;B60R22/415,B60R22/415,2421074 A;;X2421074 R,0,0,,,,EXPIRED
64,US,A,US 5050815 A,041-960-589-024-967,1991-09-24,1991,US 46717090 A,1990-01-18,US 46717090 A,1990-01-18,Compact safety belt retractor,"A compact safety belt retractor is provided with a large coil of webbing on a rotatable reel and locking pawl teeth are able to have locking engagement with toothed wheels on the reel even when the coil of webbing has a larger diameter than the diameter of a circle defined by the teeth of the ratchet wheels. The coil of webbing preferably extends the full depth of the retractor from front edges of the sidewalls of the frame to the rear frame wall of the retractor. Thus, a large coil of webbing may be stored for the depth of the retractor. To reduce the side-to-side width of retractor, it is preferred to have reel ratchet wheels mounted in the plane of the frame sidewalls and to have the pawl teeth also mounted in openings in the sidewalls of the retractor frame. The pawl teeth are elongated columns and are loaded in columnar manner with substantially small shear or bending stresses thereon. At very high loading on the belt, as at the time of accident, the reel may deflect to shift the toothed wheels to directly engage the bearing surfaces on the sidewalls of the frame when the reel is locked. Both the locking pawls and the toothed wheels are substantially coplanar with the sidewalls of the frame and are disposed within openings in the sidewalls.",OCCUPANT SAFETY SYSTEMS INC,DOTY GERALD A;;ZYGUTIS JAMES L,OCCUPANT SAFETY SYSTEMS INC (1990-01-15),https://lens.org/041-960-589-024-967,Granted Patent,yes,9,5,2,2,0,B60R22/40;;B60R22/40,B60R22/40,2421074 A;;X2421074 C,0,0,,,,EXPIRED
65,US,B2,US 7154435 B2,079-922-388-463-666,2006-12-26,2006,US 9886205 A,2005-04-04,US 9886205 A,2005-04-04,Sparse numerical array feed for compact antenna and RCS ranges,"Systems and methods enable numerically creating a flat field in a compact radar range with a curved reflector, and without use of a separate phased array of elements, at frequencies lower than those that are possible with currently known, reflector-only compact radar ranges. A compact radar range is calibrated to enable weighting factors to be computed. The weighting factors may be computed by performing an optimization algorithm. The weighting factors are used to weight separate target signals sequentially returned from a target zone such that, when combined, a numerically composite measurement has a substantially constant magnitude across the target zone.",BOEING CO,MORGAN DOUGLAS P;;DOTY JAMES D,BOEING COMPANY THE (2005-04-05),https://lens.org/079-922-388-463-666,Granted Patent,yes,10,7,5,5,0,G01R29/105;;G01R29/08;;G01R29/0892;;G01R29/105;;G01R29/105,G01S7/40,342/165;;342/169;;342/170;;342/171,2,1,111-311-918-889-097,10.1121/1.427072,"""Robust broadband matched-field localization: Results for a short, sparse vertical array"", Journal of the Acoustical Society of America, Jul. 1999, vol. 106, No. 1, p. 515-17, 6, Harrison-B-F, Vaccaro-R-J, Tufts-D-W.;;William H. Press, Brian P. Flannery, Saul A. Teukolsky, and William T. Vetterling; Numerical Recipes: The Art of Scientific Computing, chapter 10, Section 10.4 Downhill Simplex Method in Multidimensions, pp. 289-293; Cambridge, United Kingdom, Press Syndicate of the University of Cambridge, 1988.",INACTIVE
66,US,A,US 4989707 A,078-767-583-878-855,1991-02-05,1991,US 41683289 A,1989-10-03,US 41683289 A,1989-10-03,Resettable shaft clutch-disconnect for a co-axial drive shaft,"A transmission having an inner rotationally mounted shaft (42) with first and second parts (44and 46) and an outer concentric rotationally mounted shaft (49) in accordance with the invention includes a clutch (48) connected to the first and second parts of the inner shaft, which is movable between a first engaged position in which torque may be transmitted through the clutch between the first and second parts and a second position in which torque is not transmitted through the clutch; a transmission, coupling one of the parts of the inner shaft to the outer shaft to transmit torque from the inner shaft to the outer shaft when the inner shaft is rotating; an axially movable mechanism (61-80) disposed outside of and concentric with the outer shaft and projecting through the outer shaft for engaging one of the parts of the inner shaft to move the one part between first and second positions, the axially movable mechanism being movable between first and second positions to cause the one of the parts of the inner shaft to move axially between the first and second positions to move the clutch respectively between the first and second positions to control the transmission of torque between the parts of the inner shaft.",SUNDSTRAND CORP,DOTY JAMES H;;SMITH WILLIAM F,SUNDSTRAND CORPORATION (1989-09-27),https://lens.org/078-767-583-878-855,Granted Patent,yes,14,12,1,1,0,F16D11/04;;F16D11/04,F16D11/04,192 67R;;192/94;;74/15.66,0,0,,,,EXPIRED
67,CA,C,CA 1292458 C,164-682-035-726-134,1991-11-26,1991,CA 570172 A,1988-06-23,CA 570172 A,1988-06-23,SEAT BELT BUCKLE WITH SWITCH,Disclosed is a safety belt buckle including a switch which is preferably located between the buckle frame and a bottom cover of the buckle. An ejector for the tongue plate slides on a bottom web of the buckle frame and the ejector is displaced by entry of a tongue plate into the buckle frame. The ejector includes a portion projecting through an opening in the buckle base to a switch mounted in a cavity in the bottom cover and this portion engages a movable switch contact to open and close the switch.,GATEWAY INDUSTRIES,DOTY GERALD A;;ZYGUTIS JAMES L,,https://lens.org/164-682-035-726-134,Granted Patent,no,0,0,1,1,0,,A62B35/00;;B60R22/00,D32270025    M;;3060006    S;;340013501  S,0,0,,,,EXPIRED
68,CA,A,CA 434202 A,031-660-763-531-423,1946-04-16,1946,CA 434202D A,,CA 434202T A,,BED TABLE UNIT,,HARD MFG COMPANY,DOTY BOYD A;;DYETT JAMES H,,https://lens.org/031-660-763-531-423,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
69,DE,A1,DE 2541896 A1,077-600-730-817-614,1976-09-23,1976,DE 2541896 A,1975-09-19,US 55742375 A,1975-03-11,VERFAHREN ZUM BEHANDELN EINES SUBSTRATES AUS PLASTIKMATERIAL UND MATERIAL ZUR DURCHFUEHRUNG DESSELBEN,,OXY METAL INDUSTRIES CORP,DOTY WARREN RUSSELL;;KINNEY TIMOTHY JAMES,OMI INTERNATIONAL CORP. (EINE GESELLSCHAFT N.D.GES (1985-06-20),https://lens.org/077-600-730-817-614,Patent Application,no,0,0,13,13,0,C23C18/28;;H05K3/181;;H05K3/381;;C23C18/28;;H05K3/181;;H05K3/381,C23C18/22;;C23C18/24;;C23C18/28;;H05K3/18;;H05K3/38,,0,0,,,,EXPIRED
70,CN,A,CN 1750811 A,083-212-980-888-864,2006-03-22,2006,CN 02820792 A,2002-10-18,US 34754801 P,2001-10-19,Stable composition comprising particles in a frozen aqueous matrix,,BAXTER INTERNAC INC,TERESA KIPP JAMES E DOTY MARK,,https://lens.org/083-212-980-888-864,Patent Application,no,0,9,1,17,0,,A61K9/10;;A61K31/12;;A61K31/4985;;A61K31/58,,0,0,,,,DISCONTINUED
71,CA,A,CA 555332 A,196-697-680-648-717,1958-04-01,1958,CA 555332D A,,CA 555332T A,,SIDE GUARD FOR BEDS,,HARD MFG COMPANY,DYETT JAMES G;;DOTY BOYD A,,https://lens.org/196-697-680-648-717,Granted Patent,no,0,1,1,1,0,,,,0,0,,,,EXPIRED
72,US,A,US 2393598 A,019-762-237-496-851,1946-01-29,1946,US 47641443 A,1943-02-19,US 47641443 A,1943-02-19,Bed table unit,,HARD MFG COMPANY,DYETT JAMES H;;DOTY BOYD A,,https://lens.org/019-762-237-496-851,Granted Patent,no,0,14,1,1,0,A47B23/04;;A47B2200/0048;;A47B23/04;;A47B2200/0048,A47B23/04,,0,0,,,,EXPIRED
73,US,A,US 5441304 A,062-995-732-492-125,1995-08-15,1995,US 6960793 A,1993-06-01,US 6960793 A,1993-06-01,Seat belt retractor activation mechanism responsive to anti-lock braking systems,"In accordance with the present invention, there is provided a vehicle seat belt retractor having an activation system that responds to an anti-locking braking system and that actuates the retractor to prevent protraction of the seat belt. The preferred activation system includes a control circuit that energizes an activation mechanism when the anti-locking braking system is activated and prohibits energization of the activation mechanism when the braking system is deactivated. The preferred activation mechanism is a small modular unit which is externally mounted to a seat belt retractor and which generally includes a base, an activation lever and a solenoid. The base is mounted to the side of the retractor, and the solenoid and the activation lever are mounted on the base. More particularly, the activation lever is pivotally mounted on the base and extends into the retractor to a position underneath the pawl of the retractor. The activation lever rotates between a neutral position in which it is spaced from the pawl of the retractor and an actuated position in which it engages and urges the pawl into engagement with the ratchet wheels to prevent protraction of the seat belt. The activation lever also attaches to the solenoid, and the solenoid rotates the activation lever to its actuated position in response to an anti-lock braking system used in the vehicle.",TAKATA INC,ZYGUTIS JAMES L;;DOTY GERALD A,TAKATA INC (1993-05-27),https://lens.org/062-995-732-492-125,Granted Patent,yes,8,14,1,1,0,B60R22/343;;B60R22/343;;B60R2021/01311;;B60R2021/01311,B60R21/01;;B60R21/013;;B60R22/343,280/806;;180/268;;180/282;;280/807,0,0,,,,EXPIRED
74,US,A,US 2811726 A,078-162-740-135-819,1957-11-05,1957,US 42925254 A,1954-05-12,US 42925254 A,1954-05-12,Side guard for beds,,HARD MFG COMPANY,DYETT JAMES G;;DOTY BOYD A,,https://lens.org/078-162-740-135-819,Granted Patent,no,7,11,1,1,0,A47C21/08;;A61G7/0507;;A61G7/0509;;A61G7/0515;;A61G7/0507;;A47C21/08;;A61G7/0515;;A61G7/0509,A47C21/08,,0,0,,,,EXPIRED
75,CA,A1,CA 2036493 A1,096-071-041-487-865,1991-08-23,1991,CA 2036493 A,1991-02-18,US 48449990 A,1990-02-22,RETRACTOR WITH AUXILIARY BRAKING MECHANISM,"A safety belt retractor which has a belt gripping or braking mechanism that is movable between a belt gripping position and an inactive position. The braking mechanism includes a brake shoe which engages one side of the seat belt webbing and forces the opposite side of the webbing into tight frictional engagement with a compressible elastomeric pad having a high coefficient of friction. The filaments of the seat belt are compressed into the compressible pad and the pad protrudes into interstices between the filaments. This gripping action by the pad increases the pull load by a substantial amount, for example, about ten percent (10%).",OCCUPANT SAFETY SYSTEMS INC,ZYGUTIS JAMES L;;DOTY GERALD A,,https://lens.org/096-071-041-487-865,Patent Application,no,0,6,8,8,0,B60R22/42;;B60R22/00;;B60R22/42,B60R22/42,D124200431   M,0,0,,,,DISCONTINUED
76,EP,B1,EP 0688436 B1,142-733-075-900-36X,2002-07-24,2002,EP 94912220 A,1994-03-14,US 9402705 W;;US 3085393 A,1993-03-12,CRESCENT GRADIENT COILS,,DOTY SCIENT INC,DOTY F DAVID;;WILCHER JAMES K,,https://lens.org/142-733-075-900-36X,Granted Patent,yes,5,0,10,10,0,G01R33/385;;G01R33/3854;;G01R33/3856;;G01R33/3854;;G01R33/385;;G01R33/3856,G01R33/385,,3,0,,,"MAGNETIC RESONANCE IN MEDICINE., vol.21, no.1, 1 September 1991, DULUTH,MN US pages 39 - 48 E.C. WONG ET AL. 'COIL OPTIMIZATION FOR MRI BY CONJUGATE GRADIENT DESCENT';;JOURNAL OF PHYSICS E. SCIENTIFIC INSTRUMENTS, vol.15, no.2, 1 February 1982, BRISTOL GB pages 235 - 239 V. BANGERT ET AL. 'MAGNETIC FIELD GRADIENT COILS FOR NMR IMAGING' cited in the application;;JOURNAL OF MAGNETIC RESONANCE., vol.83, no.1, 1 June 1989, ORLANDO, MN US pages 152 - 159 J.P. BOEHMER ET AL. 'THE CONE COIL, AN RF GRADIENT COIL FOR SPATIAL ENCODING ALONG THE B0 AXIS IN ROTATING-FRAME IMAGING EXPERIMENTS'",EXPIRED
77,EP,B1,EP 0443764 B1,191-430-194-316-819,1994-05-18,1994,EP 91301131 A,1991-02-12,US 48449990 A,1990-02-22,Safety belt retractors.,,OCCUPANT SAFETY SYSTEMS INC,ZYGUTIS JAMES L;;DOTY GERALD ARTHUR,,https://lens.org/191-430-194-316-819,Granted Patent,yes,7,0,8,8,0,B60R22/42;;B60R22/00;;B60R22/42,B60R22/42,,0,0,,,,EXPIRED
78,WO,A1,WO 1992/018357 A1,007-671-189-437-283,1992-10-29,1992,US 9203306 W,1992-04-22,US 68998591 A,1991-04-23,DUAL-SPRING RETRACTOR,"A dual spring seat-belt retractor system with a tension-ease system (68) operable to provide one (12) of two springs continuously maintaining a retractive force on the belt (18) to maintain the belt against the wearer in the tension-ease mode, which tension-ease system is automatically initiated at the cessation of belt protraction with a slight retraction to engage latch means (76) that renders one of the springs ineffective to provide a reduced belt tension. A lost motion connection between the belt reel and the latch means permits limited belt movement by the user while maintaining the reduced tension until a predetermined retraction occurs.",TAKATA INC,ZYGUTIS JAMES L;;DOTY GERALD ARTHUR,,https://lens.org/007-671-189-437-283,Patent Application,yes,11,0,8,8,0,B60R22/44;;B60R22/44;;B60R2022/4426;;B60R2022/4426,B60R22/44,,0,0,,,,PENDING
79,US,B1,US 6520448 B1,059-061-697-544-673,2003-02-18,2003,US 87939201 A,2001-06-12,US 87939201 A,2001-06-12,Spinning-vehicle navigation using apparent modulation of navigational signals,"
    Attitude of a spinning vehicle is determined by observing at least one of the apparent amplitude modulation and the apparent phase modulation of a navigation signal received from a navigation source. Vectors describing the direction from the vehicle to the navigation source are computed and used to determine attitude relative to the navigation source. Inertial sensors are demodulated to remove rotation artifacts and used to anticipate rapid maneuvers. 
",ROCKWELL COLLINS INC,DOTY JAMES H;;MCGRAW GARY A,ROCKWELL COLLINS INC (2001-08-28);;BAE SYSTEMS INFORMATION AND ELECTRONIC SYSTEMS INTEGRATION INC (2020-07-31),https://lens.org/059-061-697-544-673,Granted Patent,yes,12,55,1,1,0,F41G7/305;;F41G7/305;;F42B15/01;;F42B15/01,F41G7/30;;F42B15/01;;G01S19/53,244/3.23;;244/3.1;;244/3.15;;244/3.19;;244/3.24;;701/207;;701/213;;342/357.01;;342/357.06;;342/450;;342/451,4,4,069-749-479-417-551;;091-454-175-862-233;;085-227-368-259-281;;037-431-071-395-837,10.2514/3.29300;;10.4271/830759;;10.1002/9780470172704;;10.2514/3.27940,"Grasshoff, L. H. ""An Onboard, Closed-Loop, Nutation Control System For Spin-Stabilized Spacecraft,"" Journal of Spacecraft and Rockets, vol. 5, May 1968, pp. 530-535.;;Hemmel, D. L. and Rider, B. F. ""A New Sensor Approach To An Attitude/Heading Reference System,"" SAE document 830759, Business Aircraft Meeting & Exposition, Wichita, KS, Apr. 12-15, 1983.;;Kayton, M. and Fried, W. R. Avionics Navigation Systems, 2nd Edition, 1997, John Wiley & Sons, Inc. pp. 235-248.;;Smay, J. W. and Slafler, L. I. ""Dual-Spin Spacecraft Stabilization Using Nuational Feedback And Inertia Coupling,"" Journal of Spacecraft and Rockets, vol. 13, Nov. 1976, pp. 650-659.",EXPIRED
80,CA,A1,CA 2034525 A1,105-047-469-587-319,1991-07-19,1991,CA 2034525 A,1991-01-18,US 46717090 A,1990-01-18,COMPACT SAFETY BELT RETRACTOR,"A compact safety belt retractor is provided with a large coil of webbing on a rotatable reel and locking pawl teeth are able to have locking engagement with toothed wheels on the reel even when the coil of webbing has a larger diameter than the diameter of a circle defined by the teeth of the ratchet wheels. The coil of webbing preferably extends the full depth of retractor from front edges of the sidewalls of the frame to the rear frame wall of the retractor. Thus, a large coil of webbing may be stored for the depth of the retractor. To reduce the side-to-side width of retractor, it is preferred to have reel ratchet wheels mounted in the plane of the frame sidewalls and to have the pawl teeth also mounted in openings in the sidewalls of the retractor frame. The pawl teeth are elongated columns and are loaded in columnar manner with substantially small shear or bending tresses thereon. At very high loading on the belt, as at the time of accident, the reel may deflect to shift the toothed wheels to directly engage the bearing surfaces on the sidewalls of the frame when the reel is locked. Both the locking pawls and the toothed wheels are substantially coplanar with the sidewalls of the frame and are disposed within openings in the sidewalls.",OCCUPANT SAFETY SYSTEMS INC,ZYGUTIS JAMES L;;DOTY GERALD A,,https://lens.org/105-047-469-587-319,Patent Application,no,0,0,2,2,0,B60R22/40;;B60R22/40,B60R22/40,D124200434   M,0,0,,,,DISCONTINUED
81,EP,A1,EP 0443764 A1,162-911-065-021-235,1991-08-28,1991,EP 91301131 A,1991-02-12,US 48449990 A,1990-02-22,Safety belt retractors.,"The disclosure relates to a safety belt retractor which has a belt gripping or braking mechanism (18) that is movable between a belt gripping position and an inactive position. The braking mechanism includes a brake shoe (50) which engages one side of the seat belt webbing (17) and forces the opposite side of the webbing into tight frictional engagement with a compressible elastomeric pad (120) having a hight coefficient of friction. The filaments of the seat belt are compressed into the compressible pad and the pad protrudes into interstices between the filaments. This gripping action by the pad increases the pull load by a substantial amount, for example, about ten percent (10%).",OCCUPANT SAFETY SYSTEMS INC,ZYGUTIS JAMES L;;DOTY GERALD ARTHUR,,https://lens.org/162-911-065-021-235,Patent Application,yes,7,5,8,8,0,B60R22/42;;B60R22/00;;B60R22/42,B60R22/42,,0,0,,,,EXPIRED
82,US,A,US 4754105 A,036-368-210-011-392,1988-06-28,1988,US 4590287 A,1987-05-01,US 4590287 A,1987-05-01,Seat belt buckle with switch,Disclosed is a safety belt buckle including a switch which is preferably located between the buckle frame and a bottom cover of the buckle. An ejector for the tongue plate slides on a bottom web of the buckle frame and the ejector is displaced by entry of a tongue plate into the buckle frame. The ejector includes a portion projecting through an opening in the buckle base to a switch mounted in a cavity in the bottom cover and this portion engages a movable switch contact to open and close the switch.,GATEWAY INDUSTRIES,DOTY GERALD A;;ZYGUTIS JAMES L,OCCUPANT SAFETY SYSTEMS INC. A DE. CORP (1989-05-31);;GATEWAY INDUSTRIES INC. 19900 GOVERNORS HIGHWAY OLYMPIA FIELDS IL 60461 A CORP OF DE (1987-06-26),https://lens.org/036-368-210-011-392,Granted Patent,yes,10,26,1,1,0,A44B11/2523;;A44B11/2523,A44B11/25,200 6158 B,0,0,,,,EXPIRED
83,US,A,US 3962497 A,088-407-371-463-141,1976-06-08,1976,US 55742375 A,1975-03-11,US 55742375 A,1975-03-11,Method for treating polymeric substrates prior to plating,"The present invention is directed to a process and composition effective prior to the electroless plating of polymeric substrates to substantially completely remove hexavalent chromium ions present in the aqueous acidic solution utilized to etch the plastic part. This novel result is accomplished by treating the polymeric substrate with a hydroxylamine salt in an acidic solution which may contain hydrochloric acid, sulfuric acid or partially neutralized acidic salts. The process and composition of this invention may be employed as a neutralizer prior to the activating step or subsequent thereto as an accelerator, or at both locations in the process for maximum effectiveness.",OXY METAL INDUSTRIES CORP,DOTY WARREN RUSSELL;;KINNEY TIMOTHY JAMES,OMI INTERNATIONAL CORPORATION (1983-09-15);;HOOKER CHEMICALS & PLASTICS CORP (1980-12-22);;OCCIDENTAL CHEMICAL CORPORATION (1982-03-30),https://lens.org/088-407-371-463-141,Granted Patent,yes,5,28,13,13,0,C23C18/28;;H05K3/181;;H05K3/381;;C23C18/28;;H05K3/181;;H05K3/381,C23C18/24;;C23C18/28;;C23C18/22;;H05K3/18;;H05K3/38,427/306,0,0,,,,EXPIRED
84,US,B1,US 9453921 B1,166-465-910-554-599,2016-09-27,2016,US 201414272633 A,2014-05-08,US 201414272633 A,2014-05-08,"Delayed-based geographic position data generation system, device, and method","Present novel and non-trivial system, device, and method for generating geographic position are disclosed. A processor receives navigation data representative of geographic position from an external source such as a global positioning system (“GPS”); receives navigation data representative of measurements of angular and linear motions from an internal source of navigation data such as an inertial measurement unit (“IMU”); and determines and generates navigation data representative of geographic position responsive to such determination. The generation of navigation data could be based upon internal source navigation data and an estimate of error of geographic position, where the estimate of error is based upon a delay of the external-sourced navigation data and a delayed output from one of the internal sources (e.g., delayed output of an IMU).",BELL DOUGLAS A;;DOTY JAMES H;;ROCKWELL COLLINS INC,BELL DOUGLAS A;;DOTY JAMES H,ROCKWELL COLLINS INC (2014-04-29),https://lens.org/166-465-910-554-599,Granted Patent,yes,3,9,1,1,0,G01S19/15;;G01S19/49;;G01S19/49;;G01S19/15,G01S19/49;;G01S19/38,,0,0,,,,ACTIVE
85,US,A,US 4271039 A,187-411-139-497-241,1981-06-02,1981,US 11575580 A,1980-01-28,US 11575580 A;;US 2485879 A,1979-03-28,Catalyst and dehydrogenation process,"A catalyst containing alkali metal, chromium, iron, lead, phosphorus and oxygen, and a process for the preparation of unsaturated lower aliphatic acids and esters of such acids by catalytic oxidative dehydrogenation of the corresponding saturated acids and esters using the catalyst.",DU PONT,STATZ ROBERT J;;DOTY JAMES K,BANKBOSTON N.A. AS AGENT (1998-06-15),https://lens.org/187-411-139-497-241,Granted Patent,yes,7,0,1,2,0,B01J27/188;;C07C51/377;;B01J27/188;;C07C51/377,B01J27/188;;C07C51/377,252/435,0,0,,,,EXPIRED
86,EP,A1,EP 0688436 A1,193-258-696-204-519,1995-12-27,1995,EP 94912220 A,1994-03-14,US 9402705 W;;US 3085393 A,1993-03-12,CRESCENT GRADIENT COILS,,DOTY SCIENT INC,DOTY F DAVID;;WILCHER JAMES K,,https://lens.org/193-258-696-204-519,Patent Application,yes,0,0,10,10,0,G01R33/385;;G01R33/3854;;G01R33/3856;;G01R33/3854;;G01R33/385;;G01R33/3856,G01R33/385,,0,0,,,,EXPIRED
87,US,A,US 5251842 A,127-581-723-548-816,1993-10-12,1993,US 68998591 A,1991-04-23,US 68998591 A,1991-04-23,Dual-spring retractor operable by a series of discs,"A dual spring seat-belt retractor system with a tension-ease system operable to provide one of two springs continuously maintaining a retractive force on the belt to maintain the belt against the wearer in the tension-ease mode, which tension-ease system is automatically initiated at the cessation of belt protraction with a slight retraction to engage latch means that renders one of the springs ineffective to provide a reduced belt tension. A lost motion connection between the belt reel and the latch means permits limited belt movement by the user while maintaining the reduced tension until a predetermined retraction occurs.",TAKATA INC,ZYGUTIS JAMES L;;DOTY GERALD A,TAKATA INC. A DE CORPORATION (1991-04-18),https://lens.org/127-581-723-548-816,Granted Patent,yes,24,4,8,8,0,B60R22/44;;B60R22/44;;B60R2022/4426;;B60R2022/4426,B60R22/44,242/107,0,0,,,,EXPIRED
88,CN,A,CN 1860003 A,058-249-268-322-982,2006-11-08,2006,CN 200480023881 A,2004-08-17,US 2004/0024383 W;;US 49601103 P,2003-08-19,Impact-modified polyamide hollow body,Hollow bodies made from impact-modified polyamide. Fuel line hoses for both liquid fuel delivery and fuel vapor recovery.,SOLVAY ADVANCED POLYMERS LLC,BI BERSTED BRUCE H DOTY JAMES,,https://lens.org/058-249-268-322-982,Patent Application,no,0,5,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,B28B1/00;;B28B3/00;;B28B5/00;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90;;B29D22/00;;B29D23/00;;B32B27/34;;C04B33/32;;C04B33/36;;C04B35/64,,0,0,,,,ACTIVE
89,US,B1,US 8321074 B1,033-058-681-887-160,2012-11-27,2012,US 201213566350 A,2012-08-03,US 201213566350 A,2012-08-03,"Altitude data generation system, device, and method","Present novel and non-trivial system, device, and method for generating altitude data and/or height data are disclosed. A processor receives navigation data from an external source such as a global positioning system (“GPS”); receives navigation data from multiple internal sources; receives object data representative of terrain or surface feature elevation; determines an instant measurement of aircraft altitude as a function of these inputs; and generates aircraft altitude data responsive to such determination. In an additional embodiment, the processor receives reference point data representative of the elevation of the stationary reference point (e.g., a landing threshold point); determines an instant measurement of aircraft height as a function of this input and the instant measurement of aircraft altitude; and generates aircraft height data responsive to such determination.",BELL DOUGLAS A;;DOTY JAMES H,BELL DOUGLAS A;;DOTY JAMES H,ROCKWELL COLLINS INC (2012-08-03),https://lens.org/033-058-681-887-160,Granted Patent,yes,4,8,1,2,0,G01C5/005;;G01C5/005;;G01C23/00;;G01C23/00,G05D1/00,701/4;;701/1;;701/3;;701/408;;701/416;;342/38;;342/120;;342/149;;342/355;;342/358;;244/75.1;;244/180;;244/191;;X244 76 R;;244/195,2,0,,,"U.S. Appl. No. 12/892,546, filed Sep. 28, 2010, Bell et al.;;U.S. Appl. No. 13/193,788, filed Jul. 29, 2011, McCusker.",ACTIVE
90,DE,T2,DE 69101985 T2,052-121-126-067-305,1994-09-01,1994,DE 69101985 T,1991-02-12,US 48449990 A,1990-02-22,Sicherheitsgurtaufroller.,,OCCUPANT SAFETY SYSTEMS INC,ZYGUTIS JAMES L;;DOTY GERALD ARTHUR,,https://lens.org/052-121-126-067-305,Granted Patent,no,0,1,8,8,0,B60R22/42;;B60R22/00;;B60R22/42,B60R22/42,,0,0,,,,EXPIRED
91,CA,A,CA 641450 A,070-419-395-682-781,1962-05-22,1962,CA 641450D A,,CA 641450T A,,OPERATING ROOM OVERHEAD GAS SERVICE FIXTURE,,DOTY GEORGE I;;NELSON JAMES F,DOTY GEORGE I;;NELSON JAMES F,,https://lens.org/070-419-395-682-781,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
92,GB,A,GB 2424959 A,182-902-828-447-180,2006-10-11,2006,GB 0605404 A,2006-03-16,US 9886205 A,2005-04-04,Compact radar range emulating far field radar by using weighting factors to provide constant magnitude flat field across target zone,"Systems and methods enable numerically creating a flat field in a compact radar range (10) with a curved reflector (20), and without use of a separate phased array of elements, at frequencies lower than those that are possible with currently known, reflector-only compact radar ranges. A compact radar range (10) is calibrated to enable weighting factors to be computed. The weighting factors may be computed by performing an optimization algorithm. The weighting factors are used to weight separate target signals sequentially returned from a target zone (12) such that, when combined, a numerically composite measurement has a substantially constant magnitude across the target zone (12). The compact radar range emulates far field radar conditions. (Radar ranges also referred to as radar cross section (RCS) test facilities).",BOEING CO,MORGAN DOUGLAS P;;DOTY JAMES D,,https://lens.org/182-902-828-447-180,Patent Application,no,4,0,5,5,0,G01R29/105;;G01R29/08;;G01R29/0892;;G01R29/105;;G01R29/105,G01R29/08,G1U UR2908        29/08,0,0,,,,INACTIVE
93,CA,A,CA 663971 A,159-836-683-197-929,1963-05-28,1963,CA 663971D A,,CA 663971T A,,PREFABRICATED MULTI-STATION PLUMBING FIXTURE,,LOGAN MFG COMPANY,NELSON JAMES F;;DOTY GEORGE I;;HUNT JAMES,,https://lens.org/159-836-683-197-929,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
94,DE,A1,DE 2437953 A1,011-493-290-115-25X,1975-04-10,1975,DE 2437953 A,1974-08-07,US 39967473 A,1973-09-21,VERFAHREN UND ZUSAMMENSETZUNG ZUR BEHANDLUNG VON KUNSTSTOFFSUBSTRATEN VOR DER PLATTIERUNG,,OXY METAL INDUSTRIES CORP,DOTY WARREN RUSSELL;;KINNEY TIMOTHY JAMES,,https://lens.org/011-493-290-115-25X,Patent Application,no,0,0,13,14,0,C23C18/30;;C23C18/208;;C23C18/24;;C23C18/285,C23C18/28;;C23C18/20,,0,0,,,,DISCONTINUED
95,CA,C,CA 2158061 C,013-180-363-373-002,2004-10-19,2004,CA 2158061 A,1994-03-14,US 3085393 A;;US 9402705 W,1993-03-12,CRESCENT GRADIENT COILS,"A high-conductivity ceramic coil form with an internal water jacket is used to simplify water cooling for 3-axis MRI gradient coil configurations on a single cylindrical coilform. Crescent-shaped, axially aligned coils are symmetrically employed on either side of the axial symmetry plane to increase transversely the region of field linearity. These crescent coils may be used in conjunction with Golay-type coils for improved switching efficiency. Lead-filled copper tubing may be us ed to reduce acoustic noise from pulsed coils in high external magnetic fields.",DOTY SCIENT INC,DOTY F DAVID;;WILCHER JAMES K,,https://lens.org/013-180-363-373-002,Granted Patent,no,0,0,10,10,0,G01R33/385;;G01R33/3854;;G01R33/3856;;G01R33/3854;;G01R33/385;;G01R33/3856,G01R33/385,,0,0,,,,EXPIRED
96,US,A,US 4232174 A,041-199-660-172-915,1980-11-04,1980,US 2485879 A,1979-03-28,US 2485879 A,1979-03-28,Catalyst and dehydrogenation process,"A catalyst containing alkali metal, chromium, iron, lead, phosphorus and oxygen, and a process for the preparation of unsaturated lower aliphatic acids and esters of such acids by catalytic oxidative dehydrogenation of the corresponding saturated acids and esters using the catalyst.",DU PONT,STATZ ROBERT J;;DOTY JAMES K,,https://lens.org/041-199-660-172-915,Granted Patent,yes,4,8,1,2,0,C07C51/377;;C07C51/377,C07C51/377,562/599,0,0,,,,EXPIRED
97,AU,A,AU 1974/069052 A,122-362-113-532-241,1975-11-20,1975,AU 1974/069052 A,1974-05-16,US 39967473 A,1973-09-21,TREATING PLASTIC SUBSTRATES,,OXY METAL INDUSTRIES CORP,DOTY WARREN RUSSELL;;KINNEY TIMOTHY JAMES,,https://lens.org/122-362-113-532-241,Patent Application,no,0,0,13,14,0,C23C18/30;;C23C18/208;;C23C18/24;;C23C18/285,C23C18/28;;C23C18/20,,0,0,,,,DISCONTINUED
98,US,A,US 4830495 A,187-798-067-025-921,1989-05-16,1989,US 4492187 A,1987-05-01,US 4492187 A,1987-05-01,Balanced dual servo VCO passive ring laser gyroscope,"A passive ring resonator gyroscope comprising a single piece body having an integral first and second resonator cavity. The first resonator cavity contains a single frequency laser means to provide a sharply tuned single frequency light source to the second resonator cavity. The single frequency light source is sharply tuned and is split to form first and second sources. The second resonator cavity is a passive high Q cavity having a closed second optical path. The two light sources are fed to the second resonator and propagate as CW and CCW beams within the second resonator. A first servo channel tunes the frequency of the CW beam to a resonance peak. A second servo channel tunes the CCW beam to its resonance peak. By converting both servo error outputs into frequency, the relative frequency difference between the CW and CCW beams are recorded as the frequency shift in response to the body rate rotation about the sensitive axis. The first and second control signals are algebraicly added to provide a passive cavity path length difference servo signal which is integrated. A SECOND ADDER adds the integrated passive cavity difference signal to the reference signal (Fm) to provide the passive cavity path length servo signal to a passive cavity path length adjusting means for constantly adjusting the passive cavity path length servo signal to keep the passive cavity at peak resonance at a frequency substantially mid-range between the propagating (FCW) and the counterpropagating beams (FCCW).",ROCKWELL INTERNATIONAL CORP,SOOHOO KIE L;;DOTY JAMES H,ROCKWELL INTERNATIONAL CORPORATION (1987-04-29),https://lens.org/187-798-067-025-921,Granted Patent,yes,4,6,1,1,0,G01C19/727;;G01C19/727,G01C19/72,356/350,1,1,124-145-355-393-821,10.1063/1.89455,"S. Ezekiel and S. R. Balsamo, Passive Ring Resonator Laser Gyroscope , Applied Physics Letters, vol. 30, No. 9, May 1, 1977, pp. 478 480.",EXPIRED
99,CA,A,CA 653168 A,072-900-512-895-342,1962-11-27,1962,CA 653168D A,,CA 653168T A,,MULTI-STATION SURFACE MOUNTED PLUMBING FIXTURE,,LOGAN MFG COMPANY,NELSON JAMES F;;HUNT JAMES;;DOTY GEORGE I,,https://lens.org/072-900-512-895-342,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
100,US,A,US 2992438 A,068-967-093-673-56X,1961-07-18,1961,US 77694158 A,1958-11-28,US 77694158 A,1958-11-28,Multi-station surface mounted plumbing fixture,,LOGAN MFG COMPANY,FOSTER NELSON JAMES;;JAMES HUNT;;DOTY GEORGE I,,https://lens.org/068-967-093-673-56X,Granted Patent,no,6,9,1,1,0,E03C1/01;;Y10T137/698;;Y10T137/698;;E03C1/01,E03C1/01,,0,0,,,,EXPIRED
101,US,A,US 2992437 A,199-341-931-209-316,1961-07-18,1961,US 77684158 A,1958-11-28,US 77684158 A,1958-11-28,Prefabricated multi-station plumbing fixture,,LOGAN MFG COMPANY,FOSTER NELSON JAMES;;JAMES HUNT;;DOTY GEORGE I,,https://lens.org/199-341-931-209-316,Granted Patent,no,7,77,1,1,0,E03C1/01;;E03C1/01;;F16L3/22;;F16L3/22;;Y10T137/698;;Y10T137/698,E03C1/01;;F16L3/22,,0,0,,,,EXPIRED
102,CA,C,CA 1295698 C,017-815-609-726-35X,1992-02-11,1992,CA 550742 A,1987-10-30,US 92486886 A,1986-10-30,START-STOP OSCILLATOR HAVING FIXED STARTING PHASE AND MINIMIZED QUIESCENT POWER DISSIPATION,"An amplifier having a resonator coupled between input and output terminals thereof supplies a dot clock signal to a character generator in a television receiver. A feedback control circuit supplies DC bias to the resonator during blanking intervals that preceed lines of characters to be displayed to ensure a consistent starting phase for oscillations, removes the DC bias and supplies operating power to the amplifier during a portion of the active video period of each displayed line for sustaining the oscillations and automatically inhibits the supply of amplifier power at the end of each active line of characters to thereby provide three oscillator operating modes of PRIMED, RUNNING and OFF so as to minimize overall power consumption for the oscillator for each field of displayed characters.",RCA CORP,DOTY JAMES H II;;GIBSON WALTER G,,https://lens.org/017-815-609-726-35X,Granted Patent,no,0,0,11,11,0,H03K3/80;;H03K3/80;;H04N5/44;;H03L7/24;;H03L7/24,H03B5/06;;H03B5/12;;H03K3/80;;H03L7/24,D23310058    M,0,0,,,,EXPIRED
103,CA,A,CA 1259129 A,024-503-536-590-703,1989-09-05,1989,CA 570825 A,1988-06-30,US 6808487 A,1987-06-30,TELEVISION FAULT PROTECTION APPARATUS,A phase-lock-loop circuit of a deflection apparatus generates a first signal at the horizontal frequency during normal operation. The first signal is coupled to a phase-control-loop circuit that maintains the timing of the deflection current in phase with the first signal. A fault protection circuit disables the generation of signal transitions in the first signal when a fault condition occurs. A circuit that detects the presence of transition edges in the first signal prevents the operation of the deflection output stage when the transition edges in the first signal are missing.,RCA LICENSING CORP,DOTY JAMES H II;;LENDARO JEFFERY B,,https://lens.org/024-503-536-590-703,Granted Patent,no,0,0,15,15,0,H04N3/19;;H04N3/20;;H04N3/20,H04N3/18;;H04N3/20,350-109,0,0,,,,EXPIRED
104,KR,B1,KR 970005221 B1,115-196-334-020-974,1997-04-14,1997,KR 880007868 A,1988-06-29,US 6808487 A,1987-06-30,TELEVISION FAULT PROTECTION APPARATUS,,RCA LICENSING CORP,DOTY N JAMES H;;LENDARO JEFFERY B,,https://lens.org/115-196-334-020-974,Granted Patent,no,0,0,15,15,0,H04N3/19;;H04N3/20;;H04N3/20,H04N3/18;;H04N3/20,,0,0,,,,EXPIRED
105,FI,A0,FI 883054 A0,038-120-645-664-054,1988-06-23,1988,FI 883054 A,1988-06-23,US 6808487 A,1987-06-30,Television viansuojalaite,,RCA LICENSING CORP,DOTY II JAMES HARRISON;;LENDARO JEFFERY BASIL,,https://lens.org/038-120-645-664-054,Patent Application,no,0,0,15,15,0,H04N3/19;;H04N3/20;;H04N3/20,H04N3/18;;H04N3/20,,0,0,,,,EXPIRED
106,WO,A3,WO 2004/015258 A3,031-310-253-504-185,2009-04-02,2009,EP 0308184 W,2003-07-24,DE 10235997 A,2002-08-06,CONTROL ELEMENT FOR VOLUMES OF MEDIA AND INTAKE DEVICE FOR INTERNAL COMBUSTION ENGINES,"The invention discloses a control element for volumes of media. The invention relates in particular to a control element for volumes of media for an intake device, especially an air intake installation of an internal combustion engine. Said control element for volumes of media comprises a housing (1, 2; 18) and a blocking element (15) that is rotatably mounted in the housing (1, 2; 18) and that has a continuous opening and a passage, by means of which the blocking element (15) can be mechanically rotated. The control element for volumes of media is optimised in the closed position either in terms of weight, flow efficiency, cubic capacity and/or impermeability.",ALTMANN OTTO;;DOTY JAMES K;;HANDER INGO,ALTMANN OTTO;;DOTY JAMES K;;HANDER INGO,,https://lens.org/031-310-253-504-185,Search Report,yes,4,0,5,5,0,F02M35/1255;;F02B27/0257;;F02B29/083;;F02B31/06;;F02D9/16;;F02M26/04;;F02M26/42;;F02M35/04;;F02M35/1222;;F02M35/14;;F16K5/0605;;F16K27/067;;Y02T10/12,F02B27/02;;F02B29/08;;F02B31/06;;F02D9/16;;F02M25/07;;F02M35/04;;F02M35/14;;F16K5/06;;F16K27/06,,0,0,,,,PENDING
107,DE,D1,DE 3877069 D1,117-804-553-785-925,1993-02-11,1993,DE 3877069 T,1988-06-29,US 6808487 A,1987-06-30,FERNSEH-FEHLERSCHUTZSCHALTUNG.,,RCA THOMSON LICENSING CORP,DOTY II JAMES HARRISON;;LENDARO JEFFERY BASIL,,https://lens.org/117-804-553-785-925,Granted Patent,no,0,0,15,15,0,H04N3/19;;H04N3/20;;H04N3/20,H04N3/18;;H04N3/20,,0,0,,,,EXPIRED
108,US,A,US 4797771 A,026-545-979-174-125,1989-01-10,1989,US 6808487 A,1987-06-30,US 6808487 A,1987-06-30,Television fault detection and protection apparatus,A phase-lock-loop circuit of a deflection apparatus generates a first signal at the horizontal frequency during normal operation. The first signal is coupled to a phase-control-loop circuit that maintains the deflection current timing in phase with the first signal. A fault protection circuit disables the generation of signal transitions in the first signal when a fault condition occurs. A circuit that detects the presence of transition edges in the first signal prevents the operation of the deflection output stage when the transition edges in the first signal are missing.,RCA LICENSING CORP,DOTY II JAMES H;;LENDARO JEFFERY B,RCA CORPORATION (1987-06-29);;RCA LICENSING CORPORATION TWO INDEPENDENCE WAY PRINCETON NJ 08540 A CORP. OF DE (1987-12-08),https://lens.org/026-545-979-174-125,Granted Patent,yes,13,1,15,15,0,H04N3/19;;H04N3/20;;H04N3/20,H04N3/18;;H04N3/20,361/88;;358/243;;361/91;;328/9,2,0,,,"A Technical Data Publication for a Bipolar Linear Integrated Circuit (IC) Silicon Monolithic TA7777p that is made by Toshiba Corp. Japan.;;U.S. Patent Application Ser. No. 068,085, entitled Deflection Synchronizing Apparatus, in the name of Jeffery Lendaro that was filed concurrently with the above captioned patent application.",EXPIRED
109,HK,A1,HK 1000179 A1,072-381-489-601-737,1998-01-16,1998,HK 97101694 A,1997-08-30,US 6808487 A,1987-06-30,A television fault protection apparatus,,RCA THOMSON LICENSING CORP,HARRISON DOTY II JAMES;;BASIL LENDARO JEFFERY,,https://lens.org/072-381-489-601-737,Unknown,no,0,0,15,15,0,H04N3/19;;H04N3/20;;H04N3/20,H04N3/18;;H04N3/20,,0,0,,,,EXPIRED
110,EP,A3,EP 0266185 A3,084-184-306-165-438,1989-09-20,1989,EP 87309517 A,1987-10-28,US 92486886 A,1986-10-30,START-STOP OSCILLATOR HAVING FIXED STARTING PHASE AND MINIMIZED QUIESCENT POWER DISSIPATION,"An amplifier (30) having a resonator (36) coupled between input (32) and output (34) terminals thereof supplies a dot clock signal (S1) to a character generator (12) in a television receiver. A feedback control circuit (40,50,60,70) supplies DC bias to the resonator during blanking intervals that preceed lines of characters to be displayed to ensure a consistent starting phase for oscillations, removes the DC bias and supplies operating power to the amplifier during a portion of the active video period of each displayed line for sustaining the oscillations and automatically inhibits the supply of amplifier power at the end of each active line of characters to thereby provide three oscillator operating modes of PRIMED, RUNNING and OFF so as to minimize overall power consumption for the oscillator for each field of displayed characters.  ",RCA LICENSING CORPORATION,"DOTY, JAMES HARRISON, II;;GIBSON, WALTER GOLD",RCA LICENSING CORPORATION (1988-06-08);;RCA THOMSON LICENSING CORPORATION (1992-05-27),https://lens.org/084-184-306-165-438,Search Report,yes,4,0,11,11,0,H03K3/80;;H03K3/80;;H04N5/44;;H03L7/24;;H03L7/24,H03B5/06;;H03B5/12;;H03K3/80;;H03L7/24,,0,0,,,,EXPIRED
111,WO,A1,WO 2007/082924 A1,123-826-159-945-796,2007-07-26,2007,EP 2007050523 W,2007-01-19,EP 06100705 A;;US 76093906 P,2006-01-23,LAMINATES WITH FLUOROPOLYMERIC AND BONDING LAYERS,"The invention relates to a multilayer polymer structure e.g shaped article such as tubes [structure (S)] comprising a layer (alpha) comprising at least one aromatic polyamide [polymer (AA)], said layer (alpha) being linked to a layer (γ) comprising at least one melt-processible fluoropolymer substantially free from recurring units derived from functional monomers [polymer (F)] via a layer (β), said layer (β) comprising a polymer composition (C-1), said polymer composition (C-1) comprising from 100 % to 3 % by weight of at least one functional fluoropolymer [polymer (I) ] , with respect to the total weight of the composition, and from 0 to 97 % by weight of at least one melt-processible fluoropolymer substantially free from recurring units derived from functional monomers [polymer (F)], with respect to the total weight of the composition, wherein said polymer (I) is a functional per (halo) fluoropolymer comprising recurring units derived from at least one fluorinated functional monomer. The multilayer structures of the invention enables obtaining structures with excellent adhesion between fluoropolymers and polyamides, whose components can withstand high processing temperature, such as those required for instance for aromatic polyamide processing and extremely harsh environment.",SOLVAY;;BUSHELMAN CORINNE;;BRINATI GIULIO;;DOTY JAMES K,BUSHELMAN CORINNE;;BRINATI GIULIO;;DOTY JAMES K,,https://lens.org/123-826-159-945-796,Patent Application,yes,6,4,1,2,0,B32B27/08;;B32B1/08;;B32B7/10;;B32B27/304;;B32B27/34;;B32B2250/24;;B32B2270/00;;B32B2597/00;;C08L51/06;;C08L77/00;;F16L11/04;;F16L2011/047,F16L11/04;;B32B1/08;;B32B27/34;;C08L27/12;;C08L29/10;;C08L41/00;;C08L77/00,,0,0,,,,PENDING
112,AU,A1,AU 2003/251481 A1,092-928-057-843-427,2004-02-25,2004,AU 2003/251481 A,2003-07-24,DE 10235997 A;;EP 0308184 W,2002-08-06,CONTROL ELEMENT FOR VOLUMES OF MEDIA AND INTAKE DEVICE FOR INTERNAL COMBUSTION ENGINES,,SOLVAY ADVANCED POLYMERS LLC;;ALTMANN OTTO,ALTMANN OTTO;;DOTY JAMES K;;HANDER INGO,,https://lens.org/092-928-057-843-427,Patent Application,no,0,0,5,5,0,F02M35/1255;;F02B27/0257;;F02B29/083;;F02B31/06;;F02D9/16;;F02M26/04;;F02M26/42;;F02M35/04;;F02M35/1222;;F02M35/14;;F16K5/0605;;F16K27/067;;Y02T10/12,F02B27/02;;F02B29/08;;F02B31/06;;F02D9/16;;F02M25/07;;F02M35/04;;F02M35/14;;F16K5/06;;F16K27/06,,0,0,,,,PENDING
113,DE,A1,DE 10235997 A1,106-376-600-318-143,2004-02-19,2004,DE 10235997 A,2002-08-06,DE 10235997 A,2002-08-06,"Control valve for air induction pipes in IC engines has spherical shape and central bore containing cylindrical tube, ribs on its outer surface having same wall thickness as tube",The control valve (5) has a spherical shape and a central bore (6) containing a cylindrical tube (10). It has ribs (7) on its outer surface which have the same wall thickness as the tube. An Independent claim is included for an air induction system for an IC engine which is fitted with the valve.,ALTMANN OTTO;;SOLVAY ADVANCED POLYMERS ALPHE,ALTMANN OTTO;;DOTY JAMES K;;HANDER INGO,"ALTMANN, OTTO, 83022 ROSENHEIM, DE (2005-01-20)",https://lens.org/106-376-600-318-143,Patent Application,no,0,10,5,5,0,F02M35/1255;;F02B27/0257;;F02B29/083;;F02B31/06;;F02D9/16;;F02M26/04;;F02M26/42;;F02M35/04;;F02M35/1222;;F02M35/14;;F16K5/0605;;F16K27/067;;Y02T10/12,F02B27/02;;F02B29/08;;F02B31/06;;F02D9/16;;F02M25/07;;F02M35/04;;F02M35/14;;F16K5/06;;F16K27/06,,0,0,,,,DISCONTINUED
114,WO,A2,WO 2004/015258 A2,022-236-297-188-656,2004-02-19,2004,EP 0308184 W,2003-07-24,DE 10235997 A,2002-08-06,CONTROL ELEMENT FOR VOLUMES OF MEDIA AND INTAKE DEVICE FOR INTERNAL COMBUSTION ENGINES,"The invention discloses a control element for volumes of media. The invention relates in particular to a control element for volumes of media for an intake device, especially an air intake installation of an internal combustion engine. Said control element for volumes of media comprises a housing (1, 2; 18) and a blocking element (15) that is rotatably mounted in the housing (1, 2; 18) and that has a continuous opening and a passage, by means of which the blocking element (15) can be mechanically rotated. The control element for volumes of media is optimised in the closed position either in terms of weight, flow efficiency, cubic capacity and/or impermeability.",SOLVAY ADVANCED POLYMERS LLC;;ALTMANN OTTO;;DOTY JAMES K;;HANDER INGO,ALTMANN OTTO;;DOTY JAMES K;;HANDER INGO,,https://lens.org/022-236-297-188-656,Patent Application,yes,0,6,5,5,0,F02M35/1255;;F02B27/0257;;F02B29/083;;F02B31/06;;F02D9/16;;F02M26/04;;F02M26/42;;F02M35/04;;F02M35/1222;;F02M35/14;;F16K5/0605;;F16K27/067;;Y02T10/12,F02B27/02;;F02B29/08;;F02B31/06;;F02D9/16;;F02M25/07;;F02M35/04;;F02M35/14;;F16K5/06;;F16K27/06,,0,0,,,,PENDING
115,EP,B1,EP 0266185 B1,068-795-620-837-59X,1993-02-03,1993,EP 87309517 A,1987-10-28,US 92486886 A,1986-10-30,START-STOP OSCILLATOR HAVING FIXED STARTING PHASE AND MINIMIZED QUIESCENT POWER DISSIPATION,,RCA THOMSON LICENSING CORPORATION,"DOTY, JAMES HARRISON, II;;GIBSON, WALTER GOLD",RCA LICENSING CORPORATION (1988-06-08);;RCA THOMSON LICENSING CORPORATION (1992-05-27),https://lens.org/068-795-620-837-59X,Granted Patent,yes,4,0,11,11,0,H03K3/80;;H03K3/80;;H04N5/44;;H03L7/24;;H03L7/24,H03B5/06;;H03B5/12;;H03K3/80;;H03L7/24,,0,0,,,,EXPIRED
116,FI,B,FI 95424 B,038-316-826-352-433,1995-10-13,1995,FI 883054 A,1988-06-23,US 6808487 A,1987-06-30,Television viansuojalaite,,RCA LICENSING CORP,DOTY II JAMES HARRISON;;LENDARO JEFFERY BASIL,,https://lens.org/038-316-826-352-433,Patent Application,no,0,0,15,15,0,H04N3/19;;H04N3/20;;H04N3/20,H04N3/18;;H04N3/20,,0,0,,,,EXPIRED
117,US,S,US D0318330 S,066-890-829-139-234,1991-07-16,1991,US 10857987 F,1987-10-15,US 10857987 F,1987-10-15,Unipolar spiral coil electrode for monitoring the electrical activity of,,DOTY JAMES R;;FURLOW JR THOMAS W,DOTY JAMES R;;FURLOW JR THOMAS W,,https://lens.org/066-890-829-139-234,Design Right,yes,15,27,1,1,0,,,D24/187,0,0,,,,EXPIRED
118,EP,A1,EP 1811219 A1,086-922-253-722-871,2007-07-25,2007,EP 06100705 A,2006-01-23,EP 06100705 A,2006-01-23,Laminates with fluoropolymeric and bonding layers,"The invention relates to a multilayer polymer structure [structure (S)] comprising a layer (α) comprising at least one polyamide [polymer (A)], said layer (α) being linked to a layer (γ) comprising at least one melt-processible fluoropolymer substantially free from recurring units derived from functional monomers [polymer (F)] via a layer (β), said layer (β) comprising a polymer composition (C-1), said polymer composition (C-1) comprising from 100% to 3% by weight of at least one functional fluoropolymer [polymer (I)], with respect to the total weight of the composition, and from 0 to 97 % by weight of at least one melt-processible fluoropolymer substantially free from recurring units derived from functional monomers [polymer (F)], with respect to the total weigh of the composition. 
The multilayer structures of the invention enables obtaining structures with excellent adhesion between fluoropolymers and polyamides, whose components can withstand high processing temperature, such as those required for instance for aromatic polyamide processing and extremely harsh environment.",SOLVAY,BUSHELMAN CORINE;;DOTY JAMES K;;BRINATI GIULIO,,https://lens.org/086-922-253-722-871,Patent Application,yes,6,2,1,2,0,B32B27/34;;B32B1/08;;B32B27/08;;B32B27/285;;B32B27/322;;B32B2250/24;;C08L51/06;;C08L77/06,F16L11/04;;B32B1/08;;B32B27/34;;C08L27/12;;C08L29/10;;C08L41/00;;C08L77/00,,0,0,,,,DISCONTINUED
119,FI,C,FI 95424 C,033-546-049-336-333,1996-01-25,1996,FI 883054 A,1988-06-23,US 6808487 A,1987-06-30,Television viansuojalaite,,RCA LICENSING CORP,DOTY II JAMES HARRISON;;LENDARO JEFFERY BASIL,,https://lens.org/033-546-049-336-333,Granted Patent,no,0,0,15,15,0,H04N3/19;;H04N3/20;;H04N3/20,H04N3/18;;H04N3/20,,0,0,,,,EXPIRED
120,AU,A8,AU 2003/251481 A8,058-355-181-301-328,2009-04-30,2009,AU 2003/251481 A,2003-07-24,DE 10235997 A;;EP 0308184 W,2002-08-06,Control element for volumes of media and intake device for internal combustion engines,,ALTMANN OTTO,HANDER INGO;;ALTMANN OTTO;;DOTY JAMES K,,https://lens.org/058-355-181-301-328,Patent Application,no,0,0,5,5,0,F02M35/1255;;F02B27/0257;;F02B29/083;;F02B31/06;;F02D9/16;;F02M26/04;;F02M26/42;;F02M35/04;;F02M35/1222;;F02M35/14;;F16K5/0605;;F16K27/067;;Y02T10/12,F02B27/02;;F02B29/08;;F02B31/06;;F02D9/16;;F02M25/07;;F02M35/04;;F02M35/14;;F16K5/06;;F16K27/06,,0,0,,,,PENDING
121,US,A,US 4727339 A,147-156-972-118-161,1988-02-23,1988,US 92486886 A,1986-10-30,US 92486886 A,1986-10-30,Start-stop oscillator having fixed starting phase and minimized quiescent power dissipation,"An amplifier having a resonator coupled between input and output terminals thereof supplies a dot clock signal to a character generator in a television receiver. A feedback control circuit supplies DC bias to the resonator during blanking intervals that preceed lines of characters to be displayed to ensure a consistent starting phase for oscillations, removes the DC bias and supplies operating power to the amplifier during a portion of the active video period of each displayed line for sustaining the oscillations and automatically inhibits the supply of amplifier power at the end of each active line of characters to thereby provide three oscillator operating modes of PRIMED, RUNNING and OFF so as to minimize overall power consumption for the oscillator for each field of displayed characters.",RCA CORP,DOTY II JAMES H;;GIBSON WALTER G,RCA CORPORATION A CORP. OF DE (1986-12-09);;RCA LICENSING CORPORATION TWO INDEPENDENCE WAY PRINCETON NJ 08540 A CORP. OF DE (1987-12-08),https://lens.org/147-156-972-118-161,Granted Patent,yes,2,11,11,11,0,H03K3/80;;H03K3/80;;H04N5/44;;H03L7/24;;H03L7/24,H03B5/06;;H03B5/12;;H03K3/80;;H03L7/24,331/173;;X331117FE,0,0,,,,EXPIRED
122,EP,B1,EP 0297846 B1,109-892-573-269-605,1992-12-30,1992,EP 88305900 A,1988-06-29,US 6808487 A,1987-06-30,A TELEVISION FAULT PROTECTION APPARATUS,,RCA THOMSON LICENSING CORPORATION,"DOTY II, JAMES HARRISON;;LENDARO, JEFFERY BASIL",RCA THOMSON LICENSING CORPORATION (1992-06-24),https://lens.org/109-892-573-269-605,Granted Patent,yes,2,0,15,15,0,H04N3/19;;H04N3/20;;H04N3/20,H04N3/18;;H04N3/20,,0,0,,,,EXPIRED
123,EP,A2,EP 0266185 A2,116-025-034-579-848,1988-05-04,1988,EP 87309517 A,1987-10-28,US 92486886 A,1986-10-30,Start-stop oscillator having fixed starting phase and minimized quiescent power dissipation.,"An amplifier (30) having a resonator (36) coupled between input (32) and output (34) terminals thereof supplies a dot clock signal (S1) to a character generator (12) in a television receiver. A feedback control circuit (40,50,60,70) supplies DC bias to the resonator during blanking intervals that preceed lines of characters to be displayed to ensure a consistent starting phase for oscillations, removes the DC bias and supplies operating power to the amplifier during a portion of the active video period of each displayed line for sustaining the oscillations and automatically inhibits the supply of amplifier power at the end of each active line of characters to thereby provide three oscillator operating modes of PRIMED, RUNNING and OFF so as to minimize overall power consumption for the oscillator for each field of displayed characters.  ",RCA CORP,DOTY JAMES HARRISON II;;GIBSON WALTER GOLD,RCA LICENSING CORPORATION (1988-06-08);;RCA THOMSON LICENSING CORPORATION (1992-05-27),https://lens.org/116-025-034-579-848,Patent Application,yes,0,0,11,11,0,H03K3/80;;H03K3/80;;H04N5/44;;H03L7/24;;H03L7/24,H03B5/06;;H03B5/12;;H03K3/80;;H03L7/24,,0,0,,,,EXPIRED
124,EP,A1,EP 0297846 A1,141-768-462-283-756,1989-01-04,1989,EP 88305900 A,1988-06-29,US 6808487 A,1987-06-30,A television fault protection apparatus.,"A phase-lock-loop circuit (20) of a deflection apparatus generates a first signal (O H ) at the horizontal frequency (f H ) during normal operation. The first signal (O H ) is coupled to a phase-control-loop circuit (25) that maintains the timing of the deflection current (i y ) in phase with the first signal (O H ). A fault protection circuit (301) disables the generation of signal transitions in the first signal (O H ) when a fault condition occurs. The phase lock-loop circuit (20) generates a second signal (O 32H ) which is used in driving the deflection output stage (99). A circuit (303) that detects the presence of transition edges in the first signal (O H ) prevents the operation of the deflection output stage (99) when the transition edges in the first signal (O H ) are missing, even if the second signal (O 32H ) continues.  ",RCA LICENSING CORP,DOTY II JAMES HARRISON;;LENDARO JEFFERY BASIL,RCA THOMSON LICENSING CORPORATION (1992-06-24),https://lens.org/141-768-462-283-756,Patent Application,yes,2,2,15,15,0,H04N3/19;;H04N3/20;;H04N3/20,H04N3/18;;H04N3/20,,0,0,,,,EXPIRED
125,US,S,US D0317502 S,199-039-610-560-538,1991-06-11,1991,US 10857687 F,1987-10-15,US 10857687 F,1987-10-15,Unipolar spiral coil electrode for monitoring the electrical activity of,,DOTY JAMES R;;FURLOW JR THOMAS W,DOTY JAMES R;;FURLOW JR THOMAS W,,https://lens.org/199-039-610-560-538,Design Right,yes,15,3,1,1,0,,,D24/187,0,0,,,,EXPIRED
126,FI,A,FI 883054 A,144-449-446-040-026,1988-12-31,1988,FI 883054 A,1988-06-23,US 6808487 A,1987-06-30,Television viansuojalaite,,RCA LICENSING CORP,DOTY II JAMES HARRISON;;LENDARO JEFFERY BASIL,,https://lens.org/144-449-446-040-026,Patent Application,no,0,0,15,15,0,H04N3/19;;H04N3/20;;H04N3/20,H04N3/18;;H04N3/20,,0,0,,,,EXPIRED
127,DE,T2,DE 3877069 T2,154-231-744-791-128,1993-05-27,1993,DE 3877069 T,1988-06-29,US 6808487 A,1987-06-30,FERNSEH-FEHLERSCHUTZSCHALTUNG.,,RCA THOMSON LICENSING CORP,DOTY II JAMES HARRISON;;LENDARO JEFFERY BASIL,,https://lens.org/154-231-744-791-128,Granted Patent,no,0,0,15,15,0,H04N3/19;;H04N3/20;;H04N3/20,H04N3/18;;H04N3/20,,0,0,,,,EXPIRED
128,EP,A4,EP 0751738 A4,077-617-977-833-879,1998-11-11,1998,EP 95912793 A,1995-03-06,US 9502874 W;;US 20747594 A,1994-03-07,METHOD AND APPARATUS FOR PERFORMING HYSTEROSCOPIC AND FALLOPOSCOPIC PROCEDURES,,CONCEPTUS INC,NIKOLCHEV JULIAN N;;ARNEY MICHELLE M;;DOTY JAMES,,https://lens.org/077-617-977-833-879,Search Report,no,1,0,5,5,0,A61B1/303;;A61B1/00135;;A61B1/00149;;A61B1/0125;;A61B1/07,A61B1/00;;A61B1/303;;A61M25/02,,1,0,,,See also references of WO 9524149A1,DISCONTINUED
129,CH,A,CH 454850 A,198-562-602-623-017,1968-04-30,1968,CH 104464 A,1964-01-29,US 25569263 A;;US 44448265 A,1963-02-01,"Verfahren zur Herstellung von 1,2-Dichlorpropenpyridinium- resp. Chinoliniumsalzen",,M & T CHEMICALS INC,FRANK PASSAL;;ARTHUR JAMES TOMSON;;WARREN RUSSELL DOTY,,https://lens.org/198-562-602-623-017,Granted Patent,no,0,0,6,19,0,C25D3/18;;C25D3/18;;C07D213/20;;C07D213/20;;C07D215/10;;C07D215/10,C07D213/20;;C07D215/10;;C25D3/18,"48A,5/08",0,0,,,,EXPIRED
130,US,A1,US 2003/0232887 A1,078-184-973-514-729,2003-12-18,2003,US 12084802 A,2002-04-10,US 12084802 A,2002-04-10,Preparation and use of a stable formulation of allosteric effector compounds,"
   A pharmaceutical composition of 2-4-2-(3,5-dimethylphenyl)amino-2-oxoethylphenoxy-2-methyl-propionic acid or its physiologically acceptable salts suitable for parenteral administration includes an aqueous formulation of 2-4-2-(3,5-dimethylphenyl)amino-2-oxoethylphenoxy-2-methyl-propionic acid or its physiologically acceptable salt and a buffer to maintain the pH from about 6 to about 11. The composition in accordance with the invention reduces the amount of particulate matter that forms in solution after heat sterilization. The invention also includes a process for making a pharmaceutical composition of 2-4-2-(3,5-dimethylphenyl)amino-2-oxoethylphenoxy-2-methyl-propionic acid or its physiologically acceptable salt that has a shelf life in excess of thirty days and is useful in parenteral administration. 
",JOHNSON DOUGLAS GILES;;DOTY MARK;;KIPP JAMES E.,JOHNSON DOUGLAS GILES;;DOTY MARK;;KIPP JAMES E,ALLOS THERAPEUTICS INC (2002-07-15),https://lens.org/078-184-973-514-729,Patent Application,yes,21,49,9,9,0,A61K31/195;;A61K31/195;;A61K9/0019;;A61K9/0019;;A61K47/12;;A61K47/12;;A61K47/18;;A61K47/18;;A61K47/183;;A61K47/183;;A61K49/10;;A61K49/10;;A61P3/10;;A61P9/00;;A61P9/10;;A61P17/00;;A61P31/04;;A61P35/00;;A61P37/02;;A61P43/00,A61K47/04;;A61B5/055;;A61K31/192;;A61K31/195;;A61K45/00;;A61K47/12;;A61K47/18;;A61K47/26;;A61K47/36;;A61K47/42;;A61K49/10;;A61P3/10;;A61P9/00;;A61P9/10;;A61P17/00;;A61P31/04;;A61P35/00;;A61P37/02;;A61P43/00,514/567,0,0,,,,DISCONTINUED
131,EP,A2,EP 1496863 A2,133-465-402-677-309,2005-01-19,2005,EP 03723859 A,2003-04-02,US 0309818 W;;US 12084802 A,2002-04-10,PREPARATION AND USE OF A STABLE FORMULATION OF ALLOSTERIC EFFECTOR COMPOUNDS,,ALLOS THERAPEUTICS INC,JOHNSON DOUGLAS GILES;;DOTY MARK;;KIPP JAMES E,,https://lens.org/133-465-402-677-309,Patent Application,yes,0,0,9,9,0,A61K31/195;;A61K31/195;;A61K9/0019;;A61K9/0019;;A61K47/12;;A61K47/12;;A61K47/18;;A61K47/18;;A61K47/183;;A61K47/183;;A61K49/10;;A61K49/10;;A61P3/10;;A61P9/00;;A61P9/10;;A61P17/00;;A61P31/04;;A61P35/00;;A61P37/02;;A61P43/00,A61K47/04;;A61B5/055;;A61K31/192;;A61K31/195;;A61K45/00;;A61K47/12;;A61K47/18;;A61K47/26;;A61K47/36;;A61K47/42;;A61K49/10;;A61P3/10;;A61P9/00;;A61P9/10;;A61P17/00;;A61P31/04;;A61P35/00;;A61P37/02;;A61P43/00,,0,0,,,,DISCONTINUED
132,US,B1,US 9464901 B1,110-768-755-474-893,2016-10-11,2016,US 201514723518 A,2015-05-28,US 201514723518 A,2015-05-28,"RNP-scaled waypoint symbology generating system, device, and method","A system, device, and method for generating an RNP-scaled waypoint symbology presentable to a pilot are disclosed. The symbology generating system may include a source of source of navigation data, a symbology generator (SG), and a presentation system. The SG may be configured to acquire navigation data representative of one or more distance measurements of an area navigation system or a required navigation performance system; and generate presentation data as a function of each distance measurement. The presentation data could be representative of waypoint symbology presentable to a viewer. In some embodiments, the waypoint symbology may be comprised of a two-dimensional object or a three-dimensional object having a plurality of shapes centered on a reference line, where a size of a first shape may be scaled to a first distance measurement, and a size of a second shape may be scaled to a second distance measurement.",BELL DOUGLAS A;;BARBER SARAH;;DOTY JAMES H;;ROCKWELL COLLINS INC,BELL DOUGLAS A;;BARBER SARAH;;DOTY JAMES H,ROCKWELL COLLINS INC (2015-05-21),https://lens.org/110-768-755-474-893,Granted Patent,yes,19,5,1,1,0,G01C23/005;;G06T3/40;;G06T11/20;;G06T2200/04;;G06T2200/28;;G01C23/005,G01C21/00;;G06T3/40;;G06T11/20,,4,0,,,"U.S. Terminal and En Route Area Navigation (RNAV) Operations, pp. 1-17, AC No. 90-100A, Mar. 1, 2007, Department of Transportation, Federal Aviation Administration.;;Approval Guidance for RNP Procedures with AR, pp. 1-5, AC No. 90-101A, Feb. 23, 2011, Department of Transportation, Federal Aviation Administration.;;Minimum Aviation System Performance Standards: Required Navigation Performance for Area Navigation, DO-236B, Oct. 28, 2003, RTCA, Inc.;;Criteria for Approval of Category I and Category II Weather Minima for Approach, AC 120-29A, Aug. 12, 2002, Department of Transportation, Federal Aviation Administration.",ACTIVE
133,AU,A1,AU 2003/230766 A1,150-025-133-767-521,2003-10-27,2003,AU 2003/230766 A,2003-04-02,US 12084802 A;;US 0309818 W,2002-04-10,PREPARATION AND USE OF A STABLE FORMULATION OF ALLOSTERIC EFFECTOR COMPOUNDS,,ALLOS THERAPEUTICS INC,JOHNSON DOUGLAS GILES;;DOTY MARK;;KIPP JAMES E,,https://lens.org/150-025-133-767-521,Patent Application,no,0,0,9,9,0,A61K31/195;;A61K31/195;;A61K9/0019;;A61K9/0019;;A61K47/12;;A61K47/12;;A61K47/18;;A61K47/18;;A61K47/183;;A61K47/183;;A61K49/10;;A61K49/10;;A61P3/10;;A61P9/00;;A61P9/10;;A61P17/00;;A61P31/04;;A61P35/00;;A61P37/02;;A61P43/00,A61K47/04;;A61B5/055;;A61K31/192;;A61K31/195;;A61K45/00;;A61K47/12;;A61K47/18;;A61K47/26;;A61K47/36;;A61K47/42;;A61K49/10;;A61P3/10;;A61P9/00;;A61P9/10;;A61P17/00;;A61P31/04;;A61P35/00;;A61P37/02;;A61P43/00,,0,0,,,,DISCONTINUED
134,US,B1,US 11585951 B1,190-283-687-571-419,2023-02-21,2023,US 202016876435 A,2020-05-18,US 202016876435 A;;US 201715673273 A,2017-08-09,Heading or pitch determination systems and methods with high confidence error bounds,Systems and methods for use in navigating aircraft are provided. The systems can use Geometry Redundant Almost Fixed Solutions (GRAFS) or Geometry Extra Redundant Almost Fixed Solutions (GERAFS) to compute high confidence error bounds for a heading angle estimate or pitch angle derived using signals received on at least two antennas.,ROCKWELL COLLINS INC,GAVRILETS VLADISLAV;;PHAN HUAN T;;DOTY JAMES H,ROCKWELL COLLINS INC (2017-08-08),https://lens.org/190-283-687-571-419,Granted Patent,yes,8,2,2,2,0,G01C21/20;;G01C23/005;;G01S19/55;;G01S19/52;;G01S19/20;;G01S19/15;;B64D43/00;;G01S19/53;;G01S19/33;;G01C23/005;;B64D43/00;;G01S19/36,G01S19/53;;B64D43/00;;G01C23/00;;G01S19/33;;G01S19/36,,4,1,025-163-207-554-128,10.1109/plans.2008.4570100,"Final Office Action on U.S. Appl. No. 15/673,273 dated Oct. 21, 2019.;;Non-Final Office Action on U.S. Appl. No. 15/673,273 dated Apr. 8, 2019.;;Notice of Allowance on U.S. Appl. No. 15/673,273 dated Jan. 29, 2020.;;Wu et al.; “Geometry Extra-Redundant Almost Fixed Solutions: a High Integrity Approach for Carrier Phase Ambiguity Resolution for High Accuracy Relative Navigation”; 2008 IEEE; 1-4244-1537-3/08; 15 pages.",ACTIVE
135,EP,A4,EP 1496863 A4,047-804-002-158-194,2006-10-04,2006,EP 03723859 A,2003-04-02,US 0309818 W;;US 12084802 A,2002-04-10,PREPARATION AND USE OF A STABLE FORMULATION OF ALLOSTERIC EFFECTOR COMPOUNDS,,ALLOS THERAPEUTICS INC,JOHNSON DOUGLAS GILES;;DOTY MARK;;KIPP JAMES E,,https://lens.org/047-804-002-158-194,Search Report,no,2,0,9,9,0,A61K9/0019;;A61K31/195;;A61K47/12;;A61K47/18;;A61K47/183;;A61K49/10;;A61P17/00;;A61P31/04;;A61P35/00;;A61P37/02;;A61P43/00;;A61P9/00;;A61P9/10;;A61P3/10;;A61K31/195;;A61K47/18;;A61K9/0019;;A61K49/10;;A61K47/183;;A61K47/12,A61B5/055;;A61K31/192;;A61K31/195;;A61K45/00;;A61K47/12;;A61K47/18;;A61K47/26;;A61K47/04;;A61K47/36;;A61K47/42;;A61K49/10;;A61P3/10;;A61P9/00;;A61P9/10;;A61P17/00;;A61P31/04;;A61P35/00;;A61P37/02;;A61P43/00,,2,1,037-758-984-690-560,9728926,"PAPASSOTIRIOU I ET AL: ""SYNTHESIZED ALLOSTERIC EFFECTORS OF THE HEMOGLOBIN MOLECULE: A POSSIBLE MECHANISM FOR IMPROVED ERYTHROCYTE OXYGEN RELEASE CAPABILITY IN HEMOGLOBINOPATHY H DISEASE"", EXPERIMENTAL HEMATOLOGY, NEW YORK, NY, US, vol. 26, no. 10, September 1998 (1998-09-01), pages 922 - 926, XP000943784, ISSN: 0301-472X;;ROWINSKY E K: ""NOVEL RADIATION SENSITIZERS TARGETING TISSUE HYPOXIA"", ONCOLOGY, PRR, HUNTINGTON, NY, US, vol. 10, no. SUPPL 5, October 1999 (1999-10-01), pages 61 - 70, XP009044613, ISSN: 0890-9091",DISCONTINUED
136,DE,T2,DE 69127193 T2,071-581-803-772-607,1997-12-18,1997,DE 69127193 T,1991-05-30,GB 9012326 A;;US 9103813 W,1990-06-01,CHROMINANZVERARBEITUNGSSYSTEM,,THOMSON CONSUMER ELECTRONICS,ERSOZ NATHANIAL;;SAEGER TIMOTHY;;DOTY JAMES;;KRANAWETTER GREG,,https://lens.org/071-581-803-772-607,Granted Patent,no,0,0,282,300,0,G06T3/4007;;H04N3/223;;H04N3/227;;H04N3/27;;H04N5/2624;;H04N5/45;;H04N7/007;;H04N7/01;;H04N7/0105;;H04N7/0122;;H04N7/015;;H04N9/64;;H04N9/641;;H04N19/90;;G06T3/04;;H04N7/01;;H04N9/641;;H04N3/27;;H04N7/0122;;H04N5/45;;H04N7/0105;;H04N3/223;;H04N7/007;;H04N9/64;;H04N3/227;;H04N7/01;;G06T3/4007;;H04N7/015;;H04N5/2624;;H04N19/90;;G06T3/04,H04N5/46;;G06F3/00;;G06T3/40;;G09G5/00;;G09G5/14;;G09G5/377;;G09G5/391;;H04N3/223;;H04N3/227;;H04N3/27;;H04N5/073;;H04N5/14;;H04N5/262;;H04N5/265;;H04N5/44;;H04N5/45;;H04N7/00;;H04N7/01;;H04N7/015;;H04N7/26;;H04N9/64;;H04N11/06;;H04N11/20;;H04N11/24,,0,0,,,,EXPIRED
137,AU,A,AU 1995/019836 A,148-831-121-374-530,1995-09-25,1995,AU 1995/019836 A,1995-03-06,US 20747594 A;;US 9502874 W,1994-03-07,Method and apparatus for performing hysteroscopic and falloposcopic procedures,,CONCEPTUS INC,NIKOLCHEV JULIAN N;;ARNEY MICHELLE M;;DOTY JAMES,,https://lens.org/148-831-121-374-530,Patent Application,no,0,0,5,5,0,A61B1/303;;A61B1/00135;;A61B1/00149;;A61B1/0125;;A61B1/07,A61B1/00;;A61B1/303;;A61M25/02,,0,0,,,,PENDING
138,WO,A1,WO 1995/024149 A1,142-595-895-146-865,1995-09-14,1995,US 9502874 W,1995-03-06,US 20747594 A,1994-03-07,METHOD AND APPARATUS FOR PERFORMING HYSTEROSCOPIC AND FALLOPOSCOPIC PROCEDURES,"Imaging of a fallopian tube (F) is accomplished using a coaxial system comprising a hysteroscope (10), an access catheter (40), and a falloposcope (60). The access catheter (40) and falloposcope (60) are designed to permit proper alignment between their respective distal ends (45) in order to enhance image quality. A support system for the hysteroscope (10) is provided so that the hysteroscope need not be manually manipulated during the procedure.",CONCEPTUS INC;;NIKOLCHEV JULIAN N;;ARNEY MICHELLE M;;DOTY JAMES,NIKOLCHEV JULIAN N;;ARNEY MICHELLE M;;DOTY JAMES,,https://lens.org/142-595-895-146-865,Patent Application,yes,7,9,5,5,0,A61B1/303;;A61B1/00135;;A61B1/00149;;A61B1/0125;;A61B1/07,A61B1/00;;A61B1/303;;A61M25/02,,1,0,,,See also references of EP 0751738A4,PENDING
139,US,A,US 5935056 A,043-074-239-034-416,1999-08-10,1999,US 92559497 A,1997-09-08,US 92559497 A;;US 54438495 A;;US 2113096 P,1995-10-10,Access catheter and method for maintaining separation between a falloposcope and a tubal wall,"A method and apparatus are provided for imaging a narrow body lumen, the method comprising maintaining separation between a distal end of an optical viewing scope and a lumen wall with a spacing structure which extends distally from the distal end of an access catheter. Optional spacing structures include distal cages and a guidewire which is fixed to and extends distally from the access catheter body. The invention is particularly beneficial during retrograde imaging of the fallopian tube, as it prevents the tubal wall from coming into such close proximity to a falloposcope as to produce ""white-out"" on the imaging monitor.",CONCEPTUS INC,KERIN JOHN;;MILO CHARLES;;NIKOLCHEV JULIAN;;DOTY JAMES,BAYER HEALTHCARE LLC (2015-07-11);;BAYER ESSURE INC (2013-10-25),https://lens.org/043-074-239-034-416,Granted Patent,yes,31,55,11,11,0,A61B1/0008;;A61B1/00082;;A61B1/00085;;A61B1/00135;;A61B1/00149;;A61B1/00165;;A61B1/04;;A61B1/07;;A61B1/303;;A61B1/32;;A61B5/6886;;A61B17/221;;A61B2017/2215;;A61B1/01;;A61B2090/0815;;A61B90/50;;A61B1/04;;A61B1/00149;;A61B17/221;;A61B1/303;;A61B1/0008;;A61B1/00135;;A61B5/6886;;A61B1/07;;A61B1/00085;;A61B1/00165;;A61B1/00082;;A61B1/32;;A61B2017/2215;;A61B1/01;;A61B90/50;;A61B2090/0815,A61B1/04;;A61B1/06;;A61B1/303;;A61B1/32;;A61B17/22;;A61B19/00,600/114;;600/127;;600/135;;604/280,2,2,065-960-382-511-187;;020-757-066-348-342,10.1016/0020-7292(91)90346-7;;10.1089/lps.1990.1.47;;2131110,"Kerin et al., Falloposcopy: A Microendoscopic Technique for Visual Exploration of the Human Fallopian Tube form the Uterotubal Ostium to the Fimria Using a Transvaginal Approach, Fertility and Sterility, vol. 54, No. 3, pp. 390 400 (1990).;;Kerin et al., Development and Application of a Falloposcope for Transvaginal Endoscopy of the Fallopian Tube, J. aparoendoscopic Surgery, vol. 1, pp. 47 56.",EXPIRED
140,EP,A1,EP 0751738 A1,047-791-059-508-124,1997-01-08,1997,EP 95912793 A,1995-03-06,US 9502874 W;;US 20747594 A,1994-03-07,METHOD AND APPARATUS FOR PERFORMING HYSTEROSCOPIC AND FALLOPOSCOPIC PROCEDURES,,CONCEPTUS INC,NIKOLCHEV JULIAN N;;ARNEY MICHELLE M;;DOTY JAMES,,https://lens.org/047-791-059-508-124,Patent Application,yes,0,0,5,5,0,A61B1/303;;A61B1/00135;;A61B1/00149;;A61B1/0125;;A61B1/07,A61B1/00;;A61B1/303;;A61M25/02,,0,0,,,,DISCONTINUED
141,WO,A3,WO 2005/077337 A3,159-701-570-109-234,2006-03-23,2006,US 2005/0002471 W,2005-01-26,US 54237204 P,2004-02-05,DISPERSIONS PREPARED BY USE OF SELF-STABILIZING AGENTS,"The present invention relates to a dispersion of an active agent, which includes a multiphase system of an organic phase and an aqueous phase. The agent, preferably poorly water soluble, possesses surface active properties and itself serves as a dispersantor a stabilizer for the dispersion. The dispersion is suitable for pharmaceutical, veterinary, cosmetic, and agricultural applications, and is suitable for in vivo delivery, particularly by parenteral routes.",BAXTER INT;;KIPP JAMES E;;DOTY MARK;;REBBECK CHRISTINE L,KIPP JAMES E;;DOTY MARK;;REBBECK CHRISTINE L,,https://lens.org/159-701-570-109-234,Search Report,yes,8,0,5,5,0,A61K9/1075;;A61K9/113;;A61K31/557;;A61K9/1075;;A61K9/113;;A61K31/557,A61K9/113;;A61K9/107;;A61K9/127;;A61K31/557;;A61K38/17;;A61K48/00,,3,0,,,"DATABASE WPI Section Ch Week 198604, Derwent World Patents Index; Class B05, AN 1986-023692, XP002362050;;DATABASE WPI Section Ch Week 199302, Derwent World Patents Index; Class B05, AN 1993-012145, XP002362051;;DATABASE WPI Section Ch Week 200403, Derwent World Patents Index; Class A96, AN 2004-026429, XP002362052",PENDING
142,WO,A2,WO 2003/086324 A2,069-418-380-950-798,2003-10-23,2003,US 0309818 W,2003-04-02,US 12084802 A,2002-04-10,PREPARATION AND USE OF A STABLE FORMULATION OF ALLOSTERIC EFFECTOR COMPOUNDS,"A pharmaceutical composition of 2-[4-[2-[(3,5-dimethylphenyl)amino]-2-oxoethyl]phenoxyl]-2-methyl-proprionic acid or its physiologically acceptable salts suitable for parenteral administration includes an aqueous formulation of 2-[4-[2-[(3,5-dimethylphenyl)amino]-2-oxoethyl]phenoxyl]-2-methyl-proprionic acid or its physiologically acceptable salt and a buffer to maintain the pH from about 6 to about 11. The composition in accordance with the invention reduces the amount of particulate matter that forms in solution after heat sterilization. The invention also includes a process for making a pharmaceutical composition of 2-[4-[2-[(3,5-dimethylphenyl)amino]-2-oxoethyl]phenoxyl]-2-methyl-proprionic acid or its physiologically acceptable salt that has a shelf life in excess of thirty days and is useful in parental administration.",ALLOS THERAPEUTICS INC,JOHNSON DOUGLAS GILES;;DOTY MARK;;KIPP JAMES E,,https://lens.org/069-418-380-950-798,Patent Application,yes,0,0,9,9,0,A61K31/195;;A61K31/195;;A61K9/0019;;A61K9/0019;;A61K47/12;;A61K47/12;;A61K47/18;;A61K47/18;;A61K47/183;;A61K47/183;;A61K49/10;;A61K49/10;;A61P3/10;;A61P9/00;;A61P9/10;;A61P17/00;;A61P31/04;;A61P35/00;;A61P37/02;;A61P43/00,A61K47/04;;A61B5/055;;A61K31/192;;A61K31/195;;A61K45/00;;A61K47/12;;A61K47/18;;A61K47/26;;A61K47/36;;A61K47/42;;A61K49/10;;A61P3/10;;A61P9/00;;A61P9/10;;A61P17/00;;A61P31/04;;A61P35/00;;A61P37/02;;A61P43/00,,0,0,,,,PENDING
143,WO,A2,WO 2005/077337 A2,102-611-791-553-956,2005-08-25,2005,US 2005/0002471 W,2005-01-26,US 54237204 P,2004-02-05,DISPERSIONS PREPARED BY USE OF SELF-STABILIZING AGENTS,"The present invention relates to a dispersion of an active agent, which includes a multiphase system of an organic phase and an aqueous phase. The agent, preferably poorly water soluble, possesses surface active properties and itself serves as a dispersantor a stabilizer for the dispersion. The dispersion is suitable for pharmaceutical, veterinary, cosmetic, and agricultural applications, and is suitable for in vivo delivery, particularly by parenteral routes.",BAXTER INT;;KIPP JAMES E;;DOTY MARK;;REBBECK CHRISTINE L,KIPP JAMES E;;DOTY MARK;;REBBECK CHRISTINE L,,https://lens.org/102-611-791-553-956,Patent Application,yes,0,2,5,5,0,A61K9/1075;;A61K9/113;;A61K31/557;;A61K9/1075;;A61K9/113;;A61K31/557,A61K9/107;;A61K9/113;;A61K9/127;;A61K31/557;;A61K38/17;;A61K48/00,,0,0,,,,PENDING
144,WO,A3,WO 2003/086324 A3,103-521-157-091-106,2004-11-04,2004,US 0309818 W,2003-04-02,US 12084802 A,2002-04-10,PREPARATION AND USE OF A STABLE FORMULATION OF ALLOSTERIC EFFECTOR COMPOUNDS,"A pharmaceutical composition of 2-[4-[2-[(3,5-dimethylphenyl)amino]-2-oxoethyl]phenoxyl]-2-methyl-proprionic acid or its physiologically acceptable salts suitable for parenteral administration includes an aqueous formulation of 2-[4-[2-[(3,5-dimethylphenyl)amino]-2-oxoethyl]phenoxyl]-2-methyl-proprionic acid or its physiologically acceptable salt and a buffer to maintain the pH from about 6 to about 11. The composition in accordance with the invention reduces the amount of particulate matter that forms in solution after heat sterilization. The invention also includes a process for making a pharmaceutical composition of 2-[4-[2-[(3,5-dimethylphenyl)amino]-2-oxoethyl]phenoxyl]-2-methyl-proprionic acid or its physiologically acceptable salt that has a shelf life in excess of thirty days and is useful in parental administration.",ALLOS THERAPEUTICS INC,JOHNSON DOUGLAS GILES;;DOTY MARK;;KIPP JAMES E,,https://lens.org/103-521-157-091-106,Search Report,yes,1,0,9,9,0,A61K31/195;;A61K31/195;;A61K9/0019;;A61K9/0019;;A61K47/12;;A61K47/12;;A61K47/18;;A61K47/18;;A61K47/183;;A61K47/183;;A61K49/10;;A61K49/10;;A61P3/10;;A61P9/00;;A61P9/10;;A61P17/00;;A61P31/04;;A61P35/00;;A61P37/02;;A61P43/00,A61K47/04;;A61B5/055;;A61K31/192;;A61K31/195;;A61K45/00;;A61K47/12;;A61K47/18;;A61K47/26;;A61K47/36;;A61K47/42;;A61K49/10;;A61P3/10;;A61P9/00;;A61P9/10;;A61P17/00;;A61P31/04;;A61P35/00;;A61P37/02;;A61P43/00,,1,0,,,See also references of EP 1496863A4,PENDING
145,AT,T1,AT E386512 T1,037-679-831-050-401,2008-03-15,2008,AT 02736532 T,2002-03-28,US 82276701 A;;US 94537401 A,2001-03-29,VORGEMISCHTE AMIODARON-HALTIGE PARENTERALE LÖSUNG UND DEREN HERSTELLUNGSVERFAHREN,,BAXTER INT,DOTY MARK;;REBBECK CHRISTINE;;KIPP JAMES;;RAGHAVAN NEERVALUR,,https://lens.org/037-679-831-050-401,Granted Patent,no,0,0,14,22,0,A61K9/0019;;A61K31/343;;A61K47/26;;A61P9/06,C07D307/80;;A61K9/00;;A61K9/08;;A61K31/343;;A61K47/02;;A61K47/10;;A61K47/18;;A61K47/26;;A61K47/34;;A61K47/36;;A61P9/06,,0,0,,,,EXPIRED
146,US,A,US 5716321 A,036-029-678-840-579,1998-02-10,1998,US 54438495 A,1995-10-10,US 54438495 A;;US 2113096 P,1995-10-10,Method for maintaining separation between a falloposcope and a tubal wall,"A method and apparatus are provided for imaging a narrow body lumen, the method comprising maintaining separation between a distal end of an optical viewing scope and a lumen wall with a spacing structure which extends distally from the distal end of an access catheter. Optional spacing structures include distal cages and a guidewire which is fixed to and extends distally from the access catheter body. The invention is particularly beneficial during retrograde imaging of the fallopian tube, as it prevents the tubal wall from coming into such close proximity to a falloposcope as to produce ""white-out"" on the imaging monitor.",CONCEPTUS INC,KERIN JOHN;;MILO CHARLES;;NIKOLCHEV JULIAN;;DOTY JAMES,BAYER HEALTHCARE LLC (2015-07-11);;BAYER ESSURE INC (2013-10-25),https://lens.org/036-029-678-840-579,Granted Patent,yes,22,208,11,11,0,A61B1/0008;;A61B1/00082;;A61B1/00085;;A61B1/00135;;A61B1/00149;;A61B1/00165;;A61B1/04;;A61B1/07;;A61B1/303;;A61B1/32;;A61B5/6886;;A61B17/221;;A61B2017/2215;;A61B1/01;;A61B2090/0815;;A61B90/50;;A61B1/04;;A61B1/00149;;A61B17/221;;A61B1/303;;A61B1/0008;;A61B1/00135;;A61B5/6886;;A61B1/07;;A61B1/00085;;A61B1/00165;;A61B1/00082;;A61B1/32;;A61B2017/2215;;A61B1/01;;A61B90/50;;A61B2090/0815,A61B1/04;;A61B1/06;;A61B1/303;;A61B1/32;;A61B17/22;;A61B19/00,600/114;;600/127;;600/104;;604/280,2,2,065-960-382-511-187;;020-757-066-348-342,10.1016/0020-7292(91)90346-7;;10.1089/lps.1990.1.47;;2131110,"Kerin et al., Falloposcopy: A Microendoscopic Technique for Visual Exploration of the Human Fallopian Tube form the Uterotubal Ostium to the Fimbria Using a Transvaginal Approach , Fertility and Sterility, vol. 54, No. 3, pp. 390 400.;;Kerin et al., Development and Application of a Falloposcope for Transvaginal Endoscopy of the Fallopian Tube , (date unavailable), J. Laparoendoscopic Surgery, vol. 1, pp. 47 56.",EXPIRED
147,US,B1,US 10677933 B1,035-375-986-216-589,2020-06-09,2020,US 201715673273 A,2017-08-09,US 201715673273 A,2017-08-09,Heading or pitch determination systems and methods with high confidence error bounds,Systems and methods for use in navigating aircraft are provided. The systems can use Geometry Redundant Almost Fixed Solutions (GRAFS) or Geometry Extra Redundant Almost Fixed Solutions (GERAFS) to compute high confidence error bounds for a heading angle estimate or pitch angle derived using signals received on at least two antennas.,ROCKWELL COLLINS INC,GAVRILETS VLADISLAV;;PHAN HUAN T;;DOTY JAMES H,ROCKWELL COLLINS INC (2017-08-08),https://lens.org/035-375-986-216-589,Granted Patent,yes,3,23,2,2,0,G01C21/20;;G01C23/005;;G01S19/55;;G01S19/52;;G01S19/20;;G01S19/15;;B64D43/00;;G01S19/53;;G01S19/33;;G01C23/005;;B64D43/00;;G01S19/36,G01S19/53;;B64D43/00;;G01C23/00;;G01S19/33;;G01S19/36,,1,1,025-163-207-554-128,10.1109/plans.2008.4570100,Wu et al.; “Geometry Extra-Redundant Almost Fixed Solutions: A High Integrity Approach for Carrier Phase Ambiguity Resolution for High Accuracy Relative Navigation”; 2008 IEEE; 1-4244-1537-3/08; 15 pages.,ACTIVE
148,DE,T1,DE 116088 T1,035-365-805-952-263,1985-01-03,1985,DE 83902850 T,1983-08-10,US 8301235 W;;US 40854182 A,1982-08-16,IMPEDANZVERGLEICHER ZUM ABFUELLEN EINES FESTWERTSPEICHERS.,,"NCR CORP., DAYTON, OHIO, US","DOTY, HARRISON, II, JAMES, SPRINGBORO, OH 45066, US",,https://lens.org/035-365-805-952-263,Patent Application,no,0,0,1,8,0,,G11C11/56,,0,0,,,,DISCONTINUED
149,CA,A1,CA 2481669 A1,129-876-415-232-693,2003-10-23,2003,CA 2481669 A,2003-04-02,US 12084802 A;;US 0309818 W,2002-04-10,PREPARATION AND USE OF A STABLE FORMULATION OF ALLOSTERIC EFFECTOR COMPOUNDS,"A pharmaceutical composition of 2-[4-[2-[(3,5-dimethylphenyl)amino]-2- oxoethyl]phenoxyl]-2-methyl-proprionic acid or its physiologically acceptabl e salts suitable for parenteral administration includes an aqueous formulation of 2-[4-[2-[(3,5-dimethylphenyl)amino]-2-oxoethyl]phenoxyl]-2-methyl- proprionic acid or its physiologically acceptable salt and a buffer to maintain the pH from about 6 to about 11. The composition in accordance with the invention reduces the amount of particulate matter that forms in solutio n after heat sterilization. The invention also includes a process for making a pharmaceutical composition of 2-[4-[2-[(3,5-dimethylphenyl)amino]-2- oxoethyl]phenoxyl]-2-methyl-proprionic acid or its physiologically acceptabl e salt that has a shelf life in excess of thirty days and is useful in parenta l administration.",ALLOS THERAPEUTICS INC,JOHNSON DOUGLAS GILES;;KIPP JAMES E;;DOTY MARK,,https://lens.org/129-876-415-232-693,Patent Application,no,0,0,9,9,0,A61K31/195;;A61K31/195;;A61K9/0019;;A61K9/0019;;A61K47/12;;A61K47/12;;A61K47/18;;A61K47/18;;A61K47/183;;A61K47/183;;A61K49/10;;A61K49/10;;A61P3/10;;A61P9/00;;A61P9/10;;A61P17/00;;A61P31/04;;A61P35/00;;A61P37/02;;A61P43/00,A61K47/04;;A61B5/055;;A61K31/192;;A61K31/195;;A61K45/00;;A61K47/12;;A61K47/18;;A61K47/26;;A61K47/36;;A61K47/42;;A61K49/10;;A61P3/10;;A61P9/00;;A61P9/10;;A61P17/00;;A61P31/04;;A61P35/00;;A61P37/02;;A61P43/00,,0,0,,,,DISCONTINUED
150,DE,D1,DE 69127193 D1,020-524-917-253-433,1997-09-11,1997,DE 69127193 T,1991-05-30,GB 9012326 A;;US 9103813 W,1990-06-01,CHROMINANZVERARBEITUNGSSYSTEM,,THOMSON CONSUMER ELECTRONICS,ERSOZ NATHANIAL;;SAEGER TIMOTHY;;DOTY JAMES;;KRANAWETTER GREG,,https://lens.org/020-524-917-253-433,Granted Patent,no,0,0,282,300,0,G06T3/4007;;H04N3/223;;H04N3/227;;H04N3/27;;H04N5/2624;;H04N5/45;;H04N7/007;;H04N7/01;;H04N7/0105;;H04N7/0122;;H04N7/015;;H04N9/64;;H04N9/641;;H04N19/90;;G06T3/04;;H04N7/01;;H04N9/641;;H04N3/27;;H04N7/0122;;H04N5/45;;H04N7/0105;;H04N3/223;;H04N7/007;;H04N9/64;;H04N3/227;;H04N7/01;;G06T3/4007;;H04N7/015;;H04N5/2624;;H04N19/90;;G06T3/04,H04N5/46;;G06F3/00;;G06T3/40;;G09G5/00;;G09G5/14;;G09G5/377;;G09G5/391;;H04N3/223;;H04N3/227;;H04N3/27;;H04N5/073;;H04N5/14;;H04N5/262;;H04N5/265;;H04N5/44;;H04N5/45;;H04N7/00;;H04N7/01;;H04N7/015;;H04N7/26;;H04N9/64;;H04N11/06;;H04N11/20;;H04N11/24,,0,0,,,,EXPIRED
151,CH,A,CH 473904 A,048-307-439-056-27X,1969-06-15,1969,CH 915467D A,1964-01-29,CH 104464 A;;US 25569263 A;;US 44448265 A,1963-02-01,Verfahren und Bad zum elektrolytischen Glanzvernickeln,,M & T CHEMICALS INC,FRANK PASSAL;;ARTHUR JAMES TOMSON;;WARREN RUSSELL DOTY,,https://lens.org/048-307-439-056-27X,Granted Patent,no,0,0,1,19,0,C25D3/18;;C07D213/20;;C07D215/10,C07D213/20;;C07D215/10;;C25D3/18,,0,0,,,,EXPIRED
152,EP,A2,EP 1711163 A2,069-576-310-173-456,2006-10-18,2006,EP 05712082 A,2005-01-26,US 2005/0002471 W;;US 54237204 P,2004-02-05,DISPERSIONS PREPARED BY USE OF SELF-STABILIZING AGENTS,,BAXTER INT,KIPP JAMES E;;DOTY MARK;;REBBECK CHRISTINE L,,https://lens.org/069-576-310-173-456,Patent Application,yes,0,0,5,5,0,A61K9/1075;;A61K9/113;;A61K31/557;;A61K9/1075;;A61K9/113;;A61K31/557,A61K9/113;;A61K9/107;;A61K9/127;;A61K31/557;;A61K38/17;;A61K48/00,,0,0,,,,DISCONTINUED
153,US,A1,US 2007/0212302 A1,056-168-067-591-038,2007-09-13,2007,US 74961007 A,2007-05-16,US 74961007 A;;US 12084802 A,2002-04-10,Preparation and Use of a Stable Formulation of Allosteric Effector Compounds,"A pharmaceutical composition of 2-[4-[2-[(3,5-dimethylphenyl)amino]-2-oxoethyl]phenoxy]-2-methyl-propionic acid or its physiologically acceptable salts suitable for parenteral administration includes an aqueous formulation of 2-[4-[2-[(3,5-dimethylphenyl)amino]-2-oxoethyl]phenoxy]-2-methyl-propionic acid or its physiologically acceptable salt and a buffer to maintain the pH from about 6 to about 11. The composition in accordance with the invention reduces the amount of particulate matter that forms in solution after heat sterilization. The invention also includes a process for making a pharmaceutical composition of 2-[4-[2-[(3,5-dimethylphenyl)amino]-2-oxoethyl]phenoxy]-2-methyl-propionic acid or its physiologically acceptable salt that has a shelf life in excess of thirty days and is useful in parenteral administration.",ALLOS THERAPEUTICS INC,JOHNSON DOUGLAS G;;DOTY MARK;;KIPP JAMES E,ALLOS THERAPEUTICS INC (2002-07-15),https://lens.org/056-168-067-591-038,Patent Application,yes,6,0,9,9,0,A61K31/195;;A61K31/195;;A61K9/0019;;A61K9/0019;;A61K47/12;;A61K47/12;;A61K47/18;;A61K47/18;;A61K47/183;;A61K47/183;;A61K49/10;;A61K49/10;;A61P3/10;;A61P9/00;;A61P9/10;;A61P17/00;;A61P31/04;;A61P35/00;;A61P37/02;;A61P43/00,A61K31/205;;A61K47/04;;A61B5/055;;A61K31/192;;A61K31/195;;A61K45/00;;A61K47/12;;A61K47/18;;A61K47/26;;A61K47/36;;A61K47/42;;A61K49/10;;A61P3/10;;A61P9/00;;A61P9/10;;A61P17/00;;A61P31/04;;A61P35/00;;A61P37/02;;A61P43/00,424/9.3;;514/555,0,0,,,,DISCONTINUED
154,US,B2,US 8082344 B2,030-611-966-425-420,2011-12-20,2011,US 67374907 A,2007-02-12,US 67374907 A,2007-02-12,Transaction manager virtualization,"A transaction manager virtualization layer is provided for supporting multiple active transaction managers in a cluster or node. By virtualizing the transaction managers, applications and services are enabled to migrate across cluster nodes or even outside a cluster that includes relevant recovery mechanisms for transactions that are not completed at the time of migration. Multiple implementations of a transaction manager may be enabled to run side-by-side in a node or cluster allowing a rolling upgrade of transaction managers in clusters.",DOTY JOHN D;;JOHNSON JAMES E;;CARLEY WILLIAM JAMES;;GUPTA KAPIL;;MICROSOFT CORP,DOTY JOHN D;;JOHNSON JAMES E;;CARLEY WILLIAM JAMES;;GUPTA KAPIL,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2007-02-09),https://lens.org/030-611-966-425-420,Granted Patent,yes,16,4,2,2,0,G06F9/466;;G06F9/466;;G06F9/4856;;G06F9/4856,G06F15/173,709/226;;709/221,7,0,,,"Iana. ""Port Numbers"". May 15, 2001.;;Kumar et al. Performance Considerations for an Operating System Transaction Manager. Jun. 1989.;;""How to Configure Multiple Instances of Distributed Transaction Coordinator (DTC) on a Windows Server Failover Cluster 2008,"" http://blogs.technet.com/askcore/archive/2009/02/18/how-to-configure-multiple-instances-of-distributed-transaction-coordinator-dtc-on-a-windows-server-failover-cluster-2008.aspx, pp. 1-22 (Copyright 2009).;;""HP NonStop server virtualization primer,"" http://209.85.229.132/search?q=cache:OtdXoQb8FfYJ:h71028.www7.hp.com/ERC/downloads/4AA0- 3156ENW.pdf+transaction+managment+virtualization+%2B+resource+%2B+clusters&cd=2&h1=en&ct=clnk&g1=uk, pp. 1-27 (Copyright 2006).;;""Moab Utility/Hosting Suite(TM),""http://www.clusterresources.com/products/moab-utilityhosting-suite.php, pp. 1-4 (Copyright 2009).;;Harzog, B., ""Virtualization Management: VMware B-hive Detailed Product Review,"" pp. 1-11, http://www.dabcc.com/article.aspx?id=7988 (Jun. 18, 2008).;;Tal, M. ""How to maximize performance in virtualized environments,"" ZDNet News, http://news.zdnet.com/2100-9595-22-207242.html, pp. 1-6 (Jun. 19, 2008).",INACTIVE
155,US,A1,US 2008/0196029 A1,177-411-145-642-81X,2008-08-14,2008,US 67374907 A,2007-02-12,US 67374907 A,2007-02-12,Transaction Manager Virtualization,"A transaction manager virtualization layer is provided for supporting multiple active transaction managers in a cluster or node. By virtualizing the transaction managers, applications and services are enabled to migrate across cluster nodes or even outside a cluster that includes relevant recovery mechanisms for transactions that are not completed at the time of migration. Multiple implementations of a transaction manager may be enabled to run side-by-side in a node or cluster allowing a rolling upgrade of transaction managers in clusters.",MICROSOFT CORP,DOTY JOHN D;;JOHNSON JAMES E;;CARLEY WILLIAM JAMES;;GUPTA KAPIL,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2007-02-09),https://lens.org/177-411-145-642-81X,Patent Application,yes,16,17,2,2,0,G06F9/466;;G06F9/466;;G06F9/4856;;G06F9/4856,G06F9/44,718/101,0,0,,,,INACTIVE
156,CA,A,CA 671929 A,062-092-634-651-084,1963-10-08,1963,CA 671929D A,,CA 671929T A,,MULTI-STATION PLUMBING FIXTURE AND OUTLET MANIFOLD THEREFOR,,LOGAN MFG COMPANY,EGE RICHARD M;;NELSON JAMES F;;DOTY GEORGE I,,https://lens.org/062-092-634-651-084,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
157,AU,A1,AU 2005/304952 A1,126-142-932-845-242,2006-05-18,2006,AU 2005/304952 A,2005-11-03,US 62603604 P;;US 64287805 P;;US 2005/0039922 W,2004-11-08,Nanoparticulate compositions of tubulin inhibitor,,BAXTER INT;;BAXTER HEALTHCARE SA,KIPP JAMES E;;ROESSLER BERTHOLD;;DOTY MARK;;PAPADOPOULOS PAVLOS,,https://lens.org/126-142-932-845-242,Patent Application,no,0,0,16,17,0,A61K9/0019;;A61K9/0095;;A61K9/10;;A61K9/145;;A61K9/146;;A61K9/5123;;A61K9/5146;;A61K31/404;;A61K31/4439;;Y10T428/2982;;C07D401/12;;A61P1/18;;A61P11/02;;A61P11/06;;A61P19/02;;A61P29/00;;A61P31/04;;A61P35/00;;A61P35/04;;A61P37/02;;A61P37/06;;A61P37/08;;A61P43/00;;B82B3/00;;H01F27/12;;H01B3/20;;H01B3/00;;Y10T428/2982;;A61K31/4439;;A61K31/404;;A61K9/5123;;A61K9/5146;;A61K9/145;;A61K9/0095;;A61K9/10;;A61K9/146;;A61K9/0019;;A61K9/14;;C07D401/12,A61K31/404;;A61K9/00;;A61P35/00,,0,0,,,,INACTIVE
158,TW,A,TW 201437125 A,142-468-210-786-527,2014-10-01,2014,TW 102144951 A,2013-12-06,US 201213729329 A,2012-12-28,Roller cleaner,"A cleaning device is provided for removing debris from rotating conveyor rollers, and includes a housing constructed and arranged for insertion between two adjacent rotating rollers, the housing having a first set of cleaning wheels at a first housing end associated with a first of the conveyor rollers, and a second set of cleaning wheels located on an opposite end of the housing and associated with a second of the conveyor rollers. At least one of the cleaning wheels is reciprocable relative to the housing between a retracted position permitting insertion of the housing between the rollers, and a extended position extending the reciprocating wheel towards the adjacent roller for limiting lateral movement of the housing between the rollers. Upon movement of the housing between the rollers in a direction parallel to a longitudinal axis of the rollers, the cleaning wheels operationally engage and remove residue collected on the rollers.",UNITED STATES GYPSUM CO,SCHENCK RONALD EDWARD;;DOTY WILLIAM JAMES;;HENRY ANTHONY A,,https://lens.org/142-468-210-786-527,Patent of Addition,no,0,1,9,9,0,B65G45/10;;B08B1/30;;B08B1/32;;B65G45/10;;B08B1/30;;B08B1/32,B65G45/10,,0,0,,,,PENDING
159,CN,C,CN 1034466 C,164-987-972-373-780,1997-04-02,1997,CN 91103728 A,1991-05-31,GB 9012326 A,1990-06-01,Chrominance processing system,,THOMSON CONSUMER ELECTRONICS,ERSOZ NATHANIEL H;;SAEGER TIMOTHY W;;JAMES H DOTY,,https://lens.org/164-987-972-373-780,Granted Patent,no,1,0,282,300,0,G06T3/4007;;H04N3/223;;H04N3/227;;H04N3/27;;H04N5/2624;;H04N5/45;;H04N7/007;;H04N7/01;;H04N7/0105;;H04N7/0122;;H04N7/015;;H04N9/64;;H04N9/641;;H04N19/90;;G06T3/04;;H04N7/01;;H04N9/641;;H04N3/27;;H04N7/0122;;H04N5/45;;H04N7/0105;;H04N3/223;;H04N7/007;;H04N9/64;;H04N3/227;;H04N7/01;;G06T3/4007;;H04N7/015;;H04N5/2624;;H04N19/90;;G06T3/04,H04N5/46;;G06F3/00;;G06T3/40;;G09G5/00;;G09G5/14;;G09G5/377;;G09G5/391;;H04N3/223;;H04N3/227;;H04N3/27;;H04N5/073;;H04N5/14;;H04N5/262;;H04N5/265;;H04N5/44;;H04N5/45;;H04N7/00;;H04N7/01;;H04N7/015;;H04N7/26;;H04N9/64;;H04N11/06;;H04N11/20;;H04N11/24,,0,0,,,,EXPIRED
160,US,B2,US 6696778 B2,101-521-533-080-441,2004-02-24,2004,US 74626300 A,2000-12-22,US 74626300 A,2000-12-22,Rigid busbar for a cathode-ray tube (CRT),"
    An apparatus and method for terminating crosswires on a tension focus mask. The apparatus includes a set of base segment side rails each having a length and two respective ends. A pair of square tubes attached perpendicular to the respective ends of said base segment side rails to substantially form a rectangle. Also included are a pair of massive side rails having a length and two respective ends mounted above said base segments perpendicularly to said square tubes on each of the side rapid. Beam shield is offered to the massive side rail and insulating members are sandwiched between the side rail and a bus bar. Finally, a tension mask is attached and crosswires are laid and affixed to the bus bar. 
",THOMSON LICENSING SA,DOTY JAMES EDWARD;;MICHALCHUK JOEY JOHN;;NOSKER RICHARD WILLIAM,THOMSON LICENSING S.A (2001-03-28),https://lens.org/101-521-533-080-441,Granted Patent,yes,3,0,2,2,0,H01J9/142;;H01J29/07;;H01J9/142;;H01J29/07,H01J9/14;;H01J29/07,313/407;;313/402;;445/30,0,0,,,,EXPIRED
161,EP,A1,EP 1658165 A1,127-099-291-165-751,2006-05-24,2006,EP 04781335 A,2004-08-17,US 2004/0026624 W;;US 49601103 P,2003-08-19,IMPACT-MODIFIED POLYAMIDE FILM,"Method for making a hollow body comprising, as sole layer(s), (1) at least one layer L1 comprising an aromatic polyamide and an impact modifier, and, optionally, (2) at least one layer L2 comprising an aliphatic polyamide, comprising extruding an aromatic polyamide and an impact modifier, and optionally extruding an aliphatic polyamide, through a die.",SOLVAY ADVANCED POLYMERS LLC,BUSHELMAN CORINNE;;WARKOSKI GREGORY;;DOTY JAMES K;;BERSTED BRUCE,"SOLVAY SPECIALTY POLYMERS USA, LLC. (2011-11-30)",https://lens.org/127-099-291-165-751,Patent Application,yes,0,1,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,B28B1/00;;B28B3/00;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90;;B29D22/00;;B29D23/00;;B32B1/08;;B32B27/34;;C08L77/06,,0,0,,,,ACTIVE
162,US,B2,US 9022206 B2,185-899-646-110-901,2015-05-05,2015,US 201213729329 A,2012-12-28,US 201213729329 A,2012-12-28,Roller cleaner,"A cleaning device is provided for removing debris from rotating conveyor rollers, and includes a housing constructed and arranged for insertion between two adjacent rotating rollers, the housing having a first set of cleaning wheels at a first housing end associated with a first of the conveyor rollers, and a second set of cleaning wheels located on an opposite end of the housing and associated with a second of the conveyor rollers. At least one of the cleaning wheels is reciprocable relative to the housing between a retracted position permitting insertion of the housing between the rollers, and a extended position extending the reciprocating wheel towards the adjacent roller for limiting lateral movement of the housing between the rollers. Upon movement of the housing between the rollers in a direction parallel to a longitudinal axis of the rollers, the cleaning wheels operationally engage and remove residue collected on the rollers.",UNITED STATES GYPSUM CO,SCHENCK RONALD EDWARD;;DOTY WILLIAM JAMES;;HENRY ANTHONY A,UNITED STATES GYPSUM COMPANY (2012-12-27),https://lens.org/185-899-646-110-901,Granted Patent,yes,4,1,9,9,0,B65G45/10;;B08B1/30;;B08B1/32;;B65G45/10;;B08B1/30;;B08B1/32,B65G45/10;;B08B1/00;;B08B1/04;;B65G45/18,198/494,0,0,,,,ACTIVE
163,WO,A1,WO 2006/052712 A1,184-284-380-908-993,2006-05-18,2006,US 2005/0039922 W,2005-11-03,US 62603604 P;;US 64287805 P,2004-11-08,NANOPARTICULATE COMPOSITIONS OF TUBULIN INHIBITOR,"The present invention is directed to novel pharmaceutical compositions comprinsing nano- and micro-particulate formulations of poorly water soluble tubulin inhibitors of the indole chemical class, preferably N-substituted indol-3-glyoxyamides, and more preferably N-(Pyridin-4-yl)-⏧1-(4-chlorobenzyl)-indol-3-yl&rsqb;glyoxylic acid amide (D-24851), also known as 旜Indibulin&rdquo;, and methods of making and using such compositions for the treatment of anti-tumor agent resistant cancers and other diseases.",BAXTER INT;;BAXTER HEALTHCARE SA;;RAAB GERHARD;;PAPADOPOULOS PAVLOS;;DOTY MARK;;KIPP JAMES E;;ROESSLER BERTHOLD,PAPADOPOULOS PAVLOS;;DOTY MARK;;KIPP JAMES E;;ROESSLER BERTHOLD,,https://lens.org/184-284-380-908-993,Patent Application,yes,1,55,16,17,0,A61K9/0019;;A61K9/0095;;A61K9/10;;A61K9/145;;A61K9/146;;A61K9/5123;;A61K9/5146;;A61K31/404;;A61K31/4439;;Y10T428/2982;;C07D401/12;;A61P1/18;;A61P11/02;;A61P11/06;;A61P19/02;;A61P29/00;;A61P31/04;;A61P35/00;;A61P35/04;;A61P37/02;;A61P37/06;;A61P37/08;;A61P43/00;;B82B3/00;;H01F27/12;;H01B3/20;;H01B3/00;;Y10T428/2982;;A61K31/4439;;A61K31/404;;A61K9/5123;;A61K9/5146;;A61K9/145;;A61K9/0095;;A61K9/10;;A61K9/146;;A61K9/0019;;A61K9/14;;C07D401/12,A61K9/00;;A61K31/404;;A61P35/00,,3,3,046-244-745-371-27X;;024-652-650-292-987;;006-217-108-185-939,10.1517/13543784.8.6.903;;15992139;;11196193;;10.1054/drup.2001.0216;;11768333,"LAVELLE F: ""AMERICAN ASSOCIATION FOR CANCER RESEARCH 1999: 10-14 APRIL, PHILADELPHIA, PENNSYLVANIA"", EXPERT OPINION ON INVESTIGATIONAL DRUGS, ASHLEY PUBLICATIONS LTD., LONDON, GB, vol. 8, no. 6, 1999, pages 903 - 909, XP001014727, ISSN: 1354-3784;;BACHER GERALD ET AL: ""D-24851, a novel synthetic microtubule inhibitor, exerts curative antitumoral activity in vivo, shows efficacy toward multidrug-resistant tumor cells, and lacks neurotoxicity"", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, vol. 61, no. 1, 2001, pages 392 - 399, XP002173885, ISSN: 0008-5472;;BROXTERMAN H J ET AL: ""CANCER RESEARCH 2001: DRUG RESISTANCE, NEW TARGETS AND DRUG COMBINATIONS"", DRUG RESISTANCE UPDATES, CHURCHILL LIVINGSTONE, EDINBURGH, GB, vol. 4, 2001, pages 197 - 209, XP008011921, ISSN: 1368-7646",PENDING
164,AR,A1,AR 093869 A1,100-234-194-142-231,2015-06-24,2015,AR P130104574 A,2013-12-06,US 201213729329 A,2012-12-28,LIMPIADOR DE RODILLO,"Se proporciona un dispositivo limpiador para remover los desechos de los rodillos transportadores rotatorios, e incluye una carcasa construida y dispuesta para la inserción entre dos rodillos rotatorios adyacentes, teniendo la carcasa un primer conjunto de ruedas limpiadoras en un primer extremo de la carcasa conectadas al primero de los rodillos transportadores, y un segundo conjunto de ruedas limpiadoras ubicadas en un extremo opuesto de la carcasa y conectadas al segundo de los rodillos transportadores. Al menos una de las medas limpiadoras es de movimiento alternativo con respecto a la carcasa entre una posición retraída permitiendo la inserción de la carcasa entre los rodillos, y una posición extendida que extiende la rueda alternativa hacia el rodillo adyacente para limitar el movimiento lateral de la carcasa entre los rodillos. Con el movimiento de la carcasa entre los rodillos en una dirección paralela a un eje longitudinal de los rodillos, las ruedas limpiadoras operativamente engranan y remueven el residuo recolectado en los rodillos.",UNITED STATES GYPSUM CO,RONALD EDWARD SCHENCK;;WILLIAM JAMES DOTY;;ANTHONY A HENRY,,https://lens.org/100-234-194-142-231,Patent Application,no,0,0,9,9,0,B65G45/10;;B08B1/30;;B08B1/32;;B65G45/10;;B08B1/30;;B08B1/32,B08B1/04;;B65G45/10,,0,0,,,,PENDING
165,EP,B1,EP 1658165 B1,010-226-400-318-152,2020-01-01,2020,EP 04781335 A,2004-08-17,US 2004/0026624 W;;US 49601103 P,2003-08-19,IMPACT-MODIFIED POLYAMIDE FILM,"Method for making a hollow body comprising, as sole layer(s), (1) at least one layer L1 comprising an aromatic polyamide and an impact modifier, and, optionally, (2) at least one layer L2 comprising an aliphatic polyamide, comprising extruding an aromatic polyamide and an impact modifier, and optionally extruding an aliphatic polyamide, through a die.",SOLVAY SPECIALTY POLYMERS USA,BUSHELMAN CORINNE;;WARKOSKI GREGORY;;DOTY JAMES K;;BERSTED BRUCE,"SOLVAY SPECIALTY POLYMERS USA, LLC. (2011-11-30)",https://lens.org/010-226-400-318-152,Granted Patent,yes,2,0,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,B28B1/00;;B28B3/00;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90;;B29D22/00;;B29D23/00;;B32B1/08;;B32B27/08;;B32B27/18;;B32B27/20;;B32B27/34;;C08L77/06,,0,0,,,,ACTIVE
166,DE,A1,DE 4126119 A1,078-414-788-074-638,1992-02-20,1992,DE 4126119 A,1991-08-07,US 56618290 A,1990-08-13,ANORDNUNG ZUM ERZEUGEN PHASENVERSCHOBENER TAKTSIGNALE,,THOMSON CONSUMER ELECTRONICS,DOTY II JAMES HARRISON;;ALBEAN DAVID LAWRENCE;;BLATTER HAROLD,,https://lens.org/078-414-788-074-638,Patent Application,no,0,0,10,10,0,H03K5/00;;H03K5/133;;H03K5/133;;H03K2005/00195;;H03K2005/00195,H01L21/8234;;H01L27/088;;H03K5/00;;H03K5/13;;H03K5/15,,0,0,,,,EXPIRED
167,US,A,US 5066868 A,107-431-734-565-604,1991-11-19,1991,US 56618290 A,1990-08-13,US 56618290 A,1990-08-13,Apparatus for generating phase shifted clock signals,"Clock phase shifting circuitry includes a cascade connection of inverting amplifiers for generating a plurality of relatively delayed clock signals. Buffer amplifiers couple alternate ones of the inverting amplifiers to a clock phase selection circuit for providing a desired one of said plurality of delayed clock signals. A capacitor is coupled between the output of each inverting amplifier and a point of constant potential. Respective circuits, having an input impedance which emulates the input impedance of the buffer amplifiers, are coupled to the output connections of the inverting amplifiers located between said alternate inverting amplifiers.",THOMSON CONSUMER ELECTRONICS,DOTY II JAMES H;;ALBEAN DAVID L;;BLATTER HAROLD,THOMSON CONSUMER ELECTRONICS INC (1990-09-19),https://lens.org/107-431-734-565-604,Granted Patent,yes,7,18,10,10,0,H03K5/00;;H03K5/133;;H03K5/133;;H03K2005/00195;;H03K2005/00195,H01L21/8234;;H01L27/088;;H03K5/00;;H03K5/13;;H03K5/15,307/262;;307/269;;307/452;;307/594;;307/605;;328/55;;328/155;;328/61,0,0,,,,EXPIRED
168,US,A,US 5112128 A,059-607-296-611-486,1992-05-12,1992,US 28142288 A,1988-12-08,US 28142288 A;;US 7713487 A,1987-07-23,Sourced locked frequency modulated dual servo PRLG,"A passive ring resonator gyroscope comprising a single piece body having an integral first and second resonator cavity. The first resonator cavity contains a single frequency laser that provides a sharply tuned single frequency light source to the second resonator cavity. The single frequency light source is split to form first and second sources. The second resonator cavity is a passive high Q cavity with a closed second optical path. The two light sources are fed into the second resonator and propagate as CW and CCW beams within the second resonator. A first servo channel develops a first control signal to tune the frequency of the CW beam to a resonance peak. A second servo channel develops a second control signal to tune the CCW beam to its resonance peak. By converting both servo error outputs into frequency, the relative frequency difference between the CW and CCW beams are recorded as the frequency shift in response to the body rate rotation about the sensitive axis. The first and second control signals are algebraically added to provide a linear laser difference servo signal which is integrated, to provide a passive cavity servo signal or, in an alternative embodiment, a laser cavity servo signal. The passive cavity servo signal is used to drive a passive cavity PZT to tune the passive cavity to be resonant at a center frequency midrange between the first and second offset frequencies. In the alternative embodiment, the cavity servo signal is used to adjust the linear laser path length to keep the linear laser center frequency at a frequency midrange between the first and second offset frequencies.",ROCKWELL INTERNATIONAL CORP,SOOHOO KIE L;;DOTY JAMES H;;ITO PAUL H,ROCKWELL INTERNATIONAL CORPORATION (1988-12-02),https://lens.org/059-607-296-611-486,Granted Patent,yes,3,15,1,1,0,G01C19/727;;G01C19/727,G01C19/72,356/350;;372/94,0,0,,,,EXPIRED
169,US,A1,US 2005/0196416 A1,107-224-290-535-938,2005-09-08,2005,US 4331405 A,2005-01-26,US 4331405 A;;US 54237204 P,2004-02-05,Dispersions prepared by use of self-stabilizing agents,"The present invention relates to a dispersion of an active agent, which includes a multiphase system of an organic phase and an aqueous phase. The agent, preferably poorly water soluble, possesses surface active properties and itself serves as a dispersant or a stabilizer for the dispersion. The dispersion is suitable for pharmaceutical, veterinary, cosmetic, and agricultural applications, and is suitable for in vivo delivery, particularly by parenteral routes.",KIPP JAMES E.;;DOTY MARK J.;;REBBECK CHRISTINE L.,KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L,BAXTER HEALTHCARE S.A (2005-04-18);;BAXTER INTERNATIONAL INC (2005-04-18),https://lens.org/107-224-290-535-938,Patent Application,yes,99,31,5,5,0,A61K9/1075;;A61K9/113;;A61K31/557;;A61K9/1075;;A61K9/113;;A61K31/557,A61K9/107;;A61K9/113;;A61K9/127;;A61K31/557;;A61K38/17;;A61K48/00,424/400;;514/12;;514/44;;514/573,0,0,,,,DISCONTINUED
170,CA,A1,CA 2535348 A1,140-872-642-436-506,2005-03-03,2005,CA 2535348 A,2004-08-17,US 49601103 P;;US 2004/0026624 W,2003-08-19,IMPACT-MODIFIED POLYAMIDE FILM,Films made from impact-modified polyamide.,SOLVAY ADVANCED POLYMERS LLC,DOTY JAMES K;;WARKOSKI GREGORY;;BUSHELMAN CORINNE;;BERSTED BRUCE,,https://lens.org/140-872-642-436-506,Patent Application,no,0,0,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,B28B1/00;;B28B3/00;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90;;B29D22/00;;B29D23/00;;B32B1/08;;B32B27/34,,0,0,,,,INACTIVE
171,DE,C3,DE 2541896 C3,021-241-289-125-364,1978-08-24,1978,DE 2541896 A,1975-09-19,US 55742375 A,1975-03-11,DE 2541896 C3,,"OXY METAL INDUSTRIES CORP., DETROIT, MICH. (V.ST.A.)","DOTY, WARREN RUSSELL, ROYAL OAK;;KINNEY, TIMOTHY JAMES, BERKLEY",OMI INTERNATIONAL CORP. (EINE GESELLSCHAFT N.D.GES (1985-06-20),https://lens.org/021-241-289-125-364,Granted Patent,no,0,0,13,13,0,C23C18/28;;H05K3/181;;H05K3/381;;C23C18/28;;H05K3/181;;H05K3/381,C23C18/22;;C23C18/24;;C23C18/28;;H05K3/18;;H05K3/38,,0,0,,,,EXPIRED
172,MX,B,MX 340774 B,040-319-221-687-826,2016-07-26,2016,MX 2015008015 A,2013-12-04,US 201213729329 A;;US 2013/0073061 W,2012-12-28,ROLLER CLEANER.,"A cleaning device (10) is provided for removing debris from rotating conveyor rollers (12), and includes a housing (18) constructed and arranged for insertion between two adjacent rotating rollers, the housing having a first set of cleaning wheels (30) at a first housing end (24) associated with a first of the conveyor rollers, and a second set of cleaning wheels (32) located on an opposite end (26) of the housing and associated with a second of the conveyor rollers. At least one of the cleaning wheels (30a) is reciprocable relative to the housing between a retracted position permitting insertion of the housing between the rollers, and a extended position extending the reciprocating wheel towards the adjacent roller for limiting lateral movement of the housing between the rollers. Upon movement of the housing between the rollers in a direction parallel to a longitudinal axis of the rollers, the cleaning wheels operationally engage and remove residue collected on the rollers.",UNITED STATES GYPSUM CO,RONALD EDWARD SCHENCK;;WILLIAM JAMES DOTY;;ANTHONY A HENRY,,https://lens.org/040-319-221-687-826,Granted Patent,no,0,0,9,9,0,B65G45/10;;B08B1/30;;B08B1/32;;B65G45/10;;B08B1/30;;B08B1/32,B65G45/10;;B08B1/00;;B08B1/04,,0,0,,,,ACTIVE
173,WO,A1,WO 2005/018892 A1,119-510-445-053-187,2005-03-03,2005,US 2004/0026624 W,2004-08-17,US 49601103 P,2003-08-19,IMPACT-MODIFIED POLYAMIDE FILM,Films made from impact-modified polyamide.,BUSHELMAN CORINNE;;WARKOSKI GREGORY;;DOTY JAMES K;;BERSTED BRUCE,BUSHELMAN CORINNE;;WARKOSKI GREGORY;;DOTY JAMES K;;BERSTED BRUCE,,https://lens.org/119-510-445-053-187,Patent Application,yes,4,7,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90;;B32B27/34,,0,0,,,,PENDING
174,DE,C2,DE 4126119 C2,070-865-606-547-37X,2002-01-31,2002,DE 4126119 A,1991-08-07,US 56618290 A,1990-08-13,Anordnung zum Erzeugen phasenverschobener Taktsignale,,THOMSON CONSUMER ELECTRONICS,DOTY II JAMES HARRISON;;ALBEAN DAVID LAWRENCE;;BLATTER HAROLD,,https://lens.org/070-865-606-547-37X,Granted Patent,no,4,0,10,10,0,H03K5/00;;H03K5/133;;H03K5/133;;H03K2005/00195;;H03K2005/00195,H01L21/8234;;H01L27/088;;H03K5/00;;H03K5/13;;H03K5/15,,0,0,,,,EXPIRED
175,KR,B1,KR 100187912 B1,084-913-454-440-152,1999-06-01,1999,KR 910013930 A,1991-08-13,US 56618290 A,1990-08-13,APPARATUS FOR GENERATING PHASE SHIFTED CLOCK SIGNALS,클럭 위상 시프트 회로는 다수의 지연된 클럭 신호를 발생시키는 반전 증폭기의 케스케이드 연결부를 포함하고 있다. 버퍼 증폭기들은 반전 증폭기들중 교호하는 증폭기들을 상기 다수의 지연된 클럭 신호들중 요망되는 신호를 제공하는 클럭 위상 선택 회로에 결합시킨다. 캐패시터가 반전 증폭기 각각의 출력과 일정한 전위점 사이에 결합되어 있다. 버퍼 증폭기들 각각의 입력 임피던스를 에뮬레이션하는 입력 임피던스를 각각 지니는 회로를 각각이 상기 반전 증폭기들의 상기 교호 증폭기들 사이에 위치된 반전 증폭기들의 출력 연결부에 결합된다.,THOMSON CONSUMER ELECTRONICS,DOTY II JAMES HARRISON;;ALBEAN DAVID LAWRENCE;;BLATTER HAROLD,,https://lens.org/084-913-454-440-152,Granted Patent,no,0,1,10,10,0,H03K5/00;;H03K5/133;;H03K5/133;;H03K2005/00195;;H03K2005/00195,H01L21/8234;;H01L27/088;;H03K5/00;;H03K5/13;;H03K5/15,,0,0,,,,EXPIRED
176,CA,A,CA 661879 A,102-651-300-629-298,1963-04-23,1963,CA 661879D A,,CA 661879T A,,RETRACTABLE EMERGENCY WASH FACILITY,,LOGAN EMERGENCY SHOWERS,LOGAN HUGH H;;DOTY KENNETH G;;NELSON JAMES F,,https://lens.org/102-651-300-629-298,Granted Patent,no,0,2,1,1,0,,,,0,0,,,,EXPIRED
177,CA,C,CA 2535348 C,006-453-777-921-491,2014-10-07,2014,CA 2535348 A,2004-08-17,US 49601103 P;;US 2004/0026624 W,2003-08-19,IMPACT-MODIFIED POLYAMIDE FILM,"A film comprising, as sole layers, either at least one layer L1 comprising a polyphthalamide and a functionalized polyolefin impact modifier, or (1) at least one layer L1 comprising a polyphthalamide and a functionalized polyolefin impact modifier, and (2) at least one layer L2 comprising an aliphatic polyamide, characterized in that the film has a thickness of from 15 to 900 microns and wherein said functionalized polyolefin impact modifier is comprised in said layer L1 from 5 to 40 weight %, based on the total weight of L1. Also, a method for making a film having a thickness of from 15 to 900 microns comprising extruding the polyphthalamide and the functionalized polyolefin impact modifier, and optionally extruding the aliphatic polyamide, into the film. The film according to the invention has high tensile properties, high impact strength and good resistance to abrasion.",SOLVAY ADVANCED POLYMERS LLC,BUSHELMAN CORINNE;;WARKOSKI GREGORY;;DOTY JAMES K;;BERSTED BRUCE,,https://lens.org/006-453-777-921-491,Granted Patent,no,0,0,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,B28B1/00;;B28B3/00;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90;;B29D22/00;;B29D23/00;;B32B1/08;;B32B27/34,,0,0,,,,INACTIVE
178,KR,A,KR 20060073604 A,048-073-070-107-284,2006-06-28,2006,KR 20067003324 A,2004-08-17,US 49601103 P;;US 2004/0026624 W,2003-08-19,IMPACT-MODIFIED POLYAMIDE FILM,Films made from impact-modified polyamide.,SOLVAY ADVANCED POLYMERS LLC,BUSHELMAN CORINNE;;WARKOSKI GREGORY;;DOTY JAMES K;;BERSTED BRUCE,,https://lens.org/048-073-070-107-284,Patent Application,no,0,1,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,B32B27/34;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90;;B32B27/18,,0,0,,,,ACTIVE
179,US,A1,US 2014/0183001 A1,077-211-865-632-597,2014-07-03,2014,US 201213729329 A,2012-12-28,US 201213729329 A,2012-12-28,ROLLER CLEANER,"A cleaning device is provided for removing debris from rotating conveyor rollers, and includes a housing constructed and arranged for insertion between two adjacent rotating rollers, the housing having a first set of cleaning wheels at a first housing end associated with a first of the conveyor rollers, and a second set of cleaning wheels located on an opposite end of the housing and associated with a second of the conveyor rollers. At least one of the cleaning wheels is reciprocable relative to the housing between a retracted position permitting insertion of the housing between the rollers, and a extended position extending the reciprocating wheel towards the adjacent roller for limiting lateral movement of the housing between the rollers. Upon movement of the housing between the rollers in a direction parallel to a longitudinal axis of the rollers, the cleaning wheels operationally engage and remove residue collected on the rollers.",UNITED STATES GYPSUM CO,SCHENCK RONALD EDWARD;;DOTY WILLIAM JAMES;;HENRY ANTHONY A,UNITED STATES GYPSUM COMPANY (2012-12-27),https://lens.org/077-211-865-632-597,Patent Application,yes,3,5,9,9,0,B65G45/10;;B08B1/30;;B08B1/32;;B65G45/10;;B08B1/30;;B08B1/32,B65G45/10,198/494,0,0,,,,ACTIVE
180,BR,A,BR PI0413672 A,082-732-821-938-740,2006-10-24,2006,BR PI0413672 A,2004-08-17,US 49601103 P;;US 2004/0026624 W,2003-08-19,"pelìcula, e, método para fabricar a mesma","Method for making a hollow body comprising, as sole layer(s), (1) at least one layer L1 comprising an aromatic polyamide and an impact modifier, and, optionally, (2) at least one layer L2 comprising an aliphatic polyamide, comprising extruding an aromatic polyamide and an impact modifier, and optionally extruding an aliphatic polyamide, through a die.",SOLVAY ADVANCED POLYMERS LLC,BUSHELMAN CORINNE;;WARKOSKI GREGORY;;DOTY JAMES;;BERSTED BRUCE H,,https://lens.org/082-732-821-938-740,Patent Application,no,0,0,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90;;B32B27/34,,0,0,,,,INACTIVE
181,US,A1,US 2002/0079812 A1,092-751-288-904-230,2002-06-27,2002,US 74626300 A,2000-12-22,US 74626300 A,2000-12-22,Rigid busbar apparatus and method,"
   An apparatus and method for terminating crosswires on a tension focus mask. The apparatus includes a set of base segment side rails each having a length and two respective ends. A pair of square tubes attached perpendicular to the respective ends of said base segment side rails to substantially form a rectangle. Also included are a pair of massive side rails having a length and two respective ends mounted above said base segments perpendicularly to said square tubes on each of the side rapid. Beam shield is offered to the massive side rail and insulating members are sandwiched between the side rail and a bus bar. Finally, a tension mask is attached and crosswires are laid and affixed to the bus bar. 
",DOTY JAMES EDWARD;;MICHALCHUK JOEY JOHN;;NOSKER RICHARD WILLIAM,DOTY JAMES EDWARD;;MICHALCHUK JOEY JOHN;;NOSKER RICHARD WILLIAM,THOMSON LICENSING S.A (2001-03-28),https://lens.org/092-751-288-904-230,Patent Application,yes,3,0,2,2,0,H01J9/142;;H01J29/07;;H01J9/142;;H01J29/07,H01J9/14;;H01J29/07,313/407;;313/402,0,0,,,,EXPIRED
182,WO,A1,WO 2014/105369 A1,127-588-633-065-927,2014-07-03,2014,US 2013/0073061 W,2013-12-04,US 201213729329 A,2012-12-28,ROLLER CLEANER,"A cleaning device (10) is provided for removing debris from rotating conveyor rollers (12), and includes a housing (18) constructed and arranged for insertion between two adjacent rotating rollers, the housing having a first set of cleaning wheels (30) at a first housing end (24) associated with a first of the conveyor rollers, and a second set of cleaning wheels (32) located on an opposite end (26) of the housing and associated with a second of the conveyor rollers. At least one of the cleaning wheels (30a) is reciprocable relative to the housing between a retracted position permitting insertion of the housing between the rollers, and a extended position extending the reciprocating wheel towards the adjacent roller for limiting lateral movement of the housing between the rollers. Upon movement of the housing between the rollers in a direction parallel to a longitudinal axis of the rollers, the cleaning wheels operationally engage and remove residue collected on the rollers.",UNITED STATES GYPSUM CO,SCHENCK RONALD EDWARD;;DOTY WILLIAM JAMES;;HENRY ANTHONY A,,https://lens.org/127-588-633-065-927,Patent Application,yes,3,1,9,9,0,B65G45/10;;B08B1/30;;B08B1/32;;B65G45/10;;B08B1/30;;B08B1/32,B08B1/00;;B65G45/10;;B08B1/04,,0,0,,,,PENDING
183,US,A,US 3093002 A,131-269-987-575-314,1963-06-11,1963,US 7695860 A,1960-12-19,US 7695860 A,1960-12-19,"Flush mounted, dustproof gas service cabinet",,LOGAN HOSPITAL EQUIPMENT CO,LOGAN HUGH H;;DOTY GEORGE I;;NELSON JAMES F,,https://lens.org/131-269-987-575-314,Granted Patent,no,6,5,1,1,0,F16K27/08;;F16K27/08,F16K27/08,,0,0,,,,EXPIRED
184,EP,A1,EP 1809279 A1,180-333-613-008-092,2007-07-25,2007,EP 05851355 A,2005-11-03,US 2005/0039922 W;;US 62603604 P;;US 64287805 P,2004-11-08,PARTICULATE COMPOSITIONS OF TUBULIN INHIBITOR,,BAXTER INT;;BAXTER HEALTHCARE SA,PAPADOPOULOS PAVLOS;;DOTY MARK;;KIPP JAMES E;;ROESSLER BERTHOLD,BAXTER HEALTHCARE S.A. (2010-01-06);;BAXTER INTERNATIONAL INC. (2010-01-06),https://lens.org/180-333-613-008-092,Patent Application,yes,0,0,16,17,0,A61K9/0019;;A61K9/0095;;A61K9/10;;A61K9/145;;A61K9/146;;A61K9/5123;;A61K9/5146;;A61K31/404;;A61K31/4439;;Y10T428/2982;;C07D401/12;;A61P1/18;;A61P11/02;;A61P11/06;;A61P19/02;;A61P29/00;;A61P31/04;;A61P35/00;;A61P35/04;;A61P37/02;;A61P37/06;;A61P37/08;;A61P43/00;;B82B3/00;;H01F27/12;;H01B3/20;;H01B3/00;;Y10T428/2982;;A61K31/4439;;A61K31/404;;A61K9/5123;;A61K9/5146;;A61K9/145;;A61K9/0095;;A61K9/10;;A61K9/146;;A61K9/0019;;A61K9/14;;C07D401/12,A61K31/404;;A61K9/00;;A61P35/00,,0,0,,,,ACTIVE
185,CA,A1,CA 2587276 A1,194-847-953-271-096,2006-05-18,2006,CA 2587276 A,2005-11-03,US 62603604 P;;US 64287805 P;;US 2005/0039922 W,2004-11-08,NANOPARTICULATE COMPOSITIONS OF TUBULIN INHIBITOR,,BAXTER INT;;BAXTER HEALTHCARE SA,PAPADOPOULOS PAVLOS;;DOTY MARK;;KIPP JAMES E;;ROESSLER BERTHOLD,,https://lens.org/194-847-953-271-096,Patent Application,no,0,0,16,17,0,A61K9/0019;;A61K9/0095;;A61K9/10;;A61K9/145;;A61K9/146;;A61K9/5123;;A61K9/5146;;A61K31/404;;A61K31/4439;;Y10T428/2982;;C07D401/12;;A61P1/18;;A61P11/02;;A61P11/06;;A61P19/02;;A61P29/00;;A61P31/04;;A61P35/00;;A61P35/04;;A61P37/02;;A61P37/06;;A61P37/08;;A61P43/00;;B82B3/00;;H01F27/12;;H01B3/20;;H01B3/00;;Y10T428/2982;;A61K31/4439;;A61K31/404;;A61K9/5123;;A61K9/5146;;A61K9/145;;A61K9/0095;;A61K9/10;;A61K9/146;;A61K9/0019;;A61K9/14;;C07D401/12,A61K9/00;;A61K31/404;;A61P35/00,,0,0,,,,DISCONTINUED
186,ES,T3,ES 2424255 T3,107-823-443-233-223,2013-09-30,2013,ES 05851355 T,2005-11-03,US 62603604 P;;US 64287805 P;;US 2005/0039922 W,2004-11-08,Composiciones particuladas de inhibidores de tubulina,"Composición farmacéutica en partículas que incluye partículas con un tamaño medio efectivo de entreaproximadamente 15 nm y aproximadamente 50 micrómetros de al menos un inhibidor de la tubulina defórmula (1): donde X es R3 es arilo o heteroarilo; R3' es hidrógeno; R4, R5, R6 y R7 son independientemente hidrógeno, halógeno o alquilo; R1 es arilalquilo; y R2 es hidrógeno, alquilo, acilo, arilo, alcoxicarbonilo, ariloxicarbonilo, heteroariloxicarbonilo, cicloalcoxicarbonilo,heterocicloalcoxicarbonilo, alqueniloxicarbonilo, cicloalqueniloxicarbonilo y heterocicloalqueniloxi-carbonilo; yal menos un agente tensioactivo seleccionado de entre el grupo consistente en agentes tensioactivos noiónicos, agentes tensioactivos aniónicos, agentes tensioactivos catiónicos, agentes tensioactivos derivadosbiológicamente, agentes tensioactivos zwitteriónicos y aminoácidos.",BAXTER INT;;BAXTER HEALTHCARE SA,PAPADOPOULOS PAVLOS;;DOTY MARK;;KIPP JAMES E;;ROESSLER BERTHOLD,,https://lens.org/107-823-443-233-223,Granted Patent,no,0,0,16,17,0,A61K9/0019;;A61K9/0095;;A61K9/10;;A61K9/145;;A61K9/146;;A61K9/5123;;A61K9/5146;;A61K31/404;;A61K31/4439;;Y10T428/2982;;C07D401/12;;A61P1/18;;A61P11/02;;A61P11/06;;A61P19/02;;A61P29/00;;A61P31/04;;A61P35/00;;A61P35/04;;A61P37/02;;A61P37/06;;A61P37/08;;A61P43/00;;B82B3/00;;H01F27/12;;H01B3/20;;H01B3/00;;Y10T428/2982;;A61K31/4439;;A61K31/404;;A61K9/5123;;A61K9/5146;;A61K9/145;;A61K9/0095;;A61K9/10;;A61K9/146;;A61K9/0019;;A61K9/14;;C07D401/12,A61K9/00;;A61K31/404;;A61P35/00,,0,0,,,,ACTIVE
187,CN,A,CN 1057150 A,184-623-082-054-735,1991-12-18,1991,CN 91103728 A,1991-05-31,GB 9012326 A,1990-06-01,CHROMINANCE PROCESSING SYSTEM,,THOMSON CONSUMER ELECTRONICS,ERSOZ NATHANIEL HALUK;;SAEGER TIMOTHY WILLIAM;;JAMES HARRISON DOTY,,https://lens.org/184-623-082-054-735,Patent Application,no,0,0,282,300,0,G06T3/4007;;H04N3/223;;H04N3/227;;H04N3/27;;H04N5/2624;;H04N5/45;;H04N7/007;;H04N7/01;;H04N7/0105;;H04N7/0122;;H04N7/015;;H04N9/64;;H04N9/641;;H04N19/90;;G06T3/04;;H04N7/01;;H04N9/641;;H04N3/27;;H04N7/0122;;H04N5/45;;H04N7/0105;;H04N3/223;;H04N7/007;;H04N9/64;;H04N3/227;;H04N7/01;;G06T3/4007;;H04N7/015;;H04N5/2624;;H04N19/90;;G06T3/04,H04N5/46;;G06F3/00;;G06T3/40;;G09G5/00;;G09G5/14;;G09G5/377;;G09G5/391;;H04N3/223;;H04N3/227;;H04N3/27;;H04N5/073;;H04N5/14;;H04N5/262;;H04N5/265;;H04N5/44;;H04N5/45;;H04N7/00;;H04N7/01;;H04N7/015;;H04N7/26;;H04N9/64;;H04N11/06;;H04N11/20;;H04N11/24,,0,0,,,,EXPIRED
188,AU,B2,AU 2005/304952 B2,071-429-775-945-294,2013-04-04,2013,AU 2005/304952 A,2005-11-03,US 62603604 P;;US 64287805 P;;US 2005/0039922 W,2004-11-08,Nanoparticulate compositions of tubulin inhibitors,"The present invention is directed to novel pharmaceutical compositions comprinsing nano- and micro-particulate formulations of poorly water soluble tubulin inhibitors of the indole chemical class, preferably N-substituted indol-3-glyoxyamides, and more preferably N-(Pyridin-4-yl)-[1-(4-chlorobenzyl)-indol-3-yl]glyoxylic acid amide (D-24851), also known as “Indibulin”, and methods of making and using such compositions for the treatment of anti-tumor agent resistant cancers and other diseases.",BAXTER HEALTHCARE SA;;BAXTER INT,PAPADOPOULOS PAVLOS;;DOTY MARK;;KIPP JAMES E;;ROESSLER BERTHOLD,,https://lens.org/071-429-775-945-294,Granted Patent,no,1,0,16,17,0,A61K9/0019;;A61K9/0095;;A61K9/10;;A61K9/145;;A61K9/146;;A61K9/5123;;A61K9/5146;;A61K31/404;;A61K31/4439;;Y10T428/2982;;C07D401/12;;A61P1/18;;A61P11/02;;A61P11/06;;A61P19/02;;A61P29/00;;A61P31/04;;A61P35/00;;A61P35/04;;A61P37/02;;A61P37/06;;A61P37/08;;A61P43/00;;B82B3/00;;H01F27/12;;H01B3/20;;H01B3/00;;Y10T428/2982;;A61K31/4439;;A61K31/404;;A61K9/5123;;A61K9/5146;;A61K9/145;;A61K9/0095;;A61K9/10;;A61K9/146;;A61K9/0019;;A61K9/14;;C07D401/12,A61K31/404;;A61K9/00;;A61P35/00,,0,0,,,,INACTIVE
189,BR,B1,BR PI0413672 B1,106-003-568-163-871,2016-03-08,2016,BR PI0413672 A,2004-08-17,US 49601103 P;;US 2004/0026624 W,2003-08-19,"película, e, método para fabricar a mesma","Method for making a hollow body comprising, as sole layer(s), (1) at least one layer L1 comprising an aromatic polyamide and an impact modifier, and, optionally, (2) at least one layer L2 comprising an aliphatic polyamide, comprising extruding an aromatic polyamide and an impact modifier, and optionally extruding an aliphatic polyamide, through a die.",SOLVAY ADVANCED POLYMERS LLC,BERSTED BRUCE H;;BUSHELMAN CORINNE;;WARKOSKI GREGORY;;DOTY JAMES,,https://lens.org/106-003-568-163-871,Granted Patent,no,0,0,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04,,0,0,,,,INACTIVE
190,EP,A4,EP 1658165 A4,006-964-876-005-928,2009-04-01,2009,EP 04781335 A,2004-08-17,US 2004/0026624 W;;US 49601103 P,2003-08-19,IMPACT-MODIFIED POLYAMIDE FILM,"Method for making a hollow body comprising, as sole layer(s), (1) at least one layer L1 comprising an aromatic polyamide and an impact modifier, and, optionally, (2) at least one layer L2 comprising an aliphatic polyamide, comprising extruding an aromatic polyamide and an impact modifier, and optionally extruding an aliphatic polyamide, through a die.",SOLVAY ADVANCED POLYMERS LLC,BUSHELMAN CORINNE;;WARKOSKI GREGORY;;DOTY JAMES K;;BERSTED BRUCE,"SOLVAY SPECIALTY POLYMERS USA, LLC. (2011-11-30)",https://lens.org/006-964-876-005-928,Search Report,no,7,0,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,B28B1/00;;B28B3/00;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90;;B29D22/00;;B29D23/00;;B32B1/08;;B32B27/34;;C08L77/06,,0,0,,,,ACTIVE
191,US,A1,US 2023/0270466 A1,107-955-501-322-14X,2023-08-31,2023,US 202318102429 A,2023-01-27,US 202318102429 A;;US 202263304108 P,2022-01-28,BONE FIXATION SYSTEM AND DEVICE,A bone fixation device configured to fix one or more bone segments is provided.,FORMA MEDICAL INC,DAVISON ANDREW CHARLES;;GAULT JAMES A;;DOTY JESSE F,FORMA MEDCIAL LLC (2022-02-01),https://lens.org/107-955-501-322-14X,Patent Application,yes,0,0,2,2,0,A61B17/1717;;A61B17/1775;;A61B17/1796;;A61B17/7291;;A61B17/848;;A61B17/8605;;A61B17/864;;A61B17/8645;;A61B17/8685;;A61B17/8897;;A61B17/90;;A61B17/56;;A61B17/7035;;A61B2017/564,A61B17/56,,0,0,,,,PENDING
192,CA,A,CA 664862 A,182-991-312-212-134,1963-06-11,1963,CA 664862D A,,CA 664862T A,,MULTI-STATION SHOWER FIXTURE WITH SLOPING SHOWER HEAD PANEL,,LOGAN MFG COMPANY,LOGAN HUGH H;;DOTY GEORGE I;;NELSON JAMES F,,https://lens.org/182-991-312-212-134,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
193,GB,B,GB 2250391 B,183-533-570-391-09X,1994-08-24,1994,GB 9117131 A,1991-08-08,US 56618290 A,1990-08-13,Apparatus for generating phase shifted clock signals,,THOMSON CONSUMER ELECTRONICS,DOTY II JAMES HARRISON;;ALBEAN DAVID LAWRENCE;;BLATTER HAROLD,,https://lens.org/183-533-570-391-09X,Granted Patent,no,1,0,10,10,0,H03K5/00;;H03K5/133;;H03K5/133;;H03K2005/00195;;H03K2005/00195,H01L21/8234;;H01L27/088;;H03K5/00;;H03K5/13;;H03K5/15,H3P PPMP          PPMP;;H3T T1PX          -;;H3T T2B2          -;;H3T T2B3          -;;H3T T2F1          -;;H3T T2T2X         -;;H3T T2T3F         -;;H3T T3F1          -;;H3T T3J           -;;H3T T4D           -;;H3T T5E           -,0,0,,,,EXPIRED
194,US,B1,US 11175657 B1,155-655-599-851-424,2021-11-16,2021,US 201715836413 A,2017-12-08,US 201715836413 A,2017-12-08,Safe system controller for autonomous aircraft,The method and corresponding system for autonomous operation may include implementing a safe system controller for autonomous vehicles to receive a set of event data for an event encountered during operation of a vehicle from a status engine of the vehicle; analyze the received set of event data; determine a vehicle system state based on the analyzed set of event data; receive a set of automation operational parameters from an automation engine of the vehicle; receive a set of autonomy operational parameters from an autonomy engine of the vehicle; determine a response to the event from the set of automation operational parameters and the set of autonomy operational parameters based on the determined vehicle system state; and provide the determined response to the automation engine and the autonomy engine to adjust an operational parameter of the vehicle.,ROCKWELL COLLINS INC,BLOOM NICHOLAS H;;MCLEAN ANGUS L;;DOTY JAMES H,ROCKWELL COLLINS INC (2017-11-16),https://lens.org/155-655-599-851-424,Granted Patent,yes,1,1,1,1,0,B64D45/00;;B64D2045/0085;;G05D1/0055;;B64D43/00;;G05D1/0055;;G07C5/0808;;B64D2045/0085;;G05D1/0088;;B64D45/00;;G05D1/101,G05D1/00;;B64D45/00;;G05D1/10;;G07C5/08,,0,0,,,,ACTIVE
195,MX,A,MX 2007005434 A,023-086-720-072-905,2007-07-10,2007,MX 2007005434 A,2005-11-03,US 62603604 P;;US 64287805 P;;US 2005/0039922 W,2004-11-08,NANOPARTICULATE COMPOSITIONS OF TUBULIN INHIBITOR.,"The present invention is directed to novel pharmaceutical compositions comprising nano- and micro-particulate formulations of poorly water soluble tubulin inhibitors of the indole chemical class, preferably N-substituted indol-3-glyoxyamides, and more preferably N-(Pyridin-4-yl)-[1-(4-chlorobenzyl)-indol-3-yl]glyoxylic acid amide (D-24851), also known as Indibulin , and methods of making and using such compositions for the treatment of anti-tumor agent resistant cancers and other diseases.",BAXTER INT,KIPP JAMES E;;PAPADOPOULOS PAVLOS;;DOTY MARK;;ROESSLER BERTHOLD,,https://lens.org/023-086-720-072-905,Patent Application,no,0,0,16,17,0,A61K9/0019;;A61K9/0095;;A61K9/10;;A61K9/145;;A61K9/146;;A61K9/5123;;A61K9/5146;;A61K31/404;;A61K31/4439;;Y10T428/2982;;C07D401/12;;A61P1/18;;A61P11/02;;A61P11/06;;A61P19/02;;A61P29/00;;A61P31/04;;A61P35/00;;A61P35/04;;A61P37/02;;A61P37/06;;A61P37/08;;A61P43/00;;B82B3/00;;H01F27/12;;H01B3/20;;H01B3/00;;Y10T428/2982;;A61K31/4439;;A61K31/404;;A61K9/5123;;A61K9/5146;;A61K9/145;;A61K9/0095;;A61K9/10;;A61K9/146;;A61K9/0019;;A61K9/14;;C07D401/12,A61K9/00;;A61P35/00;;A61K31/404,,0,0,,,,ACTIVE
196,EP,B1,EP 1809279 B1,033-088-218-845-783,2013-05-29,2013,EP 05851355 A,2005-11-03,US 2005/0039922 W;;US 62603604 P;;US 64287805 P,2004-11-08,PARTICULATE COMPOSITIONS OF TUBULIN INHIBITOR,,BAXTER INT;;BAXTER HEALTHCARE SA,PAPADOPOULOS PAVLOS;;DOTY MARK;;KIPP JAMES E;;ROESSLER BERTHOLD,BAXTER HEALTHCARE S.A. (2010-01-06);;BAXTER INTERNATIONAL INC. (2010-01-06),https://lens.org/033-088-218-845-783,Granted Patent,yes,2,1,16,17,0,A61K9/0019;;A61K9/0095;;A61K9/10;;A61K9/145;;A61K9/146;;A61K9/5123;;A61K9/5146;;A61K31/404;;A61K31/4439;;Y10T428/2982;;C07D401/12;;A61P1/18;;A61P11/02;;A61P11/06;;A61P19/02;;A61P29/00;;A61P31/04;;A61P35/00;;A61P35/04;;A61P37/02;;A61P37/06;;A61P37/08;;A61P43/00;;B82B3/00;;H01F27/12;;H01B3/20;;H01B3/00;;Y10T428/2982;;A61K31/4439;;A61K31/404;;A61K9/5123;;A61K9/5146;;A61K9/145;;A61K9/0095;;A61K9/10;;A61K9/146;;A61K9/0019;;A61K9/14;;C07D401/12,A61K31/404;;A61K9/00;;A61P35/00,,0,0,,,,ACTIVE
197,CA,A,CA 653464 A,142-509-936-325-031,1962-12-04,1962,CA 653464D A,,CA 653464T A,,"FLUSH MOUNTED, DUSTPROOF GAS SERVICE CABINET",,LOGAN HOSPITAL EQUIPMENT CO,DOTY GEORGE I;;LOGAN HUGH H;;NELSON JAMES F,,https://lens.org/142-509-936-325-031,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
198,US,A,US 2999249 A,026-077-132-029-446,1961-09-12,1961,US 86217759 A,1959-12-28,US 86217759 A,1959-12-28,Retractable emergency wash facility,,LOGAN EMERGENCY SHOWERS INC,LOGAN HUGH H;;DOTY KENNETH G;;NELSON JAMES F,,https://lens.org/026-077-132-029-446,Granted Patent,no,6,48,1,1,0,A61H35/008;;A61H35/008,A61H35/00,,0,0,,,,EXPIRED
199,GB,A,GB 2250391 A,073-281-364-480-060,1992-06-03,1992,GB 9117131 A,1991-08-08,US 56618290 A,1990-08-13,APPARATUS FOR GENERATING PHASE SHIFTED CLOCK SIGNALS,,THOMSON CONSUMER ELECTRONICS,DOTY II JAMES HARRISON;;ALBEAN DAVID LAWRENCE;;BLATTER HAROLD,,https://lens.org/073-281-364-480-060,Patent Application,no,1,3,10,10,0,H03K5/00;;H03K5/133;;H03K5/133;;H03K2005/00195;;H03K2005/00195,H01L21/8234;;H01L27/088;;H03K5/00;;H03K5/13;;H03K5/15,H3P PPMD          PPMD;;H3P PPMP          PPMP;;H3T T1PX;;H3T T2B2;;H3T T2B3;;H3T T2F1          -;;H3T T2T2X         -;;H3T T2T3F         -;;H3T T3F1          -;;H3T T3J           -;;H3T T4D           -;;H3T T5E           -,0,0,,,,EXPIRED
200,US,B1,US 8260478 B1,115-235-434-453-899,2012-09-04,2012,US 87987307 A,2007-07-19,US 87987307 A,2007-07-19,Rotation rate tracking system using GPS harmonic signals,"A spin rate tracking system comprising a guidance system suitable for adjusting a flight path of a vehicle based on a spin rate of the vehicle, a signal reception system configured for receiving signal information from a global navigation system wherein a spin rate of the vehicle is derived from a substantially harmonic pattern produced amongst a global navigation signal.",GREEN GARY B;;SCHERRER FRANCIS KEITH;;DOTY JAMES H;;ROCKWELL COLLINS INC,GREEN GARY B;;SCHERRER FRANCIS KEITH;;DOTY JAMES H,ROCKWELL COLLINS INC (2007-07-18);;BAE SYSTEMS INFORMATION AND ELECTRONIC SYSTEMS INTEGRATION INC (2020-07-31),https://lens.org/115-235-434-453-899,Granted Patent,yes,20,4,1,1,0,B64G1/36;;F42B10/26;;F42B15/01;;G05D1/108;;F42B15/01;;B64G1/36;;F42B10/26;;G05D1/108,B64G1/36,701/13;;701/3;;102/393;;102/374;;102/384;;102/501;;244/3.1;;244/3.16;;244/3.21;;244/3.22;;244/3.23,0,0,,,,ACTIVE
201,MX,A,MX 2015008015 A,014-279-917-009-058,2015-10-22,2015,MX 2015008015 A,2013-12-04,US 201213729329 A;;US 2013/0073061 W,2012-12-28,ROLLER CLEANER.,"A cleaning device (10) is provided for removing debris from rotating conveyor rollers (12), and includes a housing (18) constructed and arranged for insertion between two adjacent rotating rollers, the housing having a first set of cleaning wheels (30) at a first housing end (24) associated with a first of the conveyor rollers, and a second set of cleaning wheels (32) located on an opposite end (26) of the housing and associated with a second of the conveyor rollers. At least one of the cleaning wheels (30a) is reciprocable relative to the housing between a retracted position permitting insertion of the housing between the rollers, and a extended position extending the reciprocating wheel towards the adjacent roller for limiting lateral movement of the housing between the rollers. Upon movement of the housing between the rollers in a direction parallel to a longitudinal axis of the rollers, the cleaning wheels operationally engage and remove residue collected on the rollers.",UNITED STATES GYPSUM CO,SCHENCK RONALD EDWARD;;DOTY WILLIAM JAMES;;HENRY ANTHONY A,,https://lens.org/014-279-917-009-058,Patent Application,no,0,0,9,9,0,B65G45/10;;B08B1/30;;B08B1/32;;B65G45/10;;B08B1/30;;B08B1/32,B65G45/10;;B08B1/00;;B08B1/04,,0,0,,,,ACTIVE
202,US,B1,US 11337034 B1,041-923-378-818-983,2022-05-17,2022,US 202016993214 A,2020-08-13,US 202016993214 A,2020-08-13,Staggered examination of non-trusted receiver information,"A system detects slowly diverging navigational signals by updating the current location from purely internal navigational aids for a period of time. The updated location compared to a continuously corrected current location; if the comparison indicates a deviation outside an expected boundary threshold, the external source is excluded from further measurements. Multiple monitoring elements may be staggered such that one or more monitoring elements are always sequestered for future comparisons. The multiple monitoring elements may monitor different external sources with different weights to identify a specific faulty external source.",ROCKWELL COLLINS INC,DOTY JAMES H;;ANDERSON DAVID A;;HWANG PATRICK Y,ROCKWELL COLLINS INC (2020-07-28),https://lens.org/041-923-378-818-983,Granted Patent,yes,31,0,1,1,0,H04W4/027;;H04W4/029;;G01S19/396;;G01S19/48;;H04W4/029;;G01S19/26;;H04W4/027,H04W24/00;;G01S19/26;;H04W4/02;;H04W4/029,,0,0,,,,ACTIVE
203,US,A,US 3184762 A,172-824-480-945-889,1965-05-25,1965,US 31574063 A,1963-10-09,US 31574063 A,1963-10-09,Multi-station shower fixture with sloping shower head panel,,LOGAN MFG COMPANY,LOGAN HUGH H;;DOTY GEORGE I;;NELSON JAMES F,,https://lens.org/172-824-480-945-889,Granted Patent,no,3,8,1,1,0,E03C1/16;;E03C1/16;;E03B9/20;;E03B9/20,E03B9/20;;E03C1/16,,0,0,,,,EXPIRED
204,KR,A,KR 20070094745 A,061-463-052-606-455,2007-09-21,2007,KR 20077014394 A,2007-06-22,EP 05107816 A;;US 63020404 P,2004-11-24,IMPROVED MULTILAYER POLYMER STRUCTURE,"Multilayer Polymer Structure Mu ltilayer structure comprising at least one couple (L1-L2) of adjacent layers (L1) and (L2), wherein layer (L1) comprises at least one polymer composition (C1) comprising a grafted fluoropolymer material (M1) consisting of N1 grafted fluoropolymer(s) (P1), said polymer(s) (P1) obtained by a process comprising grafting onto an ungrafted fluoropolymer (U1) at least one grafting agent (G1) chosen from ethylenically unsaturated carboxy acids, their esters, their anhydrides and their salts, layer (L2) comprises at least one polymer composition (C2) comprising at least one impact modifier (I2) and a semi-crystalline aromatic polyamide material (M2) consisting of N2 semi-crystalline aromatic polyamide polymer(s) (P2), and the average melting temperature (Tav,1) of material (M1) differs by at most 45°C from the average melting temperature (Tav,2) of material (M2), N j being the number of polymer(s) (Pj) of material (Mj), Nj >= 1, Tav, j being equal to formula (I) wi,j being the weight amount of the ith polymer (Pj) of material (Mj), T i,j being the melting temperature of the ith polymer (Pj) of material (Mj), Wj being the total weight amount of material (Mj), fo r j = 1 and for j = 2. Process for manufacturing the above multilayer structure, which comprises co-extruding polymer compositions (C1) and (C2), so as to obtain couple (L1-L2) of adjacent layers (L1) and (L2). Shaped article comprising the above multilayer structure, and process for manufacturing it.",SOLVAY ADVANCED POLYMERS LLC,BUSHELMAN CORINNE;;DOTY JAMES K;;DE CANNIERE JEAN;;BILLIET JOHAN,,https://lens.org/061-463-052-606-455,Patent Application,no,0,0,10,10,0,B32B27/08;;B32B27/28;;B32B27/30;;B32B27/30;;B32B27/304;;B32B27/322;;B32B27/34;;B32B27/34;;Y10T428/24942;;Y10T428/24942;;Y10T428/3154;;Y10T428/3154;;Y10T428/31725;;Y10T428/31725,B32B27/28,,0,0,,,,DISCONTINUED
205,BR,A2,BR PI0518285 A2,023-822-739-828-656,2008-11-11,2008,BR PI0518285 A,2005-11-23,US 63020404 P;;EP 05107816 A;;EP 2005056181 W,2004-11-24,"estrutura de méltiplas camadas, processo para fabricar a mesma artigo moldado, e, processo para fabricar o mesmo","ESTRUTURA DE MéLTIPLAS CAMADAS, PROCESSO PARA FABRICAR A MESMA, ARTIGO MOLDADO, E, PROCESSO PARA FABRICAR O MESMO. Estrutura polimérica de múltiplas camadas que compreende pelo menos um par (L1-L2) de camadas adjacentes (L1) e (L2), em que a camada (L1) compreende pelo menos uma composição de polímero (C1) que compreende um material de fluoropolimero enxertado (Ml) que consiste de fluoropolimero(s) enxertado(s) N1 (P1), o(s) dito(s) polímero(s) (P 1) obtidos por um processo que compreende enxertar em um fluoropolímero não enxertado (Ul) pelo menos um agente de enxerto (Gl) escolhido de ácidos carbóxi etílemcamente insaturados, ésteres dos mesmos, anidridos dos mesmos e sais dos mesmos, a camada (L2) compreende pelo menos uma composição de polímero (C2) que compreende pelo menos um modificador de impacto (12) e um material de políamida aromático semícristalino (M2) que consiste de polímero(s) de políamida aromático(s) semicristalino(s) N2 (P2), e a temperatura de fusão média (T~ av,1~) do material (Ml) difere quando muito em 45°C da temperatura de fusão média (T~ av,2~) do material (M2), N~ j~ sendo o número de polímero(s) (Pj) do material (Mj), Nj 1 <242> 1, T~ av,j~ sendo igual para a fórmula (I) W ~ ij~ sendo a quantidade em peso do iº polímero (Pj) do material (Mj), T~ ij~ sendo a temperatura de fusão do iº polímero (Pj) do material (Mj), W~ i~, sendo a quantidade total em peso do material (Mj), para j = 1 e para j = 2. O processo para fabricar a estrutura de múltiplas camadas acima, que compreende as composições de polímero de co-extrusão (Cl) e (C2), de modo a obter o par (Ll-L2) de camadas adjacentes (Li) e (L2). Um artigo moldado que compreende a estrutura de múltiplas camadas acima, e o processo de fabricá-lo.",SOLVAY ADVANCED POLYMERS LLC,DOTY JAMES K;;BILLIET JOHAN;;BUSHELMAN CORINNE;;CANNIERE JEAN DE,,https://lens.org/023-822-739-828-656,Patent Application,no,0,0,10,10,0,B32B27/08;;B32B27/28;;B32B27/30;;B32B27/30;;B32B27/304;;B32B27/322;;B32B27/34;;B32B27/34;;Y10T428/24942;;Y10T428/24942;;Y10T428/3154;;Y10T428/3154;;Y10T428/31725;;Y10T428/31725,B32B27/30;;B32B27/34,,0,0,,,,DISCONTINUED
206,TW,A,TW 200510473 A,040-024-832-828-618,2005-03-16,2005,TW 93124881 A,2004-08-18,US 49601103 P,2003-08-19,Impact-modified polyamide film,"Impact-modified polyamide film. A film comprising, as sole layers, (1) at least one layer L1 comprising an aromatic polyamide and an impact modifier, and, optionally, (2) at least one layer L2 comprising an aliphatic polyamide.",SOLVAY ADVANCED POLYMERS LLC,BUSHELMAN CORINNE;;WARKOSKI GREGORY;;DOTY JAMES K;;BERSTED BRUCE H,,https://lens.org/040-024-832-828-618,Patent of Addition,no,0,0,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90;;B32B27/34,,0,0,,,,PENDING
207,US,A1,US 2006/0134150 A1,073-442-008-896-443,2006-06-22,2006,US 28339706 A,2006-02-27,US 28339706 A;;US 3582101 A;;US 95397901 A;;US 87463701 A;;US 25816000 P,2000-12-22,Submicron suspensions with polymorph control,"The present invention provides a method for preparing a suspension of a pharmaceutically active compound, the solubility of which is greater in a water miscible first organic solvent than in a second solvent which is aqueous, The process includes the steps of: (i) dissolving a first quantity of the pharmaceutically active compound in the water miscible first organic solvent to form a first solution; (ii) mixing the first solution with the second solvent to precipitate the pharmaceutically active compound; and (iii) seeding the first solution or the second solvent or the presuspension.",WERLING JANE;;KIPP JAMES E;;SRIRAM RAJARAM;;DOTY MARK J,WERLING JANE;;KIPP JAMES E;;SRIRAM RAJARAM;;DOTY MARK J,BAXTER INTERNATIONAL INC (2002-01-11),https://lens.org/073-442-008-896-443,Patent Application,yes,1,9,3,86,0,A61K9/10;;A61K9/10;;A61K9/14;;A61K9/14;;A61K9/145;;A61K9/145;;A61K9/146;;A61K9/146;;A61K9/1688;;A61K9/1688;;A61K31/495;;A61K31/495;;A61K31/496;;A61K31/496,A61K9/00;;A61K9/10;;A61K9/14;;A61K9/16;;A61K31/495;;A61K31/496,424/400,0,0,,,,DISCONTINUED
208,US,B2,US 7811671 B2,139-920-515-415-305,2010-10-12,2010,US 56861204 A,2004-08-17,US 56861204 A;;US 49601103 P;;US 2004/0026624 W,2003-08-19,Impact-modified polyamide film,Films made from impact-modified polyamide.,SOLVAY ADVANCED POLYMERS LLC,BUSHELMAN CORINNE;;WARKOSKI GREGORY;;DOTY JAMES K;;BERSTED BRUCE H,SOLVAY ADVANCED POLYMERS LLC (2005-08-20),https://lens.org/139-920-515-415-305,Granted Patent,yes,13,16,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,B32B27/34;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90;;B32B27/06,428/474.4,3,0,,,"U.S. Appl. No. 11/720,128, filed May 24, 2007, Bushelman, et al.;;U.S. Appl. No. 11/720,044, filed May 23, 2007, Bushelman, et al.;;U.S. Appl. No. 10/568,612, filed Feb. 17, 2006, Bersted, et al.",ACTIVE
209,US,A1,US 2008/0241562 A1,199-631-293-785-743,2008-10-02,2008,US 56861204 A,2004-08-17,US 56861204 A;;US 49601103 P;;US 2004/0026624 W,2003-08-19,Impact-Modified Polyamide Film,Films made from impact-modified polyamide.,SOLVAY ADVANCED POLYMERS LLC,BUSHELMAN CORINNE;;WARKOSKI GREGORY;;DOTY JAMES K;;BERSTED BRUCE H,SOLVAY ADVANCED POLYMERS LLC (2005-08-20),https://lens.org/199-631-293-785-743,Patent Application,yes,11,14,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,B32B27/34;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90,428/474.9;;428/474.7;;264/176.1,0,0,,,,ACTIVE
210,CN,B,CN 101448641 B,183-457-784-899-903,2012-05-30,2012,CN 200780018123 A,2007-04-13,EP 2007053634 W;;US 79263106 P,2006-04-18,Multilayer polymer structure,"The present invention provides a multilayer polymer structure comprising at least one couple (L1-L2) of adjacent layers (L1) and (L2), wherein: layer (L1) comprises at least one polymer composition (C1) comprising: (i) at least one semi-aromatic polyamide, and (ii) at least one impact modifier (I1); layer (L2) comprises at least one polymer composition (C2) comprising: (i) at least one un-functionalized polyolefin (PO2); (ii) at least one functionalized polyolefin (FPO2), said functionalized polyolefin comprising functional groups chosen from carboxylic groups, their esters, their anhydrides and their salts Process for manufacturing said multilayer structure, which comprises co-extruding or co-blowmolding polymer compositions (C1) and (C2) so as to obtain couple (L1- L2) of adjacent layers (L1) and (L2). Shaped article comprising the invented multilayer structure and process for manufacturing the shaped article.",SOLVAY ADVANCED POLYMERS LLC,GREGORY WARKOSKI;;DOTY JAMES K;;ALICE LIU;;JEAN DE CANNIERE,,https://lens.org/183-457-784-899-903,Granted Patent,no,0,0,18,18,0,B32B1/08;;B32B25/14;;B32B27/08;;B32B27/20;;B32B27/32;;B32B27/34;;B32B2264/108;;B32B2270/00;;B32B2307/202;;B32B2439/00;;B32B2597/00;;Y10T428/1352;;Y10T428/27;;Y10T428/1393;;Y10T428/139;;Y10T428/31725;;Y10T428/3175;;B32B1/00;;B32B27/34;;B32B27/32;;Y10T428/1352;;Y10T428/27;;Y10T428/1393;;Y10T428/139;;Y10T428/31725;;Y10T428/3175;;B32B1/08;;B32B2597/00;;B32B27/34;;B32B2264/108;;B32B27/32;;B32B2439/00;;B32B27/08;;B32B2270/00;;B32B27/20;;B32B2307/202;;B32B25/14;;B32B1/00,B32B27/32;;B32B27/34,,0,0,,,,INACTIVE
211,US,A1,US 2003/0044433 A1,130-026-390-468-353,2003-03-06,2003,US 3582101 A,2001-10-19,US 3582101 A;;US 95397901 A;;US 87463701 A;;US 25816000 P,2000-12-22,Method for preparing submicron suspensions with polymorph control,"
   The present invention provides a method for preparing a suspension of a pharmaceutically-active compound, the solubility of which is greater in a water-miscible first organic solvent than in a second solvent which is aqueous. The process includes the steps of: (i) dissolving a first quantity of the pharmaceutically-active compound in the water-miscible first organic solvent to form a first solution; (ii) mixing the first solution with the second solvent to precipitate the pharmaceutically-active compound; and (iii) seeding the first solution or the second solvent or the presuspension. 
",WERLING JANE;;KIPP JAMES E.;;SRIRAM RAJARAM;;DOTY MARK J.,WERLING JANE;;KIPP JAMES E;;SRIRAM RAJARAM;;DOTY MARK J,BAXTER INTERNATIONAL INC (2002-01-11),https://lens.org/130-026-390-468-353,Patent Application,yes,99,23,3,86,0,A61K9/10;;A61K9/10;;A61K9/14;;A61K9/14;;A61K9/145;;A61K9/145;;A61K9/146;;A61K9/146;;A61K9/1688;;A61K9/1688;;A61K31/495;;A61K31/495;;A61K31/496;;A61K31/496,A61K9/10;;A61K9/14;;A61K9/16;;A61K31/495;;A61K31/496,4244;;516/77,0,0,,,,EXPIRED
212,CN,B,CN 101065245 B,138-308-757-680-374,2010-05-05,2010,CN 200580040352 A,2005-11-23,EP 2005056181 W;;EP 05107816 A;;US 63020404 P,2004-11-24,Improved multilayer polymer structure,"Multilayer Polymer Structure comprising at least one couple (L1-L2) of adjacent layers (L1) and (L2), wherein layer (L1) comprises at least one polymer composition (C1) comprising a grafted fluoropolymer material (M1) consisting of N1 grafted fluoropolymer(s) (P1), said polymer(s) (P1) obtained by a process comprising grafting onto an ungrafted fluoropolymer (U1) at least one grafting agent (G1) chosen from ethylenically unsaturated carboxy acids, their esters, their anhydrides and their salts, layer (L2) comprises at least one polymer composition (C2) comprising at least one impact modifier (I2) and a semi-crystalline aromatic polyamide material (M2) consisting of N2 semi-crystalline aromatic polyamide polymer(s) (P2), and the average melting temperature (Tav,1) of material (M1) differs by at most 45 DEG C from the average melting temperature (Tav,2) of material (M2), Nj being the number of polymer(s) (Pj) of material (Mj), Nj = 1, Tav, j being equal to formula (I) wi,j being the weight amount of the i<th> polymer (Pj) of material (Mj), Ti,j being the melting temperature of the i<th> polymer (Pj) of material (Mj), Wj being the total weight amount of material (Mj), fo r j = 1 and for j = 2. Process for manufacturing the above multilayer structure is disclosed, which comprises co-extruding polymer compositions (C1) and (C2), so as to obtain couple (L1-L2) of adjacent layers (L1)and (L2). Shaped article comprising the above multilayer structure, and process for manufacturing it are also disclosed.",SOLVAY ADVANCED POLYMERS LLC,CORINNE BUSHELMAN;;DOTY JAMES K;;JEAN DE CANNIERE;;JOHAN BILLIET,,https://lens.org/138-308-757-680-374,Granted Patent,no,0,0,10,10,0,B32B27/08;;B32B27/28;;B32B27/30;;B32B27/30;;B32B27/304;;B32B27/322;;B32B27/34;;B32B27/34;;Y10T428/24942;;Y10T428/24942;;Y10T428/3154;;Y10T428/3154;;Y10T428/31725;;Y10T428/31725,B32B27/30;;B32B27/34,,0,0,,,,ACTIVE
213,US,A1,US 2008/0118756 A1,087-158-506-073-853,2008-05-22,2008,US 72012805 A,2005-11-23,US 72012805 A;;EP 05107816 A;;US 63020404 P;;EP 2005056181 W,2004-11-24,Multilayer Polymer Structure,"Multilayer Polymer Structure Multilayer structure comprising at least one couple (L1-L2) of adjacent layers (L1) and (L2), wherein layer (L1) comprises at least one polymer composition (C1) comprising a grafted fluoropolymer material (M1) consisting of N1 grafted fluoropolymer(s) (P1), said polymer(s) (P1) obtained by a process comprising grafting onto an ungrafted fluoropolymer (U1) at least one grafting agent (G1) chosen from ethylenically unsaturated carboxy acids, their esters, their anhydrides and their salts, layer (L2) comprises at least one polymer composition (C2) comprising at least one impact modifier (I2) and a semi-crystalline aromatic polyamide material (M2) consisting of N2 semi-crystalline aromatic polyamide polymer(s) (P2), and the average melting temperature (T av,1 ) of material (M1) differs by at most 45° C. from the average melting temperature (T av,2 ) of material (M2), N j being the number of polymer(s) (Pj) of material (Mj), Nj>1, T av,j being equal to formula (T) w i,j being the weight amount of the i th polymer (Pj) of material (Mj), T i,j being the melting temperature of the i th polymer (Pj) of material (Mj), W j being the total weight amount of material (Mj), for j=1 and for j=2. Process for manufacturing the above multilayer structure, which comprises co-extruding polymer compositions (C1) and (C2), so as to obtain couple (L1-L2) of adjacent layers (T1) and (T2). Shaped article comprising the above multilayer structure, and process for manufacturing it.",SOLVAY ADVANCE POLYMERS L L C,BUSHELMAN CORINNE;;DOTY JAMES K;;DE CANNIERE JEAN;;BILLIET JOHAN,SOLVAY ADVANCED POLYMERS L.L.C (2006-02-10),https://lens.org/087-158-506-073-853,Patent Application,yes,7,5,10,10,0,B32B27/08;;B32B27/28;;B32B27/30;;B32B27/30;;B32B27/304;;B32B27/322;;B32B27/34;;B32B27/34;;Y10T428/24942;;Y10T428/24942;;Y10T428/3154;;Y10T428/3154;;Y10T428/31725;;Y10T428/31725,B32B27/06;;B28B5/00,428/421;;264/241,0,0,,,,ACTIVE
214,US,A1,US 2011/0028650 A1,062-591-721-950-396,2011-02-03,2011,US 84903810 A,2010-08-03,US 84903810 A;;US 56861208 A;;US 2004/0026624 W;;US 49601103 P,2003-08-19,METHOD FOR MAKING A POLYAMIDE FILM,"Method for making a film comprising, as sole layer(s), at least one layer L1 consisting of a polyamide composition comprising an aromatic polyamide and an impact modifier, said method comprising extruding the polyamide composition into the film.",SOLVAY ADVANCED POLYMERS LLC,BUSHELMAN CORINNE;;WARKOSKI GREGORY;;DOTY JAMES K;;BERSTED BRUCE H,,https://lens.org/062-591-721-950-396,Patent Application,yes,33,1,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,C08L77/00;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90;;B32B27/34;;C08L15/00;;C08L53/00,525/93;;525/420;;525/178,0,0,,,,DISCONTINUED
215,AT,T1,AT E450250 T1,062-951-675-237-050,2009-12-15,2009,AT 02773797 T,2002-10-18,US 34754801 P;;US 27026702 A;;US 0233270 W,2001-10-19,STABILE ZUSAMMENSETZUNG ENHALTEND PARTIKEL IN EINER GEFRORENEN WÄSSRIGEN MATRIX,"The present invention discloses a composition of a stable suspension of a poorly water soluble pharmaceutical agent or cosmetic in the form of particles of the pharmaceutical agent or cosmetic suspended in a frozen aqueous matrix and method for its preparation. The composition is stable for a prolonged period of time, preferably six months or longer and is suitable for parenteral, oral, or non-oral routes such as pulmonary (inhalation), ophthalmic, or topical administration.",BAXTER INT,KIPP JAMES;;DOTY MARK;;REBBECK CHRISTINE;;BRYNJELSEN SEAN;;KONKEL JAMIE,,https://lens.org/062-951-675-237-050,Granted Patent,no,0,0,16,17,0,A61K8/02;;A61K8/044;;A61K9/10;;A61K9/145;;A61K9/146;;A61K31/12;;A61K31/4985;;A61K31/58;;A61K2800/92;;A61Q19/00;;A61K8/044;;A61Q19/00;;A61K31/58;;A61K9/10;;A61K8/02;;A61K9/145;;A61K31/4985;;A61K2800/92;;A61K9/146;;A61K31/12,A61K8/02;;A61K8/04;;A61K8/06;;A61K8/34;;A61K8/35;;A61K8/36;;A61K8/365;;A61K8/37;;A61K8/39;;A61K8/40;;A61K8/41;;A61K8/44;;A61K8/46;;A61K8/60;;A61K8/64;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K9/10;;A61K9/107;;A61K9/14;;A61K31/12;;A61K31/4985;;A61K31/58;;A61K47/02;;A61K47/06;;A61K47/10;;A61K47/12;;A61K47/14;;A61K47/16;;A61K47/18;;A61K47/20;;A61K47/26;;A61K47/32;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61K47/44;;A61K47/46;;A61Q19/00,,0,0,,,,EXPIRED
216,EP,A1,EP 1757443 A1,061-939-794-731-336,2007-02-28,2007,EP 05107816 A,2005-08-25,EP 05107816 A,2005-08-25,Improved multilayer polymer structure,"Multilayer structure comprising at least one couple (L1-L2) ofadjacent layers (L1) and (L2), wherein 
■ layer (L1) comprises at least one polymer composition (C1) comprising a grafted fluoropolymer material (M1) consisting of N 1  grafted fluoropolymer(s) (P1), said polymer(s) (P1) obtained by a process comprising grafting onto an ungrafted fluoropolymer (U1) at least one grafting agent (G1) chosen from ethylenically unsaturated carboxy acids, their esters, their anhydrides and their salts, 
■ layer (L2) comprises at least one polymer composition (C2) comprising at least one impact modifier (I2) and a semi-crystalline aromatic polyamide material (M2) consisting of N 2  semi-crystalline aromatic polyamide polymer(s) (P2), and 
■ the average melting temperature (T av,1 ) of material (M1) differs by at most 45°C from the average melting temperature (T av,2 ) of material (M2), 
N j  being the number of polymer(s) (Pj) of material (Mj), Nj ≥ 1, 
T av,j  being equal to   
w i,j  being the weight amount of the i th  polymer (Pj) of material (Mj), 
T i,j  being the melting temperature of the i th  polymer (Pj) of material (Mj), 
W j  being the total weight amount of material (Mj), 
for j = 1 and for j = 2. Process for manufacturing the above multilayer structure, which comprises co-extruding polymer compositions (C1) and (C2), so as to obtain couple (L1-L2) of adjacent layers (L1) and (L2). Shaped article comprising the above multilayer structure, and process for manufacturing it.",SOLVAY ADVANCED POLYMERS LLC,BUSHELMAN CORINNE;;DOTY JAMES K;;DE CANNIERE JEAN;;BILLIET JOHAN,,https://lens.org/061-939-794-731-336,Patent Application,yes,5,2,10,10,0,B32B27/30;;B32B27/34;;Y10T428/24942;;Y10T428/31725;;Y10T428/3154;;B32B27/28;;Y10T428/24942;;Y10T428/31725;;Y10T428/3154;;B32B27/08;;B32B27/304;;B32B27/322;;B32B27/34;;B32B27/30,B32B27/30;;B32B27/34,,1,0,,,"""DuPont Tefzel HT-2202 Production Information"", August 2002, DUPONT, USA, XP002358004",DISCONTINUED
217,US,B2,US 7960014 B2,072-380-927-728-937,2011-06-14,2011,US 72012805 A,2005-11-23,US 72012805 A;;EP 05107816 A;;US 63020404 P;;EP 2005056181 W,2004-11-24,Multilayer polymer structure,"Multilayer Polymer Structure Multilayer structure comprising at least one couple (L1-L2) of adjacent layers (L1) and (L2), wherein layer (L1) comprises at least one polymer composition (C1) comprising a grafted fluoropolymer material (M1) consisting of N1 grafted fluoropolymer(s) (P1), said polymer(s) (P1) obtained by a process comprising grafting onto an ungrafted fluoropolymer (U1) at least one grafting agent (G1) chosen from ethylenically unsaturated carboxy acids, their esters, their anhydrides and their salts, layer (L2) comprises at least one polymer composition (C2) comprising at least one impact modifier (I2) and a semi-crystalline aromatic polyamide material (M2) consisting of N2 semi-crystalline aromatic polyamide polymer(s) (P2), and the average melting temperature (T av,1 ) of material (M1) differs by at most 45° C. from the average melting temperature (T av,2 ) of material (M2), N j being the number of polymer(s) (Pj) of material (Mj), Nj>1, T av,j being equal to formula (T) w i,j being the weight amount of the i th polymer (Pj) of material (Mj), T i,j being the melting temperature of the i th polymer (Pj) of material (Mj), W j being the total weight amount of material (Mj), for j=1 and for j=2. Process for manufacturing the above multilayer structure, which comprises co-extruding polymer compositions (C1) and (C2), so as to obtain couple (L1-L2) of adjacent layers (T1) and (T2). Shaped article comprising the above multilayer structure, and process for manufacturing it.",SOLVAY ADVANCED POLYMERS LLC,BUSHELMAN CORINNE;;DOTY JAMES K;;DE CANNIERE JEAN;;BILLIET JOHAN,SOLVAY ADVANCED POLYMERS L.L.C (2006-02-10),https://lens.org/072-380-927-728-937,Granted Patent,yes,16,2,10,10,0,B32B27/08;;B32B27/28;;B32B27/30;;B32B27/30;;B32B27/304;;B32B27/322;;B32B27/34;;B32B27/34;;Y10T428/24942;;Y10T428/24942;;Y10T428/3154;;Y10T428/3154;;Y10T428/31725;;Y10T428/31725,B29C47/06;;B32B7/02;;B32B27/08;;B32B27/30;;B32B27/34,428/212;;428/421;;428/474.4;;156/244.11,6,0,,,"MatWeb database overview entry for PFA, Apr. 2010.;;Dupont Tefzel HT-2202 Production Information, Aug. 2002, XP002358004.;;U.S. Appl. No. 11/720,044, filed May 23, 2007, Bushelman, et al.;;U.S. Appl. No. 10/568,612, filed Feb. 16, 2006, Bushelman, et al.;;U.S. Appl. No. 12/849,039, filed Aug. 3, 2010, Bersted, et al.;;U.S. Appl. No. 12/849,038, filed Aug. 3, 2010, Bushelman, et al.",ACTIVE
218,WO,A1,WO 2007/118860 A1,090-805-326-336-122,2007-10-25,2007,EP 2007053634 W,2007-04-13,US 79263106 P,2006-04-18,MULTILAYER POLYMER STRUCTURE,"Multilayer structure comprising at least one couple (L1-L2) of adjacent layers (L1) and (L2), wherein: layer (L1) comprises at least one polymer composition (C1) comprising: (i) at least one semi-aromatic polyamide, and (ii) at least one impact modifier (I1); layer (L2) comprises at least one polymer composition (C2) comprising: (i) at least one un-functionalized polyolefin (PO2); (ii) at least one functionalized polyolefin (FPO2), said functionalized polyolefin comprising functional groups chosen from carboxylic groups, their esters, their anhydrides and their salts Process for manufacturing said multilayer structure, which comprises co-extruding or co-blowmolding polymer compositions (C1) and (C2) so as to obtain couple (L1- L2) of adjacent layers (L1) and (L2). Shaped article comprising the invented multilayer structure and process for manufacturing the shaped article.",SOLVAY ADVANCED POLYMERS LLC;;DOTY JAMES K;;LIU ALICE;;WARKOSKI GREGORY;;DE CANNIERE JEAN,DOTY JAMES K;;LIU ALICE;;WARKOSKI GREGORY;;DE CANNIERE JEAN,,https://lens.org/090-805-326-336-122,Patent Application,yes,5,3,18,18,0,B32B1/08;;B32B25/14;;B32B27/08;;B32B27/20;;B32B27/32;;B32B27/34;;B32B2264/108;;B32B2270/00;;B32B2307/202;;B32B2439/00;;B32B2597/00;;Y10T428/1352;;Y10T428/27;;Y10T428/1393;;Y10T428/139;;Y10T428/31725;;Y10T428/3175;;B32B1/00;;B32B27/34;;B32B27/32;;Y10T428/1352;;Y10T428/27;;Y10T428/1393;;Y10T428/139;;Y10T428/31725;;Y10T428/3175;;B32B1/08;;B32B2597/00;;B32B27/34;;B32B2264/108;;B32B27/32;;B32B2439/00;;B32B27/08;;B32B2270/00;;B32B27/20;;B32B2307/202;;B32B25/14;;B32B1/00,B32B27/32;;B32B27/34,,2,0,,,"DATABASE WPI Week 200336, Derwent World Patents Index; AN 2003-375872, XP002443005;;DATABASE WPI Week 199412, Derwent World Patents Index; AN 1994-097417, XP002443006",PENDING
219,WO,A1,WO 2006/056581 A1,119-612-975-496-783,2006-06-01,2006,EP 2005056181 W,2005-11-23,US 63020404 P;;EP 05107816 A,2004-11-24,IMPROVED MULTILAYER POLYMER STRUCTURE,"Multilayer Polymer Structure Mu ltilayer structure comprising at least one couple (L1-L2) of adjacent layers (L1) and (L2), wherein layer (L1) comprises at least one polymer composition (C1) comprising a grafted fluoropolymer material (M1) consisting of N1 grafted fluoropolymer(s) (P1), said polymer(s) (P1) obtained by a process comprising grafting onto an ungrafted fluoropolymer (U1) at least one grafting agent (G1) chosen from ethylenically unsaturated carboxy acids, their esters, their anhydrides and their salts, layer (L2) comprises at least one polymer composition (C2) comprising at least one impact modifier (I2) and a semi-crystalline aromatic polyamide material (M2) consisting of N2 semi-crystalline aromatic polyamide polymer(s) (P2), and the average melting temperature (Tav,1) of material (M1) differs by at most 45&deg;C from the average melting temperature (Tav,2) of material (M2), Nj being the number of polymer(s) (Pj) of material (Mj), Nj &ge; 1, Tav, j being equal to formula (I) wi,j being the weight amount of the ith polymer (Pj) of material (Mj), Ti,j being the melting temperature of the ith polymer (Pj) of material (Mj), Wj being the total weight amount of material (Mj), fo r j = 1 and for j = 2. Process for manufacturing the above multilayer structure, which comprises co-extruding polymer compositions (C1) and (C2), so as to obtain couple (L1-L2) of adjacent layers (L1) and (L2). Shaped article comprising the above multilayer structure, and process for manufacturing it.",SOLVAY ADVANCED POLYMERS LLC;;BUSHELMAN CORINNE;;DOTY JAMES K;;DE CANNIERE JEAN;;BILLIET JOHAN,BUSHELMAN CORINNE;;DOTY JAMES K;;DE CANNIERE JEAN;;BILLIET JOHAN,,https://lens.org/119-612-975-496-783,Patent Application,yes,4,13,10,10,0,B32B27/08;;B32B27/28;;B32B27/30;;B32B27/30;;B32B27/304;;B32B27/322;;B32B27/34;;B32B27/34;;Y10T428/24942;;Y10T428/24942;;Y10T428/3154;;Y10T428/3154;;Y10T428/31725;;Y10T428/31725,B32B27/30;;B32B27/34,,1,0,,,"""DuPont Tefzel HT-2202 Production Information"", August 2002, DUPONT, USA, XP002358004",PENDING
220,EP,A1,EP 1833669 A1,183-531-025-633-197,2007-09-19,2007,EP 05817096 A,2005-11-23,EP 2005056181 W;;US 63020404 P;;EP 05107816 A;;EP 05817096 A,2004-11-24,IMPROVED MULTILAYER POLYMER STRUCTURE,,SOLVAY ADVANCED POLYMERS LLC,BUSHELMAN CORINNE;;DOTY JAMES K;;DE CANNIERE JEAN;;BILLIET JOHAN,"SOLVAY SPECIALTY POLYMERS USA, LLC. (2011-11-30)",https://lens.org/183-531-025-633-197,Patent Application,yes,0,0,10,10,0,B32B27/08;;B32B27/28;;B32B27/30;;B32B27/30;;B32B27/304;;B32B27/322;;B32B27/34;;B32B27/34;;Y10T428/24942;;Y10T428/24942;;Y10T428/3154;;Y10T428/3154;;Y10T428/31725;;Y10T428/31725,B32B27/30;;B32B27/34,,1,0,,,See references of WO 2006056581A1,DISCONTINUED
221,US,A1,US 2003/0096013 A1,167-658-112-576-491,2003-05-22,2003,US 24680202 A,2002-09-17,US 24680202 A;;US 3582101 A;;US 95397901 A;;US 87463701 A;;US 25816000 P,2000-12-22,Preparation of submicron sized particles with polymorph control,"
   The present invention provides a method of preparing particles with polymorph and size control of a pharmaceutical compound, the method including the steps of: (1) providing a pharmaceutical compound in a first phase; (2) seeding the compound; (3) causing a phase change in the pharmaceutical compound to a second phase of a desired polymorphic form; and (4) wherein the mean particle size of the particles is less than 7 m. 
",WERLING JANE;;KIPP JAMES E.;;SRIRAM RAJARAM;;DOTY MARK J.,WERLING JANE;;KIPP JAMES E;;SRIRAM RAJARAM;;DOTY MARK J,BAXTER INTERNATIONAL INC (2002-09-26),https://lens.org/167-658-112-576-491,Patent Application,yes,99,37,1,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K31/495;;A61K31/496;;A61K9/10;;A61K9/1688;;A61K9/14;;A61K31/496;;A61K9/146;;A61K31/495;;A61K9/145,A61K9/10;;A61K9/14;;A61K9/16;;A61K31/495;;A61K31/496,424/489;;264/5,0,0,,,,DISCONTINUED
222,US,B2,US 6977085 B2,174-431-649-372-795,2005-12-20,2005,US 3582101 A,2001-10-19,US 3582101 A;;US 95397901 A;;US 87463701 A;;US 25816000 P,2000-12-22,Method for preparing submicron suspensions with polymorph control,"The present invention provides a method for preparing a suspension of a pharmaceutically-active compound, the solubility of which is greater in a water-miscible first organic solvent than in a second solvent which is aqueous. The process includes the steps of: (i) dissolving a first quantity of the pharmaceutically-active compound in the water-miscible first organic solvent to form a first solution; (ii) mixing the first solution with the second solvent to precipitate the pharmaceutically-active compound; and (iii) seeding the first solution or the second solvent or the pre-suspension.",BAXTER INT,WERLING JANE;;KIPP JAMES E;;SRIRAM RAJARAM;;DOTY MARK J,BAXTER INTERNATIONAL INC (2002-01-11),https://lens.org/174-431-649-372-795,Granted Patent,yes,101,21,3,86,0,A61K9/10;;A61K9/10;;A61K9/14;;A61K9/14;;A61K9/145;;A61K9/145;;A61K9/146;;A61K9/146;;A61K9/1688;;A61K9/1688;;A61K31/495;;A61K31/495;;A61K31/496;;A61K31/496,A61K9/10;;A61K9/14;;A61K9/16;;A61K31/495;;A61K31/496,424/489;;424/400;;424/450;;264/4;;264/4.1;;264/5,16,8,001-155-857-960-135;;018-188-239-454-962;;005-840-366-684-763;;004-382-489-377-69X;;012-864-980-464-648;;017-541-414-387-84X;;064-523-632-943-432;;005-840-366-684-763,10.1002/jps.2600670418;;641759;;7302990;;10.1016/0378-4274(81)90035-7;;10.1016/0378-5173(92)90051-3;;8331530;;10.1002/jps.2600820608;;10.1007/s004170050094;;9602323;;10.1016/s1081-1206(10)62949-3;;9494448;;11879753;;10.1016/s0378-5173(01)00986-3;;10.1016/0378-5173(92)90051-3,"US 5,849,884, 12/1998, Woiszwillo et al. (withdrawn);;Davis et al., ""Pulmonary Perfusion Imaging: Acute Toxicity and Safety Factors as a Function of Particle Size"", J.Nucl Med., vol. 19 (1978), pp. 1209-1213.;;Schroeder et al., ""Physiological Effects of Subvisible Microspheres Administered Intravenously to Beagle Dogs"", Journal of Pharmaceutical Sciences, vol. 67, No. 4, Apr. 1978, pp. 508-512.;;Yokel et al., ""Acute Toxicity of Latex Microspheres"",Toxicity Letters, vol. 9 (1981), pp. 165-170.;;Allen et al., ""Critical Evaluation of Acute Cardiopulminary Toxicity of Microspheres"", J.Nucl Med., vol. 19 (1987), pp. 1204-1208.;;B. Sjostrom et al., ""Preparation Of Submicron Drug Particles In Lecithin-Stabilized O/W Emulsions I. Model Studies Of The Precipitation Of Cholesteryl Acetate"", Int. J. Pharm., 88 (1992) pp 53-62.;;B. Sjostrom et al., ""A Method For The Preparation Of Submicron Particles Of Sparingly Water-Soluble Drugs By Precipitation In Oil-In-Water Emulsions. II: Influence Of The Emulsifier, The Solvent And The Drug Substance"", J. Pharm. Sci., 82(6), (1992) pp 584-589.;;Duncker and Reichelt, ""Effects of the Pharmaceutical Cosolvent hydroxypropyl-beta-cyclodextrin on Porcine Corneal Endothelium"", Graefe's Archive for Clinical and Experimental Opthalmology (Germany), 236/5 (1998), pp. 380-389.;;Volchek and Dellen, ""Anaphylaxis to Intravenous Cyclosporine and Tolerance to Oral Cyclosporine, Case Report and Review"", Annals of Allergy, Asthma, and Immunology, 80 (1998), pp. 159-163.;;Singla et al., ""Paclitaxel and its Formulations"", International Journal of Pharmaceutics, 235/1-2 (2002), pp. 179-192.;;B. Sjostrom et al., ""The Formation of Submicron Organic Particles by Precipitation in an Emulsion"", J.Dispersion Science and Technology, 15(1), 89-117 (1994).;;Avanti Polar Lipids, Inc.., website printout, www.avantilipids.com, ""Synthetic Products-Functionalized Phospholipids: Lipids for Conjugation of Proteins/Peptides/Drugs to Liposomes"" (7 pgs), Mar. 2003.;;Avanti Polar Lipids, Inc., website printout, www.avantilipids.com, ""Polymer and Polymerizable Lipids: Functionalized PEG Lipids"" (3 pgs), Mar. 2003.;;Avanti Polar Lipids, Inc.., website printout, www.avantilipids.com, ""Polymer and Polymerizable Lipids: Poly(ethylene glycol)-Lipid Conjugates"" (8 pgs) , Mar. 2003.;;B. Sjostrom et al., Preparation Of Submicron Drug Particles In Lecithin-Stabilized O/W Emulsions I. Model Studies Of The Precipiation Of Cholesteryl Acetate, Int. J. Pharm., 88 (1992) pp 53-62.;;B. Sjostrom et al., A Method For The Preparation Of Submicron Particles Of Sparingly Water-Soluble Drugs By Precipitation In Oil-In-Water Emulsions. II: Influence Of The Emulsifier, The Solvent And The Drug Substance, J. Pharm. Sci., 82(6), (1992) pp 584-589.",EXPIRED
223,US,A1,US 2003/0059472 A1,115-427-595-594-47X,2003-03-27,2003,US 18303502 A,2002-06-26,US 18303502 A;;US 96427301 A,2001-09-26,Preparation of submicron sized nanoparticles via dispersion lyophilization,"
   The present invention relates to a process for preparing submicron sized nanoparticles of a poorly water soluble compound by lyophilizing a dispersion or microdispersion of a multiphase system having an organic phase and an aqueous phase, the organic phase having the poorly water soluble organic compound therein. The method is preferably used to prepare nanoparticles of a poorly water soluble, pharmaceutically active compound suitable for in vivo delivery, particularly by parenteral routes. 
",BRYNJELSEN SEAN;;DOTY MARK;;KIPP JAMES E.;;JAYSWAL NAILESH;;NARAYANAN KRISHNASWAMY,BRYNJELSEN SEAN;;DOTY MARK;;KIPP JAMES E;;JAYSWAL NAILESH;;NARAYANAN KRISHNASWAMY,BAXTER INTERNATIONAL INC (2002-07-11),https://lens.org/115-427-595-594-47X,Patent Application,yes,99,56,7,20,0,A61K9/5169;;A61K9/5192;;A61K9/5169;;A61K9/5192,A61K9/19;;A61K9/51;;A61K31/496;;A61K9/14;;A61K45/00;;A61K47/10;;A61K47/12;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/32;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42,424/489;;264/5,0,0,,,,EXPIRED
224,US,B1,US 8498758 B1,113-093-715-597-203,2013-07-30,2013,US 201213685218 A,2012-11-26,US 201213685218 A;;US 201213566350 A,2012-08-03,"ILS-based altitude data generation system, device, and method","Present novel and non-trivial system, device, and method for generating altitude data and/or height data are disclosed. A processor receives navigation data from an external source such as a global positioning system (“GPS”); receives navigation data from multiple internal sources; receives object data representative of terrain or surface feature elevation; determines an instant measurement of aircraft altitude as a function of these inputs; and generates aircraft altitude data responsive to such determination. In an additional embodiment, the processor receives reference point data representative of the elevation of the stationary reference point (e.g., a landing threshold point); determines an instant measurement of aircraft height as a function of this input and the instant measurement of aircraft altitude; and generates aircraft height data responsive to such determination.",ROCKWELL COLLINS INC,BELL DOUGLAS A;;DOTY JAMES H;;BARBER SARAH;;TURCIOS FELIX B,ROCKWELL COLLINS INC (2013-01-17),https://lens.org/113-093-715-597-203,Granted Patent,yes,4,14,1,2,0,G01C5/005;;G01C23/005;;G01C5/005;;G01C23/005,G05D1/00,701/4;;701/1;;701/3;;701/13;;701/408;;701/416;;701/460;;701/495;;244/75.1;;244/180;;244/185;;244/188;;244/191;;342/33;;342/38;;342/65;;342/140;;342/149,0,0,,,,ACTIVE
225,US,A1,US 2022/0365165 A1,155-573-633-290-968,2022-11-17,2022,US 202117320707 A,2021-05-14,US 202117320707 A,2021-05-14,SYSTEM AND METHOD FOR MAINTAINING COOPERATIVE PRECISION NAVIGATION AND TIMING (PNT) ACROSS NETWORKED PLATFORMS IN CONTESTED ENVIRONMENTS,"A system and method established and maintains precision relative position, navigation, and timing (PNT) across a network of at least four mutually connected mobile platforms. In embodiments, a key (e.g., advantaged, absolute positioning capable) node of the network determines its pressure altitude and inertial state relative to its platform reference frame and receives inertial state and pressure altitude data from each neighboring node (in exchange for its own) to estimate the relative position and orientation of each neighbor node in its platform frame. The key node performs ranging to each neighboring node, and the neighboring nodes additionally range between each other and exchange ranging data with the key node. By correcting position and orientation estimates via ranging data, the key node determines and maintains extended relative PNT (e.g., in GPS-denied areas), which relative PNT solution is distributed across all network nodes.",ROCKWELL COLLINS INC,KIRCHNER WILLIAM T;;SATTIGERI RAMACHANDRA J;;GAVRILETS VLADISLAV;;DOTY JAMES H,,https://lens.org/155-573-633-290-968,Patent Application,yes,5,0,1,1,0,H04B7/18506;;G01S19/45;;G01S19/46;;G01S19/47;;G01S5/0289;;G01S5/0249;;H04W4/023;;G01S5/0284;;H04W76/10;;G01S19/47;;H04B7/18506;;H04W4/023,G01S5/02;;G01S19/47;;H04B7/185;;H04W4/02;;H04W76/10,,0,0,,,,PENDING
226,US,B2,US 6835396 B2,067-690-911-281-328,2004-12-28,2004,US 18303502 A,2002-06-26,US 18303502 A;;US 96427301 A,2001-09-26,Preparation of submicron sized nanoparticles via dispersion lyophilization,"
    The present invention relates to a process for preparing submicron sized nanoparticles of a poorly water soluble compound by lyophilizing a dispersion or microdispersion of a multiphase system having an organic phase and an aqueous phase, the organic phase having the poorly water soluble organic compound therein. The method is preferably used to prepare nanoparticles of a poorly water soluble, pharmaceutically active compound suitable for in vivo delivery, particularly by parenteral routes. 
",BAXTER INT,BRYNJELSEN SEAN;;DOTY MARK;;KIPP JAMES E;;JAYSWAL NAILESH;;NARAYANAN KRISHNASWAMY,BAXTER INTERNATIONAL INC (2002-07-11),https://lens.org/067-690-911-281-328,Granted Patent,yes,104,54,7,20,0,A61K9/5169;;A61K9/5192;;A61K9/5169;;A61K9/5192,A61K9/19;;A61K9/51;;A61K31/496;;A61K9/14;;A61K45/00;;A61K47/10;;A61K47/12;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/32;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42,424/450;;424/422;;424/489,16,8,004-382-489-377-69X;;001-155-857-960-135;;018-188-239-454-962;;005-840-366-684-763;;004-382-489-377-69X;;012-864-980-464-648;;017-541-414-387-84X;;064-523-632-943-432,8331530;;10.1002/jps.2600820608;;10.1002/jps.2600670418;;641759;;7302990;;10.1016/0378-4274(81)90035-7;;10.1016/0378-5173(92)90051-3;;8331530;;10.1002/jps.2600820608;;10.1007/s004170050094;;9602323;;10.1016/s1081-1206(10)62949-3;;9494448;;11879753;;10.1016/s0378-5173(01)00986-3,"Sjostrom et al., ""A method for the preparation of submicro particles of . . . and the drug substance"", Journal of Pharmaceutical Sciences, vol. 82, No. 6, Jun. 1993, pp 584-589.*;;Sjostrom et al., ""Preparation of submicro drug particles in lecithin-stabilized o/w emulstions"", Journal of Pharmaceutics, 88(1992), pp 53-62.*;;US 5,849,884, 12/1998, Woiszwillo et al. (withdrawn);;B. Sjostrom et al., ""The Formation of Submicron Organic Particles by Precipitation in an Emulsion"", J.Dispersion Science and Technology, 15(1), 89-117 (1994).;;Avanti Polar Lipids, Inc.., website printout, www.avantilipids.com, ""Synthetic Products-Functionalized Phospholipids: Lipids for Conjugation of Protein/Peptides/Drugs to Liposomes"" (7 pgs), Mar. 2003.;;Avanti Polar Lipids, Inc.., website printout, www.avantilipids, com, ""Polymer and Polymerizable Lipids: Functionalized PEG Lipids"" (3 pgs), Mar. 2003.;;Avanti Polar Lipids, Inc.., website printout, www.avantilipids.com, ""Polymer and Polymerizable Lipids: Poly(ethylene glycol)-Lipid Conjugates""(8 pgs), Mar. 2003.;;Davis et al., ""Pulmonary Perfusion Imaging: Acute Toxicity and Safety Factors as a Function of Particle Size"", J. Nucl Med., vol. 19 (1978), pp. 1209-1213.;;Schroeder et al., ""Physiological Effects of Subvisible Microspheres Administered Intravenously to Beagle Dogs"", Journal of Pharmaceutical Sciences, vol. 67, No. 4, Apr. 1978, pp. 508-512.;;Yokel et al. ""Acute Toxicity of Latex Microspheres"", Toxicity Letters, vol. 9, (1981), pp. 165-170.;;Allen et al., ""Critical Evaluation of Acute Cardiopulminary Toxicity of Microspheres"", J. Nucl Med., vol. 19 (1978), pp. 1204-1208.;;B. Sjostrom et al., ""Preparation Of Submicron Drug Particles In Lecithin-Stabilized O/W Emulsions I. Model Studies Of The Precipitation Of Cholesteryl Acetate"", Int. J. Pharm., 88 (1992) pp 53-62.;;B. Sjostrom et al., ""A Method For The Preparation Of Submicron Particles Of Sparingly Water-Soluble Drugs By Precipitation In Oil-In-Water Emulsions. II: Influence Of The Emulsifier, The Solvent And The Drug Substance"", J. Pharm. Sci., 82(6), (1992) pp 584-589.;;Duncker and Reichelt, ""Effects of the Pharmaceutical Cosolvent hydroxypropyl-beta-cyclodextrin on Porcine Corneal Endothelium"", Graefe's Archive for Clinical and Experimental Ophthalmology (Germany), 236/5 (1998), pp. 380-389.;;Volchek and Dellen, ""Anaphylaxis to Intravenous Cyclosporine and Tolerance to Oral Cyclosporine, Case Report and Review"", Annals of Allergy, Asthma, and Immunology, 80 (1998), pp. 159-163.;;Singla et al., ""Paclitaxel and its Formulations"", International Journal of Pharmaceutics, 235/1-2 (2002), pp. 179-192.",EXPIRED
227,US,B1,US 10209076 B1,181-980-235-627-829,2019-02-19,2019,US 201715473366 A,2017-03-29,US 201715473366 A,2017-03-29,"Air data, attitude and heading reference system (ADAHRS) replacement architecture","Systems and a related method for internally monitored navigation replace one or more inertial reference units (IRU) of an aircraft navigation system with GNSS-assisted multi-mode receivers (MMR) including dual-antenna receivers. Each MMR may validate inertial position data generated by a remaining IRU by detecting drift errors in the inertial position data or latent faults in the IRU. The system may include, in place of one or more IRUs, attitude heading and reference systems (AHRS) incorporating lower-grade high-performance inertial sensors. Internal monitoring of the remaining IRUs or the inertial position data generated thereby may alternatively be carried out by the AHRS. Based on internal monitoring by the MMRs and/or AHRS, user display and flight control systems of an aircraft can exclude a faulty IRU, preventing the use of position solutions incorporating erroneous inertial data.",ROCKWELL COLLINS INC,MCNAMARA JEFFREY B;;DOTY JAMES H;;GAVRILETS VLADISLAV;;OLTROGGE JESSE W,ROCKWELL COLLINS INC (2017-03-13),https://lens.org/181-980-235-627-829,Granted Patent,yes,4,7,1,1,0,G08G5/0021;;G08G5/0052;;G01S19/49;;G01S19/53;;G05D1/0077;;G01C21/188;;G01C21/1654;;B64D43/00;;G01S19/00;;G08G5/0021;;G01S19/49;;G01S19/53;;G08G5/0052;;G05D1/0077;;G01C21/188;;G01C21/1654,G01C21/16;;B64D43/00;;G08G5/00,,0,0,,,,ACTIVE
228,EP,B1,EP 2013020 B1,012-655-533-712-899,2014-01-01,2014,EP 07728099 A,2007-04-13,EP 2007053634 W;;US 79263106 P,2006-04-18,MULTILAYER POLYMER STRUCTURE,,SOLVAY SPECIALTY POLYMERS USA,DOTY JAMES K;;LIU ALICE WEIMIN;;WARKOSKI GREGORY;;DE CANNIERE JEAN,"SOLVAY SPECIALTY POLYMERS USA, LLC. (2011-11-30)",https://lens.org/012-655-533-712-899,Granted Patent,yes,5,0,18,18,0,B32B1/08;;B32B25/14;;B32B27/08;;B32B27/20;;B32B27/32;;B32B27/34;;B32B2264/108;;B32B2270/00;;B32B2307/202;;B32B2439/00;;B32B2597/00;;Y10T428/1352;;Y10T428/27;;Y10T428/1393;;Y10T428/139;;Y10T428/31725;;Y10T428/3175;;B32B1/00;;B32B27/34;;B32B27/32;;Y10T428/1352;;Y10T428/27;;Y10T428/1393;;Y10T428/139;;Y10T428/31725;;Y10T428/3175;;B32B1/08;;B32B2597/00;;B32B27/34;;B32B2264/108;;B32B27/32;;B32B2439/00;;B32B27/08;;B32B2270/00;;B32B27/20;;B32B2307/202;;B32B25/14;;B32B1/00,B32B27/32;;B32B27/34,,2,0,,,"DATABASE WPI Week 200336 Derwent Publications Ltd., London, GB; AN 2003-375872 XP002443005 & JP 2002 326326 A (TOYOBO KK) 12 November 2002 (2002-11-12);;DATABASE WPI Week 199412 Derwent Publications Ltd., London, GB; AN 1994-097417 XP002443006 & JP 06 047848 A (TOYOBO KK) 22 February 1994 (1994-02-22)",ACTIVE
229,CA,A1,CA 2649165 A1,109-397-771-477-263,2007-10-25,2007,CA 2649165 A,2007-04-13,US 79263106 P;;EP 2007053634 W,2006-04-18,MULTILAYER POLYMER STRUCTURE,,SOLVAY ADVANCED POLYMERS LLC,WEIMIN LIU ALICE;;WARKOSKI GREGORY;;DE CANNIERE JEAN;;DOTY JAMES K,,https://lens.org/109-397-771-477-263,Patent Application,no,0,0,18,18,0,B32B1/08;;B32B25/14;;B32B27/08;;B32B27/20;;B32B27/32;;B32B27/34;;B32B2264/108;;B32B2270/00;;B32B2307/202;;B32B2439/00;;B32B2597/00;;Y10T428/1352;;Y10T428/27;;Y10T428/1393;;Y10T428/139;;Y10T428/31725;;Y10T428/3175;;B32B1/00;;B32B27/34;;B32B27/32;;Y10T428/1352;;Y10T428/27;;Y10T428/1393;;Y10T428/139;;Y10T428/31725;;Y10T428/3175;;B32B1/08;;B32B2597/00;;B32B27/34;;B32B2264/108;;B32B27/32;;B32B2439/00;;B32B27/08;;B32B2270/00;;B32B27/20;;B32B2307/202;;B32B25/14;;B32B1/00,B32B27/32;;B32B27/34,,0,0,,,,DISCONTINUED
230,BR,A,BR PI0517652 A,063-845-797-605-285,2008-10-14,2008,BR PI0517652 A,2005-11-03,US 62603604 P;;US 64287805 P;;US 2005/0039922 W,2004-11-08,"composições farmacêuticas nanoparticuladas de inibidores de tubulina, métodos para as suas preparações e respectivos usos","COMPOSIçõES FARMACêUTICAS NANOPARTICULADAS DE INIBIDORES DE TUBULINA, MéTODOS PARA AS SUAS PREPARAçõES E RESPECTIVOS USOS. A presente invenção refere-se a novas composições farmacêuticas compreendendo formulações de nano e microparticulado de inibidores de tubulina pobremente solúveis em água da classe química de indol, preferivelmente indol-3-glioxiamidas N-substituídas e, mais preferivelmente, amida de ácido N-(Piridin-4-iI)-¢1 -(4-clorobenzil)-indol-3-il!glioxílico (D-24851), também conhecido como ""Indibulina,"" e métodos de preparar e empregar tais composições para o tratamento de cânceres resistentes ao agente anti-tumor e outras doenças.",BAXTER HEALTHCARE SA;;BAXTER INT,RAAB GERHARD;;PAPADOPOULOS PAVLOS;;DOTY MARK;;KIPP JAMES E;;ROESSLER BERTHOLD,"BAXTER INTERNATIONAL INC. (US) , BAXTER HEALTHCARE (2012-09-11)",https://lens.org/063-845-797-605-285,Patent Application,no,0,0,16,17,0,A61K9/0019;;A61K9/0095;;A61K9/10;;A61K9/145;;A61K9/146;;A61K9/5123;;A61K9/5146;;A61K31/404;;A61K31/4439;;Y10T428/2982;;C07D401/12;;A61P1/18;;A61P11/02;;A61P11/06;;A61P19/02;;A61P29/00;;A61P31/04;;A61P35/00;;A61P35/04;;A61P37/02;;A61P37/06;;A61P37/08;;A61P43/00;;B82B3/00;;H01F27/12;;H01B3/20;;H01B3/00;;Y10T428/2982;;A61K31/4439;;A61K31/404;;A61K9/5123;;A61K9/5146;;A61K9/145;;A61K9/0095;;A61K9/10;;A61K9/146;;A61K9/0019;;A61K9/14;;C07D401/12,A61K31/404;;A61K9/00;;A61P35/00,,0,0,,,,DISCONTINUED
231,JP,A,JP 2013166377 A,093-273-541-842-532,2013-08-29,2013,JP 2013076608 A,2013-04-02,US 79263106 P,2006-04-18,MULTILAYER POLYMER STRUCTURE,"PROBLEM TO BE SOLVED: To provide an improved multilayer polymer structure.SOLUTION: A multilayer structure includes at least one couple (L1-L2) of adjacent layers (L1) and (L2). In the multilayer structure: the layer (L1) comprises at least one polymer composition (C1) comprising: (i) at least one semi-aromatic polyamide, and (ii) at least one impact modifier (I1); the layer (L2) comprises at least one polymer composition (C2) comprising: (i) at least one un-functionalized polyolefin (PO2); (ii) at least one functionalized polyolefin (FPO2), where the functionalized polyolefin comprises functional groups chosen from carboxylic groups, their esters, their anhydrides and their salts. Process for manufacturing such multilayer structure is disclosed, which comprises co-extruding or co-blowmolding polymer compositions (C1) and (C2) so as to obtain one couple (L1-L2) of adjacent layers (L1) and (L2). Shaped article comprising such multilayer structure and process for manufacturing the shaped article are disclosed.",SOLVAY SPECIALTY POLYMERS USA,DOTY JAMES K;;LIU ALICE WEIMIN;;WARKOSKI GREGORY;;DE CANNIERE JEAN,,https://lens.org/093-273-541-842-532,Patent Application,no,6,0,18,18,0,B32B1/08;;B32B25/14;;B32B27/08;;B32B27/20;;B32B27/32;;B32B27/34;;B32B2264/108;;B32B2270/00;;B32B2307/202;;B32B2439/00;;B32B2597/00;;Y10T428/1352;;Y10T428/27;;Y10T428/1393;;Y10T428/139;;Y10T428/31725;;Y10T428/3175;;B32B1/00;;B32B27/34;;B32B27/32;;Y10T428/1352;;Y10T428/27;;Y10T428/1393;;Y10T428/139;;Y10T428/31725;;Y10T428/3175;;B32B1/08;;B32B2597/00;;B32B27/34;;B32B2264/108;;B32B27/32;;B32B2439/00;;B32B27/08;;B32B2270/00;;B32B27/20;;B32B2307/202;;B32B25/14;;B32B1/00,B32B27/32;;B29C47/06;;B29C49/04;;B29C49/22,,0,0,,,,PENDING
232,MY,A,MY 150076 A,133-847-030-434-181,2013-11-29,2013,MY PI20084125 A,2007-04-13,US 79263106 P,2006-04-18,MULTILAYER POLYMER STRUCTURE,"MULTILAYER STRUCTURE COMPRISING AT LEAST ONE COUPLE (L1-L2) OF ADJACENT LAYERS (L1) AND (L2), WHEREIN: ? LAYER (L1) COMPRISES AT LEAST ONE POLYMER COMPOSITION (C1) COMPRISING: (I) AT LEAST ONE SEMI-AROMATIC POLYAMIDE, AND (II) AT LEAST ONE IMPACT MODIFIER (I1); ? LAYER (L2) COMPRISES AT LEAST ONE POLYMER COMPOSITION (C2) COMPRISING: (I) AT LEAST ONE UN-FUNCTIONALIZED POLYOLEFIN (PO2); (II) AT LEAST ONE FUNCTIONALIZED POLYOLEFIN (FPO2), SAID FUNCTIONALIZED POLYOLEFIN COMPRISING FUNCTIONAL GROUPS CHOSEN FROM CARBOXYLIC GROUPS, THEIR ESTERS, THEIR ANHYDRIDES AND THEIR SALTS PROCESS FOR MANUFACTURING SAID MULTILAYER STRUCTURE, WHICH COMPRISES CO-EXTRUDING OR CO-BLOWMOLDING POLYMER COMPOSITIONS (C1) AND (C2) SO AS TO OBTAIN COUPLE (L1 - L2) OF ADJACENT LAYERS (L1) AND (L2). SHAPED ARTICLE COMPRISING THE INVENTED MULTILAYER STRUCTURE AND PROCESS FOR MANUFACTURING THE SHAPED ARTICLE.",SOLVAY ADVANCED POLYMERS LLC,DOTY JAMES K;;ALICE WEIMIN LIU;;GREGORY WARKOSKI;;JEAN DE CANNIERE,,https://lens.org/133-847-030-434-181,Granted Patent,no,0,0,18,18,0,B32B1/08;;B32B25/14;;B32B27/08;;B32B27/20;;B32B27/32;;B32B27/34;;B32B2264/108;;B32B2270/00;;B32B2307/202;;B32B2439/00;;B32B2597/00;;Y10T428/1352;;Y10T428/27;;Y10T428/1393;;Y10T428/139;;Y10T428/31725;;Y10T428/3175;;B32B1/00;;B32B27/34;;B32B27/32;;Y10T428/1352;;Y10T428/27;;Y10T428/1393;;Y10T428/139;;Y10T428/31725;;Y10T428/3175;;B32B1/08;;B32B2597/00;;B32B27/34;;B32B2264/108;;B32B27/32;;B32B2439/00;;B32B27/08;;B32B2270/00;;B32B27/20;;B32B2307/202;;B32B25/14;;B32B1/00,B32B27/00,,0,0,,,,ACTIVE
233,HK,A1,HK 1128442 A1,167-129-748-804-919,2009-10-30,2009,HK 09106107 A,2009-07-07,EP 2007053634 W;;US 79263106 P,2006-04-18,MULTILAYER POLYMER STRUCTURE,,SOLVAY ADVANCED POLYMERS LLC,DOTY JAMES K;;LIU ALICE WEIMIN;;WARKOSKI GREGORY;;DE CANNIERE JEAN,,https://lens.org/167-129-748-804-919,Patent Application,no,0,0,18,18,0,B32B1/08;;B32B25/14;;B32B27/08;;B32B27/20;;B32B27/32;;B32B27/34;;B32B2264/108;;B32B2270/00;;B32B2307/202;;B32B2439/00;;B32B2597/00;;Y10T428/1352;;Y10T428/27;;Y10T428/1393;;Y10T428/139;;Y10T428/31725;;Y10T428/3175;;B32B1/00;;B32B27/34;;B32B27/32;;Y10T428/1352;;Y10T428/27;;Y10T428/1393;;Y10T428/139;;Y10T428/31725;;Y10T428/3175;;B32B1/08;;B32B2597/00;;B32B27/34;;B32B2264/108;;B32B27/32;;B32B2439/00;;B32B27/08;;B32B2270/00;;B32B27/20;;B32B2307/202;;B32B25/14;;B32B1/00,B32B/,,0,0,,,,DISCONTINUED
234,US,B2,US 8722091 B2,161-191-717-289-52X,2014-05-13,2014,US 92057804 A,2004-08-17,US 92057804 A;;US 18303502 A;;US 96427301 A,2001-09-26,Preparation of submicron sized nanoparticles via dispersion lyophilization,"The present invention relates to a process for preparing submicron sized nanoparticles of a poorly water soluble compound by lyophilizing a dispersion or microdispersion of a multiphase system having an organic phase and an aqueous phase, the organic phase having the poorly water soluble organic compound therein. The method is preferably used to prepare nanoparticles of a poorly water soluble, pharmaceutically active compound suitable for in vivo delivery, particularly by parenteral routes.",BRYNJELSEN SEAN;;DOTY MARK;;KIPP JAMES E;;JAYSWAL NAILESH;;NARAYANAN KRISHNASWAMY;;BAXTER INT,BRYNJELSEN SEAN;;DOTY MARK;;KIPP JAMES E;;JAYSWAL NAILESH;;NARAYANAN KRISHNASWAMY,BAXTER INTERNATIONAL INC (2002-07-11),https://lens.org/161-191-717-289-52X,Granted Patent,yes,112,2,13,20,0,A61K9/5169;;A61K9/5192;;A61K9/145;;B01J13/04;;A61K9/5169;;A61K9/5192;;A61K9/145;;B01J13/04;;A61K9/14,A61K9/14;;A61K9/19;;A61K9/51;;A61K31/496;;A61K45/00;;A61K47/10;;A61K47/12;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/32;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;B01J13/04,424/489,44,27,001-155-857-960-135;;018-188-239-454-962;;005-840-366-684-763;;004-382-489-377-69X;;012-864-980-464-648;;017-541-414-387-84X;;064-523-632-943-432;;017-941-342-747-510;;026-723-593-893-660;;127-777-087-783-421;;011-075-606-016-388;;082-207-433-645-369;;005-210-493-767-784;;035-919-228-575-462;;016-080-604-800-855;;148-321-288-504-659;;013-572-361-844-432;;032-334-120-416-889;;117-534-654-905-212;;057-449-226-918-016;;073-577-567-102-695;;045-930-447-564-421;;122-266-283-338-249;;010-262-579-618-54X;;069-412-683-797-359;;172-810-960-405-059;;088-548-957-452-959,10.1002/jps.2600670418;;641759;;7302990;;10.1016/0378-4274(81)90035-7;;10.1016/0378-5173(92)90051-3;;8331530;;10.1002/jps.2600820608;;10.1007/s004170050094;;9602323;;10.1016/s1081-1206(10)62949-3;;9494448;;11879753;;10.1016/s0378-5173(01)00986-3;;10.1016/s0378-5173(78)80002-7;;pmc163350;;10.1128/aac.40.6.1467;;8726020;;12103427;;10.1016/s0166-3542(02)00052-9;;12960232;;10.1189/jlb.0503204;;11704885;;10.1080/135502801753248114;;10.1073/pnas.98.2.658;;pmc14644;;11136236;;10.1073/pnas.021551798;;11356986;;10.1128/cdli.9.3.515-524.2002;;pmc119973;;11986254;;9697721;;10.1086/515642;;10.1016/s0169-409x(99)00017-4;;10837765;;10.1128/aac.47.1.238-243.2003;;pmc149042;;12499197;;10.1200/jco.2004.22.90140.2135;;10.1002/jps.2600670417;;641758;;2436731;;10.1139/y87-035;;9801435;;10.1016/s0168-3659(98)00089-3;;9685869;;10.1016/s0168-3659(97)00105-3;;8959248;;10.1089/aid.1996.12.1709;;10.1016/0021-8502(89)90765-9;;10.1038/nrd1494;;15340388;;10.1021/js9700661;;9269864,"US 5,849,884, 12/1998, Woiszwillo (withdrawn);;Davis et al., ""Pulmonary Perfusion Imaging: Acute Toxicity and Safety Factors as Function of Particle Size"", J.Nucl Med., vol. 19 (1978), pp. 1209-1213.;;Schroeder et al., ""Physiological Effects of Subvisible Microspheres Administered Intravenously to Beagle Dogs"", Journal of Pharmaceutical Sciences, vol. 67, No. 4, Apr. 1978, pp. 508-512.;;Yokel et al., ""Acute Toxcoty of Latex Microspheres"", Toxicity Letters, vol. 9 (1981), pp. 165-170.;;Allen et al., ""Critical Evaluation of Acute Cardiopulminary Toxcity of Microspheres"", J. Nucl Med., vol. 19 (1987), pp. 1204-1208.;;B. Sjostrom et al., ""Preparation of Submicron Drug Particles in Lecithin-Stabilized O/W Emulsions I. Model Studies of the Precipitation of Cholesteryl Acetate"", Int. J. Pharm, 88 (1992) pp. 53-62.;;B. Sjostrom et al., ""A Method for the the Preparation of Submicron Particles of Sparingly Water-Soluble Drugs by Precipitation in Oil-In-Water Emulsions. II: Influence of the Emulsifier, The Solvent and the Drug Substance"", J. Pharm. Sci., 82(6), (1992) pp. 584-589.;;Duncker and Reichelt, ""Effects of the Pharmaceutical Cosolvent Hydroxypropyl-beta-cyclodextrin on Porcine Corneal Endothelium"", Graefe's Archive for Clinical and Experimental Ophthalmology (Germany). 236/5 (1998). pp. 380-389.;;Volcheck and Dellen, ""Anaphylaxis to Intravenous Cyclosporine and Tolerance to Oral Cyclosporine, Case Report and Review"", Annals of Allergy, Asthma and Immunology, 80 (1998), pp. 159-163.;;Singla et al., ""Paclitaxel and its Formulations"", International Journal of Pharmaceutics, 235/1-2 (2002). pp. 179-192.;;B. Sjostrom, et al., ""The Formation of Submicron Organic Particles by Precipitation in an Emulsion"", J. Dispersion Science and Technology, 15(1), 89-117, (1994).;;Avanti Polar Lipids, Inc., website printout, www.avantilipids.com, ""Synthetic Products-Functionalized Phospholipids: Lipids for Conjugation of Proteins/Peptides/Drugs to Lipsomes"" (7 pgs). Mar. 2003.;;Avanti Polar Lipids, Inc., website printout, www.avantilipids.com, ""Polymer and Polymerizable Lipids: Functionalized PEG Lipids"" (3 pgs), Mar. 2003.;;Avanti Polar Lipids, Inc., website printout, www.avantilipids.com, ""Polymer and Polymerizable Lipids: Poly(ethylene glycol)-Lipid Conjugates"" (8 pgs), Mar. 2003.;;Graham, D.T., et al., ""The Effects of Freezing on Commercial Insulin Suspensions"", International Journal of Pharmaceutics, 1978.;;Bender et al., ""Efficiency of Nanoparticles as a Carrier for Antiviral Agents in Human Immunodeficiency Virus-Infected Human Monocytes/Macrophases In Vitro"", Antimicrobial Agents and Chemotherapy, 40(6), pp. 1467-1471, Jun. 1996.;;H. von Briesen, ""Controled Release of Antiretroviral Drugs"", AIDS Rev., 2, pp. 31-38, 2000.;;Aquaro, et al., ""Macrophages and HIV infection: therapeutical approaches toward this strateaic virus reservoir"", Antiviral Research 55, pp. 209-225, 2002.;;Crowe, et al., ""The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection"", Journal of Leukocyte Biology, pp. 635-641, Nov. 2003.;;Fischer-Smith et al., CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection, Journal of NeuroVirology, 7, pp. 528-541, 2001.;;Igarashi et al., ""Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans"", PNAS, 98(2), pp. 658-663, Jan. 16, 2001.;;Limoges et al., poster presentation, 11th Conference on Retroviruses and Opportunistic Infections. Feb. 8-11, 2004.;;Moghimi et al., ""Long-Circulating and Target-Specific Nanoparticles: Theory to Practice"", Pharmacological Reviews, 53, pp. 283-318, 2001.;;Nesbit et al., ""In Vitro and Animal Models of Human Immunodeficiency Virus Infection of the Central Nervous System"", Clinical and Diagnostic Laboratory Immunology, 9(3), pp. 515-524, May 2002.;;Nottet et al., ""HIV-1 Entry into Brain: Mechanisms for the Infiltration of HIV-1 infected Macrophages Across the Blood-Brain Barrier"", The Neurology of AIDS, p. 55, 1998.;;Perno et al., ""Relative Potency of Protease Inhibitors in Monocytes/Macrophages Acutely and Chronically Infected with Human Immunodeficiency Virus"", The Journal of Infectious Diseases, 178, pp. 413-422, 1998.;;Sawchuk et al., ""Investigation of distribution, transport and uptake of an anti-HIV drugs to the central nervous system"", Advanced Drug Delivery Reviews, 39, pp. 5-31, 1999.;;Solas et al., ""Discrepancies between Protease Inhibitor Concentrations and Viral Loan in Reservoirs and Sanctuary Sites in Human Immunodeficiency Virus-Infected Patients"", Antimicrobiologv Agents and Chemotherapy, 47 (1), pp. 238-243, Jan. 2003.;;Shrayer, et al., ""Ceramide, a mediator of apoptosis, synergizes with paclitaxel to induce regression of the L 3.6 human pancreatic carcinoma implanted in SCDI mice"", Journal of Clinical Oncology, vol. 22, No. 14S, Abstract, 2004:2135.;;Schroeder et al., ""Distribution of Radiolabeled Subvisible Microspheres after Intravenous Administration to Beagle Dogs"", Journal of Pharmaceutical Sciences, vol. 67, No. 4, pp. 504-507, Apr. 1978.;;Allen et al., ""Effects on the murine mononuclear phagocyte system of chronic administration of liposomes containing drug or lipid a compared with empty liposomes"", Can. J. Physiol. Pharmacol., vol. 65, pp. 185-190, 1987.;;Heiati et al., ""Solid lipid nanoparticles as drug carriers: II. Plasma stability and biodistribution of solid lipid nanoparticles containing the lipophilic prodrug 3'-azido-3'-deoxythymidine palmitate in mice,"" Int. J. Pharmaceutics, 174:71-80 (1998).;;Li et al., Poly(vinyl alcohol) nanoparticles prepared by freezing-thawing process for protein/peptide drug delivery, J. Control. Release, 56:117-26 (1998).;;Lobenberg et al., ""Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after i.v. injection to rats,"" J. Control. Release, 50:21-30 (1998).;;Lobenberg et al., ""Macrophage targeting of azidothymidine: a promising strategy for AIDS therapy,"" AIDS Res. Hum. Retroviruses, 12:1709-1715 (1996).;;Mroczka, ""Integral nsform technique in particle sizing,"" J. Aerosol Sci., 20:1075-1077 (1989).;;Nonfinal office action from U.S. Appl. No. 11/425,122, dated May 26, 2010.;;Nonfinal office action from U.S. Appl. No. 11/425,125, dated Jun. 7, 2010.;;Rabinow, ""Nanosuspensions in drug delivery,"" Nat. Rev. Drug Discov., 3:785-796 (2004).;;Subramaniam et al., ""Pharmaceutical processing with supercritical carbon dioxide,"" J. Pharm. Sci., 86:885-890 (1997).;;Pikal et al., The impact of the freezing stage in lyophilization: effects of the ice nucleation temperature on process design and product quality, American Pharmaceutical Review (2008). Downloaded from the Internet at: .;;USPTO Office Action issued in U.S. Appl. No. 11/425,122, dated Oct. 26, 2010.;;Anonymous, Crystal growing. 9 pages. Retrieved from the Internet on Aug. 20, 2007: .;;Ricketts, Project Habbakuk, Retrieved from the Internet on Aug. 20, 2007, .",EXPIRED
235,JP,A,JP 2012097120 A,116-875-262-473-843,2012-05-24,2012,JP 2012030443 A,2012-02-15,US 62603604 P;;US 64287805 P,2004-11-08,NANOPARTICULATE COMPOSITION OF TUBULIN INHIBITOR COMPOUND,"PROBLEM TO BE SOLVED: To provide nanoparticulate compositions of tubulin inhibitor compounds.SOLUTION: The present invention is directed to novel pharmaceutical compositions comprising nano- and micro-particulate formulations of poorly water soluble tubulin inhibitors of the indole chemical class, preferably N-substituted indol-3-glyoxyamides, and more preferably N-(Pyridin-4-yl)-[1-(4-chlorobenzyl)-indol-3-yl]glyoxylic acid amide (D-24851), also known as ""Indibulin"", and methods of making and using such compositions for the treatment of anti-tumor agent resistant cancers and other diseases.",BAXTER INT;;BAXTER HEALTHCARE SA,PAPADOPOULOS PAVLOS;;GERHARD RAAB;;DOTY MARK;;KIPP JAMES E;;ROESSLER BERTHOLD,,https://lens.org/116-875-262-473-843,Patent Application,no,0,0,16,17,0,A61K9/0019;;A61K9/0095;;A61K9/10;;A61K9/145;;A61K9/146;;A61K9/5123;;A61K9/5146;;A61K31/404;;A61K31/4439;;Y10T428/2982;;C07D401/12;;A61P1/18;;A61P11/02;;A61P11/06;;A61P19/02;;A61P29/00;;A61P31/04;;A61P35/00;;A61P35/04;;A61P37/02;;A61P37/06;;A61P37/08;;A61P43/00;;B82B3/00;;H01F27/12;;H01B3/20;;H01B3/00;;Y10T428/2982;;A61K31/4439;;A61K31/404;;A61K9/5123;;A61K9/5146;;A61K9/145;;A61K9/0095;;A61K9/10;;A61K9/146;;A61K9/0019;;A61K9/14;;C07D401/12,A61K31/4439;;A61K9/14;;A61K9/51;;A61K31/405;;A61K47/02;;A61K47/10;;A61K47/28;;A61K47/34;;A61P11/02;;A61P11/06;;A61P19/02;;A61P29/00;;A61P31/04;;A61P35/00;;A61P35/04;;A61P37/02;;A61P37/06;;A61P37/08;;A61P43/00;;C07D209/18;;C07D401/12,,0,0,,,,PENDING
236,HU,A2,HU P0304086 A2,120-798-059-333-579,2004-04-28,2004,HU P0304086 A,2002-03-28,US 0210094 W;;US 82276701 A;;US 94537401 A,2001-03-29,PREMIXED AMIODARONE SOLUTION FOR PARENTERAL USE AND METHOD FOR MAKING THE SAME,,BAXTER INT,DOTY MARK J;;KIPP JAMES E;;RAGHAVAN NEERVALUR;;REBBECK CHRISTINE L,,https://lens.org/120-798-059-333-579,Patent Application,no,0,0,14,22,0,A61K9/0019;;A61K31/343;;A61K47/26;;A61P9/06,A61K9/00;;C07D307/80;;A61K9/08;;A61K31/343;;A61K47/02;;A61K47/10;;A61K47/18;;A61K47/26;;A61K47/34;;A61K47/36;;A61P9/06,,0,0,,,,PENDING
237,ES,T3,ES 2453943 T3,192-711-767-208-127,2014-04-09,2014,ES 07728099 T,2007-04-13,US 79263106 P;;EP 2007053634 W,2006-04-18,Estructura polimérica multicapa,"Una estructura multicapa que comprende al menos un par (L1-L2) de capas adyacentes (L1) y (L2), en la que: - la capa (L1) comprende al menos una composición polimérica (C1) que comprende: (i) al menos una poliamida semiaromática y (ii) al menos un modificador de impactos (I1); - la capa (L2) comprende al menos una composición polimérica (C2) que comprende: (i) al menos una poliolefina no funcionalizada (PO2) y (ii) al menos una poliolefina funcionalizada (FPO2).",SOLVAY ADVANCED POLYMERS LLC;;SOLVAY SPECIALTY POLYMERS USA,DOTY JAMES K;;LIU ALICE WEIMIN;;WARKOSKI GREGORY;;DE CANNIERE JEAN,,https://lens.org/192-711-767-208-127,Granted Patent,no,0,0,18,18,0,B32B1/08;;B32B25/14;;B32B27/08;;B32B27/20;;B32B27/32;;B32B27/34;;B32B2264/108;;B32B2270/00;;B32B2307/202;;B32B2439/00;;B32B2597/00;;Y10T428/1352;;Y10T428/27;;Y10T428/1393;;Y10T428/139;;Y10T428/31725;;Y10T428/3175;;B32B1/00;;B32B27/34;;B32B27/32;;Y10T428/1352;;Y10T428/27;;Y10T428/1393;;Y10T428/139;;Y10T428/31725;;Y10T428/3175;;B32B1/08;;B32B2597/00;;B32B27/34;;B32B2264/108;;B32B27/32;;B32B2439/00;;B32B27/08;;B32B2270/00;;B32B27/20;;B32B2307/202;;B32B25/14;;B32B1/00,B32B27/32;;B32B27/34,,0,0,,,,ACTIVE
238,US,B2,US 8206834 B2,197-499-111-052-568,2012-06-26,2012,US 29675707 A,2007-04-13,US 29675707 A;;US 79263106 P;;EP 2007053634 W,2006-04-18,Multilayer polymer structure,"Multilayer structure comprising at least one couple (L 1 -L 2 ) of adjacent layers (L 1 ) and (L 2 ), wherein: the layer (L 1 ) comprises at least one polymer composition (C 1 ) comprising: (i) at least one semi-aromatic polyamide, and (ii) at least one impact modifier (I 1 );the layer (L 2 ) comprises at least one polymer composition (C 2 ) comprising: (i) at least one un-functionalized polyolefin (PO 2 ); (ii) at least one functionalized polyolefin (FPO 2 ), the functionalized polyolefin comprising functional groups chosen from carboxylic groups, their esters, their anhydrides and their salts. Process for manufacturing such multilayer structure, which comprises co-extruding or co-blowmolding polymer compositions (C 1 ) and (C 2 ) so as to obtain one couple (L 1 -L 2 ) of adjacent layers (L 1 ) and (L 2 ). Shaped article comprising such multilayer structure and process for manufacturing the shaped article.",DOTY JAMES K;;LIU ALICE WEIMIN;;WARKOSKI GREGORY;;DE CANNIERE JEAN;;SOLVAY ADVANCED POLYMERS LLC,DOTY JAMES K;;LIU ALICE WEIMIN;;WARKOSKI GREGORY;;DE CANNIERE JEAN,SOLVAY ADVCANCED POLYMERS L.L.C (2007-04-23),https://lens.org/197-499-111-052-568,Granted Patent,yes,36,1,18,18,0,B32B1/08;;B32B25/14;;B32B27/08;;B32B27/20;;B32B27/32;;B32B27/34;;B32B2264/108;;B32B2270/00;;B32B2307/202;;B32B2439/00;;B32B2597/00;;Y10T428/1352;;Y10T428/27;;Y10T428/1393;;Y10T428/139;;Y10T428/31725;;Y10T428/3175;;B32B1/00;;B32B27/34;;B32B27/32;;Y10T428/1352;;Y10T428/27;;Y10T428/1393;;Y10T428/139;;Y10T428/31725;;Y10T428/3175;;B32B1/08;;B32B2597/00;;B32B27/34;;B32B2264/108;;B32B27/32;;B32B2439/00;;B32B27/08;;B32B2270/00;;B32B27/20;;B32B2307/202;;B32B25/14;;B32B1/00,B32B27/00,428/476.3;;428/36.9;;428/36.91;;428/135.7;;428/340;;428/474.4;;264/104;;264/173.19;;264/106;;138/140;;138/141,2,0,,,"Titles of ISO test methods, 1133 and 1183.;;PCT International Search Report dated Jul. 26, 2007 for International Application No. PCT/EP2007/053634 (3 p.).",ACTIVE
239,MX,A,MX 2008013347 A,048-121-244-615-582,2009-01-26,2009,MX 2008013347 A,2007-04-13,US 79263106 P;;EP 2007053634 W,2006-04-18,MULTILAYER POLYMER STRUCTURE.,"Multilayer structure comprising at least one couple (L1-L2) of adjacent layers (L1) and (L2), wherein: layer (L1) comprises at least one polymer composition (C1) comprising: (i) at least one semi-aromatic polyamide, and (ii) at least one impact modifier (I1); layer (L2) comprises at least one polymer composition (C2) comprising: (i) at least one un-functionalized polyolefin (PO2); (ii) at least one functionalized polyolefin (FPO2), said functionalized polyolefin comprising functional groups chosen from carboxylic groups, their esters, their anhydrides and their salts Process for manufacturing said multilayer structure, which comprises co-extruding or co-blowmolding polymer compositions (C1) and (C2) so as to obtain couple (L1- L2) of adjacent layers (L1) and (L2). Shaped article comprising the invented multilayer structure and process for manufacturing the shaped article.",SOLVAY ADVANCED POLYMERS LLC,CANNIERE JEAN DE;;DOTY JAMES K;;LIU ALICE WEIMIN;;WARKOSKI GREGORY,,https://lens.org/048-121-244-615-582,Patent Application,no,0,0,18,18,0,B32B1/08;;B32B25/14;;B32B27/08;;B32B27/20;;B32B27/32;;B32B27/34;;B32B2264/108;;B32B2270/00;;B32B2307/202;;B32B2439/00;;B32B2597/00;;Y10T428/1352;;Y10T428/27;;Y10T428/1393;;Y10T428/139;;Y10T428/31725;;Y10T428/3175;;B32B1/00;;B32B27/34;;B32B27/32;;Y10T428/1352;;Y10T428/27;;Y10T428/1393;;Y10T428/139;;Y10T428/31725;;Y10T428/3175;;B32B1/08;;B32B2597/00;;B32B27/34;;B32B2264/108;;B32B27/32;;B32B2439/00;;B32B27/08;;B32B2270/00;;B32B27/20;;B32B2307/202;;B32B25/14;;B32B1/00,B32B27/32;;B32B27/34,,0,0,,,,ACTIVE
240,KR,A,KR 20090005179 A,118-051-221-682-295,2009-01-12,2009,KR 20087027811 A,2007-04-13,US 79263106 P;;EP 2007053634 W,2006-04-18,MULTILAYER POLYMER STRUCTURE,"Multilayer structure comprising at least one couple (L1-L2) of adjacent layers (L1) and (L2), wherein: layer (L1) comprises at least one polymer composition (C1) comprising: (i) at least one semi-aromatic polyamide, and (ii) at least one impact modifier (I1); layer (L2) comprises at least one polymer composition (C2) comprising: (i) at least one un-functionalized polyolefin (PO2); (ii) at least one functionalized polyolefin (FPO2), said functionalized polyolefin comprising functional groups chosen from carboxylic groups, their esters, their anhydrides and their salts Process for manufacturing said multilayer structure, which comprises co-extruding or co-blowmolding polymer compositions (C1) and (C2) so as to obtain couple (L1-L2) of adjacent layers (L1) and (L2). Shaped article comprising the invented multilayer structure and process for manufacturing the shaped article.",SOLVAY ADVANCED POLYMERS LLC,DOTY JAMES K;;LIU ALICE WEIMIN;;WARKOSKI GREGORY;;DE CANNIERE JEAN,,https://lens.org/118-051-221-682-295,Patent Application,no,0,0,18,18,0,B32B1/08;;B32B25/14;;B32B27/08;;B32B27/20;;B32B27/32;;B32B27/34;;B32B2264/108;;B32B2270/00;;B32B2307/202;;B32B2439/00;;B32B2597/00;;Y10T428/1352;;Y10T428/27;;Y10T428/1393;;Y10T428/139;;Y10T428/31725;;Y10T428/3175;;B32B1/00;;B32B27/34;;B32B27/32;;Y10T428/1352;;Y10T428/27;;Y10T428/1393;;Y10T428/139;;Y10T428/31725;;Y10T428/3175;;B32B1/08;;B32B2597/00;;B32B27/34;;B32B2264/108;;B32B27/32;;B32B2439/00;;B32B27/08;;B32B2270/00;;B32B27/20;;B32B2307/202;;B32B25/14;;B32B1/00,B32B27/32;;B32B27/34,,0,0,,,,INACTIVE
241,US,A1,US 2009/0280282 A1,128-855-776-432-624,2009-11-12,2009,US 29675707 A,2007-04-13,US 29675707 A;;US 79263106 P;;EP 2007053634 W,2006-04-18,MULTILAYER POLYMER STRUCTURE,"Multilayer structure comprising at least one couple (L 1 -L 2 ) of adjacent layers (L 1 ) and (L 2 ), wherein: the layer (L 1 ) comprises at least one polymer composition (C 1 ) comprising: (i) at least one semi-aromatic polyamide, and (ii) at least one impact modifier (I 1 );the layer (L 2 ) comprises at least one polymer composition (C 2 ) comprising: (i) at least one un-functionalized polyolefin (PO 2 ); (ii) at least one functionalized polyolefin (FPO 2 ), the functionalized polyolefin comprising functional groups chosen from carboxylic groups, their esters, their anhydrides and their salts. Process for manufacturing such multilayer structure, which comprises co-extruding or co-blowmolding polymer compositions (C 1 ) and (C 2 ) so as to obtain one couple (L 1 -L 2 ) of adjacent layers (L 1 ) and (L 2 ). Shaped article comprising such multilayer structure and process for manufacturing the shaped article.",SOLVAY ADVANCED POLYMERS LLC,DOTY JAMES K;;LIU ALICE WEIMIN;;WARKOSKI GREGORY;;DE CANNIERE JEAN,SOLVAY ADVCANCED POLYMERS L.L.C (2007-04-23),https://lens.org/128-855-776-432-624,Patent Application,yes,26,17,18,18,0,B32B1/08;;B32B25/14;;B32B27/08;;B32B27/20;;B32B27/32;;B32B27/34;;B32B2264/108;;B32B2270/00;;B32B2307/202;;B32B2439/00;;B32B2597/00;;Y10T428/1352;;Y10T428/27;;Y10T428/1393;;Y10T428/139;;Y10T428/31725;;Y10T428/3175;;B32B1/00;;B32B27/34;;B32B27/32;;Y10T428/1352;;Y10T428/27;;Y10T428/1393;;Y10T428/139;;Y10T428/31725;;Y10T428/3175;;B32B1/08;;B32B2597/00;;B32B27/34;;B32B2264/108;;B32B27/32;;B32B2439/00;;B32B27/08;;B32B2270/00;;B32B27/20;;B32B2307/202;;B32B25/14;;B32B1/00,B29C47/06;;B32B1/08;;B29C49/00;;B32B27/08,428/36.91;;428/476.3;;428/35.7;;428/340;;264/104;;264/173.19,0,0,,,,ACTIVE
242,US,A1,US 2005/0013868 A1,004-643-814-414-953,2005-01-20,2005,US 92057804 A,2004-08-17,US 92057804 A;;US 18303502 A;;US 96427301 A,2001-09-26,Preparation of submicron sized nanoparticles via dispersion lyophilization,"The present invention relates to a process for preparing submicron sized nanoparticles of a poorly water soluble compound by lyophilizing a dispersion or microdispersion of a multiphase system having an organic phase and an aqueous phase, the organic phase having the poorly water soluble organic compound therein. The method is preferably used to prepare nanoparticles of a poorly water soluble, pharmaceutically active compound suitable for in vivo delivery, particularly by parenteral routes.",BRYNJELSEN SEAN;;DOTY MARK;;KIPP JAMES E.;;JAYSWAL NAILESH;;NARAYANAN KRISHNASWAMY,BRYNJELSEN SEAN;;DOTY MARK;;KIPP JAMES E;;JAYSWAL NAILESH;;NARAYANAN KRISHNASWAMY,BAXTER INTERNATIONAL INC (2002-07-11),https://lens.org/004-643-814-414-953,Patent Application,yes,98,37,13,20,0,A61K9/5169;;A61K9/5192;;A61K9/145;;B01J13/04;;A61K9/5169;;A61K9/5192;;A61K9/145;;B01J13/04;;A61K9/14,A61K9/19;;A61K9/14;;A61K9/51;;A61K31/496;;A61K45/00;;A61K47/10;;A61K47/12;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/32;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;B01J13/04,424/489,0,0,,,,EXPIRED
243,EP,A1,EP 2013020 A1,012-193-368-963-366,2009-01-14,2009,EP 07728099 A,2007-04-13,EP 2007053634 W;;US 79263106 P,2006-04-18,MULTILAYER POLYMER STRUCTURE,,SOLVAY ADVANCED POLYMERS LLC,DOTY JAMES K;;LIU ALICE WEIMIN;;WARKOSKI GREGORY;;DE CANNIERE JEAN,"SOLVAY SPECIALTY POLYMERS USA, LLC. (2011-11-30)",https://lens.org/012-193-368-963-366,Patent Application,yes,0,0,18,18,0,B32B1/08;;B32B25/14;;B32B27/08;;B32B27/20;;B32B27/32;;B32B27/34;;B32B2264/108;;B32B2270/00;;B32B2307/202;;B32B2439/00;;B32B2597/00;;Y10T428/1352;;Y10T428/27;;Y10T428/1393;;Y10T428/139;;Y10T428/31725;;Y10T428/3175;;B32B1/00;;B32B27/34;;B32B27/32;;Y10T428/1352;;Y10T428/27;;Y10T428/1393;;Y10T428/139;;Y10T428/31725;;Y10T428/3175;;B32B1/08;;B32B2597/00;;B32B27/34;;B32B2264/108;;B32B27/32;;B32B2439/00;;B32B27/08;;B32B2270/00;;B32B27/20;;B32B2307/202;;B32B25/14;;B32B1/00,B32B27/32;;B32B27/34,,0,0,,,,ACTIVE
244,US,A1,US 2023/0064429 A1,000-990-847-304-516,2023-03-02,2023,US 202217890198 A,2022-08-17,US 202217890198 A;;US 202163234773 P,2021-08-19,IMMEDIATE RELEASE FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS,"A solid oral immediate release formulation of LSD, including LSD contained within a dosage form of a capsule, tablet, or orally disintegrating tablet. A method of making a solid oral immediate release formulation of LSD as a free base or in a salt form by granulation, including moisture-activated dry granulation or dry blending. A method of treating an individual, by administering a solid oral immediate release formulation of LSD and treating the individual.",MIND MEDICINE INC,MACK PETER;;MELTON DUSTIN;;DOTY BETHANY AMBER;;SCHROEDER JON;;COGHILL JAMES,MIND MEDICINE INC (2022-10-27),https://lens.org/000-990-847-304-516,Patent Application,yes,0,0,14,14,0,A61K31/48;;A61K9/0056;;A61K9/2063;;A61K9/2018;;A61K9/205;;A61K31/48;;A61K9/20;;A61K47/60;;A61K47/22;;A61K47/36;;A61K47/6923;;A61K47/26;;A61K47/10;;A61K9/0056;;A61K9/2013;;A61K9/2054;;A61K9/2095;;A61K9/2018;;A61K9/205,A61K31/48;;A61K9/20;;A61K47/10;;A61K47/22;;A61K47/26;;A61K47/36;;A61K47/60;;A61K47/69,,0,0,,,,PENDING
245,KR,A,KR 20070074610 A,035-054-811-791-242,2007-07-12,2007,KR 20077010342 A,2007-05-07,US 62603604 P;;US 64287805 P,2004-11-08,NANOPARTICULATE COMPOSITIONS OF TUBULIN INHIBITOR,"The present invention is directed to novel pharmaceutical compositions comprinsing nano-and micro-particulate formulations of poorly water soluble tubulin inhibitors of the indole chemical class, preferably N-substituted indol-3-glyoxyamides, and more preferably N-(Pyridin-4-yl)-[1-(4-chlorobenzyl)-indol-3-yl]glyoxylic acid amide (D-24851), also known as ""Indibulin"", and methods of making and using such compositions for the treatment of anti-tumor agent resistant cancers and other diseases.",BAXTER INT;;BAXTER HEALTHCARE SA,PAPADOPOULOS PAVLOS;;DOTY MARK;;KIPP JAMES E;;ROESSLER BERTHOLD;;RAAB GERHARD,,https://lens.org/035-054-811-791-242,Patent Application,no,0,0,16,17,0,A61K9/0019;;A61K9/0095;;A61K9/10;;A61K9/145;;A61K9/146;;A61K9/5123;;A61K9/5146;;A61K31/404;;A61K31/4439;;Y10T428/2982;;C07D401/12;;A61P1/18;;A61P11/02;;A61P11/06;;A61P19/02;;A61P29/00;;A61P31/04;;A61P35/00;;A61P35/04;;A61P37/02;;A61P37/06;;A61P37/08;;A61P43/00;;B82B3/00;;H01F27/12;;H01B3/20;;H01B3/00;;Y10T428/2982;;A61K31/4439;;A61K31/404;;A61K9/5123;;A61K9/5146;;A61K9/145;;A61K9/0095;;A61K9/10;;A61K9/146;;A61K9/0019;;A61K9/14;;C07D401/12,A61K9/16;;A61K31/404;;A61P35/00,,0,0,,,,DISCONTINUED
246,US,B1,US 8098197 B1,068-940-735-943-171,2012-01-17,2012,US 54991309 A,2009-08-28,US 54991309 A,2009-08-28,System and method for providing hybrid global positioning system/height of burst antenna operation with optimizied radiation patterns,"The present invention is a device which includes an antenna and circuitry. The antenna may receive a circularly-polarized signal as first and second linearly-polarized signals. The circuitry is connected to the antenna and is configured for combining the first and second linearly-polarized signals to produce at least two reception patterns. The reception patterns are created by summing the first and second linearly-polarized signals via phase shifting. The reception patterns are optimized for at least two substantially different directional orientations. Further, the antenna may simultaneously allow/provide spec-compliant Global Positioning System operation and spec compliant Height of Burst operation.",HERTING BRIAN J;;PAULSEN LEE M;;DOTY JAMES H;;WEST JAMES B;;LOWER NATHAN P;;ROCKWELL COLLINS INC,HERTING BRIAN J;;PAULSEN LEE M;;DOTY JAMES H;;WEST JAMES B;;LOWER NATHAN P,ROCKWELL COLLINS INC (2009-08-26),https://lens.org/068-940-735-943-171,Granted Patent,yes,2,24,1,1,0,F42B15/01;;G01S19/36;;H01Q9/0492;;H04B7/10;;H04B7/10;;F42B15/01;;G01S19/36;;H01Q9/0492,H04B7/10,342/365,0,0,,,,ACTIVE
247,EP,A2,EP 1372637 A2,133-257-914-645-144,2004-01-02,2004,EP 02736532 A,2002-03-28,US 0210094 W;;US 82276701 A;;US 94537401 A,2001-03-29,PREMIXED AMIODARONE PARENTERAL SOLUTION AND METHOD FOR MAKING THE SAME,,BAXTER INT,DOTY MARK J;;REBBECK CHRISTINE L;;KIPP JAMES E;;RAGHAVAN NEERVALUR V,,https://lens.org/133-257-914-645-144,Patent Application,yes,0,2,14,22,0,A61K9/0019;;A61K31/343;;A61K47/26;;A61P9/06,A61K9/00;;C07D307/80;;A61K9/08;;A61K31/343;;A61K47/02;;A61K47/10;;A61K47/18;;A61K47/26;;A61K47/34;;A61K47/36;;A61P9/06,,0,0,,,,EXPIRED
248,CA,A1,CA 2442365 A1,176-702-946-393-546,2002-10-10,2002,CA 2442365 A,2002-03-28,US 82276701 A;;US 94537401 A;;US 0210094 W,2001-03-29,PREMIXED AMIODARONE PARENTERAL SOLUTION AND METHOD FOR MAKING THE SAME,"A premix parenteral solution for intravenous administration having amiodarone, as an active ingredient, solubilized in a solution of water for injection and about 0.4 - 12 mg/ml of a non-ionic surfactant to a concentration range of from 0.2 to 6 mg/ml is disclosed. The solution optionally may include an osmotic agent. No dilution of the solution is required before administering to a patient and the sterile packaged solution has an initial pH within the range of from about 2.9 to about 3.2, preferably about 3.1. Additionally, a method for producing an amiodarone solution suitable for intravenous administration is further disclosed.",BAXTER INT,RAGHAVAN NEERVALUR V;;KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L,,https://lens.org/176-702-946-393-546,Patent Application,no,0,0,14,22,0,A61K9/0019;;A61K31/343;;A61K47/26;;A61P9/06,C07D307/80;;A61K9/00;;A61K9/08;;A61K31/343;;A61K47/02;;A61K47/10;;A61K47/18;;A61K47/26;;A61K47/34;;A61K47/36;;A61P9/06,,0,0,,,,DISCONTINUED
249,US,A1,US 2006/0110462 A1,125-491-309-314-887,2006-05-25,2006,US 26651805 A,2005-11-03,US 26651805 A;;US 62603604 P;;US 64287805 P,2004-11-08,Nanoparticulate compositions of tubulin inhibitor compounds,"The present invention is directed to novel pharmaceutical compositions comprising nano- and micro-particulate formulations of poorly water soluble tubulin inhibitors of the indole chemical class, preferably N-substituted indol-3-glyoxyamides, and more preferably N-(Pyridin-4-yl)-[1-(4-chlorobenzyl)-indol-3-yl]glyoxylic acid amide (D-24851), also known as “Indibulin,” and methods of making and using such compositions for the treatment of anti-tumor agent resistant cancers and other diseases.",PAPADOPOULOS PAVLOS;;RAAB GERHARD;;DOTY MARK J;;KIPP JAMES E;;ROESSLER BERTHOLD,PAPADOPOULOS PAVLOS;;RAAB GERHARD;;DOTY MARK J;;KIPP JAMES E;;ROESSLER BERTHOLD,BAXTER HEALTHCARE S.A (2006-01-10);;BAXTER INTERNATIONAL INC (2006-01-10);;ZIOPHARM ONCOLOGY INC (2010-10-18),https://lens.org/125-491-309-314-887,Patent Application,yes,15,18,16,17,0,A61K9/0019;;A61K9/0095;;A61K9/10;;A61K9/145;;A61K9/146;;A61K9/5123;;A61K9/5146;;A61K31/404;;A61K31/4439;;Y10T428/2982;;C07D401/12;;A61P1/18;;A61P11/02;;A61P11/06;;A61P19/02;;A61P29/00;;A61P31/04;;A61P35/00;;A61P35/04;;A61P37/02;;A61P37/06;;A61P37/08;;A61P43/00;;B82B3/00;;H01F27/12;;H01B3/20;;H01B3/00;;Y10T428/2982;;A61K31/4439;;A61K31/404;;A61K9/5123;;A61K9/5146;;A61K9/145;;A61K9/0095;;A61K9/10;;A61K9/146;;A61K9/0019;;A61K9/14;;C07D401/12,A61K31/4439;;A61K9/14,424/489;;514/337;;977/906,1,1,066-115-097-910-400,10.1016/0378-5173(88)90235-9,"Bisrat et al. ""Physicochemical aspects of drug release. VIII. The relation between particle size and surface specific dissolution rate in agitated suspensions"", 1988, Volume 47, Issues 1-3, Pages 223-231.",DISCONTINUED
250,EP,A2,EP 1267865 A2,142-606-707-229-577,2003-01-02,2003,EP 01923027 A,2001-03-30,US 0110598 W;;US 53944600 A,2000-03-30,AMIODARONE-CONTAINING PARENTERAL SOLUTION,"The present invention provides an amiodarone parenteral solution suitable for intravenous administration without the necessity of dilution. The parenteral solution has an amiodarone concentration from 0.2 to 10 mg/ml and a buffer solution selected from the group consisting of lactate buffer, methanesulfonate buffer, or combinations thereof, the solution having a pH within the range from approximately 2.5-4.5.",BAXTER INT,KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;EILERT JAN Y,,https://lens.org/142-606-707-229-577,Patent Application,yes,0,0,15,15,0,A61K9/0019;;A61K31/34;;A61K47/12;;A61P9/06;;A61K9/0019;;A61K47/12;;A61K31/34,A61K9/08;;A61K9/00;;A61K31/34;;A61K31/343;;A61K47/04;;A61K47/10;;A61K47/12;;A61K47/18;;A61K47/20;;A61K47/26;;A61P9/06,,0,0,,,,EXPIRED
251,WO,A2,WO 2002/078605 A2,029-887-094-793-120,2002-10-10,2002,US 0210094 W,2002-03-28,US 82276701 A;;US 94537401 A,2001-03-29,PREMIXED AMIODARONE PARENTERAL SOLUTION AND METHOD FOR MAKING THE SAME,"A premix parenteral solution for intravenous administration having amiodarone, as an active ingredient, solubilized in a solution of water for injection and about 0.4 - 12 mg/ml of a non-ionic surfactant to a concentration range of from 0.2 to 6 mg/ml is disclosed. The solution optionally may include an osmotic agent. No dilution of the solution is required before administering to a patient and the sterile packaged solution has an initial pH within the range of from about 2.9 to about 3.2, preferably about 3.1. Additionally, a method for producing an amiodarone solution suitable for intravenous administration is further disclosed.",BAXTER INT,DOTY MARK J;;REBBECK CHRISTINE L;;KIPP JAMES E;;RAGHAVAN NEERVALUR V,,https://lens.org/029-887-094-793-120,Patent Application,yes,0,0,14,22,0,A61K9/0019;;A61K31/343;;A61K47/26;;A61P9/06,A61K9/00;;C07D307/80;;A61K9/08;;A61K31/343;;A61K47/02;;A61K47/10;;A61K47/18;;A61K47/26;;A61K47/34;;A61K47/36;;A61P9/06,,0,0,,,,PATENTED
252,EP,B1,EP 1267865 B1,033-649-301-546-247,2006-02-15,2006,EP 01923027 A,2001-03-30,US 0110598 W;;US 53944600 A,2000-03-30,AMIODARONE-CONTAINING PARENTERAL SOLUTION,"The present invention provides an amiodarone parenteral solution suitable for intravenous administration without the necessity of dilution. The parenteral solution has an amiodarone concentration from 0.2 to 10 mg/ml and a buffer solution selected from the group consisting of lactate buffer, methanesulfonate buffer, or combinations thereof, the solution having a pH within the range from approximately 2.5-4.5.",BAXTER INT,KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;EILERT JAN Y,,https://lens.org/033-649-301-546-247,Granted Patent,yes,2,0,15,15,0,A61K9/0019;;A61K31/34;;A61K47/12;;A61P9/06;;A61K9/0019;;A61K47/12;;A61K31/34,A61K9/08;;A61K31/34;;A61K9/00;;A61K31/343;;A61K47/04;;A61K47/10;;A61K47/12;;A61K47/18;;A61K47/20;;A61K47/26;;A61P9/06,,0,0,,,,EXPIRED
253,EP,B1,EP 0621047 B1,081-949-884-094-304,1996-12-11,1996,EP 94302110 A,1994-03-23,US 5064193 A,1993-04-22,Hollow fibre blood oxygenator,,COBE LAB,CARSON GARY A;;DOTY ROBERT E;;HOGLUND MICHAEL R;;ISAACSON JAMES D,,https://lens.org/081-949-884-094-304,Granted Patent,yes,4,7,11,29,0,A61M1/1698;;B01D63/02;;B01D63/021;;F28F21/062;;B01D2313/105;;B01D2313/125;;A61M1/1625;;A61M1/1629;;B01D2313/221;;A61M1/3623;;A61M1/1625;;A61M1/1629;;A61M1/3623;;B01D63/033;;B01D63/0233,A61M1/14;;A61M1/16;;B01D63/02;;F28F21/06,,0,0,,,,EXPIRED
254,US,A,US 5733398 A,117-952-015-163-947,1998-03-31,1998,US 64898096 A,1996-05-17,US 64898096 A;;US 54804895 A;;US 26130894 A;;US 5064193 A;;US 97078192 A,1992-11-03,Efficient methods of manufacturing hollow fiber exchangers,"An exchanger includes an outer casing having an inlet port and an outlet port for a first fluid, and an inlet port and an outlet port for a second fluid, and a bundle of hollow fibers located within the outer casing and being in flow communication with the inlet and outlet port for the second fluid. A central core is located in the outer casing and the bundle of fibers is arranged around the central core. The central core includes an inlet manifold connected to the first fluid inlet port, and an outlet manifold connected to the first fluid outlet port.",COBE LAB,CARSON GARY A;;DOTY ROBERT E;;HOGLUND MICHAEL R;;ISAACSON JAMES D,COBE CARDIOVASCULAR OPERATING CO. INC (1999-05-17);;COBE CARDIOVASCULAR INC (1999-10-31),https://lens.org/117-952-015-163-947,Granted Patent,yes,100,19,3,29,0,A61M1/1698;;A61M2205/366;;B01D63/02;;B01D63/021;;F28D9/0025;;F28F21/062;;B01D2313/105;;B01D2313/125;;B01D2313/21;;A61M1/1625;;A61M1/1629;;B01D2313/221;;A61M1/3623;;A61M2205/366;;F28F21/062;;A61M1/1698;;F28D9/0025;;B01D2313/125;;B01D2313/105;;B01D2313/21;;A61M1/1625;;A61M1/1629;;B01D2313/221;;A61M1/3623;;B01D63/0233,A61M1/16;;B01D63/02;;F28D9/00;;F28F21/06,156/69;;422/46,2,0,,,"Hot Plate Welders, Ultrasonic Welders, Spin Welders, Vibration Welders, Thermo Stakers, Leak Testers; Sales Brochure, Forward Technology Industries Inc., Minneapolis, Minnesota, Jun. 1991.;;Pall Blood Filter Brochure, Pall Corporation, 1984.",EXPIRED
255,JP,A,JP 2009102404 A,060-116-266-472-752,2009-05-14,2009,JP 2009017366 A,2009-01-28,US 82276701 A;;US 94537401 A,2001-03-29,PREMIXED AMIODARONE PARENTERAL SOLUTION AND METHOD FOR MAKING THE SAME,"<P>PROBLEM TO BE SOLVED: To disclose a premix parenteral solution for intravenous administration having amiodarone, as an active ingredient, solubilized in a solution of distilled water for injection and about 0.4-12 mg/mL of a non-ionic surfactant to a concentration range of from 0.2 to 6 mg/mL. <P>SOLUTION: The solution optionally may include an osmotic regulating agent. No dilution of the solution is required before administering to a patient and the sterile packaged solution has an initial pH within the range of from about 2.9 to about 3.2, preferably about 3.1. Additionally, a method for producing an amiodarone solution suitable for intravenous administration is further disclosed. <P>COPYRIGHT: (C)2009,JPO&INPIT",BAXTER INT,DOTY MARK J;;REBBECK CHRISTINE L;;KIPP JAMES E;;RAGHAVAN NEERVALUR V,,https://lens.org/060-116-266-472-752,Patent Application,no,0,0,8,22,0,A61K9/0019;;A61K31/343;;A61K47/26;;A61P9/06;;A61K9/0019;;A61K47/26;;A61K31/343,A61K31/343;;C07D307/80;;A61K9/00;;A61K9/08;;A61K47/02;;A61K47/10;;A61K47/18;;A61K47/26;;A61K47/34;;A61K47/36;;A61P9/06,,0,0,,,,DISCONTINUED
256,EP,B1,EP 1372637 B1,183-054-653-903-566,2008-02-20,2008,EP 02736532 A,2002-03-28,US 0210094 W;;US 82276701 A;;US 94537401 A,2001-03-29,PREMIXED AMIODARONE PARENTERAL SOLUTION AND METHOD FOR MAKING THE SAME,,BAXTER INT,DOTY MARK J;;REBBECK CHRISTINE L;;KIPP JAMES E;;RAGHAVAN NEERVALUR V,,https://lens.org/183-054-653-903-566,Granted Patent,yes,3,0,14,22,0,A61K9/0019;;A61K31/343;;A61K47/26;;A61P9/06,A61K31/343;;A61K9/00;;C07D307/80;;A61K9/08;;A61K47/02;;A61K47/10;;A61K47/18;;A61K47/26;;A61K47/34;;A61K47/36;;A61P9/06,,3,0,,,"BOURY F. ET AL: ""Interfacial properties of amiodarone: The stabilizing effect of phosphate anions."" COLLOIDS AND SURFACES B: BIOINTERFACES, (2001) 20/3 (219-227). , XP001098868;;WEIR S J ET AL: ""Sorption of amiodarone to polyvinyl chloride infusion bags and administration sets."" AMERICAN JOURNAL OF HOSPITAL PHARMACY. UNITED STATES DEC 1985, vol. 42, no. 12, December 1985 (1985-12), pages 2679-2683, XP001117445 ISSN: 0002-9289;;CAMPBELL S ET AL: ""Stability of amiodarone hydrochloride in admixtures with other injectable drugs."" AMERICAN JOURNAL OF HOSPITAL PHARMACY. UNITED STATES APR 1986, vol. 43, no. 4, April 1986 (1986-04), pages 917-921, XP001107000 ISSN: 0002-9289",EXPIRED
257,US,A1,US 2002/0143051 A1,028-696-333-138-839,2002-10-03,2002,US 82276701 A,2001-03-29,US 82276701 A,2001-03-29,Premixed amiodarone parenteral solution and method for making the same,"
   A premix parenteral solution for intravenous administration having amiodarone, as an active ingredient, solubilized in a solution of distilled water and about 0.4-12 mg/ml of a non-ionic surfactant to a concentration range of from 0.2 to 6 mg/ml is disclosed. The solution optionally may include an osmotic agent. No dilution of the solution is required before administering to a patient and the sterile packaged solution has an initial pH within the range of from about 2.9 to about 3.2, preferably about 3.1. Additionally, a method for producing an amiodarone solution suitable for intravenous administration is further disclosed. 
",DOTY MARK J.;;REBBECK CHRISTINE L.;;KIPP JAMES E.;;RAGHAVAN NEERVALUR V.,DOTY MARK J;;REBBECK CHRISTINE L;;KIPP JAMES E;;RAGHAVAN NEERVALUR V,BAXTER INTERNATIONAL INC (2001-07-06),https://lens.org/028-696-333-138-839,Patent Application,yes,0,0,8,22,0,A61K9/0019;;A61K31/343;;A61K47/26;;A61P9/06;;A61K9/0019;;A61K47/26;;A61K31/343,A61K9/00;;A61K9/08;;C07D307/80;;A61K31/343;;A61K47/02;;A61K47/10;;A61K47/18;;A61K47/26;;A61K47/34;;A61K47/36;;A61P9/06,514/469;;514/23,0,0,,,,DISCONTINUED
258,US,S,US D0710233 S,037-581-620-221-877,2014-08-05,2014,US 201329443457 F,2013-01-17,US 201329443457 F,2013-01-17,End cap for a vehicle tire deflation device,,WERSCHING JAMES P;;UTHE GARY L;;BLOCK RICHARD W;;DOTY DOUGLAS A;;STOP STICK LTD,WERSCHING JAMES P;;UTHE GARY L;;BLOCK RICHARD W;;DOTY DOUGLAS A,STOP STICK LTD (2014-05-28),https://lens.org/037-581-620-221-877,Design Right,no,0,1,1,1,0,,,1005;;D10/121,0,0,,,,ACTIVE
259,WO,A2,WO 2009/094097 A2,070-014-904-628-359,2009-07-30,2009,US 2008/0088487 W,2008-12-29,US 2042708 A,2008-01-25,STREAMING OBJECT INSTANTIATION USING BOOKMARKS,"Bookmarking of tokens in a set of streaming tokens, each representing an instantiation instruction or instantiation context. A navigator receives a set of streaming tokens, and provides the tokens to the instantiation manager. However, if the navigator receives an instruction to bookmark a particular token, the navigator buffers the set of streaming instructions at least beginning at the bookmarked token (and possible even earlier if there were prior bookmarks). The navigator replays the set of streaming tokens beginning at a bookmark in response to an instruction from an instantiation manager. The instantiation manager receives the set of streaming tokens. If the instantiation manager is not presently capable of handling the instruction of a particular token, the instantiation manager instructs the navigator to bookmark the particular token. When the instantiation manager later receives a token that permits the instantiation manager to return to the bookmark, the instantiation manager returns to the bookmark to replay the instantiation instructions beginning at the bookmark.",MICROSOFT CORP,DOTY JOHN DAVID;;SCHLIMMER JEFFREY C;;ANDERSON CHRISTOPHER LEE;;GUDGIN MARTIN JAMES,,https://lens.org/070-014-904-628-359,Patent Application,yes,1,0,10,10,0,G06F9/544;;G06F9/4493;;G06F9/544;;G06F9/4493,G06F15/00;;G06F15/16,,1,0,,,"""Serialization"", 22 January 2008, pages: 1 - 13",PENDING
260,WO,A3,WO 2001/074395 A3,090-680-337-261-326,2002-02-07,2002,US 0110598 W,2001-03-30,US 53944600 A,2000-03-30,AMIODARONE-CONTAINING PARENTERAL SOLUTION,"The present invention provides an amiodarone parenteral solution suitable for intravenous administration without the necessity of dilution. The parenteral solution has an amiodarone concentration from 0.2 to 10 mg/ml and a buffer solution selected from the group consisting of lactate buffer, methanesulfonate buffer, or combinations thereof, the solution having a pH within the range from approximately 2.5 - 4.5.",BAXTER INT,KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;EILERT JAN Y,,https://lens.org/090-680-337-261-326,Search Report,yes,2,0,15,15,0,A61K9/0019;;A61K31/34;;A61K47/12;;A61P9/06;;A61K9/0019;;A61K47/12;;A61K31/34,A61K9/00;;A61K31/34;;A61K31/343;;A61K9/08;;A61K47/04;;A61K47/10;;A61K47/12;;A61K47/18;;A61K47/20;;A61K47/26;;A61P9/06,,0,0,,,,PATENTED
261,DE,D1,DE 60225122 D1,188-506-258-907-096,2008-04-03,2008,DE 60225122 T,2002-03-28,US 82276701 A;;US 94537401 A;;US 0210094 W,2001-03-29,VORGEMISCHTE AMIODARON-HALTIGE PARENTERALE LÖSUNG UND DEREN HERSTELLUNGSVERFAHREN,,BAXTER INT,DOTY MARK J;;REBBECK CHRISTINE L;;KIPP JAMES E;;RAGHAVAN NEERVALUR V,,https://lens.org/188-506-258-907-096,Granted Patent,no,0,0,8,22,0,A61K9/0019;;A61K31/343;;A61K47/26;;A61P9/06;;A61K9/0019;;A61K47/26;;A61K31/343,A61K31/343;;C07D307/80;;A61K9/00;;A61K9/08;;A61K47/02;;A61K47/10;;A61K47/18;;A61K47/26;;A61K47/34;;A61K47/36;;A61P9/06,,0,0,,,,EXPIRED
262,WO,A3,WO 2009/094097 A3,146-509-881-836-330,2009-09-17,2009,US 2008/0088487 W,2008-12-29,US 2042708 A,2008-01-25,STREAMING OBJECT INSTANTIATION USING BOOKMARKS,"Bookmarking of tokens in a set of streaming tokens, each representing an instantiation instruction or instantiation context. A navigator receives a set of streaming tokens, and provides the tokens to the instantiation manager. However, if the navigator receives an instruction to bookmark a particular token, the navigator buffers the set of streaming instructions at least beginning at the bookmarked token (and possible even earlier if there were prior bookmarks). The navigator replays the set of streaming tokens beginning at a bookmark in response to an instruction from an instantiation manager. The instantiation manager receives the set of streaming tokens. If the instantiation manager is not presently capable of handling the instruction of a particular token, the instantiation manager instructs the navigator to bookmark the particular token. When the instantiation manager later receives a token that permits the instantiation manager to return to the bookmark, the instantiation manager returns to the bookmark to replay the instantiation instructions beginning at the bookmark.",MICROSOFT CORP,DOTY JOHN DAVID;;SCHLIMMER JEFFREY C;;ANDERSON CHRISTOPHER LEE;;GUDGIN MARTIN JAMES,,https://lens.org/146-509-881-836-330,Search Report,yes,4,0,10,10,0,G06F9/544;;G06F9/4493;;G06F9/544;;G06F9/4493,G06F15/00;;G06F15/16,,0,0,,,,PENDING
263,US,A,US 5674452 A,194-714-456-738-59X,1997-10-07,1997,US 54804895 A,1995-10-25,US 54804895 A;;US 26130894 A;;US 5064193 A;;US 97078192 A,1992-11-03,Hollow fiber exchangers,"An exchanger includes an outer casing having an inlet port and an outlet port for a first fluid, and an inlet port and an outlet port for a second fluid, and a bundle of hollow fibers located within the outer casing and being in flow communication with the inlet and outlet port for the second fluid. A central core is located in the outer casing and the bundle of fibers is arranged around the central core. The central core includes an inlet manifold connected to the first fluid inlet port, and an outlet manifold connected to the first fluid outlet port.",COBE LAB,CARSON GARY A;;DOTY ROBERT E;;HOGLUND MICHAEL R;;ISAACSON JAMES D,COBE CARDIOVASCULAR OPERATING CO. INC (1999-05-17);;COBE CARDIOVASCULAR INC (1999-10-31),https://lens.org/194-714-456-738-59X,Granted Patent,yes,100,22,3,29,0,A61M1/1698;;A61M2205/366;;B01D63/02;;B01D63/021;;F28D9/0025;;F28F21/062;;B01D2313/105;;B01D2313/125;;B01D2313/21;;A61M1/1625;;A61M1/1629;;B01D2313/221;;A61M1/3623;;A61M2205/366;;F28F21/062;;A61M1/1698;;F28D9/0025;;B01D2313/125;;B01D2313/105;;B01D2313/21;;A61M1/1625;;A61M1/1629;;B01D2313/221;;A61M1/3623;;B01D63/0233,A61M1/16;;B01D63/02;;F28D9/00;;F28F21/06,422/46;;422/48;;210/321.76;;210/321.84;;210/645;;604/4,2,0,,,"Hot Plate Welders, Ultrasonic Welders, Spin Welders, Vibration Welders, Thermo Stakers, Leak Testers; Sales Brochure, Forward Technology Industries Inc., Minneapolis, Minnesota, Jun. 1991.;;Pall Blood Filter Brohcure, Pall Corporation, 1984.",EXPIRED
264,EP,A4,EP 2248036 A4,028-013-875-863-204,2011-12-21,2011,EP 08871356 A,2008-12-29,US 2008/0088487 W;;US 2042708 A,2008-01-25,STREAMING OBJECT INSTANTIATION USING BOOKMARKS,,MICROSOFT CORP,DOTY JOHN DAVID;;SCHLIMMER JEFFREY C;;ANDERSON CHRISTOPHER LEE;;GUDGIN MARTIN JAMES,"MICROSOFT TECHNOLOGY LICENSING, LLC (2015-03-18)",https://lens.org/028-013-875-863-204,Search Report,no,2,0,10,10,0,G06F9/544;;G06F9/4493;;G06F9/544;;G06F9/4493,G06F15/16;;G06F9/44;;G06F15/00,,5,0,,,"ANONYMOUS: ""Seralization"", 22 January 2008 (2008-01-22), pages 1 - 13, XP002662524, Retrieved from the Internet <URL:http://en.wikipedia.org/w/index.php?title=Serialization&oldid=186083449> [retrieved on 20111028];;ANONYMOUS: ""Lexical analysis"", 15 January 2008 (2008-01-15), pages 1 - 4, XP002662525, Retrieved from the Internet <URL:http://en.wikipedia.org/w/index.php?title=Lexical_analysis&oldid=184563542> [retrieved on 20111031];;ANONYMOUS: ""Parsing"", 16 January 2008 (2008-01-16), pages 1 - 5, XP002662526, Retrieved from the Internet <URL:http://en.wikipedia.org/w/index.php?title=Parsing&oldid=184750647> [retrieved on 20111031];;ANONYMOUS: ""Extensible Application Markup Language"", 16 January 2008 (2008-01-16), pages 1 - 2, XP002662688, Retrieved from the Internet <URL:http://en.wikipedia.org/w/index.php?title=Extensible_Application_Markup_Language&direction=prev&oldid=188665921> [retrieved on 20111103];;See also references of WO 2009094097A2",DISCONTINUED
265,US,A1,US 2002/0143050 A1,078-556-931-935-562,2002-10-03,2002,US 94537401 A,2001-08-31,US 94537401 A;;US 82276701 A,2001-03-29,Premixed amiodarone parenteral solution and method for making the same,"
   A premix parenteral solution for intravenous administration having amiodarone, as an active ingredient, solubilized in a solution of water for injection and about 0.4-12 mg/ml of a non-ionic surfactant to a concentration range of from 0.2 to 6 mg/ml is disclosed. The solution optionally may include an osmotic agent. No dilution of the solution is required before administering to a patient and the sterile packaged solution has an initial pH within the range of from about 2.9 to about 3.2, preferably about 3.1. Additionally, a method for producing an amiodarone solution suitable for intravenous administration is further disclosed. 
",DOTY MARK J.;;REBBECK CHRISTINE L.;;KIPP JAMES E.;;RAGHAVEN NEERVALUR V.,DOTY MARK J;;REBBECK CHRISTINE L;;KIPP JAMES E;;RAGHAVEN NEERVALUR V,BAXTER INTERNATIONAL INC (2001-11-27),https://lens.org/078-556-931-935-562,Patent Application,yes,1,6,8,22,0,A61K9/0019;;A61K31/343;;A61K47/26;;A61P9/06;;A61K9/0019;;A61K47/26;;A61K31/343,A61K9/00;;C07D307/80;;A61K9/08;;A61K31/343;;A61K47/02;;A61K47/10;;A61K47/18;;A61K47/26;;A61K47/34;;A61K47/36;;A61P9/06,514/464;;424/422,0,0,,,,EXPIRED
266,US,A1,US 2009/0193136 A1,121-370-214-274-046,2009-07-30,2009,US 2042708 A,2008-01-25,US 2042708 A,2008-01-25,STREAMING OBJECT INSTANTIATION USING BOOKMARKS,"Bookmarking of tokens in a set of streaming tokens, each representing an instantiation instruction or instantiation context. A navigator receives a set of streaming tokens, and provides the tokens to the instantiation manager. However, if the navigator receives an instruction to bookmark a particular token, the navigator buffers the set of streaming instructions at least beginning at the bookmarked token (and possible even earlier if there were prior bookmarks). The navigator replays the set of streaming tokens beginning at a bookmark in response to an instruction from an instantiation manager. The instantiation manager receives the set of streaming tokens. If the instantiation manager is not presently capable of handling the instruction of a particular token, the instantiation manager instructs the navigator to bookmark the particular token. When the instantiation manager later receives a token that permits the instantiation manager to return to the bookmark, the instantiation manager returns to the bookmark to replay the instantiation instructions beginning at the bookmark.",MICROSOFT CORP,DOTY JOHN DAVID;;SCHLIMMER JEFFREY C;;ANDERSON CHRISTOPHER LEE;;GUDGIN MARTIN JAMES,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2008-01-24),https://lens.org/121-370-214-274-046,Patent Application,yes,12,1,10,10,0,G06F9/544;;G06F9/4493;;G06F9/544;;G06F9/4493,G06F15/16,709/231,0,0,,,,INACTIVE
267,US,A1,US 2014/0199118 A1,135-439-526-649-135,2014-07-17,2014,US 201414158387 A,2014-01-17,US 201414158387 A;;US 201361753656 P,2013-01-17,VEHICLE TIRE DEFLATION DEVICE,"A vehicle tire deflation device includes a housing structure, a core structure, a plurality of spikes, a first end cap and a second end cap. The housing structure includes a first end and a second end. The core structure resides within the housing structure. The plurality of spikes is maintained by the core structure and positioned in a predetermined orientation. The predetermined orientation positions the spikes to penetrate a tire when a vehicle travels over the vehicle tire deflation device. Each end cap selectively attaches to the respective ends of the housing structure. Each end cap defines an opening and comprises an outer wall. Each of the openings communicates with the interior of the device so as to permit air to pass from the interior to the exterior of the device. Methods of using a vehicle tire deflation device are also described.",WERSCHING JAMES P;;UTHE GARY L;;BLOCK RICHARD W;;DOTY DOUGLAS A,WERSCHING JAMES P;;UTHE GARY L;;BLOCK RICHARD W;;DOTY DOUGLAS A,,https://lens.org/135-439-526-649-135,Patent Application,yes,15,18,1,1,0,E01F13/12;;E01F13/12,E01F13/12,404/6;;404/72,0,0,,,,DISCONTINUED
268,WO,A2,WO 2001/074395 A2,155-599-750-917-649,2001-10-11,2001,US 0110598 W,2001-03-30,US 53944600 A,2000-03-30,AMIODARONE-CONTAINING PARENTERAL SOLUTION,"The present invention provides an amiodarone parenteral solution suitable for intravenous administration without the necessity of dilution. The parenteral solution has an amiodarone concentration from 0.2 to 10 mg/ml and a buffer solution selected from the group consisting of lactate buffer, methanesulfonate buffer, or combinations thereof, the solution having a pH within the range from approximately 2.5 - 4.5.",BAXTER INT,KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;EILERT JAN Y,,https://lens.org/155-599-750-917-649,Patent Application,yes,0,17,15,15,0,A61K9/0019;;A61K31/34;;A61K47/12;;A61P9/06;;A61K9/0019;;A61K47/12;;A61K31/34,A61K9/00;;A61K9/08;;A61K31/34;;A61K31/343;;A61K47/04;;A61K47/10;;A61K47/12;;A61K47/18;;A61K47/20;;A61K47/26;;A61P9/06,,0,0,,,,PATENTED
269,US,A1,US 2002/0102901 A1,038-207-730-875-544,2002-08-01,2002,US 74723100 A,2000-12-22,US 74723100 A,2000-12-22,Method and apparatus for applying crosswires to a tension focus mask,"
   A method and apparatus for applying crosswires to a tension mask. The method includes winding crosswires around various drum assemblies and then using transfer devices to remove sections of crosswires and transfer them to tension mask frame assemblies. 
",DOTY JAMES EDWARD;;GARRITY EDWARD RICHARD;;THOMSON MARK ALLEN;;WILBUR LEONARD PRATT,DOTY JAMES EDWARD;;GARRITY EDWARD RICHARD;;THOMSON MARK ALLEN;;WILBUR LEONARD PRATT,THOMSON LICENSING S.A (2001-04-10),https://lens.org/038-207-730-875-544,Patent Application,yes,0,0,9,9,0,H01J9/14;;H01J9/16;;H01J9/24;;H01J9/14;;H01J9/16,H01J9/14;;H01J9/16,445/37,0,0,,,,EXPIRED
270,CN,B,CN 101925889 B,063-742-446-849-307,2012-10-10,2012,CN 200880125603 A,2008-12-29,US 2008/0088487 W;;US 2042708 A,2008-01-25,Streaming object instantiation using bookmarks,"Bookmarking of tokens in a set of streaming tokens, each representing an instantiation instruction or instantiation context. A navigator receives a set of streaming tokens, and provides the tokens to the instantiation manager. However, if the navigator receives an instruction to bookmark a particular token, the navigator buffers the set of streaming instructions at least beginning at the bookmarked token (and possible even earlier if there were prior bookmarks). The navigator replays the set of streaming tokens beginning at a bookmark in response to an instruction from an instantiation manager. The instantiation manager receives the set of streaming tokens. If the instantiation manager is not presently capable of handling the instruction of a particular token, the instantiation manager instructs the navigator to bookmark the particular token. When the instantiation manager later receives a token that permits the instantiation manager to return to the bookmark, the instantiation manager returns to the bookmark to replay the instantiation instructions beginning at the bookmark.",MICROSOFT CORP,DAVID DOTY JOHN;;SCHLIMMER JEFFREY C;;LEE ANDERSON CHRISTOPHER;;JAMES GUDGIN MARTIN,MICROSOFT TECHNOLOGY LICENSING LLC (2015-04-28),https://lens.org/063-742-446-849-307,Granted Patent,no,0,0,10,10,0,G06F9/544;;G06F9/4493;;G06F9/544;;G06F9/4493,G06F15/16;;G06F15/00,,0,0,,,,ACTIVE
271,AT,T1,AT E317695 T1,065-080-600-582-907,2006-03-15,2006,AT 01923027 T,2001-03-30,US 53944600 A,2000-03-30,PARENTERALE LÖSUNG ENTHALTEND AMIODARON,"The present invention provides an amiodarone parenteral solution suitable for intravenous administration without the necessity of dilution. The parenteral solution has an amiodarone concentration from 0.2 to 10 mg/ml and a buffer solution selected from the group consisting of lactate buffer, methanesulfonate buffer, or combinations thereof, the solution having a pH within the range from approximately 2.5-4.5.",BAXTER INT,KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;EILERT JAN Y,,https://lens.org/065-080-600-582-907,Granted Patent,no,0,0,15,15,0,A61K9/0019;;A61K31/34;;A61K47/12;;A61P9/06;;A61K9/0019;;A61K47/12;;A61K31/34,A61K9/08;;A61K9/00;;A61K31/34;;A61K31/343;;A61K47/04;;A61K47/10;;A61K47/12;;A61K47/18;;A61K47/20;;A61K47/26;;A61P9/06,,0,0,,,,EXPIRED
272,AU,B2,AU 675496 B2,130-871-548-968-816,1997-02-06,1997,AU 1994/059037 A,1994-03-25,US 5064193 A,1993-04-22,Hollow fiber blood oxygenator,,COBE LAB,CARSON GARY A;;DOTY ROBERT E;;HOGLUND MICHAEL R;;ISAACSON JAMES D,"COBE CARDIOVASCULAR, INC. (2000-05-04)",https://lens.org/130-871-548-968-816,Granted Patent,no,2,0,11,29,0,A61M1/1698;;B01D63/02;;B01D63/021;;F28F21/062;;B01D2313/105;;B01D2313/125;;A61M1/1625;;A61M1/1629;;B01D2313/221;;A61M1/3623;;A61M1/1625;;A61M1/1629;;A61M1/3623;;B01D63/033;;B01D63/0233,A61M1/14;;A61M1/16;;B01D63/02;;F28F21/06,,0,0,,,,EXPIRED
273,US,B1,US 9091759 B1,143-658-338-797-210,2015-07-28,2015,US 201313767390 A,2013-02-14,US 201313767390 A,2013-02-14,Smart beam selection for radar aided navigation,"A method of determining the ground speed or drift angle of an aircraft is described. It is determined whether or not a weather threshold has been met based on returns of a radar beam which is pulse compressed in a first scan. If the weather threshold is determined to have not been met, a ground speed or drift angle of the aircraft is determined based on Doppler processing of radar beam returns of a radar beam in a second scan. If the weather threshold has been met, a bottom radar beam is directed lower to the ground, and a ground speed or drift angle of the aircraft is determined based on Doppler processing returns of the bottom radar beam directed lower to the ground. A corresponding radar system is also described.",SISHTLA VENKATA A;;GODFREY MARK B;;DOTY JAMES H;;KERLEY KEITH L;;ROCKWELL COLLINS INC,SISHTLA VENKATA A;;GODFREY MARK B;;DOTY JAMES H;;KERLEY KEITH L,ROCKWELL COLLINS INC (2013-01-31),https://lens.org/143-658-338-797-210,Granted Patent,yes,10,4,1,1,0,G01S13/60;;G01S13/60;;G01S7/40;;G01S7/40;;G01S13/28;;G01S13/28;;G01S13/42;;G01S13/42;;G01S13/87;;G01S13/87;;G01S13/953;;G01S13/953;;Y02A90/10;;Y02A90/10,G01S13/60;;G01S13/00;;G01S13/95,,0,0,,,,ACTIVE
274,US,A,US 5489413 A,015-410-831-006-507,1996-02-06,1996,US 26130894 A,1994-06-16,US 26130894 A;;US 5064193 A;;US 97078192 A,1992-11-03,Hollow fiber blood oxygenator,"An exchanger includes an outer casing having an inlet port and an outlet-port for a first fluid, and an inlet port and an outlet port for a second fluid, and a bundle of hollow fibers located within the outer casing and being in flow communication with the inlet and outlet port for the second fluid. A central core is located in the outer casing and the bundle of fibers is arranged around the central core. The central core includes an inlet manifold connected to the first fluid inlet port, and an outlet manifold connected to the first fluid outlet port.",COBE LAB,CARSON GARY A;;DOTY ROBERT E;;HOGLUND MICHAEL R;;ISAACSON JAMES D,COBE CARDIOVASCULAR OPERATING CO. INC (1999-05-17);;COBE CARDIOVASCULAR INC (1999-10-31),https://lens.org/015-410-831-006-507,Granted Patent,yes,77,21,3,29,0,A61M1/1698;;A61M2205/366;;B01D63/02;;B01D63/021;;F28D9/0025;;F28F21/062;;B01D2313/105;;B01D2313/125;;B01D2313/21;;A61M1/1625;;A61M1/1629;;B01D2313/221;;A61M1/3623;;A61M2205/366;;F28F21/062;;A61M1/1698;;F28D9/0025;;B01D2313/125;;B01D2313/105;;B01D2313/21;;A61M1/1625;;A61M1/1629;;B01D2313/221;;A61M1/3623;;B01D63/0233,A61M1/16;;B01D63/02;;F28D9/00;;F28F21/06,422/46;;422/48;;210/321.76;;210/321.84;;210/645,0,0,,,,EXPIRED
275,CA,A1,CA 2404298 A1,154-172-880-958-917,2001-10-11,2001,CA 2404298 A,2001-03-30,US 53944600 A;;US 0110598 W,2000-03-30,AMIODARONE-CONTAINING PARENTERAL SOLUTION,"The present invention provides an amiodarone parenteral solution suitable fo r intravenous administration without the necessity of dilution. The parenteral solution has an amiodarone concentration from 0.2 to 10 mg/ml and a buffer solution selected from the group consisting of lactate buffer, methanesulfonate buffer, or combinations thereof, the solution having a pH within the range from approximately 2.5 - 4.5.",BAXTER INT,REBBECK CHRISTINE L;;KIPP JAMES E;;EILERT JAN Y;;DOTY MARK J,,https://lens.org/154-172-880-958-917,Patent Application,no,0,0,15,15,0,A61K9/0019;;A61K31/34;;A61K47/12;;A61P9/06;;A61K9/0019;;A61K47/12;;A61K31/34,A61K9/08;;A61K9/00;;A61K31/34;;A61K31/343;;A61K47/04;;A61K47/10;;A61K47/12;;A61K47/18;;A61K47/20;;A61K47/26;;A61P9/06,,0,0,,,,DISCONTINUED
276,US,B2,US 7067143 B2,190-455-257-186-957,2006-06-27,2006,US 94537401 A,2001-08-31,US 94537401 A;;US 82276701 A,2001-03-29,Premixed amiodarone parenteral solution and method for making the same,"A premix parenteral solution for intravenous administration having amiodarone, as an active ingredient, solubilized in a solution of water for injection and about 0.4-12 mg/ml of a non-ionic surfactant to a concentration range of from 0.2 to 6 mg/ml is disclosed. The solution optionally may include an osmotic agent. No dilution of the solution is required before administering to a patient and the sterile packaged solution has an initial pH within the range of from about 2.9 to about 3.2, preferably about 3.1. Additionally, a method for producing an amiodarone solution suitable for intravenous administration is further disclosed.",BAXTER INT,DOTY MARK J;;REBBECK CHRISTINE L;;KIPP JAMES E;;RAGHAVAN NEERVALUR V,BAXTER INTERNATIONAL INC (2001-11-27),https://lens.org/190-455-257-186-957,Granted Patent,yes,5,6,8,22,0,A61K9/0019;;A61K31/343;;A61K47/26;;A61P9/06;;A61K9/0019;;A61K47/26;;A61K31/343,A61K9/00;;A61K9/08;;C07D307/80;;A61K31/343;;A61K47/02;;A61K47/10;;A61K47/18;;A61K47/26;;A61K47/34;;A61K47/36;;A61P9/06,424/423;;424/426;;424/422,3,3,002-681-858-108-282;;107-131-434-581-034;;069-608-547-165-415,11172977;;10.1016/s0927-7765(00)00195-8;;4083289;;10.1093/ajhp/42.12.2679;;3706337;;10.1093/ajhp/43.4.917,"Boury, F., et al., ""Interfacial Properties of Amiodarone: The Stabilizing Effect of Phosphate Anions,"" Colloids and Surfaces B: Biointerfaces 20 (2001), pp. 219-227.;;Weir, S. J., et al., ""Sorption of Amiodarone to Polyvinyl Chloride Infusion Bags and Administration Sets,"" American Journal of Hospital Pharmacy, vol. 42, Dec., 1985, pp. 2679-2683.;;Campbell, Suzanne, et al., ""Stability of Amiodarone Hydrochloride in Admixtures With Other Injectable Drugs,"" American Journal of Hospital Pharmacy, vol. 43, Apr., 1986, pp. 917-921.",EXPIRED
277,WO,A3,WO 2002/078605 A3,036-908-721-595-224,2003-02-06,2003,US 0210094 W,2002-03-28,US 82276701 A;;US 94537401 A,2001-03-29,PREMIXED AMIODARONE PARENTERAL SOLUTION AND METHOD FOR MAKING THE SAME,"A premix parenteral solution for intravenous administration having amiodarone, as an active ingredient, solubilized in a solution of water for injection and about 0.4 - 12 mg/ml of a non-ionic surfactant to a concentration range of from 0.2 to 6 mg/ml is disclosed. The solution optionally may include an osmotic agent. No dilution of the solution is required before administering to a patient and the sterile packaged solution has an initial pH within the range of from about 2.9 to about 3.2, preferably about 3.1. Additionally, a method for producing an amiodarone solution suitable for intravenous administration is further disclosed.",BAXTER INT,DOTY MARK J;;REBBECK CHRISTINE L;;KIPP JAMES E;;RAGHAVAN NEERVALUR V,,https://lens.org/036-908-721-595-224,Search Report,yes,3,0,14,22,0,A61K9/0019;;A61K31/343;;A61K47/26;;A61P9/06,A61K9/00;;A61K9/08;;A61K31/343;;C07D307/80;;A61K47/02;;A61K47/10;;A61K47/18;;A61K47/26;;A61K47/34;;A61K47/36;;A61P9/06,,3,3,002-681-858-108-282;;107-131-434-581-034;;069-608-547-165-415,11172977;;10.1016/s0927-7765(00)00195-8;;4083289;;10.1093/ajhp/42.12.2679;;3706337;;10.1093/ajhp/43.4.917,"BOURY F. ET AL: ""Interfacial properties of amiodarone: The stabilizing effect of phosphate anions."", COLLOIDS AND SURFACES B: BIOINTERFACES, (2001) 20/3 (219-227)., XP001098868;;WEIR S J ET AL: ""Sorption of amiodarone to polyvinyl chloride infusion bags and administration sets."", AMERICAN JOURNAL OF HOSPITAL PHARMACY. UNITED STATES DEC 1985, vol. 42, no. 12, December 1985 (1985-12-01), pages 2679 - 2683, XP001117445, ISSN: 0002-9289;;CAMPBELL S ET AL: ""Stability of amiodarone hydrochloride in admixtures with other injectable drugs."", AMERICAN JOURNAL OF HOSPITAL PHARMACY. UNITED STATES APR 1986, vol. 43, no. 4, April 1986 (1986-04-01), pages 917 - 921, XP001107000, ISSN: 0002-9289",PATENTED
278,PL,A1,PL 364558 A1,140-647-595-393-345,2004-12-13,2004,PL 36455802 A,2002-03-28,US 0210094 W;;US 82276701 A,2001-03-29,PREMIXED AMIODARONE PARENTERAL SOLUTION AND METHOD FOR MAKING THE SAME,,BAXTER INT,DOTY MARK J;;REBBECK CHRISTINE L;;KIPP JAMES E;;RAGHAVAN NEERVALUR V,,https://lens.org/140-647-595-393-345,Patent Application,no,0,0,8,22,0,A61K9/0019;;A61K31/343;;A61K47/26;;A61P9/06;;A61K9/0019;;A61K47/26;;A61K31/343,C07D307/80;;A61K9/00;;A61K9/08;;A61K31/343;;A61K47/02;;A61K47/10;;A61K47/18;;A61K47/26;;A61K47/34;;A61K47/36;;A61P9/06,,0,0,,,,DISCONTINUED
279,EP,A2,EP 2248036 A2,145-178-862-227-513,2010-11-10,2010,EP 08871356 A,2008-12-29,US 2008/0088487 W;;US 2042708 A,2008-01-25,STREAMING OBJECT INSTANTIATION USING BOOKMARKS,,MICROSOFT CORP,DOTY JOHN DAVID;;SCHLIMMER JEFFREY C;;ANDERSON CHRISTOPHER LEE;;GUDGIN MARTIN JAMES,"MICROSOFT TECHNOLOGY LICENSING, LLC (2015-03-18)",https://lens.org/145-178-862-227-513,Patent Application,yes,0,0,10,10,0,G06F9/544;;G06F9/4493;;G06F9/544;;G06F9/4493,G06F15/16;;G06F9/44;;G06F15/00,,0,0,,,,DISCONTINUED
280,US,B1,US 10288738 B1,037-443-460-092-619,2019-05-14,2019,US 201414231850 A,2014-04-01,US 201414231850 A,2014-04-01,Precision mobile baseline determination device and related method,"Devices, systems, and methods for determining azimuth, elevation, or object position relative to a baseline using an integrated sighting device. The integrated sighting device includes a GPS receiver, an inertial measurement unit (IMU), an optical aperture, a microcomputer, and a handheld housing. The integrated sighting device, during transit from a reference position to a sighting position, determines a first angle between the sighting position and the reference position based on carrier phase input received during the transit. Orientation input is received from the IMU at the sighting position as the integrated sighting device is aimed and sighted along a line of sight to the reference position. The baseline is generated based on a second angle of the orientation input correlating with the first angle. The baseline is used as a reference for determining azimuth, elevation, or position of other objects or devices.",ROCKWELL COLLINS INC,KOENCK STEVEN E;;DOTY JAMES H;;WALKER BRAD A;;GOKAY MICHAEL C,ROCKWELL COLLINS INC (2014-03-24),https://lens.org/037-443-460-092-619,Granted Patent,yes,22,3,1,1,0,G01S19/05;;G01S19/51;;G01S19/51,G01S19/05,,1,0,,,Bushnell Laser rangefinder User Manual 2010 (Year: 2010).,INACTIVE
281,DE,T2,DE 60225122 T2,066-255-349-856-960,2009-03-05,2009,DE 60225122 T,2002-03-28,US 82276701 A;;US 94537401 A;;US 0210094 W,2001-03-29,HREN ZU DEREN HERSTELLUNG,,BAXTER INT,DOTY MARK J;;REBBECK CHRISTINE L;;KIPP JAMES E;;RAGHAVAN NEERVALUR V,,https://lens.org/066-255-349-856-960,Granted Patent,no,0,0,8,22,0,A61K9/0019;;A61K31/343;;A61K47/26;;A61P9/06;;A61K9/0019;;A61K47/26;;A61K31/343,A61K31/343;;C07D307/80;;A61K9/00;;A61K9/08;;A61K47/02;;A61K47/10;;A61K47/18;;A61K47/26;;A61K47/34;;A61K47/36;;A61P9/06,,0,0,,,,EXPIRED
282,JP,A,JP 2009114208 A,069-734-436-036-167,2009-05-28,2009,JP 2009043155 A,2009-02-25,US 53944600 A,2000-03-30,AMIODARONE-CONTAINING PARENTERAL SOLUTION,"<P>PROBLEM TO BE SOLVED: To provide an aminodarone parenteral solution suitable for intravenous administration without the necessity of dilution. <P>SOLUTION: The present invention relates to an aminodarone antiarrhythmic agent, more particularly, an amiodarone parenteral solution for parenteral infusion. The parenteral solution has an amiodarone concentration from 0.2 to 10 mg/mL and a buffer solution selected from the group consisting of lactate buffer, methanesulfonate buffer, or combinations thereof, the solution having a pH within the range from approximately 2.5-4.5. The solution may also optionally include an osmotic agent such as glucose, mannitol, sorbitol, glycerol, amino acids such as glycine, or salts such as sodium chloride. <P>COPYRIGHT: (C)2009,JPO&INPIT",BAXTER INT,KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;EILERT JAN Y,,https://lens.org/069-734-436-036-167,Patent Application,no,1,0,15,15,0,A61K9/0019;;A61K31/34;;A61K47/12;;A61P9/06;;A61K9/0019;;A61K47/12;;A61K31/34,A61K9/08;;A61K31/343;;A61K9/00;;A61K31/34;;A61K47/04;;A61K47/10;;A61K47/12;;A61K47/18;;A61K47/20;;A61K47/26;;A61P9/06;;C07D307/80,,0,0,,,,DISCONTINUED
283,CA,A1,CA 2120829 A1,178-163-936-769-186,1994-10-23,1994,CA 2120829 A,1994-04-07,US 5064193 A,1993-04-22,Hollow Fiber Blood Oxygenator,,COBE LAB,CARSON GARY A;;DOTY ROBERT E;;HOGLUND MICHAEL R;;ISAACSON JAMES D,,https://lens.org/178-163-936-769-186,Patent Application,no,0,0,11,29,0,A61M1/1698;;B01D63/02;;B01D63/021;;F28F21/062;;B01D2313/105;;B01D2313/125;;A61M1/1625;;A61M1/1629;;B01D2313/221;;A61M1/3623;;A61M1/1625;;A61M1/1629;;A61M1/3623;;B01D63/033;;B01D63/0233,A61M1/14;;A61M1/16;;B01D63/02;;F28F21/06,,0,0,,,,EXPIRED
284,EP,A2,EP 0621047 A2,056-193-379-318-086,1994-10-26,1994,EP 94302110 A,1994-03-23,US 5064193 A,1993-04-22,Hollow fibre blood oxygenator.,"An exchanger includes an outer casing (22) having an inlet port (28) and an outlet port (30) for a first fluid, and an inlet port (29) and an outlet port (31) for a second fluid, and a bundle of hollow fibers (32) located within the outer casing (22) and being in flow communication with the inlet (29) and outlet (31) port for the second fluid. A central core (42) is located in the outer casing (22) and the bundle of fibers (32) is arranged around the central core (42). The central core (42) includes an inlet manifold (44) connected to the first fluid inlet port (28), and an outlet manifold (46) connected to the first fluid outlet port (30).",COBE LAB,CARSON GARY A;;DOTY ROBERT E;;HOGLUND MICHAEL R;;ISAACSON JAMES D,,https://lens.org/056-193-379-318-086,Patent Application,yes,0,11,11,29,0,A61M1/1698;;B01D63/02;;B01D63/021;;F28F21/062;;B01D2313/105;;B01D2313/125;;A61M1/1625;;A61M1/1629;;B01D2313/221;;A61M1/3623;;A61M1/1625;;A61M1/1629;;A61M1/3623;;B01D63/033;;B01D63/0233,A61M1/14;;A61M1/16;;B01D63/02;;F28F21/06,,0,0,,,,EXPIRED
285,CN,A,CN 101925889 A,085-389-840-028-471,2010-12-22,2010,CN 200880125603 A,2008-12-29,US 2008/0088487 W;;US 2042708 A,2008-01-25,Streaming object instantiation using bookmarks,"Bookmarking of tokens in a set of streaming tokens, each representing an instantiation instruction or instantiation context. A navigator receives a set of streaming tokens, and provides the tokens to the instantiation manager. However, if the navigator receives an instruction to bookmark a particular token, the navigator buffers the set of streaming instructions at least beginning at the bookmarked token (and possible even earlier if there were prior bookmarks). The navigator replays the set of streaming tokens beginning at a bookmark in response to an instruction from an instantiation manager. The instantiation manager receives the set of streaming tokens. If the instantiation manager is not presently capable of handling the instruction of a particular token, the instantiation manager instructs the navigator to bookmark the particular token. When the instantiation manager later receives a token that permits the instantiation manager to return to the bookmark, the instantiation manager returns to the bookmark to replay the instantiation instructions beginning at the bookmark.",MICROSOFT CORP,DAVID DOTY JOHN;;SCHLIMMER JEFFREY C;;LEE ANDERSON CHRISTOPHER;;JAMES GUDGIN MARTIN,MICROSOFT TECHNOLOGY LICENSING LLC (2015-04-28),https://lens.org/085-389-840-028-471,Patent Application,no,0,0,10,10,0,G06F9/544;;G06F9/4493;;G06F9/544;;G06F9/4493,G06F15/16;;G06F15/00,,0,0,,,,ACTIVE
286,AU,B2,AU 2001/249766 B2,161-345-013-841-899,2004-10-07,2004,AU 2001/249766 A,2001-03-30,US 53944600 A;;US 0110598 W,2000-03-30,Amiodarone-containing parenteral solution,"The present invention provides an amiodarone parenteral solution suitable for intravenous administration without the necessity of dilution. The parenteral solution has an amiodarone concentration from 0.2 to 10 mg/ml and a buffer solution selected from the group consisting of lactate buffer, methanesulfonate buffer, or combinations thereof, the solution having a pH within the range from approximately 2.5-4.5.",BAXTER INT,EILERT JAN Y;;REBBECK CHRISTINE L;;DOTY MARK J;;KIPP JAMES E,,https://lens.org/161-345-013-841-899,Granted Patent,no,1,0,15,15,0,A61K9/0019;;A61K31/34;;A61K47/12;;A61P9/06;;A61K9/0019;;A61K47/12;;A61K31/34,A61K9/08;;A61K9/00;;A61K31/34;;A61K31/343;;A61K47/04;;A61K47/10;;A61K47/12;;A61K47/18;;A61K47/20;;A61K47/26;;A61P9/06,,0,0,,,,EXPIRED
287,DE,T2,DE 69401085 T2,025-410-463-884-383,1997-04-03,1997,DE 69401085 T,1994-03-23,US 5064193 A,1993-04-22,Blutoxygenator mit Hohlfasern,,COBE LAB,CARSON GARY A;;DOTY ROBERT E;;HOGLUND MICHAEL R;;ISAACSON JAMES D,"COBE CARDIOVASCULAR, INC. (N.D. GESETZEN DES STAAT (2001-09-13)",https://lens.org/025-410-463-884-383,Granted Patent,no,0,0,11,29,0,A61M1/1698;;B01D63/02;;B01D63/021;;F28F21/062;;B01D2313/105;;B01D2313/125;;A61M1/1625;;A61M1/1629;;B01D2313/221;;A61M1/3623;;A61M1/1625;;A61M1/1629;;A61M1/3623;;B01D63/033;;B01D63/0233,A61M1/14;;A61M1/16;;B01D63/02;;F28F21/06,,0,0,,,,EXPIRED
288,CA,C,CA 2120829 C,081-163-022-339-641,1999-07-13,1999,CA 2120829 A,1994-04-07,US 5064193 A,1993-04-22,HOLLOW FIBER BLOOD OXYGENATOR,"An exchanger includes an outer casing having an inlet port and an outlet port for a first fluid, and an inlet port and an outlet port for a second fluid, and a bundle of hollow fibers located within the outer casing and being in flow communication with the inlet and outlet port for the second fluid. A central core is located in the outer casing and the bundle of fibers is arranged around the central core. The central core includes an inlet manifold connected to the first fluid inlet port, and an outlet manifold connected to the first fluid outlet port.",COBE LAB,CARSON GARY A;;DOTY ROBERT E;;HOGLUND MICHAEL R;;ISAACSON JAMES D,,https://lens.org/081-163-022-339-641,Granted Patent,no,0,0,11,29,0,A61M1/1698;;B01D63/02;;B01D63/021;;F28F21/062;;B01D2313/105;;B01D2313/125;;A61M1/1625;;A61M1/1629;;B01D2313/221;;A61M1/3623;;A61M1/1625;;A61M1/1629;;A61M1/3623;;B01D63/033;;B01D63/0233,A61M1/14;;A61M1/16;;B01D63/02;;F28F21/06,,0,0,,,,EXPIRED
289,BR,A,BR 0208475 A,117-141-520-920-591,2004-03-09,2004,BR 0208475 A,2002-03-28,US 82276701 A;;US 94537401 A;;US 0210094 W,2001-03-29,"Solução para administração intravenosa, e, método para a produção de uma solução de amiodarona adequada para administração intravenosa","""SOLUçãO PARA ADMINISTRAçãO INTRAVENOSA, E, MéTODO PARA A PRODUçãO DE UMA SOLUçãO DE AMIODARONA ADEQUADA PARA ADMIMSTRAçãO INTRAVENOSA"". é apresentada uma solução parenteral pré-misturada para administração intravenosa, tendo amiodarona, como um ingrediente ativo, solubilizada em uma solução de água para injeção e cerca de 0,4 a 12 mg/ml de tensoativo não iónico em uma faixa de concentração de 0,2 a 6 mg/ml. Uma solução opcionalmente pode incluir um agente osmótico. Nenhuma diluição da solução é necessária antes da administração a um paciente e a solução embalada estéril tem um pH inicial dentro da faixa de cerca de 2,9 a cerca de 3,2, preferivelmente de cerca de 3,1. Adicionalmente, um método para produzir uma solução de amiodarona adequada para a administração intravenosa é ainda apresentado.",BAXTER INT,DOTY MARK J;;REBBECK CHRISTINE L;;KIPP JAMES E;;RAGHAVAN NEERVALUR V,,https://lens.org/117-141-520-920-591,Patent Application,no,0,0,14,22,0,A61K9/0019;;A61K31/343;;A61K47/26;;A61P9/06,C07D307/80;;A61K9/00;;A61K9/08;;A61K31/343;;A61K47/02;;A61K47/10;;A61K47/18;;A61K47/26;;A61K47/34;;A61K47/36;;A61P9/06,,0,0,,,,DISCONTINUED
290,AU,A,AU 2001/049766 A,197-570-685-463-613,2001-10-15,2001,AU 2001/049766 A,2001-03-30,US 53944600 A;;US 0110598 W,2000-03-30,Amiodarone-containing parenteral solution,"The present invention provides an amiodarone parenteral solution suitable for intravenous administration without the necessity of dilution. The parenteral solution has an amiodarone concentration from 0.2 to 10 mg/ml and a buffer solution selected from the group consisting of lactate buffer, methanesulfonate buffer, or combinations thereof, the solution having a pH within the range from approximately 2.5-4.5.",BAXTER INT,KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;EILERT JAN Y,,https://lens.org/197-570-685-463-613,Patent Application,no,0,0,15,15,0,A61K9/0019;;A61K31/34;;A61K47/12;;A61P9/06;;A61K9/0019;;A61K47/12;;A61K31/34,A61K9/08;;A61K9/00;;A61K31/34;;A61K31/343;;A61K47/04;;A61K47/10;;A61K47/12;;A61K47/18;;A61K47/20;;A61K47/26;;A61P9/06,,0,0,,,,PENDING
291,US,B2,US 7979566 B2,002-834-335-214-945,2011-07-12,2011,US 2042708 A,2008-01-25,US 2042708 A,2008-01-25,Streaming object instantiation using bookmarks,"Bookmarking of tokens in a set of streaming tokens, each representing an instantiation instruction or instantiation context. A navigator receives a set of streaming tokens, and provides the tokens to the instantiation manager. However, if the navigator receives an instruction to bookmark a particular token, the navigator buffers the set of streaming instructions at least beginning at the bookmarked token (and possible even earlier if there were prior bookmarks). The navigator replays the set of streaming tokens beginning at a bookmark in response to an instruction from an instantiation manager. The instantiation manager receives the set of streaming tokens. If the instantiation manager is not presently capable of handling the instruction of a particular token, the instantiation manager instructs the navigator to bookmark the particular token. When the instantiation manager later receives a token that permits the instantiation manager to return to the bookmark, the instantiation manager returns to the bookmark to replay the instantiation instructions beginning at the bookmark.",MICROSOFT CORP,DOTY JOHN DAVID;;SCHLIMMER JEFFREY C;;ANDERSON CHRISTOPHER LEE;;GUDGIN MARTIN JAMES,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2008-01-24),https://lens.org/002-834-335-214-945,Granted Patent,yes,13,0,10,10,0,G06F9/544;;G06F9/4493;;G06F9/544;;G06F9/4493,G06F15/16,709/229;;709/201;;709/213;;709/218;;709/238,2,0,,,Application Management Overview (7 pages) http://msdn2.microsoft.com/en-us/library/ms743714.aspx.;;How to: Create Custom Silverlight Controls (5 pages) http://www.silverlight.net/QuickStarts/BuildUi/CustomControl.aspx.,INACTIVE
292,AU,A,AU 1994/059037 A,006-003-537-927-52X,1994-10-27,1994,AU 1994/059037 A,1994-03-25,US 5064193 A,1993-04-22,Hollow fiber blood oxygenator,,COBE CARDIOVASCULAR INC,CARSON GARY A;;DOTY ROBERT E;;HOGLUND MICHAEL R;;ISAACSON JAMES D,"COBE CARDIOVASCULAR, INC. (2000-05-04)",https://lens.org/006-003-537-927-52X,Patent Application,no,0,0,11,29,0,A61M1/1698;;B01D63/02;;B01D63/021;;F28F21/062;;B01D2313/105;;B01D2313/125;;A61M1/1625;;A61M1/1629;;B01D2313/221;;A61M1/3623;;A61M1/1625;;A61M1/1629;;A61M1/3623;;B01D63/033;;B01D63/0233,A61M1/14;;A61M1/16;;B01D63/02;;F28F21/06,,0,0,,,,EXPIRED
293,US,B1,US 6479541 B1,033-727-161-502-621,2002-11-12,2002,US 53944600 A,2000-03-30,US 53944600 A,2000-03-30,Amiodarone-containing parenteral administration,"
    The present invention provides an amiodarone parenteral solution suitable for intravenous administration without the necessity of dilution. The parenteral solution has an amiodarone concentration from 0.2 to 10 mg/ml and a buffer solution selected from the group consisting of lactate buffer, methanesulfonate buffer, or combinations thereof, the solution having a pH within the range from approximately 2.5-4.5. 
",BAXTER INTERNAT,KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;EILERT JAN Y,BAXTER INTERNATIONAL INC (2000-01-28),https://lens.org/033-727-161-502-621,Granted Patent,yes,4,9,15,15,0,A61K9/0019;;A61K31/34;;A61K47/12;;A61P9/06;;A61K9/0019;;A61K47/12;;A61K31/34,A61K9/00;;A61K9/08;;A61K31/34;;A61K31/343;;A61K47/04;;A61K47/10;;A61K47/12;;A61K47/18;;A61K47/20;;A61K47/26;;A61P9/06,514/469;;514/557,0,0,,,,EXPIRED
294,DE,D1,DE 69401085 D1,036-132-312-436-227,1997-01-23,1997,DE 69401085 T,1994-03-23,US 5064193 A,1993-04-22,Blutoxygenator mit Hohlfasern,,COBE LAB,CARSON GARY A;;DOTY ROBERT E;;HOGLUND MICHAEL R;;ISAACSON JAMES D,"COBE CARDIOVASCULAR, INC. (N.D. GESETZEN DES STAAT (2001-09-13)",https://lens.org/036-132-312-436-227,Granted Patent,no,0,0,11,29,0,A61M1/1698;;B01D63/02;;B01D63/021;;F28F21/062;;B01D2313/105;;B01D2313/125;;A61M1/1625;;A61M1/1629;;B01D2313/221;;A61M1/3623;;A61M1/1625;;A61M1/1629;;A61M1/3623;;B01D63/033;;B01D63/0233,A61M1/14;;A61M1/16;;B01D63/02;;F28F21/06,,0,0,,,,EXPIRED
295,ZA,B,ZA 200307492 B,094-629-514-994-427,2004-07-06,2004,ZA 200307492 A,2003-09-26,US 82276701 A,2001-03-29,Premixed amiodarone parenteral solution and method for making the same.,,BAXTER INT,DOTY MARK J;;REBBECK CHRISTINE L;;KIPP JAMES E;;RAGHAVAN NEERVALUR V,,https://lens.org/094-629-514-994-427,Granted Patent,no,0,0,8,22,0,A61K9/0019;;A61K31/343;;A61K47/26;;A61P9/06;;A61K9/0019;;A61K47/26;;A61K31/343,A61K9/00;;C07D307/80;;A61K9/08;;A61K31/343;;A61K47/02;;A61K47/10;;A61K47/18;;A61K47/26;;A61K47/34;;A61K47/36;;A61P9/06,,0,0,,,,EXPIRED
296,US,A1,US 2014/0212495 A1,102-651-255-550-264,2014-07-31,2014,US 201313967798 A,2013-08-15,US 201313967798 A;;US 26651805 A;;US 62603604 P;;US 64287805 P,2004-11-08,NANOPARTICULATE COMPOSITIONS OF TUBULIN INHIBITOR COMPOUNDS,"The present invention is directed to novel pharmaceutical compositions comprising nano- and micro-particulate formulations of poorly water soluble tubulin inhibitors of the indole chemical class, preferably N-substituted indol-3-glyoxyamides, and more preferably N-(Pyridin-4-yl)-[1-(4-chlorobenzyl)-indol-3-yl]glyoxylic acid amide (D-24851), also known as “Indibulin,” and methods of making and using such compositions for the treatment of anti-tumor agent resistant cancers and other diseases.",ZIOPHARM ONCOLOGY INC,PAPADOPOULOS PAVLOS;;RAAB GERHARD;;DOTY MARK J;;KIPP JAMES E;;ROESSLER BERTHOLD,,https://lens.org/102-651-255-550-264,Patent Application,yes,0,0,16,17,0,A61K9/0019;;A61K9/0095;;A61K9/10;;A61K9/145;;A61K9/146;;A61K9/5123;;A61K9/5146;;A61K31/404;;A61K31/4439;;Y10T428/2982;;C07D401/12;;A61P1/18;;A61P11/02;;A61P11/06;;A61P19/02;;A61P29/00;;A61P31/04;;A61P35/00;;A61P35/04;;A61P37/02;;A61P37/06;;A61P37/08;;A61P43/00;;B82B3/00;;H01F27/12;;H01B3/20;;H01B3/00;;Y10T428/2982;;A61K31/4439;;A61K31/404;;A61K9/5123;;A61K9/5146;;A61K9/145;;A61K9/0095;;A61K9/10;;A61K9/146;;A61K9/0019;;A61K9/14;;C07D401/12,C07D401/12;;A61K9/14;;A61K31/4439,424/489;;428/402;;546/278.1;;514/339,0,0,,,,DISCONTINUED
297,EP,A3,EP 0621047 A3,166-424-561-515-629,1995-02-15,1995,EP 94302110 A,1994-03-23,US 5064193 A,1993-04-22,Hollow fibre blood oxygenator.,"An exchanger includes an outer casing (22) having an inlet port (28) and an outlet port (30) for a first fluid, and an inlet port (29) and an outlet port (31) for a second fluid, and a bundle of hollow fibers (32) located within the outer casing (22) and being in flow communication with the inlet (29) and outlet (31) port for the second fluid. A central core (42) is located in the outer casing (22) and the bundle of fibers (32) is arranged around the central core (42). The central core (42) includes an inlet manifold (44) connected to the first fluid inlet port (28), and an outlet manifold (46) connected to the first fluid outlet port (30).",COBE LAB,CARSON GARY A;;DOTY ROBERT E;;HOGLUND MICHAEL R;;ISAACSON JAMES D,,https://lens.org/166-424-561-515-629,Search Report,yes,4,0,11,29,0,A61M1/1698;;B01D63/02;;B01D63/021;;F28F21/062;;B01D2313/105;;B01D2313/125;;A61M1/1625;;A61M1/1629;;B01D2313/221;;A61M1/3623;;A61M1/1625;;A61M1/1629;;A61M1/3623;;B01D63/033;;B01D63/0233,A61M1/14;;A61M1/16;;B01D63/02;;F28F21/06,,0,0,,,,EXPIRED
298,KR,B1,KR 100195362 B1,184-033-826-014-411,1999-06-15,1999,KR 920703035 A,1992-11-30,GB 9012326 A;;US 9103813 W,1990-06-01,CHROMINANCE PROCESSING SYSTEM,"비디오 신호로부터의 비디오 휘도 데이터는 제1 라인 메모리(356)를 포함하는 제1 신호 경로에서 선택적으로 압축 및 확장된다. 병렬 신호 경로에서의 제2 라인 메모리(358)는 비디오 신호로부터의 비디오 색도 데이터를 처리한다. 제어회로(320)는 라인 메모리에 데이터를 기록하고 라인 메모리로부터 데이터를 판독하기 위해 각각의 타이밍 신호를 방생시킨다. 제어 수단을 위한 타이밍 지연 회로(337)는 비디오 압축 및 확장의 동작 모드를 갖는다. 압축 모드 동안, 제2 라인 메모리의 판독은 제2 라인 메모리의 기록에 비해 지연된다. 확장 모드 동안, 제1 라인 메모리의 기록은 제2 라인 메모리의 기록에 비해 지연되거나 제2 라인 메모리의 판독이 제2 라인 메모리의 기록에 비해 지연된다. 타이밍 지연 시간은 선택 가능한 값들의 범위에서 선택될 수 있다. 상기 라인 메모리는 독립적으로 인에이블되는 기록 및 판독 포트를 갖는 선입선출(FIFO) 장치이다.",THOMSON CONSUMER ELECTRONICS,ERSOZ NATHANIRL HALUK;;SAEGER TIMOTHY WILLIAM;;DOTY JAMES HARRISON;;KRANAWETTER GREG ALAN,,https://lens.org/184-033-826-014-411,Granted Patent,no,0,0,282,300,0,G06T3/4007;;H04N3/223;;H04N3/227;;H04N3/27;;H04N5/2624;;H04N5/45;;H04N7/007;;H04N7/01;;H04N7/0105;;H04N7/0122;;H04N7/015;;H04N9/64;;H04N9/641;;H04N19/90;;G06T3/04;;H04N7/01;;H04N9/641;;H04N3/27;;H04N7/0122;;H04N5/45;;H04N7/0105;;H04N3/223;;H04N7/007;;H04N9/64;;H04N3/227;;H04N7/01;;G06T3/4007;;H04N7/015;;H04N5/2624;;H04N19/90;;G06T3/04,H04N5/46;;G06F3/00;;G06T3/40;;G09G5/00;;G09G5/14;;G09G5/377;;G09G5/391;;H04N3/223;;H04N3/227;;H04N3/27;;H04N5/073;;H04N5/14;;H04N5/262;;H04N5/265;;H04N5/44;;H04N5/45;;H04N7/00;;H04N7/01;;H04N7/015;;H04N7/26;;H04N9/64;;H04N11/06;;H04N11/20;;H04N11/24,,0,0,,,,EXPIRED
299,US,B1,US 10066944 B1,055-195-869-804-944,2018-09-04,2018,US 201715473406 A,2017-03-29,US 201715473406 A,2017-03-29,Multi-mode receiver (MMR) based inertial integration,"Systems for multi-mode receiver (MMR)-based inertial integration of position solutions replace expensive IRUs with lower-grade but high-performance inertial sensors and GNSS-assisted MMRs, collecting inertial position data indicative of an aircraft position and integrating the inertial data with georeferenced position data within the MMRs. The inertial sensors may include microelectromechanical attitude and heading reference systems capable of generating coasted position solutions based on secondary inertial data and integrated with georeferenced data when it is available. The coasted position solutions may be used as a standby alternative to primary integrated solutions, or serve as an additional primary position solution.",ROCKWELL COLLINS INC,MCNAMARA JEFFREY B;;DOTY JAMES H;;GAVRILETS VLADISLAV;;TATHAM GILLES;;OLTROGGE JESSE W,ROCKWELL COLLINS INC (2017-03-13),https://lens.org/055-195-869-804-944,Granted Patent,yes,3,5,1,1,0,G01S19/49;;G01C21/1654;;G01S19/49;;B64C13/503;;G01C21/1654,G01C21/00;;B64C13/50;;G01C21/16;;G01P5/165;;G01S19/49,,2,0,,,"Philipp Clausen et al., Position Accuracy with Redundant MEMS IMU for Road Applications, European Navigation Conference GNSS, Apr. 7-10, 2015, Proceedings of the ENC-GNSS 2015, 8 pages.;;Glen Gibbons, Challenges in GNSS/INS Integration, Inside GNSS, Jan./Feb. 2012, http://insidegnss.com/node/2950, 2 pages.",ACTIVE
300,US,A1,US 2002/0127278 A1,104-575-799-865-601,2002-09-12,2002,US 87463701 A,2001-06-05,US 87463701 A;;US 25816000 P,2000-12-22,Microprecipitation method for preparing submicron suspensions,"
   The present invention provides a method for preparing submicron sized particles of an organic compound, the solubility of which is greater in a water-miscible first solvent than in a second solvent which is aqueous, the process including the steps of: (i) dissolving the organic compound in the water-miscible first solvent to form a solution, (ii) mixing the solution with the second solvent to define a pre-suspension; and (iii) adding energy to the pre-suspension to form particles having an average effective particle size of 400 nm to 2 microns. 
",KIPP JAMES E.;;WONG JOSEPH CHUNG TAK;;DOTY MARK J.;;REBBECK CHRISTINE L.,KIPP JAMES E;;WONG JOSEPH CHUNG TAK;;DOTY MARK J;;REBBECK CHRISTINE L,BAXTER INTERNATIONAL INC (2001-06-01),https://lens.org/104-575-799-865-601,Patent Application,yes,99,37,7,86,0,A61K9/10;;A61K9/10;;A61K9/14;;A61K9/14;;A61K9/145;;A61K9/145;;A61K9/146;;A61K9/146;;A61K9/1688;;A61K9/1688;;A61K31/495;;A61K31/495;;A61K31/496;;A61K31/496;;Y10T428/2984;;Y10T428/2984;;Y10T428/2985;;Y10T428/2985,A61K/;;A61K9/10;;A61K9/14;;A61K9/16;;A61K31/495;;A61K31/496,424/489;;264/4.1;;514/56,0,0,,,,EXPIRED
301,US,A1,US 2002/0176935 A1,144-233-956-150-134,2002-11-28,2002,US 87479901 A,2001-06-05,US 87479901 A;;US 25816000 P,2000-12-22,Microprecipitation method for preparing submicron suspensions,"
   The present invention provides a method for preparing submicron sized particles of an organic compound, the solubility of which is greater in a water-miscible first solvent than in a second solvent which is aqueous, the process including the steps of: (i) dissolving the organic compound in the water-miscible first solvent to form a solution, (ii) mixing the solution with the second solvent to define a pre-suspension; and (iii) adding energy to the pre-suspension to form particles having an average effective particle size of 400 nm to 2 microns. 
",KIPP JAMES E.;;TAK WONG JOSEPH CHUNG;;DOTY MARK J.;;REBBECK CHRISTINE L.,KIPP JAMES E;;TAK WONG JOSEPH CHUNG;;DOTY MARK J;;REBBECK CHRISTINE L,BAXTER INTERNATIONAL INC (2001-06-01),https://lens.org/144-233-956-150-134,Patent Application,yes,88,20,7,86,0,A61K9/10;;A61K9/10;;A61K9/14;;A61K9/14;;A61K9/145;;A61K9/145;;A61K9/146;;A61K9/146;;A61K9/1688;;A61K9/1688;;A61K31/495;;A61K31/495;;A61K31/496;;A61K31/496;;Y10T428/2984;;Y10T428/2984;;Y10T428/2985;;Y10T428/2985,A61K/;;A61K9/10;;A61K9/14;;A61K9/16;;A61K31/495;;A61K31/496,427/213.3,0,0,,,,EXPIRED
302,EP,A1,EP 1831019 A1,062-225-944-590-738,2007-09-12,2007,EP 05808046 A,2005-11-22,EP 2005056158 W;;US 63020504 P;;EP 05107690 A;;EP 05808046 A,2004-11-24,MULTILAYER POLYMER STRUCTURE,,SOLVAY ADVANCED POLYMERS LLC,BUSHELMAN CORINNE;;DOTY JAMES K;;DE CANNIERE JEAN;;DEHENNAU CLAUDE;;COLLARD MARIE-PAULE,"SOLVAY SPECIALTY POLYMERS USA, LLC. (2011-11-30)",https://lens.org/062-225-944-590-738,Patent Application,yes,0,0,14,14,0,B29C48/21;;B32B1/08;;B32B27/08;;B32B27/32;;B32B1/00;;B32B27/08;;B32B27/32;;B32B27/34;;Y10T428/1352;;Y10T428/1379;;Y10T428/3175;;Y10T428/31757;;B29C48/21;;Y10T428/1352;;Y10T428/1379;;Y10T428/3175;;Y10T428/31757;;B32B27/18;;B32B2439/00;;B29C48/21;;B32B27/08;;B32B27/32;;B32B27/34;;B32B1/00;;B32B1/08,B32B27/34;;B29C48/21;;B29C48/32;;B32B27/08;;B32B27/32,,0,0,,,,ACTIVE
303,EP,A4,EP 0532635 A4,057-748-897-888-153,1993-12-22,1993,EP 91911305 A,1991-05-30,GB 9012326 A;;US 9103813 W,1990-06-01,CHROMINANCE PROCESSING SYSTEM,,"THOMSON CONSUMER ELECTRONICS, INC.","ERSOZ, NATHANIEL, HALUK;;SAEGER, TIMOTHY, WILLIAM;;DOTY, JAMES, HARRISON, II;;KRANAWETTER, GREG, ALAN",,https://lens.org/057-748-897-888-153,Search Report,no,1,0,282,300,0,G06T3/4007;;H04N3/223;;H04N3/227;;H04N3/27;;H04N5/2624;;H04N5/45;;H04N7/007;;H04N7/01;;H04N7/0105;;H04N7/0122;;H04N7/015;;H04N9/64;;H04N9/641;;H04N19/90;;G06T3/04;;H04N7/01;;H04N9/641;;H04N3/27;;H04N7/0122;;H04N5/45;;H04N7/0105;;H04N3/223;;H04N7/007;;H04N9/64;;H04N3/227;;H04N7/01;;G06T3/4007;;H04N7/015;;H04N5/2624;;H04N19/90;;G06T3/04,H04N5/46;;G06F3/00;;G06T3/40;;G09G5/00;;G09G5/14;;G09G5/377;;G09G5/391;;H04N3/223;;H04N3/227;;H04N3/27;;H04N5/073;;H04N5/14;;H04N5/262;;H04N5/265;;H04N5/44;;H04N5/45;;H04N7/00;;H04N7/01;;H04N7/015;;H04N7/26;;H04N9/64;;H04N11/06;;H04N11/20;;H04N11/24,,0,0,,,,EXPIRED
304,BR,A2,BR PI0518272 A2,108-337-524-086-336,2008-11-11,2008,BR PI0518272 A,2005-11-22,US 63020504 P;;EP 05107690 A;;EP 2005056158 W,2004-11-24,"estrutura de multicamadas, processo para fabricar a mesma, artigo moldado, e, processo de fabricar o mesmo","ESTRUTURA DE MULTICAMADAS, PROCESSO PARA FABRICAR A MESMA, ARTIGO MOLDADO, E, PROCESSO DE FABRICAR O MESMO. Estrutura polimérica de multicamadas compreendendo pelo menos um par de camadas adjacentes (L1-L2), caracterizada pelo fato de que: camada (L1) compreende pelo menos uma composição polimérica (C1) compreendendo pelo menos uma pohftalarmda semi-cristalina e pelo menos uma modificador de impacto (Ii), e camada (L2) compreende pelo menos uma composição polímérica (C2) compreendendo pelo menos uma poliolefina funcionalízada (FPO2), a citada poliolefina funcionalizada compreendendo grupos funcionais escolhidos de grupos carboxílico, seus ésteres, seus anidridos e seus sais. Processo para fabricar a citada estrutura de multicamadas, que compreende co-extrusar as composições de polímero (Cl) e (C2) de modo a obter par de camadas adjacentes (Li) e (L2). Artigo moldado compreendendo a estrutura de multicamadas inventada e processo para fabricar o artigo moldado.",SOLVAY ADVANCED POLYMERS LLC,BUSHELMAN CORINE;;CANNIERE JEAN DE;;DEHENNAU CLAUDE;;COLLARD MARIE-PAULE;;DOTY JAMES K,,https://lens.org/108-337-524-086-336,Patent Application,no,0,0,14,14,0,B29C48/21;;B32B1/08;;B32B27/08;;B32B27/32;;B32B1/00;;B32B27/08;;B32B27/32;;B32B27/34;;Y10T428/1352;;Y10T428/1379;;Y10T428/3175;;Y10T428/31757;;B29C48/21;;Y10T428/1352;;Y10T428/1379;;Y10T428/3175;;Y10T428/31757;;B32B27/18;;B32B2439/00;;B29C48/21;;B32B27/08;;B32B27/32;;B32B27/34;;B32B1/00;;B32B1/08,B32B27/34;;B29C48/21;;B29C48/32;;B32B27/08;;B32B27/32,,0,0,,,,INACTIVE
305,AU,A,AU 1991/079967 A,113-178-896-918-784,1991-12-31,1991,AU 1991/079967 A,1991-05-30,GB 9012326 A,1990-06-01,CHROMINANCE PROCESSING SYSTEM,,THOMSON CONSUMER ELECTRONICS INC,ERSOZ NATHANIEL HALUK;;SAEGER TIMOTHY WILLIAM;;DOTY JAMES HARRISON II;;KRANAWETTER GREG ALAN,,https://lens.org/113-178-896-918-784,Patent Application,no,0,0,282,300,0,G06T3/4007;;H04N3/223;;H04N3/227;;H04N3/27;;H04N5/2624;;H04N5/45;;H04N7/007;;H04N7/01;;H04N7/0105;;H04N7/0122;;H04N7/015;;H04N9/64;;H04N9/641;;H04N19/90;;G06T3/04;;H04N7/01;;H04N9/641;;H04N3/27;;H04N7/0122;;H04N5/45;;H04N7/0105;;H04N3/223;;H04N7/007;;H04N9/64;;H04N3/227;;H04N7/01;;G06T3/4007;;H04N7/015;;H04N5/2624;;H04N19/90;;G06T3/04,H04N5/46;;G06F3/00;;G06T3/40;;G09G5/00;;G09G5/14;;G09G5/377;;G09G5/391;;H04N3/223;;H04N3/227;;H04N3/27;;H04N5/073;;H04N5/14;;H04N5/262;;H04N5/265;;H04N5/44;;H04N5/45;;H04N7/00;;H04N7/01;;H04N7/015;;H04N7/26;;H04N9/64;;H04N11/06;;H04N11/20;;H04N11/24,,0,0,,,,PENDING
306,WO,A1,WO 1991/019399 A1,097-839-933-191-308,1991-12-12,1991,US 9103813 W,1991-05-30,GB 9012326 A,1990-06-01,CHROMINANCE PROCESSING SYSTEM,"Video luminance data from a video signal is selectably compressed and expanded in a first signal path including a first line memory (356). A second line memory (358) in a parallel signal path processes video chrominance data from the video signal. A control circuit (320) generates respective timing signals for writing data into the line memories and for reading data from the line memories. A timing delay circuit (337) for the control means, has video compression and expansion modes of operation. During the compression mode, reading of the second line memory is delayed relative to writing of the second line memory. During said expansion mode, writing of the first line memory is delayed relative to writing of the second line memory or reading of the second line memory is delayed relative to writing of the second line memory. The duration of the timing delays can be selected from a range of values. The line memories are first in first out (FIFO) devices having independently enabled write and read ports.",THOMSON CONSUMER ELECTRONICS,ERSOZ NATHANIEL HALUK;;SAEGER TIMOTHY WILLIAM;;DOTY JAMES HARRISON II;;KRANAWETTER GREG ALAN,,https://lens.org/097-839-933-191-308,Patent Application,yes,9,1,282,300,0,G06T3/4007;;H04N3/223;;H04N3/227;;H04N3/27;;H04N5/2624;;H04N5/45;;H04N7/007;;H04N7/01;;H04N7/0105;;H04N7/0122;;H04N7/015;;H04N9/64;;H04N9/641;;H04N19/90;;G06T3/04;;H04N7/01;;H04N9/641;;H04N3/27;;H04N7/0122;;H04N5/45;;H04N7/0105;;H04N3/223;;H04N7/007;;H04N9/64;;H04N3/227;;H04N7/01;;G06T3/4007;;H04N7/015;;H04N5/2624;;H04N19/90;;G06T3/04,G06F3/00;;G06T3/40;;H04N5/46;;G09G5/00;;G09G5/14;;G09G5/377;;G09G5/391;;H04N3/223;;H04N3/227;;H04N3/27;;H04N5/073;;H04N5/14;;H04N5/262;;H04N5/265;;H04N5/44;;H04N5/45;;H04N7/00;;H04N7/01;;H04N7/015;;H04N7/26;;H04N9/64;;H04N11/06;;H04N11/20;;H04N11/24,,1,0,,,See also references of EP 0532635A4,PATENTED
307,US,A,US 5345272 A,156-311-879-646-318,1994-09-06,1994,US 94087892 A,1992-11-03,GB 9012326 A;;US 9103813 W,1990-06-01,Delay matching for video data during expansion and compression,"Video luminance data from a video signal is selectably compressed and expanded in a first signal path including a first line memory. A second line memory in a parallel signal path processes video chrominance data from the video signal. A control circuit generates respective timing signals for writing data into each of the first and second memories and for reading data from each of first and second the line memories. A timing delay circuit for the control circuit, has video compression and expansion modes of operation. During the compression mode, reading of the second line memory is delayed relative to writing of the second line memory. During the expansion mode, writing of the first line memory is delayed relative to writing of the second line memory or reading of the second line memory is delayed relative to writing of the second line memory. The duration of the timing delays can be selected from a range of values. The line memories are first in first out (FIFO) devices having independently enabled write and read ports.",THOMSON CONSUMER ELECTRONICS,ERSOZ NATHANIEL H;;SAEGER TIMOTHY W;;DOTY II JAMES H;;KRANAWETTER GREG A,THOMSON CONSUMER ELECTRONICS INC (1992-08-06),https://lens.org/156-311-879-646-318,Granted Patent,yes,12,127,1,300,0,H04N7/0122;;H04N7/0122;;H04N3/223;;H04N3/223;;H04N3/27;;H04N3/27;;H04N5/45;;H04N5/45;;H04N7/007;;H04N7/007;;H04N7/01;;H04N7/01;;H04N7/0105;;H04N7/0105;;H04N9/641;;H04N9/641,H04N3/223;;H04N3/27;;H04N5/45;;H04N7/00;;H04N7/01;;H04N9/64,348/561;;348/578;;348/445;;348/565,0,0,,,,EXPIRED
308,CN,B,CN 102514324 B,163-980-581-444-109,2015-07-01,2015,CN 201110351239 A,2005-11-22,EP 05107690 A;;US 63020504 P;;CN 200580040382 A,2004-11-24,Multilayer polymer structure,,SOLVAY ADVANCED POLYMERS LLC,BUSHELMAN CORINNE;;DOTY JAMES K;;DE CANNIERE JEAN;;DEHENNAU CLAUDE;;COLLARD MARIE-PAULE,,https://lens.org/163-980-581-444-109,Granted Patent,no,0,0,14,14,0,B29C48/21;;B32B1/08;;B32B27/08;;B32B27/32;;B32B1/00;;B32B27/08;;B32B27/32;;B32B27/34;;Y10T428/1352;;Y10T428/1379;;Y10T428/3175;;Y10T428/31757;;B29C48/21;;Y10T428/1352;;Y10T428/1379;;Y10T428/3175;;Y10T428/31757;;B32B27/18;;B32B2439/00;;B29C48/21;;B32B27/08;;B32B27/32;;B32B27/34;;B32B1/00;;B32B1/08,B32B27/08;;B29C48/21;;B29C48/32;;B32B27/18;;B32B27/32;;B32B27/34,,0,0,,,,INACTIVE
309,EP,B2,EP 1831019 B2,184-089-788-202-843,2016-03-09,2016,EP 05808046 A,2005-11-22,EP 2005056158 W;;US 63020504 P;;EP 05107690 A;;EP 05808046 A,2004-11-24,MULTILAYER POLYMER STRUCTURE,,SOLVAY SPECIALTY POLYMERS USA,BUSHELMAN CORINNE;;DOTY JAMES K;;DE CANNIERE JEAN;;DEHENNAU CLAUDE;;COLLARD MARIE-PAULE,"SOLVAY SPECIALTY POLYMERS USA, LLC. (2011-11-30)",https://lens.org/184-089-788-202-843,Granted Patent,yes,3,0,14,14,0,B29C48/21;;B32B1/08;;B32B27/08;;B32B27/32;;B32B1/00;;B32B27/08;;B32B27/32;;B32B27/34;;Y10T428/1352;;Y10T428/1379;;Y10T428/3175;;Y10T428/31757;;B29C48/21;;Y10T428/1352;;Y10T428/1379;;Y10T428/3175;;Y10T428/31757;;B32B27/18;;B32B2439/00;;B29C48/21;;B32B27/08;;B32B27/32;;B32B27/34;;B32B1/00;;B32B1/08,B32B27/34;;B29C48/21;;B29C48/32;;B32B27/08;;B32B27/32,,0,0,,,,ACTIVE
310,CN,A,CN 102514324 A,158-120-206-449-812,2012-06-27,2012,CN 201110351239 A,2005-11-22,EP 05107690 A;;US 63020504 P;;CN 200580040382 A,2004-11-24,Multilayer polymer structure,"The invention refers to a multilayer polymer structure comprising at least one couple of adjacent layers (L1-L2), characterized in that: layer (L1) comprises at least one polymer composition (C1) comprising at least one semi-crystalline polyphthalamide and at least one impact modifier (I1), and layer (L2) comprises at least one polymer composition (C2) comprising at least one functionalized polyolefin (FPO2), said functionalized polyolefin comprising functional groups chosen from carboxylic groups, their esters, their anhydrides and their salts. Process for manufacturing said multilayer structure, which comprises co-extruding polymer compositions (C1) and (C2) so as to obtain couple of adjacent layers (L1-L2). The invention also refers to a shaped article comprising the invented multilayer structure and process for manufacturing the shaped article.",SOLVAY ADVANCED POLYMERS LLC,CORINNE BUSHELMAN;;DOTY JAMES K;;JEAN DE CANNIERE;;CLAUDE DEHENNAU;;MARIE-PAULE COLLARD,,https://lens.org/158-120-206-449-812,Patent Application,no,3,0,14,14,0,B29C48/21;;B32B1/08;;B32B27/08;;B32B27/32;;B32B1/00;;B32B27/08;;B32B27/32;;B32B27/34;;Y10T428/1352;;Y10T428/1379;;Y10T428/3175;;Y10T428/31757;;B29C48/21;;Y10T428/1352;;Y10T428/1379;;Y10T428/3175;;Y10T428/31757;;B32B27/18;;B32B2439/00;;B29C48/21;;B32B27/08;;B32B27/32;;B32B27/34;;B32B1/00;;B32B1/08,B32B27/08;;B29C48/21;;B29C48/32;;B32B27/18;;B32B27/32;;B32B27/34,,2,0,,,"董晨空 等: ""《塑料新型加工助剂应用技术》"", 30 June 1999, 中国石化出版社;;CHARLES A.HARPER: ""《现代塑料手册》"", 31 March 2003, 中国石化出版社",INACTIVE
311,BR,B1,BR PI0518272 B1,091-471-750-807-017,2016-01-26,2016,BR PI0518272 A,2005-11-22,US 63020504 P;;EP 05107690 A;;EP 2005056158 W,2004-11-24,"estrutura de multicamadas compreendendo pelo menos um par de camadas adjacentes (l1-l2), processo para fabricar estrutura de multicamadas, artigo moldado e processo de fabricar artigo moldado","estrutura de multicamadas, processo para fabricar a mesma, artigo moldado, e, processo de fabricar o mesmo. estrutura polimérica de multicamadas compreendendo pelo menos um par de camadas adjacentes (l1-l2), caracterizada pelo fato de que: camada (l1) compreende pelo menos uma composição polimérica (c1) compreendendo pelo menos uma pohftalarmda semi-cristalina e pelo menos uma modificador de impacto (ii), e camada (l2) compreende pelo menos uma composição polímérica (c2) compreendendo pelo menos uma poliolefina funcionalízada (fpo2), a citada poliolefina funcionalizada compreendendo grupos funcionais escolhidos de grupos carboxílico, seus ésteres, seus anidridos e seus sais. processo para fabricar a citada estrutura de multicamadas, que compreende co-extrusar as composições de polímero (cl) e (c2) de modo a obter par de camadas adjacentes (li) e (l2). artigo moldado compreendendo a estrutura de multicamadas inventada e processo para fabricar o artigo moldado.",SOLVAY ADVANCED POLYMERS LLC,BUSHELMAN CORINNE;;DEHENNAU CLAUDE;;DOTY JAMES K;;CANNIERE JEAN DE;;COLLARD MARIE-PAULE,,https://lens.org/091-471-750-807-017,Granted Patent,no,0,0,14,14,0,B29C48/21;;B32B1/08;;B32B27/08;;B32B27/32;;B32B1/00;;B32B27/08;;B32B27/32;;B32B27/34;;Y10T428/1352;;Y10T428/1379;;Y10T428/3175;;Y10T428/31757;;B29C48/21;;Y10T428/1352;;Y10T428/1379;;Y10T428/3175;;Y10T428/31757;;B32B27/18;;B32B2439/00;;B29C48/21;;B32B27/08;;B32B27/32;;B32B27/34;;B32B1/00;;B32B1/08,B29C48/21;;B29C48/32;;B32B1/02;;B32B1/08;;B32B27/08;;B32B27/32,,0,0,,,,INACTIVE
312,US,A1,US 2014/0193596 A1,031-420-503-334-025,2014-07-10,2014,US 201414179230 A,2014-02-12,US 201414179230 A;;EP 05107690 A;;US 72004407 A;;EP 2005056158 W;;US 63020504 P,2004-11-24,MULTILAYER POLYMER STRUCTURE,"Multilayer polymer structure comprising at least one couple of adjacent layers (L1-L2), characterized in that: layer (L1) comprises at least one polymer composition (C1) comprising at least one semi-crystalline polyphthalamide and at least one impact modifier (I1), andlayer (L2) comprises at least one polymer composition (C2) comprising at least one functionalized polyolefin (FPO2), said functionalized polyolefin comprising functional groups chosen from carboxylic groups, their esters, their anhydrides and their salts. Process for manufacturing said multilayer structure, which comprises co-extruding polymer compositions (C1) and (C2) so as to obtain couple of adjacent layers (L1-L2). Shaped article comprising the invented multilayer structure and process for manufacturing the shaped article.",SOLVAY ADVANCED POLYMER L L C,BUSHELMAN CORINNE;;DOTY JAMES K;;DE CANNIERE JEAN;;DEHENNAU CLAUDE;;COLLARD MARIE-PAULE,SOLVAY SPECIALTY POLYMERS USA L.L.C (2007-10-12),https://lens.org/031-420-503-334-025,Patent Application,yes,0,0,14,14,0,B29C48/21;;B32B1/08;;B32B27/08;;B32B27/32;;B32B1/00;;B32B27/08;;B32B27/32;;B32B27/34;;Y10T428/1352;;Y10T428/1379;;Y10T428/3175;;Y10T428/31757;;B29C48/21;;Y10T428/1352;;Y10T428/1379;;Y10T428/3175;;Y10T428/31757;;B32B27/18;;B32B2439/00;;B29C48/21;;B32B27/08;;B32B27/32;;B32B27/34;;B32B1/00;;B32B1/08,B32B1/02;;B29C48/21;;B29C48/32;;B32B1/08;;B32B27/08,428/36.6;;428/476.3;;428/476.9;;264/171.26;;264/173.19,0,0,,,,DISCONTINUED
313,EP,A1,EP 1757444 A1,023-865-491-011-65X,2007-02-28,2007,EP 05107690 A,2005-08-22,EP 05107690 A,2005-08-22,Multilayer polymer structure,"Multilayer polymer structure comprising at least one couple of adjacent layers (L1-L2), characterized in that: 
■ layer (L1) comprises at least one polymer composition (C1) comprising at least one semi-crystalline polyphthalamide and at least one impact modifier (I1), and 
■ layer (L2) comprises at least one polymer composition (C2) comprising at least one functionalized polyolefin (FPO2), said functionalized polyolefin comprising functional groups chosen from carboxylic groups, their esters, their anhydrides and their salts. Process for manufacturing said multilayer structure, which comprises co-extruding polymer compositions (C1) and (C2) so as to obtain couple of adjacent layers (L1-L2). Shaped article comprising the invented multilayer structure and process for manufacturing the shaped article.",SOLVAY ADVANCED POLYMERS LLC,BUSHELMAN CORINNE;;DOTY JAMES K;;DE CANNIERE JEAN;;DEHENNAU CLAUDE;;COLLARD MARIE-PAULE,,https://lens.org/023-865-491-011-65X,Patent Application,yes,3,0,14,14,0,B29C48/21;;B32B1/08;;B32B27/08;;B32B27/32;;B32B1/00;;B32B27/08;;B32B27/32;;B32B27/34;;Y10T428/1352;;Y10T428/1379;;Y10T428/3175;;Y10T428/31757;;B29C48/21;;Y10T428/1352;;Y10T428/1379;;Y10T428/3175;;Y10T428/31757;;B32B27/18;;B32B2439/00;;B29C48/21;;B32B27/08;;B32B27/32;;B32B27/34;;B32B1/00;;B32B1/08,B32B27/34;;B29C48/21;;B29C48/32;;B32B27/08;;B32B27/32,,0,0,,,,DISCONTINUED
314,EP,B1,EP 1831019 B1,040-427-853-605-161,2012-10-10,2012,EP 05808046 A,2005-11-22,EP 2005056158 W;;US 63020504 P;;EP 05107690 A;;EP 05808046 A,2004-11-24,MULTILAYER POLYMER STRUCTURE,,SOLVAY SPECIALTY POLYMERS USA,BUSHELMAN CORINNE;;DOTY JAMES K;;DE CANNIERE JEAN;;DEHENNAU CLAUDE;;COLLARD MARIE-PAULE,"SOLVAY SPECIALTY POLYMERS USA, LLC. (2011-11-30)",https://lens.org/040-427-853-605-161,Granted Patent,yes,4,0,14,14,0,B29C48/21;;B32B1/08;;B32B27/08;;B32B27/32;;B32B1/00;;B32B27/08;;B32B27/32;;B32B27/34;;Y10T428/1352;;Y10T428/1379;;Y10T428/3175;;Y10T428/31757;;B29C48/21;;Y10T428/1352;;Y10T428/1379;;Y10T428/3175;;Y10T428/31757;;B32B27/18;;B32B2439/00;;B29C48/21;;B32B27/08;;B32B27/32;;B32B27/34;;B32B1/00;;B32B1/08,B32B27/34;;B29C48/21;;B29C48/32;;B32B27/08;;B32B27/32,,0,0,,,,ACTIVE
315,WO,A1,WO 2020/146828 A1,053-467-679-268-152,2020-07-16,2020,US 2020/0013224 W,2020-01-10,US 202062959737 P;;US 201962791709 P;;US 201962816452 P;;US 201962898522 P,2019-01-11,VAPORIZER INCLUDING POSITIVE TEMPERATURE COEFFICIENT OF RESISTIVITY HEATER,"A vaporizer device includes a housing including an air inlet (105), a heating element (110) within the housing and a heat exchanger. The heating element includes a nonlinear positive temperature coefficient of resistance material. The heat exchanger is thermally coupled to the heating element and arranged to receive airflow from the air inlet. The heat exchanger is configured to transfer heat between the heating element and the airflow to produce a heated airflow. The heated airflow exiting the heat exchanger is configured to vaporize a vaporizable material (155). Related apparatus, systems, techniques and articles are also described.",JUUL LABS INC,ALSTON WILLIAM;;BOWEN ADAM;;GARCIA-DOTY IAN;;KURZMAN JOSHUA;;MONSEES JAMES;;VIEIRA PAUL,,https://lens.org/053-467-679-268-152,Patent Application,yes,3,0,2,14,0,A24F40/10;;A24F40/20;;A24F40/30;;A24F40/46;;A24F40/57;;A24F40/60;;A24F40/65;;H05B3/06;;H05B2203/02;;H05B2203/022;;H05B3/46;;A24F40/485;;A24F40/10;;A24F40/46;;A24F40/44;;A24F40/42;;H05B1/0244;;H05B3/06;;H05B2203/02;;H05B2203/022,A24F40/46;;A24F40/10;;A24F40/20;;A24F40/30;;A24F40/57;;A24F40/60;;A24F40/65;;H05B3/12,,1,1,039-501-181-928-378,10.1109/tia.1985.349538,"HOWARD BECKER ET AL: ""PTC Heating Elements-Background Analysis and Design Attributes"", IEEE TRANSACTIONS ON INDUSTRY APPLICATIONS, IEEE SERVICE CENTER, PISCATAWAY, NJ, US, vol. IA-21, no. 4, 1 July 1985 (1985-07-01), pages 896 - 898, XP001455256, ISSN: 0093-9994",PENDING
316,EP,B1,EP 0532635 B1,074-842-437-821-000,1997-08-06,1997,EP 91911305 A,1991-05-30,GB 9012326 A;;US 9103813 W,1990-06-01,CHROMINANCE PROCESSING SYSTEM,,THOMSON CONSUMER ELECTRONICS,ERSOZ NATHANIAL HALUK;;SAEGER TIMOTHY WILLIAM;;DOTY JAMES HARRISON II;;KRANAWETTER GREG ALAN,,https://lens.org/074-842-437-821-000,Granted Patent,yes,10,0,282,300,0,G06T3/4007;;H04N3/223;;H04N3/227;;H04N3/27;;H04N5/2624;;H04N5/45;;H04N7/007;;H04N7/01;;H04N7/0105;;H04N7/0122;;H04N7/015;;H04N9/64;;H04N9/641;;H04N19/90;;G06T3/04;;H04N7/01;;H04N9/641;;H04N3/27;;H04N7/0122;;H04N5/45;;H04N7/0105;;H04N3/223;;H04N7/007;;H04N9/64;;H04N3/227;;H04N7/01;;G06T3/4007;;H04N7/015;;H04N5/2624;;H04N19/90;;G06T3/04,H04N5/46;;G06F3/00;;G06T3/40;;G09G5/00;;G09G5/14;;G09G5/377;;G09G5/391;;H04N3/223;;H04N3/227;;H04N3/27;;H04N5/073;;H04N5/14;;H04N5/262;;H04N5/265;;H04N5/44;;H04N5/45;;H04N7/00;;H04N7/01;;H04N7/015;;H04N7/26;;H04N9/64;;H04N11/06;;H04N11/20;;H04N11/24,,0,0,,,,EXPIRED
317,EP,A1,EP 0532635 A1,154-337-025-088-490,1993-03-24,1993,EP 91911305 A,1991-05-30,GB 9012326 A;;US 9103813 W,1990-06-01,CHROMINANCE PROCESSING SYSTEM.,"Des données de luminance fournies par un signal vidéo sont sélectivement comprimées et décomprimées dans une première voie de signaux comportant une première mémoire de lignes (356). Une deuxième mémoire de lignes (358) traite, dans une voie de signaux parallèle, les données de chrominance vidéo fournies par le signal vidéo. Un circuit de commande (320) génère des signaux de synchronisation respectifs pour l'enregistrment des données dans les mémoires de lignes et pour la lecture des données à partir des mémoires de ligne. Un circuit de temporisation (337) pour le dispositif de commande peut fonctionner en mode compression vidéo ou en mode décompression vidéo. En mode compression, la lecture de la deuxième mémoire de lignes est différée par rapport à l'enregristrement de la deuxième mémoire de lignes. En mode décompression, l'enregistrement de la première mémoire de lignes est différé par rapport à l'enregistrement de la deuxième mémoire de lignes ou la lecture de la deuxième mémoire de lignes est différée par rapport à l'enregistrement de la deuxième mémoire de lignes. La durée des temporisations peut être sélectionnée à partir d'une plage de valeurs. Les mémoires de lignes sont des dispositifs premier entré-premier sorti comportant des portes de lecture ou d'enregistrement actionnées indépendamment.",THOMSON CONSUMER ELECTRONICS,ERSOZ NATHANIEL HALUK;;SAEGER TIMOTHY WILLIAM;;DOTY JAMES HARRISON II;;KRANAWETTER GREG ALAN,,https://lens.org/154-337-025-088-490,Patent Application,yes,0,0,282,300,0,G06T3/4007;;H04N3/223;;H04N3/227;;H04N3/27;;H04N5/2624;;H04N5/45;;H04N7/007;;H04N7/01;;H04N7/0105;;H04N7/0122;;H04N7/015;;H04N9/64;;H04N9/641;;H04N19/90;;G06T3/04;;H04N7/01;;H04N9/641;;H04N3/27;;H04N7/0122;;H04N5/45;;H04N7/0105;;H04N3/223;;H04N7/007;;H04N9/64;;H04N3/227;;H04N7/01;;G06T3/4007;;H04N7/015;;H04N5/2624;;H04N19/90;;G06T3/04,H04N5/46;;G06F3/00;;G06T3/40;;G09G5/00;;G09G5/14;;G09G5/377;;G09G5/391;;H04N3/223;;H04N3/227;;H04N3/27;;H04N5/073;;H04N5/14;;H04N5/262;;H04N5/265;;H04N5/44;;H04N5/45;;H04N7/00;;H04N7/01;;H04N7/015;;H04N7/26;;H04N9/64;;H04N11/06;;H04N11/20;;H04N11/24,,0,0,,,,EXPIRED
318,ES,T3,ES 2106083 T3,175-275-687-754-537,1997-11-01,1997,ES 91911305 T,1991-05-30,GB 9012326 A,1990-06-01,SISTEMA DE TRATAMIENTO DE CROMINANCIA.,"SE COMPRIMEN SELECTIVAMENTE DATOS DE LUMINANCIA DE VIDEO DE UNA SEÑAL DE VIDEO Y SE EXPANDEN EN UNA VIA DE SEÑAL PRIMERA QUE INCLUYE UNA MEMORIA DE LINEA PRIMERA (356). UNA MEMORIA DE LINEA SEGUNDA (358) EN UNA VIA DE SEÑAL PARALELA PROCESA DATOS DE CROMINANCIA DE VIDEO DE LA SEÑAL DE VIDEO. UN CIRCUITO DE CONTROL (320) GENERA SEÑALES DE TIEMPO RESPECTIVAS PARA GRABAR DATOS EN LAS MEMORIAS DE LINEA Y PARA LEER DATOS DE LAS MEMORIAS DE LINEA. UN CIRCUITO DE RETARDO TEMPORAL (337) PARA EL SISTEMA DE CONTROL, POSEE MODOS OPERATIVOS DE EXPANSION Y COMPRESION DE VIDEO. DURANTE EL MODO DE COMPRESION, LA LECTURA DE LA MEMORIA DE LINEA SEGUNDA SE RETARDA CON RESPECTO A LA GRABACION DE LA MEMORIA DE LINEA SEGUNDA. DURANTE DICHO MODO DE EXPANSION, LA GRABACION DE LA MEMORIA DE LINEA PRIMERA SE RETARDA CON RESPECTO A LA GRABACION DE LA MEMORIA DE LINEA SEGUNDA O LA LECTURA DE LA MEMORIA DE LINEA SEGUNDA SE RETARDA CON RESPECTO A LA GRABACION DE LA MEMORIA DE LINEA SEGUNDA, LA DURACION DE LOS RETRASOSDE TIEMPO PUEDE SELECCIONARSE DE UNA SERIE DE VALORES. LA MEMORIAS DE LINEAS SON DISPOSITIVOS FIFO (PRIMERO EN ENTRAR PRIMERO EN SALIR) QUE TIENEN PUERTOS DE LECTURA Y GRABACION HABILITADOS INDEPENDIENTEMENTE.",THOMSON CONSUMER ELECTRONICS,ERSOZ NATHANIAL HALUK;;SAEGER TIMOTHY WILLIAM;;DOTY JAMES HARRISON II;;KRANAWETTER GREG ALAN,,https://lens.org/175-275-687-754-537,Granted Patent,no,0,0,282,300,0,G06T3/4007;;H04N3/223;;H04N3/227;;H04N3/27;;H04N5/2624;;H04N5/45;;H04N7/007;;H04N7/01;;H04N7/0105;;H04N7/0122;;H04N7/015;;H04N9/64;;H04N9/641;;H04N19/90;;G06T3/04;;H04N7/01;;H04N9/641;;H04N3/27;;H04N7/0122;;H04N5/45;;H04N7/0105;;H04N3/223;;H04N7/007;;H04N9/64;;H04N3/227;;H04N7/01;;G06T3/4007;;H04N7/015;;H04N5/2624;;H04N19/90;;G06T3/04,H04N5/46;;G06F3/00;;G06T3/40;;G09G5/00;;G09G5/14;;G09G5/377;;G09G5/391;;H04N3/223;;H04N3/227;;H04N3/27;;H04N5/073;;H04N5/14;;H04N5/262;;H04N5/265;;H04N5/44;;H04N5/45;;H04N7/00;;H04N7/01;;H04N7/015;;H04N7/26;;H04N9/64;;H04N11/06;;H04N11/20;;H04N11/24,,0,0,,,,EXPIRED
319,DE,C2,DE 3248000 C2,190-224-582-105-753,1986-03-27,1986,DE 3248000 A,1982-12-24,US 33578081 A,1981-12-30,DE 3248000 C2,,"OMI INTERNATIONAL CORP. (EINE GESELLSCHAFT N.D.GES.D. STAATES DELAWARE), WARREN, MICH., US","DOTY, WARREN RUSSELL, LOS ALAMOS, N.MEX., US;;KINNEY, TIMOTHY JAMES, BERKLEY, MICH., US",OMI INTERNATIONAL CORP. (EINE GESELLSCHAFT N.D.GES (1985-06-20),https://lens.org/190-224-582-105-753,Granted Patent,no,0,0,4,5,0,C23C18/28;;H05K3/181;;H05K3/38,C23C18/28;;C23C18/30;;H05K3/18;;H05K3/38,,0,0,,,,EXPIRED
320,US,B2,US 6869617 B2,047-654-097-139-672,2005-03-22,2005,US 87463701 A,2001-06-05,US 87463701 A;;US 25816000 P,2000-12-22,Microprecipitation method for preparing submicron suspensions,"The present invention provides a method for preparing submicron sized particles of an organic compound, the solubility of which is greater in a water-miscible first solvent than in a second solvent which is aqueous, the process including the steps of: (i) dissolving the organic compound in the water-miscible first solvent to form a solution, (ii) mixing the solution with the second solvent to define a pre-suspension; and (iii) adding energy to the pre-suspension to form particles having an average effective particle size of 400 nm to 2 microns.",BAXTER INT,KIPP JAMES E;;WONG JOSEPH CHUNG TAK;;DOTY MARK J;;REBBECK CHRISTINE L,BAXTER INTERNATIONAL INC (2001-06-01),https://lens.org/047-654-097-139-672,Granted Patent,yes,102,58,7,86,0,A61K9/10;;A61K9/10;;A61K9/14;;A61K9/14;;A61K9/145;;A61K9/145;;A61K9/146;;A61K9/146;;A61K9/1688;;A61K9/1688;;A61K31/495;;A61K31/495;;A61K31/496;;A61K31/496;;Y10T428/2984;;Y10T428/2984;;Y10T428/2985;;Y10T428/2985,A61K/;;A61K9/10;;A61K9/14;;A61K9/16;;A61K31/495;;A61K31/496,424/489;;424/400;;424/450;;264/4;;264/4.1;;264/5,18,7,005-840-366-684-763;;004-382-489-377-69X;;001-155-857-960-135;;018-188-239-454-962;;012-864-980-464-648;;017-541-414-387-84X;;064-523-632-943-432,10.1016/0378-5173(92)90051-3;;8331530;;10.1002/jps.2600820608;;10.1002/jps.2600670418;;641759;;7302990;;10.1016/0378-4274(81)90035-7;;10.1007/s004170050094;;9602323;;10.1016/s1081-1206(10)62949-3;;9494448;;11879753;;10.1016/s0378-5173(01)00986-3,"US 5,849,884, 12/1998, Woiszwillo et al. (withdrawn);;B. Sjostrom et al., Preparation Of Submicron Drug Particles In Lecithin-Stabilized O/W Emulsions I. Model Studies Of The Precipitation Of Cholesteryl Acetate, Int. J. Pharm., 88 (1992) pp 53-62.;;B. Sjostrom et al., A Method For The Preparation Of Submicron Particles Of Sparingly Water-Soluble Drugs By Precipitation In Oil-In-Water Emulsions. II: Influence Of The Emulsifier, The Solvent And The Drug Substance, J. Pharm. Sci., 82(6), (1992) pp 584-589.;;Davis et al., ""Pulmonary Perfusion IMaging: Acute Toxicity and Safety Factors as a Function of Particle Size"", J.Nucl Med., vol. 19 (1978), pp. 1209-1213.;;Schroeder et al., ""Physiological Effects of Subvisible Microspheres Administered Intravenously to Beagle Dogs"", Journal of Pharmaceutical Sciences, vol. 67, No. 4, Apr. 1978, pp. 508-512.;;Yokel et al., ""Acute Toxicity of Latex Microspheres"", Toxicity Letters, vol. 9 (1981), pp. 165-170.;;Allen et al., ""Critical Evaluation of Acute Cardiopulminary Toxicity of Microspheres"", J. Nucl Med., vol. 19 (1987), pp. 1204-1208.;;B. Sjostrom et al., ""Preparation Of Submicron Drug Particles In Lecithin-Stabilized O/W Emulsions I. Model Studies Of The Precipitation Of Cholesteryl Acetate"", Int. J. Pharm., 88 (1992) pp 53-62.;;B. Sjostrom et al., ""A Method For The Preparation Of Submicron Particles Of Sparingly Water-Soluble Drugs By Precipitation In Oil-In-Water Emulsions. II: Influence Of The Emulsifier, The Solvent And The Drug Substance"", J. Pharm. Sci., 82(6), (1992) pp 584-589.;;Duncker and Reichelt, ""Effects of the Pharmaceutical Cosolvent hydroxypropyl-beta-cyclodextrin on Porcine Corneal Endothelium"", Graefe's Archive for Clinical and Experimental Ophthalmology (Germany), 236/5 (1998), pp. 380-389.;;Volchek and Dellen, ""Anaphylaxis to Intravenous Cyclosporine and Tolerance to Oral Cyclosporine, Case Report and Review"", Annals of Allergy, Asthama, and Immunology, 80 (1998), pp. 159-163.;;Singla et al., ""Paclitaxel and its Formulations"", International Journal of Pharmaceutics, 235/1-2 (2002), pp. 179-192.;;B. Sjostrom et al., ""The Formation of Submicron Organic Particles by Precipitation in an Emulsion"", J.Dispersion Science and Technology, 15(1), 89-117 (1994).;;Avanti Polar Lipids, Inc.., website printout, www.avantilipids.com, ""Synthetic Products-Functionalized Phospholipids: LIpids for Conjugation of Proteins/Peptides/Drugs to Liposomes"" (7 pgs), Mar. 2003.;;Avanti Polar Lipids, Inc.., website printout, www.avantilipids.com, ""Polymer and Polymerizable Lipids: Functionalized PEG Lipids"" (3 pgs), Mar. 2003.;;Avanti Polar Lipids, Inc.., website printout, www.avantilipids.com, ""Polymer and Polymerizable Lipids: Poly(ethylene glycol)-Lipid Conjugates"" (8 pgs), Mar. 2003.;;PCT/USO1/49737 Written Opinion.;;PCT/USO1/49737 International Preliminary Examination Report.",EXPIRED
321,MY,A,MY 106816 A,033-516-020-065-122,1995-07-31,1995,MY PI19910898 A,1991-05-25,GB 9012326 A,1990-06-01,CHROMINANCE PROCESSING SYSTEM.,"VIDEO LUMINANCE DATA FROM A VIDEO SIGNAL SELECTABLY COMPRESSED AND EXPANDED IN A FIRST SIGNAL PATH INCLUDING A FIRST LINE MEMORY. A SECOND LINE MEMORY IN A PARALLEL SIGNAL PATH PROCESSES VIDEO CHROMINANCE DATA FROM THE VIDEO SIGNAL. A CONTROL CIRCUIT GENERATES RESPECTIVE TIMING SIGNALS FOR WRITING DATA INTO THE LINE MEMORIES AND FOR READING DATA FROM THE LINE MEMORIES. A TIMING DELAY CIRCUIT FOR THE CONTROL MEANS, HAS VIDEO COMPRESSION AND EXPANSION MODES OF OPERATION. DURING THE COMPRESSION MODE, READING OF THE SECOND LINE MEMORY IS DELAYED RELATIVE TO WRITING OF THE SECOND LINE MEMORY. DURING SAID EXPANSION MODE, WRITING OF THE FIRST LINE MEMORY IS DELAYED RELATIVE TO WRITING OF THE SECOND LINE MEMORY OR READING OF THE SECOND LINE MEMORY IS DELAYED RELATIVE TO WRITING OF THE SECOND LINE MEMORY. THE DURATION OF THE TIMING DELAYS CAN BE SELECTED FROM A RANGE OF VALUES. THE LINE MEMORIES ARE FIRST OUT (FIFO) DEVICES HAVING INDEPENDENTLY ENABLED WRITE AND READ PORTS.( FIG. 9 )",THOMSON CONSUMER ELECTRONICS INC,JAMES HARRISON DOTY II;;GREG ALAN KRANAWETTER;;NATHANIEL HALUK ERSOZ;;TIMOTHY WILLIAM SAEGER,,https://lens.org/033-516-020-065-122,Granted Patent,no,0,0,282,300,0,G06T3/4007;;H04N3/223;;H04N3/227;;H04N3/27;;H04N5/2624;;H04N5/45;;H04N7/007;;H04N7/01;;H04N7/0105;;H04N7/0122;;H04N7/015;;H04N9/64;;H04N9/641;;H04N19/90;;G06T3/04;;H04N7/01;;H04N9/641;;H04N3/27;;H04N7/0122;;H04N5/45;;H04N7/0105;;H04N3/223;;H04N7/007;;H04N9/64;;H04N3/227;;H04N7/01;;G06T3/4007;;H04N7/015;;H04N5/2624;;H04N19/90;;G06T3/04,H04N5/46;;H04N7/04;;G06F3/00;;G06T3/40;;G09G5/00;;G09G5/14;;G09G5/377;;G09G5/391;;H04N3/223;;H04N3/227;;H04N3/27;;H04N5/073;;H04N5/14;;H04N5/262;;H04N5/265;;H04N5/44;;H04N5/45;;H04N7/00;;H04N7/01;;H04N7/015;;H04N7/26;;H04N9/64;;H04N11/06;;H04N11/20;;H04N11/24,,0,0,,,,EXPIRED
322,US,B2,US 6607784 B2,053-610-570-236-535,2003-08-19,2003,US 87479901 A,2001-06-05,US 87479901 A;;US 25816000 P,2000-12-22,Microprecipitation method for preparing submicron suspensions,"
    The present invention provides a method for preparing submicron sized particles of an organic compound, the solubility of which is greater in a water-miscible first solvent than in a second solvent which is aqueous, the process including the steps of (i) dissolving the organic compound in the water-miscible first solvent to form a solution, (ii) mixing the solution with the second solvent to define a pre-suspension; and (iii) adding energy to the pre-suspension to form particles having an average effective particle size of 400 nm to 2 microns. 
",BAXTER INT,KIPP JAMES E;;WONG JOSEPH CHUNG TAK;;DOTY MARK J;;REBBECK CHRISTINE L,BAXTER INTERNATIONAL INC (2001-06-01),https://lens.org/053-610-570-236-535,Granted Patent,yes,99,73,7,86,0,A61K9/10;;A61K9/10;;A61K9/14;;A61K9/14;;A61K9/145;;A61K9/145;;A61K9/146;;A61K9/146;;A61K9/1688;;A61K9/1688;;A61K31/495;;A61K31/495;;A61K31/496;;A61K31/496;;Y10T428/2984;;Y10T428/2984;;Y10T428/2985;;Y10T428/2985,A61K/;;A61K9/10;;A61K9/14;;A61K9/16;;A61K31/495;;A61K31/496,427/213.3;;264/4.1;;264/4.3;;264/4.6;;424/489;;424/490;;424/493;;428/402.2;;428/402.21;;427/213.31;;524/801;;524/803,3,2,005-840-366-684-763;;004-382-489-377-69X,10.1016/0378-5173(92)90051-3;;8331530;;10.1002/jps.2600820608,"US 5,849,884, 12/1998, Woiszwillo et al. (withdrawn);;B. Sjostrom et al., Preparation Of Submicron Drug Particles In Lecithin-Stabilized O/W Emulsions I. Model Studies Of The Precipitation Of Cholesteryl Acetate, Int. J. Pharm., 88 (1992) pp. 53-62.;;B. Sjostrom et al., A Method For The Preparation Of Submicron Particles Of Sparingly Water-Soluble Drugs By Precipitation In Oil-In-Water Emulsions. II: Influence Of The Emulsifier, The Solvent And The Drug Substance, J. Pharm. Sci., 82(6), (1992) pp. 584-589.",EXPIRED
323,US,B2,US 7037528 B2,085-455-195-049-036,2006-05-02,2006,US 87449901 A,2001-06-05,US 87449901 A;;US 25816000 P,2000-12-22,Microprecipitation method for preparing submicron suspensions,"The present invention provides a method for preparing submicron sized particles of an organic compound, the solubility of which is greater in a water-miscible first solvent than in a second solvent which is aqueous, the process including the steps of: (i) dissolving the organic compound in the water-miscible first solvent to form a solution, (ii) mixing the solution with the second solvent to define a pre-suspension; and (iii) adding energy to the pre-suspension to form particles having an average effective particle size of 400 nm to 2 microns.",BAXTER INT,KIPP JAMES E;;WONG JOSEPH CHUNG TAK;;DOTY MARK J;;REBBECK CHRISTINE L,BAXTER INTERNATIONAL INC (2001-06-01),https://lens.org/085-455-195-049-036,Granted Patent,yes,101,36,7,86,0,A61K9/10;;A61K9/10;;A61K9/14;;A61K9/14;;A61K9/145;;A61K9/145;;A61K9/146;;A61K9/146;;A61K9/1688;;A61K9/1688;;A61K31/495;;A61K31/495;;A61K31/496;;A61K31/496;;Y10T428/2984;;Y10T428/2984;;Y10T428/2985;;Y10T428/2985,A61K9/14;;A61K/;;A61K9/10;;A61K9/16;;A61K31/495;;A61K31/496;;B01J13/00,424/489;;424/400;;424/450;;264/4;;264/4.1;;264/5,18,7,001-155-857-960-135;;018-188-239-454-962;;005-840-366-684-763;;004-382-489-377-69X;;012-864-980-464-648;;017-541-414-387-84X;;064-523-632-943-432,10.1002/jps.2600670418;;641759;;7302990;;10.1016/0378-4274(81)90035-7;;10.1016/0378-5173(92)90051-3;;8331530;;10.1002/jps.2600820608;;10.1007/s004170050094;;9602323;;10.1016/s1081-1206(10)62949-3;;9494448;;11879753;;10.1016/s0378-5173(01)00986-3,"US 5,849,884, 12/1998, Woiszwillo et al. (withdrawn);;PCT/US01/49737 Written Opinion.;;PCT/US01/49737 International Preliminary Examination Report.;;Davis et al., ""Pulmonary Perfusion Imaging: Acute Toxicity and Safety Factors as a Function of Particle Size"", J.Nucl Med., vol. 19 (1978), pp. 1209-1213.;;Schroeder et al., ""Physiological Effects of Subvisible Microspheres Administered Intravenously to Beagle Dogs"", Journal of Pharmaceutical Sciences, vol. 67, No. 4, Apr. 1978, pp. 508-512.;;Yokel et al., ""Acute Toxicity of Latex Microspheres"", Toxicity Letters, vol. 9, (1981), pp. 165-170.;;Allen et al., ""Critical Evaluation of Acute Cardiopulminary Toxicity of Microspheres"", J.Nucl Med., vol. 19 (1987), pp. 1204-1208.;;B. Sjostrom et al., ""Preparation Of Submicron Drug Particles In Lecithin-Stabilized O/W Emulsions I. Model Studies Of The Precipitation Of Cholesteryl Acetate"", Int. J. Pharm, 88 (1992) pp 53-62.;;B. Sjostrom et al., ""A Method For The Preparation Of Submicron Particles Of Sparingly Water-Soluble Drugs By Precipitation In Oil-In-Water Emulsions. II: Influence Of The Emulsifier, The Solvent And The Drug Substance"", J. Pharm. Sci., 82(6), (1992) pp 584-589.;;Duncker and Reichelt, ""Effects of the Pharmaceutical Cosolvent hydroxypropyl-beta-cyclodextrin on Porcine Corneal Endothelium"", Graefe's Archive for Clinical and Experimental Ophthalmology (Germany), 236/5 (1998), pp. 380-389.;;Volchek and Dellen, ""Anaphylaxis to Intravenous Cyclosporine and Tolerance to Oral Cyclosporine, Case Report and Review"", Annals of Allergy, Asthma, and Immunology, 80 (1998), pp. 159-163.;;Singla et al., ""Paclitaxel and its Formulations"", International Journal of Pharmaceutics, 235/1-2 (2002), pp. 179-192.;;B. Sjostrom et al., ""The Formation of Submicron Organic Particles by Precipitation in an Emulsion"", J.Dispersion Science and Technology, 15(1), 89-117 (1994).;;Avanti Polar Lipids, Inc., website printout, www.avantilipids.com, ""Synthetic Products-Functionalized Phospholipids: Lipids for Conjugation of Proteins/Peptides/Drugs to Liposomes"" (7 pgs), Mar. 2003.;;Avanti Polar Lipids, Inc., website printout, www.avantilipds.com, ""Polymer and Polymerizable Lipids: Functionalized PEG Lipids"" (3 pgs), Mar. 2003.;;Avanti Polar Lipids, Inc. website printout, www.avantilipids.com, ""Polymer and Polymerizable Lipids: Poly(ethylene glycol)-Lipid Conjugates"" (8 pgs), Mar. 2003.;;B. Sjostrom et al., Preparation Of Submicron Drug Particles In Lecithin-Stabilized O/W Emulsions I. Model Studies Of The Precipitation Of Cholesteryl Acetate, Int. J. Pharm., 88 (1992) pp. 53-62.;;B. Sjostrom et al., A Method For The Preparation Of Submicron Particles Of Sparingly Water-Soluble Drugs By Precipitation In Oil-In-Water Emulsions. II: Influence Of The Emulsifier, The Solvent And The Drug Substance, J. Pharm. Sci., 82(6), (1992) pp 584-589.",EXPIRED
324,SG,A1,SG 81864 A1,102-065-635-625-115,2001-07-24,2001,SG 1996002332 A,1991-05-30,GB 9012326 A,1990-06-01,CHROMINANCE PROCESSING SYSTEM,,TMOMSON CONSUMER ELECTRONICS I,ERSOZ NATHANIAL HALUK;;SAEGER TIMOTHY WILLIAM;;DOTY II JAMES HARRISON;;KRANAWETTER GREG ALAN,,https://lens.org/102-065-635-625-115,Patent Application,no,7,0,282,300,0,G06T3/4007;;H04N3/223;;H04N3/227;;H04N3/27;;H04N5/2624;;H04N5/45;;H04N7/007;;H04N7/01;;H04N7/0105;;H04N7/0122;;H04N7/015;;H04N9/64;;H04N9/641;;H04N19/90;;G06T3/04;;H04N7/01;;H04N9/641;;H04N3/27;;H04N7/0122;;H04N5/45;;H04N7/0105;;H04N3/223;;H04N7/007;;H04N9/64;;H04N3/227;;H04N7/01;;G06T3/4007;;H04N7/015;;H04N5/2624;;H04N19/90;;G06T3/04,H04N5/46;;G06F3/00;;G06T3/40;;G09G5/00;;G09G5/14;;G09G5/377;;G09G5/391;;H04N3/223;;H04N3/227;;H04N3/27;;H04N5/073;;H04N5/14;;H04N5/262;;H04N5/265;;H04N5/44;;H04N5/45;;H04N7/00;;H04N7/01;;H04N7/015;;H04N7/26;;H04N9/64;;H04N11/06;;H04N11/20;;H04N11/24,,0,0,,,,PENDING
325,CN,A,CN 1526151 A,069-291-438-258-265,2004-09-01,2004,CN 01820923 A,2001-12-18,US 74723100 A,2000-12-22,Method and apparatus for applying crosswires to a tension focus mask,一种将交叉线(46)施加到张力荫罩(30)上的方法和装置。该方法包括将交叉线缠绕在各个鼓轮组件(301，404，504)上，然后利用传送装置(307，406，550)取下交叉线(46)的片段并将其传送到张力荫罩(30)上。,THOMSON LICENSING SA,DOTY JAMES EDWARD;;GARRITY EDWARD RICHARD JR;;WILBUR LEONARD PRATT JR;;THOMSON MARK,,https://lens.org/069-291-438-258-265,Patent Application,no,0,0,9,9,0,H01J9/14;;H01J9/16;;H01J9/24;;H01J9/14;;H01J9/16,H01J9/14;;H01J9/16,,0,0,,,,DISCONTINUED
326,US,A1,US 2002/0168402 A1,009-841-278-163-909,2002-11-14,2002,US 87449901 A,2001-06-05,US 87449901 A;;US 25816000 P,2000-12-22,Microprecipitation method for preparing submicron suspensions,"
   The present invention provides a method for preparing submicron sized particles of an organic compound, the solubility of which is greater in a water-miscible first solvent than in a second solvent which is aqueous, the process including the steps of: (i) dissolving the organic compound in the water-miscible first solvent to form a solution, (ii) mixing the solution with the second solvent to define a pre-suspension; and (iii) adding energy to the pre-suspension to form particles having an average effective particle size of 400 nm to 2 microns. 
",KIPP JAMES E.;;TAK WONG JOSEPH CHUNG;;DOTY MARK J.;;REBBECK CHRISTINE L.,KIPP JAMES E;;TAK WONG JOSEPH CHUNG;;DOTY MARK J;;REBBECK CHRISTINE L,BAXTER INTERNATIONAL INC (2001-06-01),https://lens.org/009-841-278-163-909,Patent Application,yes,99,51,7,86,0,A61K9/10;;A61K9/10;;A61K9/14;;A61K9/14;;A61K9/145;;A61K9/145;;A61K9/146;;A61K9/146;;A61K9/1688;;A61K9/1688;;A61K31/495;;A61K31/495;;A61K31/496;;A61K31/496;;Y10T428/2984;;Y10T428/2984;;Y10T428/2985;;Y10T428/2985,A61K/;;A61K9/10;;A61K9/14;;A61K9/16;;A61K31/495;;A61K31/496,42445,0,0,,,,EXPIRED
327,WO,A1,WO 2006/056574 A1,038-543-137-335-996,2006-06-01,2006,EP 2005056158 W,2005-11-22,US 63020504 P;;EP 05107690 A,2004-11-24,MULTILAYER POLYMER STRUCTURE,"Multilayer polymer structure comprising at least one couple of adjacent layers (L1-L2), characterized in that: layer (L1) comprises at least one polymer composition (C1) comprising at least one semi-crystalline polyphthalamide and at least one impact modifier (I1), and layer (L2) comprises at least one polymer composition (C2) comprising at least one functionalized polyolefin (FPO2), said functionalized polyolefin comprising functional groups chosen from carboxylic groups, their esters, their anhydrides and their salts. Process for manufacturing said multilayer structure, which comprises co-extruding polymer compositions (C1) and (C2) so as to obtain couple of adjacent layers (L1-L2). Shaped article comprising the invented multilayer structure and process for manufacturing the shaped article.",SOLVAY ADVANCED POLYMERS LLC;;BUSHELMAN CORINNE;;DOTY JAMES K;;DE CANNIERE JEAN;;DEHENNAU CLAUDE;;COLLARD MARIE-PAULE,BUSHELMAN CORINNE;;DOTY JAMES K;;DE CANNIERE JEAN;;DEHENNAU CLAUDE;;COLLARD MARIE-PAULE,,https://lens.org/038-543-137-335-996,Patent Application,yes,5,6,14,14,0,B29C48/21;;B32B1/08;;B32B27/08;;B32B27/32;;B32B1/00;;B32B27/08;;B32B27/32;;B32B27/34;;Y10T428/1352;;Y10T428/1379;;Y10T428/3175;;Y10T428/31757;;B29C48/21;;Y10T428/1352;;Y10T428/1379;;Y10T428/3175;;Y10T428/31757;;B32B27/18;;B32B2439/00;;B29C48/21;;B32B27/08;;B32B27/32;;B32B27/34;;B32B1/00;;B32B1/08,B32B27/34;;B29C48/21;;B29C48/32;;B32B27/08;;B32B27/32,,0,0,,,,PENDING
328,PT,A,PT 97816 A,061-645-890-371-269,1993-06-30,1993,PT 9781691 A,1991-05-31,GB 9012326 A,1990-06-01,DISPOSITIVO DE PROCESSAMENTO DE CROMINANCIA,,THOMSON CONSUMER ELECTRONICS,ERSOZ NATHANIEL HALUK;;SAEGER TIMOTHY WILLIAM;;DOTY JAMES HARRISON II;;KRANAWETTER GREG ALAN,,https://lens.org/061-645-890-371-269,Patent Application,no,0,0,282,300,0,G06T3/4007;;H04N3/223;;H04N3/227;;H04N3/27;;H04N5/2624;;H04N5/45;;H04N7/007;;H04N7/01;;H04N7/0105;;H04N7/0122;;H04N7/015;;H04N9/64;;H04N9/641;;H04N19/90;;G06T3/04;;H04N7/01;;H04N9/641;;H04N3/27;;H04N7/0122;;H04N5/45;;H04N7/0105;;H04N3/223;;H04N7/007;;H04N9/64;;H04N3/227;;H04N7/01;;G06T3/4007;;H04N7/015;;H04N5/2624;;H04N19/90;;G06T3/04,H04N5/46;;G06F3/00;;G06T3/40;;G09G5/00;;G09G5/14;;G09G5/377;;G09G5/391;;H04N3/223;;H04N3/227;;H04N3/27;;H04N5/073;;H04N5/14;;H04N5/262;;H04N5/265;;H04N5/44;;H04N5/45;;H04N7/00;;H04N7/01;;H04N7/015;;H04N7/26;;H04N9/64;;H04N11/06;;H04N11/20;;H04N11/24,,0,0,,,,EXPIRED
329,PT,B,PT 97816 B,141-358-231-990-128,1998-12-31,1998,PT 9781691 A,1991-05-31,GB 9012326 A,1990-06-01,DISPOSITIVO DE PROCESSAMENTO DE CROMINANCIA,,THOMSON CONSUMER ELECTRONICS,ERSOZ NATHANIEL HALUK;;SAEGER TIMOTHY WILLIAM;;DOTY JAMES HARRISON II;;KRANAWETTER GREG ALAN,,https://lens.org/141-358-231-990-128,Granted Patent,no,0,0,282,300,0,G06T3/4007;;H04N3/223;;H04N3/227;;H04N3/27;;H04N5/2624;;H04N5/45;;H04N7/007;;H04N7/01;;H04N7/0105;;H04N7/0122;;H04N7/015;;H04N9/64;;H04N9/641;;H04N19/90;;G06T3/04;;H04N7/01;;H04N9/641;;H04N3/27;;H04N7/0122;;H04N5/45;;H04N7/0105;;H04N3/223;;H04N7/007;;H04N9/64;;H04N3/227;;H04N7/01;;G06T3/4007;;H04N7/015;;H04N5/2624;;H04N19/90;;G06T3/04,H04N5/46;;G06F3/00;;G06T3/40;;G09G5/00;;G09G5/14;;G09G5/377;;G09G5/391;;H04N3/223;;H04N3/227;;H04N3/27;;H04N5/073;;H04N5/14;;H04N5/262;;H04N5/265;;H04N5/44;;H04N5/45;;H04N7/00;;H04N7/01;;H04N7/015;;H04N7/26;;H04N9/64;;H04N11/06;;H04N11/20;;H04N11/24,,0,0,,,,EXPIRED
330,US,A1,US 2008/0057244 A1,186-826-344-586-372,2008-03-06,2008,US 72004405 A,2005-11-22,US 72004405 A;;EP 05107690 A;;US 63020504 P;;EP 2005056158 W,2004-11-24,Multilayer Polymer Structure,"Multilayer polymer structure comprising at least one couple of adjacent layers (L 1 -L 2 ), characterized in that: layer (L 1 ) comprises at least one polymer composition (C 1 ) comprising at least one semi-crystalline polyphthalamide and at least one impact modifier (I 1 ), andlayer (L 2 ) comprises at least one polymer composition (C 2 ) comprising at least one functionalized polyolefin (FPO 2 ), said functionalized polyolefin comprising functional groups chosen from carboxylic groups, their esters, their anhydrides and their salts. Process for manufacturing said multilayer structure, which comprises co-extruding polymer compositions (C 1 ) and (C 2 ) so as to obtain couple of adjacent layers (L 1 -L 2 ). Shaped article comprising the invented multilayer structure and process for manufacturing the shaped article.",SOLVAY ADVANCED POLYMERS LLC,BUSHELMAN CORINNE;;DOTY JAMES K;;DE CANNIERE JEAN;;DEHENNAU CLAUDE;;COLLARD MARIE-PAULE,SOLVAY ADVANCED POLYMERS L.L.C (2005-07-06),https://lens.org/186-826-344-586-372,Patent Application,yes,14,7,14,14,0,B29C48/21;;B32B1/08;;B32B27/08;;B32B27/32;;B32B1/00;;B32B27/08;;B32B27/32;;B32B27/34;;Y10T428/1352;;Y10T428/1379;;Y10T428/3175;;Y10T428/31757;;B29C48/21;;Y10T428/1352;;Y10T428/1379;;Y10T428/3175;;Y10T428/31757;;B32B27/18;;B32B2439/00;;B29C48/21;;B32B27/08;;B32B27/32;;B32B27/34;;B32B1/00;;B32B1/08,B32B1/08;;B29C48/21;;B29C48/32;;B32B27/08;;B32B27/32;;B32B27/34,428/35.7;;264/176.1;;428/476.3;;525/178;;525/66,0,0,,,,DISCONTINUED
331,TW,A,TW 202315627 A,163-529-075-421-995,2023-04-16,2023,TW 111131359 A,2022-08-19,US 202163234773 P,2021-08-19,"Composition of a solid oral immediate release formulation of LSD, method of making a solid oral immediate release formulation of LSD, and method of making a solid oral immediate release formulation of LSD by dry blending","A solid oral immediate release formulation of LSD, including LSD contained within a dosage form of a capsule, tablet, or orally disintegrating tablet. A method of making a solid oral immediate release formulation of LSD as a free base or in a salt form by granulation, including moisture-activated dry granulation or dry blending. A method of treating an individual, by administering a solid oral immediate release formulation of LSD and treating the individual.",MIND MEDICINE INC,MACK PETER;;MELTON DUSTIN;;DOTY BETHANY AMBER;;SCHROEDER JON;;COGHILL JAMES;;LEVY DANIEL EMIL,,https://lens.org/163-529-075-421-995,Patent of Addition,no,0,0,14,14,0,A61K31/48;;A61K9/0056;;A61K9/2063;;A61K9/2018;;A61K9/205;;A61K31/48;;A61K9/20;;A61K47/60;;A61K47/22;;A61K47/36;;A61K47/6923;;A61K47/26;;A61K47/10;;A61K9/0056;;A61K9/2013;;A61K9/2054;;A61K9/2095;;A61K9/2018;;A61K9/205,A61K31/437;;A61K31/137;;A61K31/40;;A61K31/435;;A61K31/48;;A61P25/00;;A61P25/22;;A61P25/24,,0,0,,,,PENDING
332,US,A1,US 2006/0222710 A1,024-942-562-118-917,2006-10-05,2006,US 42512206 A,2006-06-19,US 42512206 A;;US 27026702 A;;US 34754801 P,2001-10-19,COMPOSITION OF AND METHOD FOR PREPARING STABLE PARTICLES IN A FROZEN AQUEOUS MATRIX,"The present invention discloses a composition of a stable suspension of a poorly water soluble pharmaceutical agent or cosmetic in the form of particles of the pharmaceutical agent or cosmetic suspended in a frozen aqueous matrix and method for its preparation. The composition is stable for a prolonged period of time, preferably six months or longer and is suitable for parenteral, oral, or non-oral routes such as pulmonary (inhalation), ophthalmic, or topical administration.",KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN;;KONKEL JAMIE T,KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN;;KONKEL JAMIE T,BAXTER INTERNATIONAL INC (2002-10-23),https://lens.org/024-942-562-118-917,Patent Application,yes,99,5,16,17,0,A61K8/02;;A61K8/044;;A61K9/10;;A61K9/145;;A61K9/146;;A61K31/12;;A61K31/4985;;A61K31/58;;A61K2800/92;;A61Q19/00;;A61K8/044;;A61Q19/00;;A61K31/58;;A61K9/10;;A61K8/02;;A61K9/145;;A61K31/4985;;A61K2800/92;;A61K9/146;;A61K31/12,A61K31/573;;A61K8/02;;A61K8/04;;A61K8/06;;A61K8/34;;A61K8/35;;A61K8/36;;A61K8/365;;A61K8/37;;A61K8/39;;A61K8/40;;A61K8/41;;A61K8/44;;A61K8/46;;A61K8/60;;A61K8/64;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K9/10;;A61K9/107;;A61K9/14;;A61K31/12;;A61K31/496;;A61K31/4985;;A61K31/58;;A61K47/02;;A61K47/06;;A61K47/10;;A61K47/12;;A61K47/14;;A61K47/16;;A61K47/18;;A61K47/20;;A61K47/26;;A61K47/32;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61K47/44;;A61K47/46;;A61Q19/00,424/484;;514/179;;514/254.07,0,0,,,,DISCONTINUED
333,EP,B1,EP 1435909 B1,046-834-814-645-941,2009-12-02,2009,EP 02773797 A,2002-10-18,US 0233270 W;;US 34754801 P;;US 27026702 A,2001-10-19,STABLE COMPOSITION COMPRISING PARTICLES IN A FROZEN AQUEOUS MATRIX,"The present invention discloses a composition of a stable suspension of a poorly water soluble pharmaceutical agent or cosmetic in the form of particles of the pharmaceutical agent or cosmetic suspended in a frozen aqueous matrix and method for its preparation. The composition is stable for a prolonged period of time, preferably six months or longer and is suitable for parenteral, oral, or non-oral routes such as pulmonary (inhalation), ophthalmic, or topical administration.",BAXTER INT,KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN;;KONKEL JAMIE TERESA,,https://lens.org/046-834-814-645-941,Granted Patent,yes,2,0,16,17,0,A61K8/02;;A61K8/044;;A61K9/10;;A61K9/145;;A61K9/146;;A61K31/12;;A61K31/4985;;A61K31/58;;A61K2800/92;;A61Q19/00;;A61K8/044;;A61Q19/00;;A61K31/58;;A61K9/10;;A61K8/02;;A61K9/145;;A61K31/4985;;A61K2800/92;;A61K9/146;;A61K31/12,A61K9/10;;A61K8/02;;A61K8/04;;A61K8/06;;A61K8/34;;A61K8/35;;A61K8/36;;A61K8/365;;A61K8/37;;A61K8/39;;A61K8/40;;A61K8/41;;A61K8/44;;A61K8/46;;A61K8/60;;A61K8/64;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K9/107;;A61K9/14;;A61K31/12;;A61K31/4985;;A61K31/58;;A61K47/02;;A61K47/06;;A61K47/10;;A61K47/12;;A61K47/14;;A61K47/16;;A61K47/18;;A61K47/20;;A61K47/26;;A61K47/32;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61K47/44;;A61K47/46;;A61Q19/00,,0,0,,,,EXPIRED
334,US,A1,US 2017/0262612 A1,070-192-071-224-780,2017-09-14,2017,US 201615064071 A,2016-03-08,US 201615064071 A,2016-03-08,EVIDENCE ANALYSIS AND PRESENTATION TO INDICATE REASONS FOR MEMBERSHIP IN POPULATIONS,"A method, a machine-readable storage medium and at least one processing device are provided for analyzing and tracking results of multiple conditions associated with a population criteria, which is evaluated for each entity of at least one entity. The at least one processing device performs analytics associated with the population criteria, which is evaluated for each entity. Results of the analyzing of the multiple conditions are selectively tracked by the at least one processing device. The at least one processing device presents the tracked results to indicate a status of the at least one entity with respect to the tracked analytics.",IBM,BAIERA JAMES C;;DOTY JILL R;;KIM DANIEL;;KWASNY DAVID A;;MEIL DOUGLAS S,MERATIVE US L.P (2022-06-30);;INTERNATIONAL BUSINESS MACHINES CORPORATION (2016-03-08),https://lens.org/070-192-071-224-780,Patent Application,yes,4,1,2,4,0,G16H50/70;;G16H50/70,G06F19/00,,0,0,,,,ACTIVE
335,US,A1,US 2006/0222711 A1,065-143-940-454-245,2006-10-05,2006,US 42512506 A,2006-06-19,US 42512506 A;;US 27026702 A;;US 34754801 P,2001-10-19,COMPOSITION OF AND METHOD FOR PREPARING STABLE PARTICLES IN A FROZEN AQUEOUS MATRIX,"The present invention discloses a composition of a stable suspension of a poorly water soluble pharmaceutical agent or cosmetic in the form of particles of the pharmaceutical agent or cosmetic suspended in a frozen aqueous matrix and method for its preparation. The composition is stable for a prolonged period of time, preferably six months or longer and is suitable for parenteral, oral, or non-oral routes such as pulmonary (inhalation), ophthalmic, or topical administration.",KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN;;KONKEL JAMIE T,KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN;;KONKEL JAMIE T,BAXTER INTERNATIONAL INC (2002-10-23),https://lens.org/065-143-940-454-245,Patent Application,yes,5,5,16,17,0,A61K8/02;;A61K8/044;;A61K9/10;;A61K9/145;;A61K9/146;;A61K31/12;;A61K31/4985;;A61K31/58;;A61K2800/92;;A61Q19/00;;A61K8/044;;A61Q19/00;;A61K31/58;;A61K9/10;;A61K8/02;;A61K9/145;;A61K31/4985;;A61K2800/92;;A61K9/146;;A61K31/12,A61K31/573;;A61K8/02;;A61K8/04;;A61K8/06;;A61K8/34;;A61K8/35;;A61K8/36;;A61K8/365;;A61K8/37;;A61K8/39;;A61K8/40;;A61K8/41;;A61K8/44;;A61K8/46;;A61K8/60;;A61K8/64;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K9/10;;A61K9/107;;A61K9/14;;A61K31/12;;A61K31/496;;A61K31/4985;;A61K31/58;;A61K47/02;;A61K47/06;;A61K47/10;;A61K47/12;;A61K47/14;;A61K47/16;;A61K47/18;;A61K47/20;;A61K47/26;;A61K47/32;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61K47/44;;A61K47/46;;A61Q19/00,424/484;;514/179;;514/254.07;;424/401,0,0,,,,DISCONTINUED
336,CA,A1,CA 3228975 A1,083-980-218-247-805,2023-02-23,2023,CA 3228975 A,2022-08-17,US 202163234773 P;;US 2022/0040653 W,2021-08-19,IMMEDIATE RELEASE FORMULATIONS OF D-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS,"A solid oral immediate release formulation of LSD, including LSD contained within a dosage form of a capsule, tablet, or orally disintegrating tablet. A method of making a solid oral immediate release formulation of LSD as a free base or in a salt form by granulation, including moisture-activated dry granulation or dry blending. A method of treating an individual, by administering a solid oral immediate release formulation of LSD and treating the individual.",MIND MEDICINE INC,MACK PETER;;MELTON DUSTIN;;DOTY BETHANY AMBER;;SCHROEDER JON;;COGHILL JAMES;;LEVY DANIEL EMIL,,https://lens.org/083-980-218-247-805,Patent Application,no,0,0,14,14,0,A61K31/48;;A61K9/0056;;A61K9/2063;;A61K9/2018;;A61K9/205;;A61K31/48;;A61K9/20;;A61K47/60;;A61K47/22;;A61K47/36;;A61K47/6923;;A61K47/26;;A61K47/10;;A61K9/0056;;A61K9/2013;;A61K9/2054;;A61K9/2095;;A61K9/2018;;A61K9/205,A61P25/28,,0,0,,,,PENDING
337,ES,T3,ES 2340261 T3,089-939-796-973-263,2010-06-01,2010,ES 02773797 T,2002-10-18,US 34754801 P;;US 27026702 A,2001-10-19,COMPOSICION ESTABLE QUE COMPRENDE PARTICULAS EN UNA MATRIZ ACUOSA CONGELADA.,"The present invention discloses a composition of a stable suspension of a poorly water soluble pharmaceutical agent or cosmetic in the form of particles of the pharmaceutical agent or cosmetic suspended in a frozen aqueous matrix and method for its preparation. The composition is stable for a prolonged period of time, preferably six months or longer and is suitable for parenteral, oral, or non-oral routes such as pulmonary (inhalation), ophthalmic, or topical administration.",BAXTER INT,KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN;;KONKEL JAMIE TERESA,,https://lens.org/089-939-796-973-263,Granted Patent,no,0,0,16,17,0,A61K8/02;;A61K8/044;;A61K9/10;;A61K9/145;;A61K9/146;;A61K31/12;;A61K31/4985;;A61K31/58;;A61K2800/92;;A61Q19/00;;A61K8/044;;A61Q19/00;;A61K31/58;;A61K9/10;;A61K8/02;;A61K9/145;;A61K31/4985;;A61K2800/92;;A61K9/146;;A61K31/12,A61K9/10;;A61K8/02;;A61K8/04;;A61K8/06;;A61K8/34;;A61K8/35;;A61K8/36;;A61K8/365;;A61K8/37;;A61K8/39;;A61K8/40;;A61K8/41;;A61K8/44;;A61K8/46;;A61K8/60;;A61K8/64;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K9/107;;A61K9/14;;A61K31/12;;A61K31/4985;;A61K31/58;;A61K47/02;;A61K47/06;;A61K47/10;;A61K47/12;;A61K47/14;;A61K47/16;;A61K47/18;;A61K47/20;;A61K47/26;;A61K47/32;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61K47/44;;A61K47/46;;A61Q19/00,,0,0,,,,EXPIRED
338,DK,T3,DK 1435909 T3,111-704-264-761-576,2010-03-15,2010,DK 02773797 T,2002-10-18,US 34754801 P;;US 27026702 A;;US 0233270 W,2001-10-19,Stabil sammensætning indeholdende partikler i en frossen vandig matrix,"The present invention discloses a composition of a stable suspension of a poorly water soluble pharmaceutical agent or cosmetic in the form of particles of the pharmaceutical agent or cosmetic suspended in a frozen aqueous matrix and method for its preparation. The composition is stable for a prolonged period of time, preferably six months or longer and is suitable for parenteral, oral, or non-oral routes such as pulmonary (inhalation), ophthalmic, or topical administration.",BAXTER INT,KONKEL JAMIE TERESA;;KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN,,https://lens.org/111-704-264-761-576,Granted Patent,no,0,0,16,17,0,A61K8/02;;A61K8/044;;A61K9/10;;A61K9/145;;A61K9/146;;A61K31/12;;A61K31/4985;;A61K31/58;;A61K2800/92;;A61Q19/00;;A61K8/044;;A61Q19/00;;A61K31/58;;A61K9/10;;A61K8/02;;A61K9/145;;A61K31/4985;;A61K2800/92;;A61K9/146;;A61K31/12,A61K9/10;;A61K8/02;;A61K8/04;;A61K8/06;;A61K8/34;;A61K8/35;;A61K8/36;;A61K8/365;;A61K8/37;;A61K8/39;;A61K8/40;;A61K8/41;;A61K8/44;;A61K8/46;;A61K8/60;;A61K8/64;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K9/107;;A61K9/14;;A61K31/12;;A61K31/4985;;A61K31/58;;A61K47/02;;A61K47/06;;A61K47/10;;A61K47/12;;A61K47/14;;A61K47/16;;A61K47/18;;A61K47/20;;A61K47/26;;A61K47/32;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61K47/44;;A61K47/46;;A61Q19/00,,0,0,,,,EXPIRED
339,US,A1,US 2023/0107398 A1,123-802-368-470-938,2023-04-06,2023,US 202218077096 A,2022-12-07,US 202218077096 A;;US 202217890198 A;;US 202163234773 P,2021-08-19,IMMEDIATE RELEASE FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS,"A solid oral immediate release formulation of LSD, including LSD contained within a dosage form of a capsule, tablet, or orally disintegrating tablet. A method of making a solid oral immediate release formulation of LSD as a free base or in a salt form by granulation, including moisture-activated dry granulation or dry blending. A method of treating an individual, by administering a solid oral immediate release formulation of LSD and treating the individual.",MIND MEDICINE INC,MACK PETER;;MELTON DUSTIN;;DOTY BETHANY AMBER;;SCHROEDER JON;;COGHILL JAMES;;LEVY DANIEL EMIL,MIND MEDICINE INC (2022-10-27),https://lens.org/123-802-368-470-938,Patent Application,yes,2,0,14,14,0,A61K31/48;;A61K9/0056;;A61K9/2063;;A61K9/2018;;A61K9/205;;A61K31/48;;A61K9/20;;A61K47/60;;A61K47/22;;A61K47/36;;A61K47/6923;;A61K47/26;;A61K47/10;;A61K9/0056;;A61K9/2013;;A61K9/2054;;A61K9/2095;;A61K9/2018;;A61K9/205,A61K31/48;;A61K9/20;;A61K47/10;;A61K47/22;;A61K47/26;;A61K47/36;;A61K47/60;;A61K47/69,,9,6,010-598-818-147-175;;030-521-563-940-808;;078-177-515-777-489;;123-574-759-586-311;;066-779-808-368-470;;086-336-415-166-176,17763144;;10.1080/10837450701369253;;10.22270/jddt.v8i3.1748;;10.1208/s12249-017-0869-z;;28905241;;10.29161/pt.v5.i12.2017.58;;10.1016/j.ijpharm.2013.08.027;;23994013;;10.1016/j.apt.2017.02.015,"am Ende et al. “Improving the Content Uniformity of a Low-Dose Tablet Formulation Through Roller Compaction Optimization,” Pharmaceutical Development and Technology, 12:391–404, 2007 (Year: 2007);;Bhaskar et al. “A REVIEW ON FORMULATION APPROACHES IN IMMEDIATE RELEASE TABLET,” Journal of Drug Delivery & Therapeutics. 2018; 8(3): 153-161. (Year: 2018);;Psychedelic Experience web page retrieved from The Wayback Machine on 4/23/3021 (Year: 2021);;Celestino et al. “Rational use of antioxidants in solid oral pharmaceutical preparations,” Brazilian Journal of Pharmaceutical Sciences vol. 48, n. 3, jul./sep., 2012. (Year: 2012);;Janga et al. “Photostability Issues in Pharmaceutical Dosage Forms and Photostabilization,” AAPS PharmSciTech, Vol. 19, No. 1, January 2018. (Year: 2018);;Sharma et al. “Review on Moisture activated Dry Granulation Process,” PharmaTutor; 2017; 5(12); 58-67; (Year: 2017);;Takasaki et al. “Importance of excipient wettability on tablet characteristics preparedby moisture activated dry granulation (MADG),” International Journal of Pharmaceutics 456 (2013) 58– 64; (Year: 2013);;Ullah et al. “Moisture-Activated Dry Granulation-Part I: A Guide to Excipient and Equipment Selection and Formulation Development,” Pharmaceutical Technology-11-02-2009, Volume 33, Issue 11 (Year: 2009);;Moravkar et al. “Application of moisture activated dry granulation (MADG) process to develop high dose immediate release (IR) formulations,” Advanced Powder Technology 28 (2017) 1270–1280. (Year: 2017)",PENDING
340,US,A1,US 2003/0077329 A1,154-328-729-702-300,2003-04-24,2003,US 27026702 A,2002-10-11,US 27026702 A;;US 34754801 P,2001-10-19,Composition of and method for preparing stable particles in a frozen aqueous matrix,"
   The present invention discloses a composition of a stable suspension of a poorly water soluble pharmaceutical agent or cosmetic in the form of particles of the pharmaceutical agent or cosmetic suspended in a frozen aqueous matrix and method for its preparation. The composition is stable for a prolonged period of time, preferably six months or longer and is suitable for parenteral, oral, or non-oral routes such as pulmonary (inhalation), ophthalmic, or topical administration. 
",KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN;;TERESA KONKEL JAMIE,KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN;;TERESA KONKEL JAMIE,BAXTER INTERNATIONAL INC (2002-10-23),https://lens.org/154-328-729-702-300,Patent Application,yes,99,153,16,17,0,A61K8/02;;A61K8/044;;A61K9/10;;A61K9/145;;A61K9/146;;A61K31/12;;A61K31/4985;;A61K31/58;;A61K2800/92;;A61Q19/00;;A61K8/044;;A61Q19/00;;A61K31/58;;A61K9/10;;A61K8/02;;A61K9/145;;A61K31/4985;;A61K2800/92;;A61K9/146;;A61K31/12,A61K8/02;;A61K8/04;;A61K8/06;;A61K8/34;;A61K8/35;;A61K8/36;;A61K8/365;;A61K8/37;;A61K8/39;;A61K8/40;;A61K8/41;;A61K8/44;;A61K8/46;;A61K8/60;;A61K8/64;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K9/10;;A61K9/107;;A61K9/14;;A61K31/12;;A61K31/4985;;A61K31/58;;A61K47/02;;A61K47/06;;A61K47/10;;A61K47/12;;A61K47/14;;A61K47/16;;A61K47/18;;A61K47/20;;A61K47/26;;A61K47/32;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61K47/44;;A61K47/46;;A61Q19/00,424 489000;;424 179000;;424 254070;;424 184100;;424 001110,0,0,,,,EXPIRED
341,GB,A,GB 2474368 A,105-651-304-721-47X,2011-04-13,2011,GB 201017221 A,2010-10-12,US 57741809 A,2009-10-12,Determining characteristics of a radar cross section (RCS) test range,"A method for determining characteristics of a Radar Cross Section (RCS) test range may include vertically orienting a field probe 120 including an elongated rigid body 122 at a predetermined location within the RCS test range. The method may also include generating incident radar waves at a selected frequency and polarization and pivoting the field probe in a vertical direction broadside to the incident radar waves. The method may additionally include receiving return radar data scattered by the field probe during pivoting of the field probe. The method may further include determining a field distribution along the elongated rigid body of the field probe from the return radar data to determine characteristics of the RCS test range. The rigid body is rotated by lengthening or shortening ropes 130, 132, 134, 136 which are attached to the lower end of the body 126 and various points on the ceiling 138 of the test range.",BOEING CO,WEI PAX;;REED ANTHONY W;;ERICKSEN CRAIG N;;DOTY JAMES D;;SCHUESSLER ROBERT K,,https://lens.org/105-651-304-721-47X,Patent Application,no,4,3,5,5,0,G01R29/105;;G01S7/4004;;G01S7/41;;G01S7/40;;G01S7/41;;G01S7/4004;;G01R29/105;;G01S7/41,G01S7/40;;G01S7/41,,0,0,,,,ACTIVE
342,EP,A1,EP 1435909 A1,183-945-110-830-03X,2004-07-14,2004,EP 02773797 A,2002-10-18,US 0233270 W;;US 34754801 P;;US 27026702 A,2001-10-19,STABLE COMPOSITION COMPRISING PARTICLES IN A FROZEN AQUEOUS MATRIX,"The present invention discloses a composition of a stable suspension of a poorly water soluble pharmaceutical agent or cosmetic in the form of particles of the pharmaceutical agent or cosmetic suspended in a frozen aqueous matrix and method for its preparation. The composition is stable for a prolonged period of time, preferably six months or longer and is suitable for parenteral, oral, or non-oral routes such as pulmonary (inhalation), ophthalmic, or topical administration.",BAXTER INT,KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN;;KONKEL JAMIE TERESA,,https://lens.org/183-945-110-830-03X,Patent Application,yes,0,0,16,17,0,A61K8/02;;A61K8/044;;A61K9/10;;A61K9/145;;A61K9/146;;A61K31/12;;A61K31/4985;;A61K31/58;;A61K2800/92;;A61Q19/00;;A61K8/044;;A61Q19/00;;A61K31/58;;A61K9/10;;A61K8/02;;A61K9/145;;A61K31/4985;;A61K2800/92;;A61K9/146;;A61K31/12,A61K8/02;;A61K8/04;;A61K8/06;;A61K8/34;;A61K8/35;;A61K8/36;;A61K8/365;;A61K8/37;;A61K8/39;;A61K8/40;;A61K8/41;;A61K8/44;;A61K8/46;;A61K8/60;;A61K8/64;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K9/10;;A61K9/107;;A61K9/14;;A61K31/12;;A61K31/4985;;A61K31/58;;A61K47/02;;A61K47/06;;A61K47/10;;A61K47/12;;A61K47/14;;A61K47/16;;A61K47/18;;A61K47/20;;A61K47/26;;A61K47/32;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61K47/44;;A61K47/46;;A61Q19/00,,0,0,,,,EXPIRED
343,AU,B2,AU 2002/337894 B2,056-424-798-649-870,2007-07-12,2007,AU 2002/337894 A,2002-10-18,US 27026702 A;;US 34754801 P;;US 0233270 W,2001-10-19,Stable composition comprising particles in a frozen aqueous matrix,"The present invention discloses a composition of a stable suspension of a poorly water soluble pharmaceutical agent or cosmetic in the form of particles of the pharmaceutical agent or cosmetic suspended in a frozen aqueous matrix and method for its preparation. The composition is stable for a prolonged period of time, preferably six months or longer and is suitable for parenteral, oral, or non-oral routes such as pulmonary (inhalation), ophthalmic, or topical administration.",BAXTER INT,KONKEL JAMIE TERESA;;DOTY MARK J;;BRYNJELSEN SEAN;;REBBECK CHRISTINE L;;KIPP JAMES E,,https://lens.org/056-424-798-649-870,Granted Patent,no,1,0,16,17,0,A61K8/02;;A61K8/044;;A61K9/10;;A61K9/145;;A61K9/146;;A61K31/12;;A61K31/4985;;A61K31/58;;A61K2800/92;;A61Q19/00;;A61K8/044;;A61Q19/00;;A61K31/58;;A61K9/10;;A61K8/02;;A61K9/145;;A61K31/4985;;A61K2800/92;;A61K9/146;;A61K31/12,A61K9/10;;A61K8/02;;A61K8/04;;A61K8/06;;A61K8/34;;A61K8/35;;A61K8/36;;A61K8/365;;A61K8/37;;A61K8/39;;A61K8/40;;A61K8/41;;A61K8/44;;A61K8/46;;A61K8/60;;A61K8/64;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K9/107;;A61K9/14;;A61K31/12;;A61K31/4985;;A61K31/58;;A61K47/02;;A61K47/06;;A61K47/10;;A61K47/12;;A61K47/14;;A61K47/16;;A61K47/18;;A61K47/20;;A61K47/26;;A61K47/32;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61K47/44;;A61K47/46;;A61Q19/00,,2,1,017-941-342-747-510,10.1016/s0378-5173(78)80002-7,"Project Habbakuk (1943);;D.T Graham et al, International Journal of Pharmaceutics, 1, (1978) pp315 -322",EXPIRED
344,US,A1,US 2023/0285386 A1,044-884-460-906-78X,2023-09-14,2023,US 202318199244 A,2023-05-18,US 202318199244 A;;US 202218077096 A;;US 202217890198 A;;US 202163234773 P,2021-08-19,IMMEDIATE RELEASE FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS,"A solid oral immediate release formulation of LSD, including LSD contained within a dosage form of a capsule, tablet, or orally disintegrating tablet. A method of making a solid oral immediate release formulation of LSD as a free base or in a salt form by granulation, including moisture-activated dry granulation or dry blending. A method of treating an individual, by administering a solid oral immediate release formulation of LSD and treating the individual.",MIND MEDICINE INC,MACK PETER;;MELTON DUSTIN;;DOTY BETHANY AMBER;;SCHROEDER JON;;COGHILL JAMES;;LEVY DANIEL EMIL,MIND MEDICINE INC (2022-10-27),https://lens.org/044-884-460-906-78X,Patent Application,yes,0,0,14,14,0,A61K31/48;;A61K9/0056;;A61K9/2063;;A61K9/2018;;A61K9/205;;A61K31/48;;A61K9/20;;A61K47/60;;A61K47/22;;A61K47/36;;A61K47/6923;;A61K47/26;;A61K47/10;;A61K9/0056;;A61K9/2013;;A61K9/2054;;A61K9/2095;;A61K9/2018;;A61K9/205,A61K31/48;;A61K9/00;;A61K9/20;;A61K47/10;;A61K47/22;;A61K47/26;;A61K47/36;;A61K47/60;;A61K47/69,,0,0,,,,PENDING
345,US,B2,US 7112340 B2,090-524-611-248-681,2006-09-26,2006,US 27026702 A,2002-10-11,US 27026702 A;;US 34754801 P,2001-10-19,Compositions of and method for preparing stable particles in a frozen aqueous matrix,"The present invention discloses a composition of a stable suspension of a poorly water soluble pharmaceutical agent or cosmetic in the form of particles of the pharmaceutical agent or cosmetic suspended in a frozen aqueous matrix and method for its preparation. The composition is stable for a prolonged period of time, preferably six months or longer and is suitable for parenteral, oral, or non-oral routes such as pulmonary (inhalation), ophthalmic, or topical administration.",BAXTER INT,KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN;;KONKEL JAMIE TERESA,BAXTER INTERNATIONAL INC (2002-10-23),https://lens.org/090-524-611-248-681,Granted Patent,yes,103,13,16,17,0,A61K8/02;;A61K8/044;;A61K9/10;;A61K9/145;;A61K9/146;;A61K31/12;;A61K31/4985;;A61K31/58;;A61K2800/92;;A61Q19/00;;A61K8/044;;A61Q19/00;;A61K31/58;;A61K9/10;;A61K8/02;;A61K9/145;;A61K31/4985;;A61K2800/92;;A61K9/146;;A61K31/12,A61K9/14;;A61K8/02;;A61K8/04;;A61K8/06;;A61K8/34;;A61K8/35;;A61K8/36;;A61K8/365;;A61K8/37;;A61K8/39;;A61K8/40;;A61K8/41;;A61K8/44;;A61K8/46;;A61K8/60;;A61K8/64;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K9/10;;A61K9/107;;A61K31/12;;A61K31/4985;;A61K31/58;;A61K47/02;;A61K47/06;;A61K47/10;;A61K47/12;;A61K47/14;;A61K47/16;;A61K47/18;;A61K47/20;;A61K47/26;;A61K47/32;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61K47/44;;A61K47/46;;A61Q19/00,424/489;;424/484;;424/488,16,7,001-155-857-960-135;;018-188-239-454-962;;005-840-366-684-763;;004-382-489-377-69X;;012-864-980-464-648;;017-541-414-387-84X;;064-523-632-943-432,10.1002/jps.2600670418;;641759;;7302990;;10.1016/0378-4274(81)90035-7;;10.1016/0378-5173(92)90051-3;;8331530;;10.1002/jps.2600820608;;10.1007/s004170050094;;9602323;;10.1016/s1081-1206(10)62949-3;;9494448;;11879753;;10.1016/s0378-5173(01)00986-3,"US 5,849,884, 12/1998, Woiszwillo et al. (withdrawn);;B. Sjostrom et al., ""The Formation of Submicron Organic Particles by Precipitation in an Emulsion"", J.Dispersion Science and Technology, 15(1), 89-117 (1994).;;Avanti Polar Lipids, Inc.., website printout, www.avantilipids.com, ""Synthetic Products-Functionalized Phospholipids: Lipids for Conjugation of Proteins/Peptides/Drugs to Liposomes"" (7 pgs), Mar. 2003.;;Avanti Polar Lipids, Inc.., website printout, www.avantilipids.com, ""Polymer and Polymerizable Lipids: Functionalized PEG Lipids"" (3 pgs), Mar. 2003.;;Avanti Polar Lipids, Inc.., website printout, www.avantilipids.com, ""Polymer and Polymerizable Lipids: Poly(ethylene glycol)-Lipid Conjugates"" (8 pgs) , Mar. 2003.;;Davis et al., ""Pulmonary Perfusion Imaging: Acute Toxicity and Safety Factors as a Function of Particle Size"", J.Nucl Med., vol. 19 (1978), pp. 1209-1213.;;Schroeder et al., ""Physiological Effects of Subvisible Microspheres Administered Intravenously to Beagle Dogs"", Journal of Pharmaceutical Sciences, vol. 67, No. 4, Apr. 1978, pp. 508-512.;;Yokel et al., ""Acute Toxicity of Latex Microspheres"", Toxicity Letters, vol. 9 (1981), pp. 165-170.;;Allen et al., ""Critical Evaluation of Acute Cardiopulminary Toxicity of Microspheres"", J.Nucl Med., vol. 19 (1987), pp. 1204-1208.;;B. Sjostrom et al., ""Preparation Of Submicron Drug Particles In Lecithin-Stabilized O/W Emulsions I. Model Studies Of The Precipitation Of Cholesteryl Acetate"", Int. J. Pharm., 88 (1992) pp. 53-62.;;B. Sjostrom et al., ""A Method For The Preparation Of Submicron Particles Of Sparingly Water-Soluble Drugs By Precipitation In Oil-In-Water Emulsions. II: Influence Of The Emulsifier, The Solvent And The Drug Substance"" , J. Pharm. Sci., 82(6), (1992) pp. 584-589.;;Duncker and Reichelt, ""Effects of the Pharmaceutical Cosolvent hydroxypropyl-beta-cyclodextrin on Porcine Corneal Endothelium"", Graefe's Archive for Clinical and Experimental Ophthalmology (Germany), 236/5 (1998), pp. 380-389.;;Volchek and Dellen, ""Anaphylaxis to Intravenous Cyclosporine and Tolerance to Oral Cyclosporine, Case Report and Review"", Annals of Allergy, Asthma, and Immunology, 80 (1998), pp. 159-163.;;Singla et al., ""Paclitaxel and its Formulations"", International Journal of Pharmaceutics, 235/1-2 (2002), pp. 179-192.;;Publication: ""The Effects of Freezing on Commercial Insulin Suspensions"", by D.T. Graham and A.R. Pomeroy, published by International Journal of Pharmaceutics, 1978.;;PCT/US2002/33270 International Search Report, dated Jan. 31, 2003.",EXPIRED
346,AT,T1,AT E552309 T1,136-954-747-363-918,2012-04-15,2012,AT 10182066 T,2004-08-17,US 49601103 P,2003-08-19,HOHLKÖRPER AUS SCHLAGZÄHEM POLYAMID,"Method for making a hollow body comprising, as sole layer(s), (1) at least one layer L1 comprising an aromatic polyamide and an impact modifier, and, optionally, (2) at least one layer L2 comprising an aliphatic polyamide, comprising extruding an aromatic polyamide and an impact modifier, and optionally extruding an aliphatic polyamide, through a die.",SOLVAY SPECIALTY POLYMERS USA,BERSTED BRUCE H;;DOTY JAMES;;DE CANNIERE JEAN;;WARKOSKI GREGORY;;BUSHELMAN CORINNE;;BILLIET JOHAN,,https://lens.org/136-954-747-363-918,Granted Patent,no,0,0,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,B29C48/90;;B32B27/34,,0,0,,,,ACTIVE
347,US,A1,US 2003/0072807 A1,198-009-037-849-422,2003-04-17,2003,US 27026802 A,2002-10-11,US 27026802 A;;US 24680202 A;;US 3582101 A;;US 2169202 A;;US 95397901 A;;US 87463701 A;;US 25816000 P,2000-12-22,Solid particulate antifungal compositions for pharmaceutical use,"
   The present invention relates to compositions of submicron-to micron-size particles of antifungal agents. More particularly the invention relates to aqueous suspensions of antifungal agents for pharmaceutical use. 
",WONG JOSEPH CHUNG-TAK;;KIPP JAMES E.;;DOTY MARK J.;;REBBECK CHRISTINE;;PAPADOPOULOS PAVLOS,WONG JOSEPH CHUNG-TAK;;KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE;;PAPADOPOULOS PAVLOS,BAXTER INTERNATIONAL INC (2002-10-24),https://lens.org/198-009-037-849-422,Patent Application,yes,98,71,14,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K9/5015;;A61K9/5031;;A61K9/5036;;A61K9/5042;;A61K31/495;;A61K31/496;;A61P31/10;;A61K9/10;;A61K9/10;;A61K9/145;;A61K9/5036;;A61K9/5031;;A61K9/14;;A61K31/496;;A61K31/495;;A61K9/5015;;A61K9/1688;;A61K9/146;;A61K9/5042,A61K9/10;;A61K9/14;;A61K9/16;;A61K9/50;;A61K31/495;;A61K31/496,42449;;514/254.07;;514/383,0,0,,,,DISCONTINUED
348,WO,A1,WO 2003/035031 A1,048-156-223-012-619,2003-05-01,2003,US 0233270 W,2002-10-18,US 34754801 P;;US 27026702 A,2001-10-19,STABLE COMPOSITION COMPRISING PARTICLES IN A FROZEN AQUEOUS MATRIX,"The present invention discloses a composition of a stable suspension of a poorly water soluble pharmaceutical agent or cosmetic in the form of particles of the pharmaceutical agent or cosmetic suspended in a frozen aqueous matrix and method for its preparation. The composition is stable for a prolonged period of time, preferably six months or longer and is suitable for parenteral, oral, or non-oral routes such as pulmonary (inhalation), ophthalmic, or topical administration.",BAXTER INT,KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN;;KONKEL JAMIE TERESA,,https://lens.org/048-156-223-012-619,Patent Application,yes,3,0,16,17,0,A61K8/02;;A61K8/044;;A61K9/10;;A61K9/145;;A61K9/146;;A61K31/12;;A61K31/4985;;A61K31/58;;A61K2800/92;;A61Q19/00;;A61K8/044;;A61Q19/00;;A61K31/58;;A61K9/10;;A61K8/02;;A61K9/145;;A61K31/4985;;A61K2800/92;;A61K9/146;;A61K31/12,A61K8/02;;A61K8/04;;A61K8/06;;A61K8/34;;A61K8/35;;A61K8/36;;A61K8/365;;A61K8/37;;A61K8/39;;A61K8/40;;A61K8/41;;A61K8/44;;A61K8/46;;A61K8/60;;A61K8/64;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K9/10;;A61K9/107;;A61K9/14;;A61K31/12;;A61K31/4985;;A61K31/58;;A61K47/02;;A61K47/06;;A61K47/10;;A61K47/12;;A61K47/14;;A61K47/16;;A61K47/18;;A61K47/20;;A61K47/26;;A61K47/32;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61K47/44;;A61K47/46;;A61Q19/00,,1,1,017-941-342-747-510,10.1016/s0378-5173(78)80002-7,"GRAHAM D T ET AL: ""THE EFFECTS OF FREEZING ON COMMERCIAL INSULIN SUSPENSIONS"", INTERNATIONAL JOURNAL OF PHARMACEUTICS, AMSTERDAM, NL, vol. 1, no. 6, 1 November 1978 (1978-11-01), pages 315 - 322, XP000569033, ISSN: 0378-5173",PATENTED
349,CA,A1,CA 2463313 A1,100-812-089-502-110,2003-05-01,2003,CA 2463313 A,2002-10-18,US 34754801 P;;US 27026702 A;;US 0233270 W,2001-10-19,STABLE COMPOSITION COMPRISING PARTICLES IN A FROZEN AQUEOUS MATRIX,"The present invention discloses a composition of a stable suspension of a poorly water soluble pharmaceutical agent or cosmetic in the form of particl es of the pharmaceutical agent or cosmetic suspended in a frozen aqueous matrix and method for its preparation. The composition is stable for a prolonged period of time, preferably six months or longer and is suitable for parenteral, oral, or non-oral routes such as pulmonary (inhalation), ophthalmic, or topical administration.",BAXTER INT,DOTY MARK J;;KONKEL JAMIE TERESA;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN;;KIPP JAMES E,,https://lens.org/100-812-089-502-110,Patent Application,no,0,0,16,17,0,A61K8/02;;A61K8/044;;A61K9/10;;A61K9/145;;A61K9/146;;A61K31/12;;A61K31/4985;;A61K31/58;;A61K2800/92;;A61Q19/00;;A61K8/044;;A61Q19/00;;A61K31/58;;A61K9/10;;A61K8/02;;A61K9/145;;A61K31/4985;;A61K2800/92;;A61K9/146;;A61K31/12,A61K8/02;;A61K8/04;;A61K8/06;;A61K8/34;;A61K8/35;;A61K8/36;;A61K8/365;;A61K8/37;;A61K8/39;;A61K8/40;;A61K8/41;;A61K8/44;;A61K8/46;;A61K8/60;;A61K8/64;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K9/10;;A61K9/107;;A61K9/14;;A61K31/12;;A61K31/4985;;A61K31/58;;A61K47/02;;A61K47/06;;A61K47/10;;A61K47/12;;A61K47/14;;A61K47/16;;A61K47/18;;A61K47/20;;A61K47/26;;A61K47/32;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61K47/44;;A61K47/46;;A61Q19/00,,0,0,,,,DISCONTINUED
350,US,B2,US 11120915 B2,147-618-180-094-476,2021-09-14,2021,US 201615064071 A,2016-03-08,US 201615064071 A,2016-03-08,Evidence analysis and presentation to indicate reasons for membership in populations,"A method, a machine-readable storage medium and at least one processing device are provided for analyzing and tracking results of multiple conditions associated with a population criteria, which is evaluated for each entity of at least one entity. The at least one processing device performs analytics associated with the population criteria, which is evaluated for each entity. Results of the analyzing of the multiple conditions are selectively tracked by the at least one processing device. The at least one processing device presents the tracked results to indicate a status of the at least one entity with respect to the tracked analytics.",IBM,BAIERA JAMES C;;DOTY JILL R;;KIM DANIEL;;KWASNY DAVID A;;MEIL DOUGLAS S,MERATIVE US L.P (2022-06-30);;INTERNATIONAL BUSINESS MACHINES CORPORATION (2016-03-08),https://lens.org/147-618-180-094-476,Granted Patent,yes,12,0,2,4,0,G16H50/70;;G16H50/70,G16H50/70,,7,4,040-713-977-573-090;;016-968-191-779-454;;163-841-508-119-481;;005-793-710-661-474,24190931;;10.1136/amiajnl-2013-001939;;pmc3861933;;10529027;;10.1016/s0895-4356(99)00071-2;;10901357;;10.1097/00005650-200007000-00006;;10.1016/j.jbi.2015.01.012;;25661261,"Pathak, Jyotishman et al. “Normalization and standardization of electronic health records for high-throughput phenotyping: the SHARPn consortium.” Journal of the American Medical Informatics Association : JAMIA vol. 20,e2 (2013): e341-8. doi:10.1136/amiajnl-2013-001939. (Year: 2013).;;Wyrwich, Kathleen W., William M. Tierney, and Fredric D. Wolinsky. “Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life.” Journal of clinical epidemiology 52.9 (1999): 861-873. (Year: 1999).;;Coste et al.; Ttl: A population-based analytical approach to assessing patterns, determinants, and outcomes of health care with application to ectopic pregnancy; Publication Ttl: Medical Care, vol. 38, No. 7, pp. 739-749; 2000; Publisher: Lippincott Williams &Wilkins; Country of Publication: USA; ISSN:0025-7079; Database: SciSearch.;;Raths; Ttl: Healthcare analytics: Moving from Setup to Use Cases. Pioneer patient care organizations are moving rapidly to leverage analytics for population health and accountable care; Publication Ttl: Healthcare Informatics, vol. 32, No. 4, pp. 58(3); Jul. 2015; Publisher: Vendome Group LLC; Country of Publication: USA; ISSN:1050-9135; Database: Gale Group, 4 pages.;;“The Explorys Platform”, IBM Watson Health, Solution Brief, Produced in the United States of America, Nov. 2015, 4 pages.;;List of IBM Patents or Patent Applications Treated as Related, Jul. 2017, 1 page.;;T. Tran, et al., “Learning vector representation of medical objects via EMR-driven nonnegative restricted Boltzmann machines (eNRBM)”, Journal of Biomedical Informatics 54 (2015) 96-105, 10 pages.",ACTIVE
351,US,A1,US 2017/0300639 A1,126-740-813-262-685,2017-10-19,2017,US 201715639328 A,2017-06-30,US 201715639328 A;;US 201615064071 A,2016-03-08,EVIDENCE ANALYSIS AND PRESENTATION TO INDICATE REASONS FOR MEMBERSHIP IN POPULATIONS,"A method, a machine-readable storage medium and at least one processing device are provided for analyzing and tracking results of multiple conditions associated with a population criteria, which is evaluated for each entity of at least one entity. The at least one processing device performs analytics associated with the population criteria, which is evaluated for each entity. Results of the analyzing of the multiple conditions are selectively tracked by the at least one processing device. The at least one processing device presents the tracked results to indicate a status of the at least one entity with respect to the tracked analytics.",IBM,BAIERA JAMES C;;DOTY JILL R;;KIM DANIEL;;KWASNY DAVID A;;MEIL DOUGLAS S,MERATIVE US L.P (2022-06-30);;INTERNATIONAL BUSINESS MACHINES CORPORATION (2016-03-08),https://lens.org/126-740-813-262-685,Patent Application,yes,4,0,2,4,0,G16H50/70;;G16H10/60;;G16H50/70;;G16H10/60,G06F19/00;;G06Q50/22,,0,0,,,,ACTIVE
352,ES,T3,ES 2385439 T3,113-251-732-685-951,2012-07-24,2012,ES 10182066 T,2004-08-17,US 49601103 P,2003-08-19,Cuerpo hueco de poliamida modificada para impacto,"Method for making a hollow body comprising, as sole layer(s), (1) at least one layer L1 comprising an aromatic polyamide and an impact modifier, and, optionally, (2) at least one layer L2 comprising an aliphatic polyamide, comprising extruding an aromatic polyamide and an impact modifier, and optionally extruding an aliphatic polyamide, through a die.",SOLVAY ADVANCED POLYMERS LLC;;SOLVAY SPECIALTY POLYMERS USA,BERSTED BRUCE H;;DOTY JAMES;;DE CANNIERE JEAN;;WARKOSKI GREGORY;;BUSHELMAN CORINNE;;BILLIET JOHAN,,https://lens.org/113-251-732-685-951,Granted Patent,no,0,0,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,C08L77/06;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90;;B32B1/08;;B32B27/34;;F16L11/04,,0,0,,,,ACTIVE
353,WO,A1,WO 2023/023192 A1,172-208-037-359-472,2023-02-23,2023,US 2022/0040653 W,2022-08-17,US 202163234773 P,2021-08-19,IMMEDIATE RELEASE FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS,"A solid oral immediate release formulation of LSD, including LSD contained within a dosage form of a capsule, tablet, or orally disintegrating tablet. A method of making a solid oral immediate release formulation of LSD as a free base or in a salt form by granulation, including moisture-activated dry granulation or dry blending. A method of treating an individual, by administering a solid oral immediate release formulation of LSD and treating the individual.",MIND MEDICINE INC,MACK PETER;;MELTON DUSTIN;;DOTY BETHANY AMBER;;SCHROEDER JON;;COGHILL JAMES;;LEVY DANIEL EMIL,,https://lens.org/172-208-037-359-472,Patent Application,yes,5,0,14,14,0,A61K31/48;;A61K9/0056;;A61K9/2063;;A61K9/2018;;A61K9/205;;A61K31/48;;A61K9/20;;A61K47/60;;A61K47/22;;A61K47/36;;A61K47/6923;;A61K47/26;;A61K47/10;;A61K9/0056;;A61K9/2013;;A61K9/2054;;A61K9/2095;;A61K9/2018;;A61K9/205,A61K31/48;;A61K9/00;;A61P25/28,,0,0,,,,PENDING
354,AU,A1,AU 2002/231043 A1,182-380-793-259-095,2002-07-08,2002,AU 2002/231043 A,2001-12-18,US 74723100 A;;US 0149100 W,2000-12-22,Method and apparatus for applying crosswires to a tension focus mask,,THOMSON LICENSING SA,WILBUR LEONARD PRATT JR;;GARRITY EDWARD RICHARD JR;;DOTY JAMES EDWARD;;THOMSON MARK ALLEN,,https://lens.org/182-380-793-259-095,Patent Application,no,0,0,9,9,0,H01J9/14;;H01J9/16;;H01J9/24;;H01J9/14;;H01J9/16,H01J9/14;;H01J9/16,,0,0,,,,DISCONTINUED
355,EP,B1,EP 2277675 B1,017-519-272-870-391,2012-04-04,2012,EP 10182066 A,2004-08-17,EP 04779443 A;;US 49601103 P,2003-08-19,Impact-modified polyamide hollow body,"Method for making a hollow body comprising, as sole layer(s), (1) at least one layer L1 comprising an aromatic polyamide and an impact modifier, and, optionally, (2) at least one layer L2 comprising an aliphatic polyamide, comprising extruding an aromatic polyamide and an impact modifier, and optionally extruding an aliphatic polyamide, through a die.",SOLVAY SPECIALTY POLYMERS USA,BERSTED BRUCE H;;DOTY JAMES;;DE CANNIERE JEAN;;WARKOSKI GREGORY;;BUSHELMAN CORINNE;;BILLIET JOHAN,"SOLVAY SPECIALTY POLYMERS USA, LLC. (2011-11-30)",https://lens.org/017-519-272-870-391,Granted Patent,yes,7,0,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,C08L77/06;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90;;B32B1/08;;B32B27/34;;F16L11/04,,0,0,,,,INACTIVE
356,US,B2,US 6604974 B2,148-029-225-911-064,2003-08-12,2003,US 74723100 A,2000-12-22,US 74723100 A,2000-12-22,Method and apparatus for applying crosswires to a tension focus mask,"
    A method and apparatus for applying crosswires to a tension mask. The method includes winding crosswires around various drum assemblies and then using transfer devices to remove sections of crosswires and transfer them to tension mask frame assemblies. 
",THOMSON LICENSING SA,DOTY JAMES EDWARD;;GARRITY JR EDWARD RICHARD;;THOMSON MARK ALLEN;;WILBUR JR LEONARD PRATT,THOMSON LICENSING S.A (2001-04-10),https://lens.org/148-029-225-911-064,Granted Patent,yes,4,2,9,9,0,H01J9/14;;H01J9/16;;H01J9/24;;H01J9/14;;H01J9/16,H01J9/14;;H01J9/16,445/37;;445/36;;445/47;;445/67;;445/68;;242/166;;242/439.5,0,0,,,,EXPIRED
357,WO,A3,WO 2002/052601 A3,151-292-653-299-955,2003-06-05,2003,US 0149100 W,2001-12-18,US 74723100 A,2000-12-22,METHOD AND APPARATUS FOR APPLYING CROSSWIRES TO A TENSION FOCUS MASK,"A method and apparatus for applying crosswires (46) to a tension mask (30). The method includes winding crosswires around various drum assemblies (301, 404, 504) and then using transfer devices (307, 406, 550) to remove sections of crosswires (46) and transfer them to tension masks (30).",THOMSON LICENSING SA;;DOTY JAMES EDWARD;;GARRITY EDWARD RICHARD JR;;THOMSON MARK ALLEN;;WILBUR LEONARD PRATT JR,DOTY JAMES EDWARD;;GARRITY EDWARD RICHARD JR;;THOMSON MARK ALLEN;;WILBUR LEONARD PRATT JR,,https://lens.org/151-292-653-299-955,Search Report,yes,2,0,9,9,0,H01J9/14;;H01J9/16;;H01J9/24;;H01J9/14;;H01J9/16,H01J9/14;;H01J9/16,,0,0,,,,PENDING
358,AU,A1,AU 2022/331317 A1,157-852-994-244-013,2024-02-29,2024,AU 2022/331317 A,2022-08-17,US 202163234773 P;;US 2022/0040653 W,2021-08-19,IMMEDIATE RELEASE FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS,"A solid oral immediate release formulation of LSD, including LSD contained within a dosage form of a capsule, tablet, or orally disintegrating tablet. A method of making a solid oral immediate release formulation of LSD as a free base or in a salt form by granulation, including moisture-activated dry granulation or dry blending. A method of treating an individual, by administering a solid oral immediate release formulation of LSD and treating the individual.",MIND MEDICINE INC,MACK PETER;;MELTON DUSTIN;;DOTY BETHANY AMBER;;SCHROEDER JON;;COGHILL JAMES;;LEVY DANIEL EMIL,,https://lens.org/157-852-994-244-013,Patent Application,no,0,0,14,14,0,A61K31/48;;A61K9/0056;;A61K9/2063;;A61K9/2018;;A61K9/205;;A61K31/48;;A61K9/20;;A61K47/60;;A61K47/22;;A61K47/36;;A61K47/6923;;A61K47/26;;A61K47/10;;A61K9/0056;;A61K9/2013;;A61K9/2054;;A61K9/2095;;A61K9/2018;;A61K9/205,A61K31/48;;A61K9/00;;A61P25/28,,0,0,,,,PENDING
359,WO,A2,WO 2002/052601 A2,153-442-193-644-159,2002-07-04,2002,US 0149100 W,2001-12-18,US 74723100 A,2000-12-22,METHOD AND APPARATUS FOR APPLYING CROSSWIRES TO A TENSION FOCUS MASK,"A method and apparatus for applying crosswires (46) to a tension mask (30). The method includes winding crosswires around various drum assemblies (301, 404, 504) and then using transfer devices (307, 406, 550) to remove sections of crosswires (46) and transfer them to tension masks (30).",THOMSON LICENSING SA;;DOTY JAMES EDWARD;;GARRITY EDWARD RICHARD JR;;THOMSON MARK ALLEN;;WILBUR LEONARD PRATT JR,DOTY JAMES EDWARD;;GARRITY EDWARD RICHARD JR;;THOMSON MARK ALLEN;;WILBUR LEONARD PRATT JR,,https://lens.org/153-442-193-644-159,Patent Application,yes,0,0,9,9,0,H01J9/14;;H01J9/16;;H01J9/24;;H01J9/14;;H01J9/16,H01J9/14;;H01J9/16,,0,0,,,,PENDING
360,US,B2,US 11127505 B2,185-845-352-324-492,2021-09-21,2021,US 201715639328 A,2017-06-30,US 201715639328 A;;US 201615064071 A,2016-03-08,Evidence analysis and presentation to indicate reasons for membership in populations,"A method, a machine-readable storage medium and at least one processing device are provided for analyzing and tracking results of multiple conditions associated with a population criteria, which is evaluated for each entity of at least one entity. The at least one processing device performs analytics associated with the population criteria, which is evaluated for each entity. Results of the analyzing of the multiple conditions are selectively tracked by the at least one processing device. The at least one processing device presents the tracked results to indicate a status of the at least one entity with respect to the tracked analytics.",IBM,BAIERA JAMES C;;DOTY JILL R;;KIM DANIEL;;KWASNY DAVID A;;MEIL DOUGLAS S,MERATIVE US L.P (2022-06-30);;INTERNATIONAL BUSINESS MACHINES CORPORATION (2016-03-08),https://lens.org/185-845-352-324-492,Granted Patent,yes,13,0,2,4,0,G16H50/70;;G16H10/60;;G16H50/70;;G16H10/60,G16H50/70;;G16H10/60,,7,4,005-793-710-661-474;;163-841-508-119-481;;040-713-977-573-090;;016-968-191-779-454,10.1016/j.jbi.2015.01.012;;25661261;;10901357;;10.1097/00005650-200007000-00006;;24190931;;10.1136/amiajnl-2013-001939;;pmc3861933;;10529027;;10.1016/s0895-4356(99)00071-2,"Tran, Truyen, et al. “Learning vector representation of medical objects via EMR-driven nonnegative restricted Boltzmann machines (eNRBM).” Journal of biomedical informatics 54 (2015): 96-105. (Year: 2015).;;“The Explorys Platform”, IBM Watson Health, Solution Brief, Produced in the United States of America, Nov. 2015, 4 pages.;;Coste et al.; Ttl: A population-based analytical approach to assessing patterns, determinants, and outcomes of health care with application to ectopic pregnancy; Publication Ttl: Medical Care, vol. 38, No. 7, pp. 739-749; 2000; Publisher: Lippincott Williams Country of Publication: USA; ISSN:0025-7079; Database: SciSearch.;;Raths; Ttl: Healthcare analytics: Moving from Setup to Use Cases. Pioneer patient care organizations are moving rapidly to leverage analytics for population health and accountable care; Publication Ttl: Healthcare Informatics, vol. 32, No. 4, pp. 58(3); Jul. 2015; Publisher: Vendome Group LLC; Country of Publication: USA; ISSN:1050-9135; Database: Gale Group, 4 pages.;;List of IBM Patents or Patent Applications Treated as Related, Jul. 2017, 1 page.;;Jyotishman Pathak, et al., “Normalization and standardization of electronic health records for high-throughput phenotyping: the SHARPn consortium”, Journal of the American Medical Informatics Association : JAMIA vol. 20,e2 (2013): e341-8. doi:10.1136/amiajnl-2013-001939, (Year 2013), https://academic.oup.com/jamia/article/20/e2/e341/2909250, 8 pages.;;Nyrwich, Kathleen W., William M. Tierney, and Fredric D. Wolinsky. “Futher evidence supporting an SEM-based citerion for identifying meaningful intra-individual changes in health-related quality of life.” Journal of clinical epidemiology 52.9 (1999): 861-873. (Year: 1999).",ACTIVE
361,EP,A1,EP 2277675 A1,191-397-234-140-511,2011-01-26,2011,EP 10182066 A,2004-08-17,EP 04779443 A;;US 49601103 P,2003-08-19,Impact-modified polyamide hollow body,"Method for making a hollow body comprising, as sole layer(s), 
(1) at least one layer L1 comprising an aromatic polyamide and an impact modifier, and, optionally, 
(2) at least one layer L2 comprising an aliphatic polyamide, 
comprising extruding an aromatic polyamide and an impact modifier, and optionally extruding an aliphatic polyamide, through a die.
",SOLVAY ADVANCED POLYMERS LLC,BERSTED BRUCE H;;DOTY JAMES;;DE CANNIERE JEAN;;WARKOSKI GREGORY;;BUSHELMAN CORINNE;;BILLIET JOHAN,"SOLVAY SPECIALTY POLYMERS USA, LLC. (2011-11-30)",https://lens.org/191-397-234-140-511,Patent Application,yes,19,0,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,C08L77/06;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90;;B32B1/08;;B32B27/34;;F16L11/04,,0,0,,,,INACTIVE
362,DE,D1,DE 60234618 D1,190-889-689-311-254,2010-01-14,2010,DE 60234618 T,2002-10-18,US 34754801 P;;US 27026702 A;;US 0233270 W,2001-10-19,STABILE ZUSAMMENSETZUNG ENHALTEND PARTIKEL IN EINER GEFRORENEN WÄSSRIGEN MATRIX,"The present invention discloses a composition of a stable suspension of a poorly water soluble pharmaceutical agent or cosmetic in the form of particles of the pharmaceutical agent or cosmetic suspended in a frozen aqueous matrix and method for its preparation. The composition is stable for a prolonged period of time, preferably six months or longer and is suitable for parenteral, oral, or non-oral routes such as pulmonary (inhalation), ophthalmic, or topical administration.",BAXTER INT,KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN;;KONKEL JAMIE TERESA,,https://lens.org/190-889-689-311-254,Granted Patent,no,0,0,16,17,0,A61K8/02;;A61K8/044;;A61K9/10;;A61K9/145;;A61K9/146;;A61K31/12;;A61K31/4985;;A61K31/58;;A61K2800/92;;A61Q19/00;;A61K8/044;;A61Q19/00;;A61K31/58;;A61K9/10;;A61K8/02;;A61K9/145;;A61K31/4985;;A61K2800/92;;A61K9/146;;A61K31/12,A61K9/10;;A61K8/02;;A61K8/04;;A61K8/06;;A61K8/34;;A61K8/35;;A61K8/36;;A61K8/365;;A61K8/37;;A61K8/39;;A61K8/40;;A61K8/41;;A61K8/44;;A61K8/46;;A61K8/60;;A61K8/64;;A61K8/73;;A61K8/86;;A61K8/89;;A61K8/891;;A61K9/107;;A61K9/14;;A61K31/12;;A61K31/4985;;A61K31/58;;A61K47/02;;A61K47/06;;A61K47/10;;A61K47/12;;A61K47/14;;A61K47/16;;A61K47/18;;A61K47/20;;A61K47/26;;A61K47/32;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61K47/44;;A61K47/46;;A61Q19/00,,0,0,,,,EXPIRED
363,AT,T1,AT E454004 T1,183-372-961-913-196,2010-01-15,2010,AT 05110465 T,2005-11-08,US 452804 A,2004-12-03,NACHRICHTENAUSTAUSCH ÜBER VERHANDLUNGEN VON PROTOKOLLERWEITERUNG,,MICROSOFT CORP,LANGWORTHY DAVID E;;JOHNSON JAMES E;;DOTY JOHN D;;FEINGOLD MAX A;;CLARK MICHAEL R,,https://lens.org/183-372-961-913-196,Granted Patent,no,0,0,13,13,0,H04L67/02;;H04L69/24;;H04L69/329;;H04W28/16;;H04W80/00;;G06F15/16;;H04L69/24;;H04L69/329;;H04L67/02,,,0,0,,,,INACTIVE
364,WO,A1,WO 2005/018891 A1,058-753-731-748-209,2005-03-03,2005,US 2004/0024383 W,2004-08-17,US 49601103 P,2003-08-19,IMPACT-MODIFIED POLYAMIDE HOLLOW BODY,Hollow bodies made from impact-modified polyamide. Fuel line hoses for both liquid fuel delivery and fuel vapor recovery.,BERSTED BRUCE;;DOTY JAMES;;DE CANNIERE JEAN;;DEHENNAU CLAUDE;;WARKOWSKI GREGORY;;BUSHELMAN CORINNE;;BILLIET JOHAN,BERSTED BRUCE;;DOTY JAMES;;DE CANNIERE JEAN;;DEHENNAU CLAUDE;;WARKOWSKI GREGORY;;BUSHELMAN CORINNE;;BILLIET JOHAN,,https://lens.org/058-753-731-748-209,Patent Application,yes,6,34,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90;;B32B27/34,,0,0,,,,PENDING
365,HK,A1,HK 1079704 A1,075-726-567-646-309,2006-04-13,2006,HK 05112084 A,2005-12-29,US 27026802 A;;US 0331411 W,2002-10-11,SOLID PARTICULATE ANTIFUNGAL COMPOSITIONS FOR PHARMACEUTICAL USE,,BAXTER INT,WONG JOSEPH CHUNG TAK;;KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;PAPADOPOULOS PAVLOS,,https://lens.org/075-726-567-646-309,Patent Application,no,0,0,14,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K9/5015;;A61K9/5031;;A61K9/5036;;A61K9/5042;;A61K31/495;;A61K31/496;;A61P31/10;;A61K9/10;;A61K9/10;;A61K9/145;;A61K9/5036;;A61K9/5031;;A61K9/14;;A61K31/496;;A61K31/495;;A61K9/5015;;A61K9/1688;;A61K9/146;;A61K9/5042,A61K/;;A61K9/10;;A61K9/14;;A61K9/16;;A61K9/50;;A61K31/495;;A61K31/496,,0,0,,,,PENDING
366,US,A1,US 2003/0003155 A1,097-454-068-181-377,2003-01-02,2003,US 95397901 A,2001-09-17,US 95397901 A;;US 87463701 A;;US 25816000 P,2000-12-22,Microprecipitation method for preparing submicron suspensions,"
   The present invention provides a method for preparing submicron sized particles of an organic compound, the solubility of which is greater in a water-miscible first solvent than in a second solvent which is aqueous, the process including the steps of: (i) dissolving the organic compound in the water-miscible first solvent to form a solution, (ii) mixing the solution with the second solvent to define a pre-suspension; and (iii) adding energy to the pre-suspension to form particles having an average effective particle size of less than about 2 m. 
",KIPP JAMES E.;;WONG JOSEPH CHUNG TAK;;DOTY MARK J.;;REBBECK CHRISTINE L.;;BRYNJELSEN SEAN,KIPP JAMES E;;WONG JOSEPH CHUNG TAK;;DOTY MARK J;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN,BAXTER INTERNATIONAL INC (2002-03-22),https://lens.org/097-454-068-181-377,Patent Application,yes,99,36,2,86,0,A61K31/495;;A61K31/495;;A61K9/10;;A61K9/10;;A61K9/14;;A61K9/14;;A61K9/145;;A61K9/145;;A61K9/146;;A61K9/146;;A61K9/1688;;A61K9/1688;;A61K31/496;;A61K31/496,A61K9/10;;A61K9/14;;A61K9/16;;A61K31/495;;A61K31/496,424/489;;264/5,0,0,,,,EXPIRED
367,CA,A1,CA 2498488 A1,194-217-755-374-151,2004-04-22,2004,CA 2498488 A,2003-10-02,US 27026802 A;;US 0331411 W,2002-10-11,SOLID PARTICULATE ANTIFUNGAL COMPOSITIONS FOR PHARMACEUTICALUSE,The present invention relates to compositions of submicron- to micron-size particles of antifungal agents. More particularly the invention relates to aqueous suspensions of antifungal agents for pharmaceutical use.,BAXTER INT,PAPADOPOULOS PAVLOS;;REBBECK CHRISTINE L;;DOTY MARK J;;KIPP JAMES E;;WONG JOSEPH CHUNG TAK,,https://lens.org/194-217-755-374-151,Patent Application,no,0,0,14,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K9/5015;;A61K9/5031;;A61K9/5036;;A61K9/5042;;A61K31/495;;A61K31/496;;A61P31/10;;A61K9/10;;A61K9/10;;A61K9/145;;A61K9/5036;;A61K9/5031;;A61K9/14;;A61K31/496;;A61K31/495;;A61K9/5015;;A61K9/1688;;A61K9/146;;A61K9/5042,A61K9/10;;A61K9/14;;A61K9/16;;A61K9/50;;A61K31/495;;A61K31/496,,0,0,,,,DISCONTINUED
368,WO,A2,WO 2010/105226 A2,027-806-008-302-779,2010-09-16,2010,US 2010/0027234 W,2010-03-12,US 16007709 P,2009-03-13,"ENDOPHYTIC YEAST STRAINS, METHODS FOR ETHANOL AND XYLITOL PRODUCTION, METHODS FOR BIOLOGICAL NITROGEN FIXATION, AND A GENETIC SOURCE FOR IMPROVEMENT OF INDUSTRIAL STRAINS",The present invention provides novel endophytic yeast strains capable of metabolizing both pentose and hexose sugars. Methods of producing ethanol and xylitol using the novel endophytic yeast are provided herein. Also provided are methods of fixing nitrogen and fertilizing a crop using the novel endophytic yeast strains provided herein.,UNIV WASHINGTON;;DOTY SHARON L;;STALEY JAMES;;SU MICHAEL;;VAJZOVIC AZRA;;BURA RENATA;;REDMAN REGINA;;KHAN ZAREEN,DOTY SHARON L;;STALEY JAMES;;SU MICHAEL;;VAJZOVIC AZRA;;BURA RENATA;;REDMAN REGINA;;KHAN ZAREEN,,https://lens.org/027-806-008-302-779,Patent Application,yes,0,2,6,6,0,C05F11/08;;C05F11/08;;C12N1/145;;C12N1/145;;C12N9/0006;;C12N9/0006;;C12N15/815;;C12P7/06;;C12P7/06;;C12P7/10;;C12P7/10;;C12P7/18;;C12P7/18;;C12R2001/645;;C12R2001/645;;Y02E50/10;;Y02E50/10;;Y02P20/52,C12P7/06;;A01H1/06;;A23K1/00;;C12N1/19;;C12N15/53;;C12N15/63;;C12P7/04;;C12P7/10,,0,0,,,,PENDING
369,KR,A,KR 20060073605 A,129-070-405-788-521,2006-06-28,2006,KR 20067003325 A,2004-08-17,US 2004/0024383 W;;US 49601103 P,2003-08-19,IMPACT-MODIFIED POLYAMIDE HOLLOW BODY,Hollow bodies made from impact-modified polyamide. Fuel line hoses for both liquid fuel delivery and fuel vapor recovery.,SOLVAY ADVANCED POLYMERS LLC,BERSTED BRUCE;;DOTY JAMES;;DE CANNIERE JEAN;;DEHENNAU CLAUDE;;WARKOWSKI GREGORY;;BUSHELMAN CORINNE;;BILLIET JOHAN,,https://lens.org/129-070-405-788-521,Patent Application,no,0,1,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,B32B27/34;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90;;B32B27/18,,0,0,,,,ACTIVE
370,JP,A,JP 2013060014 A,103-606-923-603-450,2013-04-04,2013,JP 2012235545 A,2012-10-25,US 49601103 P,2003-08-19,IMPACT-MODIFIED POLYAMIDE HOLLOW BODY,"PROBLEM TO BE SOLVED: To provide a hollow body made from impact-modified polyamide, such as a fuel line hose for both liquid fuel delivery and fuel vapor recovery.SOLUTION: The hollow body includes: (1) at least one layer L1 comprising an aromatic polyamide and an impact modifier; and (2) at least one layer L2 comprising an aliphatic polyamide. The impact modifier is included 5 to 40 mass% based on the total mass of the layer L1, in the layer L1.",SOLVAY ADVANCED POLYMERS LLC,BERSTED BRUCE;;DOTY JAMES;;DE CANNIERE JEAN;;DEHENNAU CLAUDE;;WARKOSKI GREGORY;;BUSHELMAN CORINNE;;BILLIET JOHAN,,https://lens.org/103-606-923-603-450,Patent Application,no,21,1,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,B32B1/02;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90;;B32B1/08;;B32B27/18;;B32B27/34;;B65D35/02;;F16L11/08,,0,0,,,,ACTIVE
371,EP,A1,EP 1565166 A1,101-279-529-155-508,2005-08-24,2005,EP 03773118 A,2003-10-02,US 0331411 W;;US 27026802 A,2002-10-11,SOLID PARTICULATE ANTIFUNGAL COMPOSITIONS FOR PHARMACEUTICAL USE,,BAXTER INT,WONG JOSEPH CHUNG TAK;;KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;PAPADOPOULOS PAVLOS,,https://lens.org/101-279-529-155-508,Patent Application,yes,0,0,14,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K9/5015;;A61K9/5031;;A61K9/5036;;A61K9/5042;;A61K31/495;;A61K31/496;;A61P31/10;;A61K9/10;;A61K9/10;;A61K9/145;;A61K9/5036;;A61K9/5031;;A61K9/14;;A61K31/496;;A61K31/495;;A61K9/5015;;A61K9/1688;;A61K9/146;;A61K9/5042,A61K9/10;;A61K9/14;;A61K9/16;;A61K9/50;;A61K31/495;;A61K31/496,,0,0,,,,DISCONTINUED
372,EP,A1,EP 1658163 A1,125-150-507-593-607,2006-05-24,2006,EP 04779443 A,2004-08-17,US 2004/0024383 W;;US 49601103 P,2003-08-19,IMPACT-MODIFIED POLYAMIDE HOLLOW BODY,"Method for making a hollow body comprising, as sole layer(s), (1) at least one layer L1 comprising an aromatic polyamide and an impact modifier, and, optionally, (2) at least one layer L2 comprising an aliphatic polyamide, comprising extruding an aromatic polyamide and an impact modifier, and optionally extruding an aliphatic polyamide, through a die.",SOLVAY ADVANCED POLYMERS LLC,BERSTED BRUCE;;DOTY JAMES;;DE CANNIERE JEAN;;DEHENNAU CLAUDE;;WARKOWSKI GREGORY;;BUSHELMAN CORINNE;;BILLIET JOHAN,"SOLVAY SPECIALTY POLYMERS USA, LLC. (2011-11-30)",https://lens.org/125-150-507-593-607,Patent Application,yes,19,0,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,B28B1/00;;B28B3/00;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90;;B29D22/00;;B29D23/00;;B32B1/08;;B32B27/34;;C08L77/06,,0,0,,,,ACTIVE
373,CA,C,CA 2535344 C,151-822-375-934-773,2015-10-06,2015,CA 2535344 A,2004-08-17,US 49601103 P;;US 2004/0024383 W,2003-08-19,IMPACT-MODIFIED POLYAMIDE HOLLOW BODY,"A hollow body selected from liquid storage and handling containers, tubing, pipes, and hoses constituted by any number of contiguous layers of the order [(L1)n/(L2)mb where x is an integer of 1 or greater, n is an integer of 1 or greater, and m is 1 or 2, wherein: layer L1 comprises an aromatic polyamide and a functionalized impact modifier, and layer L2 comprises an aliphatic polyamide, wherein said aromatic polyamide is selected from the group consisting of: aromatic polyamides comprising more than 50 mole % of recurring units formed by the polycondensation reaction between at least one aliphatic diacid and metaxylylenediamine, and aromatic polyamides comprising more than 50 mole % of recurring units formed by the polycondensation reaction between at least one of terephthalic acid, isophthalic acid, and phthalic acid and hexamethylenediamine, and wherein said functionalized impact modifier is in an amount of from 5 weight % to 40 weight %, based on total weight of the composition L1. A method for preparing the same. A fossil fuel device comprising a hose defined by said hollow body.",SOLVAY ADVANCED POLYMERS LLC,BERSTED BRUCE;;DOTY JAMES;;DE CANNIERE JEAN;;DEHENNAU CLAUDE;;WARKOSKI GREGORY;;BUSHELMAN CORINNE;;BILLIET JOHAN,,https://lens.org/151-822-375-934-773,Granted Patent,no,0,0,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,B32B27/34;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90;;B29D23/00;;B32B1/08;;B60K15/01;;F16L9/12;;F16L11/04,,0,0,,,,ACTIVE
374,US,B2,US 7193084 B2,119-730-913-918-589,2007-03-20,2007,US 21335202 A,2002-08-05,US 21335202 A;;US 3582101 A;;US 95397901 A;;US 87463701 A;;US 25816000 P,2000-12-22,Polymorphic form of itraconazole,The present invention provides a polymorphic form of itraconazole.,BAXTER INT,WERLING JANE;;DOTY MARK J;;REBBECK CHRISTINE L;;WONG JOSEPH CHUNG TAK;;KIPP JAMES E,BAXTER INTERNATIONAL INC (2003-01-09),https://lens.org/119-730-913-918-589,Granted Patent,yes,100,4,2,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K31/495;;A61K31/496;;A61K9/10;;A61K31/495;;A61K9/145;;A61K9/14;;A61K9/146;;A61K9/1688;;A61K31/496,C07D403/00;;A61K9/10;;A61K9/14;;A61K9/16;;A61K31/495;;A61K31/496;;A61K31/497,544/366;;544/358;;514/254.07;;514/254.05,16,7,001-155-857-960-135;;018-188-239-454-962;;005-840-366-684-763;;004-382-489-377-69X;;012-864-980-464-648;;017-541-414-387-84X;;064-523-632-943-432,10.1002/jps.2600670418;;641759;;7302990;;10.1016/0378-4274(81)90035-7;;10.1016/0378-5173(92)90051-3;;8331530;;10.1002/jps.2600820608;;10.1007/s004170050094;;9602323;;10.1016/s1081-1206(10)62949-3;;9494448;;11879753;;10.1016/s0378-5173(01)00986-3,"The Merck Index (Abstract of The Merck Index, 12th edition 1996, pp. 894-895) (Abstract Sent).;;US 5,849,884, 12/1998, Woiszwillo et al. (withdrawn);;PCT/US2004/036604 International Search Report, dated Mar. 22, 2005.;;B. Sjostrom et al., ""The Formation of Submicron Organic Particles by Precipitation in an Emulsion"", J.Dispersion Science and Technology, 15(1), 89-117 (1994).;;Avanti Polar Lipids, Inc.., website printout, www.avantilipids.com, ""Synthetic Products-Functionalized Phospholipids: Lipids for Conjugation of Proteins/Peptides/Drugs to Liposomes"" (7 pgs), Mar. 2003.;;Avanti Polar Lipids, Inc.., website printout, www.avantilipids.com, ""Polymer and Polymerizable Lipids: Functionalized PEG Lipids"" (3 pgs), Mar. 2003.;;Avanti Polar Lipids, Inc.., website printout, www.avantilipids.com, ""Polymer and Polymerizable Lipids: Poly(ethylene glycol)-Lipid Conjugates"" (8 pgs) , Mar. 2003.;;Davis et al., ""Pulmonary Perfusion Imaging: Acute Toxicity and Safety Factors as a Function of Particle Size"", J.Nucl Med., vol. 19 (1978), pp. 1209-1213.;;Schroeder et al., ""Physiological Effects of Subvisible Microspheres Administered Intravenously to Beagle Dogs"", Journal of Pharmaceutical Sciences, vol. 67, No. 4, Apr. 1978, pp. 508-512.;;Yokel et al., ""Acute Toxicity of Latex Microspheres"", Toxicity Letters, vol. 9 (1981), pp. 165-170.;;Allen et al., ""Critical Evaluation of Acute Cardiopulminary Toxicity of Microspheres"", J.Nucl Med., vol. 19 (1987), pp. 1204-1208.;;B. Sjostrom et al., ""Preparation Of Submicron Drug Particles In Lecithin-Stabilized O/W Emulsions I. Model Studies Of The Precipitation Of Cholesteryl Acetate"", Int. J. Pharm., 88 (1992) pp. 53-62.;;B. Sjostrom et al., ""A Method For The Preparation Of Submicron Particles Of Sparingly Water-Soluble Drugs By Precipitation In Oil-In-Water Emulsions. II: Influence Of The Emulsifier, The Solvent And The Drug Substance"", J. Pharm. Sci., 82(6), (1992) pp. 584-589.;;Duncker and Reichelt, ""Effects of the Pharmaceutical Cosolvent hydroxypropyl-beta-cyclodextrin on Porcine Corneal Endothelium"", Graef's Archive for Clinical and Experimental Ophthalmology (Germany), 236/5 (1998), pp. 380-389.;;Volchek and Dellen, ""Anaphylaxis to Intravenous Cyclosporine and Tolerance to Oral Cyclosporine, Case Report and Review"", Annals of Allergy, Asthma, and Immunology, 80 (1998), pp. 159-163.;;Singla et al., ""Paclitaxel and its Formulations"", International Journal of Pharmaceutics, 235/1-2 (2002), pp. 179-192.",EXPIRED
375,NO,D0,NO 20052285 D0,078-873-191-704-134,2005-05-10,2005,NO 20052285 A,2005-05-10,US 27026802 A;;US 0331411 W,2002-10-11,"Faste, partikkelformige, antifungale preparater for farmasoytisk anvendelse",,BAXTER INT,KIPP JAMES E;;WONG JOSEPH CHUNG TAK;;DOTY MARK J;;REBBECK CHRISTINE L;;PAPADOPOULOS PAVLOS,,https://lens.org/078-873-191-704-134,Patent Application,no,0,0,14,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K9/5015;;A61K9/5031;;A61K9/5036;;A61K9/5042;;A61K31/495;;A61K31/496;;A61P31/10;;A61K9/10;;A61K9/10;;A61K9/145;;A61K9/5036;;A61K9/5031;;A61K9/14;;A61K31/496;;A61K31/495;;A61K9/5015;;A61K9/1688;;A61K9/146;;A61K9/5042,A61K9/10;;A61K9/14;;A61K9/16;;A61K9/50;;A61K31/495;;A61K31/496,,0,0,,,,DISCONTINUED
376,US,B2,US 8728781 B2,114-683-394-115-176,2014-05-20,2014,US 201013256426 A,2010-03-12,US 201013256426 A;;US 16007709 P;;US 2010/0027234 W,2009-03-13,"Endophytic yeast strains, methods for ethanol and xylitol production, methods for biological nitrogen fixation, and a genetic source for improvement of industrial strains",The present invention provides novel endophytic yeast strains capable of metabolizing both pentose and hexose sugars. Methods of producing ethanol and xylitol using the novel endophytic yeast are provided herein. Also provided are methods of fixing nitrogen and fertilizing a crop using the novel endophytic yeast strains provided herein.,DOTY SHARON L;;STALEY JAMES;;SU MICHAEL;;VAJZOVIC AZRA;;BURA RENATA;;REDMAN REGINA;;KHAN ZAREEN;;UNIV WASHINGTON THROUGH ITS CT OF COMMERCIALIZATION,DOTY SHARON L;;STALEY JAMES;;SU MICHAEL;;VAJZOVIC AZRA;;BURA RENATA;;REDMAN REGINA;;KHAN ZAREEN,UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (2011-09-28),https://lens.org/114-683-394-115-176,Granted Patent,yes,1,2,6,6,48,C05F11/08;;C05F11/08;;C12N1/145;;C12N1/145;;C12N9/0006;;C12N9/0006;;C12N15/815;;C12P7/06;;C12P7/06;;C12P7/10;;C12P7/10;;C12P7/18;;C12P7/18;;C12R2001/645;;C12R2001/645;;Y02E50/10;;Y02E50/10;;Y02P20/52,C12N1/19,435/158;;435/254.2,9,9,041-041-133-525-264;;000-938-322-005-89X;;061-859-656-899-093;;002-237-474-008-345;;072-370-062-059-009;;035-778-345-312-446;;023-772-213-149-55X;;045-299-254-038-415;;041-041-133-525-264,3921014;;10.1042/bj2260669;;pmc1144764;;10.1002/1097-0134(20001001)41:1<98::aid-prot120>3.3.co;2-j;;10.1002/1097-0134(20001001)41:1<98::aid-prot120>3.0.co;2-s;;10944397;;15029827;;10.1017/s0033583503003901;;11796105;;10.1016/s0969-2126(01)00703-1;;15994074;;10.1016/j.copbio.2005.06.004;;18057449;;10.1007/s12010-007-8003-4;;10.1016/j.procbio.2005.01.011;;4397824;;10.1016/s0021-9258(18)62107-6;;3921014;;10.1042/bj2260669;;pmc1144764,"Verduyn et al., Properties of the NAD(P)H-dependent xylose reductase from the xylose-fermenting yeast Pichia stipis. Biochem. J. 1985, 226: 669-677.;;Devos et al., Proteins: Structure, Function and Genetics, 2000, vol. 41: 98-107.;;Whisstock et al., Quarterly Reviews of Biophysics 2003, vol. 36 (3): 307-340.;;Kisselev L., Structure, 2002, vol. 10: 8-9.;;Chica et al., Semi-rational approaches to engineering enzyme activity: combining the benefits of directed evolution and rational design. Current Opin. Biotechnol. 16 (4):378-84, 2005.;;Sen et al., Developments in Directed Evolution for Improving Enzyme Functions. Appl Biochem Biotechnol. 143 (3):212-23, 2007.;;Aksu, Z., et al., Carotenoids prodiction by the yeast Rhondotorula mucilaginosa: Use of agricultural wastes as a carbon source, Process Biochemistry, (2005), vol. 40, pp. 2985-2991.;;Sheys, G. H., et al., Aldose Reductase from Rhondotorula, J. Biol. Chem., (1971), vol. 246, pp. 3824-3827.;;Verduyn, C., et al., Properties of the NAD(P)H-dependent xylose reductase from the xylose-fermenting yeast Pichia stipitis, Biochem. J., (1985), vol. 226, pp. 669-677.",ACTIVE
377,US,B2,US 6951656 B2,170-497-613-559-626,2005-10-04,2005,US 95397901 A,2001-09-17,US 95397901 A;;US 87463701 A;;US 25816000 P,2000-12-22,Microprecipitation method for preparing submicron suspensions,"The present invention provides a method for preparing submicron sized particles of an organic compound, the solubility of which is greater in a water-miscible first solvent than in a second solvent which is aqueous, the process including the steps of: (i) dissolving the organic compound in the water-miscible first solvent to form a solution, (ii) mixing the solution with the second solvent to define a pre-suspension; and (iii) adding energy to the pre-suspension to form particles having an average effective particle size of less than about 2 μm.",BAXTER INT,KIPP JAMES E;;WONG JOSEPH CHUNG TAK;;DOTY MARK J;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN,BAXTER INTERNATIONAL INC (2002-03-22),https://lens.org/170-497-613-559-626,Granted Patent,yes,101,5,2,86,0,A61K31/495;;A61K31/495;;A61K9/10;;A61K9/10;;A61K9/14;;A61K9/14;;A61K9/145;;A61K9/145;;A61K9/146;;A61K9/146;;A61K9/1688;;A61K9/1688;;A61K31/496;;A61K31/496,A61K9/10;;A61K9/14;;A61K9/16;;A61K31/495;;A61K31/496,424/489;;424/400;;424/450;;264/4;;264/4.1;;264/5,17,7,005-840-366-684-763;;004-382-489-377-69X;;001-155-857-960-135;;018-188-239-454-962;;012-864-980-464-648;;017-541-414-387-84X;;064-523-632-943-432,10.1016/0378-5173(92)90051-3;;8331530;;10.1002/jps.2600820608;;10.1002/jps.2600670418;;641759;;7302990;;10.1016/0378-4274(81)90035-7;;10.1007/s004170050094;;9602323;;10.1016/s1081-1206(10)62949-3;;9494448;;11879753;;10.1016/s0378-5173(01)00986-3,"B. Sjostrom et al., Preparation Of Submicron Drug Particles In Lecithin-Stabilized O/W Emulsions I Model Studies Of The Precipitation Of Cholesteryl Acetate, Int. J. Pharm., 88 (1992) pp 53-62.;;B. Sjostrom et al., A Method For The Preparation Of Submicron Particles Of Sparingly Water-Soluble Drugs By Precipitation In Oil-In-Water Emulsions. II: Influence Of The Emulsifier, The Solvent And The Drug Substance, J. Pharm. Sci., 82(6), (1992) pp 584-589.;;Davis et al., ""Pulmonary Perfusion Imaging: Acute Toxicity and Safety Factors as a Function of Particle Size"", J.Nucl Med., vol. 19 (1978), pp. 1209-1213.;;Schroeder et al., ""Physiological Effects of Subvisible Microspheres Administered Intravenously to Beagle Dogs"", Journal of Pharmaceutical Sciences, vol. 67, No. 4, Apr. 1978, pp. 508-512.;;Yokel et al., ""Acute Toxicity of Latex Microspheres"", Toxicity Letters, vol. 9 (1981), pp. 165-170.;;Allen et al., ""Critical Evaluation of Acute Cardiopulminary Toxicity of Microspheres"", J.Nucl Med., vol. 19 (1987), pp.1204-1208.;;B. Sjostrom et al., ""Preparation Of Submicron Drug Particles In Lecithin-Stabilized O/W Emulsions I. Model Studies Of The Precipitation Of Cholesteryl Acetate"", Int. J. Pharm., 88 (1992) pp 53-62.;;B. Sjostrom et al., ""A Method For The Preparation Of Submicron Particles Of Sparingly Water-Soluble Drugs By Precipitation In Oil-In-Water Emulsions. II: Influence Of The Emulsifier, The Solvent And The Drug Substance"", J. Pharm. Sci., 82(6), (1992) pp 584-589.;;Duncker and Reichelt, ""Effects of the Pharmaceutical Cosolvent hydroxypropyl-beta-cyclodextrin on Porcine Corneal Endothelium"", Graefe's Archive for Clinical and Experimental Ophthalmology (Germany), 236/5 (1998), pp. 380-389.;;Volchek and Dellen, ""Anaphylaxis to Intravenous Cyclosporine and Tolerance to Oral Cyclosporine, Case Report and Review"", Annals of Allergy, Asthma, and Immunology, 80 (1998), pp. 159-163.;;Singla et al., ""Paclitaxel and its Formulations"", International Journal of Pharmaceutics, 235/1-2 (2002), pp. 179-192.;;B. Sjostrom et al., ""The Formation of Submicron Organic Particles by Precipitation in an Emulsion"", J.Dispersion Science and Technology, 15(1), 89-117 (1994).;;Avanti Polar Lipids, Inc.., website printout, www.avantilipids.com, ""Synthetic Products-Functionalized Phospholipids: Lipids for Conjugation of Proteins/Peptides/Drugs to Liposomes"" (7 pgs), Mar. 2003.;;Avanti Polar Lipids, Inc.., website printout, www.avantilipids.com, ""Polymer and Polymerizable Lipids: Functionalized PEG Lipids"" (3 pgs), Mar. 2003.;;Avanti Polar Lipids, Inc.., website printout, www.avantilipids.com, ""Polymer and Polymerizable Lipids: Poly(ethylene glycol)-Lipid Conjugates"" (8 pgs), Mar. 2003.;;PCT/US01/49737 Written Opinion.;;PCT/US01/49737 International Preliminary Examination Report.",EXPIRED
378,CN,B,CN 1832472 B,036-188-855-924-617,2011-04-06,2011,CN 200510118873 A,2005-11-03,US 452804 A,2004-12-03,Message exchange protocol extension negotiation,"A mechanism for negotiating a relatively transport agnostic communication protocol for use in accomplishing a distributed activity. The potential protocols subject to negotiation may be, for example, extensions to Web Services Coordination. In that case, when the initiator creates a transaction, the initiator also negotiates the desired protocol with its transaction manager. The transaction manager and any other participants in the transaction will then follow that negotiated protocol when communicating with the transaction manager. The protocol may be selected to improve performance and may be tailored to existing needs and capabilities.",MICROSOFT CORP,JOHNSON JAMES E;;DOTY JOHN D;;FEINGOLD MAX A;;CLARK MICHAEL R;;LANGWORTHY DAVID E,MICROSOFT TECHNOLOGY LICENSING LLC (2015-04-28),https://lens.org/036-188-855-924-617,Granted Patent,no,0,0,13,13,0,H04L67/02;;H04L69/24;;H04L69/329;;H04W28/16;;H04W80/00;;G06F15/16;;H04L69/24;;H04L69/329;;H04L67/02,H04L29/06;;H04L12/56,,0,0,,,,INACTIVE
379,DE,D1,DE 602005018592 D1,107-903-287-538-374,2010-02-11,2010,DE 602005018592 T,2005-11-08,US 452804 A,2004-12-03,Nachrichtenaustausch über Verhandlungen von Protokollerweiterung,,MICROSOFT CORP,LANGWORTHY DAVID E;;JOHNSON JAMES E;;DOTY JOHN D;;FEINGOLD MAX A;;CLARK MICHAEL R,,https://lens.org/107-903-287-538-374,Granted Patent,no,0,0,13,13,0,H04L67/02;;H04L69/24;;H04L69/329;;H04W28/16;;H04W80/00;;G06F15/16;;H04L69/24;;H04L69/329;;H04L67/02,H04L29/08;;H04L29/06,,0,0,,,,ACTIVE
380,US,A1,US 2012/0107889 A1,009-340-321-898-551,2012-05-03,2012,US 201013256426 A,2010-03-12,US 201013256426 A;;US 16007709 P;;US 2010/0027234 W,2009-03-13,"ENDOPHYTIC YEAST STRAINS, METHODS FOR ETHANOL AND XYLITOL PRODUCTION, METHODS FOR BIOLOGICAL NITROGEN FIXATION, AND A GENETIC SOURCE FOR IMPROVEMENT OF INDUSTRIAL STRAINS",The present invention provides novel endophytic yeast strains capable of metabolizing both pentose and hexose sugars. Methods of producing ethanol and xylitol using the novel endophytic yeast are provided herein. Also provided are methods of fixing nitrogen and fertilizing a crop using the novel endophytic yeast strains provided herein.,DOTY SHARON L;;STALEY JAMES;;SU MICHAEL;;VAJZOVIC AZRA;;BURA RENATA;;REDMAN REGINA;;KHAN ZAREEN,DOTY SHARON L;;STALEY JAMES;;SU MICHAEL;;VAJZOVIC AZRA;;BURA RENATA;;REDMAN REGINA;;KHAN ZAREEN,UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (2011-09-28),https://lens.org/009-340-321-898-551,Patent Application,yes,1,15,6,6,48,C05F11/08;;C05F11/08;;C12N1/145;;C12N1/145;;C12N9/0006;;C12N9/0006;;C12N15/815;;C12P7/06;;C12P7/06;;C12P7/10;;C12P7/10;;C12P7/18;;C12P7/18;;C12R2001/645;;C12R2001/645;;Y02E50/10;;Y02E50/10;;Y02P20/52,C12P7/06;;C12N1/19;;C12N15/53;;C12P7/18,435/158;;435/161;;435/254.2;;435/254.21;;435/254.22;;536/23.2,6,6,041-041-133-525-264;;000-938-322-005-89X;;061-859-656-899-093;;002-237-474-008-345;;072-370-062-059-009;;035-778-345-312-446,3921014;;10.1042/bj2260669;;pmc1144764;;10.1002/1097-0134(20001001)41:1<98::aid-prot120>3.3.co;2-j;;10.1002/1097-0134(20001001)41:1<98::aid-prot120>3.0.co;2-s;;10944397;;15029827;;10.1017/s0033583503003901;;11796105;;10.1016/s0969-2126(01)00703-1;;15994074;;10.1016/j.copbio.2005.06.004;;18057449;;10.1007/s12010-007-8003-4,"Verduyn et al., Properties of the NAD(P)H-dependent xylose reductase from the xylose-fermenting yeast Pichia stipis. Biochem. J. 1985, 226: 669-677.;;Devos et al., Proteins: Structure, Function and Genetics, 2000, Vol. 41: 98-107.;;Whisstock et al., Quarterly Reviews of Biophysics 2003, Vol. 36 (3): 307-340.;;Kisselev L., Structure, 2002, Vol. 10: 8-9.;;Chica et al., Semi-rational approaches to engineering enzyme activity: combining the benefits of directed evolution and rational design. Current Opin. Biotechnol. 16 (4):378-84, 2005.;;Sen et al., Developments in Directed Evolution for Improving Enzyme Functions. Appl Biochem Biotechnol. 143 (3):212-23, 2007.",ACTIVE
381,US,B2,US 7912973 B2,020-954-165-395-729,2011-03-22,2011,US 452804 A,2004-12-03,US 452804 A,2004-12-03,Message exchange protocol extension negotiation,"A mechanism for negotiating a relatively transport agnostic communication protocol for use in accomplishing a distributed activity. The potential protocols subject to negotiation may be, for example, extensions to Web Services Coordination. In that case, when the initiator creates a transaction, the initiator also negotiates the desired protocol with its transaction manager. The transaction manager and any other participants in the transaction will then follow that negotiated protocol when communicating with the transaction manager. The protocol may be selected to improve performance and may be tailored to existing needs and capabilities.",MICROSOFT CORP,FEINGOLD MAX A;;LANGWORTHY DAVID E;;JOHNSON JAMES E;;DOTY JOHN D;;CLARK MICHAEL R,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2005-02-20),https://lens.org/020-954-165-395-729,Granted Patent,yes,26,5,13,13,0,H04L67/02;;H04L69/24;;H04L69/329;;H04W28/16;;H04W80/00;;G06F15/16;;H04L69/24;;H04L69/329;;H04L67/02,G06F15/16,709/230,7,0,,,"Cabrera, Luis Felip, et al. Web Services Coordination (WS-Coordination), BEA Systems, International Business Machines Corporation, Microsoft Corporation, Nov. 2004.;;First Office Action, dated Aug. 21, 2009, issued in Chinese Application No. 200510118873.3, 14 pp.;;Second Office Action, dated Jul. 6, 2010, issued in Chinese Application No. 200510118873.3, 9 pp.;;European Search Report, dated May 12, 2006, issued in European Application No. 05110465.1, 8 pp.;;Office Action, dated Jan. 8, 2007, issued in European Application No. 05110465.1, 1 pp.;;Response to Office Action, dated May 16, 2007, issued in European Application No. 05110465.1, 13 pp.;;Decision to Grant a European Patent, dated Dec. 3, 2009, issued in European Application No. 05110465.1, 2 pp.",ACTIVE
382,US,A1,US 2006/0123128 A1,098-111-245-238-453,2006-06-08,2006,US 452804 A,2004-12-03,US 452804 A,2004-12-03,Message exchange protocol extension negotiation,"A mechanism for negotiating a relatively transport agnostic communication protocol for use in accomplishing a distributed activity. The potential protocols subject to negotiation may be, for example, extensions to Web Services Coordination. In that case, when the initiator creates a transaction, the initiator also negotiates the desired protocol with its transaction manager. The transaction manager and any other participants in the transaction will then follow that negotiated protocol when communicating with the transaction manager. The protocol may be selected to improve performance and may be tailored to existing needs and capabilities.",MICROSOFT CORP,FEINGOLD MAX A;;LANGWORTHY DAVID E;;JOHNSON JAMES E;;DOTY JOHN D;;CLARK MICHAEL R,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2005-02-20),https://lens.org/098-111-245-238-453,Patent Application,yes,25,21,13,13,0,H04L67/02;;H04L69/24;;H04L69/329;;H04W28/16;;H04W80/00;;G06F15/16;;H04L69/24;;H04L69/329;;H04L67/02,G06F15/16,709/230,0,0,,,,ACTIVE
383,CA,A1,CA 2535344 A1,103-997-108-180-544,2005-03-03,2005,CA 2535344 A,2004-08-17,US 49601103 P;;US 2004/0024383 W,2003-08-19,IMPACT-MODIFIED POLYAMIDE HOLLOW BODY,Hollow bodies made from impact-modified polyamide. Fuel line hoses for both liquid fuel delivery and fuel vapor recovery.,SOLVAY ADVANCED POLYMERS LLC,WARKOWSKI GREGORY;;BUSHELMAN CORINNE;;DEHENNAU CLAUDE;;BERSTED BRUCE;;BILLIET JOHAN;;DE CANNIERE JEAN;;DOTY JAMES,,https://lens.org/103-997-108-180-544,Patent Application,no,0,0,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,B28B1/00;;B28B3/00;;B28B5/00;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90;;B29D22/00;;B29D23/00;;B32B1/08;;B32B27/34;;C04B33/32;;C04B33/36;;C04B35/64,,0,0,,,,ACTIVE
384,EP,A4,EP 1658163 A4,113-781-329-098-472,2009-04-01,2009,EP 04779443 A,2004-08-17,US 2004/0024383 W;;US 49601103 P,2003-08-19,IMPACT-MODIFIED POLYAMIDE HOLLOW BODY,"Method for making a hollow body comprising, as sole layer(s), (1) at least one layer L1 comprising an aromatic polyamide and an impact modifier, and, optionally, (2) at least one layer L2 comprising an aliphatic polyamide, comprising extruding an aromatic polyamide and an impact modifier, and optionally extruding an aliphatic polyamide, through a die.",SOLVAY ADVANCED POLYMERS LLC,BERSTED BRUCE;;DOTY JAMES;;DE CANNIERE JEAN;;DEHENNAU CLAUDE;;WARKOWSKI GREGORY;;BUSHELMAN CORINNE;;BILLIET JOHAN,"SOLVAY SPECIALTY POLYMERS USA, LLC. (2011-11-30)",https://lens.org/113-781-329-098-472,Search Report,no,8,0,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,B28B1/00;;B28B3/00;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90;;B29D22/00;;B29D23/00;;B32B1/08;;B32B27/34;;C08L77/06,,0,0,,,,ACTIVE
385,WO,A1,WO 2004/032902 A1,107-019-726-913-643,2004-04-22,2004,US 0331411 W,2003-10-02,US 27026802 A,2002-10-11,SOLID PARTICULATE ANTIFUNGAL COMPOSITIONS FOR PHARMACEUTICAL USE,The present invention relates to compositions of submicron- to micron-size particles of antifungal agents. More particularly the invention relates to aqueous suspensions of antifungal agents for pharmaceutical use.,BAXTER INT,WONG JOSEPH CHUNG TAK;;KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;PAPADOPOULOS PAVLOS,,https://lens.org/107-019-726-913-643,Patent Application,yes,6,9,14,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K9/5015;;A61K9/5031;;A61K9/5036;;A61K9/5042;;A61K31/495;;A61K31/496;;A61P31/10;;A61K9/10;;A61K9/10;;A61K9/145;;A61K9/5036;;A61K9/5031;;A61K9/14;;A61K31/496;;A61K31/495;;A61K9/5015;;A61K9/1688;;A61K9/146;;A61K9/5042,A61K9/10;;A61K9/14;;A61K9/16;;A61K9/50;;A61K31/495;;A61K31/496,,1,0,,,"PATENT ABSTRACTS OF JAPAN vol. 015, no. 092 (C - 0811) 6 March 1991 (1991-03-06)",PENDING
386,NO,L,NO 20052285 L,005-903-762-887-808,2005-05-10,2005,NO 20052285 A,2005-05-10,US 27026802 A;;US 0331411 W,2002-10-11,"Faste, partikkelformige, antifungale preparater for farmasoytisk anvendelse",Preparater av submikrometer- til mikrometer-store partikler av antifungale midler. Det beskrives også vandige suspensjoner av antifungale midler for farmasøytisk anvendelse.,BAXTER INT,KIPP JAMES E;;WONG JOSEPH CHUNG TAK;;DOTY MARK J;;REBBECK CHRISTINE L;;PAPADOPOULOS PAVLOS,,https://lens.org/005-903-762-887-808,Abstract,no,0,0,14,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K9/5015;;A61K9/5031;;A61K9/5036;;A61K9/5042;;A61K31/495;;A61K31/496;;A61P31/10;;A61K9/10;;A61K9/10;;A61K9/145;;A61K9/5036;;A61K9/5031;;A61K9/14;;A61K31/496;;A61K31/495;;A61K9/5015;;A61K9/1688;;A61K9/146;;A61K9/5042,A61K9/10;;A61K9/14;;A61K9/16;;A61K9/50;;A61K31/495;;A61K31/496,,0,0,,,,DISCONTINUED
387,US,B2,US 7807245 B2,033-145-002-372-743,2010-10-05,2010,US 56869204 A,2004-08-17,US 56869204 A;;US 49601103 P;;US 2004/0024383 W,2003-08-19,Impact-modified polyamide hollow body,Hollow bodies made from impact-modified polyamide. Fuel line hoses for both liquid fuel delivery and fuel vapor recovery.,SOLVAY ADVANCED POLYMERS LLC,BERSTED BRUCE;;DOTY JAMES;;DE CANNIERE JEAN;;DEHENNAU CLAUDE;;WARKOWSKI GREGORY;;BUSHELMAN CORINNE;;BILLIET JOHAN,SOLVAY ADVANCED POLYMERS L.L.C (2005-06-22),https://lens.org/033-145-002-372-743,Granted Patent,yes,33,16,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,B29D22/00;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90;;B29D23/00;;B32B1/08;;B32B27/34,428/36.91;;428/36.9;;428/474.4,3,0,,,"U.S. Appl. No. 11/720,128, filed May 24, 20007, Bushelman, et al.;;U.S. Appl. No. 11/720,044, filed May 23, 20007, Bushelman, et al.;;U.S. Appl. No. 10/568,612, filed Feb. 16, 2006, Bushelman, et al.",ACTIVE
388,EP,A2,EP 1667403 A2,166-834-914-089-410,2006-06-07,2006,EP 05110465 A,2005-11-08,US 452804 A,2004-12-03,Message exchange protocol extension negotiation,"A mechanism for negotiating a relatively transport agnostic communication protocol for use in accomplishing a distributed activity. The potential protocols subject to negotiation may be, for example, extensions to Web Services Coordination. In that case, when the initiator creates a transaction, the initiator also negotiates the desired protocol with its transaction manager. The transaction manager and any other participants in the transaction will then follow that negotiated protocol when communicating with the transaction manager. The protocol may be selected to improve performance and may be tailored to existing needs and capabilities.
",MICROSOFT CORP,LANGWORTHY DAVID E;;JOHNSON JAMES E;;DOTY JOHN D;;FEINGOLD MAX A;;CLARK MICHAEL R,"MICROSOFT TECHNOLOGY LICENSING, LLC, US (2015-07-24);;MICROSOFT TECHNOLOGY LICENSING, LLC, REDMOND, US (2015-01-26)",https://lens.org/166-834-914-089-410,Patent Application,yes,0,0,13,13,0,H04L67/02;;H04L69/24;;H04L69/329;;H04W28/16;;H04W80/00;;G06F15/16;;H04L69/24;;H04L69/329;;H04L67/02,H04L29/08;;H04L29/06,,0,0,,,,ACTIVE
389,EP,B1,EP 1667403 B1,020-004-574-379-317,2009-12-30,2009,EP 05110465 A,2005-11-08,US 452804 A,2004-12-03,Message exchange protocol extension negotiation,,MICROSOFT CORP,LANGWORTHY DAVID E;;JOHNSON JAMES E;;DOTY JOHN D;;FEINGOLD MAX A;;CLARK MICHAEL R,"MICROSOFT TECHNOLOGY LICENSING, LLC, US (2015-07-24);;MICROSOFT TECHNOLOGY LICENSING, LLC, REDMOND, US (2015-01-26)",https://lens.org/020-004-574-379-317,Granted Patent,yes,3,0,13,13,0,H04L67/02;;H04L69/24;;H04L69/329;;H04W28/16;;H04W80/00;;G06F15/16;;H04L69/24;;H04L69/329;;H04L67/02,H04L29/08;;H04L29/06,,1,0,,,"MICROSOFT: ""Web Services Coordination (WS-Coordination)""[Online] November 2004 (2004-11), pages 1-20, XP002377983 Retrieved from the Internet: URL:http://specs.xmlsoap.org/ws/2004/10/ws coor/wscoor1104.pdf> [retrieved on 2006-04-21]",ACTIVE
390,AU,A1,AU 2003/279785 A1,036-275-291-420-792,2004-05-04,2004,AU 2003/279785 A,2003-10-02,US 27026802 A;;US 0331411 W,2002-10-11,SOLID PARTICULATE ANTIFUNGAL COMPOSITIONS FOR PHARMACEUTICAL USE,,BAXTER INT,WONG JOSEPH CHUNG TAK;;KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;PAPADOPOULOS PAVLOS,,https://lens.org/036-275-291-420-792,Patent Application,no,0,0,14,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K9/5015;;A61K9/5031;;A61K9/5036;;A61K9/5042;;A61K31/495;;A61K31/496;;A61P31/10;;A61K9/10;;A61K9/10;;A61K9/145;;A61K9/5036;;A61K9/5031;;A61K9/14;;A61K31/496;;A61K31/495;;A61K9/5015;;A61K9/1688;;A61K9/146;;A61K9/5042,A61K9/10;;A61K9/14;;A61K9/16;;A61K9/50;;A61K31/495;;A61K31/496,,0,0,,,,DISCONTINUED
391,EP,B1,EP 1658163 B1,080-467-482-522-160,2020-01-01,2020,EP 04779443 A,2004-08-17,US 2004/0024383 W;;US 49601103 P,2003-08-19,IMPACT-MODIFIED POLYAMIDE HOLLOW BODY,"Method for making a hollow body comprising, as sole layer(s), (1) at least one layer L1 comprising an aromatic polyamide and an impact modifier, and, optionally, (2) at least one layer L2 comprising an aliphatic polyamide, comprising extruding an aromatic polyamide and an impact modifier, and optionally extruding an aliphatic polyamide, through a die.",SOLVAY SPECIALTY POLYMERS USA,BERSTED BRUCE;;DOTY JAMES;;DE CANNIERE JEAN;;DEHENNAU CLAUDE;;WARKOWSKI GREGORY;;BUSHELMAN CORINNE;;BILLIET JOHAN,"SOLVAY SPECIALTY POLYMERS USA, LLC. (2011-11-30)",https://lens.org/080-467-482-522-160,Granted Patent,yes,10,0,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,B32B1/08;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90;;B29K21/00;;B29K77/00;;B29L9/00;;B29L23/00;;B29L31/00;;B29L31/30;;B32B27/08;;B32B27/18;;B32B27/20;;B32B27/30;;B32B27/32;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04,,0,0,,,,ACTIVE
392,BR,A,BR 0315215 A,140-763-139-340-432,2005-08-16,2005,BR 0315215 A,2003-10-02,US 27026802 A;;US 0331411 W,2002-10-11,Composições antifúngicas em partìculas sólidas para uso farmacêutico,"""COMPOSIçõES ANTIFúNGICAS EM PARTìCULAS SóLIDAS PARA USO FARMACêUTICO"". A presente invenção refere-se a composições de partículas com tamanho de submícrons a mícrons de agentes antifúngicos. Mais particularmente, a invenção se refere a suspensões aquosas de agentes antifúngicos para uso farmacêutico.",BAXTER INT,WONG JOSEPH CHUNG TAK;;KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;PAPADOPOULOS PAVLOS,,https://lens.org/140-763-139-340-432,Patent Application,no,0,0,14,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K9/5015;;A61K9/5031;;A61K9/5036;;A61K9/5042;;A61K31/495;;A61K31/496;;A61P31/10;;A61K9/10;;A61K9/10;;A61K9/145;;A61K9/5036;;A61K9/5031;;A61K9/14;;A61K31/496;;A61K31/495;;A61K9/5015;;A61K9/1688;;A61K9/146;;A61K9/5042,A61K9/10;;A61K9/14;;A61K9/16;;A61K9/50;;A61K31/495;;A61K31/496,,0,0,,,,DISCONTINUED
393,JP,A,JP 2006166456 A,129-793-736-790-721,2006-06-22,2006,JP 2005351276 A,2005-12-05,US 452804 A,2004-12-03,MESSAGE EXCHANGE PROTOCOL EXTENSION NEGOTIATION,"<P>PROBLEM TO BE SOLVED: To provide a mechanism for negotiating a relatively transport agnostic communication protocol for use in accomplishing a distributed activity. <P>SOLUTION: The potential protocols subject to negotiation may be, for example, extension to Web Service Coordination. In that case, when an initiator creates a transaction, the initiator also negotiates a desired protocol with its transaction manager. The transaction manager and any other participants in the transaction will then follow that negotiated protocol when communicating with the transaction manager. The protocol may be selected to improve performance and may be tailored to existing needs and capabilities. <P>COPYRIGHT: (C)2006,JPO&NCIPI",MICROSOFT CORP,LANGWORTHY DAVID E;;JOHNSON JAMES E;;DOTY JOHN D;;FEINGOLD MAX A;;CLARK MICHAEL R,,https://lens.org/129-793-736-790-721,Patent Application,no,6,3,13,13,0,H04L67/02;;H04L69/24;;H04L69/329;;H04W28/16;;H04W80/00;;G06F15/16;;H04L69/24;;H04L69/329;;H04L67/02,H04L29/06;;G06F13/00,,0,0,,,,INACTIVE
394,KR,A,KR 20050055754 A,165-283-690-973-842,2005-06-13,2005,KR 20057006050 A,2005-04-08,US 27026802 A,2002-10-11,SOLID PARTICULATE ANTIFUNGAL COMPOSITIONS FOR PHARMACEUTICAL USE,The present invention relates to compositions of submicron- to micron-size particles of antifungal agents. More particularly the invention relates to aqueous suspensions of antifungal agents for pharmaceutical use.,BAXTER INT,WONG JOSEPH CHUNG TAK;;KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;PAPADOPOULOS PAVLOS,,https://lens.org/165-283-690-973-842,Patent Application,no,0,1,14,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K9/5015;;A61K9/5031;;A61K9/5036;;A61K9/5042;;A61K31/495;;A61K31/496;;A61P31/10;;A61K9/10;;A61K9/10;;A61K9/145;;A61K9/5036;;A61K9/5031;;A61K9/14;;A61K31/496;;A61K31/495;;A61K9/5015;;A61K9/1688;;A61K9/146;;A61K9/5042,A61K9/10;;A61K9/14;;A61K9/16;;A61K9/50;;A61K31/495;;A61K31/496,,0,0,,,,DISCONTINUED
395,US,A1,US 2003/0100568 A1,013-432-247-082-927,2003-05-29,2003,US 21335202 A,2002-08-05,US 21335202 A;;US 3582101 A;;US 95397901 A;;US 87463701 A;;US 25816000 P,2000-12-22,Polymorphic form of itraconazole,"
   The present invention provides a polymorphic form of itraconazole. 
",WERLING JANE;;DOTY MARK J.;;REBBECK CHRISTINE L.;;WONG JOSEPH CHUNG TAK;;KIPP JAMES E.,WERLING JANE;;DOTY MARK J;;REBBECK CHRISTINE L;;WONG JOSEPH CHUNG TAK;;KIPP JAMES E,BAXTER INTERNATIONAL INC (2003-01-09),https://lens.org/013-432-247-082-927,Patent Application,yes,99,18,2,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K31/495;;A61K31/496;;A61K9/10;;A61K31/495;;A61K9/145;;A61K9/14;;A61K9/146;;A61K9/1688;;A61K31/496,A61K9/10;;A61K9/14;;A61K9/16;;A61K31/495;;A61K31/496,514/254.07;;544/366,0,0,,,,EXPIRED
396,EP,A3,EP 1667403 A3,067-464-864-542-234,2006-06-14,2006,EP 05110465 A,2005-11-08,US 452804 A,2004-12-03,Message exchange protocol extension negotiation,"A mechanism for negotiating a relatively transport agnostic communication protocol for use in accomplishing a distributed activity. The potential protocols subject to negotiation may be, for example, extensions to Web Services Coordination. In that case, when the initiator creates a transaction, the initiator also negotiates the desired protocol with its transaction manager. The transaction manager and any other participants in the transaction will then follow that negotiated protocol when communicating with the transaction manager. The protocol may be selected to improve performance and may be tailored to existing needs and capabilities.
",MICROSOFT CORP,LANGWORTHY DAVID E;;JOHNSON JAMES E;;DOTY JOHN D;;FEINGOLD MAX A;;CLARK MICHAEL R,"MICROSOFT TECHNOLOGY LICENSING, LLC, US (2015-07-24);;MICROSOFT TECHNOLOGY LICENSING, LLC, REDMOND, US (2015-01-26)",https://lens.org/067-464-864-542-234,Search Report,yes,3,0,13,13,0,H04L67/02;;H04L69/24;;H04L69/329;;H04W28/16;;H04W80/00;;G06F15/16;;H04L69/24;;H04L69/329;;H04L67/02,H04L29/08;;H04L29/06,,1,0,,,"MICROSOFT: ""Web Services Coordination (WS-Coordination)"", November 2004 (2004-11-01), pages 1 - 20, XP002377983, Retrieved from the Internet <URL:http://specs.xmlsoap.org/ws/2004/10/wscoor/wscoor1104.pdf> [retrieved on 20060421]",ACTIVE
397,KR,A,KR 20060063655 A,094-439-769-006-286,2006-06-12,2006,KR 20050104950 A,2005-11-03,US 452804 A,2004-12-03,MESSAGE EXCHANGE PROTOCOL EXTENSION NEGOTIATION,,MICROSOFT CORP,LANGWORTHY DAVID E;;JOHNSON JAMES E;;DOTY JOHN D;;FEINGOLD MAX A;;CLARK MICHAEL R,,https://lens.org/094-439-769-006-286,Patent Application,no,0,0,13,13,0,H04L67/02;;H04L69/24;;H04L69/329;;H04W28/16;;H04W80/00;;G06F15/16;;H04L69/24;;H04L69/329;;H04L67/02,G06F15/16;;H04Q7/38,,0,0,,,,ACTIVE
398,WO,A3,WO 2010/105226 A3,127-960-653-780-731,2011-04-21,2011,US 2010/0027234 W,2010-03-12,US 16007709 P,2009-03-13,"ENDOPHYTIC YEAST STRAINS, METHODS FOR ETHANOL AND XYLITOL PRODUCTION, METHODS FOR BIOLOGICAL NITROGEN FIXATION, AND A GENETIC SOURCE FOR IMPROVEMENT OF INDUSTRIAL STRAINS",The present invention provides novel endophytic yeast strains capable of metabolizing both pentose and hexose sugars. Methods of producing ethanol and xylitol using the novel endophytic yeast are provided herein. Also provided are methods of fixing nitrogen and fertilizing a crop using the novel endophytic yeast strains provided herein.,UNIV WASHINGTON;;DOTY SHARON L;;STALEY JAMES;;SU MICHAEL;;VAJZOVIC AZRA;;BURA RENATA;;REDMAN REGINA;;KHAN ZAREEN,DOTY SHARON L;;STALEY JAMES;;SU MICHAEL;;VAJZOVIC AZRA;;BURA RENATA;;REDMAN REGINA;;KHAN ZAREEN,,https://lens.org/127-960-653-780-731,Search Report,yes,1,0,6,6,0,C05F11/08;;C05F11/08;;C12N1/145;;C12N1/145;;C12N9/0006;;C12N9/0006;;C12N15/815;;C12P7/06;;C12P7/06;;C12P7/10;;C12P7/10;;C12P7/18;;C12P7/18;;C12R2001/645;;C12R2001/645;;Y02E50/10;;Y02E50/10;;Y02P20/52,C12P7/06;;A01H1/06;;A23K1/00;;C12N1/19;;C12N15/53;;C12N15/63;;C12P7/04;;C12P7/10,,3,3,041-041-133-525-264;;023-772-213-149-55X;;045-299-254-038-415,3921014;;10.1042/bj2260669;;pmc1144764;;10.1016/j.procbio.2005.01.011;;4397824;;10.1016/s0021-9258(18)62107-6,"VERDUYN, C. ET AL., BIOCHEM. J., vol. 226, 1985, pages 669 - 677;;AKSU, Z. ET AL., PROCESS BIOCHEMISTRY, vol. 40, 2005, pages 2985 - 2991;;SHEYS, G. H. ET AL., J. BIOL. CHEM., vol. 246, 1971, pages 3824 - 3827",PENDING
399,US,B2,US 7730487 B2,039-222-716-634-359,2010-06-01,2010,US 20420905 A,2005-08-15,US 20420905 A,2005-08-15,Synchronizing transaction ambient state among multiple transaction managers,"The present invention extends to methods, systems, and computer program products for synchronizing ambient state among multiple transaction managers. A coordinating transaction manager establishes transaction ambient state for an application initiated transaction. The coordinating transaction manager sends and a subordinate transaction manager receives a pointer to an ambient state delegate. The subordinate transaction manager sends a request to invoke the ambient state delegate to the coordinating transaction manager in response to receiving an operation. The coordinating transaction manager invokes the ambient state delegate to format the transaction ambient state for the subordinate transaction manager. The coordinating transaction manager sends and the subordinate transaction manager receives the formatted transaction ambient state such that the subordinate transaction manager can appropriately process the operation within the scope of the transaction. The subordinate transaction manager utilizes the formatted transaction ambient state to appropriately process the operation within the scope of the transaction.",MICROSOFT CORP,CARLEY WILLIAM JAMES;;JOHNSON JAMES ERNEST;;DOTY JOHN DAVID;;CARGILLE JONATHAN MORELL;;GUPTA KAPIL;;FEINGOLD MAX A;;CLARK MICHAEL R,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2005-09-20),https://lens.org/039-222-716-634-359,Granted Patent,yes,6,0,2,2,0,G06F9/466;;G06F9/466,G06F9/46,718/101;;719/313;;719/320;;707/8,0,0,,,,INACTIVE
400,AU,A,AU 1996/072522 A,001-912-550-463-754,1997-04-30,1997,AU 1996/072522 A,1996-10-01,US 54438495 A;;US 2113096 P;;US 9615766 W,1995-10-10,Access catheter and method for maintaining separation between a falloposcope and a tubal wall,,BAYER ESSURE INC,KERIN JOHN;;MILO CHARLES;;NIKOLCHEV JULIAN;;DOTY JAMES;;TON DAI;;HILL RICHARD;;SCHRANER MARC;;KRAMER TOM,,https://lens.org/001-912-550-463-754,Patent Application,no,0,0,11,11,0,A61B1/0008;;A61B1/00082;;A61B1/00085;;A61B1/00135;;A61B1/00149;;A61B1/00165;;A61B1/04;;A61B1/07;;A61B1/303;;A61B1/32;;A61B5/6886;;A61B17/221;;A61B2017/2215;;A61B1/01;;A61B2090/0815;;A61B90/50;;A61B1/04;;A61B1/00149;;A61B17/221;;A61B1/303;;A61B1/0008;;A61B1/00135;;A61B5/6886;;A61B1/07;;A61B1/00085;;A61B1/00165;;A61B1/00082;;A61B1/32;;A61B2017/2215;;A61B1/01;;A61B90/50;;A61B2090/0815,A61B1/04;;A61B1/06;;A61B1/303;;A61B1/32;;A61B17/22;;A61B19/00,,0,0,,,,EXPIRED
401,US,B2,US 9487451 B2,050-520-083-816-550,2016-11-08,2016,US 201414209709 A,2014-03-13,US 201414209709 A;;US 201113256426 A;;US 2010/0027234 W;;US 16007709 P,2009-03-13,"Endophytic yeast strains, methods for ethanol and xylitol production, methods for biological nitrogen fixation, and a genetic source for improvement of industrial strains",The present invention provides novel endophytic yeast strains capable of metabolizing both pentose and hexose sugars. Methods of producing ethanol and xylitol using the novel endophytic yeast are provided herein. Also provided are methods of fixing nitrogen and fertilizing a crop using the novel endophytic yeast strains provided herein.,UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION,DOTY SHARON L;;STALEY JAMES TROTTER;;SU MICHAEL;;VAJZOVIC AZRA;;BURA RENATA;;REDMAN REGINA;;KHAN ZAREEN,UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (2014-10-21),https://lens.org/050-520-083-816-550,Granted Patent,yes,2,13,6,6,48,C05F11/08;;C05F11/08;;C12N1/145;;C12N1/145;;C12N9/0006;;C12N9/0006;;C12N15/815;;C12P7/06;;C12P7/06;;C12P7/10;;C12P7/10;;C12P7/18;;C12P7/18;;C12R2001/645;;C12R2001/645;;Y02E50/10;;Y02E50/10;;Y02P20/52,C12P7/18;;C05F11/08;;C12N9/04;;C12N15/81;;C12P7/06;;C12P7/10;;C12R1/645,,8,8,023-772-213-149-55X;;072-370-062-059-009;;000-938-322-005-89X;;002-237-474-008-345;;035-778-345-312-446;;045-299-254-038-415;;041-041-133-525-264;;061-859-656-899-093,10.1016/j.procbio.2005.01.011;;15994074;;10.1016/j.copbio.2005.06.004;;10.1002/1097-0134(20001001)41:1<98::aid-prot120>3.3.co;2-j;;10.1002/1097-0134(20001001)41:1<98::aid-prot120>3.0.co;2-s;;10944397;;11796105;;10.1016/s0969-2126(01)00703-1;;18057449;;10.1007/s12010-007-8003-4;;4397824;;10.1016/s0021-9258(18)62107-6;;3921014;;10.1042/bj2260669;;pmc1144764;;15029827;;10.1017/s0033583503003901,"Aksu, Z., et al., Carotenoids prodiction by the yeast Rhondotorula mucilaginosa: Use of agricultural wastes as a carbon source, Process Biochemistry, (2005), vol. 40, pp. 2985-2991.;;Chica et al., Semi-rational approaches to engineering enzyme activity: combining the benefits of directed evolution and rational design. Current Opin. Biotechnol. 16 (4):378-84, 2005.;;Devos et al., Proteins: Structure, Function and Genetics, 2000, vol. 41: 98-107.;;Kisselev L., Structure, 2002, vol. 10:8-9.;;Sen et al., Developments in Directed Evolution for Improving Enzyme Functions. Appl Biochem Biotechnol. 143 (3):212-23, 2007.;;Sheys, G. H., et al., Aldose Reductase from Rhondotorula, J. Biol. Chem., (1971), vol. 246, pp. 3824-3827.;;Verduyn, C., et al., Properties of the NAD(P)H-dependent xylose reductase from the xylose-fermenting yeast Pichia stipitis, Biochem. J., (1985), vol. 226, pp. 669-677.;;Whisstock et al., Quarterly Reviews of Biophysics 2003, vol. 36 (3): 307-340.",ACTIVE
402,CA,A1,CA 2231607 A1,196-104-123-031-152,1997-04-17,1997,CA 2231607 A,1996-10-01,US 2113096 P;;US 54438495 A,1995-10-10,ACCESS CATHETER AND METHOD FOR MAINTAINING SEPARATION BETWEEN A FALLOPOSCOPE AND A TUBAL WALL,"A method and apparatus are provided for imaging a narrow body lumen (16), the method comprising maintaining separation between a distal end (20) of an optical viewing scope (14) and a lumen wall (16) with a spacing structure (74) which extends distally from the distal end of an access catheter (72). Optional spacing structures include distal cages (74) and a guidewire (122) which is fixed to and extends distally from the access catheter body. The invention is beneficial during retrograde imaging of the fallopian tube, and also allows antigrade imaging and advancing the access catheter and scope under the direction of the image provided, as it prevents the tubal wall from coming into such close proximity to a falloposcope as to produce ""white-out"" on the imaging monitor.",CONCEPTUS INC,KRAMER TOM;;HILL RICHARD;;SCHRANER MARC;;TON DAI;;KERIN JOHN;;DOTY JAMES;;MILO CHARLES;;NIKOLCHEV JULIAN,,https://lens.org/196-104-123-031-152,Patent Application,no,0,0,11,11,0,A61B1/0008;;A61B1/00082;;A61B1/00085;;A61B1/00135;;A61B1/00149;;A61B1/00165;;A61B1/04;;A61B1/07;;A61B1/303;;A61B1/32;;A61B5/6886;;A61B17/221;;A61B2017/2215;;A61B1/01;;A61B2090/0815;;A61B90/50;;A61B1/04;;A61B1/00149;;A61B17/221;;A61B1/303;;A61B1/0008;;A61B1/00135;;A61B5/6886;;A61B1/07;;A61B1/00085;;A61B1/00165;;A61B1/00082;;A61B1/32;;A61B2017/2215;;A61B1/01;;A61B90/50;;A61B2090/0815,A61B1/04;;A61B1/06;;A61B1/303;;A61B1/32;;A61B17/22;;A61B19/00,,0,0,,,,DISCONTINUED
403,EP,A1,EP 3908135 A1,072-412-197-424-280,2021-11-17,2021,EP 20704967 A,2020-01-10,US 201962791709 P;;US 201962816452 P;;US 201962898522 P;;US 2020/0013224 W,2019-01-11,VAPORIZER INCLUDING POSITIVE TEMPERATURE COEFFICIENT OF RESISTIVITY HEATER,,JUUL LABS INC,ALSTON WILLIAM W;;BOWEN ADAM;;GARCIA-DOTY IAN;;KURZMAN JOSHUA A;;MONSEES JAMES;;VIEIRA PAUL R,,https://lens.org/072-412-197-424-280,Patent Application,yes,0,0,2,14,0,A24F40/10;;A24F40/20;;A24F40/30;;A24F40/46;;A24F40/57;;A24F40/60;;A24F40/65;;H05B3/06;;H05B3/46;;H05B2203/02;;H05B2203/022,A24F40/46;;A24F40/10;;A24F40/20;;A24F40/30;;A24F40/57;;A24F40/60;;A24F40/65;;H05B3/12,,0,0,,,,PENDING
404,US,A1,US 2021/0337872 A1,012-087-795-456-669,2021-11-04,2021,US 202117372357 A,2021-07-09,US 202117372357 A;;US 2020/0013224 W;;US 202062959737 P;;US 201962898522 P;;US 201962816452 P;;US 201962791709 P,2019-01-11,VAPORIZER INCLUDING POSITIVE TEMPERATURE COEFFICIENT OF RESISTIVITY HEATER,"A vaporizer device includes a housing including an air inlet, a heating element within the housing and a heat exchanger. The heating element includes a nonlinear positive temperature coefficient of resistance material. The heat exchanger is thermally coupled to the heating element and arranged to receive airflow from the air inlet. The heat exchanger is configured to transfer heat between the heating element and the airflow to produce a heated airflow. The heated airflow exiting the heat exchanger is configured to vaporize a vaporizable material. Related apparatus, systems, techniques and articles are also described.",JUUL LABS INC,ALSTON WILLIAM W;;BOWEN ADAM;;GARCIA-DOTY IAN;;KURZMAN JOSHUA A;;MONSEES JAMES;;VIEIRA PAUL R,JUUL LABS INC (2021-01-11),https://lens.org/012-087-795-456-669,Patent Application,yes,2,1,2,14,0,A24F40/10;;A24F40/20;;A24F40/30;;A24F40/46;;A24F40/57;;A24F40/60;;A24F40/65;;H05B3/06;;H05B2203/02;;H05B2203/022;;H05B3/46;;A24F40/485;;A24F40/10;;A24F40/46;;A24F40/44;;A24F40/42;;H05B1/0244;;H05B3/06;;H05B2203/02;;H05B2203/022,A24F40/46;;A24F40/10;;A24F40/42;;A24F40/44;;A24F40/485;;H05B1/02;;H05B3/06,,0,0,,,,PENDING
405,US,A1,US 2011/0084873 A1,189-238-078-365-056,2011-04-14,2011,US 57741809 A,2009-10-12,US 57741809 A,2009-10-12,DETERMINING CHARACTERISTICS OF A RADAR CROSS SECTION (RCS) TEST RANGE,A method for determining characteristics of a RCS test range may include vertically orienting a field probe including an elongated rigid body at a predetermined location within the RCS test range. The method may also include generating incident radar waves at a selected frequency and polarization and pivoting the field probe in a vertical direction broadside to the incident radar waves. The method may additionally include receiving return radar data scattered by the field probe during pivoting of the field probe. The method may further include determining a field distribution along the elongated rigid body of the field probe from the return radar data to determine characteristics of the RCS test range.,WEI PAX S P;;REED ANTHONY W;;ERICKSEN CRAIG N;;DOTY JAMES D;;SCHUESSLER ROBERT K,WEI PAX S P;;REED ANTHONY W;;ERICKSEN CRAIG N;;DOTY JAMES D;;SCHUESSLER ROBERT K,THE BOEING COMPANY (2009-10-05),https://lens.org/189-238-078-365-056,Patent Application,yes,7,7,5,5,0,G01R29/105;;G01S7/4004;;G01S7/41;;G01S7/40;;G01S7/41;;G01S7/4004;;G01R29/105;;G01S7/41,G01S7/40,342/165,0,0,,,,INACTIVE
406,BR,A,BR PI0413653 A,148-611-762-212-967,2006-10-17,2006,BR PI0413653 A,2004-08-17,US 49601103 P;;US 2004/0024383 W,2003-08-19,"corpo oco, dispositivo acionado por combustìvel fóssil, e, método para fabricar um corpo oco","Method for making a hollow body comprising, as sole layer(s), (1) at least one layer L1 comprising an aromatic polyamide and an impact modifier, and, optionally, (2) at least one layer L2 comprising an aliphatic polyamide, comprising extruding an aromatic polyamide and an impact modifier, and optionally extruding an aliphatic polyamide, through a die.",SOLVAY ADVANCED POLYMERS LLC,BERSTED BRUCE H;;DOTY JAMES;;CANNIERE JEAN DE;;DEHENNAU CLAUDE;;WARKOSKI GREGORY;;BUSLELMAN CORINNE;;BILLIET JOHAN,,https://lens.org/148-611-762-212-967,Patent Application,no,0,0,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90;;B32B27/34,,0,0,,,,DISCONTINUED
407,US,B2,US 7498977 B2,171-580-859-876-908,2009-03-03,2009,US 46541706 A,2006-08-17,US 46541706 A,2006-08-17,Field probe from the angular response of a rigid body,"Probing incident radar fields in a target test zone of a RCS test facility by exploiting angular radar response of a long and uniform rigid body supported horizontally across or vertically through the test zone. The rigid body is free to rotate about the broadside condition. Thus, the angle of the rigid body is gradually changed with respect to the direction of arrival of the incident wave. Radar echo from the rigid body is measured as a function of the rigid body angle. The data is then processed to yield a profile of the incident wave intensity along the rigid body. By varying the azimuth angle continuously while recording radar data, the data may be processed by the fast Fourier transform (FFT) algorithm to yield a profile of the incident wave intensity along the rigid body.",BOEING CO,WEI PAX S P;;REED ANTHONY W;;ERICKSEN CRAIG N;;DOTY JAMES D;;SCHUESSLER ROBERT K,THE BOEING COMPANY (2006-08-15),https://lens.org/171-580-859-876-908,Granted Patent,yes,7,7,2,2,0,G01S7/40;;G01S7/40;;G01S7/41;;G01S7/41,G01S7/40;;G01S13/00,342/165;;342/173;;342/174;;342/196,17,3,159-766-196-429-664;;158-642-663-197-794;;157-192-214-452-903,10.1109/tap.1979.1142020;;10.1109/aps.2001.959491;;10.1109/nrc.1988.10959,"Garat (Electrotechnical Conference, 1996. MELECON '96., 8th Mediterranean, May 13-16, 1996, vol. 1, On pp. 80-86).;;Wei et al.[2] (Wideband radar echoes from cylindrical rods, Antennas and Propagation Society International Symposium, 1999. IEEE, vol. 2, Jul. 11-16, 1999 pp. 1418-1421).;;Lahaie et al. (Scattering of electromagnetic waves by a slowly rotating rectangular metal plate, Antennas and Propagation, IEEE Transactions on [legacy, pre-1988], vol. 27; Issue: Jan. 1, 1979, pp. 40-46).;;W. H. Press, S. A. Teukolsky, W. T. Vetterling, and B. P. Flannery, ""Numerical Recipes in C.,"" (Cambridge Univ. Press, 2nd ed., 1992, reprinted 1999), pp. 553-556; also, same authors, ""Numerical Recipes in FORTRAN,"" (2nd ed., 1992), pp. 547-548.;;P.S.P. Wei, A.W. Reed, and C.N. Ericksen, ""Radar Cross Section Measurements Amid Interfering Backgrounds"" Proc. 22nd AMTA, (2000), pp. 99.;;Silz, R.; ""Design of the GE aircraft engine compact range facility"", Antennas and Propagation Society International Symposium, 2001. IEEE, vol. 4, Jul. 8-13, 2001 pp. 432-435.;;Scheer, J.A.; Chastain, W.E., Alexander, N.T.; Bruder, J.A.; Scheer, C.R.: Horst,M.M.; Trostel, J.M.;""MMW radar cross section range characterizes targets""; Radar Conference, 1988., Proceedings of the IEEE National , Apr. 20-21, 1988 pp. 209-213.;;Knott, E. F. et al., ""Broadside Radar Echoes from Wires and Strings,"" Microwave Journal, vol. 42, Jan. 1999, pp. 102, 104, 106, 108 and 110.;;Knott, E. F., ""Radar Cross Section Measurements,"" Van Nostrand Reinhold, New York, 1993, pp. 326-338.;;Mensa, D. L., ""High Resolution Radar Cross-section Imaging,"" Artech House, Boston, 1991, pp. 115-116.;;Wei, P. S. P., ""Discrete Hilbert Transform and Analytic Envelope,"" Boeing Document D180-32736-1, Apr. 16, 1991 pp. 1-29, (unpublished).;;Wei, P. S. P., ""Study of DFT Windows for Radar Imaging,"" Proc., 17.sup.th Antenna Measurement Techniques Association (AMTA), Williamsburg, VA, Nov. 13-17, 1995, pp. 111-116.;;Wei, P. S. P. et al., ""Study of Wires and Strings of Finite Sizes,"" Proc., 20.sup.th Antenna Measurement Techniques Association (AMTA), 1998, pp. 221-226.;;Wei, P. S. P. et al.,""Uncertainty Analysis on the RCS Measurements from Calibration Objects,"" Proc. 23d Antenna Measurement Techniques Association (AMTA), Symposium, Denver, CO, Oct. 22-26, 2001, pp. 123-128.;;E. F. Knott and P. S. P. Wei, ""The Long String as a Field Probe,"" IEEE Antennas and Porpagation Magazine, accepted for publication (2005): also presented at the AMTA Symposium, (Newport, R.I., Nov. 1st), Proc. 27th AMTA, pp. 136-141 (2005).;;P. S. P. Wei, A. W. Reed, C. N. Ericksen, and M. D. Bushbeck, ""Study of RCS Measure-ments from a Large Flat Plate,"" Proc. 27th AMTA, pp. 3-8 (2005).;;P. S. P. Wei, A. W. Reed, And C. N. Ericksen, ""VHF Capability and RCS Measurements from Long Cylinders,"" Proc. 24th AMTA, pp. 192-197 (2002).",INACTIVE
408,AU,B2,AU 715261 B2,191-408-636-992-048,2000-01-20,2000,AU 1996/072522 A,1996-10-01,US 54438495 A;;US 2113096 P;;US 9615766 W,1995-10-10,Access catheter and method for maintaining separation between a falloposcope and a tubal wall,,CONCEPTUS INC,KERIN JOHN;;MILO CHARLES;;NIKOLCHEV JULIAN;;DOTY JAMES;;TON DAI;;HILL RICHARD;;SCHRANER MARC;;KRAMER TOM,,https://lens.org/191-408-636-992-048,Granted Patent,no,3,0,11,11,0,A61B1/0008;;A61B1/00082;;A61B1/00085;;A61B1/00135;;A61B1/00149;;A61B1/00165;;A61B1/04;;A61B1/07;;A61B1/303;;A61B1/32;;A61B5/6886;;A61B17/221;;A61B2017/2215;;A61B1/01;;A61B2090/0815;;A61B90/50;;A61B1/04;;A61B1/00149;;A61B17/221;;A61B1/303;;A61B1/0008;;A61B1/00135;;A61B5/6886;;A61B1/07;;A61B1/00085;;A61B1/00165;;A61B1/00082;;A61B1/32;;A61B2017/2215;;A61B1/01;;A61B90/50;;A61B2090/0815,A61B1/04;;A61B1/06;;A61B1/303;;A61B1/32;;A61B17/22;;A61B19/00,,0,0,,,,EXPIRED
409,US,B2,US 8098194 B2,028-534-098-332-532,2012-01-17,2012,US 57741809 A,2009-10-12,US 57741809 A,2009-10-12,Determining characteristics of a radar cross section (RCS) test range,A method for determining characteristics of a RCS test range may include vertically orienting a field probe including an elongated rigid body at a predetermined location within the RCS test range. The method may also include generating incident radar waves at a selected frequency and polarization and pivoting the field probe in a vertical direction broadside to the incident radar waves. The method may additionally include receiving return radar data scattered by the field probe during pivoting of the field probe. The method may further include determining a field distribution along the elongated rigid body of the field probe from the return radar data to determine characteristics of the RCS test range.,WEI PAX S P;;REED ANTHONY W;;ERICKSEN CRAIG N;;DOTY JAMES D;;SCHUESSLER ROBERT K;;BOEING CO,WEI PAX S P;;REED ANTHONY W;;ERICKSEN CRAIG N;;DOTY JAMES D;;SCHUESSLER ROBERT K,THE BOEING COMPANY (2009-10-05),https://lens.org/028-534-098-332-532,Granted Patent,yes,7,3,5,5,0,G01R29/105;;G01S7/4004;;G01S7/41;;G01S7/40;;G01S7/41;;G01S7/4004;;G01R29/105;;G01S7/41,G01S7/40,342/165,7,1,108-059-822-687-060,10.1109/map.2005.1608710,"Knott, E.F. et al. ""Broadside Radar Echoes From Wires and Strings."" Microwave Journal, vol. 42, Horizon House, Jan. 1999, p. 102 et seq.;;Knott, E.F. et al. ""The Long String as a Field Probe."" IEEE Antennas and Propagation Magazine, vol. 47, No. 6, Dec. 2005, pp. 22-27.;;Sherman, W.D. et al. ""Stereo Optical Tracker for Compact Range Models."" Proc 14th AMTA, 1992, pp. 9-3-9-8.;;Wei, P.S.P. ""Study of DFT Windows for Radar Imaging."" Proc. 17th AMTA, 1995, pp. 111-116.;;Wei, P.S.P. et al. ""Study of RCS Measurements from a Large Flat Plate."" Proc. 27th AMTA, 2005, pp. 3-8.;;Wei, P.S.P. et al. ""Study of Wires and Strings of Finite Sizes."" Proc. 20th AMTA, 221-226 (1998).;;GB Intellectual Property Office, Combined Search and Examination Report for GB Application No. GB1017221.1 dated Feb. 7, 2011.",INACTIVE
410,WO,A1,WO 1997/013451 A1,106-692-119-827-536,1997-04-17,1997,US 9615766 W,1996-10-01,US 54438495 A;;US 2113096 P,1995-10-10,ACCESS CATHETER AND METHOD FOR MAINTAINING SEPARATION BETWEEN A FALLOPOSCOPE AND A TUBAL WALL,"A method and apparatus are provided for imaging a narrow body lumen (16), the method comprising maintaining separation between a distal end (20) of an optical viewing scope (14) and a lumen wall (16) with a spacing structure (74) which extends distally from the distal end of an access catheter (72). Optional spacing structures include distal cages (74) and a guidewire (122) which is fixed to and extends distally from the access catheter body. The invention is beneficial during retrograde imaging of the fallopian tube, and also allows antigrade imaging and advancing the access catheter and scope under the direction of the image provided, as it prevents the tubal wall from coming into such close proximity to a falloposcope as to produce 'white-out' on the imaging monitor.",CONCEPTUS INC,KERIN JOHN;;MILO CHARLES;;NIKOLCHEV JULIAN;;DOTY JAMES;;TON DAI;;HILL RICHARD;;SCHRANER MARC;;KRAMER TOM,,https://lens.org/106-692-119-827-536,Patent Application,yes,13,21,11,11,0,A61B1/0008;;A61B1/00082;;A61B1/00085;;A61B1/00135;;A61B1/00149;;A61B1/00165;;A61B1/04;;A61B1/07;;A61B1/303;;A61B1/32;;A61B5/6886;;A61B17/221;;A61B2017/2215;;A61B1/01;;A61B2090/0815;;A61B90/50;;A61B1/04;;A61B1/00149;;A61B17/221;;A61B1/303;;A61B1/0008;;A61B1/00135;;A61B5/6886;;A61B1/07;;A61B1/00085;;A61B1/00165;;A61B1/00082;;A61B1/32;;A61B2017/2215;;A61B1/01;;A61B90/50;;A61B2090/0815,A61B1/04;;A61B1/06;;A61B1/303;;A61B1/32;;A61B17/22;;A61B19/00,,4,3,065-960-382-511-187;;065-960-382-511-187;;020-757-066-348-342,10.1016/0020-7292(91)90346-7;;10.1016/0020-7292(91)90346-7;;10.1089/lps.1990.1.47;;2131110,"FERTILITY AND STERILITY, 1990, Vol. 54, No. 3, KERIN et al., ""Falloposcopy: A Microendoscopic Techinque for Visual Exploration of the Human Fallopian Tube from the Uterotubal Ostium to the Fimbria Using a Transvaginal Approach"", pages 390-400.;;KERIN ET AL., FERTIL. STERIL. (1990), vol. 54, pages 390-400;;KERIN ET AL., J. LAPAROENDOSCOPIC SURG., vol. 1, pages 47-56;;See also references of EP 0955857A4",PENDING
411,GB,B,GB 2474368 B,185-362-829-596-49X,2012-07-25,2012,GB 201017221 A,2010-10-12,US 57741809 A,2009-10-12,Determining characteristics of a radar cross section (RCS) test range,,BOEING CO,WEI PAX S P;;REED ANTHONY W;;ERICKSEN CRAIG N;;DOTY JAMES D;;SCHUESSLER ROBERT K,,https://lens.org/185-362-829-596-49X,Granted Patent,no,4,0,5,5,0,G01R29/105;;G01S7/4004;;G01S7/41;;G01S7/40;;G01S7/41;;G01S7/4004;;G01R29/105;;G01S7/41,G01S7/40;;G01S7/41,,0,0,,,,ACTIVE
412,US,A1,US 2014/0283569 A1,117-650-069-100-331,2014-09-25,2014,US 201414209709 A,2014-03-13,US 201414209709 A;;US 201113256426 A;;US 2010/0027234 W;;US 16007709 P,2009-03-13,"ENDOPHYTIC YEAST STRAINS, METHODS FOR ETHANOL AND XYLITOL PRODUCTION, METHODS FOR BIOLOGICAL NITROGEN FIXATION, AND A GENETIC SOURCE FOR IMPROVEMENT OF INDUSTRIAL STRAINS",The present invention provides novel endophytic yeast strains capable of metabolizing both pentose and hexose sugars. Methods of producing ethanol and xylitol using the novel endophytic yeast are provided herein. Also provided are methods of fixing nitrogen and fertilizing a crop using the novel endophytic yeast strains provided herein.,UNIV WASHINGTON CT COMMERCIALI,DOTY SHARON L;;STALEY JAMES TROTTER;;SU MICHAEL;;VAJZOVIC AZRA;;BURA RENATA;;REDMAN REGINA;;KHAN ZAREEN,UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (2014-10-21),https://lens.org/117-650-069-100-331,Patent Application,yes,1,1,6,6,48,C05F11/08;;C05F11/08;;C12N1/145;;C12N1/145;;C12N9/0006;;C12N9/0006;;C12N15/815;;C12P7/06;;C12P7/06;;C12P7/10;;C12P7/10;;C12P7/18;;C12P7/18;;C12R2001/645;;C12R2001/645;;Y02E50/10;;Y02E50/10;;Y02P20/52,C05F11/08;;C12N15/81,71/11;;435/254.2,0,0,,,,ACTIVE
413,EP,A1,EP 0955857 A1,175-214-790-240-682,1999-11-17,1999,EP 96933998 A,1996-10-01,US 9615766 W;;US 54438495 A;;US 2113096 P,1995-10-10,ACCESS CATHETER AND METHOD FOR MAINTAINING SEPARATION BETWEEN A FALLOPOSCOPE AND A TUBAL WALL,,CONCEPTUS INC,KERIN JOHN;;MILO CHARLES;;NIKOLCHEV JULIAN;;DOTY JAMES;;TON DAI;;HILL RICHARD;;SCHRANER MARC;;KRAMER TOM,,https://lens.org/175-214-790-240-682,Patent Application,yes,0,0,11,11,0,A61B1/0008;;A61B1/00082;;A61B1/00085;;A61B1/00135;;A61B1/00149;;A61B1/00165;;A61B1/04;;A61B1/07;;A61B1/303;;A61B1/32;;A61B5/6886;;A61B17/221;;A61B2017/2215;;A61B1/01;;A61B2090/0815;;A61B90/50;;A61B1/04;;A61B1/00149;;A61B17/221;;A61B1/303;;A61B1/0008;;A61B1/00135;;A61B5/6886;;A61B1/07;;A61B1/00085;;A61B1/00165;;A61B1/00082;;A61B1/32;;A61B2017/2215;;A61B1/01;;A61B90/50;;A61B2090/0815,A61B1/04;;A61B1/06;;A61B1/303;;A61B1/32;;A61B17/22;;A61B19/00,,0,0,,,,DISCONTINUED
414,US,A1,US 2009/0033546 A1,092-048-511-696-848,2009-02-05,2009,US 46541706 A,2006-08-17,US 46541706 A,2006-08-17,FIELD PROBE FROM THE ANGULAR RESPONSE OF A RIGID BODY,"Probing incident radar fields in a target test zone of a RCS test facility by exploiting angular radar response of a long and uniform rigid body supported horizontally across or vertically through the test zone. The rigid body is free to rotate about the broadside condition. Thus, the angle of the rigid body is gradually changed with respect to the direction of arrival of the incident wave. Radar echo from the rigid body is measured as a function of the rigid body angle. The data is then processed to yield a profile of the incident wave intensity along the rigid body. By varying the azimuth angle continuously while recording radar data, the data may be processed by the fast Fourier transform (FFT) algorithm to yield a profile of the incident wave intensity along the rigid body.",WEI PAX S P;;REED ANTHONY W;;ERICKSEN CRAIG N;;DOTY JAMES D;;SCHUESSLER ROBERT K,WEI PAX S P;;REED ANTHONY W;;ERICKSEN CRAIG N;;DOTY JAMES D;;SCHUESSLER ROBERT K,THE BOEING COMPANY (2006-08-15),https://lens.org/092-048-511-696-848,Patent Application,yes,7,6,2,2,0,G01S7/40;;G01S7/40;;G01S7/41;;G01S7/41,G01S7/40,342/165,0,0,,,,INACTIVE
415,KR,A,KR 20060002829 A,012-115-964-740-990,2006-01-09,2006,KR 20057017518 A,2005-09-16,US 39033303 A,2003-03-17,METHOD FOR PREPARING SMALL PARTICLES,"The present invention is concerned with the formation of small particles or organic compounds by precipitating the organic compounds in an aqueous medium to form a pre-suspension followed by adding energy to stabilize a coating of the particle or to alter the lattice structure of the particle. The process includes the steps of: (i) dissolving the organic compound in the water-miscible first solvent to form a solution; (ii) mixing the solution with the second solvent to define a presuspension of particles; and (iii) adding energy to the presuspension to form a suspension of particles having an average effective particle size of less than about 100 mum. The process is preferably used to prepare a suspension of small particles of a poorly water-soluble, pharmaceutically active compound suitable for in vivo delivery by an administrate route such as parenteral, oral, pulmonary, nasal, buccal, topical ophthalmic, rectal, vaginal, transdermal or the like.",BAXTER INT,KIPP JAMES E;;WONG JOSEPH CHUNG TAK;;WERLING JANE;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN;;DOTY MARK J,,https://lens.org/012-115-964-740-990,Patent Application,no,0,3,12,12,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1682;;A61K9/1688;;A61K31/12;;A61K31/337;;A61K31/495;;A61K31/496;;A61K31/55;;A61K31/573;;A61K9/16;;A61K31/496;;A61K31/495;;A61K9/1682;;A61K9/145;;A61K9/14;;A61K31/496;;A61K31/337;;A61K9/146;;A61K31/573;;A61K9/10;;A61K31/12;;A61K9/1688;;A61K31/55,A61K9/16;;A61K9/10;;A61K9/14;;A61K31/12;;A61K31/337;;A61K31/495;;A61K31/496;;A61K31/55;;A61K31/573,,0,0,,,,DISCONTINUED
416,EP,A2,EP 1429749 A2,028-213-229-868-808,2004-06-23,2004,EP 02773579 A,2002-09-25,US 0230447 W;;US 96427301 A;;US 18303502 A,2001-09-26,PREPARATION OF SUBMICRON SIZED NANOPARTICLES VIA DISPERSION AND SOLVENT OR LIQUID PHASE REMOVAL,,BAXTER INT,BRYNJELSEN SEAN;;STERNBERG SHMUEL;;DUNHAM ANDREW J;;DOTY MARK J;;KIPP JAMES E;;JAYSWAL NAILESH;;NARAYANAN KRISHNASWAMY,,https://lens.org/028-213-229-868-808,Patent Application,yes,0,0,13,20,0,A61K9/5169;;A61K9/5192;;A61K9/145;;B01J13/04;;A61K9/5169;;A61K9/5192;;A61K9/145;;B01J13/04;;A61K9/14,A61K9/19;;A61K9/14;;A61K9/51;;A61K31/496;;A61K45/00;;A61K47/10;;A61K47/12;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/32;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;B01J13/04,,0,0,,,,DISCONTINUED
417,US,A1,US 2003/0031719 A1,113-639-507-450-161,2003-02-13,2003,US 2169201 A,2001-12-12,US 2169201 A;;US 95397901 A;;US 87463701 A;;US 25816000 P,2000-12-22,Method for preparing submicron particle suspensions,"
   The present invention provides a method for preparing a suspension of a pharmaceutically-active compound, the solubility of which is greater in a water-miscible first organic solvent than in a second solvent which is aqueous. The process includes the steps of: (i) dissolving a first quantity of the pharmaceutically-active compound in the water-miscible first organic solvent to form a first solution; (ii) mixing the first solution with the second solvent to precipitate the pharmaceutically-active compound; and (iii) seeding the first solution or the second solvent or the pre-suspension. 
",KIPP JAMES E.;;WONG JOSEPH CHUNG TAK;;DOTY MARK J.;;WERLING JANE;;REBBECK CHRISTINE L.;;BRYNJELSEN SEAN,KIPP JAMES E;;WONG JOSEPH CHUNG TAK;;DOTY MARK J;;WERLING JANE;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN,,https://lens.org/113-639-507-450-161,Patent Application,yes,99,41,4,86,0,A61K9/10;;A61K9/10;;A61K9/14;;A61K9/14;;A61K9/145;;A61K9/145;;A61K9/146;;A61K9/146;;A61K9/1688;;A61K9/1688;;A61K31/495;;A61K31/495;;A61K31/496;;A61K31/496,A61K9/10;;A61K9/14;;A61K9/16;;A61K31/495;;A61K31/496,424/489;;264/5,0,0,,,,EXPIRED
418,EP,A1,EP 1605914 A1,147-398-275-352-085,2005-12-21,2005,EP 04714628 A,2004-02-25,US 2004/0005696 W;;US 39033303 A,2003-03-17,METHOD FOR PREPARING SMALL PARTICLES,,BAXTER INT,KIPP JAMES E;;WONG JOSEPH CHUNG TAK;;WERLING JANE;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN;;DOTY MARK J,,https://lens.org/147-398-275-352-085,Patent Application,yes,0,0,12,12,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1682;;A61K9/1688;;A61K31/12;;A61K31/337;;A61K31/495;;A61K31/496;;A61K31/55;;A61K31/573;;A61K9/16;;A61K31/496;;A61K31/495;;A61K9/1682;;A61K9/145;;A61K9/14;;A61K31/496;;A61K31/337;;A61K9/146;;A61K31/573;;A61K9/10;;A61K31/12;;A61K9/1688;;A61K31/55,A61K9/10;;A61K9/14;;A61K9/16;;A61K31/12;;A61K31/337;;A61K31/495;;A61K31/496;;A61K31/55;;A61K31/573,,0,0,,,,DISCONTINUED
419,US,B1,US 9562788 B1,178-733-392-144-509,2017-02-07,2017,US 201113250798 A,2011-09-30,US 201113250798 A,2011-09-30,System and method for doppler aided navigation using weather radar,"An airborne navigation system that uses Doppler information from an on-board weather radar to improve the system's accuracy and/or fault tolerance. The system can determine a drift angle and ground speed from Doppler information associated with radar returns from the Earth's surface. Alternatively, the system can be configured to determine heading angle using the drift angle and a track angle received from another sensor.",JINKINS RICHARD D;;GAVRILETS VLADISLAV;;RADEMAKER RICHARD M;;WOODELL DANIEL L;;JOURDAN DAMIEN B;;DOTY JAMES H;;ROCKWELL COLLINS INC,JINKINS RICHARD D;;GAVRILETS VLADISLAV;;RADEMAKER RICHARD M;;WOODELL DANIEL L;;JOURDAN DAMIEN B;;DOTY JAMES H,ROCKWELL COLLINS INC (2011-09-29),https://lens.org/178-733-392-144-509,Granted Patent,yes,102,7,1,14,0,G01C23/00;;G01S13/60;;G01S13/86;;G01S13/953;;Y02A90/10;;G01C23/00;;G01S13/87;;G01S13/60;;G01S13/86;;G01S13/874;;G01S13/953;;Y02A90/10,G05D1/00;;G01C23/00;;G01S13/60;;G01S13/86;;G01S13/87;;G01S13/95;;G05D3/00;;G06F7/00;;G06F17/00,,12,0,,,"Office Action for U.S. Appl. No. 13/250,307, mail date Nov. 5, 2013, 11 pages.;;U.S. Appl. No. 13/250,307, filed Sep. 30, 2011, Jinkins et al.;;U.S. Appl. No. 13/224,992, filed Sep. 2, 2011, Hufnagel et al.;;Final Office Action on U.S. Appl. No. 13/250,307 Dated Jun. 11, 2014, 8 pages.;;Notice of Allowance on U.S. Appl. No. 12/263,282 dated Jan. 29, 2016, 8 pages.;;Notice of Allowance on U.S. Appl. No. 14/301,199 dated Mar. 1, 2016, 11 pages.;;G2000, Garmin, printed from website https://buy.garmin.com/shop/shop.do?cID=153&pID=97668 on Jun. 28, 2011, 2 pages.;;G3000, Garmin, printed from website https://buy.garmin.com/shop/shop.do?cID=153&pID=66916 on Jun. 28, 2011, 2 pages.;;G5000, Garmin, printed from website https://buy.garmin.com/shop/shop.do?cID=153&pID=90821&ra=true on Apr. 20, 2011, 2 pages.;;Office Action for U.S. Appl. No. 13/224,992, mail date Feb. 28, 2013, 10 pages.;;Office Action for U.S. Appl. No. 13/743,182, mail date Apr. 8, 2013, 10 pages.;;Non-Final Office Action on U.S. Appl. No. 14/482,681, dated Dec. 20, 2016, 9 pages.",ACTIVE
420,EP,A2,EP 1642571 A2,140-998-154-230-318,2006-04-05,2006,EP 05077486 A,2001-12-20,EP 01998077 A;;US 25816000 P;;US 87479901 A;;US 87463701 A;;US 87449901 A;;US 95397901 A;;US 3582101 A;;US 2169201 A,2000-12-22,Method for preparing submicron particle suspensions,"The present invention provides a method a method for preparing a suspension of a pharmaceutically-active compound, the solubility of which is greater in a water-miscible first organic solvent than in a second solvent which is aqueous, the process comprising the steps of (i) dissolving a first quantity of the pharmaceutically-active compound in the water-miscible first organic solvent to form a first solution; (ii) mixing the first solution with the second solvent to precipitate the pharmaceutically-active compound to create a presuspension; and (iii) seeding the first solution or the second solvent prior to the mixing step or seeding the pre-suspension after the mixing step.",BAXTER INT,KIPP JAMES E;;WONG JOSEPH;;DOTY MARK J;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN;;WERLING JANE;;SRIRAM RAJARAM,,https://lens.org/140-998-154-230-318,Patent Application,yes,0,4,27,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K31/495;;A61K31/496;;A61P31/10,A61K9/10;;A61K9/14;;C07D407/14;;A61K9/16;;A61K31/495;;A61K31/496;;A61K47/12;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61P31/10;;B01D9/02;;B01D21/01,,0,0,,,,DISCONTINUED
421,US,B2,US 7533080 B2,150-701-256-528-337,2009-05-12,2009,US 40102906 A,2006-04-10,US 40102906 A,2006-04-10,Commit tree optimization based on recovery topology information,Minimizing transaction managers. A method that may be practiced in a commit tree topology including a plurality of transaction managers to manage transactions. The transactions include a set of operations that are all performed if a transaction is completed or all aborted if a transaction is not completed. The transaction managers store transaction result information to allow recovery of a transaction in case of system failure. The method includes acts for minimizing storage overhead by minimizing the number of transaction managers used to coordinate transactions. The method includes identifying a set of transaction managers. A first transaction manager is selected from among the set of transaction managers. A second transaction manager is identified from among the set of transaction managers that is always available when the first transaction manager is available. Messages are redirected from a subordinate associated with the first transaction manager to the second transaction manager.,MICROSOFT CORP,GROFF DANA D;;JOHNSON JAMES E;;DOTY JOHN D;;CARGILLE JONATHAN M;;GUPTA KAPIL;;CLARK MICHAEL R,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2006-04-10),https://lens.org/150-701-256-528-337,Granted Patent,yes,5,4,2,2,0,G06F9/466;;G06F9/466;;Y10S707/99932,G06F17/30,707/2;;718/101,3,1,127-119-670-069-247,10.1007/bf01200845,"""Optimizing use of Local Coordinators in Distributed Applications"", IBM Technical Disclosure Bulletin, vol. 40, issue No. 2. TDB-ACC-NO: NN9702199. pp. 199-204. Publication date: Feb. 1, 1997.;;M. Gerla and J.T.-C. Tsai, ""Multicluster, mobile, multimedia radio network"", ACM/Baltzer Journal of Wireless Networks. vol. 1, (No. 3), 1995, p. 255-265. http://citeseer.ist.psu.edu/gerla95multicluster.html.;;A. B. Kulkarni et al., An Active Network Architecture for ATM WANs, presented at the Mobile Multimedia Commun. Conference at Princeton, NJ, Sep. 25-27, 1996. http://citeseer.ist.psu.edu/kulkarni96active.html.",INACTIVE
422,WO,A2,WO 2004/054500 A2,061-528-150-570-059,2004-07-01,2004,US 0324353 W,2003-08-04,US 21335202 A;;US 24680202 A,2002-08-05,PREPARATION OF SUBMICRON SIZED PARTICLES WITH POLYMORPH CONTROL AND NEW POLYMORPH OF ITRACONAZOLE,"The present invention provides a method of preparing particles with polymorph and size control of a pharmaceutical compound, the method including the steps of: (1) providing pharmaceutical compound in a first phase; (2) seeding the compound; (3) causing a phase change in the pharmaceutical compound to a second phase of a desired polymorphic form; and (4) wherein the mean particle size of the particles is less than 7쎽m. The present invention further provides a polymorphic form of itraconazole.",BAXTER INT,WERLING JANE;;KIPP JAMES E;;SRIRAM RAJARAM;;DOTY MARK J;;REBBECK CHRISTINE L;;WONG JOSEPH CHUNG TAK,,https://lens.org/061-528-150-570-059,Patent Application,yes,0,5,5,86,0,A61K9/14;;A61K9/0019;;A61K9/10;;A61K31/495,A61K9/00;;A61K31/495,,0,0,,,,PENDING
423,US,B2,US 6884436 B2,196-481-160-616-33X,2005-04-26,2005,US 2169201 A,2001-12-12,US 2169201 A;;US 95397901 A;;US 87463701 A;;US 25816000 P,2000-12-22,Method for preparing submicron particle suspensions,"The present invention provides a method for preparing a suspension of a pharmaceutically-active compound, the solubility of which is greater in a water-miscible first organic solvent than in a second solvent which is aqueous. The process includes the steps of: (i) dissolving a first quantity of the pharmaceutically-active compound in the water-miscible first organic solvent to form a first solution; (ii) mixing the first solution with the second solvent to precipitate the pharmaceutically-active compound; and (iii) seeding the first solution or the second solvent or the pre-suspension.",BAXTER INT,KIPP JAMES E;;WONG JOSEPH CHUNG TAK;;DOTY MARK J;;WERLING JANE;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN,BAXTER INTERNATIONAL INC (2002-05-10),https://lens.org/196-481-160-616-33X,Granted Patent,yes,102,65,4,86,0,A61K9/10;;A61K9/10;;A61K9/14;;A61K9/14;;A61K9/145;;A61K9/145;;A61K9/146;;A61K9/146;;A61K9/1688;;A61K9/1688;;A61K31/495;;A61K31/495;;A61K31/496;;A61K31/496,A61K9/10;;A61K9/14;;A61K9/16;;A61K31/495;;A61K31/496,424/489;;424/400;;424/450;;264/4;;264/4.1;;264/5,16,7,005-840-366-684-763;;004-382-489-377-69X;;001-155-857-960-135;;018-188-239-454-962;;012-864-980-464-648;;017-541-414-387-84X;;064-523-632-943-432,10.1016/0378-5173(92)90051-3;;8331530;;10.1002/jps.2600820608;;10.1002/jps.2600670418;;641759;;7302990;;10.1016/0378-4274(81)90035-7;;10.1007/s004170050094;;9602323;;10.1016/s1081-1206(10)62949-3;;9494448;;11879753;;10.1016/s0378-5173(01)00986-3,"US 5,849,884, 12/1998, Woiszwillo et al. (withdrawn);;B. Sjostrom et al., Preparation Of Submicron Drug Particles In Lecithin-Stabilized O/W Emulsions I. Model Studies Of The Precipitation Of Cholesteryl Acetate, Int. J. Pharm., 88 (1992) pp. 53-62.;;B. Sjostrom et al., A Method For The Preparation Of Submicron Particles Of Sparingly Water-Soluble Drugs By Precipitation In Oil-In-Water Emulsions. II: Influence Of The Emulsifier, The Solvent And The Drug Substance, J. Pharm. Sci., 82(6), (1992) pp. 584-589.;;Davis et al., ""Pulmonary Perfusion Imaging: Acute Toxicity and Safety Factors as a Function of Particle Size"", J.Nucl Med., vol. 19 (1978), pp. 1209-1213.;;Schroeder et al., ""Physiological Effects of Subvisible Microspheres Administered Intravenously to Beagle Dogs"", Journal of Pharmaceutical Sciences, vol. 67, No. 4, Apr. 1978, pp. 508-512.;;Yokel et al., ""Acute Toxicity of Latex Microspheres"", Toxicity Letters, vol. 9 (1981), pp. 165-170.;;Allen et al., ""Critical Evaluation of Acute Cardiopulminary Toxicity of Microspheres"", J.Nucl Med., vol. 19 (1987), pp. 1204-1208.;;Duncker and Reichelt, ""Effects of the Pharmaceutical Cosolvent hydroxypropyl-beta-cyclodextrin on Porcine Corneal Endothelium"", Graefe's Archive for Clinical and Experimental Ophthalmology (Germany), 236/5 (1998), pp. 380-389.;;Volchek and Dellen, ""Anaphylaxis to Intravenous Cyclosporine and Tolerance to Oral Cyclosporine, Case Report and Review"", Annals of Allergy, Asthma, and Immunology, 80 (1998), pp. 159-163.;;Singla et al., ""Paclitaxel and its Formulations"", International Journal of Pharmaceutics, 235/1-2 (2002), pp. 179-192.;;B. Sjostrom et al., ""The Formation of Submicron Organic Particles by Precipitation in an Emulsion"", J.Dispersion Science and Technology, 15(1), 89-117 (1994).;;Avanti Polar Lipids, Inc.., website printout, www.avantilipids.com, ""Synthetic Products-Functionalized Phospholipids: Lipids for Conjugation of Proteins/Peptides/Drugs to Liposomes"" (7 pgs), Mar. 2003.;;Avanti Polar Lipids, Inc., website printout, www.avantilipids.com, ""Polymer and Polymerizable Lipids: Functionalized PEG Lipids"" (3 pgs), Mar. 2003.;;Avanti Polar Lipids, Inc.., website printout, www.avantilipids.com, ""Polymer and Polymerizable Lipids: Poly(ethylene glycol)-Lipid Conjugates"" (8 pgs) , Mar. 2003.;;PCT/US01/49737 Written Opinion.;;PCT/US01/49737 International Preliminary Examination Report.",EXPIRED
424,AU,B2,AU 2002/337692 B2,033-819-265-586-549,2007-09-13,2007,AU 2002/337692 A,2002-09-25,US 96427301 A;;US 18303502 A;;US 0230447 W,2001-09-26,Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal,,BAXTER INT,DUNHAM ANDREW J;;BRYNJELSEN SEAN;;JAYSWAL NAILESH;;DOTY MARK J;;NARAYANAN KRISHNASWAMY;;STERNBERG SHMUEL;;KIPP JAMES E,,https://lens.org/033-819-265-586-549,Granted Patent,no,1,0,13,20,0,A61K9/5169;;A61K9/5192;;A61K9/145;;B01J13/04;;A61K9/5169;;A61K9/5192;;A61K9/145;;B01J13/04;;A61K9/14,A61K9/14;;A61K9/19;;A61K9/51;;A61K31/496;;A61K45/00;;A61K47/10;;A61K47/12;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/32;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;B01J13/04,,0,0,,,,EXPIRED
425,CA,A1,CA 2517589 A1,058-211-468-388-253,2004-09-30,2004,CA 2517589 A,2004-02-25,US 39033303 A;;US 2004/0005696 W,2003-03-17,METHOD FOR PREPARING SMALL PARTICLES,"The present invention is concerned with the formation of small particles or organic compounds by precipitating the organic compounds in an aqueous mediu m to form a pre-suspension followed by adding energy to stabilize a coating of the particle or to alter the lattice structure of the particle. The process includes the steps of: (i) dissolving the organic compound in the water- miscible first solvent to form a solution; (ii) mixing the solution with the second solvent to define a presuspension of particles; and (iii) adding ener gy to the presuspension to form a suspension of particles having an average effective particle size of less than about 100 .mu.m. The process is preferably used to prepare a suspension of small particles of a poorly water - soluble, pharmaceutically active compound suitable for in vivo delivery by a n administrate route such as parenteral, oral, pulmonary, nasal, buccal, topic al ophthalmic, rectal, vaginal, transdermal or the like.",BAXTER INT,WONG JOSEPH CHUNG TAK;;KIPP JAMES E;;WERLING JANE;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN;;DOTY MARK J,,https://lens.org/058-211-468-388-253,Patent Application,no,0,0,12,12,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1682;;A61K9/1688;;A61K31/12;;A61K31/337;;A61K31/495;;A61K31/496;;A61K31/55;;A61K31/573;;A61K9/16;;A61K31/496;;A61K31/495;;A61K9/1682;;A61K9/145;;A61K9/14;;A61K31/496;;A61K31/337;;A61K9/146;;A61K31/573;;A61K9/10;;A61K31/12;;A61K9/1688;;A61K31/55,A61K9/10;;A61K9/14;;A61K9/16;;A61K31/12;;A61K31/337;;A61K31/495;;A61K31/496;;A61K31/55;;A61K31/573,,0,0,,,,DISCONTINUED
426,CA,A1,CA 2498043 A1,068-294-851-004-59X,2004-07-01,2004,CA 2498043 A,2003-08-04,US 21335202 A;;US 24680202 A;;US 0324353 W,2002-08-05,PREPARATION OF SUBMICRON SIZED PARTICLES WITH POLYMORPH CONTROL AND NEW POLYMORPH OF ITRACONAZOLE,"The present invention provides a method of preparing particles with polymorp h and size control of a pharmaceutical compound, the method including the step s of: (1) providing pharmaceutical compound in a first phase; (2) seeding the compound; (3) causing a phase change in the pharmaceutical compound to a second phase of a desired polymorphic form; and (4) wherein the mean particl e size of the particles is less than 7~m. The present invention further provid es a polymorphic form of itraconazole.",BAXTER INT,KIPP JAMES E;;WERLING JANE;;DOTY MARK J;;SRIRAM RAJARAM;;WONG JOSEPH CHUNG TAK;;REBBECK CHRISTINE L,,https://lens.org/068-294-851-004-59X,Patent Application,no,0,0,5,86,0,A61K9/14;;A61K9/0019;;A61K9/10;;A61K31/495,A61K9/00;;A61K31/495,,0,0,,,,DISCONTINUED
427,WO,A3,WO 2004/054500 A3,141-172-479-101-958,2004-08-26,2004,US 0324353 W,2003-08-04,US 21335202 A;;US 24680202 A,2002-08-05,PREPARATION OF SUBMICRON SIZED PARTICLES WITH POLYMORPH CONTROL AND NEW POLYMORPH OF ITRACONAZOLE,"The present invention provides a method of preparing particles with polymorph and size control of a pharmaceutical compound, the method including the steps of: (1) providing pharmaceutical compound in a first phase; (2) seeding the compound; (3) causing a phase change in the pharmaceutical compound to a second phase of a desired polymorphic form; and (4) wherein the mean particle size of the particles is less than 7쎽m. The present invention further provides a polymorphic form of itraconazole.",BAXTER INT,WERLING JANE;;KIPP JAMES E;;SRIRAM RAJARAM;;DOTY MARK J;;REBBECK CHRISTINE L;;WONG JOSEPH CHUNG TAK,,https://lens.org/141-172-479-101-958,Search Report,yes,2,0,5,86,0,A61K9/14;;A61K9/0019;;A61K9/10;;A61K31/495,A61K9/00;;A61K31/495,,0,0,,,,PENDING
428,CN,A,CN 1558755 A,156-351-315-654-108,2004-12-29,2004,CN 02818959 A,2002-09-25,US 96427301 A;;US 18303502 A,2001-09-26,Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal,本发明涉及制备水溶性差的化合物的亚微米大小的纳米颗粒的方法，该方法是通过声处理蒸发部分有机相，或通过冻干多相系统的分散液或微分散液，所述的多相系统具有有机相和水相，在所述的有机相中含有水溶性差的有机化合物。该方法优选用于制备水溶性差的药物活性化合物的纳米颗粒，所述的药物活性化合物适合用于体内释放，特别适用于胃肠外给药途径。,BAXTER INT,SEAN BRYNJELSEN;;SHMUEL STERNBERG;;DUNHAM ANDREW J;;DOTY MARK J;;KIPP JAMES E;;NAILESH JAYSWAL;;KRISHNASWAMY NARAYANAN,,https://lens.org/156-351-315-654-108,Patent Application,no,0,5,13,20,0,A61K9/5169;;A61K9/5192;;A61K9/145;;B01J13/04;;A61K9/5169;;A61K9/5192;;A61K9/145;;B01J13/04;;A61K9/14,A61K9/19;;A61K9/14;;A61K9/51;;A61K31/496;;A61K45/00;;A61K47/10;;A61K47/12;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/32;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;B01J13/04,,0,0,,,,DISCONTINUED
429,US,A1,US 2007/0239736 A1,099-797-109-658-379,2007-10-11,2007,US 40102906 A,2006-04-10,US 40102906 A,2006-04-10,Commit tree optimization based on recovery topology information,Minimizing transaction managers. A method that may be practiced in a commit tree topology including a plurality of transaction managers to manage transactions. The transactions include a set of operations that are all performed if a transaction is completed or all aborted if a transaction is not completed. The transaction managers store transaction result information to allow recovery of a transaction in case of system failure. The method includes acts for minimizing storage overhead by minimizing the number of transaction managers used to coordinate transactions. The method includes identifying a set of transaction managers. A first transaction manager is selected from among the set of transaction managers. A second transaction manager is identified from among the set of transaction managers that is always available when the first transaction manager is available. Messages are redirected from a subordinate associated with the first transaction manager to the second transaction manager.,MICROSOFT CORP,GROFF DANA D;;JOHNSON JAMES E;;DOTY JOHN D;;CARGILLE JONATHAN M;;GUPTA KAPIL;;CLARK MICHAEL R,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2006-04-10),https://lens.org/099-797-109-658-379,Patent Application,yes,5,7,2,2,0,G06F9/466;;G06F9/466;;Y10S707/99932,G06F17/30,707/10,0,0,,,,INACTIVE
430,BR,A,BR 0212833 A,034-723-105-119-685,2004-10-13,2004,BR 0212833 A,2002-09-25,US 96427301 A;;US 18303502 A;;US 0230447 W,2001-09-26,Preparação de nanopartìculas de tamanho submìcron através de dispersão e de remoção de solvente ou de fase lìquida,"""PREPARAçãO DE NANOPARTìCULAS DE TAMANHO SUBMìCRON ATRAVéS DE DISPERSãO E DE REMOçãO DE SOLVENTE OU DE FASE LìQUIDA"". A presente invenção refere-se a um processo para a preparação de nanopartículas do tamanho submícron de um comporto fracamente solúvel em água através de sonicação para a evaporação de uma parte da fase orgânica ou através da liofilização de uma dispersão ou microdispersão de um sistema de fases múltiplas que tem uma fase orgânica e uma fase aquosa, a fase orgânica tendo nela um composto fracamente solúvel na água. O método é usado de preferência para a preparação de nanopartículas de um composto farmaceuticamente ativo fracamente solúvel na água, adequado para o suprimento in vivo, de modo específico através de vias parenterais.",BAXTER INT,BRYNJELSEN SEAN;;STERNBERG SHMUEL;;DUNHAM ANDREW J;;DOTY MARK J;;KIPP JAMES E;;JAYSWAL NAILESH;;NARAYANAN KRISHNASWAMY,,https://lens.org/034-723-105-119-685,Patent Application,no,0,0,13,20,0,A61K9/5169;;A61K9/5192;;A61K9/145;;B01J13/04;;A61K9/5169;;A61K9/5192;;A61K9/145;;B01J13/04;;A61K9/14,A61K9/19;;A61K9/14;;A61K9/51;;A61K31/496;;A61K45/00;;A61K47/10;;A61K47/12;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/32;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;B01J13/04,,0,0,,,,DISCONTINUED
431,WO,A3,WO 2003/026611 A3,127-368-210-146-536,2003-07-03,2003,US 0230447 W,2002-09-25,US 96427301 A;;US 18303502 A,2001-09-26,PREPARATION OF SUBMICRON SIZED NANOPARTICLES VIA DISPERSION AND SOLVENT OR LIQUID PHASE REMOVAL,"The present invention relates to a process for preparing submicron sized nanoparticles of a poorly water soluble compound by sonicating to evaporate a portion of the organic phase or by lyophilizing a dispersion or microdispersion of a multiphase system having an organic phase and an aqueous phase, the organic phase havingthe poorly water soluble organic compound therein. The method is preferably used to prepare nanoparticles of a poorly water soluble, pharmaceutically active compound suitable for in vivo delivery, particularly by parenteral routes.",BAXTER INT,BRYNJELSEN SEAN;;STERNBERG SHMUEL;;DUNHAM ANDREW J;;DOTY MARK J;;KIPP JAMES E;;JAYSWAL NAILESH;;NARAYANAN KRISHNASWAMY,,https://lens.org/127-368-210-146-536,Search Report,yes,5,0,13,20,0,A61K9/5169;;A61K9/5192;;A61K9/145;;B01J13/04;;A61K9/5169;;A61K9/5192;;A61K9/145;;B01J13/04;;A61K9/14,A61K9/19;;A61K9/14;;A61K9/51;;A61K31/496;;A61K45/00;;A61K47/10;;A61K47/12;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/32;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;B01J13/04,,2,2,048-731-572-240-44X;;004-382-489-377-69X,10.1080/01932699408943545;;8331530;;10.1002/jps.2600820608,"SJÖSTRÖM B ET AL: ""THE FORMATION OF SUBMICRON ORGANIC PARTICLES BY PRECIPITATION IN AN EMULSION"", JOURNAL OF DISPERSION SCIENCE AND TECHNOLOGY, vol. 15, no. 1, 1994, pages 89 - 117, XP009002392;;SJOSTROM B ET AL: ""A METHOD FOR THE PREPARATION OF SUBMICRON PARTICLES OF SPARINGLY WATER-SOLUBLE DRUGS BY PRECIPITATION IN OIL-IN-WATER EMULSIONS. II: INFLUENCE OF THE EMULSIFIER, THE SOLVENT, AND THE DRUG SUBSTANCE"", JOURNAL OF PHARMACEUTICAL SCIENCES, AMERICAN PHARMACEUTICAL ASSOCIATION. WASHINGTON, US, vol. 82, no. 6, 1 June 1993 (1993-06-01), pages 584 - 589, XP000367863, ISSN: 0022-3549",PENDING
432,EP,B1,EP 1347747 B1,139-997-855-401-407,2006-03-08,2006,EP 01998077 A,2001-12-20,US 0149737 W;;US 25816000 P;;US 87479901 A;;US 87463701 A;;US 87449901 A;;US 95397901 A;;US 3582101 A;;US 2169201 A,2000-12-22,METHOD FOR PREPARING SUBMICRON PARTICLE SUSPENSIONS OF PHARMACEUTICAL AGENTS,,BAXTER INT,KIPP JAMES E;;WONG JOSEPH;;DOTY MARK J;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN;;WERLING JANE;;SRIRAM RAJARAM,,https://lens.org/139-997-855-401-407,Granted Patent,yes,10,1,27,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K31/495;;A61K31/496;;A61P31/10,A61K9/20;;A61K9/10;;C07D407/14;;A61K9/14;;A61K9/16;;A61K9/51;;A61K31/192;;A61K31/495;;A61K31/496;;A61K31/55;;A61K31/573;;A61K47/12;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61P31/10,,0,0,,,,EXPIRED
433,CA,A1,CA 2461349 A1,165-708-668-537-375,2003-04-03,2003,CA 2461349 A,2002-09-25,US 96427301 A;;US 18303502 A;;US 0230447 W,2001-09-26,PREPARATION OF SUBMICRON SIZED NANOPARTICLES VIA DISPERSION AND SOLVENT OR LIQUID PHASE REMOVAL,"The present invention relates to a process for preparing submicron sized nanoparticles of a poorly water soluble compound by sonicating to evaporate a portion of the organic phase or by lyophilizing a dispersion or microdispersion of a multiphase system having an organic phase and an aqueou s phase, the organic phase havingthe poorly water soluble organic compound therein. The method is preferably used to prepare nanoparticles of a poorly water soluble, pharmaceutically active compound suitable for in vivo deliver y, particularly by parenteral routes.",BAXTER INT,KIPP JAMES E;;DUNHAM ANDREW J;;DOTY MARK J;;NARAYANAN KRISHNASWAMY;;STERNBERG SHMUEL;;JAYSWAL NAILESH;;BRYNJELSEN SEAN,,https://lens.org/165-708-668-537-375,Patent Application,no,0,0,13,20,0,A61K9/5169;;A61K9/5192;;A61K9/145;;B01J13/04;;A61K9/5169;;A61K9/5192;;A61K9/145;;B01J13/04;;A61K9/14,A61K9/19;;A61K9/14;;A61K9/51;;A61K31/496;;A61K45/00;;A61K47/10;;A61K47/12;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/32;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;B01J13/04,,0,0,,,,EXPIRED
434,US,A1,US 2006/0280888 A1,191-400-687-314-451,2006-12-14,2006,US 56869204 A,2004-08-17,US 56869204 A;;US 49601103 P;;US 2004/0024383 W,2003-08-19,Impact-modified polyamide hollow body,Hollow bodies made from impact-modified polyamide. Fuel line hoses for both liquid fuel delivery and fuel vapor recovery.,SOLVAY ADVANCED POLYMERS LLC,BERSTED BRUCE H;;DOTY JAMES K;;DE CANNIERE JEAN;;DEHENNAU CLAUDE;;WARKOWSKI GREGORY;;BUSHELMAN CORRINE;;BILLIET JOHAN,SOLVAY ADVANCED POLYMERS L.L.C (2005-06-22),https://lens.org/191-400-687-314-451,Patent Application,yes,26,16,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,B32B1/08;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90;;B32B27/08;;B32B27/34,428/36.91;;428/35.7;;428/36.9,0,0,,,,ACTIVE
435,US,A9,US 2003/0206959 A9,066-063-309-722-275,2003-11-06,2003,US 2169201 A,2001-12-12,US 2169201 A;;US 95397901 A;;US 87463701 A;;US 25816000 P,2000-12-22,Method for preparing submicron particle suspensions,"
   The present invention provides a method for preparing a suspension of a pharmaceutically-active compound, the solubility of which is greater in a water-miscible first organic solvent than in a second solvent which is aqueous. The process includes the steps of: (i) dissolving a first quantity of the pharmaceutically-active compound in the water-miscible first organic solvent to form a first solution; (ii) mixing the first solution with the second solvent to precipitate the pharmaceutically-active compound; and (iii) seeding the first solution or the second solvent or the pre-suspension. 
",KIPP JAMES E.;;WONG JOSEPH CHUNG TAK;;DOTY MARK J.;;WERLING JANE;;REBBECK CHRISTINE L.;;BRYNJELSEN SEAN,KIPP JAMES E;;WONG JOSEPH CHUNG TAK;;DOTY MARK J;;WERLING JANE;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN,BAXTER INTERNATIONAL INC (2002-05-10),https://lens.org/066-063-309-722-275,Amended Application,yes,99,34,4,86,0,A61K9/10;;A61K9/10;;A61K9/14;;A61K9/14;;A61K9/145;;A61K9/145;;A61K9/146;;A61K9/146;;A61K9/1688;;A61K9/1688;;A61K31/495;;A61K31/495;;A61K31/496;;A61K31/496,A61K9/10;;A61K9/14;;A61K9/16;;A61K31/495;;A61K31/496,424/489;;264/5,0,0,,,,EXPIRED
436,EP,A2,EP 1534239 A2,096-458-832-387-971,2005-06-01,2005,EP 03811294 A,2003-08-04,US 0324353 W;;US 21335202 A;;US 24680202 A,2002-08-05,PREPARATION OF SUBMICRON SIZED PARTICLES WITH POLYMORPH CONTROL AND NEW POLYMORPH OF ITRACONAZOLE,,BAXTER INT,WERLING JANE;;KIPP JAMES E;;SRIRAM RAJARAM;;DOTY MARK J;;REBBECK CHRISTINE L;;WONG JOSEPH CHUNG TAK,,https://lens.org/096-458-832-387-971,Patent Application,yes,0,0,5,86,0,A61K9/14;;A61K9/0019;;A61K9/10;;A61K31/495,A61K9/00;;A61K31/495,,1,0,,,See references of WO 2004054500A3,DISCONTINUED
437,AU,A1,AU 2003/302162 A1,118-368-993-311-916,2004-07-09,2004,AU 2003/302162 A,2003-08-04,US 21335202 A;;US 24680202 A;;US 0324353 W,2002-08-05,PREPARATION OF SUBMICRON SIZED PARTICLES WITH POLYMORPH CONTROL AND NEW POLYMORPH OF ITRACONAZOLE,,BAXTER INT,WERLING JANE;;KIPP JAMES E;;SRIRAM RAJARAM;;DOTY MARK J;;REBBECK CHRISTINE L;;WONG JOSEPH CHUNG TAK,,https://lens.org/118-368-993-311-916,Patent Application,no,0,0,5,86,0,A61K9/14;;A61K9/0019;;A61K9/10;;A61K31/495,A61K9/00;;A61K31/495,,0,0,,,,DISCONTINUED
438,EP,A1,EP 2016938 A1,183-260-901-153-889,2009-01-21,2009,EP 08075760 A,2002-09-25,EP 02773579 A;;US 96427301 A;;US 18303502 A,2001-09-26,Preparation of submicron sized particles via dispersion and solevnt or liquid phase removal,"The present invention relates to a process for preparing submicron sized particles comprising the steps of: providing a crude dispersion of a multiphase system having an organic phase and an aqueous phase, the organic phase having a pharmaceutically active compound therein; providing energy to the crude dispersion to form a fine dispersion; freezing the fine dispersion; and lyophilizing the frozen dispersion to obtain particles having a mean particle size of less than 500nm.
",BAXTER INT,BRYNJELSEN SEAN;;STERNBERG SHMUEL;;DUNHAM ANDREW J;;NARAYANAN KRISHNASWAMY;;DOTY MARK J;;KIPP JAMES E;;JAYSWAL NAILESH,,https://lens.org/183-260-901-153-889,Patent Application,yes,29,5,7,20,0,A61K9/5169;;A61K9/5192;;A61K9/5169;;A61K9/5192,A61K9/14;;A61K9/19;;A61K9/51;;A61K31/496;;A61K45/00;;A61K47/10;;A61K47/12;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/32;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42,,2,2,048-731-572-240-44X;;004-382-489-377-69X,10.1080/01932699408943545;;8331530;;10.1002/jps.2600820608,"SJÖSTRÖM B ET AL: ""THE FORMATION OF SUBMICRON ORGANIC PARTICLES BY PRECIPITATION IN AN EMULSION"", JOURNAL OF DISPERSION SCIENCE AND TECHNOLOGY, vol. 15, no. 1, 1994, pages 89 - 117, XP009002392;;SJOSTROM B ET AL: ""A METHOD FOR THE PREPARATION OF SUBMICRON PARTICLES OF SPARINGLY WATER-SOLUBLE DRUGS BY PRECIPITATION IN OIL-IN-WATER EMULSIONS. II: INFLUENCE OF THE EMULSIFIER, THE SOLVENT, AND THE DRUG SUBSTANCE"", JOURNAL OF PHARMACEUTICAL SCIENCES, AMERICAN PHARMACEUTICAL ASSOCIATION. WASHINGTON, US, vol. 82, no. 6, 1 June 1993 (1993-06-01), pages 584 - 589, XP000367863, ISSN: 0022-3549",DISCONTINUED
439,ES,T3,ES 2260337 T3,001-535-371-978-575,2006-11-01,2006,ES 01998077 T,2001-12-20,US 25816000 P;;US 87479901 A;;US 87463701 A;;US 87449901 A;;US 3582101 A;;US 2169201 A;;US 95397901 A;;US 0149737 W,2000-12-22,PROCEDIMIENTO PARA PREPARAR SUSPENSIONES DE PARTICULAS SUBMICRONICAS DE AGENTES FARMACEUTICOS.,"Método para preparar partículas de tamaño submicrométrico de un compuesto farmacéuticamente activo cuya solubilidad es mayor en un primer disolvente miscible en agua que en un segundo disolvente que es acuoso, comprendiendo el proceso las etapas de: (i) disolver el compuesto farmacéuticamente activo en el primer disolvente miscible en agua para formar una solución, seleccionándose el primer disolvente de entre el grupo formado por N-metil-2-pirrolidinona, 2- pirrolidona, sulfóxido de dimetilo, dimetilacetamida, ácido láctico, metanol, etanol, isopropanol, 3- pentanol, n-propanol, glicerina, butilenglicol, etilenglicol, propilenglicol, monoglicéridos mono- y di-acilados, isosorbido de dimetilo, acetona, dimetilformamida, 1, 4-dioxano, acetato de etilo, acetato de propilo, polietilenglicol, polietilenglicol ésteres, sorbitanos de polietilenglicol, monoalquil polietilenglicol éteres, polipropilenglicol, alginato de polipropileno, propilenglicol 10 butanodiol, propilenglicol 10 metilglucosa éter, propilenglicol 20 metilglucosa éter, propilenglicol 15 estearil éter, dicaprilato de propilenglicol, dicaprato de propilenglicol, laurato de propilenglicol; (ii) mezclar la solución con el segundo disolvente para definir una presuspensión; y (iii) añadir energía a la presuspensión para formar partículas que tengan un tamaño de partícula medio efectivo inferior a aproximadamente 2 ìm, y dicha etapa de adición de energía comprende homogeneización, homogeneización por flujo a contracorriente, microfluidización o sonicación.",BAXTER INT,KIPP JAMES E;;WONG JOSEPH CHUNG TAK;;DOTY MARK J;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN;;WERLING JANE,,https://lens.org/001-535-371-978-575,Granted Patent,no,0,1,27,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K31/495;;A61K31/496;;A61P31/10,A61K9/10;;A61K9/14;;A61K9/16;;A61K31/495;;A61K31/496;;A61K47/12;;A61K47/14;;C07D407/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61P31/10,,0,0,,,,EXPIRED
440,CA,C,CA 2461349 C,035-340-171-894-549,2011-11-29,2011,CA 2461349 A,2002-09-25,US 96427301 A;;US 18303502 A;;US 0230447 W,2001-09-26,PREPARATION OF SUBMICRON SIZED NANOPARTICLES VIA DISPERSION AND SOLVENT OR LIQUID PHASE REMOVAL,"The present invention relates to a process for preparing submicron sized nanoparticles of a poorly water soluble compound by sonicating to evaporate a portion of the organic phase or by lyophilizing a dispersion or microdispersion of a multiphase system having an organic phase and an aqueous phase, the organic phase havingthe poorly water soluble organic compound therein. The method is preferably used to prepare nanoparticles of a poorly water soluble, pharmaceutically active compound suitable for in vivo delivery, particularly by parenteral routes.",BAXTER INT,BRYNJELSEN SEAN;;STERNBERG SHMUEL;;DUNHAM ANDREW J;;DOTY MARK J;;KIPP JAMES E;;JAYSWAL NAILESH;;NARAYANAN KRISHNASWAMY,,https://lens.org/035-340-171-894-549,Granted Patent,no,0,0,13,20,0,A61K9/5169;;A61K9/5192;;A61K9/145;;B01J13/04;;A61K9/5169;;A61K9/5192;;A61K9/145;;B01J13/04;;A61K9/14,A61K9/14;;A61K9/19;;A61K9/51;;A61K31/496;;A61K45/00;;A61K47/10;;A61K47/12;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/32;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;B01J13/04,,0,0,,,,EXPIRED
441,BR,A,BR PI0501648 A,165-786-213-567-395,2006-12-12,2006,BR PI0501648 A,2005-04-06,BR PI0501648 A,2005-04-06,preparação de partìculas de tamanho submìcron com controle polimorfo e novo polimorfo de itraconazol,"""PREPARAçãO DE PARTìCULAS DE TAMANHO SUBMìCRON COM CONTROLE POLIMORFO E NOVO POLIMORFO DE ITRACONAZOL"". A presente invenção refere-se a um processo de preparação de partículas com controle de polimorfo e tamanho de um composto farmacêutico, o processo incluindo as etapas de: (1) provimento de composto farmacêutico em uma primeira fase; (2) semeadura de composto; (3) causar uma mudança de fase no composto farmacêutico para uma segunda fase de uma desejada forma polimórfica; e (4) onde o tamanho de partícula médio das partículas é menos que 7 <109>m. A presente invenção ainda refere-se a uma forma polimórfica de itraconazol.",BAXTER INT,WERLING JANE;;KIPP JAMES E;;SRIRAM RAJARAM;;DOTY MARK J;;REBBECK CHRISTINE L;;WONG JOSEPH CHUNG TAK,,https://lens.org/165-786-213-567-395,Patent Application,no,0,0,1,1,0,,A61K9/00;;A61K9/127;;A61K9/14;;A61K31/495,,0,0,,,,DISCONTINUED
442,CN,A,CN 1688288 A,110-947-833-034-273,2005-10-26,2005,CN 03823792 A,2003-08-04,US 21335202 A,2002-08-05,Preparation of submicron sized particles with polymorph control and new polymorph of itraconazole,,BAXTER INT,JANE WERLING;;KIPP JAMES E;;RAJARAM SRIRAM;;DOTY MARK J;;REBBECK CHRISTINE L;;TAK WONG JOSEPH CHUNG,,https://lens.org/110-947-833-034-273,Patent Application,no,0,5,1,86,0,,A61K9/00,,0,0,,,,DISCONTINUED
443,US,B1,US 9596073 B1,174-722-025-780-694,2017-03-14,2017,US 201614993973 A,2016-01-12,US 201614993973 A,2016-01-12,Picosecond clock synchronization technique for communication and navigation platform equipment,"Systems and related methods for simultaneous high precision synchronization and syntonization of multiple sensors or clocks utilize a precision estimator that receives clock signals and time mark signals from both sensors (a reference sensor and a clock to be measured against the reference sensor). A precision time and frequency estimator determines a time offset, frequency offset, and phase offset of the measured sensor relative to the reference sensor. Associated systems can additionally determine the propagation delay between two remote subsystems connected by a communications channel. The communications channel may be a bidirectional duplexed or multiplexed channel allowing for mutual exchange of timing information along a single non-dedicated cable between sensors. Sensors may be synchronized to within 10 ps of each other without the need for THz clocks or fiber-optic cabling.",ROCKWELL COLLINS INC,REYES GINA M;;TIMMERMAN JASON H;;DOTY JAMES H;;HWANG PATRICK Y;;PENG GUOLIN;;MCGRAW GARY A,ROCKWELL COLLINS INC (2016-01-11),https://lens.org/174-722-025-780-694,Granted Patent,yes,2,22,1,1,0,G01R25/00;;H04J3/0638;;H04J3/0688;;H04J3/14;;H04J3/0676;;H04L7/0037;;H04L7/0045;;H04J3/0688;;H03L7/081;;H04J3/0638;;H04J3/14;;G01R25/00,H04L7/04;;H04L7/00,,9,3,002-126-560-383-801;;036-275-585-448-854;;127-006-235-102-638,10.1109/freq.2010.5556289;;10.1109/ispcs.2015.7324687;;10.1109/freq.1975.200112,"Silicon Labs, SyncE and IEEE 1588: Sync Distribution for a Unified Network, Jul. 2014, Silicon Laboratories, 16 pages.;;Pedro Moreira et al., Digital Dual Mixer Time Difference for Sub-Nanosecond Time Synchronization in Ethernet, Jun. 2010, Frequency Control Symposium (FCS), 2010 IEEE International, pp. 449-453.;;Opher Ronen et al., Enhanced Synchronization Accuracy in IEEE1588, Precision Clock Synchronization for Measurement, Control, and Communication (ISPCS), 2015 IEEE International Symposium, Oct. 11-16, 2015, pp. 76-81.;;J. Serrano, et al., The White Rabbit Project, 2013, Found online at , 7 pages.;;Gina Reyes et al., Picosecond-level Timing and Frequency Coordination Between Dissimilar Clocks, The Institute of Navigation, Jan. 27, 2016, 7 pages.;;J. Serrano et al., The White Rabbit Project, Proceedings of ICALEPCS2009, Kobe, Japan, Oct. 12-16, 2009, 3 pages.;;David W. Allan et al., Picosecond Time Difference Measurement System, 29th Annual Symposium on Frequency Control, 1975, IEEE, pp. 404-411.;;Tomasz Wlostowski, Precise time and frequency transfer in a White Rabbit network, Master's thesis, Warsaw University of Technology, May 2011, 98 pages.;;Maciej Lipinski, White Rabbit Ethernet-based solution for sub-ns synchronization and deterministic, reliable data delivery, Jul. 15, 2013, IEEE Plenary Meeting Geneve, 70 pages.",ACTIVE
444,CN,B,CN 1860003 B,005-424-015-214-361,2010-12-08,2010,CN 200480023881 A,2004-08-17,US 2004/0024383 W;;US 49601103 P,2003-08-19,"Impact-modified polyamide hollow body, manufacturing method thereof and fossil fuel driving apparatus",Hollow bodies made from impact-modified polyamide. Fuel line hoses for both liquid fuel delivery and fuel vapor recovery.,SOLVAY ADVANCED POLYMERS LLC,JEAN DE CANNIERE;;GREGORY WARKOSKI;;BERSTED BRUCE H;;DOTY JAMES K;;CLAUDE DEHENNAU;;CORRINE BUSHELMAN;;JOHAN BILLIET,,https://lens.org/005-424-015-214-361,Granted Patent,no,0,0,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,B28B1/00;;B28B3/00;;B28B5/00;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90;;B29D22/00;;B29D23/00;;B32B1/08;;B32B27/34;;C04B33/32;;C04B33/36;;C04B35/64,,0,0,,,,ACTIVE
445,US,A1,US 2004/0022862 A1,078-180-343-726-163,2004-02-05,2004,US 39033303 A,2003-03-17,US 39033303 A;;US 24680202 A;;US 3582101 A;;US 95397901 A;;US 87463701 A;;US 25816000 P,2000-12-22,Method for preparing small particles,"
   The present invention is concerned with the formation of small particles of organic compounds by precipitating the organic compounds in an aqueous medium to form a pre-suspension followed by adding energy to stabilize a coating of the particle or to alter the lattice structure of the particle. The process includes the steps of: (i) dissolving the organic compound in the water-miscible first solvent to form a solution; (ii) mixing the solution with the second solvent to define a presuspension of particles; and (iii) adding energy to the presuspension to form a suspension of particles having an average effective particle size of less than about 100 m. The process is preferably used to prepare a suspension of small particles of a poorly water-soluble, pharmaceutically active compound suitable for in vivo delivery by an administrate route such as parenteral, oral, pulmonary, nasal, buccal, topical ophthalmic, rectal, vaginal, transdermal or the like. 
",KIPP JAMES E.;;WONG JOSEPH CHUNG TAK;;DOTY MARK J.;;WERLING JANE;;REBBECK CHRISTINE L.;;BRYNJELSEN SEAN,KIPP JAMES E;;WONG JOSEPH CHUNG TAK;;DOTY MARK J;;WERLING JANE;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN,BAXTER INTERNATIONAL INC (2003-03-18),https://lens.org/078-180-343-726-163,Patent Application,yes,98,73,12,12,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1682;;A61K9/1688;;A61K31/12;;A61K31/337;;A61K31/495;;A61K31/496;;A61K31/55;;A61K31/573;;A61K9/16;;A61K31/496;;A61K31/495;;A61K9/1682;;A61K9/145;;A61K9/14;;A61K31/496;;A61K31/337;;A61K9/146;;A61K31/573;;A61K9/10;;A61K31/12;;A61K9/1688;;A61K31/55,A61K9/10;;A61K9/14;;A61K9/16;;A61K31/12;;A61K31/337;;A61K31/495;;A61K31/496;;A61K31/55;;A61K31/573,42449;;264/4,0,0,,,,DISCONTINUED
446,WO,A2,WO 2003/026611 A2,139-848-245-727-320,2003-04-03,2003,US 0230447 W,2002-09-25,US 96427301 A;;US 18303502 A,2001-09-26,PREPARATION OF SUBMICRON SIZED NANOPARTICLES VIA DISPERSION AND SOLVENT OR LIQUID PHASE REMOVAL,"The present invention relates to a process for preparing submicron sized nanoparticles of a poorly water soluble compound by sonicating to evaporate a portion of the organic phase or by lyophilizing a dispersion or microdispersion of a multiphase system having an organic phase and an aqueous phase, the organic phase havingthe poorly water soluble organic compound therein. The method is preferably used to prepare nanoparticles of a poorly water soluble, pharmaceutically active compound suitable for in vivo delivery, particularly by parenteral routes.",BAXTER INT,BRYNJELSEN SEAN;;STERNBERG SHMUEL;;DUNHAM ANDREW J;;DOTY MARK J;;KIPP JAMES E;;JAYSWAL NAILESH;;NARAYANAN KRISHNASWAMY,,https://lens.org/139-848-245-727-320,Patent Application,yes,0,0,13,20,0,A61K9/5169;;A61K9/5192;;A61K9/145;;B01J13/04;;A61K9/5169;;A61K9/5192;;A61K9/145;;B01J13/04;;A61K9/14,A61K9/19;;A61K9/14;;A61K9/51;;A61K31/496;;A61K45/00;;A61K47/10;;A61K47/12;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/32;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;B01J13/04,,0,0,,,,PENDING
447,US,A1,US 2010/0314793 A1,057-337-469-609-748,2010-12-16,2010,US 84903910 A,2010-08-03,US 84903910 A;;US 56869204 A;;US 2004/0024383 W;;US 49601103 P,2003-08-19,METHOD FOR MAKING A POLYAMIDE HOLLOW BODY,"Method for making a hollow body comprising, as sole layer(s), at least one layer L1 consisting of a polyamide composition comprising an aromatic polyamide and an impact modifier, said method comprising extruding the polyamide composition through a die.",SOLVAY ADVANCED POLYMERS LLC,BERSTED BRUCE H;;DOTY JAMES K;;DE CANNIERE JEAN;;DEHENNAU CLAUDE;;WARKOSKI GREGORY;;BUSHELMAN CORINNE;;BILLIET JOHAN,,https://lens.org/057-337-469-609-748,Patent Application,yes,2,2,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,D01D5/24;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90;;B32B27/34,264/209.1,0,0,,,,ACTIVE
448,US,A1,US 2005/0170002 A1,043-910-223-362-918,2005-08-04,2005,US 5227605 A,2005-02-07,US 5227605 A;;US 2169201 A;;US 95397901 A;;US 87463701 A;;US 3582101 A;;US 25816000 P,2000-12-22,Method for preparing submicron particle suspensions,"The present invention provides a method for preparing a suspension of a pharmaceutically-active compound, the solubility of which is greater in a water-miscible first organic solvent than in a second solvent which is aqueous. The process includes the steps of: (i) dissolving a first quantity of the pharmaceutically-active compound in the water-miscible first organic solvent to form a first solution; (ii) mixing the first solution with the second solvent to precipitate the pharmaceutically-active compound; and (iii) seeding the first solution or the second solvent or the pre-suspension.",KIPP JAMES E.;;TAK WONG JOSEPH C.;;DOTY MARK J.;;WERLING JANE;;REBBECK CHRISTINE L.;;BRYNJELSEN SEAN,KIPP JAMES E;;TAK WONG JOSEPH C;;DOTY MARK J;;WERLING JANE;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN,BAXTER HEALTHCARE S.A (2007-06-18);;BAXTER INTERNATIONAL INC (2007-06-18),https://lens.org/043-910-223-362-918,Patent Application,yes,99,11,4,86,0,A61K9/10;;A61K9/10;;A61K9/14;;A61K9/14;;A61K9/145;;A61K9/145;;A61K9/146;;A61K9/146;;A61K9/1688;;A61K9/1688;;A61K31/495;;A61K31/495;;A61K31/496;;A61K31/496,A61K9/10;;A61K9/14;;A61K9/16;;A61K31/495;;A61K31/496,424/489;;264/4,0,0,,,,DISCONTINUED
449,US,B2,US 8057732 B2,091-264-703-142-161,2011-11-15,2011,US 84903910 A,2010-08-03,US 84903910 A;;US 56869204 A;;US 2004/0024383 W;;US 49601103 P,2003-08-19,Method for making a polyamide hollow body,"Method for making a hollow body comprising, as sole layer(s), at least one layer L1 consisting of a polyamide composition comprising an aromatic polyamide and an impact modifier, said method comprising extruding the polyamide composition through a die.",BERSTED BRUCE H;;DOTY JAMES K;;DE CANNIERE JEAN;;DEHENNAU CLAUDE;;WARKOSKI GREGORY;;BUSHELMAN CORINNE;;BILLIET JOHAN;;SOLVAY ADVANCED POLYMERS LLC,BERSTED BRUCE H;;DOTY JAMES K;;DE CANNIERE JEAN;;DEHENNAU CLAUDE;;WARKOSKI GREGORY;;BUSHELMAN CORINNE;;BILLIET JOHAN,,https://lens.org/091-264-703-142-161,Granted Patent,yes,39,2,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,B29C45/00;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90;;B32B27/34;;B32B37/00,264/514;;264/464;;264/177.14,1,0,,,"Third Party Observations (Article 115 EPS), mailed Aug. 9, 2011, against European Patent No. 04 779 443.3 (EP 1 685 163 A1).",ACTIVE
450,TW,A,TW 200512226 A,193-489-625-982-215,2005-04-01,2005,TW 93124882 A,2004-08-18,US 49601103 P,2003-08-19,Impact-modified polyamide hollow body,Hollow bodies made from impact-modified polyamide. Fuel line hoses for both liquid fuel delivery and fuel vapor recovery.,SOLVAY ADVANCED POLYMERS LLC,BERSTED BRUCE H;;DOTY JAMES K;;DE CANNIERE JEAN;;DEHENNAU CLAUDE;;WARKOSKI GREGORY;;BUSHELMAN CORINNE;;BILLIET JOHAN,,https://lens.org/193-489-625-982-215,Patent of Addition,no,0,0,41,41,0,B29C48/86;;B32B1/08;;B32B27/34;;C08L77/06;;F16L11/04;;B29K2021/00;;B29K2077/00;;B29K2995/0089;;B29L2009/00;;B29L2023/005;;B29L2023/22;;B29L2031/30;;B29L2031/712;;B32B1/08;;B32B27/34;;C08L23/04;;C08L23/28;;C08L51/06;;C08L77/06;;F16L11/04;;F16L2011/047;;B29C48/08;;B29C48/10;;B29C48/13;;B29C48/0017;;B29C48/0018;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/903;;B32B27/18;;B32B27/20;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B27/302;;B32B2307/558;;B32B27/34;;B32B27/18;;Y10T428/1393;;Y10T428/1352;;Y10T428/139;;Y10T428/31732;;Y10T428/31728;;Y10T428/31725;;B32B27/32;;B32B27/08;;B32B2377/00;;B32B27/302;;B32B2307/558;;B32B2323/16;;B32B2325/00;;B32B27/34;;B29L2023/005;;B29L2031/712;;C08L51/06;;B29K2995/0089;;B29K2021/00;;B29L2031/30;;C08L23/28;;B29L2023/22;;B29K2077/00;;C08L77/06;;B32B1/08;;B29L2009/00;;F16L11/04;;C08L23/04;;F16L2011/047;;B29C48/10;;B29C48/903;;B29C48/0017;;B29C48/16;;B29C48/0018;;B29C48/86;;B29C48/13;;B29C48/08;;B29C48/21;;B32B27/20;;B32B27/18,B29C48/08;;B29C48/10;;B29C48/13;;B29C48/16;;B29C48/21;;B29C48/86;;B29C48/90;;B32B27/34,,0,0,,,,PENDING
451,US,B1,US 8909471 B1,132-098-843-515-710,2014-12-09,2014,US 201113250307 A,2011-09-30,US 201113250307 A,2011-09-30,Voting system and method using doppler aided navigation,"A position determining voting system that uses Doppler information from an on-board weather radar to improve the system's accuracy and/or fault tolerance includes a comparison function and an error integration function. The comparison function is used to monitor the independent position sources for correct operation, comparing and identifying a position source that should not be used based on its relative error compared with the other position sources and their characteristics. The integration function provides corrections to relative position sources by integrating the data from multiple absolute position sources when they are mutually consistent.",JINKINS RICHARD D;;RADEMAKER RICHARD M;;WOODELL DANIEL L;;DOTY JAMES H;;KERLEY KEITH L;;YOUNG JR JAMES ALVA;;YOUNG SHIH-YIH;;ROCKWELL COLLINS INC,JINKINS RICHARD D;;RADEMAKER RICHARD M;;WOODELL DANIEL L;;DOTY JAMES H;;KERLEY KEITH L;;YOUNG JR JAMES ALVA;;YOUNG SHIH-YIH,ROCKWELL COLLINS INC (2011-09-29),https://lens.org/132-098-843-515-710,Granted Patent,yes,73,20,1,1,0,G01S13/60;;G01S13/953;;G01S19/49;;Y02A90/10;;G01S13/60;;G01S13/953;;G01S19/49,G01S5/00,701/468;;701/1;;701/4;;701/41;;701/120;;701/470;;342/350;;342/352;;342/357.2;;342/357.24,9,0,,,"G2000, Garmin, printed from website https://buy.garmin.com/shop/shop.do?cID=153&pID=97668 on Jun. 28, 2011, 2 pages.;;G3000, Garmin, printed from website https://buy.garmin.com/shop/shop.do?cID=153&pID=66916 on Jun. 28, 2011, 2 pages.;;G5000, Garmin, printed from website https://buy.garmin.com/shop/shop.do?cID=153&pID=90821&ra=true on Apr. 20, 2011, 2 pages.;;Office Action for U.S. Appl. No. 13/224,992, mail date Feb. 28, 2013, 10 pages.;;Office Action for U.S. Appl. No. 13/743,182, mail date Apr. 8, 2013, 10 pages.;;U.S. Appl. No. 13/224,992, filed Sep. 2, 2011, Hufnagel et al.;;U.S. Appl. No. 13/250,798, filed Sep. 30, 2011, Jinkins et al.;;Office Action on U.S. Appl. No. 13/250,798 Dated Apr. 23, 2014, 15 pages.;;Final Office Action on U.S. Appl. No. 13/250,798 Dated Sep. 4, 2014, 22 pages.",ACTIVE
452,US,A,US 5873815 A,088-822-228-422-863,1999-02-23,1999,US 87966197 A,1997-06-23,US 87966197 A;;US 54438495 A;;US 2113096 P,1995-10-10,Access catheter and method for maintaining separation between a falloposcope and a tubal wall,"A method and apparatus are provided for imaging a narrow body lumen, the method comprising maintaining separation between a distal end of an optical viewing scope and a lumen wall with a spacing structure which extends distally from the distal end of an access catheter. Optional spacing structures include distal cages and a guidewire which is fixed to and extends distally from the access catheter body. The invention is beneficial during either retrograde imaging of the fallopian tube, and also allows antigrade imaging and advancing the access catheter and scope under the direction of the image provided, as it prevents the tubal wall from coming into such close proximity to a falloposcope as to produce ""white-out"" on the imaging monitor.",CONCEPTUS INC,KERIN JOHN;;MILO CHARLES;;NIKOLCHEV JULIAN N;;DOTY JAMES;;TON DAI T;;HILL RICHARD;;SCHRANER MARC;;KRAMER TOM,BAYER HEALTHCARE LLC (2015-07-11);;BAYER ESSURE INC (2013-10-25),https://lens.org/088-822-228-422-863,Granted Patent,yes,26,160,11,11,0,A61B1/0008;;A61B1/00082;;A61B1/00085;;A61B1/00135;;A61B1/00149;;A61B1/00165;;A61B1/04;;A61B1/07;;A61B1/303;;A61B1/32;;A61B5/6886;;A61B17/221;;A61B2017/2215;;A61B1/01;;A61B2090/0815;;A61B90/50;;A61B1/04;;A61B1/00149;;A61B17/221;;A61B1/303;;A61B1/0008;;A61B1/00135;;A61B5/6886;;A61B1/07;;A61B1/00085;;A61B1/00165;;A61B1/00082;;A61B1/32;;A61B2017/2215;;A61B1/01;;A61B90/50;;A61B2090/0815,A61B1/04;;A61B1/06;;A61B1/303;;A61B1/32;;A61B17/22;;A61B19/00,600/114;;600/127;;600/135;;604/208,2,2,065-960-382-511-187;;020-757-066-348-342,10.1016/0020-7292(91)90346-7;;10.1089/lps.1990.1.47;;2131110,"Kerin et al., Falloposcopy: A Microendoscopic Technique for Visual Exploration of the Human Fallopian Tube form the Uterotubal Ostium to the Fimria Using a Transvaginal Approach, Fertility and Sterility , vol. 54, No. 3, pp. 390 400 (1990).;;Kerin et al., Development and Application of a Falloposcope for Transvaginal Endoscopy of the Fallopian Tube, J. Laparoendoscopic Surgery , vol. 1 pp. 47 56.",EXPIRED
453,US,B1,US 6196966 B1,196-190-426-609-816,2001-03-06,2001,US 22200798 A,1998-12-30,US 22200798 A;;US 87966197 A;;US 54438495 A;;US 2113096 P,1995-10-10,Access catheter and method for maintaining separation between a falloposcope and a tubal wall,"A method and apparatus are provided for imaging a narrow body lumen, the method comprising maintaining separation between a distal end of an optical viewing scope and a lumen wall with a spacing structure which extends distally from the distal end of an access catheter. Optional spacing structures include distal cages and a guidewire which is fixed to and extends distally from the access catheter body. The invention is beneficial during either retrograde imaging of the fallopian tube, and also allows antigrade imaging and advancing the access catheter and scope under the direction of the image provided, as it prevents the tubal wall from coming into such close proximity to a falloposcope as to produce ""white-out"" on the imaging monitor.",CONCEPTUS INC,KERIN JOHN;;MILO CHARLES;;NIKOLCHEV JULIAN N;;DOTY JAMES;;TON DAI T;;HILL RICHARD;;SCHRANER MARC;;KRAMER TOM,BAYER HEALTHCARE LLC (2015-07-11);;BAYER ESSURE INC (2013-10-25),https://lens.org/196-190-426-609-816,Granted Patent,yes,33,110,11,11,0,A61B1/0008;;A61B1/00082;;A61B1/00085;;A61B1/00135;;A61B1/00149;;A61B1/00165;;A61B1/04;;A61B1/07;;A61B1/303;;A61B1/32;;A61B5/6886;;A61B17/221;;A61B2017/2215;;A61B1/01;;A61B2090/0815;;A61B90/50;;A61B1/04;;A61B1/00149;;A61B17/221;;A61B1/303;;A61B1/0008;;A61B1/00135;;A61B5/6886;;A61B1/07;;A61B1/00085;;A61B1/00165;;A61B1/00082;;A61B1/32;;A61B2017/2215;;A61B1/01;;A61B90/50;;A61B2090/0815,A61B1/04;;A61B1/06;;A61B1/303;;A61B1/32;;A61B17/22;;A61B19/00,600/114;;600/127;;600/104;;604/280,2,2,065-960-382-511-187;;020-757-066-348-342,10.1016/0020-7292(91)90346-7;;10.1089/lps.1990.1.47;;2131110,"Kerin, John et al., ""Falloposcopy: a microendoscopic technique for visual exploration of the human fallopian tube from the uterotubal ostium to the fimbria using a transvaginal approach,"" Fertility and Sterility, vol. 54, No. 3, Sep. 1990, pp. 390-400.;;Kerin, John et al., ""Development and Application of a Falloposcope for Transvaginal Endoscopy of the Fallopian Tube,"" Journal of Laparoeroscopic Surgery, vol. 1, No. 1, 1990, pp. 47-56.",EXPIRED
454,CA,C,CA 2431705 C,191-027-059-846-251,2010-10-05,2010,CA 2431705 A,2001-12-20,US 25816000 P;;US 87479901 A;;US 87463701 A;;US 87449901 A;;US 95397901 A;;US 3582101 A;;US 2169201 A;;US 0149737 W,2000-12-22,METHOD FOR PREPARING SUBMICRON PARTICLE SUSPENSIONS,"The present invention provides a method for preparing a suspension of a pharmaceutically-active compound, the solubility of which is greater in a water-miscible first organic solvent than in a second solvent which is aqueous. The process includes the steps of : (i) dissolving a first quantity of the pharmaceutically-active compound in the water-miscible first organic solvent to form a first solution ; (ii) mixing the first solution with the second solvent to precipitate the pharmaceutically-active compound ; and (iii) seeding the first solution or the second solvent or the presuspension.",BAXTER INT,KIPP JAMES E;;WONG JOSEPH CHUNG TAK;;DOTY MARK J;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN;;WERLING JANE;;SRIRAM RAJARAM,,https://lens.org/191-027-059-846-251,Granted Patent,no,0,0,27,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K31/495;;A61K31/496;;A61P31/10,A61K9/20;;C07D407/14;;A61K9/10;;A61K9/14;;A61K9/16;;A61K9/51;;A61K31/495;;A61K31/496;;A61K47/12;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61P31/10,,0,0,,,,EXPIRED
455,AU,B2,AU 2002/249836 B2,027-330-024-876-536,2006-12-14,2006,AU 2002/249836 A,2001-12-20,US 87479901 A;;US 3582101 A;;US 87463701 A;;US 2169201 A;;US 87449901 A;;US 25816000 P;;US 95397901 A;;US 0149737 W,2000-12-22,Method for preparing submicron particle suspensions,,BAXTER INT,BRYNJELSEN SEAN;;REBBECK CHRISTINE L;;KIPP JAMES E;;WONG JOSEPH CHUNG TAK;;DOTY MARK J;;WERLING JANE;;SRIRAM RAJARAM,,https://lens.org/027-330-024-876-536,Granted Patent,no,9,0,27,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K31/495;;A61K31/496;;A61P31/10,C07D407/14;;A61K9/10;;A61K9/14;;A61K9/16;;A61K31/495;;A61K31/496;;A61K47/12;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61P31/10,,0,0,,,,EXPIRED
456,AU,A1,AU 2006/201943 A1,125-803-960-203-596,2006-06-01,2006,AU 2006/201943 A,2006-05-10,US 25816000 P;;US 87479901 A;;US 87463701 A;;US 87449901 A;;US 95397901 A;;US 3582101 A;;US 2169201 A;;US 0149737 W,2000-12-22,Polymorphic pharmaceutically-active compounds,,BAXTER INT,SRIRAM RAJARAM;;KIPP JAMES E;;BRYNJELSEN SEAN;;DOTY MARK J;;WERLING JANE;;REBBECK CHRISTINE L;;WONG JOSEPH CHUNG TAK,,https://lens.org/125-803-960-203-596,Patent Application,no,0,0,27,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K31/495;;A61K31/496;;A61P31/10,A61K9/10;;C07D407/14;;A61K9/14;;A61K9/16;;A61K31/495;;A61K31/496;;A61K47/12;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61P31/10,,0,0,,,,DISCONTINUED
457,CA,A1,CA 2431705 A1,151-096-701-711-046,2002-07-18,2002,CA 2431705 A,2001-12-20,US 25816000 P;;US 87479901 A;;US 87463701 A;;US 87449901 A;;US 95397901 A;;US 3582101 A;;US 2169201 A;;US 0149737 W,2000-12-22,METHOD FOR PREPARING SUBMICRON PARTICLE SUSPENSIONS,"The present invention provides a method for preparing a suspension of a pharmaceutically-active compound, the solubility of which is greater in a water-miscible first organic solvent than in a second solvent which is aqueous. The process includes the steps of : (i) dissolving a first quantity of the pharmaceutically-active compound in the water-miscible first organic solvent to form a first solution ; (ii) mixing the first solution with the second solvent to precipitate the pharmaceutically-active compound ; and (ii i) seeding the first solution or the second solvent or the presuspension.</SDOA B>",BAXTER INT,BRYNJELSEN SEAN;;WERLING JANE;;REBBECK CHRISTINE L;;DOTY MARK J;;SRIRAM RAJARAM;;KIPP JAMES E;;WONG JOSEPH CHUNG TAK,,https://lens.org/151-096-701-711-046,Patent Application,no,0,0,27,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K31/495;;A61K31/496;;A61P31/10,C07D407/14;;A61K9/10;;A61K9/14;;A61K9/16;;A61K31/495;;A61K31/496;;A61K47/12;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61P31/10,,0,0,,,,EXPIRED
458,US,A1,US 2022/0064068 A1,029-930-766-019-738,2022-03-03,2022,US 202117409952 A,2021-08-24,US 202117409952 A;;US 202063073243 P,2020-09-01,Polymer Masonry Unit and Method Therefor,"A polymer masonry unit is disclosed that can include a polymer added to a quarry byproduct to manufacture a quality brick unit. The present disclosure solves the technological problem of providing a structurally sound brick or concrete alternative without the need for kiln firing, using traditionally unusable waste material. By combining quarry byproduct and a polymer, a polymer masonry unit can be fabricated having compressive strength and architectural utility. In one exemplary embodiment, fiber elements can be added to the byproduct and polymer mixture to increase structural stability. The present disclosure improves the performance of the system itself by providing a basic block or brick unit using an environmentally responsible manufacturing process that reduces cost and waste. The manufacturing process includes a polymer/base material that can be poured into molds that cures over a predetermined period, without the need for kiln firing.",LITHIC IND HOLDING CO,DENTON TODD;;DOTY MICHAEL;;WILLIAMS GRIFFITH J;;LOPEZ SAMUEL;;HILL KAMERON ANTHONY;;ROSS JONATHAN;;HAGAN DYLLON;;KENNEDY TIMOTHY JAMES,LITHIC INDUSTRIES HOLDING CO (2020-08-31),https://lens.org/029-930-766-019-738,Patent Application,yes,0,0,11,11,0,B29C67/243;;C04B26/04;;C04B26/045;;B28B1/14;;C04B20/008;;C04B14/28;;C04B41/5022;;C04B40/0032;;C04B26/04;;B29C67/243;;C04B41/65;;C04B41/009;;C04B26/045;;C04B14/28;;B28B1/14;;C04B41/5022;;C04B41/65;;C04B41/009,C04B26/04;;B28B1/14;;C04B14/28;;C04B41/00;;C04B41/50;;C04B41/65,,0,0,,,,PENDING
459,WO,A2,WO 2002/055059 A2,067-774-684-109-971,2002-07-18,2002,US 0149737 W,2001-12-20,US 25816000 P;;US 87479901 A;;US 87463701 A;;US 87449901 A;;US 95397901 A;;US 3582101 A;;US 2169201 A,2000-12-22,METHOD FOR PREPARING SUBMICRON PARTICLE SUSPENSIONS,"The present invention provides a method for preparing a suspension of a pharmaceutically-active compound, the solubility of which is greater in a water-miscible first organic solvent than in a second solvent which is aqueous. The process includes the steps of : (i) dissolving a first quantity of the pharmaceutically-active compound in the water-miscible first organic solvent to form a first solution ; (ii) mixing the first solution with the second solvent to precipitate the pharmaceutically-active compound ; and (iii) seeding the first solution or the second solvent or the presuspension.",BAXTER INT,KIPP JAMES E;;WONG JOSEPH CHUNG TAK;;DOTY MARK J;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN;;WERLING JANE;;SRIRAM RAJARAM,,https://lens.org/067-774-684-109-971,Patent Application,no,0,0,27,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K31/495;;A61K31/496;;A61P31/10,A61K9/10;;A61K9/14;;C07D407/14;;A61K9/16;;A61K31/495;;A61K31/496;;A61K47/12;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61P31/10,,0,0,,,,PATENTED
460,US,A1,US 2023/0062972 A1,087-891-017-634-068,2023-03-02,2023,US 202217677376 A,2022-02-22,US 202217677376 A;;US 202117409952 A;;US 202063073243 P,2020-09-01,Polymer Masonry Unit and Method Therefor,"A polymer-based compound, useful as a polymer masonry unit is disclosed that can include a polymer added to a quarry byproduct to manufacture a quality brick unit. The present disclosure solves the technological problem of providing a structurally sound brick or concrete alternative without the need for kiln firing, using traditionally unusable waste material. By combining quarry byproduct and a polymer, a polymer masonry unit can be fabricated having compressive strength and architectural utility. In one exemplary embodiment, fiber elements can be added to the byproduct and polymer mixture to increase structural stability. The present disclosure improves the performance of the system itself by providing a basic block or brick unit using an environmentally responsible manufacturing process that reduces cost and waste. The manufacturing process includes a polymer/base material that can be poured into molds that cures over a predetermined period, without the need for kiln firing.",LITHIC IND HOLDING CO,DENTON TODD;;DOTY MICHAEL;;WILLIAMS GRIFFITH J;;LOPEZ SAMUEL;;HILL KAMERON ANTHONY;;ROSS JONATHAN;;HAGAN DYLLON;;KENNEDY TIMOTHY JAMES,LITHIC INDUSTRIES HOLDING CO (2020-08-31),https://lens.org/087-891-017-634-068,Patent Application,yes,0,0,11,11,0,B29C67/243;;C04B26/04;;C04B26/045;;B28B1/14;;C04B20/008;;C04B14/28;;C04B41/5022;;C04B40/0032;;C04B26/04;;B29C67/243;;C04B41/65;;C04B41/009;;C04B26/045;;C04B14/28;;B28B1/14;;C04B41/5022;;C04B41/65;;C04B41/009,C04B26/04;;B28B1/14;;C04B14/28;;C04B41/00;;C04B41/50;;C04B41/65,,0,0,,,,ACTIVE
461,NO,L,NO 20032860 L,136-066-535-324-946,2003-08-21,2003,NO 20032860 A,2003-06-20,US 25816000 P;;US 87479901 A;;US 87463701 A;;US 87449901 A;;US 95397901 A;;US 3582101 A;;US 2169201 A;;US 0149737 W,2000-12-22,Fremgangsmåte for fremstilling av suspensjoner av submikrometerpartikler,,BAXTER INT,KIPP JAMES E;;WONG JOSEPH CHUNG TAK;;DOTY MARK J;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN;;WERLING JANE;;SRIRAM RAJARAM,,https://lens.org/136-066-535-324-946,Abstract,no,0,0,27,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K31/495;;A61K31/496;;A61P31/10,A61K9/10;;C07D407/14;;A61K9/14;;A61K9/16;;A61K31/495;;A61K31/496;;A61K47/12;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61P31/10,,0,0,,,,DISCONTINUED
462,EP,A3,EP 1642571 A3,010-247-513-645-232,2007-06-27,2007,EP 05077486 A,2001-12-20,EP 01998077 A;;US 25816000 P;;US 87479901 A;;US 87463701 A;;US 87449901 A;;US 95397901 A;;US 3582101 A;;US 2169201 A,2000-12-22,Method for preparing submicron particle suspensions,"The present invention provides a method a method for preparing a suspension of a pharmaceutically-active compound, the solubility of which is greater in a water-miscible first organic solvent than in a second solvent which is aqueous, the process comprising the steps of (i) dissolving a first quantity of the pharmaceutically-active compound in the water-miscible first organic solvent to form a first solution; (ii) mixing the first solution with the second solvent to precipitate the pharmaceutically-active compound to create a presuspension; and (iii) seeding the first solution or the second solvent prior to the mixing step or seeding the pre-suspension after the mixing step.",BAXTER INT,KIPP JAMES E;;WONG JOSEPH CHUNG TAK;;DOTY MARK J;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN;;WERLING JANE;;SRIRAM RAJARAM,,https://lens.org/010-247-513-645-232,Search Report,yes,8,0,27,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K31/495;;A61K31/496;;A61P31/10,A61K9/10;;A61K9/14;;C07D407/14;;A61K9/16;;A61K31/495;;A61K31/496;;A61K47/12;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61P31/10;;B01D9/02;;B01D21/01,,2,0,,,"EUGEN MÜLLER ED.: ""Methoden der Organischen Chemie - Allgemeine Laboratoriumspraxis"", 1958, GEORG THIEME VERLAG, STUTTGART, XP002376822;;ANONYMOUS: ""Crystal growth"", 11 April 2006 (2006-04-11), XP002376820, Retrieved from the Internet <URL:http://www.chem.tamu.edu/xray/pdf/guide%20to%20crystal%20growth.pdf> [retrieved on 20060411]",DISCONTINUED
463,WO,A3,WO 2002/055059 A3,157-037-842-735-904,2002-09-06,2002,US 0149737 W,2001-12-20,US 25816000 P;;US 87479901 A;;US 87463701 A;;US 87449901 A;;US 95397901 A;;US 3582101 A;;US 2169201 A,2000-12-22,METHOD FOR PREPARING SUBMICRON PARTICLE SUSPENSIONS,"The present invention provides a method for preparing a suspension of a pharmaceutically-active compound, the solubility of which is greater in a water-miscible first organic solvent than in a second solvent which is aqueous. The process includes the steps of : (i) dissolving a first quantity of the pharmaceutically-active compound in the water-miscible first organic solvent to form a first solution ; (ii) mixing the first solution with the second solvent to precipitate the pharmaceutically-active compound ; and (iii) seeding the first solution or the second solvent or the presuspension.",BAXTER INT,KIPP JAMES E;;WONG JOSEPH CHUNG TAK;;DOTY MARK J;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN;;WERLING JANE;;SRIRAM RAJARAM,,https://lens.org/157-037-842-735-904,Search Report,yes,10,0,27,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K31/495;;A61K31/496;;A61P31/10,A61K9/10;;A61K9/14;;A61K9/16;;C07D407/14;;A61K31/495;;A61K31/496;;A61K47/12;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61P31/10,,0,0,,,,PATENTED
464,BR,A,BR 0116377 A,166-518-084-630-92X,2005-12-13,2005,BR 0116377 A,2001-12-20,US 25816000 P;;US 87463701 A;;US 87479901 A;;US 87449901 A;;US 95397901 A;;US 3582101 A;;US 2169201 A;;US 0149737 W,2000-12-22,"Métodos para preparar partìculas submicronicamente dimensionadas de um composto orgânico, e para preparar uma suspensão de um composto farmaceuticamente ativo, e, composição de matéria","""MéTODOS PARA PREPARAR PARTìCULAS SUBMICRONICAMENTE DIMENSIONADAS DE UM COMPOSTO ORGâNICO, E PARA PREPARAR UMA SUSPENSãO DE UM COMPOSTO FARMACEUTICAMENTE ATIVO, E, COMPOSIçãO DE MATERIAL"". A presente invenção provê um método para preparar uma suspensão de um composto farmaceuticamente ativo, cuja solubilidade é maior em um primeiro solvente orgânico miscível em água do que em um segundo solvente que é aquoso. O processo inclui as etapas de: (i) dissolver uma primeira quantidade do composto farmaceuticamente ativo no primeiro solvente orgânico miscível em água, para formar uma primeira solução; (ii) misturar a primeira solução com o segundo solvente, para precipitar o composto farmaceuticamente ativo; e (iii) semear a primeira solução ou o segundo solvente ou a suspensão.",BAXTER INT,KIPP JAMES E;;WONG JOSEPH CHUNG TAK;;DOTY MARK J;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN;;WERLING JANE;;SRIRAM AJARAM,,https://lens.org/166-518-084-630-92X,Patent Application,no,0,0,27,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K31/495;;A61K31/496;;A61P31/10,C07D407/14;;A61K9/10;;A61K9/14;;A61K9/16;;A61K31/495;;A61K31/496;;A61K47/12;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61P31/10,,0,0,,,,DISCONTINUED
465,ZA,B,ZA 200304742 B,147-398-857-259-008,2004-08-24,2004,ZA 200304742 A,2003-06-19,US 25816000 P,2000-12-22,Method for preparing submicron particle suspensions.,,BAXTER INT,KIPP JAMES E;;WONG JOSEPH CHUNG TAK;;DOTY MARK J;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN;;WERLING JANE;;SPIRAM RAJARAM,,https://lens.org/147-398-857-259-008,Granted Patent,no,0,0,7,86,0,A61K9/10;;A61K9/10;;A61K9/14;;A61K9/14;;A61K9/145;;A61K9/145;;A61K9/146;;A61K9/146;;A61K9/1688;;A61K9/1688;;A61K31/495;;A61K31/495;;A61K31/496;;A61K31/496;;Y10T428/2984;;Y10T428/2984;;Y10T428/2985;;Y10T428/2985,A61K/;;A61K9/10;;A61K9/14;;A61K9/16;;A61K31/495;;A61K31/496,,0,0,,,,EXPIRED
466,US,B1,US 11608296 B1,045-690-435-855-969,2023-03-21,2023,US 202217677376 A,2022-02-22,US 202217677376 A;;US 202117409952 A;;US 202063073243 P,2020-09-01,Polymer masonry unit and method therefor,"A polymer-based compound, useful as a polymer masonry unit is disclosed that can include a polymer added to a quarry byproduct to manufacture a quality brick unit. The present disclosure solves the technological problem of providing a structurally sound brick or concrete alternative without the need for kiln firing, using traditionally unusable waste material. By combining quarry byproduct and a polymer, a polymer masonry unit can be fabricated having compressive strength and architectural utility. In one exemplary embodiment, fiber elements can be added to the byproduct and polymer mixture to increase structural stability. The present disclosure improves the performance of the system itself by providing a basic block or brick unit using an environmentally responsible manufacturing process that reduces cost and waste. The manufacturing process includes a polymer/base material that can be poured into molds that cures over a predetermined period, without the need for kiln firing.",LITHIC IND HOLDING CO,DENTON TODD;;DOTY MICHAEL;;WILLIAMS GRIFFITH J;;LOPEZ SAMUEL;;HILL KAMERON ANTHONY;;ROSS JONATHAN;;HAGAN DYLLON;;KENNEDY TIMOTHY JAMES,LITHIC INDUSTRIES HOLDING CO (2020-08-31),https://lens.org/045-690-435-855-969,Granted Patent,yes,5,0,11,11,0,B29C67/243;;C04B26/04;;C04B26/045;;B28B1/14;;C04B20/008;;C04B14/28;;C04B41/5022;;C04B40/0032;;C04B26/04;;B29C67/243;;C04B41/65;;C04B41/009;;C04B26/045;;C04B14/28;;B28B1/14;;C04B41/5022;;C04B41/65;;C04B41/009,C04B26/04;;B28B1/14;;C04B14/28;;C04B41/00;;C04B41/50;;C04B41/65,,2,1,046-620-557-776-065,10.1016/j.conbuildmat.2014.06.061,"Baghini et al. Effect of styrene-butadiene copolymer latex on properties and durability of road base stabilized with Portland cement additive. Construction and Building Materials 68 (2014) 740-749. (Year: 2014).;;Beatite 30 data Sheet, Onyx Marbles Granules. pp. 1-2 (Year: 2003).",ACTIVE
467,NZ,A,NZ 526608 A,100-149-947-853-067,2006-06-30,2006,NZ 52660801 A,2001-12-20,US 25816000 P;;US 87479901 A;;US 87463701 A;;US 87449901 A;;US 95397901 A;;US 3582101 A;;US 2169201 A;;US 0149737 W,2000-12-22,Method for preparing submicron particle suspensions,"A method for preparing submicron sized particles of a pharmaceutically-active compound, the solubility of which is greater in a water-miscible first solvent than in a second solvent which is aqueous is disclosed, wherein the process comprises the steps of: (i) dissolving the pharmaceutically-active compound in the water-miscible first solvent to form a solution, the first solvent being selected from the group consisting of N methyl-2-pyrrolidinone, 2-pyrrolidone, dimethyl sulfoxide, dimethylacetamide, lactic acid, methanol, ethanol, isopropanol, 3-pentanol, n-propanol, glycerol, butylene glycol, ethylene glycol, polypropylene glycol, mono- and diacylated monoglycerides, dimethyl isosorbide, acetone, dimethylformamide, 1,4-dioxane, ethyl acetate, propyl acetate, polyethylene glycol, polyethylene glycol esters, polyethylene glycol sorbitans, polyethylene glycol monoalkyl ethers, polypolypropylene glycol, polypropylene alginate, polypolypropylene glycol-10 butanediol, polypolypropylene glycol-10 methyl glucose ether, polypolypropylene glycol-20 methyl glucose ether, polypolypropylene glycol-15 stearyl ether, polypolypropylene glycol dicaprylate, polypropylene glycol dicaprate, polypropylene glycol laurate; (ii) mixing the solution with the second solvent to define a pre-suspension; and (iii) adding energy to the pre-suspension to form particles having an average effective particle size of less than about 2 micron, and said adding energy step comprises homogenization, counter-current flow homogenization, microfluidization or sonication.",BAXTER INT,KIPP JAMES E;;WONG JOSEPH CHUNG TAK;;DOTY MARK J;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN;;WERLING JANE;;SRIRAM RAJARAM,,https://lens.org/100-149-947-853-067,Patent Application,no,0,0,27,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K31/495;;A61K31/496;;A61P31/10,A61K9/10;;A61K9/14;;A61K9/16;;C07D407/14;;A61K31/495;;A61K31/496;;A61K47/12;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61P31/10,,0,0,,,,DISCONTINUED
468,EP,A2,EP 1347747 A2,160-947-140-361-363,2003-10-01,2003,EP 01998077 A,2001-12-20,US 0149737 W;;US 25816000 P;;US 87479901 A;;US 87463701 A;;US 87449901 A;;US 95397901 A;;US 3582101 A;;US 2169201 A,2000-12-22,METHOD FOR PREPARING SUBMICRON PARTICLE SUSPENSIONS OF PHARMACEUTICAL AGENTS,,BAXTER INT,KIPP JAMES E;;WONG JOSEPH CHUNG TAK;;DOTY MARK J;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN;;WERLING JANE;;SRIRAM RAJARAM,,https://lens.org/160-947-140-361-363,Patent Application,yes,0,1,27,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K31/495;;A61K31/496;;A61P31/10,A61K9/10;;A61K9/14;;A61K9/16;;A61K31/495;;A61K31/496;;A61K47/12;;C07D407/14;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61P31/10,,0,0,,,,EXPIRED
469,DK,T3,DK 1347747 T3,018-042-816-982-799,2006-04-10,2006,DK 01998077 T,2001-12-20,US 25816000 P;;US 87479901 A;;US 87463701 A;;US 87449901 A;;US 95397901 A;;US 3582101 A;;US 2169201 A,2000-12-22,Fremgangsmåde til behandling af submikropartikelsuspensioner af farmaceutiske midler,,BAXTER INT,WONG JOSEPH CHUNG TAK;;BRYNJELSEN SEAN;;WERLING JANE;;SRIRAM RAJARAM;;KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L,,https://lens.org/018-042-816-982-799,Granted Patent,no,0,0,27,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K31/495;;A61K31/496;;A61P31/10,A61K9/20;;A61K9/10;;C07D407/14;;A61K9/14;;A61K9/16;;A61K9/51;;A61K31/192;;A61K31/495;;A61K31/496;;A61K31/55;;A61K31/573;;A61K47/12;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61P31/10,,0,0,,,,EXPIRED
470,HU,A2,HU P0501030 A2,056-802-095-887-640,2007-02-28,2007,HU P0501030 A,2001-12-20,US 25816000 P;;US 87479901 A;;US 87463701 A;;US 3582101 A;;US 87449901 A;;US 95397901 A;;US 2169201 A;;US 0149737 W,2000-12-22,METHOD FOR PREPARING SUBMICRON PARTICLE SUSPENSIONS,,BAXTER INT,KIPP JAMES E;;WONG JOSEPH CHUNG TAK;;DOTY MARK J;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN;;WERLING JANE;;SRIRAM RAJARAM,,https://lens.org/056-802-095-887-640,Patent Application,no,0,0,27,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K31/495;;A61K31/496;;A61P31/10,C07D407/14;;A61K9/10;;A61K9/14;;A61K9/16;;A61K31/495;;A61K31/496;;A61K47/12;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61P31/10,,0,0,,,,DISCONTINUED
471,US,A,US 3267955 A,104-288-424-489-978,1966-08-23,1966,US 31295863 A,1963-10-01,US 31295863 A,1963-10-01,Hospital recovery room facility,,LOGAN HOSPITAL EQUIPMENT CO,LOGAN HUGH H;;DOTY GEORGE I;;NELSON JAMES F;;ALFULTIS FRANK K;;LOCKHART JR CHARLES E;;WHITE HENRY M,,https://lens.org/104-288-424-489-978,Granted Patent,no,2,28,1,1,0,A61G10/00;;E04H3/08;;Y10T137/8593;;Y10T137/6969;;Y10T137/8593;;Y10T137/6969;;A61G10/00;;E04H3/08,A61G10/00;;E04H3/08,,0,0,,,,EXPIRED
472,CN,A,CN 1505503 A,164-861-478-589-849,2004-06-16,2004,CN 01821103 A,2001-12-20,US 25816000 P;;US 87479901 A;;US 87463701 A;;US 87449901 A;;US 95397901 A;;US 3582101 A;;US 2169201 A,2000-12-22,Method for preparing submicron particle suspensions,本发明提供了制备药物活性化合物悬浮液的方法，这种化合物在可与水混溶的第一溶剂中的溶解度大于在第二含水溶剂中的溶解度。制备过程包括的步骤有：(i)将初始量的药物活性化合物溶解到可与水混溶的第一有机溶剂中，形成第一溶液；(ii)将第一溶液和第二溶剂混合，沉淀药物活性化合物；(iii)向第一溶液，或第二溶剂，或预悬浮液中引入晶种。,BAXTER INT,REBBECK CHRISTINE L;;TAK WONG JOSEPH CHUNG;;DOTY MARK J;;SEAN BRYNJELSEN;;KIPP JAMES E;;RAJARAM SRIRAM;;JANE WERLING,,https://lens.org/164-861-478-589-849,Patent Application,no,0,3,27,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K31/495;;A61K31/496;;A61P31/10,C07D407/14;;A61K9/10;;A61K9/14;;A61K9/16;;A61K31/495;;A61K31/496;;A61K47/12;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61P31/10,,0,0,,,,EXPIRED
473,NO,D0,NO 20032860 D0,064-938-789-898-97X,2003-06-20,2003,NO 20032860 A,2003-06-20,US 25816000 P;;US 87479901 A;;US 87463701 A;;US 87449901 A;;US 95397901 A;;US 3582101 A;;US 2169201 A;;US 0149737 W,2000-12-22,Fremgangsmåte for fremstilling av partikkelsuspensjoner med submikronstörrelse,,BAXTER INT,KIPP JAMES E;;WONG JOSEPH CHUNG TAK;;DOTY MARK J;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN;;WERLING JANE;;SRIRAM RAJARAM,,https://lens.org/064-938-789-898-97X,Patent Application,no,0,0,27,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K31/495;;A61K31/496;;A61P31/10,A61K9/10;;C07D407/14;;A61K9/14;;A61K9/16;;A61K31/495;;A61K31/496;;A61K47/12;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61P31/10,,0,0,,,,DISCONTINUED
474,CA,A,CA 770343 A,036-590-307-136-228,1967-10-31,1967,CA 770343D A,,CA 770343T A,,HOSPITAL RECOVERY ROOM FACILITY AND THE LIKE,,LOGAN HOSPITAL EQUIPMENT CO,WHITE HENRY M;;NELSON JAMES F;;ALFULTIS FRANK K;;DOTY GEORGE I;;LOCKHART CHARLES E JR;;LOGAN HUGH H,,https://lens.org/036-590-307-136-228,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
475,AT,T1,AT E319432 T1,118-747-444-975-218,2006-03-15,2006,AT 01998077 T,2001-12-20,US 25816000 P;;US 87479901 A;;US 87463701 A;;US 87449901 A;;US 95397901 A;;US 3582101 A;;US 2169201 A,2000-12-22,VERFAHREN ZUR HERSTELLUNG VON SUBMIKROPARTIKEL- SUSPENSIONEN PHARMAZEUTISCHER SUBSTANZEN,,BAXTER INT,KIPP JAMES E;;WONG JOSEPH CHUNG TAK;;DOTY MARK J;;REBBECK CHRISTINE L;;BRYNJELSEN SEAN;;WERLING JANE;;SRIRAM RAJARAM,,https://lens.org/118-747-444-975-218,Granted Patent,no,0,0,27,86,0,A61K9/10;;A61K9/14;;A61K9/145;;A61K9/146;;A61K9/1688;;A61K31/495;;A61K31/496;;A61P31/10,C07D407/14;;A61K9/10;;A61K9/14;;A61K9/16;;A61K31/495;;A61K31/496;;A61K47/12;;A61K47/14;;A61K47/18;;A61K47/20;;A61K47/24;;A61K47/28;;A61K47/34;;A61K47/36;;A61K47/38;;A61K47/42;;A61P31/10,,0,0,,,,EXPIRED
476,US,A1,US 2018/0280971 A1,065-179-720-088-380,2018-10-04,2018,US 201815942052 A,2018-03-30,US 201815942052 A;;US 201762480905 P,2017-04-03,MICROFLUIDIC SYSTEM FOR EVALUATION OF CHEMOTHERAPEUTIC AND IMMUNOTHERAPEUTIC DRUGS,"Systems and methods for conducting assays on tissue fragment samples including providing a suspension maintaining pump, and a plurality of fluid reservoirs, wherein the fluid reservoirs are configured to hold a volume of fluid. The fluid reservoirs are fluidically coupled to a microfluidic assay chip, wherein the microfluidic assay chip includes a plurality of parallel assay channels, a first inlet port for introduction of a tissue fragment sample into the microfluidic assay ship, and a second inlet port coupled to the fluid reservoir. Each channel of the microfluidic assay chip also includes a retention barrier configured to trap the tissue fragment sample such that the fluid perfuses through the tissue sample, as well as an outlet port fluidically coupled to a waste receptacle.",CHARLES STARK DRAPER LABORATORY INC,BORENSTEIN JEFFREY T;;GIMBEL ALLA A;;SANTOS JOSE A;;DOTY DANIEL T;;MOORE NATHAN F;;KRATCHMAN LOUIS B;;TRUSLOW JAMES,THE CHARLES STARK DRAPER LABORATORY INC (2020-11-10),https://lens.org/065-179-720-088-380,Patent Application,yes,0,1,4,4,0,B01L3/502746;;B01L2400/086;;B01L3/502761;;B01L3/50273;;C12Q1/24;;G01N33/5011;;B01L2200/027;;B01L2400/04;;B01L2300/0864;;B01L2200/0647;;B01L3/502761;;B01L3/502746;;B01L2400/086,B01L3/00;;C12Q1/24;;G01N33/50,,0,0,,,,ACTIVE
477,US,A1,US 2007/0038650 A1,103-903-513-786-371,2007-02-15,2007,US 20420905 A,2005-08-15,US 20420905 A,2005-08-15,Synchronizing transaction ambient state among multiple transaction managers,"The present invention extends to methods, systems, and computer program products for synchronizing ambient state among multiple transaction managers. A coordinating transaction manager establishes transaction ambient state for an application initiated transaction. The coordinating transaction manager sends and a subordinate transaction manager receives a pointer to an ambient state delegate. The subordinate transaction manager sends a request to invoke the ambient state delegate to the coordinating transaction manager in response to receiving an operation. The coordinating transaction manager invokes the ambient state delegate to format the transaction ambient state for the subordinate transaction manager. The coordinating transaction manager sends and the subordinate transaction manager receives the formatted transaction ambient state such that the subordinate transaction manager can appropriately process the operation within the scope of the transaction. The subordinate transaction manager utilizes the formatted transaction ambient state to appropriately process the operation within the scope of the transaction.",MICROSOFT CORP,CARLEY WILLIAM J;;JOHNSON JAMES E;;DOTY JOHN D;;CARGILLE JONATHAN M;;GUPTA KAPIL;;FEINGOLD MAX A;;CLARK MICHAEL R,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2005-09-20),https://lens.org/103-903-513-786-371,Patent Application,yes,6,9,2,2,0,G06F9/466;;G06F9/466,G06F7/00,707/100,0,0,,,,INACTIVE
478,WO,A1,WO 2018/187181 A1,199-662-895-854-672,2018-10-11,2018,US 2018/0025497 W,2018-03-30,US 201762480905 P,2017-04-03,MICROFLUIDIC SYSTEM FOR EVALUATION OF CHEMOTHERAPEUTIC AND IMMUNOTHERAPEUTIC DRUGS,"Systems and methods for conducting assays on tissue fragment samples including providing a suspension maintaining pump, and a plurality of fluid reservoirs, wherein the fluid reservoirs are configured to hold a volume of fluid. The fluid reservoirs are fluidically coupled to a microfluidic assay chip, wherein the microfluidic assay chip includes a plurality of parallel assay channels, a first inlet port for introduction of a tissue fragment sample into the microfluidic assay ship, and a second inlet port coupled to the fluid reservoir. Each channel of the microfluidic assay chip also includes a retention barrier configured to trap the tissue fragment sample such that the fluid perfuses through the tissue sample, as well as an outlet port fluidically coupled to a waste receptacle.",CHARLES STARK DRAPER LABORATORY INC,BORENSTEIN JEFFREY T;;GIMBEL ALLA A;;SANTOS JOSE A;;DOTY DANIEL T;;MOORE NATHAN F;;KRATCHMAN LOUIS B;;TRUSLOW JAMES,,https://lens.org/199-662-895-854-672,Patent Application,yes,4,0,4,4,0,B01L3/502746;;B01L2400/086;;B01L3/502761;;B01L3/50273;;C12Q1/24;;G01N33/5011;;B01L2200/027;;B01L2400/04;;B01L2300/0864;;B01L2200/0647;;B01L3/502761;;B01L3/502746;;B01L2400/086,B01L3/00,,0,0,,,,PENDING
479,US,B2,US 11628437 B2,038-731-930-223-816,2023-04-18,2023,US 201815942052 A,2018-03-30,US 201815942052 A;;US 201762480905 P,2017-04-03,Microfluidic system for evaluation of chemotherapeutic and immunotherapeutic drugs,"Systems and methods for conducting assays on tissue fragment samples including providing a suspension maintaining pump, and a plurality of fluid reservoirs, wherein the fluid reservoirs are configured to hold a volume of fluid. The fluid reservoirs are fluidically coupled to a microfluidic assay chip, wherein the microfluidic assay chip includes a plurality of parallel assay channels, a first inlet port for introduction of a tissue fragment sample into the microfluidic assay ship, and a second inlet port coupled to the fluid reservoir. Each channel of the microfluidic assay chip also includes a retention barrier configured to trap the tissue fragment sample such that the fluid perfuses through the tissue sample, as well as an outlet port fluidically coupled to a waste receptacle.",CHARLES STARK DRAPER LABORATORY INC,BORENSTEIN JEFFREY T;;GIMBEL ALLA A;;SANTOS JOSE A;;DOTY DANIEL T;;MOORE NATHAN F;;KRATCHMAN LOUIS B;;TRUSLOW JAMES,THE CHARLES STARK DRAPER LABORATORY INC (2020-11-10),https://lens.org/038-731-930-223-816,Granted Patent,yes,20,0,4,4,0,B01L3/502746;;B01L2400/086;;B01L3/502761;;B01L3/50273;;C12Q1/24;;G01N33/5011;;B01L2200/027;;B01L2400/04;;B01L2300/0864;;B01L2200/0647;;B01L3/502761;;B01L3/502746;;B01L2400/086,B01L3/00;;C12Q1/24;;G01N33/50,,15,6,034-429-643-662-717;;052-934-670-414-233;;037-220-493-883-400;;012-843-870-486-309;;032-113-634-002-844;;027-089-202-689-023,10.3389/fonc.2013.00090;;pmc3628362;;23616948;;10.1007/s10439-011-0428-9;;21997391;;22160577;;10.1007/s10439-011-0480-5;;10.1038/nbt1208-1345;;19060870;;10.1039/b802395f;;18818801;;pmc2560179;;pmc4017600;;23358873;;10.1007/s10544-012-9734-8,"Schiavoni et al. The tumor microenvironment: a pitch for multiple players. Front. Oncol. 2013;3(90):1-15.;;Office Action dated Mar. 4, 2015 in U.S. Appl. No. 14/070,444.;;Office Action dated Dec. 3, 2015 in U.S. Appl. No. 14/070,444.;;International Search Report and Written Opinion dated Jan. 31, 2014 in PCT Application No. PCT/US2013/068168 (9 pages).;;Office Action dated Jun. 21, 2017 in U.S. Appl. No. 14/586,577.;;Notice of Allowance dated Oct. 12, 2017 in U.S. Appl. No. 14/586,577.;;Doran, Marianne, Fine-Needle Aspiration Biopsy for Ocular and Orbital Tumors, Oncology, EyeNet, pp. 37-39, Jul. 2012.;;Hattersley et al., A Microfludic System for Testing the Responses of Head and Neck Squamous Cell Carcinoma Tissue Biopsies to Treatment with Chemotherapy Drugs, Annals of Biomedical Engineering, vol. 40, No. 6, pp. 1277-1288 (Jun. 2012).;;Prot et al, The Current Status of Alternative to Animal Testing and Predictive Toxicology Methods Using Liver Microfluidic Biochips, Annals of biomedical engineering, vol. 40, No. 6, pp. 1228-1243 (Jun. 2012).;;Sorger, Peter K., Microfluidic closes in on point-of-care assays, Nature Biotechnology, vol. 26, No. 12, pp. 1345-1346 (Dec. 2008).;;Vickerman et al., Design, fabrication and implementation of a novel multi-parameter control microfluidic platform for three-dimensional cell culture and real-time imaging, Lab on a Chip, vol. 8, No. 9, pp. 1468-1477 (Jul. 2008).;;Zhang et al, Microfluidics and cancer: are we there yet?, Biomed Microdevices, vol. 15, No. 4, pp. 595-609 (Jan. 2013).;;FNBA. Procedures/diagnostic tests: interventional radiology. Clinical Center National Institutes of Health. 2010; 1-5.;;Kim et al. In-situ synthesized and patterned nanowire arrays in microfluidic channel for particle trapping and cell lysis applications. 15th International Conference on Miniaturized Systems for Chemistry and Life Sciences. 2011; 1789-1791.;;International Search Report and Written Opinion dated Jun. 6, 2018 in PCT Application No. PCT/US2018/025497.",ACTIVE
480,EP,A1,EP 3606669 A1,008-569-370-898-602,2020-02-12,2020,EP 18719010 A,2018-03-30,US 201762480905 P;;US 2018/0025497 W,2017-04-03,MICROFLUIDIC SYSTEM FOR EVALUATION OF CHEMOTHERAPEUTIC AND IMMUNOTHERAPEUTIC DRUGS,,CHARLES STARK DRAPER LABORATORY INC,BORENSTEIN JEFFREY T;;GIMBEL ALLA A;;SANTOS JOSE A;;DOTY DANIEL T;;MOORE NATHAN F;;KRATCHMAN LOUIS B;;TRUSLOW JAMES,,https://lens.org/008-569-370-898-602,Patent Application,yes,0,0,4,4,0,B01L3/502746;;B01L2400/086;;B01L3/502761;;B01L3/50273;;C12Q1/24;;G01N33/5011;;B01L2200/027;;B01L2400/04;;B01L2300/0864;;B01L2200/0647;;B01L3/502761;;B01L3/502746;;B01L2400/086,B01L3/00,,0,0,,,,PENDING
481,US,A1,US 2010/0088685 A1,006-459-831-106-111,2010-04-08,2010,US 41594909 A,2009-03-31,US 41594909 A;;US 10313508 P,2008-10-06,SYSTEM AND METHOD FOR MAPPING A DOMAIN MODELING LANGUAGE TO A RELATIONAL STORE,A method and system for mapping between constructs in a domain modeling language and a relational storage language is provided. A source code authored in a source language is received and a set of constructs in the source code are identified. The set of constructs in the source code are mapped to a set of constructs in a target language. The source code is then compiled into a target code authored in the target language such that one of the source code or target code include a declarative constraint-based and/or order-independent execution model.,MICROSOFT CORP,AHMED HAROON;;BLOESCH ANTHONY C;;DOTY JOHN DAVID;;GUDGIN MARTIN JAMES;;KEISER JOHN BRADEN;;LANGWORTHY DAVID EVANS;;SZYPERSKI CLEMENS ALDEN,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2009-03-31),https://lens.org/006-459-831-106-111,Patent Application,yes,24,8,1,1,0,G06F8/51;;G06F8/51;;G06F16/2435;;G06F16/2435;;G06F16/284;;G06F16/284,G06F9/45;;G06F9/44,717/140;;717/117,1,0,,,"Jernej Kovse, ""Metaprogramming for Relational Databases"" , Springer-Verlag Berlin Heidelberg , 2004 , , Pages 1-14",DISCONTINUED
482,ES,T3,ES 2418858 T3,000-625-855-267-721,2013-08-16,2013,ES 07024235 T,2007-12-13,US 61044406 A;;US 86715807 A,2006-12-13,Soporte costal para paneles de alas,"Una estructura de avión (400; 526) que comprende: una costilla (506-510); una pluralidad de larguerillos (512-522) que tiene pestañas de revestimiento metálico (608-612) en extremos de lapluralidad de larguerillos (512-522) capaces de ser sujetados a una revestimiento metálico (524) para la estructurade avión (400; 526); y un conjunto de uniones contra cizalladura (600, 602) que se extienden desde las costillas (506-510) y que tienenun conjunto de miembros alargados (624-635) en los que el conjunto de miembros alargados están unidos apestañas de revestimiento metálico (608-612) de la pluralidad de larguerillos (512-522), en la que el conjunto de uniones contra cizalladura (600, 602) están unidas a las pestañas o pestañas (608-612)de revestimiento metálico de la pluralidad de larguerillos y a un revestimiento metálico (524), en la que el conjunto de miembros alargados incluye un conjunto de cartelas o cartelas (624-630), en la que un larguerillo (520) en la pluralidad de larguerillos (512-522) tiene una pestaña (608) de revestimientometálico, una primera cartela (626) en el conjunto de cartelas (624 -630) está situada sobre un primer lado dellarguerillo (520), una segunda cartela (628) en el conjunto de cartelas (624 -630) está situada sobre un segundolado del larguerillo (520), una primer pestaña (662) para la primera cartela (626) está sujeta a la pestaña (608) derevestimiento metálico y una segunda pestaña (664) para la segunda cartela (628) está sujeta a la pestaña (608)de revestimiento metálico, en la que la primera y segunda pestañas (662, 664) están sujetas a la pestaña (608) de revestimiento metálico delarguerillo mediante sujetadores (616, 618) que también sujetan el revestimiento metálico (524) a la pestaña (608)de revestimiento metálico de larguerillo, caracterizada por que el primer larguerillo (520) tiene una pestaña (648) libre de larguerillo que comprende una sección estrecha (100)para permitir que la primera y segunda cartelas (626, 628) estén más cerca entre sí, en que la pestaña libre delarguerillo se ensancha hacia fuera de la sección estrecha (800).",BOEING CO,TANNER RICHARD B;;BURFORD IAN C;;GENDZWILL THOMAS V;;DOTY GREGORY B;;HUCK JAMES R;;WILSON DEAN E;;KORENAGA BRIAN H,,https://lens.org/000-625-855-267-721,Granted Patent,no,0,0,9,13,0,B64C3/187;;B64C3/26;;B64C3/187;;B64C3/26,B64C3/00;;B64C1/00;;B64C3/18;;B64C3/26,,0,0,,,,ACTIVE
483,US,A1,US 2008/0210821 A1,148-878-483-586-045,2008-09-04,2008,US 61044406 A,2006-12-13,US 61044406 A,2006-12-13,RIB SUPPORT FOR WING PANELS,"An innovative wing structure provides ribs to support skin panels without an attachment between the rib and the stringer free flange or the web. The support is provided by rib shear ties installed directly to the stringer skin flange. The rib incorporates a cut away to allow the stringer to pass through the rib. The composite stringer is an ‘I’ section and is stable under compression, not requiring mechanical methods to prevent rolling over.",BOEING CO,TANNER RICHARD B;;BURFORD IAN C;;GENDZWILL THOMAS V;;DOTY GREGORY B;;HUCK JAMES R;;WILSON DEAN E;;KORENAGA BRIAN H,THE BOEING COMPANY (2006-12-07),https://lens.org/148-878-483-586-045,Patent Application,yes,13,18,4,13,0,B64C3/182;;B64C3/187;;B64C3/26;;B64C3/182;;B64C3/26;;B64C3/187,B64C3/26;;B64C3/18,244/123.3,0,0,,,,ACTIVE
484,EP,B1,EP 1942052 B1,166-497-617-988-482,2013-04-10,2013,EP 07024235 A,2007-12-13,US 61044406 A;;US 86715807 A,2006-12-13,Rib support for wing panels,,BOEING CO,TANNER RICHARD B;;BURFORD IAN C;;GENDZWILL THOMAS V;;DOTY GREGORY B;;HUCK JAMES R;;WILSON DEAN E;;KORENAGA BRIAN H,,https://lens.org/166-497-617-988-482,Granted Patent,yes,5,1,9,13,0,B64C3/187;;B64C3/26;;B64C3/187;;B64C3/26,B64C3/00;;B64C1/00;;B64C3/18;;B64C3/26,,0,0,,,,ACTIVE
485,EP,A1,EP 1942052 A1,079-996-678-638-112,2008-07-09,2008,EP 07024235 A,2007-12-13,US 61044406 A;;US 86715807 A,2006-12-13,Rib support for wing panels,"A method and apparatus for an aircraft structure. In one advantageous embodiment, the aircraft structure (400,526) may have a rib (506-510), a plurality of stringers (512-522), and a set of shear ties (600,602). The plurality of stringers may have skin flanges (608-612) at ends of the plurality of stringers capable of being fastened to skin (524) for the aircraft structure. The set of shear ties may extend from the rib and have a set of elongate members (624-635) in which the set of elongate members are attached to the plurality of stringers.
",BOEING CO,TANNER RICHARD B;;BURFORD IAN C;;GENDZWILL THOMAS V;;DOTY GREGORY B;;HUCK JAMES R;;WILSON DEAN E;;KORENAGA BRIAN H,,https://lens.org/079-996-678-638-112,Patent Application,yes,6,11,9,13,0,B64C3/187;;B64C3/26;;B64C3/187;;B64C3/26,B64C3/00;;B64C1/00;;B64C3/18;;B64C3/26,,0,0,,,,ACTIVE
486,ES,T5,ES 2418858 T5,140-586-920-259-160,2017-05-19,2017,ES 07024235 T,2007-12-13,US 61044406 A;;US 86715807 A,2006-12-13,Soporte costal para paneles de alas,,BOEING CO,TANNER RICHARD B;;BURFORD IAN C;;GENDZWILL THOMAS V;;DOTY GREGORY B;;HUCK JAMES R;;WILSON DEAN E;;KORENAGA BRIAN H,,https://lens.org/140-586-920-259-160,Amended Patent,no,0,0,9,13,0,B64C3/187;;B64C3/26;;B64C3/187;;B64C3/26,B64C3/00;;B64C1/00;;B64C3/18;;B64C3/26,,0,0,,,,ACTIVE
487,US,B2,US 7721995 B2,087-001-910-591-462,2010-05-25,2010,US 61044406 A,2006-12-13,US 61044406 A,2006-12-13,Rib support for wing panels,"An innovative wing structure provides fibs to support skin panels without an attachment between the rib and the stringer free flange or the web. The support is provided by rib shear ties installed directly to the stringer skin flange. The rib incorporates a cut away to allow the stringer to pass through the rib. The composite stringer is an ‘I’ section and is stable under compression, not requiring mechanical methods to prevent rolling over.",BOEING CO,TANNER RICHARD B;;BURFORD IAN C;;GENDZWILL THOMAS V;;DOTY GREGORY B;;HUCK JAMES R;;WILSON DEAN E;;KORENAGA BRIAN H,THE BOEING COMPANY (2006-12-07),https://lens.org/087-001-910-591-462,Granted Patent,yes,13,24,4,13,0,B64C3/182;;B64C3/187;;B64C3/26;;B64C3/182;;B64C3/26;;B64C3/187,B64C1/12,244/132,0,0,,,,ACTIVE
488,JP,A,JP 2008174223 A,146-308-336-038-615,2008-07-31,2008,JP 2007320940 A,2007-12-12,US 61044406 A;;US 86715807 A,2006-12-13,AIRCRAFT STRUCTURE AND METHOD FOR MANUFACTURING THE SAME,"<P>PROBLEM TO BE SOLVED: To provide a structural element provided with an improved load passage when supporting a rib of a wing panel. <P>SOLUTION: This aircraft structure may have the rib 400, a plurality of longitudinal penetrating materials 412 and a pair of shear ties 406. The plurality of longitudinal penetrating materials 412 may have outer plate flanges fastened to an outer plate 416 for the aircraft structure at end parts of the plurality of longitudinal penetrating materials 412. The pair of shear ties 406 are capable of being extended from the rib 400 and having a pair of elongate members. In the pair of shear ties 406, the pair of elongate members are mounted on the plurality of longitudinal penetrating materials 412. <P>COPYRIGHT: (C)2008,JPO&INPIT",BOEING CO,TANNER RICHARD B;;BURFORD IAN C;;GENDZWILL THOMAS V;;DOTY GREGORY B;;HUCK JAMES R;;WILSON DEAN E;;KORENAGA BRIAN H,,https://lens.org/146-308-336-038-615,Patent Application,no,3,3,9,13,0,B64C3/187;;B64C3/26;;B64C3/187;;B64C3/26,B64C1/06,,0,0,,,,ACTIVE
489,US,A1,US 2008/0173757 A1,120-000-729-933-333,2008-07-24,2008,US 86715807 A,2007-10-04,US 86715807 A;;US 61044406 A,2006-12-13,RIB SUPPORT FOR WING PANELS,"A method and apparatus for an aircraft structure. In one advantageous embodiment, the aircraft structure may have a rib, a plurality of stringers, and a set of shear ties. The plurality of stringers may have skin flanges at ends of the plurality of stringers capable of being fastened to skin for the aircraft structure. The set of shear ties may extend from the rib and have a set of elongate members in which the set of elongate members are attached to the plurality of stringers.",TANNER RICHARD B;;BURFORD IAN C;;GENDZWILL THOMAS V;;DOTY GREGORY B;;HUCK JAMES R;;WILSON DEAN E;;KORENAGA BRIAN H,TANNER RICHARD B;;BURFORD IAN C;;GENDZWILL THOMAS V;;DOTY GREGORY B;;HUCK JAMES R;;WILSON DEAN E;;KORENAGA BRIAN H,THE BOEING COMPANY (2007-10-02),https://lens.org/120-000-729-933-333,Patent Application,yes,11,14,9,13,0,B64C3/187;;B64C3/26;;B64C3/187;;B64C3/26,B64C1/12,244/119,0,0,,,,ACTIVE
490,US,B2,US 7686251 B2,137-663-557-650-314,2010-03-30,2010,US 86715807 A,2007-10-04,US 86715807 A;;US 61044406 A,2006-12-13,Rib support for wing panels,"A method and apparatus for an aircraft structure. In one advantageous embodiment, the aircraft structure may have a rib, a plurality of stringers, and a set of shear ties. The plurality of stringers may have skin flanges at ends of the plurality of stringers capable of being fastened to skin for the aircraft structure. The set of shear ties may extend from the rib and have a set of elongate members in which the set of elongate members are attached to the plurality of stringers.",BOEING CO,TANNER RICHARD B;;BURFORD IAN C;;GENDZWILL THOMAS V;;DOTY GREGORY B;;HUCK JAMES R;;WILSON DEAN E;;KORENAGA BRIAN H,THE BOEING COMPANY (2007-10-02),https://lens.org/137-663-557-650-314,Granted Patent,yes,11,17,9,13,0,B64C3/187;;B64C3/26;;B64C3/187;;B64C3/26,B64C1/12,244/132;;244/123.1,0,0,,,,ACTIVE
491,EP,B2,EP 1942052 B2,010-380-980-818-553,2016-11-02,2016,EP 07024235 A,2007-12-13,US 61044406 A;;US 86715807 A,2006-12-13,Rib support for wing panels,,BOEING CO,TANNER RICHARD B;;BURFORD IAN C;;GENDZWILL THOMAS V;;DOTY GREGORY B;;HUCK JAMES R;;WILSON DEAN E;;KORENAGA BRIAN H,,https://lens.org/010-380-980-818-553,Granted Patent,yes,4,0,9,13,0,B64C3/187;;B64C3/26;;B64C3/187;;B64C3/26,B64C3/00;;B64C1/00;;B64C3/18;;B64C3/26,,0,0,,,,ACTIVE
492,US,B2,US 8263131 B2,116-844-579-151-875,2012-09-11,2012,US 41448409 A,2009-03-30,US 41448409 A;;US 83454104 A;;US 27026802 A;;US 2169201 A;;US 95397901 A;;US 87463701 A;;US 3582101 A;;US 24680202 A;;US 46635403 P;;US 25816000 P,2000-12-22,Method for treating infectious organisms normally considered to be resistant to an antimicrobial drug,"The present invention relates to compositions of submicron- to micron-size particles of antimicrobial agents. More particularly the invention relates to a composition of an antimicrobial agent that renders the agent potent against organisms normally considered to be resistant to the agent. The composition comprises an aqueous suspension of submicron- to micron-size particles containing the agent coated with at least one surfactant selected from the group consisting of: ionic surfactants, non-ionic surfactants, biologically derived surfactants, and amino acids and their derivatives. The particles have a volume-weighted mean particle size of less than 5 μm as measured by laser diffractometry.",RABINOW BARRETT;;WHITE RANDY;;SUN CHONG-SON;;WONG JOSEPH CHUNG TAKE;;KIPP JAMES E;;DOTY MARK;;REBBECK CHRISTINE L;;PAPADOPOULOS PAVLOS;;BAXTER INT;;BAXTER HEALTHCARE SA,RABINOW BARRETT;;WHITE RANDY;;SUN CHONG-SON;;WONG JOSEPH CHUNG TAKE;;KIPP JAMES E;;DOTY MARK;;REBBECK CHRISTINE L;;PAPADOPOULOS PAVLOS,BAXTER HEALTHCARE S.A (2004-08-31);;BAXTER INTERNATIONAL INC (2004-08-31),https://lens.org/116-844-579-151-875,Granted Patent,yes,102,0,3,86,0,A61K9/10;;A61K9/10;;A61K9/14;;A61K9/14;;A61K9/145;;A61K9/145;;A61K9/146;;A61K9/146;;A61K9/1688;;A61K9/1688;;A61K9/5015;;A61K9/5015;;A61K9/5031;;A61K9/5031;;A61K9/5036;;A61K9/5036;;A61K9/5042;;A61K9/5042;;A61K9/5123;;A61K9/5123;;A61K9/5138;;A61K9/5138;;A61K9/5146;;A61K9/5146;;A61K9/5192;;A61K9/5192;;A61K31/495;;A61K31/495;;A61K31/496;;A61K31/496;;A61P31/10,A61K9/14;;A61K9/10;;A61K9/16;;A61K9/50;;A61K9/51;;A61K31/495;;A61K31/496,424/489,49,34,023-472-452-533-132;;073-577-567-102-695;;034-014-902-162-764;;127-777-087-783-421;;024-652-650-292-987;;026-723-593-893-660;;006-217-108-185-939;;011-075-606-016-388;;012-864-980-464-648;;082-207-433-645-369;;017-941-342-747-510;;119-833-547-951-97X;;005-210-493-767-784;;085-347-131-566-853;;046-244-745-371-27X;;122-266-283-338-249;;010-262-579-618-54X;;035-919-228-575-462;;069-412-683-797-359;;002-728-188-175-800;;016-080-604-800-855;;148-321-288-504-659;;172-810-960-405-059;;013-572-361-844-432;;057-449-226-918-016;;001-155-857-960-135;;117-534-654-905-212;;064-523-632-943-432;;004-382-489-377-69X;;005-840-366-684-763;;032-334-120-416-889;;088-548-957-452-959;;017-541-414-387-84X;;018-188-239-454-962,10.1093/jac/44.4.429;;10588302;;2436731;;10.1139/y87-035;;10.1016/0014-5793(87)80506-9;;3666140;;12103427;;10.1016/s0166-3542(02)00052-9;;11196193;;pmc163350;;10.1128/aac.40.6.1467;;8726020;;10.1054/drup.2001.0216;;11768333;;12960232;;10.1189/jlb.0503204;;10.1007/s004170050094;;9602323;;11704885;;10.1080/135502801753248114;;10.1016/s0378-5173(78)80002-7;;10.1097/00000542-200209002-01153;;10.1073/pnas.98.2.658;;pmc14644;;11136236;;10.1073/pnas.021551798;;14615656;;10.1097/00126334-200312010-00005;;10.1517/13543784.8.6.903;;15992139;;9685869;;10.1016/s0168-3659(97)00105-3;;8959248;;10.1089/aid.1996.12.1709;;11356986;;10.1016/0021-8502(89)90765-9;;10.1023/a:1018831415131;;10227713;;10.1128/cdli.9.3.515-524.2002;;pmc119973;;11986254;;9697721;;10.1086/515642;;10.1038/nrd1494;;15340388;;10.1016/s0169-409x(99)00017-4;;10837765;;10.1002/jps.2600670417;;641758;;10.1002/jps.2600670418;;641759;;10.1200/jco.2004.22.90140.2135;;11879753;;10.1016/s0378-5173(01)00986-3;;8331530;;10.1002/jps.2600820608;;10.1016/0378-5173(92)90051-3;;10.1128/aac.47.1.238-243.2003;;pmc149042;;12499197;;10.1021/js9700661;;9269864;;10.1016/s1081-1206(10)62949-3;;9494448;;7302990;;10.1016/0378-4274(81)90035-7,"Martin, The use of fluconazole and itraconazole in the treatment of Candida albicans infections, Journal of Antimicrobial Chemotherapy, 1999, 44, 429-437.;;http://www.who.int/mediacentre/factsheets/fs194/en/, accessed May 20, 2011.;;Allen et al., ""Critical evaluation of acute cardiopulmonary toxicity of microspheres,"" J. Nucl. Med., 19:1204-8 (1987).;;Allen et al., ""Effects on the murine mononuclear phagocyte system of chronic administration of liposomes containing cytotoxic drug or lipid A compared with empty liposomes,"" Can. J. Physiol. Pharmacol., 65:185-90 (1987).;;Allen et al., ""Large unilamellar liposomes with low uptake into the reticuloendothelial system,"" FEBS Lett., 223:42-46 1987.;;Anonymous, Crystal growing, retrieved from the Internet: URL:http://www.chem.tamu.edu/xray/pdf/guide%20to%20crystal%20growth.pdf >, 2009.;;Aquaro et al., ""Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir,"" Antiviral Res., 55:209-25 (2002).;;Avanti Polar Lipids, Inc., ""Polymer and polymerizable lipids: polyethylene glycol)-lipid conjugates,"" (Mar. 2003), retrieved from the Internet: .;;Avanti Polar Lipids, Inc., ""Polymer and polymerizable lipids: functionalized PEG lipids,"" (Mar. 2003), retrieved from the Internet: .;;Avanti Polar Lipids, Inc., ""Synthetic products-functionalized phospholipids: lipids for conjugation of proteins/pepetides/drugs to lipsomes,"" (Mar. 2003), retrieved from the Internet: .;;Bacher et al., ""D-24851, a novel synthetic microtubule inhibitor, exerts curative antitumoral activity in vivo, shows efficacy toward multidrug-resistant tumor cells, and lacks neurotoxicity,"" Cancer Res., 61: 392-9 (2001).;;Bender et al., ""Efficiency of nanoparticles as a carrier for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophases in vitro, antimicrobial agents and chemotherapy,"" Antimicrob. Agents Chemother., 40:1467-71 (1996).;;Broxterman et al., ""Cancer research 2001: Drug resistance, new targets and drug combinations"" Drug Resistance Updates, 4:197-209 (2001).;;Crowe et al., ""The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection,"" J. Leukoc. Biol., 74:635-641 (2003).;;Davis et al., ""Pulmonary perfusion imaging: acute toxicity and safety factors as a function of particle size,"" J. Nucl. Med., 19:1209-1213 (1978).;;Duncker et al., ""Effects of the pharmaceutical cosolvent hydroxypropyl-beta-cyclodextrin on porcine corneal endothelium,"" Graefes Arch. Clin. Exp. Opthalmol., 236::380-9 (1998).;;Eugen Müller (ed.), Methoden der Organischen Chemie-Allgemeine Laboratoriumspraxis, 1958, Georg Thieme Verlag, Stuttgart, p. 375.;;Fischer-Smith et al., ""CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection,"" J. Neurovirol., 7:528-41 (2001).;;Graham et al., ""The effects of freezing on commercial insulin suspensions,"" Int. J. Pharmaceutics, (1978).;;Gurinder et al., ""Analysis of systems failure leading to medication errors: The role of sentinel events for anesthesiologists,"" Anesthesiology Abstracts of Scientific Papers Annual Meeting, No. 2002, Abstract No. A-1153 (2002).;;Heiati et al., ""Solid lipid nanoparticles as drug carriers: II. Plasma stability and biodistribution of solid lipid nanoparticles containing the lipophilic prodrug 3'' -azido-3'' -deoxythymidine palmitate in mice,"" Int. J. Pharmaceutics, 174:71-80 (1998).;;Igarashi et al., ""Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): implications for HIV-1 infections of humans,"" Proc. Natl. Acad. Sci. USA, 98:658-63 (2001).;;Kinman et al., ""Lipid-drug association enhanced HIV-1 protease inhibitor indinavir localize ion in lymphoid tissues and viral load reduction: a proof of concept study in HIV-2287-infected macaques,"" J. Acquir. Immune Defic. Syndr., 34:387-97 (2003).;;Lavelle et al., ""American Association for Cancer Research 1999: Apr. 10-14, Philadelphia, Pennsylvania,"" Exp. Opin. Investigations Drugs, 8:903-9 (1999).;;Limoges et al., ""Sustained antiretroviral activity of indinavir nanosuspensions in primary monocyte-derived macrophages,"" poster presentation, 11th Conference on Retroviruses and Opportunistic Infections, Feb. 8-11, 2004.;;Lobenberg et al., ""Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after i.v. injection to rats,"" J. Control. Release, 50:21-30 (1998).;;Lobenberg et al., ""Macrophage targeting of azidothymidine: a promising strategy for AIDS therapy,"" AIDS Res. Hum. Retroviruses, 12:1709-15 (1996).;;Meyer et al., ""High-pressure sterilization of foods,"" Food Technology, 54:67-72 (Nov. 2000).;;Moghimi et al., ""Long-circulating and target-specific nanoparticles: theory to practice,"" Pharmacol. Rev., 53:283-318 (2001).;;Mroczka, ""Integral transform technique in particle sizing,"" J. Aerosol Sci., 20:1075-7 (1989).;;Na et al., ""Cloud point of nonionic surfactants: modulation with pharmaceutical excipients,"" Pharmaceutical Research, 16:562-8 (1999).;;Nesbit et al., ""In vitro and animal models of human immunodeficiency virus infection of the central nervous system,"" Clin. Diagn. Lab. Immunol., 9:515-24 (2002).;;Nottet et al., ""HIV-1 entry into brain: Mechanisms for the infiltration of HIV-1-infected macrophages across the blood-brain barrier,"" p. 55, in Gendelman (ed.) et al., The Neurology of AIDS, New York: Hodder Arnold Publication (1997).;;Perno et al., ""Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus,"" J. Infect. Dis., 178:413-22 (1998).;;Rabinow, ""Nanosuspensions in drug delivery,"" Nat. Rev. Drug Discov., 3:785-96 (2004).;;Ricketts, Project Habbakuk, Retrieved from the Internet on Aug. 20, 2007, .;;Sawchuk et al., ""Investigation of distribution, transport and uptake of anti-HIV drugs to the central nervous system,"" Adv. Drug Deliv. Rev., 39:5-31 (1999).;;Schroeder et al., ""Distribution of radiolabeled subvisible microspheres after intravenous administration to beagle dogs,"" J. Pharm. Sci., 67:504-7 (1978).;;Schroeder et al., ""Physiological effects of subvisible microspheres administered intravenously to beagle dogs,"" J. Pharm. Sci., 67:508-13 (1978).;;Shrayer et al., Ceramide, a mediator of apoptosis, synergizes with paclitaxel to induce regression of the L3.6 human pancreatic carcinoma implanted in SCID mice, J. Clin. Oncol., 22:2135 (2004).;;Singla et al., ""Paclitaxel and its formulations,"" Int. J. Pharm., 235:179-192 (2002).;;Sjostrom et al., ""A method for the preparation of submicron particles of sparingly water-soluble drugs by precipitation in oil-in-water emulsions. II: Influence of the emulsifier, the solvent, and the drug substance,"" J. Pharm. Sci., 82:584-9 (1993).;;Sjostrom et al., ""Preparation of submicron drug particles in lecithin-stabilized o/w emulsions I. Model studies of the precipitation of cholesteryl acetate,"" Int. J. Pharm., 88:53-62 (1992).;;Sjostrom et al., ""The formation of submicron organic particles by precipitation in an emulsion,"" J. Dispers. Sci. Tech., 15:89-117 (1994).;;Solas et al., ""Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients,"" Antimicrob. Agents Chemother., 47:238-43 (2003).;;Subramaniam et al., ""Pharmaceutical processing with supercritical carbon dioxide,"" J. Pharm. Sci., 86:885-90 (1997).;;Volcheck et al., ""Anaphylaxis to intravenous cyclosporine and tolerance to oral cyclosporine: case resort and review,"" Ann. Allergy Asthma Immunol., 80:159-63 (1998).;;Von Briesen et al., ""Controlled release of antiretroviral drugs,"" AIDS Rev., 2:31-8 (2000).;;Yokel et al., ""Acute toxicity of latex microspheres,"" Toxicol. Lett., 9:165-70 (1981).",EXPIRED
493,CN,B,CN 101249885 B,174-992-882-179-836,2013-03-27,2013,CN 200710303537 A,2007-12-13,US 61044406 A;;US 86715807 A,2006-12-13,Rib support for wing panels,,BOEING CO,WILSON DEAN E;;HUCK JAMES R;;GENDZWILL THOMAS V;;BURFORD IAN C;;DOTY GREGORY B;;KORENAGA BRIAN H;;TANNER RICHARD B,,https://lens.org/174-992-882-179-836,Granted Patent,no,0,0,4,13,0,B64C3/182;;B64C3/187;;B64C3/26;;B64C3/182;;B64C3/26;;B64C3/187,B64C3/18,,0,0,,,,ACTIVE
494,US,A1,US 2020/0146352 A1,080-429-805-097-57X,2020-05-14,2020,US 201916679057 A,2019-11-08,US 201916679057 A;;US 201862757689 P;;US 201962821305 P;;US 201962930542 P;;US 201962791709 P;;US 201962816452 P;;US 201962898522 P,2018-11-08,Vaporizer Device With More Than One Heating Element,"Various embodiments of a vaporization device are described that include one or more features, such as for generating a combined inhalable aerosol. In some embodiments, the vaporization device can include one or more heaters that are configured to heat one or more vaporizable materials. Various embodiments of heating elements and heating systems for use in vaporization devices are also described.",JUUL LABS INC,ALSTON WILLIAM W;;BOWEN ADAM;;DAVIS JACOB R;;GARCIA-DOTY IAN;;INGEBRETHSEN BRADLEY J;;KURZMAN JOSHUA A;;MONSEES JAMES;;VIEIRA PAUL R,JUUL LABS INC (2021-03-11);;SWOPE DESIGN SOLUTIONS LLC (2021-03-15),https://lens.org/080-429-805-097-57X,Patent Application,yes,0,8,10,14,0,A61M11/042;;A24F40/10;;A24F40/42;;A24F40/46;;A24F40/57;;A24F40/30;;A24F40/485;;A24F40/20;;A61M15/06;;A61M11/042;;A61M15/0005;;A61M15/002;;A61M2205/3653;;A61M2205/82;;A24F40/46;;A24F40/10;;A24F40/42;;A24F40/30,A24F40/46;;A24F40/42,,0,0,,,,ACTIVE
495,US,A1,US 2005/0048126 A1,152-444-766-554-883,2005-03-03,2005,US 83454104 A,2004-04-29,US 83454104 A;;US 27026802 A;;US 24680202 A;;US 3582101 A;;US 2169201 A;;US 95397901 A;;US 87463701 A;;US 46635403 P;;US 25816000 P,2000-12-22,Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug,"The present invention relates to compositions of submicron- to micron-size particles of antimicrobial agents. More particularly the invention relates to a composition of an antimicrobial agent that renders the agent potent against organisms normally considered to be resistant to the agent. The composition comprises an aqueous suspension of submicron- to micron-size particles containing the agent coated with at least one surfactant selected from the group consisting of: ionic surfactants, non-ionic surfactants, biologically derived surfactants, and amino acids and their derivatives. The particles have a volume-weighted mean particle size of less than 5 μm as measured by laser diffractometry.",RABINOW BARRETT;;WHITE RANDY;;SUN CHONG-SON;;WONG JOSEPH CHUNG TAK;;KIPP JAMES E.;;DOTY MARK J.;;REBBECK CHRISTINE;;PAPADOPOULOS PAVLOS GEORGE,RABINOW BARRETT;;WHITE RANDY;;SUN CHONG-SON;;WONG JOSEPH CHUNG TAK;;KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE;;PAPADOPOULOS PAVLOS GEORGE,BAXTER INTERNATIONAL INC (2004-08-31),https://lens.org/152-444-766-554-883,Patent Application,yes,3,48,3,86,0,A61K9/10;;A61K9/10;;A61K9/14;;A61K9/14;;A61K9/145;;A61K9/145;;A61K9/146;;A61K9/146;;A61K9/1688;;A61K9/1688;;A61K9/5015;;A61K9/5015;;A61K9/5031;;A61K9/5031;;A61K9/5036;;A61K9/5036;;A61K9/5042;;A61K9/5042;;A61K9/5123;;A61K9/5123;;A61K9/5138;;A61K9/5138;;A61K9/5146;;A61K9/5146;;A61K9/5192;;A61K9/5192;;A61K31/495;;A61K31/495;;A61K31/496;;A61K31/496;;A61P31/10,A61K9/10;;A61K9/14;;A61K9/16;;A61K9/50;;A61K9/51;;A61K31/495;;A61K31/496,424/489;;514/254.07;;514/383,0,0,,,,DISCONTINUED
496,US,A1,US 2010/0086611 A1,186-135-799-992-34X,2010-04-08,2010,US 41448409 A,2009-03-30,US 41448409 A;;US 83454104 A;;US 27026802 A;;US 2169201 A;;US 95397901 A;;US 87463701 A;;US 3582101 A;;US 24680202 A;;US 46635403 P;;US 25816000 P,2000-12-22,Method for Treating Infectious Organisms Normally Considered to be Resistant to an Antimicrobial Drug,"The present invention relates to compositions of submicron- to micron-size particles of antimicrobial agents. More particularly the invention relates to a composition of an antimicrobial agent that renders the agent potent against organisms normally considered to be resistant to the agent. The composition comprises an aqueous suspension of submicron- to micron-size particles containing the agent coated with at least one surfactant selected from the group consisting of: ionic surfactants, non-ionic surfactants, biologically derived surfactants, and amino acids and their derivatives. The particles have a volume-weighted mean particle size of less than 5 μm as measured by laser diffractometry.",BAXTER INT;;BAXTER HEALTHCARE SA,RABINOW BARRETT;;WHITE RANDY;;SUN CHONG-SON;;WONG JOSEPH CHUNG TAK;;KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE;;PAPADOPOULOS PAVLOS GEORGE,BAXTER HEALTHCARE S.A (2004-08-31);;BAXTER INTERNATIONAL INC (2004-08-31),https://lens.org/186-135-799-992-34X,Patent Application,yes,99,2,3,86,0,A61K9/10;;A61K9/10;;A61K9/14;;A61K9/14;;A61K9/145;;A61K9/145;;A61K9/146;;A61K9/146;;A61K9/1688;;A61K9/1688;;A61K9/5015;;A61K9/5015;;A61K9/5031;;A61K9/5031;;A61K9/5036;;A61K9/5036;;A61K9/5042;;A61K9/5042;;A61K9/5123;;A61K9/5123;;A61K9/5138;;A61K9/5138;;A61K9/5146;;A61K9/5146;;A61K9/5192;;A61K9/5192;;A61K31/495;;A61K31/495;;A61K31/496;;A61K31/496;;A61P31/10,A61K9/14;;A61K9/10;;A61K9/16;;A61K9/50;;A61K9/51;;A61K31/4164;;A61K31/4196;;A61K31/495;;A61K31/496;;A61K31/505;;A61P31/10,424/490;;514/383;;514/254.07;;514/396;;514/256,0,0,,,,EXPIRED
497,WO,A1,WO 2004/096180 A1,143-968-565-048-977,2004-11-11,2004,US 2004/0013268 W,2004-04-29,US 46635403 P,2003-04-29,FORMULATION TO RENDER AN ANTIMICROBIAL DRUG POTENT AGAINST ORGANISMS NORMALLY CONSIDERED TO BE RESISTANT TO THE DRUG,"The present invention relates to compositions of submicron- to micron-size particles of antimicrobial agents. More particularly the invention relates to a composition of an antimicrobial agent that renders the agent potent against organisms normally considered to be resistant to the agent. The composition comprises an aqueous suspension of submicron-tomicron-size particles containing the agent coated with at least one surfactant selected from the group consisting of: ionic surfactants, non-ionic surfactants, biologically derived surfactants, and amino acids and their derivatives. The particles have a volume-weighted mean particle size of less than 5 쎽m as measured by laser diffractonetry.",BAXTER INT;;RABINOW BARRETT E;;WHITE RANDY;;SUN CHONG-SON;;WONG JOSEPH CHUNG TAK;;KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;PAPADOPOULOS PAVLOS,RABINOW BARRETT E;;WHITE RANDY;;SUN CHONG-SON;;WONG JOSEPH CHUNG TAK;;KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;PAPADOPOULOS PAVLOS,,https://lens.org/143-968-565-048-977,Patent Application,yes,5,5,12,86,0,A61K9/16;;A61K9/5123;;A61K9/5015;;A61K9/5138;;A61K9/5146;;A61K9/5192;;A61K31/496;;A61K31/496;;A61P31/04;;A61P31/10;;B82Y5/00,A61K9/50;;A61K9/51;;A61K31/496,,0,0,,,,PENDING
498,EP,A1,EP 1617818 A1,074-252-446-554-936,2006-01-25,2006,EP 04760446 A,2004-04-29,US 2004/0013268 W;;US 46635403 P,2003-04-29,FORMULATION TO RENDER AN ANTIMICROBIAL DRUG POTENT AGAINST ORGANISMS NORMALLY CONSIDERED TO BE RESISTANT TO THE DRUG,,BAXTER INT,RABINOW BARRETT E;;WHITE RANDY;;SUN CHONG-SON;;WONG JOSEPH CHUNG TAK;;KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;PAPADOPOULOS PAVLOS,,https://lens.org/074-252-446-554-936,Patent Application,yes,0,0,12,86,0,A61K9/16;;A61K9/5123;;A61K9/5015;;A61K9/5138;;A61K9/5146;;A61K9/5192;;A61K31/496;;A61K31/496;;A61P31/04;;A61P31/10;;B82Y5/00,A61K9/50;;A61K9/51;;A61K31/496,,1,0,,,See references of WO 2004096180A1,DISCONTINUED
499,AU,A1,AU 2004/234003 A1,085-011-744-042-228,2004-11-11,2004,AU 2004/234003 A,2004-04-29,US 46635403 P;;US 2004/0013268 W,2003-04-29,Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug,,BAXTER INT,RABINOW BARRETT E;;REBBECK CHRISTINE L;;KIPP JAMES E;;SUN CHONG-SON;;WONG JOSEPH CHUNG TAK;;DOTY MARK J;;PAPADOPOULOS PAVLOS;;WHITE RANDY,,https://lens.org/085-011-744-042-228,Patent Application,no,0,0,12,86,0,A61K9/16;;A61K9/5123;;A61K9/5015;;A61K9/5138;;A61K9/5146;;A61K9/5192;;A61K31/496;;A61K31/496;;A61P31/04;;A61P31/10;;B82Y5/00,A61K9/50;;A61K9/51;;A61K31/496,,0,0,,,,DISCONTINUED
500,BR,A,BR PI0409929 A,130-288-083-838-203,2006-04-25,2006,BR PI0409929 A,2004-04-29,US 46635403 P;;US 2004/0013268 W,2003-04-29,formulação para tornar uma droga antimicrobiana potente contra organismos normalmente considerados serem resistentes à droga,"""FORMULAçãO PARA TORNAR UMA DROGA ANTI-MICROBIANA POTENTE CONTRA ORGANISMOS NORMALMENTE CONSIDERADOS SEREM RESISTENTES à DROGA"". A presente invenção refere-se a composições de partículas de tamanho submícron a mícron de agentes antimicrobianos. Mais particularmente a invenção refere-se a uma composição de um agente antimicrobiano que torna o agente potente contra organismos normalmente considerados serem resistentes ao agente. A composição compreende uma suspensão aquosa de partículas de tamanho submícron a mícron contendo o agente revestidas com pelo menos um tensoativo selecionado do grupo consistindo em: tensoativos iónicos, tensoativos não-iónicos, tensoativos derivados biologicamente, e aminoácidos e seus derivados. As partículas têm um tamanho de partícula médio de volume pesado de menos que 5 <109>m como medido por difratometria de laser.",BAXTER INT,RABINOW BARRETT E;;WHITE RANDY;;SUN CHONG-SON;;WONG JOSEPH CHUNG TAK;;KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;PAPADOPOULOS PAVLOS,,https://lens.org/130-288-083-838-203,Patent Application,no,0,0,12,86,0,A61K9/16;;A61K9/5123;;A61K9/5015;;A61K9/5138;;A61K9/5146;;A61K9/5192;;A61K31/496;;A61K31/496;;A61P31/04;;A61P31/10;;B82Y5/00,A61K9/50;;A61K9/51;;A61K31/496,,0,0,,,,DISCONTINUED
501,ZA,B,ZA 200508467 B,103-290-209-784-786,2006-09-27,2006,ZA 200508467 A,2005-10-19,US 46635403 P,2003-04-29,Formulation to render an antimicrobial drug potentagainst organisms normally considered to be resistant to the drug,,BAXTER INTERNAIONAL INC,RABINOW BARRETT E;;WHITE RANDY;;SUN CHONG-SON;;WONG JOSEPH CHUNG TAK;;KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;PADADOPOULOS PAVLOS,,https://lens.org/103-290-209-784-786,Granted Patent,no,0,0,12,86,0,A61K9/16;;A61K9/5123;;A61K9/5015;;A61K9/5138;;A61K9/5146;;A61K9/5192;;A61K31/496;;A61K31/496;;A61P31/04;;A61P31/10;;B82Y5/00,A61K/;;A61K9/50;;A61K9/51;;A61K31/496,,0,0,,,,ACTIVE
502,NO,D0,NO 20055616 D0,120-543-997-387-755,2005-11-28,2005,NO 20055616 A,2005-11-28,US 46635403 P;;US 2004/0013268 W,2003-04-29,Formulering som gir et antimikrobielt medikament som er virksomt mot organismer som normalt er resistente mot medikamentet,,BAXTER INT,KIPP JAMES E;;WONG JOSEPH CHUNG TAK;;DOTY MARK J;;REBBECK CHRISTINE L;;SUN CHONG-SON;;PAPADOPOULOS PAVLOS;;RABINOW BARRETT E;;WHITE RANDY,,https://lens.org/120-543-997-387-755,Patent Application,no,0,0,12,86,0,A61K9/16;;A61K9/5123;;A61K9/5015;;A61K9/5138;;A61K9/5146;;A61K9/5192;;A61K31/496;;A61K31/496;;A61P31/04;;A61P31/10;;B82Y5/00,A61K9/50;;A61K9/51;;A61K31/496,,0,0,,,,DISCONTINUED
503,KR,A,KR 20060015553 A,123-053-885-746-562,2006-02-17,2006,KR 20057020567 A,2005-10-28,US 46635403 P,2003-04-29,FORMULATION TO RENDER AN ANTIMICROBIAL DRUG POTENT AGAINST ORGANISMS NORMALLY CONSIDERED TO BE RESISTANT TO THE DRUG,"The present invention relates to compositions of submicron- to micron- size particles of antimicrobial agents. More particularly the invention relates to a composition of an antimicrobial agent that renders the agent potent against organisms normally considered to be resistant to the agent. The composition comprises an aqueous suspension of submicron-tomicron- size particles containing the agent coated with at least one surfactant selected from the group consisting of: ionic surfactants, non-ionic surfactants, biologically derived surfactants, and amino acids and their derivatives. The particles have a volume-weighted mean particle size of less than 5 mum as measured by laser diffractonetry.",BAXTER INT,RABINOW BARRETT E;;WHITE RANDY;;SUN CHONG SON;;WONG JOSEPH CHUNG TAK;;KIPP JAMES E;;DOTY MARK J;;REBBECK CHRISTINE L;;PAPADOPOULOS PAVLOS,,https://lens.org/123-053-885-746-562,Patent Application,no,0,0,12,86,0,A61K9/16;;A61K9/5123;;A61K9/5015;;A61K9/5138;;A61K9/5146;;A61K9/5192;;A61K31/496;;A61K31/496;;A61P31/04;;A61P31/10;;B82Y5/00,A61K9/16;;A61K9/50;;A61K9/51;;A61K31/496;;A61P31/04,,0,0,,,,DISCONTINUED
504,NO,L,NO 20055616 L,003-673-445-927-446,2006-01-25,2006,NO 20055616 A,2005-11-28,US 46635403 P;;US 2004/0013268 W,2003-04-29,Formulering som gir et antimikrobielt medikament som er virksomt mot organismer som normalt er resistente mot medikamentet,"Foreliggende oppfinnelse gjelder preparater av partikler av submikrometer- til mikrometerstørrelse av antimikrobielle midler. Nærmere bestemt gjelder oppfinnelsen et preparat av et antimikrobielt middel som gjør midlet aktivt mot organismer som normalt anses å være resistente overfor midlet. Preparatet omfatter en vandig suspensjon av partikler av submikrometer- til mikrometerstørrelse som inneholder midlet, belagt med minst én surfaktant utvalgt fra gruppen som består av ioniske surfaktanter, ikke-ioniske surfaktanter, biologisk avledede surfaktanter og aminosyrer og deres derivater. Partiklene har en volumveiet gjennomsnittelig partikkelstørrelse på mindre enn 5 (m, målt ved laserdiffraktometri.",BAXTER INT,KIPP JAMES E;;WONG JOSEPH CHUNG TAK;;DOTY MARK J;;REBBECK CHRISTINE L;;SUN CHONG-SON;;PAPADOPOULOS PAVLOS;;RABINOW BARRETT E;;WHITE RANDY,,https://lens.org/003-673-445-927-446,Abstract,no,0,0,12,86,0,A61K9/16;;A61K9/5123;;A61K9/5015;;A61K9/5138;;A61K9/5146;;A61K9/5192;;A61K31/496;;A61K31/496;;A61P31/04;;A61P31/10;;B82Y5/00,A61K9/14;;A61K9/50;;A61K9/51;;A61K31/496,,0,0,,,,DISCONTINUED
505,CA,A1,CA 2523151 A1,187-304-129-997-177,2004-11-11,2004,CA 2523151 A,2004-04-29,US 46635403 P;;US 2004/0013268 W,2003-04-29,FORMULATION TO RENDER AN ANTIMICROBIAL DRUG POTENT AGAINST ORGANISMS NORMALLY CONSIDERED TO BE RESISTANT TO THE DRUG,"The present invention relates to compositions of submicron- to micron-size particles of antimicrobial agents. More particularly the invention relates t o a composition of an antimicrobial agent that renders the agent potent agains t organisms normally considered to be resistant to the agent. The composition comprises an aqueous suspension of submicron-tomicron-size particles containing the agent coated with at least one surfactant selected from the group consisting of: ionic surfactants, non-ionic surfactants, biologically derived surfactants, and amino acids and their derivatives. The particles ha ve a volume-weighted mean particle size of less than 5 ~m as measured by laser diffractonetry.",BAXTER INT,RABINOW BARRETT E;;WHITE RANDY;;PAPADOPOULOS PAVLOS;;REBBECK CHRISTINE L;;SUN CHONG-SON;;KIPP JAMES E;;WONG JOSEPH CHUNG TAK;;DOTY MARK J,,https://lens.org/187-304-129-997-177,Patent Application,no,0,0,12,86,0,A61K9/16;;A61K9/5123;;A61K9/5015;;A61K9/5138;;A61K9/5146;;A61K9/5192;;A61K31/496;;A61K31/496;;A61P31/04;;A61P31/10;;B82Y5/00,A61K9/50;;A61K9/51;;A61K31/496,,0,0,,,,DISCONTINUED
506,WO,A1,WO 2020/097567 A1,145-632-136-521-264,2020-05-14,2020,US 2019/0060624 W,2019-11-08,US 201962816452 P;;US 201962791709 P;;US 201962898522 P;;US 201962821305 P;;US 201862757689 P;;US 201962930542 P,2018-11-08,VAPORIZER DEVICE WITH MORE THAN ONE HEATING ELEMENT,"Various embodiments of a vaporization device are described that include one or more features, such as for generating a combined inhalable aerosol. In some embodiments, the vaporization device can include one or more heaters that are configured to heat one or more vaporizable materials. Various embodiments of heating elements and heating systems for use in vaporization devices are also described.",JUUL LABS INC,ALSTON WILLIAM W;;BOWEN ADAM;;DAVIS JACOB R;;GARCIA-DOTY IAN;;INGEBRETHSEN BRADLEY;;KURZMAN JOSHUA A;;MONSEES JAMES;;PAPPAS ANDREW J;;VIEIRA PAUL R;;WATSON TIMOTHY J;;WILINSKI JR,,https://lens.org/145-632-136-521-264,Patent Application,yes,10,0,10,14,0,A61M11/042;;A24F40/10;;A24F40/42;;A24F40/46;;A24F40/57;;A24F40/30;;A24F40/485;;A24F40/20;;A61M15/06;;A61M11/042;;A61M15/0005;;A61M15/002;;A61M2205/3653;;A61M2205/82;;A24F40/46;;A24F40/10;;A24F40/42;;A24F40/30,A24F47/00;;A61M11/04;;A61M15/00;;A61M15/06,,1,0,,,See also references of EP 3876770A4,PENDING
507,CA,A1,CA 3118504 A1,008-777-218-446-907,2020-05-14,2020,CA 3118504 A,2019-11-08,US 201862757689 P;;US 201962791709 P;;US 201962816452 P;;US 201962821305 P;;US 201962898522 P;;US 201962930542 P;;US 2019/0060624 W,2018-11-08,VAPORIZER DEVICE WITH MORE THAN ONE HEATING ELEMENT,"Various embodiments of a vaporization device are described that include one or more features, such as for generating a combined inhalable aerosol. In some embodiments, the vaporization device can include one or more heaters that are configured to heat one or more vaporizable materials. Various embodiments of heating elements and heating systems for use in vaporization devices are also described.",JUUL LABS INC,ALSTON WILLIAM W;;BOWEN ADAM;;DAVIS JACOB R;;GARCIA-DOTY IAN;;INGEBRETHSEN BRADLEY;;KURZMAN JOSHUA A;;MONSEES JAMES;;PAPPAS ANDREW J;;VIEIRA PAUL R;;WATSON TIMOTHY J;;WILINSKI JR,,https://lens.org/008-777-218-446-907,Patent Application,no,0,0,10,14,0,A61M11/042;;A24F40/10;;A24F40/42;;A24F40/46;;A24F40/57;;A24F40/30;;A24F40/485;;A24F40/20;;A61M15/06;;A61M11/042;;A61M15/0005;;A61M15/002;;A61M2205/3653;;A61M2205/82;;A24F40/46;;A24F40/10;;A24F40/42;;A24F40/30,A24F47/00;;A61M11/04;;A61M15/00;;A61M15/06,,0,0,,,,PENDING
508,CN,A,CN 111213915 A,142-875-949-252-943,2020-06-02,2020,CN 201911089861 A,2019-11-08,US 201862757689 P;;US 201962791709 P;;US 201962816452 P;;US 201962821305 P;;US 201962898522 P;;US 201962930542 P,2018-11-08,Vaporization Device With More Than One Heating Element,"Various embodiments of a vaporization device are described that include one or more features, such as for generating a combined inhalable aerosol. In some embodiments, the vaporization device can include one or more heaters that are configured to heat one or more vaporizable materials. Various embodiments of heating elements and heating systems for use in vaporization devices are also described.",JUUL LABS INC,ALSTON WILLIAM W;;BOWEN ADAM;;DAVIS JACOB R;;GARCIA-DOTY IAN;;INGEBRETHSEN BRADLEY J;;KURZMAN JOSHUA A;;MONSEES JAMES;;PAPPAS ANDREW J;;VIEIRA PAUL R;;WATSON TIMOTHY J;;WILINSKI JR,,https://lens.org/142-875-949-252-943,Patent Application,no,0,2,10,14,0,A61M11/042;;A24F40/10;;A24F40/42;;A24F40/46;;A24F40/57;;A24F40/30;;A24F40/485;;A24F40/20;;A61M15/06;;A61M11/042;;A61M15/0005;;A61M15/002;;A61M2205/3653;;A61M2205/82;;A24F40/46;;A24F40/10;;A24F40/42;;A24F40/30,A24F40/40;;A24F40/30;;A24F40/42;;A24F40/46;;A24F40/50;;A61M11/04,,0,0,,,,PENDING
509,KR,A,KR 20210073595 A,147-969-336-285-055,2021-06-18,2021,KR 20217016745 A,2019-11-08,US 201862757689 P;;US 201962791709 P;;US 201962816452 P;;US 201962821305 P;;US 201962898522 P;;US 201962930542 P;;US 2019/0060624 W,2018-11-08,하나 초과의 가열 요소를 갖는 증발기 장치,"예를 들어 조합된 흡입 가능한 에어로졸을 생성하기 위해 하나 이상의 특징을 포함하는 증발 장치의 다양한 실시예가 설명된다. 일부 실시예에서, 증발 장치는 하나 이상의 증발 가능한 재료를 가열하도록 구성된 하나 이상의 히터를 포함할 수 있다. 증발 장치에 사용하기 위한 가열 요소 및 가열 시스템의 다양한 실시예가 또한 설명된다.",JUUL LABS INC,ALSTON WILLIAM W;;BOWEN ADAM;;DAVIS JACOB R;;GARCIA DOTY IAN;;INGEBRETHSEN BRADLEY;;KURZMAN JOSHUA A;;MONSEES JAMES;;PAPPAS ANDREW J;;VIEIRA PAUL R;;WATSON TIMOTHY J;;WILINSKI JR JOSEPH S,,https://lens.org/147-969-336-285-055,Patent Application,no,0,0,10,14,0,A61M11/042;;A24F40/10;;A24F40/42;;A24F40/46;;A24F40/57;;A24F40/30;;A24F40/485;;A24F40/20;;A61M15/06;;A61M11/042;;A61M15/0005;;A61M15/002;;A61M2205/3653;;A61M2205/82;;A24F40/46;;A24F40/10;;A24F40/42;;A24F40/30,A61M15/06;;A61M11/04;;A61M15/00,,0,0,,,,PENDING
510,EP,A4,EP 3876770 A4,047-106-735-928-91X,2022-09-14,2022,EP 19882975 A,2019-11-08,US 201862757689 P;;US 201962791709 P;;US 201962816452 P;;US 201962821305 P;;US 201962898522 P;;US 201962930542 P;;US 2019/0060624 W,2018-11-08,VAPORIZER DEVICE WITH MORE THAN ONE HEATING ELEMENT,,JUUL LABS INC,ALSTON WILLIAM W;;BOWEN ADAM;;DAVIS JACOB R;;GARCIA-DOTY IAN;;INGEBRETHSEN BRADLEY;;KURZMAN JOSHUA A;;MONSEES JAMES;;PAPPAS ANDREW J;;VIEIRA PAUL R;;WATSON TIMOTHY J;;WILINSKI JR JOSEPH S,,https://lens.org/047-106-735-928-91X,Search Report,no,4,0,10,14,0,A61M11/042;;A24F40/10;;A24F40/42;;A24F40/46;;A24F40/57;;A24F40/30;;A24F40/485;;A24F40/20;;A61M15/06;;A61M11/042;;A61M15/0005;;A61M15/002;;A61M2205/3653;;A61M2205/82;;A24F40/46;;A24F40/10;;A24F40/42;;A24F40/30,A24F40/485;;A24F40/10;;A24F40/20;;A24F40/30;;A24F40/42;;A24F40/46;;A24F40/57,,1,0,,,See also references of WO 2020097567A1,PENDING
511,EP,A1,EP 3876770 A1,024-934-254-272-517,2021-09-15,2021,EP 19882975 A,2019-11-08,US 201862757689 P;;US 201962791709 P;;US 201962816452 P;;US 201962821305 P;;US 201962898522 P;;US 201962930542 P;;US 2019/0060624 W,2018-11-08,VAPORIZER DEVICE WITH MORE THAN ONE HEATING ELEMENT,,JUUL LABS INC,ALSTON WILLIAM W;;BOWEN ADAM;;DAVIS JACOB R;;GARCIA-DOTY IAN;;INGEBRETHSEN BRADLEY;;KURZMAN JOSHUA A;;MONSEES JAMES;;PAPPAS ANDREW J;;VIEIRA PAUL R;;WATSON TIMOTHY J;;WILINSKI JR JOSEPH S,,https://lens.org/024-934-254-272-517,Patent Application,yes,0,0,10,14,0,A61M11/042;;A24F40/10;;A24F40/42;;A24F40/46;;A24F40/57;;A24F40/30;;A24F40/485;;A24F40/20;;A61M15/06;;A61M11/042;;A61M15/0005;;A61M15/002;;A61M2205/3653;;A61M2205/82;;A24F40/46;;A24F40/10;;A24F40/42;;A24F40/30,A24F47/00;;A61M11/04;;A61M15/00;;A61M15/06,,0,0,,,,PENDING
512,US,A1,US 2022/0279846 A1,073-020-977-466-207,2022-09-08,2022,US 202217736707 A,2022-05-04,US 202217736707 A;;US 201916679057 A;;US 201862757689 P;;US 201962930542 P;;US 201962898522 P;;US 201962821305 P;;US 201962816452 P;;US 201962791709 P,2018-11-08,Vaporizer Device With More Than One Heating Element,"Various embodiments of a vaporization device are described that include one or more features, such as for generating a combined inhalable aerosol. In some embodiments, the vaporization device can include one or more heaters that are configured to heat one or more vaporizable materials. Various embodiments of heating elements and heating systems for use in vaporization devices are also described.",JUUL LABS INC,ALSTON WILLIAM W;;BOWEN ADAM;;DAVIS JACOB R;;GARCIA-DOTY IAN;;INGEBRETHSEN BRADLEY J;;KURZMAN JOSHUA A;;MONSEES JAMES;;PAPPAS ANDREW J;;VIEIRA PAUL R;;WATSON TIMOTHY J;;WILINSKI JR JOSEPH S,JUUL LABS INC (2021-03-11);;SWOPE DESIGN SOLUTIONS LLC (2021-03-15),https://lens.org/073-020-977-466-207,Patent Application,yes,3,1,10,14,0,A61M11/042;;A24F40/10;;A24F40/42;;A24F40/46;;A24F40/57;;A24F40/30;;A24F40/485;;A24F40/20;;A61M15/06;;A61M11/042;;A61M15/0005;;A61M15/002;;A61M2205/3653;;A61M2205/82;;A24F40/46;;A24F40/10;;A24F40/42;;A24F40/30,A24F40/42;;A24F40/10,,0,0,,,,PENDING
513,US,B2,US 11350664 B2,156-026-113-548-05X,2022-06-07,2022,US 201916679057 A,2019-11-08,US 201916679057 A;;US 201862757689 P;;US 201962821305 P;;US 201962930542 P;;US 201962791709 P;;US 201962816452 P;;US 201962898522 P,2018-11-08,Vaporizer device with more than one heating element,"Various embodiments of a vaporization device are described that include one or more features, such as for generating a combined inhalable aerosol. In some embodiments, the vaporization device can include one or more heaters that are configured to heat one or more vaporizable materials. Various embodiments of heating elements and heating systems for use in vaporization devices are also described.",JUUL LABS INC,ALSTON WILLIAM W;;BOWEN ADAM;;DAVIS JACOB R;;GARCIA-DOTY IAN;;INGEBRETHSEN BRADLEY J;;KURZMAN JOSHUA A;;MONSEES JAMES;;PAPPAS ANDREW J;;VIEIRA PAUL R;;WATSON TIMOTHY J;;WILINSKI JR JOSEPH S,JUUL LABS INC (2021-03-11);;SWOPE DESIGN SOLUTIONS LLC (2021-03-15),https://lens.org/156-026-113-548-05X,Granted Patent,yes,215,1,10,14,0,A61M11/042;;A24F40/10;;A24F40/42;;A24F40/46;;A24F40/57;;A24F40/30;;A24F40/485;;A24F40/20;;A61M15/06;;A61M11/042;;A61M15/0005;;A61M15/002;;A61M2205/3653;;A61M2205/82;;A24F40/46;;A24F40/10;;A24F40/42;;A24F40/30,A24F40/42;;A24F40/10;;A24F40/30;;A24F40/46,,0,0,,,,ACTIVE
514,JP,A,JP 2020096584 A,091-018-852-838-222,2020-06-25,2020,JP 2019203362 A,2019-11-08,US 201862757689 P;;US 201962791709 P;;US 201962816452 P;;US 201962821305 P;;US 201962898522 P;;US 201962930542 P,2018-11-08,VAPORIZER DEVICE COMPRISING ONE OR MORE HEATER ELEMENTS,"To provide a vaporizer device comprising a heating element and a heating system capable of efficiently and effectively heating one or more types of volatile materials.SOLUTION: A vaporizer device for generating a mixed aerosol which can be sucked comprises: a body comprising a penetrating ventilation flue; a first cartridge container configured to have a first volatile material; a second cartridge container configured to have a second volatile material; a first heater for heating the first volatile material and forming a first aerosol which can be sucked; a second heater for heating the second volatile material and forming a second aerosol which can be sucked. The ventilation flue comprises: one or more heaters which extend adjacently the first heater and the second heater, and heat one or more volatile materials for forming a mixed aerosol to be sucked by a user from an end part by mixing the first aerosol and second aerosol which can be sucked.SELECTED DRAWING: None",JUUL LABS INC,WILLIAM W ALSTON;;ADAM M BOWEN;;JACOB R DAVIS;;IAN GARCIA-DOTY;;BRADLEY J INGEBRETHSEN;;JOSHUA A KURZMAN;;JAMES MONSEES;;ANDREW J PAPPAS;;PAUL R VIEIRA;;TIMOTHY J WATSON;;JOSEPH S WILINSKI JR,,https://lens.org/091-018-852-838-222,Patent Application,no,0,1,10,14,0,A61M11/042;;A24F40/10;;A24F40/42;;A24F40/46;;A24F40/57;;A24F40/30;;A24F40/485;;A24F40/20;;A61M15/06;;A61M11/042;;A61M15/0005;;A61M15/002;;A61M2205/3653;;A61M2205/82;;A24F40/46;;A24F40/10;;A24F40/42;;A24F40/30,A24F47/00,,0,0,,,,PENDING
515,WO,A1,WO 2021/226334 A1,030-450-109-409-800,2021-11-11,2021,US 2021/0031084 W,2021-05-06,US 202063021470 P,2020-05-07,VAPORIZER CARTRIDGE FOR HEATING MORE THAN ONE VAPORIZABLE MATERIAL,"Various embodiments of a vaporization device are described that include one or more features for generating a combined inhalable aerosol. In some embodiments, the vaporization device can include one or more heating elements that are configured to heat one or more vaporizable materials. Various embodiments of heating elements, as well as heating and airflow systems for use in vaporization devices for generating the combined inhalable aerosol are also described.",JUUL LABS INC,ALSTON WILLIAM;;BOWEN ADAM;;DAVIS JACOB;;GARCIA-DOTY IAN;;GONZALEZ EDDIE G;;INGEBRETHSEN BRADLEY J;;KURZMAN JOSHUA A;;MONSEES JAMES;;PAPPAS ANDREW J;;SWOPE BRETTON M;;VIEIRA PAUL R;;WATSON TIMOTHY J;;WILINSKI JR,,https://lens.org/030-450-109-409-800,Patent Application,yes,4,0,3,3,0,A24F40/30;;A61M15/06;;A24F40/42;;A24F40/10;;A24F40/485;;A61M11/042;;A61M15/0021;;A61M2205/3368;;A24F40/10;;A24F40/46;;A24F40/20;;A24F40/30;;A24F40/42,A24F40/30;;A24F40/46,,0,0,,,,PENDING
516,WO,A1,WO 2021/046452 A1,184-751-143-892-14X,2021-03-11,2021,US 2020/0049547 W,2020-09-04,US 201962897087 P;;GR 20190100383 A,2019-09-06,CARTRIDGE-BASED HEAT NOT BURN VAPORIZER,"A vaporizer device including a vaporizer cartridge configured to efficiently and effectively heat a non-liquid vaporizable material is described. The vaporizer cartridge may include a heating element configured to vaporize the vaporizable material by delivery of heat to the vaporizable material. The cartridge may include a cartridge contact in electrical communication with the heating element. The cartridge contact may be configured to couple to a receptacle contact along a vaporizer body of the vaporizer device having a power source to allow power to pass from the power source to the heating element. The heating element can include electrically resistive features such that current traveling along the heating element can cause the heating element to increase in temperature to within a desired temperature range. Related systems, methods, and articles of manufacture are also described.",JUUL LABS INC,BATLEY OLIVER;;BOWEN ADAM;;CHEUNG BRANDON;;CHRISTENSEN STEVEN;;GARCIA-DOTY IAN;;GONZALEZ EDDIE;;JOBANPUTRA RISHI;;KALOGEROPOULOS XENOFON;;KURZMAN JOSHUA;;LEON DUQUE ESTEBAN;;LOMELI KEVIN;;MONSEES JAMES;;NEWBOLD ANDREW;;O'MALLEY CLAIRE;;SHAH NIHIR;;VIEIRA PAUL,,https://lens.org/184-751-143-892-14X,Patent Application,yes,4,0,3,3,0,A24F40/42;;A24F40/20;;A24F40/46;;A24F40/46;;A24F40/20;;A24F40/42;;A61M15/06;;H05B3/34;;H05B2203/002;;H05B2203/008,A24F40/42;;A24F25/02;;A24F40/20;;A24F40/46;;A24F40/465;;A24F40/57;;A24F40/65,,0,0,,,,PENDING
517,US,A1,US 2023/0054752 A1,196-725-738-420-009,2023-02-23,2023,US 202217982230 A,2022-11-07,US 202217982230 A;;US 2021/0031084 W;;US 202063021470 P,2020-05-07,VAPORIZER CARTRIDGE FOR HEATING MORE THAN ONE VAPORIZABLE MATERIAL,"Various embodiments of a vaporization device are described that include one or more features for generating a combined inhalable aerosol. In some embodiments, the vaporization device can include one or more heating elements that are configured to heat one or more vaporizable materials. Various embodiments of heating elements, as well as heating and airflow systems for use in vaporization devices for generating the combined inhalable aerosol are also described.",JUUL LABS INC,ALSTON WILLIAM W;;BOWEN ADAM;;DAVIS JACOB R;;GARCIA-DOTY IAN;;GONZALEZ EDDIE G;;INGEBRETHSEN BRADLEY J;;KURZMAN JOSHUA A;;MONSEES JAMES;;PAPPAS ANDREW J;;SWOPE BRETTON M;;VIEIRA PAUL R;;WATSON TIMOTHY J;;WILINSKI JR JOSEPH S,JUUL LABS INC (2021-07-27);;SWOPE DESIGN SOLUTIONS (2021-07-29),https://lens.org/196-725-738-420-009,Patent Application,yes,0,2,3,3,0,A24F40/30;;A61M15/06;;A24F40/42;;A24F40/10;;A24F40/485;;A61M11/042;;A61M15/0021;;A61M2205/3368;;A24F40/10;;A24F40/46;;A24F40/20;;A24F40/30;;A24F40/42,A24F40/30;;A24F40/10;;A24F40/20;;A24F40/42;;A24F40/46,,0,0,,,,PENDING
518,EP,A1,EP 4146026 A1,104-191-134-625-416,2023-03-15,2023,EP 21729114 A,2021-05-06,US 202063021470 P;;US 2021/0031084 W,2020-05-07,VAPORIZER CARTRIDGE FOR HEATING MORE THAN ONE VAPORIZABLE MATERIAL,,JUUL LABS INC,ALSTON WILLIAM W;;BOWEN ADAM;;DAVIS JACOB R;;GARCIA-DOTY IAN;;GONZALEZ EDDIE G;;INGEBRETHSEN BRADLEY J;;KURZMAN JOSHUA A;;MONSEES JAMES;;PAPPAS ANDREW J;;SWOPE BRETTON M;;VIEIRA PAUL R;;WATSON TIMOTHY J;;WILINSKI JR JOSEPH S,,https://lens.org/104-191-134-625-416,Patent Application,yes,0,0,3,3,0,A24F40/30;;A61M15/06;;A24F40/42;;A24F40/10;;A24F40/485;;A61M11/042;;A61M15/0021;;A61M2205/3368;;A24F40/10;;A24F40/46;;A24F40/20;;A24F40/30;;A24F40/42,A24F40/30;;A24F40/46,,0,0,,,,PENDING
519,EP,A1,EP 4025084 A1,001-277-761-958-749,2022-07-13,2022,EP 20775143 A,2020-09-04,GR 20190100383 A;;US 201962897087 P;;US 2020/0049547 W,2019-09-06,CARTRIDGE-BASED HEAT NOT BURN VAPORIZER,,JUUL LABS INC,BATLEY OLIVER J;;BOWEN ADAM;;CHEUNG BRANDON;;CHRISTENSEN STEVEN;;GARCIA-DOTY IAN;;GONZALEZ EDDIE G;;JOBANPUTRA RISHI D;;KALOGEROPOULOS XENOFON;;KURZMAN JOSHUA A;;LEON DUQUE ESTEBAN;;LOMELI KEVIN;;MONSEES JAMES;;NEWBOLD ANDREW;;O'MALLEY CLAIRE;;SHAH NIHIR B;;VIEIRA PAUL R,,https://lens.org/001-277-761-958-749,Patent Application,yes,0,0,3,3,0,A24F40/42;;A24F40/20;;A24F40/46;;A24F40/46;;A24F40/20;;A24F40/42;;A61M15/06;;H05B3/34;;H05B2203/002;;H05B2203/008,A24F40/42;;A24F25/02;;A24F40/20;;A24F40/46;;A24F40/465;;A24F40/57;;A24F40/65,,0,0,,,,PENDING
520,US,A1,US 2022/0183366 A1,137-121-988-000-966,2022-06-16,2022,US 202217687496 A,2022-03-04,US 202217687496 A;;GR 20190100383 A;;US 2020/0049547 W;;US 201962897087 P,2019-09-06,CARTRIDGE-BASED HEAT NOT BURN VAPORIZER,"A vaporizer device including a vaporizer cartridge configured to efficiently and effectively heat a non-liquid vaporizable material is described. The vaporizer cartridge may include a heating element configured to vaporize the vaporizable material by delivery of heat to the vaporizable material. The cartridge may include a cartridge contact in electrical communication with the heating element. The cartridge contact may be configured to couple to a receptacle contact along a vaporizer body of the vaporizer device having a power source to allow power to pass from the power source to the heating element. The heating element can include electrically resistive features such that current traveling along the heating element can cause the heating element to increase in temperature to within a desired temperature range. Related systems, methods, and articles of manufacture are also described.",JUUL LABS INC,BATLEY OLIVER J;;BOWEN ADAM;;CHEUNG BRANDON;;CHRISTENSEN STEVEN;;GARCIA-DOTY IAN;;GONZALEZ EDDIE G;;JOBANPUTRA RISHI D;;KALOGEROPOULOS XENOFON;;KURZMAN JOSHUA A;;LEON DUQUE ESTEBAN;;LOMELI KEVIN;;MONSEES JAMES;;NEWBOLD ANDREW;;O'MALLEY CLAIRE;;SHAH NIHIR B;;VIEIRA PAUL R,CAMBRIDGE CONSULTANTS INC (2020-12-21);;CAMBRIDGE CONSULTANTS LTD (2020-12-21);;JUUL LABS INC (2020-12-21),https://lens.org/137-121-988-000-966,Patent Application,yes,0,1,3,3,0,A24F40/42;;A24F40/20;;A24F40/46;;A24F40/46;;A24F40/20;;A24F40/42;;A61M15/06;;H05B3/34;;H05B2203/002;;H05B2203/008,A24F40/46;;A24F40/20;;A24F40/42;;H05B3/34,,0,0,,,,PENDING
521,CA,C,CA 2456794 C,006-650-639-349-127,2007-12-18,2007,CA 2456794 A,2002-07-24,US 92376301 A;;US 0223352 W,2001-08-06,RECLOSABLE CONTAINER LID,"A reclosable lid 10 for a container holding a flowable substance has a first piece or cover 12, and a movable second piece or disk 50. The cover 10 has a top wall 14, a side wall 16 and a mounting portion 22 for connecting the lid 10 on the container. The cover 12 has an opening 28 adapted to permit the flow of the substance through the lid 10 . The cover 12 further includes a slot 30 located in the top wall 14. The disk 50 has at least one aperture 78, a post 54, and a projection 52. The aperture 78 and the projection 52 are ea ch cooperatively dimensioned with the opening 28. The post 54 is adapted to be received by th e slot 30 in the cover 12. The disk 50 is movable between a first position wherein at least a portion of the projection 52 is received in the opening 28 in the first position, and a second position wherein the aperture 78 is aligned with the opening 28 in the second positio n. A support ledge 102 and a support edge 104 on an inner surface 100 of the cover 12 are adapted to provide rotatable support to the disk 50.",SOLO CUP CO,JOINES JAMES TAM JR;;SULLIVAN STEPHEN WILLIAM;;WIEDMEYER WARREN GILES;;LANGELAN DAVID RAYMOND;;HUSTON DAWN ELLEN;;CHAUHAN RAJENDRA RANJITBHAI;;HURST WILLIAM EDWARD;;DOTY HEATH A;;GITSCHLAG JOHN STEWART;;BONE BRIAN C;;AHMED MOHAMMED MAQSOOD;;ANHALT MARK GERALD;;CHIN RICH MATTHEW;;SMITH STEPHEN ALAN;;RUTTER BRYCE G;;SMITH KEVIN RAY,,https://lens.org/006-650-639-349-127,Granted Patent,no,0,0,36,36,0,B65D43/0212;;B65D47/26;;B65D47/265;;B65D55/024;;B65D2543/00046;;B65D2543/00092;;B65D2543/00296;;B65D2543/00351;;B65D2543/00527;;B65D2543/00537;;B65D2543/00638;;B65D2543/00685;;B65D2543/00731;;B65D2543/00796;;B65D2543/00805;;B65D2543/00842;;B65D47/26;;B65D43/0212;;B65D55/024;;B65D2543/00296;;B65D2543/00842;;B65D47/265;;B65D47/26;;B65D2543/00796;;B65D2543/00527;;B65D2543/00092;;B65D2543/00805;;B65D2543/00638;;B65D2543/00685;;B65D2543/00046;;B65D2543/00731;;B65D2543/00537;;B65D2543/00351,B65D47/26;;B65D55/02,,0,0,,,,EXPIRED
522,AU,A2,AU 2002/355395 A2,108-461-836-146-535,2003-02-24,2003,AU 2002/355395 A,2002-07-24,US 92376301 A;;US 0223352 W,2001-08-06,Reclosable container lid,,SOLO CUP CO,SMITH STEPHEN ALAN;;HUSTON DAWN ELLEN;;WIEDMEYER WARREN GILES;;SULLIVAN STEPHEN WILLIAM;;CHIN RICH MATTHEW;;AHMED MOHAMMED MAQSOOD;;GITSCHLAG JOHN STEWART;;LANGELAN DAVID RAYMOND;;CHAUHAN RAJENDRA RANJITBHAI;;HURST WILLIAM EDWARD;;JOINES JAMES TAM JR;;SMITH KEVIN RAY;;ANHALT MARK GERALD;;RUTTER BRYCE G;;BONE BRIAN C;;DOTY HEATH A,,https://lens.org/108-461-836-146-535,Patent Application,no,0,0,36,36,0,B65D43/0212;;B65D47/26;;B65D47/265;;B65D55/024;;B65D2543/00046;;B65D2543/00092;;B65D2543/00296;;B65D2543/00351;;B65D2543/00527;;B65D2543/00537;;B65D2543/00638;;B65D2543/00685;;B65D2543/00731;;B65D2543/00796;;B65D2543/00805;;B65D2543/00842;;B65D47/26;;B65D43/0212;;B65D55/024;;B65D2543/00296;;B65D2543/00842;;B65D47/265;;B65D47/26;;B65D2543/00796;;B65D2543/00527;;B65D2543/00092;;B65D2543/00805;;B65D2543/00638;;B65D2543/00685;;B65D2543/00046;;B65D2543/00731;;B65D2543/00537;;B65D2543/00351,B65D47/26;;B65D55/02,,0,0,,,,EXPIRED
523,DE,D1,DE 60219045 D1,123-728-775-894-014,2007-05-03,2007,DE 60219045 T,2002-07-24,US 92376301 A;;US 0223352 W,2001-08-06,WIEDERVERSCHLIESSBARER BEHÄLTERDECKEL,,SOLO CUP OPERATING CORP,SMITH STEPHEN ALAN;;HUSTON DAWN ELLEN;;WIEDMEYER WARREN GILES;;SULLIVAN STEPHEN WILLIAM;;CHIN RICH MATTHEW;;AHMED MOHAMMED MAQSOOD;;GITSCHLAG JOHN STEWART;;LANGELAN DAVID RAYMOND;;CHAUHAN RAJENDRA RANJITBHAI;;HURST WILLIAM EDWARD;;JOINES JAMES TAM;;SMITH KEVIN RAY;;ANHALT MARK GERALD;;RUTTER BRYCE G;;BONE BRIAN C;;DOTY HEATH A,,https://lens.org/123-728-775-894-014,Granted Patent,no,0,0,36,36,0,B65D43/0212;;B65D47/26;;B65D47/265;;B65D55/024;;B65D2543/00046;;B65D2543/00092;;B65D2543/00296;;B65D2543/00351;;B65D2543/00527;;B65D2543/00537;;B65D2543/00638;;B65D2543/00685;;B65D2543/00731;;B65D2543/00796;;B65D2543/00805;;B65D2543/00842;;B65D47/26;;B65D43/0212;;B65D55/024;;B65D2543/00296;;B65D2543/00842;;B65D47/265;;B65D47/26;;B65D2543/00796;;B65D2543/00527;;B65D2543/00092;;B65D2543/00805;;B65D2543/00638;;B65D2543/00685;;B65D2543/00046;;B65D2543/00731;;B65D2543/00537;;B65D2543/00351,B65D47/26;;B65D55/02,,0,0,,,,EXPIRED
524,CR,A,CR 7274 A,192-322-825-720-438,2005-02-22,2005,CR 7274 A,2004-03-05,US 92376301 A,2001-08-06,TAPA DE RECIPIENTE QUE PUEDE VOLVER A CERRARSE,"Una tapa que puede volver a cerrarse 10 para un recipiente que contiene una sustancia liquida, tiene una primera pieza o tapa 12, y una segunda pieza movible o disco 50. La tapa 10 tiene una pared superior 14, una pared lateral 16 y una porcion como montadura 22 para conectar la tapa 10 sobre el recipiente. La tapa 12 ademas incluye una ranura 30 localizada en la pared superior 14. El disco 50 tiene al menos una abertura 78, un poste 54 y una saliente 52. La abertura 78 y la saliente 52 tienen dimensiones cooperativas con la abertura 28. El poste 54 se adapta para ser recibido por la ranura 30 de la tapa 12. El disco 50 es movible entre una primera posicion en donde al menos una porcion de la saliente 52 es recibida en la apertura 28 en la primera posicion, y una segunda posicion en donde la abertura 78 esta alineada con la abertura 28 en la segunda posicion.",SOLO CUP CO,MOHAMMED MAQSOOD AHMED;;STEPHEN ALAN SMITH;;DAWN ELLEN HUSTON;;WARREN GILES WIEDMEYER;;STEPHEN WILLIAM SULLIVAN;;RICH MATTHEW CHIN;;JOHN STEWART GITSCHLAG;;DAVID RAYMOND LANGELAN;;RAJENDRA RANJITBHAI CHAUHAN;;WILLIAM EDWARD HURST;;JAMES TAM JOINES JR;;KEVIN RAY SMITH;;MARK GERALD ANHALT;;BRYCE G RUTTER;;BRIAN C BONE;;HEATH A DOTY,,https://lens.org/192-322-825-720-438,Patent Application,no,0,0,36,36,0,B65D43/0212;;B65D47/26;;B65D47/265;;B65D55/024;;B65D2543/00046;;B65D2543/00092;;B65D2543/00296;;B65D2543/00351;;B65D2543/00527;;B65D2543/00537;;B65D2543/00638;;B65D2543/00685;;B65D2543/00731;;B65D2543/00796;;B65D2543/00805;;B65D2543/00842;;B65D47/26;;B65D43/0212;;B65D55/024;;B65D2543/00296;;B65D2543/00842;;B65D47/265;;B65D47/26;;B65D2543/00796;;B65D2543/00527;;B65D2543/00092;;B65D2543/00805;;B65D2543/00638;;B65D2543/00685;;B65D2543/00046;;B65D2543/00731;;B65D2543/00537;;B65D2543/00351,B65D47/26;;B65D55/02,,0,0,,,,DISCONTINUED
525,AT,T1,AT E357379 T1,106-310-098-099-376,2007-04-15,2007,AT 02752530 T,2002-07-24,US 92376301 A,2001-08-06,WIEDERVERSCHLIESSBARER BEHÄLTERDECKEL,,SOLO CUP OPERATING CORP,SMITH STEPHEN ALAN;;HUSTON DAWN ELLEN;;WIEDMEYER WARREN GILES;;SULLIVAN STEPHEN WILLIAM;;CHIN RICH MATTHEW;;AHMED MOHAMMED MAQSOOD;;GITSCHLAG JOHN STEWART;;LANGELAN DAVID RAYMOND;;CHAUHAN RAJENDRA RANJITBHAI;;HURST WILLIAM EDWARD;;JOINES JAMES TAM JR;;SMITH KEVIN RAY;;ANHALT MARK GERALD;;RUTTER BRYCE G;;BONE BRIAN C;;DOTY HEATH A,,https://lens.org/106-310-098-099-376,Granted Patent,no,0,0,36,36,0,B65D43/0212;;B65D47/26;;B65D47/265;;B65D55/024;;B65D2543/00046;;B65D2543/00092;;B65D2543/00296;;B65D2543/00351;;B65D2543/00527;;B65D2543/00537;;B65D2543/00638;;B65D2543/00685;;B65D2543/00731;;B65D2543/00796;;B65D2543/00805;;B65D2543/00842;;B65D47/26;;B65D43/0212;;B65D55/024;;B65D2543/00296;;B65D2543/00842;;B65D47/265;;B65D47/26;;B65D2543/00796;;B65D2543/00527;;B65D2543/00092;;B65D2543/00805;;B65D2543/00638;;B65D2543/00685;;B65D2543/00046;;B65D2543/00731;;B65D2543/00537;;B65D2543/00351,B65D47/26;;B65D55/02,,0,0,,,,EXPIRED
526,US,A1,US 2004/0035868 A1,030-617-270-179-687,2004-02-26,2004,US 64526803 A,2003-08-21,US 64526803 A;;US 92376301 A,2001-08-06,Reclosable container lid,"
    A reclosable lid 10  for a container holding a flowable substance has a first piece or cover 12 , and a movable second piece or disk 50 . The cover 10  has a top wall 14 , a side wall 16  and a mounting portion 22  for connecting the lid 10  on the container. The cover 12  has an opening 28  adapted to permit the flow of the substance through the lid 10 . The cover 12  further includes a slot 30  located in the top wall 14 . The disk 50  has at least one aperture 78 , a post 54 , and a projection 52 . The aperture 78  and the projection 52  are each cooperatively dimensioned with the opening 28 . The post 54  is adapted to be received by the slot 30  in the cover 12 . The disk 50  is movable between a first position wherein at least a portion of the projection 52  is received in the opening 28  in the first position, and a second position wherein the aperture 78  is aligned with the opening 28  in the second position. A support ledge 102  and a support edge 104  on an inner surface 100  of the cover 12  are adapted to provide rotatable support to the disk 50. 
",SMITH STEPHEN ALAN;;HUSTON DAWN ELLEN;;WIEDMEYER WARREN GILES;;SULLIVAN STEPHEN WILLIAM;;CHIN RICH MATTHEW;;AHMED MOHAMMED MAQSOOD;;GITSCHLAG JOHN STEWART;;LANGELAN DAVID RAYMOND;;CHAUHAN RAJENDRA RANJITBHAI;;HURST WILLIAM EDWARD;;JOINES JAMES TAM;;SMITH KEVIN RAY;;ANHALT MARK GERALD;;RUTTER BRYCE G.;;BONE BRIAN C.;;DOTY HEATH A.,SMITH STEPHEN ALAN;;HUSTON DAWN ELLEN;;WIEDMEYER WARREN GILES;;SULLIVAN STEPHEN WILLIAM;;CHIN RICH MATTHEW;;AHMED MOHAMMED MAQSOOD;;GITSCHLAG JOHN STEWART;;LANGELAN DAVID RAYMOND;;CHAUHAN RAJENDRA RANJITBHAI;;HURST WILLIAM EDWARD;;JOINES JAMES TAM;;SMITH KEVIN RAY;;ANHALT MARK GERALD;;RUTTER BRYCE G;;BONE BRIAN C;;DOTY HEATH A,SOLO CUP OPERATING CORPORATION (2005-10-03),https://lens.org/030-617-270-179-687,Patent Application,yes,99,10,36,36,0,B65D43/0212;;B65D47/26;;B65D47/265;;B65D55/024;;B65D2543/00046;;B65D2543/00092;;B65D2543/00296;;B65D2543/00351;;B65D2543/00527;;B65D2543/00537;;B65D2543/00638;;B65D2543/00685;;B65D2543/00731;;B65D2543/00796;;B65D2543/00805;;B65D2543/00842;;B65D47/26;;B65D43/0212;;B65D55/024;;B65D2543/00296;;B65D2543/00842;;B65D47/265;;B65D47/26;;B65D2543/00796;;B65D2543/00527;;B65D2543/00092;;B65D2543/00805;;B65D2543/00638;;B65D2543/00685;;B65D2543/00046;;B65D2543/00731;;B65D2543/00537;;B65D2543/00351,B65D47/26;;B65D55/02,220/253;;220/259.3;;220/711;;220/715,0,0,,,,EXPIRED
527,US,A1,US 2006/0000832 A1,044-583-238-801-232,2006-01-05,2006,US 21131905 A,2005-08-25,US 21131905 A;;US 44708503 A;;US 92376301 A,2001-08-06,Reclosable container lid,"A reclosable lid 10 for a container holding a flowable substance has a first piece or cover 12 , and a movable second piece or disk 50 . The cover 10 has a top wall 14 , a side wall 16 and a mounting portion 22 for connecting the lid 10 on the container. The cover 12 has an opening 28 adapted to permit the flow of the substance through the lid 10 . The cover 12 further includes a slot 30 located in the top wall 14 . The disk 50 has at least one aperture 78 , a post 54 , and a projection 52 . The aperture 78 and the projection 52 are each cooperatively dimensioned with the opening 28 . The post 54 is adapted to be received by the slot 30 in the cover 12 . The disk 50 is movable between a first position wherein at least a portion of the projection 52 is received in the opening 28 in the first position, and a second position wherein the aperture 78 is aligned with the opening 28 in the second position. A support ledge 102 and a support edge 104 on an inner surface 100 of the cover 12 are adapted to provide rotatable support to the disk 50.",SMITH STEPHEN A;;HUSTON DAWN E;;WIEDMEYER WARREN G;;SULLIVAN STEPHEN W;;CHIN RICH M;;AHMED MOHAMMED M;;GITSCHLAG JOHN S;;LANGELAN DAVID R;;CHAUHAN RAJENDRA R;;HURST WILLIAM E;;JOINES JAMES T JR;;SMITH KEVIN R;;ANHALT MARK G;;RUTTER BRYCE G;;BONE BRIAN C;;DOTY HEATH A,SMITH STEPHEN A;;HUSTON DAWN E;;WIEDMEYER WARREN G;;SULLIVAN STEPHEN W;;CHIN RICH M;;AHMED MOHAMMED M;;GITSCHLAG JOHN S;;LANGELAN DAVID R;;CHAUHAN RAJENDRA R;;HURST WILLIAM E;;JOINES JAMES T JR;;SMITH KEVIN R;;ANHALT MARK G;;RUTTER BRYCE G;;BONE BRIAN C;;DOTY HEATH A,SOLO CUP OPERATING CORPORATION (2005-10-03),https://lens.org/044-583-238-801-232,Patent Application,yes,99,17,36,36,0,B65D43/0212;;B65D47/26;;B65D47/265;;B65D55/024;;B65D2543/00046;;B65D2543/00092;;B65D2543/00296;;B65D2543/00351;;B65D2543/00527;;B65D2543/00537;;B65D2543/00638;;B65D2543/00685;;B65D2543/00731;;B65D2543/00796;;B65D2543/00805;;B65D2543/00842;;B65D47/26;;B65D43/0212;;B65D55/024;;B65D2543/00296;;B65D2543/00842;;B65D47/265;;B65D47/26;;B65D2543/00796;;B65D2543/00527;;B65D2543/00092;;B65D2543/00805;;B65D2543/00638;;B65D2543/00685;;B65D2543/00046;;B65D2543/00731;;B65D2543/00537;;B65D2543/00351,A47G19/22;;B65D47/26;;B65D55/02,220/253;;220/713;;220/715;;229/404,0,0,,,,DISCONTINUED
528,NO,L,NO 20040541 L,194-510-868-898-974,2004-04-05,2004,NO 20040541 A,2004-02-05,US 92376301 A;;US 0223352 W,2001-08-06,Lokk for beholder som kan benyttes flere ganger.,"Et gjenlukkbart lokk 10 for en beholder som inneholder en strømbar substans omfatter en første del eller et deksel 12 og en bevegelig andre del eller en plate 50. Dekselet 10 har en toppvegg 14, en sidevegg 16 og en festedel 22 for å feste lokket 10 på beholderen. Dekselet 12 har en åpning 28 innrettet for å muliggjøre strømning av substansen gjennom lokket 10. Dekselet 12 omfatter videre en slisse 30 tilveiebrakt i toppveggen 14. Platen 50 har minst ett hull 78, en oppstikker 54 og en uthevning 52. Hullet 78 og uthevningen 52 er dimensjonert i overensstemmelse med åpningen 28. Oppstikkeren. 54 er innrettet for å bli mottatt i slissen 30 i dekselet 12. Platen 50 er bevegelig mellom en første posisjon der i hvert fall en andel av uthevningen 52 er mottatt i åpningen 28 og en andre posisjon der hullet 78 er linjeført med åpningen 28. En støtteskulder 102 og en støttekant 104 på en innvendig overflate 100 av dekselet 12 er innrettet for å gi roterbar understøtte for platen 50.",SOLO CUP CO,SMITH STEPHEN ALAN;;HUSTON DAWN ELLEN;;WIEDMEYER WARREN GILES;;SULLIVAN STEPHEN WILLIAM;;CHIN RICH MATTHEW;;AHMED MOHAMMED MAQSOOD;;GITSCHLAG JOHN STEWART;;LANGELAN DAVID RAYMOND;;CHAUHAN RAJENDRA RANJITBHAI;;HURST WILLIAM EDWARD;;JOINES JR JAMES TAM;;SMITH KEVIN RAY;;ANHALT MARK GERALD;;RUTTER BRYCE G;;BONE BRIAN C;;DOTY HEATH A,,https://lens.org/194-510-868-898-974,Abstract,no,0,0,36,36,0,B65D43/0212;;B65D47/26;;B65D47/265;;B65D55/024;;B65D2543/00046;;B65D2543/00092;;B65D2543/00296;;B65D2543/00351;;B65D2543/00527;;B65D2543/00537;;B65D2543/00638;;B65D2543/00685;;B65D2543/00731;;B65D2543/00796;;B65D2543/00805;;B65D2543/00842;;B65D47/26;;B65D43/0212;;B65D55/024;;B65D2543/00296;;B65D2543/00842;;B65D47/265;;B65D47/26;;B65D2543/00796;;B65D2543/00527;;B65D2543/00092;;B65D2543/00805;;B65D2543/00638;;B65D2543/00685;;B65D2543/00046;;B65D2543/00731;;B65D2543/00537;;B65D2543/00351,B65D47/26;;B65D51/18;;B65D55/02,,0,0,,,,DISCONTINUED
529,EP,A2,EP 1429974 A2,064-398-357-878-014,2004-06-23,2004,EP 02752530 A,2002-07-24,US 0223352 W;;US 92376301 A,2001-08-06,RECLOSABLE CONTAINER LID,,SOLO CUP CO,SMITH STEPHEN ALAN;;HUSTON DAWN ELLEN;;WIEDMEYER WARREN GILES;;SULLIVAN STEPHEN WILLIAM;;CHIN RICH MATTHEW;;AHMED MOHAMMED MAQSOOD;;GITSCHLAG JOHN STEWART;;LANGELAN DAVID RAYMOND;;CHAUHAN RAJENDRA RANJITBHAI;;HURST WILLIAM EDWARD;;JOINES JAMES TAM JR;;SMITH KEVIN RAY;;ANHALT MARK GERALD;;RUTTER BRYCE G;;BONE BRIAN C;;DOTY HEATH A,,https://lens.org/064-398-357-878-014,Patent Application,yes,0,0,36,36,0,B65D43/0212;;B65D47/26;;B65D47/265;;B65D55/024;;B65D2543/00046;;B65D2543/00092;;B65D2543/00296;;B65D2543/00351;;B65D2543/00527;;B65D2543/00537;;B65D2543/00638;;B65D2543/00685;;B65D2543/00731;;B65D2543/00796;;B65D2543/00805;;B65D2543/00842;;B65D47/26;;B65D43/0212;;B65D55/024;;B65D2543/00296;;B65D2543/00842;;B65D47/265;;B65D47/26;;B65D2543/00796;;B65D2543/00527;;B65D2543/00092;;B65D2543/00805;;B65D2543/00638;;B65D2543/00685;;B65D2543/00046;;B65D2543/00731;;B65D2543/00537;;B65D2543/00351,B65D47/26;;B65D55/02,,0,0,,,,EXPIRED
530,US,A1,US 2003/0197012 A1,165-178-036-521-513,2003-10-23,2003,US 44708503 A,2003-05-28,US 44708503 A;;US 92376301 A,2001-08-06,Reclosable container lid,"
    A reclosable lid 10  for a container holding a flowable substance has a first piece or cover 12 , and a movable second piece or disk 50 . The cover 10  has a top wall 14 , a side wall 16  and a mounting portion 22  for connecting the lid 10  on the container. The cover 12  has an opening 28  adapted to permit the flow of the substance through the lid 10 . The cover 12  further includes a slot 30  located in the top wall 14 . The disk 50  has at least one aperture 78 , a post 54 , and a projection 52 . The aperture 78  and the projection 52  are each cooperatively dimensioned with the opening 28 . The post 54  is adapted to be received by the slot 30  in the cover 12 . The disk 50  is movable between a first position wherein at least a portion of the projection 52  is received in the opening 28  in the first position, and a second position wherein the aperture 78  is aligned with the opening 28  in the second position. A support ledge 102  and a support edge 104  on an inner surface 100  of the cover 12  are adapted to provide rotatable support to the disk 50. 
",SMITH STEPHEN ALAN;;HUSTON DAWN ELLEN;;WIEDMEYER WARREN GILES;;SULLIVAN STEPHEN WILLIAM;;CHIN RICH MATTHEW;;AHMED MOHAMMED MAQSOOD;;GITSCHLAG JOHN STEWART;;LANGELAN DAVID RAYMOND;;CHAUHAN RAJENDRA RANJITBHAI;;HURST WILLIAM EDWARD;;JOINES JAMES TAM;;SMITH KEVIN RAY;;ANHALT MARK GERALD;;RUTTER BRYCE G.;;BONE BRIAN C.;;DOTY HEATH A.,SMITH STEPHEN ALAN;;HUSTON DAWN ELLEN;;WIEDMEYER WARREN GILES;;SULLIVAN STEPHEN WILLIAM;;CHIN RICH MATTHEW;;AHMED MOHAMMED MAQSOOD;;GITSCHLAG JOHN STEWART;;LANGELAN DAVID RAYMOND;;CHAUHAN RAJENDRA RANJITBHAI;;HURST WILLIAM EDWARD;;JOINES JAMES TAM;;SMITH KEVIN RAY;;ANHALT MARK GERALD;;RUTTER BRYCE G;;BONE BRIAN C;;DOTY HEATH A,SOLO CUP OPERATING CORPORATION (2005-10-03),https://lens.org/165-178-036-521-513,Patent Application,yes,99,10,36,36,0,B65D43/0212;;B65D47/26;;B65D47/265;;B65D55/024;;B65D2543/00046;;B65D2543/00092;;B65D2543/00296;;B65D2543/00351;;B65D2543/00527;;B65D2543/00537;;B65D2543/00638;;B65D2543/00685;;B65D2543/00731;;B65D2543/00796;;B65D2543/00805;;B65D2543/00842;;B65D47/26;;B65D43/0212;;B65D55/024;;B65D2543/00296;;B65D2543/00842;;B65D47/265;;B65D47/26;;B65D2543/00796;;B65D2543/00527;;B65D2543/00092;;B65D2543/00805;;B65D2543/00638;;B65D2543/00685;;B65D2543/00046;;B65D2543/00731;;B65D2543/00537;;B65D2543/00351,B65D47/26;;B65D55/02,220/253;;220/715,0,0,,,,EXPIRED
531,NZ,A,NZ 530975 A,085-747-043-222-316,2006-12-22,2006,NZ 53097502 A,2002-07-24,US 92376301 A;;US 0223352 W,2001-08-06,Reclosable container lid,"A reclosable lid 10 for a container holding a flowable substance is disclosed. The lid has a cover 12 for attachment to the container, with the cover having an opening and a support member extending inward from an inner surface of a side wall. The cover 12 also has an opening 28 to permit the flow of the substance through the lid and a further slot 30. A movable disk 50 is rotatably supported by the support member. The disk 50 has at least one aperture, and an actuator 54. The actuator 54 protrudes through the slot 30 to allow manipulation of the actuator to cause rotation of the disk between a first closed position and a second open position where the opening 28 is aligned with the aperture in the disk to allow the substance to flow through the lid.",SOLO CUP CO,SMITH STEPHEN ALAN;;HUSTON DAWN ELLEN;;WIEDMEYER WARREN GILES;;SULLIVAN STEPHEN WILLIAM;;CHIN RICH MATTHEW;;AHMED MOHAMMED MAQSOOD;;GITSCHLAG JOHN STEWART;;LANGELAN DAVID RAYMOND;;CHAUHAN RAJENDRA RANJITBHAI;;HURST WILLIAM EDWARD;;JOINES JAMES TAM;;SMITH KEVIN RAY;;ANHALT MARK GERALD;;RUTTER BRYCE G;;BONE BRIAN C;;DOTY HEATH A,,https://lens.org/085-747-043-222-316,Patent Application,no,0,0,36,36,0,B65D43/0212;;B65D47/26;;B65D47/265;;B65D55/024;;B65D2543/00046;;B65D2543/00092;;B65D2543/00296;;B65D2543/00351;;B65D2543/00527;;B65D2543/00537;;B65D2543/00638;;B65D2543/00685;;B65D2543/00731;;B65D2543/00796;;B65D2543/00805;;B65D2543/00842;;B65D47/26;;B65D43/0212;;B65D55/024;;B65D2543/00296;;B65D2543/00842;;B65D47/265;;B65D47/26;;B65D2543/00796;;B65D2543/00527;;B65D2543/00092;;B65D2543/00805;;B65D2543/00638;;B65D2543/00685;;B65D2543/00046;;B65D2543/00731;;B65D2543/00537;;B65D2543/00351,B65D47/26;;B65D55/02,,0,0,,,,PENDING
532,WO,A2,WO 2003/013969 A2,106-961-040-265-246,2003-02-20,2003,US 0223352 W,2002-07-24,US 92376301 A,2001-08-06,RECLOSABLE CONTAINER LID,"A reclosable lid 10 for a container holding a flowable substance has a first piece or cover 12, and a movable second piece or disk 50. The cover 10 has a top wall 14, a side wall 16 and a mounting portion 22 for connecting the lid 10 on the container. The cover 12 has an opening 28 adapted to permit the flow of the substance through the lid 10. The cover 12 further includes a slot 30 located in the top wall 14. The disk 50 has at least one aperture 78, a post 54, and a projection 52. The aperture 78 and the projection 52 are each cooperatively dimensioned with the opening 28. The post 54 is adapted to be received by the slot 30 in the cover 12. The disk 50 is movable between a first position wherein at least a portion of the projection 52 is received in the opening 28 in the first position, and a second position wherein the aperture 78 is aligned with the opening 28 in the second position. A support ledge 102 and a support edge 104 on an inner surface 100 of the cover 12 are adapted to provide rotatable support to the disk 50.",SOLO CUP CO,SMITH STEPHEN ALAN;;HUSTON DAWN ELLEN;;WIEDMEYER WARREN GILES;;SULLIVAN STEPHEN WILLIAM;;CHIN RICH MATTHEW;;AHMED MOHAMMED MAQSOOD;;GITSCHLAG JOHN STEWART;;LANGELAN DAVID RAYMOND;;CHAUHAN RAJENDRA RANJITBHAI;;HURST WILLIAM EDWARD;;JOINES JAMES TAM JR;;SMITH KEVIN RAY;;ANHALT MARK GERALD;;RUTTER BRYCE G;;BONE BRIAN C;;DOTY HEATH A,,https://lens.org/106-961-040-265-246,Patent Application,yes,0,0,36,36,0,B65D43/0212;;B65D47/26;;B65D47/265;;B65D55/024;;B65D2543/00046;;B65D2543/00092;;B65D2543/00296;;B65D2543/00351;;B65D2543/00527;;B65D2543/00537;;B65D2543/00638;;B65D2543/00685;;B65D2543/00731;;B65D2543/00796;;B65D2543/00805;;B65D2543/00842;;B65D47/26;;B65D43/0212;;B65D55/024;;B65D2543/00296;;B65D2543/00842;;B65D47/265;;B65D47/26;;B65D2543/00796;;B65D2543/00527;;B65D2543/00092;;B65D2543/00805;;B65D2543/00638;;B65D2543/00685;;B65D2543/00046;;B65D2543/00731;;B65D2543/00537;;B65D2543/00351,B65D47/26;;B65D55/02,,0,0,,,,PATENTED
533,WO,A3,WO 2003/013969 A3,104-782-978-052-974,2004-04-08,2004,US 0223352 W,2002-07-24,US 92376301 A,2001-08-06,RECLOSABLE CONTAINER LID,"A reclosable lid 10 for a container holding a flowable substance has a first piece or cover 12, and a movable second piece or disk 50. The cover 10 has a top wall 14, a side wall 16 and a mounting portion 22 for connecting the lid 10 on the container. The cover 12 has an opening 28 adapted to permit the flow of the substance through the lid 10. The cover 12 further includes a slot 30 located in the top wall 14. The disk 50 has at least one aperture 78, a post 54, and a projection 52. The aperture 78 and the projection 52 are each cooperatively dimensioned with the opening 28. The post 54 is adapted to be received by the slot 30 in the cover 12. The disk 50 is movable between a first position wherein at least a portion of the projection 52 is received in the opening 28 in the first position, and a second position wherein the aperture 78 is aligned with the opening 28 in the second position. A support ledge 102 and a support edge 104 on an inner surface 100 of the cover 12 are adapted to provide rotatable support to the disk 50.",SOLO CUP CO,SMITH STEPHEN ALAN;;HUSTON DAWN ELLEN;;WIEDMEYER WARREN GILES;;SULLIVAN STEPHEN WILLIAM;;CHIN RICH MATTHEW;;AHMED MOHAMMED MAQSOOD;;GITSCHLAG JOHN STEWART;;LANGELAN DAVID RAYMOND;;CHAUHAN RAJENDRA RANJITBHAI;;HURST WILLIAM EDWARD;;JOINES JAMES TAM JR;;SMITH KEVIN RAY;;ANHALT MARK GERALD;;RUTTER BRYCE G;;BONE BRIAN C;;DOTY HEATH A,,https://lens.org/104-782-978-052-974,Search Report,yes,8,0,36,36,0,B65D43/0212;;B65D47/26;;B65D47/265;;B65D55/024;;B65D2543/00046;;B65D2543/00092;;B65D2543/00296;;B65D2543/00351;;B65D2543/00527;;B65D2543/00537;;B65D2543/00638;;B65D2543/00685;;B65D2543/00731;;B65D2543/00796;;B65D2543/00805;;B65D2543/00842;;B65D47/26;;B65D43/0212;;B65D55/024;;B65D2543/00296;;B65D2543/00842;;B65D47/265;;B65D47/26;;B65D2543/00796;;B65D2543/00527;;B65D2543/00092;;B65D2543/00805;;B65D2543/00638;;B65D2543/00685;;B65D2543/00046;;B65D2543/00731;;B65D2543/00537;;B65D2543/00351,B65D47/26;;B65D55/02,,1,0,,,"PATENT ABSTRACTS OF JAPAN vol. 1998, no. 10 31 August 1998 (1998-08-31)",PATENTED
534,US,B2,US 6732875 B2,074-351-609-868-096,2004-05-11,2004,US 92376301 A,2001-08-06,US 92376301 A,2001-08-06,Reclosable container lid,"
    A reclosable lid  10  for a container holding a flowable substance has a first piece or cover  12  , and a movable second piece or disk  50  . The cover  10  has a top wall  14  , a side wall  16  and a mounting portion  22  for connecting the lid  10  on the container. The cover  12  has an opening  28  adapted to permit the flow of the substance through the lid  10  . The cover  12  further includes a slot  30  located in the top wall  14  . The disk  50  has at least one aperture  78  , a post  54  , and a projection  52  . The aperture  78  and the projection  52  are each cooperatively dimensioned with the opening  28  . The post  54  is adapted to be received by the slot  30  in the cover  12  . The disk  50  is movable between a first position wherein at least a portion of the projection  52  is received in the opening  28  in the first position, and a second position wherein the aperture  78  is aligned with the opening  28  in the second position. A support ledge  102  and a support edge  104  on an inner surface  100  of the cover  12  are adapted to provide rotatable support to the disk  50. 
",SOLO CUP CO,SMITH STEPHEN ALAN;;HUSTON DAWN ELLEN;;WIEDMEYER WARREN GILES;;SULLIVAN STEPHEN WILLIAM;;CHIN RICH MATTHEW;;AHMED MOHAMMED MAQSOOD;;GITSCHLAG JOHN STEWART;;LANGELAN DAVID RAYMOND;;CHAUHAN RAJENDRA RANJITBHAI;;HURST WILLIAM EDWARD;;JOINES JR JAMES TAM;;SMITH KEVIN RAY;;ANHALT MARK GERALD;;RUTTER BRYCE G;;BONE BRIAN C;;DOTY HEATH A,SOLO CUP COMPANY (2001-10-12);;SOLO CUP OPERATING CORPORATION (2005-10-03),https://lens.org/074-351-609-868-096,Granted Patent,yes,106,95,36,36,0,B65D43/0212;;B65D47/26;;B65D47/265;;B65D55/024;;B65D2543/00046;;B65D2543/00092;;B65D2543/00296;;B65D2543/00351;;B65D2543/00527;;B65D2543/00537;;B65D2543/00638;;B65D2543/00685;;B65D2543/00731;;B65D2543/00796;;B65D2543/00805;;B65D2543/00842;;B65D47/26;;B65D43/0212;;B65D55/024;;B65D2543/00296;;B65D2543/00842;;B65D47/265;;B65D47/26;;B65D2543/00796;;B65D2543/00527;;B65D2543/00092;;B65D2543/00805;;B65D2543/00638;;B65D2543/00685;;B65D2543/00046;;B65D2543/00731;;B65D2543/00537;;B65D2543/00351,B65D47/26;;B65D55/02,220/253;;220/713;;220/715;;220/256.1,7,0,,,"US 6,003,721, 12/1999, Fleming (withdrawn);;Copy of photograph of HotJo Ceramic Mug/Lid obtained through market research, Apr. 2000.;;Copy of photograph of Starbucks Cup/Lid obtained through market research, Apr. 2000.;;Copy of photograph of Super America Cup/Lid obtained through market research, Apr. 2000.;;Copy of photograph of Dunkin Donuts Cup/Lid obtained through market research, Apr. 2000.;;Seven (7) color photographs showing different views of Whirley Thermo Mug/Lid obtained in Feb. 2003.;;Berrington, N., International Search Report, Sep. 4, 2002, 6 pp., Patent Cooperation Treaty, Rijswijk, Netherlands.",EXPIRED
535,EP,B1,EP 1429974 B1,089-229-560-027-266,2007-03-21,2007,EP 02752530 A,2002-07-24,US 0223352 W;;US 92376301 A,2001-08-06,RECLOSABLE CONTAINER LID,,SOLO CUP OPERATING CORP,SMITH STEPHEN ALAN;;HUSTON DAWN ELLEN;;WIEDMEYER WARREN GILES;;SULLIVAN STEPHEN WILLIAM;;CHIN RICH MATTHEW;;AHMED MOHAMMED MAQSOOD;;GITSCHLAG JOHN STEWART;;LANGELAN DAVID RAYMOND;;CHAUHAN RAJENDRA RANJITBHAI;;HURST WILLIAM EDWARD;;JOINES JAMES TAM JR;;SMITH KEVIN RAY;;ANHALT MARK GERALD;;RUTTER BRYCE G;;BONE BRIAN C;;DOTY HEATH A,,https://lens.org/089-229-560-027-266,Granted Patent,yes,8,0,36,36,0,B65D43/0212;;B65D47/26;;B65D47/265;;B65D55/024;;B65D2543/00046;;B65D2543/00092;;B65D2543/00296;;B65D2543/00351;;B65D2543/00527;;B65D2543/00537;;B65D2543/00638;;B65D2543/00685;;B65D2543/00731;;B65D2543/00796;;B65D2543/00805;;B65D2543/00842;;B65D47/26;;B65D43/0212;;B65D55/024;;B65D2543/00296;;B65D2543/00842;;B65D47/265;;B65D47/26;;B65D2543/00796;;B65D2543/00527;;B65D2543/00092;;B65D2543/00805;;B65D2543/00638;;B65D2543/00685;;B65D2543/00046;;B65D2543/00731;;B65D2543/00537;;B65D2543/00351,B65D47/26;;B65D55/02,,1,0,,,"PATENT ABSTRACTS OF JAPAN vol. 1998, no. 10, 31 August 1998 (1998-08-31) -& JP 10 129706 A (ZOJIRUSHI CORP), 19 May 1998 (1998-05-19)",EXPIRED
536,US,A1,US 2003/0024929 A1,146-371-521-291-438,2003-02-06,2003,US 92376301 A,2001-08-06,US 92376301 A,2001-08-06,Reclosable container lid,"
    A reclosable lid 10  for a container holding a flowable substance has a first piece or cover 12 , and a movable second piece or disk 50 . The cover 10  has a top wall 14  , a side wall 16  and a mounting portion 22  for connecting the lid 10  on the container. The cover 12  has an opening 28  adapted to permit the flow of the substance through the lid 10 . The cover 12  further includes a slot 30  located in the top wall 14 . The disk 50  has at least one aperture 78 , a post 54 , and a projection 52 . The aperture 78  and the projection 52  are each cooperatively dimensioned with the opening 28 . The post 54  is adapted to be received by the slot 30  in the cover 12 . The disk 50  is movable between a first position wherein at least a portion of the projection 52  is received in the opening 28  in the first position, and a second position wherein the aperture 78  is aligned with the opening 28  in the second position. A support ledge 102  and a support edge 104  on an inner surface 100  of the cover 12  are adapted to provide rotatable support to the disk 50. 
",SMITH STEPHEN ALAN;;HUSTON DAWN ELLEN;;WIEDMEYER WARREN GILES;;SULLIVAN STEPHEN WILLIAM;;CHIN RICH MATTHEW;;AHMED MOHAMMED MAQSOOD;;GITSCHLAG JOHN STEWART;;LANGELAN DAVID RAYMOND;;CHAUHAN RAJENDRA RANJITBHAI;;HURST WILLIAM EDWARD;;JOINES JAMES TAM;;SMITH KEVIN RAY;;ANHALT MARK GERALD;;RUTTER BRYCE G.;;BONE BRIAN C.;;DOTY HEATH A.,SMITH STEPHEN ALAN;;HUSTON DAWN ELLEN;;WIEDMEYER WARREN GILES;;SULLIVAN STEPHEN WILLIAM;;CHIN RICH MATTHEW;;AHMED MOHAMMED MAQSOOD;;GITSCHLAG JOHN STEWART;;LANGELAN DAVID RAYMOND;;CHAUHAN RAJENDRA RANJITBHAI;;HURST WILLIAM EDWARD;;JOINES JAMES TAM;;SMITH KEVIN RAY;;ANHALT MARK GERALD;;RUTTER BRYCE G;;BONE BRIAN C;;DOTY HEATH A,SOLO CUP COMPANY (2001-10-12);;SOLO CUP OPERATING CORPORATION (2005-10-03),https://lens.org/146-371-521-291-438,Patent Application,yes,1,22,36,36,0,B65D43/0212;;B65D47/26;;B65D47/265;;B65D55/024;;B65D2543/00046;;B65D2543/00092;;B65D2543/00296;;B65D2543/00351;;B65D2543/00527;;B65D2543/00537;;B65D2543/00638;;B65D2543/00685;;B65D2543/00731;;B65D2543/00796;;B65D2543/00805;;B65D2543/00842;;B65D47/26;;B65D43/0212;;B65D55/024;;B65D2543/00296;;B65D2543/00842;;B65D47/265;;B65D47/26;;B65D2543/00796;;B65D2543/00527;;B65D2543/00092;;B65D2543/00805;;B65D2543/00638;;B65D2543/00685;;B65D2543/00046;;B65D2543/00731;;B65D2543/00537;;B65D2543/00351,B65D47/26;;B65D55/02,220/253;;220/713;;220/715,0,0,,,,EXPIRED
537,CA,A1,CA 2456794 A1,056-228-090-918-096,2003-02-20,2003,CA 2456794 A,2002-07-24,US 92376301 A;;US 0223352 W,2001-08-06,RECLOSABLE CONTAINER LID,"A reclosable lid 10 for a container holding a flowable substance has a first piece or cover 12, and a movable second piece or disk 50. The cover 10 has a top wall 14, a side wall 16 and a mounting portion 22 for connecting the lid 10 on the container. The cover 12 has an opening 28 adapted to permit the fl ow of the substance through the lid 10. The cover 12 further includes a slot 30 located in the top wall 14. The disk 50 has at least one aperture 78, a post 54, and a projection 52. The aperture 78 and the projection 52 are each cooperatively dimensioned with the opening 28. The post 54 is adapted to be received by the slot 30 in the cover 12. The disk 50 is movable between a first position wherein at least a portion of the projection 52 is received i n the opening 28 in the first position, and a second position wherein the aperture 78 is aligned with the opening 28 in the second position. A support ledge 102 and a support edge 104 on an inner surface 100 of the cover 12 are adapted to provide rotatable support to the disk 50.",SOLO CUP CO,HURST WILLIAM EDWARD;;CHAUHAN RAJENDRA RANJITBHAI;;SULLIVAN STEPHEN WILLIAM;;WIEDMEYER WARREN GILES;;CHIN RICH MATTHEW;;JOINES JAMES TAM JR;;LANGELAN DAVID RAYMOND;;RUTTER BRYCE G;;GITSCHLAG JOHN STEWART;;BONE BRIAN C;;ANHALT MARK GERALD;;DOTY HEATH A;;SMITH KEVIN RAY;;AHMED MOHAMMED MAQSOOD;;HUSTON DAWN ELLEN;;SMITH STEPHEN ALAN,,https://lens.org/056-228-090-918-096,Patent Application,no,0,0,36,36,0,B65D43/0212;;B65D47/26;;B65D47/265;;B65D55/024;;B65D2543/00046;;B65D2543/00092;;B65D2543/00296;;B65D2543/00351;;B65D2543/00527;;B65D2543/00537;;B65D2543/00638;;B65D2543/00685;;B65D2543/00731;;B65D2543/00796;;B65D2543/00805;;B65D2543/00842;;B65D47/26;;B65D43/0212;;B65D55/024;;B65D2543/00296;;B65D2543/00842;;B65D47/265;;B65D47/26;;B65D2543/00796;;B65D2543/00527;;B65D2543/00092;;B65D2543/00805;;B65D2543/00638;;B65D2543/00685;;B65D2543/00046;;B65D2543/00731;;B65D2543/00537;;B65D2543/00351,B65D47/26;;B65D55/02,,0,0,,,,EXPIRED
538,HK,A1,HK 1065006 A1,073-991-868-915-845,2005-02-08,2005,HK 04106664 A,2004-09-03,US 92376301 A;;US 0223352 W,2001-08-06,Reclosable container lid,,SOLO CUP OPERATING CORP,SMITH STEPHEN ALAN;;HUSTON DAWN ELLEN;;WIEDMEYER WARREN GILES;;SULLIVAN STEPHEN WILLIAM;;CHIN RICH MATTHEW;;AHMED MOHAMMED MAQSOOD;;GITSCHLAG JOHN STEWART;;LANGELAN DAVID RAYMOND;;CHAUHAN RAJENDRA RANJITBHAI;;HURST WILLIAM EDWARD;;JOINES JAMES TAM JR;;SMITH KEVIN RAY;;ANHALT MARK GERALD;;RUTTER BRYCE G;;BONE BRIAN C;;DOTY HEATH A,,https://lens.org/073-991-868-915-845,Patent Application,no,0,0,36,36,0,B65D43/0212;;B65D47/26;;B65D47/265;;B65D55/024;;B65D2543/00046;;B65D2543/00092;;B65D2543/00296;;B65D2543/00351;;B65D2543/00527;;B65D2543/00537;;B65D2543/00638;;B65D2543/00685;;B65D2543/00731;;B65D2543/00796;;B65D2543/00805;;B65D2543/00842;;B65D47/26;;B65D43/0212;;B65D55/024;;B65D2543/00296;;B65D2543/00842;;B65D47/265;;B65D47/26;;B65D2543/00796;;B65D2543/00527;;B65D2543/00092;;B65D2543/00805;;B65D2543/00638;;B65D2543/00685;;B65D2543/00046;;B65D2543/00731;;B65D2543/00537;;B65D2543/00351,B65D/;;B65D47/26;;B65D55/02,,0,0,,,,DISCONTINUED
539,DE,T2,DE 60219045 T2,130-697-514-134-767,2007-12-13,2007,DE 60219045 T,2002-07-24,US 92376301 A;;US 0223352 W,2001-08-06,WIEDERVERSCHLIESSBARER BEHÄLTERDECKEL,,SOLO CUP OPERATING CORP,SMITH STEPHEN ALAN;;HUSTON DAWN ELLEN;;WIEDMEYER WARREN GILES;;SULLIVAN STEPHEN WILLIAM;;CHIN RICH MATTHEW;;AHMED MOHAMMED MAQSOOD;;GITSCHLAG JOHN STEWART;;LANGELAN DAVID RAYMOND;;CHAUHAN RAJENDRA RANJITBHAI;;HURST WILLIAM EDWARD;;JOINES JAMES TAM;;SMITH KEVIN RAY;;ANHALT MARK GERALD;;RUTTER BRYCE G;;BONE BRIAN C;;DOTY HEATH A,,https://lens.org/130-697-514-134-767,Granted Patent,no,0,2,36,36,0,B65D43/0212;;B65D47/26;;B65D47/265;;B65D55/024;;B65D2543/00046;;B65D2543/00092;;B65D2543/00296;;B65D2543/00351;;B65D2543/00527;;B65D2543/00537;;B65D2543/00638;;B65D2543/00685;;B65D2543/00731;;B65D2543/00796;;B65D2543/00805;;B65D2543/00842;;B65D47/26;;B65D43/0212;;B65D55/024;;B65D2543/00296;;B65D2543/00842;;B65D47/265;;B65D47/26;;B65D2543/00796;;B65D2543/00527;;B65D2543/00092;;B65D2543/00805;;B65D2543/00638;;B65D2543/00685;;B65D2543/00046;;B65D2543/00731;;B65D2543/00537;;B65D2543/00351,B65D47/26;;B65D55/02,,0,0,,,,EXPIRED
540,AU,B2,AU 2002/355395 B2,000-092-040-261-370,2008-11-06,2008,AU 2002/355395 A,2002-07-24,US 92376301 A;;US 0223352 W,2001-08-06,Reclosable container lid,,SOLO CUP CO,SULLIVAN STEPHEN WILLIAM;;SMITH KEVIN RAY;;HURST WILLIAM EDWARD;;CHAUHAN RAJENDRA RANJITBHAI;;DOTY HEATH A;;WIEDMEYER WARREN GILES;;ANHALT MARK GERALD;;AHMED MOHAMMED MAQSOOD;;JOINES JAMES TAM JR;;BONE BRIAN C;;HUSTON DAWN ELLEN;;GITSCHLAG JOHN STEWART;;RUTTER BRYCE G;;CHIN RICH MATTHEW;;SMITH STEPHEN ALAN;;LANGELAN DAVID RAYMOND,,https://lens.org/000-092-040-261-370,Granted Patent,no,9,0,36,36,0,B65D43/0212;;B65D47/26;;B65D47/265;;B65D55/024;;B65D2543/00046;;B65D2543/00092;;B65D2543/00296;;B65D2543/00351;;B65D2543/00527;;B65D2543/00537;;B65D2543/00638;;B65D2543/00685;;B65D2543/00731;;B65D2543/00796;;B65D2543/00805;;B65D2543/00842;;B65D47/26;;B65D43/0212;;B65D55/024;;B65D2543/00296;;B65D2543/00842;;B65D47/265;;B65D47/26;;B65D2543/00796;;B65D2543/00527;;B65D2543/00092;;B65D2543/00805;;B65D2543/00638;;B65D2543/00685;;B65D2543/00046;;B65D2543/00731;;B65D2543/00537;;B65D2543/00351,B65D47/26;;B65D55/02,,0,0,,,,EXPIRED
541,BR,A,BR 0211746 A,172-583-277-193-314,2004-10-13,2004,BR 0211746 A,2002-07-24,US 92376301 A;;US 0223352 W,2001-08-06,Tampa para recipiente capaz de ser fechada novamente,"""TAMPA PARA RECIPIENTE CAPAZ DE SER FECHADA NOVAMENTE"". A presente invenção refere-se à tampa capaz de ser fechada novamente (10) para um recipiente que retém uma substância fluida apresenta uma primeira peça ou cobertura (12), e uma segunda peça ou disco (50). A cobertura (10) apresenta uma parede de topo (14), uma parede lateral (16) e uma porção de montagem (22) para conectar a tampa (10) no recipiente. A cobertura (12) apresenta uma abertura (28) adaptada para permitir o fluxo da substância através da tampa (10). A cobertura (12) adicionalmente inclui uma fenda (30) localizada na parede de topo (14). O disco (50) apresenta pelo menos um orifício (78), um montante vertical (54), e uma projeção (52). O orifício (78) e a projeção (52) são cada qual cooperativamente dimensionados com a abertura (28). O montante vertical (54) é adaptado para ser recebido pela fenda (30) na cobertura (12). O disco (50) é móvel entre uma primeira posição, na qual pelo menos uma porção da projeção (52) é recebida na abertura (28) na primeira posição, e uma segunda posição, na qual o orifício (78) é alinhado com a abertura (28) na segunda posição. Uma saliência de suporte (102) e uma borda de suporte (104) na superfície interna (100) da cobertura (12) são adaptadas para proverem suporte giratório ao disco (50).",SOLO CUP CO,SMITH STEPHEN ALAN;;HUSTON DAWN ELLEN;;WIEDMEYER WARREN GILES;;SULLIVAN STEPHEN WILLIAM;;CHIN RICH MATTHEW;;AHMED MOHAMMED MAQSOOD;;GITSCHLAG JOHN STEWART;;LANGELAN DAVID RAYMOND;;CHAUHAN RAJENDRA RANJITBHAI;;HURST WILLIAM EDWARD;;JOINES JAMES TAM JR;;SMITH KEVIN RAY;;ANHALT MARK GERALD;;RUTTER BRYCE G;;BONE BRIAN C;;DOTY HEATH A,,https://lens.org/172-583-277-193-314,Patent Application,no,0,0,36,36,0,B65D43/0212;;B65D47/26;;B65D47/265;;B65D55/024;;B65D2543/00046;;B65D2543/00092;;B65D2543/00296;;B65D2543/00351;;B65D2543/00527;;B65D2543/00537;;B65D2543/00638;;B65D2543/00685;;B65D2543/00731;;B65D2543/00796;;B65D2543/00805;;B65D2543/00842;;B65D47/26;;B65D43/0212;;B65D55/024;;B65D2543/00296;;B65D2543/00842;;B65D47/265;;B65D47/26;;B65D2543/00796;;B65D2543/00527;;B65D2543/00092;;B65D2543/00805;;B65D2543/00638;;B65D2543/00685;;B65D2543/00046;;B65D2543/00731;;B65D2543/00537;;B65D2543/00351,B65D47/26;;B65D55/02,,0,0,,,,DISCONTINUED
542,US,B2,US 7159732 B2,099-657-368-950-29X,2007-01-09,2007,US 64526803 A,2003-08-21,US 64526803 A;;US 92376301 A,2001-08-06,Reclosable container lid,"A reclosable lid 10 for a container holding a flowable substance has a first piece or cover 12 , and a movable second piece or disk 50 . The cover 10 has a top wall 14 , a side wall 16 and a mounting portion 22 for connecting the lid 10 on the container. The cover 12 has an opening 28 adapted to permit the flow of the substance through the lid 10 . The cover 12 further includes a slot 30 located in the top wall 14 . The disk 50 has at least one aperture 78 , a post 54 , and a projection 52 . The aperture 78 and the projection 52 are each cooperatively dimensioned with the opening 28 . The post 54 is adapted to be received by the slot 30 in the cover 12 . The disk 50 is movable between a first position wherein at least a portion of the projection 52 is received in the opening 28 in the first position, and a second position wherein the aperture 78 is aligned with the opening 28 in the second position. A support ledge 102 and a support edge 104 on an inner surface 100 of the cover 12 are adapted to provide rotatable support to the disk 50.",SOLO CUP OPERATING CORP,SMITH STEPHEN ALAN;;HUSTON DAWN ELLEN;;WIEDMEYER WARREN GILES;;SULLIVAN STEPHEN WILLIAM;;CHIN RICH MATTHEW;;AHMED MOHAMMED MAQSOOD;;GITSCHLAG JOHN STEWART;;LANGELAN DAVID RAYMOND;;CHAUHAN RAJENDRA RANJITBHAI;;HURST WILLIAM EDWARD;;JOINES JR JAMES TAM;;SMITH KEVIN RAY;;ANHALT MARK GERALD;;RUTTER BRYCE G;;BONE BRIAN C;;DOTY HEATH A,SOLO CUP OPERATING CORPORATION (2005-10-03),https://lens.org/099-657-368-950-29X,Granted Patent,yes,105,71,36,36,0,B65D43/0212;;B65D47/26;;B65D47/265;;B65D55/024;;B65D2543/00046;;B65D2543/00092;;B65D2543/00296;;B65D2543/00351;;B65D2543/00527;;B65D2543/00537;;B65D2543/00638;;B65D2543/00685;;B65D2543/00731;;B65D2543/00796;;B65D2543/00805;;B65D2543/00842;;B65D47/26;;B65D43/0212;;B65D55/024;;B65D2543/00296;;B65D2543/00842;;B65D47/265;;B65D47/26;;B65D2543/00796;;B65D2543/00527;;B65D2543/00092;;B65D2543/00805;;B65D2543/00638;;B65D2543/00685;;B65D2543/00046;;B65D2543/00731;;B65D2543/00537;;B65D2543/00351,B65D51/18;;A47G19/22;;B65D43/18;;B65D47/26;;B65D55/02,220/253;;220/713;;220/254.4;;220/711;;220/715,7,0,,,"US 6,003,721, 12/1999, Fleming (withdrawn);;*Copy of photograph of HotJo Ceramic Mug/Lid obtained through market research, Apr. 2000.;;*Copy of photograph of Starbucks Cup/Lid obtained through market research, Apr. 2000.;;*Copy of photograph of Super America Cup/Lid obtained through market research, Apr. 2000.;;*Copy of photograph of Dunkin Donuts Cup/Lid obtained through market research, Apr. 2000.;;*Berrington, N., International Search Report, Sep. 4, 2002, 6 pp., Patent Cooperation Treaty, Rijswijk, Netherlands.;;*Seven (7) color photgraphs showing different views of Whirley Thermo Mug/Lid obtained in Feb. 2003.",EXPIRED
543,US,B2,US 7156251 B2,186-318-986-799-096,2007-01-02,2007,US 44708503 A,2003-05-28,US 44708503 A;;US 92376301 A,2001-08-06,Reclosable container lid,"A reclosable lid 10 for a container holding a flowable substance has a first piece or cover 12 , and a movable second piece or disk 50 . The cover 10 has a top wall 14 , a side wall 16 and a mounting portion 22 for connecting the lid 10 on the container. The cover 12 has an opening 28 adapted to permit the flow of the substance through the lid 10 . The cover 12 further includes a slot 30 located in the top wall 14 . The disk 50 has at least one aperture 78 , a post 54 , and a projection 52 . The aperture 78 and the projection 52 are each cooperatively dimensioned with the opening 28 . The post 54 is adapted to be received by the slot 30 in the cover 12 . The disk 50 is movable between a first position wherein at least a portion of the projection 52 is received in the opening 28 in the first position, and a second position wherein the aperture 78 is aligned with the opening 28 in the second position. A support ledge 102 and a support edge 104 on an inner surface 100 of the cover 12 are adapted to provide rotatable support to the disk 50.",SOLO CUP OPERATING CORP,SMITH STEPHEN ALAN;;HUSTON DAWN ELLEN;;WIEDMEYER WARREN GILES;;SULLIVAN STEPHEN WILLIAM;;CHIN RICH MATTHEW;;AHMED MOHAMMED MAQSOOD;;GITSCHLAG JOHN STEWART;;LANGELAN DAVID RAYMOND;;CHAUHAN RAJENDRA RANJITBHAI;;HURST WILLIAM EDWARD;;JOINES JR JAMES TAM;;SMITH KEVIN RAY;;ANHALT MARK GERALD;;RUTTER BRYCE G;;BONE BRIAN C;;DOTY HEATH A,SOLO CUP OPERATING CORPORATION (2005-10-03),https://lens.org/186-318-986-799-096,Granted Patent,yes,108,51,36,36,0,B65D43/0212;;B65D47/26;;B65D47/265;;B65D55/024;;B65D2543/00046;;B65D2543/00092;;B65D2543/00296;;B65D2543/00351;;B65D2543/00527;;B65D2543/00537;;B65D2543/00638;;B65D2543/00685;;B65D2543/00731;;B65D2543/00796;;B65D2543/00805;;B65D2543/00842;;B65D47/26;;B65D43/0212;;B65D55/024;;B65D2543/00296;;B65D2543/00842;;B65D47/265;;B65D47/26;;B65D2543/00796;;B65D2543/00527;;B65D2543/00092;;B65D2543/00805;;B65D2543/00638;;B65D2543/00685;;B65D2543/00046;;B65D2543/00731;;B65D2543/00537;;B65D2543/00351,B65D51/18;;A47G19/22;;B65D47/26;;B65D55/02;;G09F3/00,220/253;;220/713;;220/715;;220/254.4;;40/311,6,0,,,"Photograph of HotJo Ceramic Mug/Lid obtained through market research, Apr. 2000.;;Photograph of Starbucks Cup/Lid obtained through market research, Apr. 2000.;;Photograph of Super America Cup/Lid obtained through market research, Apr. 2000.;;Photograph of Dunkin Donuts Cup/Lid obtained through market research, Apr. 2000.;;Berrington, N., International Search Report, Sep. 4, 2002, 6 pp., Patent Cooperation Treaty, Rijswijk, Netherlands.;;Seven (7) color photographs showing different views of Whirley Thermo Mug/Lid obtained in early 2003.",EXPIRED
544,US,A1,US 2004/0089662 A1,008-185-411-032-854,2004-05-13,2004,US 62237403 A,2003-07-18,US 62237403 A;;US 92376301 A,2001-08-06,Reclosable container lid,"
    A reclosable lid 310  for a container holding a flowable substance has a cover 312  and a rotatable element 50  rotatably supported by the cover 312.  The cover 312  has an opening 28  and a slot 30  located in a top wall 14  of the cover 312.  The cover 312  also has a tab 323  extending outward from a portion of the cover 312.  The rotatable element 50  has at least one aperture 78  and an actuator 54  that is accessible through the slot 30.  The element 50  is moveable by manipulation of the actuator 54  between a first position wherein the aperture 78  is misaligned with the opening 28,  and a second position wherein the aperture 78  is aligned with the opening 28.  The cover 312  has at least one support member 102  extending radially inward from an inner surface 100  of the cover 312,  wherein the support member 102  rotatably supports the element 50. 
",SMITH STEPHEN ALAN;;HUSTON DAWN ELLEN;;WIEDMEYER WARREN GILES;;SULLIVAN STEPHEN WILLIAM;;CHIN RICH MATTHEW;;AHMED MOHAMMED MAQSOOD;;GITSCHLAG JOHN STEWART;;LANGELAN DAVID RAYMOND;;CHAUHAN RAJENDRA RANJITBHAI;;HURST WILLIAM EDWARD;;JOINES JAMES TAM;;SMITH KEVIN RAY;;ANHALT MARK GERALD;;RUTTER BRYCE G.;;BONE BRIAN C.;;DOTY HEATH A.;;SANDUSKY RICHARD MICHAEL,SMITH STEPHEN ALAN;;HUSTON DAWN ELLEN;;WIEDMEYER WARREN GILES;;SULLIVAN STEPHEN WILLIAM;;CHIN RICH MATTHEW;;AHMED MOHAMMED MAQSOOD;;GITSCHLAG JOHN STEWART;;LANGELAN DAVID RAYMOND;;CHAUHAN RAJENDRA RANJITBHAI;;HURST WILLIAM EDWARD;;JOINES JAMES TAM;;SMITH KEVIN RAY;;ANHALT MARK GERALD;;RUTTER BRYCE G;;BONE BRIAN C;;DOTY HEATH A;;SANDUSKY RICHARD MICHAEL,SOLO CUP COMPANY (2003-11-26);;SOLO CUP OPERATING CORPORATION (2005-10-03),https://lens.org/008-185-411-032-854,Patent Application,yes,99,31,13,13,0,B65D43/0212;;B65D47/26;;B65D47/265;;B65D55/024;;B65D2543/00046;;B65D2543/00092;;B65D2543/00296;;B65D2543/00351;;B65D2543/00527;;B65D2543/00537;;B65D2543/00638;;B65D2543/00685;;B65D2543/00731;;B65D2543/00805;;B65D2543/00842;;Y10T29/49876;;Y10T29/4984;;Y10T29/49876;;Y10T29/4984;;B65D47/265;;B65D2543/00805;;B65D43/0212;;B65D2543/00537;;B65D2543/00046;;B65D2543/00842;;B65D47/26;;B65D2543/00638;;B65D2543/00092;;B65D2543/00527;;B65D2543/00731;;B65D55/024;;B65D2543/00351;;B65D2543/00685;;B65D2543/00296,B65D43/02;;B65D47/26;;B65D55/02,220/253;;220/256.1;;220/715,0,0,,,,EXPIRED
545,US,B2,US 7246715 B2,197-164-481-920-284,2007-07-24,2007,US 62237403 A,2003-07-18,US 62237403 A;;US 92376301 A,2001-08-06,Reclosable container lid,"A reclosable lid 310 for a container holding a flowable substance has a cover 312 and a rotatable element 50 rotatably supported by the cover 312 . The cover 312 has an opening 28 and a slot 30 located in a top wall 14 of the cover 312 . The cover 312 also has a tab 323 extending outward from a portion of the cover 312 . The rotatable element 50 has at least one aperture 78 and an actuator 54 that is accessible through the slot 30 . The element 50 is moveable by manipulation of the actuator 54 between a first position wherein the aperture 78 is misaligned with the opening 28 , and a second position wherein the aperture 78 is aligned with the opening 28 . The cover 312 has at least one support member 102 extending radially inward from an inner surface 100 of the cover 312 , wherein the support member 102 rotatably supports the element 50.",SOLO CUP OPERATING CORP,SMITH STEPHEN ALAN;;HUSTON DAWN ELLEN;;WIEDMEYER WARREN GILES;;SULLIVAN STEPHEN WILLIAM;;CHIN RICH MATTHEW;;AHMED MOHAMMED MAQSOOD;;GITSCHLAG JOHN STEWART;;LANGELAN DAVID RAYMOND;;CHAUHAN RAJENDRA RANJITBHAI;;HURST WILLIAM EDWARD;;JOINES JR JAMES TAM;;SMITH KEVIN RAY;;ANHALT MARK GERALD;;RUTTER BRYCE G;;BONE BRIAN C;;DOTY HEATH A;;SANDUSKY RICHARD MICHAEL,SOLO CUP COMPANY (2003-11-26);;SOLO CUP OPERATING CORPORATION (2005-10-03),https://lens.org/197-164-481-920-284,Granted Patent,yes,110,48,13,13,0,B65D43/0212;;B65D47/26;;B65D47/265;;B65D55/024;;B65D2543/00046;;B65D2543/00092;;B65D2543/00296;;B65D2543/00351;;B65D2543/00527;;B65D2543/00537;;B65D2543/00638;;B65D2543/00685;;B65D2543/00731;;B65D2543/00805;;B65D2543/00842;;Y10T29/49876;;Y10T29/4984;;Y10T29/49876;;Y10T29/4984;;B65D47/265;;B65D2543/00805;;B65D43/0212;;B65D2543/00537;;B65D2543/00046;;B65D2543/00842;;B65D47/26;;B65D2543/00638;;B65D2543/00092;;B65D2543/00527;;B65D2543/00731;;B65D55/024;;B65D2543/00351;;B65D2543/00685;;B65D2543/00296,B65D51/18;;A47G19/22;;B23P11/00;;B65D41/18;;B65D43/02;;B65D47/26;;B65D55/02,220/253;;220/793;;220/256.1;;220/715;;29/434;;29/453,7,0,,,"US 6,003,721, 12/1999, Fleming (withdrawn);;Photograph of HotJo Ceramic Mug/Lid obtained through market research, Apr. 2000.;;Photograph of Starbucks Cup/Lid obtained through market research, Apr. 2000.;;Photograph of Super America Cup/Lid obtained through market research, Apr. 2000.;;Photograph of Dunkin Donuts Cup/Lid obtained through market research, Apr. 2000.;;Berrington, N., International Search Report, Sep. 4, 2002, 6 pp., Patent Cooperation Treaty; Rijswijk, Netherlands.;;Seven (7) color photographs showing different views of Whirley Thermo Mug/Lid obtained in Feb. 2003.",EXPIRED
546,WO,A1,WO 2005/016778 A1,009-890-718-996-930,2005-02-24,2005,US 2004/0009560 W,2004-03-29,US 62237403 A,2003-07-18,RECLOSABLE CONTAINER LID,"A reclosable lid (310) for a container holding a flowable substance has a cover (312) and a rotatable element (50) rotatably supported by the cover (312). The cover (3l2) has an opening (28) and a slot (30) located in a top wall (14) of the cover (312). The cover (312) also has a tab (323) extending outward from a portion of the cover (312). The rotatable element (50) has at least one aperture (78) and an actuator (54) that is accessible through the slot (30). The element (50) is moveable by manipulation of the actuator (54) between a first position wherein the aperture (78) is misaligned with the opening (28), and a second position wherein the aperture (78) is aligned with the opening (28). The cover (312) has at least one support member (l02) extending radially inward from an inner surface (100) of the cover (312), wherein the support member (102) rotatably supports the element (50).",SOLO CUP CO;;SMITH STEPHEN ALAN;;HUSTON DAWN ELLEN;;WIEDMEYER WARREN GILES;;SULLIVAN STEPHEN WILLIAM;;CHIN RICH MATTHEW;;AHMED MOHAMMED MAQSOOD;;GITSCHLAG JOHN STEWART;;LANGELAN DAVID RAYMOND;;CHAUHAN RAJENDRA RANJITBHAI;;HURST WILLIAM EDWARD;;JOINES JAMES TAM JR;;SMITH KEVIN RAY;;ANHALT MARK GERALD;;RUTTER BRYCE G;;BONE BRIAN C;;DOTY HEATH A;;SANDUSKY RICHARD MICHAEL,SMITH STEPHEN ALAN;;HUSTON DAWN ELLEN;;WIEDMEYER WARREN GILES;;SULLIVAN STEPHEN WILLIAM;;CHIN RICH MATTHEW;;AHMED MOHAMMED MAQSOOD;;GITSCHLAG JOHN STEWART;;LANGELAN DAVID RAYMOND;;CHAUHAN RAJENDRA RANJITBHAI;;HURST WILLIAM EDWARD;;JOINES JAMES TAM JR;;SMITH KEVIN RAY;;ANHALT MARK GERALD;;RUTTER BRYCE G;;BONE BRIAN C;;DOTY HEATH A;;SANDUSKY RICHARD MICHAEL,,https://lens.org/009-890-718-996-930,Patent Application,yes,4,8,13,13,0,B65D43/0212;;B65D47/26;;B65D47/265;;B65D55/024;;B65D2543/00046;;B65D2543/00092;;B65D2543/00296;;B65D2543/00351;;B65D2543/00527;;B65D2543/00537;;B65D2543/00638;;B65D2543/00685;;B65D2543/00731;;B65D2543/00805;;B65D2543/00842;;Y10T29/49876;;Y10T29/4984;;Y10T29/49876;;Y10T29/4984;;B65D47/265;;B65D2543/00805;;B65D43/0212;;B65D2543/00537;;B65D2543/00046;;B65D2543/00842;;B65D47/26;;B65D2543/00638;;B65D2543/00092;;B65D2543/00527;;B65D2543/00731;;B65D55/024;;B65D2543/00351;;B65D2543/00685;;B65D2543/00296,B65D43/02;;B65D47/26;;B65D55/02,,0,0,,,,PENDING
547,CA,A1,CA 2532987 A1,150-757-616-650-647,2005-02-24,2005,CA 2532987 A,2004-03-29,US 62237403 A;;US 2004/0009560 W,2003-07-18,RECLOSABLE CONTAINER LID,"A reclosable lid (310) for a container holding a flowable substance has a cover (312) and a rotatable element (50) rotatably supported by the cover (312). The cover (3l2) has an opening (28) and a slot (30) located in a top wall (14) of the cover (312). The cover (312) also has a tab (323) extending outward from a portion of the cover (312). The rotatable element (50) has at least one aperture (78) and an actuator (54) that is accessible through the slot (30). The element (50) is moveable by manipulation of the actuator (54) between a first position wherein the aperture (78) is misaligned with the opening (28), and a second position wherein the aperture (78) is aligned wit h the opening (28). The cover (312) has at least one support member (l02) extending radially inward from an inner surface (100) of the cover (312), wherein the support member (102) rotatably supports the element (50).</SDOAB >",SOLO CUP OPERATING CORP,SMITH KEVIN RAY;;RUTTER BRYCE G;;JOINES JAMES TAM JR;;HURST WILLIAM EDWARD;;CHAUHAN RAJENDRA RANJITBHAI;;ANHALT MARK GERALD;;DOTY HEATH A;;SANDUSKY RICHARD MICHAEL;;WIEDMEYER WARREN GILES;;SMITH STEPHEN ALAN;;HUSTON DAWN ELLEN;;LANGELAN DAVID RAYMOND;;BONE BRIAN C;;GITSCHLAG JOHN STEWART;;AHMED MOHAMMED MAQSOOD;;CHIN RICH MATTHEW;;SULLIVAN STEPHEN WILLIAM,,https://lens.org/150-757-616-650-647,Patent Application,no,0,0,13,13,0,B65D43/0212;;B65D47/26;;B65D47/265;;B65D55/024;;B65D2543/00046;;B65D2543/00092;;B65D2543/00296;;B65D2543/00351;;B65D2543/00527;;B65D2543/00537;;B65D2543/00638;;B65D2543/00685;;B65D2543/00731;;B65D2543/00805;;B65D2543/00842;;Y10T29/49876;;Y10T29/4984;;Y10T29/49876;;Y10T29/4984;;B65D47/265;;B65D2543/00805;;B65D43/0212;;B65D2543/00537;;B65D2543/00046;;B65D2543/00842;;B65D47/26;;B65D2543/00638;;B65D2543/00092;;B65D2543/00527;;B65D2543/00731;;B65D55/024;;B65D2543/00351;;B65D2543/00685;;B65D2543/00296,B65D47/26;;B65D43/02;;B65D55/02,,0,0,,,,DISCONTINUED
548,EP,A1,EP 1646568 A1,153-285-515-850-101,2006-04-19,2006,EP 04801838 A,2004-03-29,US 2004/0009560 W;;US 62237403 A,2003-07-18,RECLOSABLE CONTAINER LID,,SOLO CUP OPERATING CORP,SMITH STEPHEN ALAN;;HUSTON DAWN ELLEN;;WIEDMEYER WARREN GILES;;SULLIVAN STEPHEN WILLIAM;;CHIN RICH MATTHEW;;AHMED MOHAMMED MAQSOOD;;GITSCHLAG JOHN STEWART;;LANGELAN DAVID RAYMOND;;CHAUHAN RAJENDRA RANJITBHAI;;HURST WILLIAM EDWARD;;JOINES JAMES TAM JR;;SMITH KEVIN RAY;;ANHALT MARK GERALD;;RUTTER BRYCE G;;BONE BRIAN C;;DOTY HEATH A;;SANDUSKY RICHARD MICHAEL,,https://lens.org/153-285-515-850-101,Patent Application,yes,0,0,13,13,0,B65D43/0212;;B65D47/26;;B65D47/265;;B65D55/024;;B65D2543/00046;;B65D2543/00092;;B65D2543/00296;;B65D2543/00351;;B65D2543/00527;;B65D2543/00537;;B65D2543/00638;;B65D2543/00685;;B65D2543/00731;;B65D2543/00805;;B65D2543/00842;;Y10T29/49876;;Y10T29/4984;;Y10T29/49876;;Y10T29/4984;;B65D47/265;;B65D2543/00805;;B65D43/0212;;B65D2543/00537;;B65D2543/00046;;B65D2543/00842;;B65D47/26;;B65D2543/00638;;B65D2543/00092;;B65D2543/00527;;B65D2543/00731;;B65D55/024;;B65D2543/00351;;B65D2543/00685;;B65D2543/00296,B65D43/02;;B65D47/26;;B65D55/02,,0,0,,,,PENDING
549,NO,L,NO 20056243 L,133-392-233-876-23X,2006-04-06,2006,NO 20056243 A,2005-12-30,US 62237403 A;;US 2004/0009560 W,2003-07-18,Gjenlukkbart beholderlokk,"Et gjenlukkbart lokk (310) for en beholder som kan inneholde en strømmingsdyktig substans har et deksel (312) og et roterbart element (50) som roterbart understøttes av dekslet (312). Dekslet (312) har en åpning (28) og en sliss (30) lokalisert i en toppvegg (14) av dekslet (312). Dekslet (312) har også en flik (323) som strekker seg utover fra en del av dekslet (312). Det roterbare element (50) har minst én apertur (78) og en aktuator (54) som er tilgjengelig gjennom slissen (30). Elementet (50) er bevegelig ved manipulasjon av aktuatoren (54) mellom en første posisjon hvori aper- turen (78) er mistilpasset med åpningen (28), og en andre posisjon, hvori aperturen (78) er innrettet på linje med åpningen (28). Dekslet (312) har minst et støtteelement (102) som strekker seg radielt innover fra en indre overflate (100) av dekslet (312) hvori støtteelementet (102) roterbart understøtter elementet (50).",SOLO CUP OPERATING CORP,SMITH STEPHEN ALAN;;HUSTON DAWN ELLEN;;WIEDMEYER WARREN GILES;;CHIN RICH MATTHEW;;GITSCHLAG JOHN STEWART;;LANGELAN DAVID RAYMOND;;CHAUHAN RAJENDRA RANJITBHAI;;HURST WILLIAM EDWARD;;JOINES JR JAMES TAM;;SMITH KEVIN RAY;;ANHALT MARK GERALD;;RUTTER BRYCE G;;BONE BRIAN C;;DOTY HEATH A;;SULLIVAN STEPHEN WILLIAM;;AHMED MOHAMMED MAQSOOD;;SANDUSKY RICHARD MICHAEL,,https://lens.org/133-392-233-876-23X,Abstract,no,0,0,13,13,0,B65D43/0212;;B65D47/26;;B65D47/265;;B65D55/024;;B65D2543/00046;;B65D2543/00092;;B65D2543/00296;;B65D2543/00351;;B65D2543/00527;;B65D2543/00537;;B65D2543/00638;;B65D2543/00685;;B65D2543/00731;;B65D2543/00805;;B65D2543/00842;;Y10T29/49876;;Y10T29/4984;;Y10T29/49876;;Y10T29/4984;;B65D47/265;;B65D2543/00805;;B65D43/0212;;B65D2543/00537;;B65D2543/00046;;B65D2543/00842;;B65D47/26;;B65D2543/00638;;B65D2543/00092;;B65D2543/00527;;B65D2543/00731;;B65D55/024;;B65D2543/00351;;B65D2543/00685;;B65D2543/00296,B65D47/20;;B65D43/02;;B65D47/26;;B65D55/02,,0,0,,,,DISCONTINUED
550,EP,A3,EP 1667020 A3,086-081-692-943-787,2006-09-13,2006,EP 05110695 A,2005-11-14,US 330704 A,2004-12-03,Interface infrastructure for creating and interacting with web services,"A web services namespace pertains to an infrastructure for enabling creation of a wide variety of applications. The infrastructure provides a foundation for building message-based applications of various scale and complexity. The infrastructure or framework provides APIs for basic messaging, secure messaging, reliable messaging and transacted messaging. In some embodiments, the associated APIs are factored into a hierarchy of namespaces in a manner that balances utility, usability, extensibility and versionability.
",MICROSOFT CORP,STERN AARON ABRAHAM;;DRIVER DAVID OWEN;;WALTER DOUGLAS A;;PURDY DOUGLAS M;;WAINGOLD ELLIOT LEE;;CHRISTENSEN ERIK BO;;HONEYCUTT ERIN P;;OSOVETSKY EVGENY;;EPPLEY GEARY L;;DELLA-LIBERA GIOVANNI;;JOHNSON JAMES E;;DEJARNATT ALEXANDER MARTIN;;RUIZ-SCOUGALL JESUS;;DOTY JOHN DAVID;;WHEELER JONATHAN T;;GUPTA KAPIL;;WOLF KENNETH DAVID;;SRINIVASAN SOWMYANARAYANAN;;OLSON LANCE E;;TAVIS MATTHEW THOMAS,,https://lens.org/086-081-692-943-787,Search Report,yes,2,0,8,8,0,G06F9/547;;H04L67/02;;G06F17/00;;G06F15/16;;G06F9/547;;H04L67/02,G06F9/46,,0,0,,,,DISCONTINUED
551,EP,A2,EP 1667020 A2,175-008-945-572-108,2006-06-07,2006,EP 05110695 A,2005-11-14,US 330704 A,2004-12-03,Interface infrastructure for creating and interacting with web services,"A web services namespace pertains to an infrastructure for enabling creation of a wide variety of applications. The infrastructure provides a foundation for building message-based applications of various scale and complexity. The infrastructure or framework provides APIs for basic messaging, secure messaging, reliable messaging and transacted messaging. In some embodiments, the associated APIs are factored into a hierarchy of namespaces in a manner that balances utility, usability, extensibility and versionability.
",MICROSOFT CORP,STERN AARON ABRAHAM;;DRIVER DAVID OWEN;;WALTER DOUGLAS A;;PURDY DOUGLAS M;;WAINGOLD ELLIOT LEE;;CHRISTENSEN ERIK BO;;HONEYCUTT ERIN P;;OSOVETSKY EVGENY;;EPPLEY GEARY L;;DELLA-LIBERA GIOVANNI;;JOHNSON JAMES E;;DEJARNATT ALEXANDER MARTIN;;RUIZ-SCOUGALL JESUS;;DOTY JOHN DAVID;;WHEELER JONATHAN T;;GUPTA KAPIL;;WOLF KENNETH DAVID;;SRINIVASAN SOWMYANARAYANAN;;OLSON LANCE E;;TAVIS MATTHEW THOMAS,,https://lens.org/175-008-945-572-108,Patent Application,yes,0,0,8,8,0,G06F9/547;;H04L67/02;;G06F17/00;;G06F15/16;;G06F9/547;;H04L67/02,G06F9/46,,1,0,,,"GOWRY S. PARAMASIVAM: ""Cryptography in Microsoft.NET Part I: Encryptionm"", C# CORNER, 12 December 2002 (2002-12-12), Retrieved from the Internet <URL:http://www.c-sharpcorner.com/UploadFile/gsparamasivam/CryptEncryption11282005061028AM/CryptEncryption.aspx> [retrieved on 20081201]",DISCONTINUED
552,KR,A,KR 20060063665 A,009-763-387-192-492,2006-06-12,2006,KR 20050110841 A,2005-11-18,US 330704 A,2004-12-03,INTERFACE INFRASTRUCTURE FOR CREATING AND INTERACTING WITH WEB SERVICES,,MICROSOFT CORP,STERN AARON ABRAHAM;;DEJARNATT ALEXANDER MARTIN;;LEE ALFRED M IV;;KASIOLAS ANASTASIOS;;UPADHYAY CHAITANYA D;;KALER CHRISTOPHER G;;CRITCHLEY GRAIG ANDREW;;WORTENDYKE DAVID;;LEVIN DAVID EDWIN;;DRIVER DAVID OWEN;;WALTER DOUGLAS A;;PURDY DOUGLAS M;;WAINGOLD ELLIOT LEE;;CHRISTENSEN ERIK BO;;HONEYCUTT ERIN P;;OSOVETSKY EVGENY;;EPPLEY GEARY L;;DELLA LIBERA GIOVANNI M;;JOHNSON JAMES E;;RUIZ SCOUGALL JESUS;;DOTY JOHN DAVID;;WHEELER JONATHAN T;;GUPTA KAPIL;;WOLF KENNETH DAVID;;SRINIVASAN SOWMYANARAYANAN;;OLSON LANCE E;;TAVIS MATTHEW THOMAS;;OTTAVIANI MAURO;;FEINGOLD MAX ATTAR;;COULSON MICHAEL JAMES;;MARUCHECK MICHAEL JON;;VERNAL MICHAEL STEVEN;;DICE MICHAEL THOMAS;;MAKARECHIAN MOHAMMAD;;JETHANANDANI NATASHA HARISH;;HILL RICHARD DOUGLAS;;DIEVENDORFF RICHARD;;STURGELL RYAN THOMAS;;NOG SAURAB;;SEELY SCOTT CHRISTOPHER;;COHEN SHY;;MILLET STEPHEN J;;SWARTZ STEPHEN T;;VISHWANATH TIRUNELVELI;;JANCZUK TOMASZ;;HEGDE UDAY S;;MADAN UMESH;;GAJJALA VIJAY K;;MODI VIPUL ARUNKANT;;PESSACH YANIV;;SHOHOUD YASSER;;BALAYOGAN VAITHIALINGAM B;;PHARIES STEFAN HARRINGTON;;BATRES STEFAN;;PURI SIDDHARTHA;;SVERDLOV SERGE;;RAMADAN MOHAMED HANY ESSAM;;SRINIVASAN KRISHNAN;;SHVETZ EUGENE;;RJAGOPALAN ANAND,,https://lens.org/009-763-387-192-492,Patent Application,no,0,0,8,8,0,G06F9/547;;H04L67/02;;G06F17/00;;G06F15/16;;G06F9/547;;H04L67/02,G06F17/00,,0,0,,,,ACTIVE
553,US,B2,US 7512957 B2,093-230-441-237-167,2009-03-31,2009,US 330704 A,2004-12-03,US 330704 A,2004-12-03,Interface infrastructure for creating and interacting with web services,"A web services namespace pertains to an infrastructure for enabling creation of a wide variety of applications. The infrastructure provides a foundation for building message-based applications of various scale and complexity. The infrastructure or framework provides APIs for basic messaging, secure messaging, reliable messaging and transacted messaging. In some embodiments, the associated APIs are factored into a hierarchy of namespaces in a manner that balances utility, usability, extensibility and versionability.",MICROSOFT CORP,COHEN SHY;;EPPLEY GEARY L;;PURDY DOUGLAS M;;JOHNSON JAMES E;;MILLET STEPHEN J;;SWARTZ STEPHEN T;;GAJJALA VIJAY K;;STERN AARON ABRAHAM;;DEJARNATT ALEXANDER MARTIN;;LEE IV ALFRED M;;RJAGOPALAN ANAND;;KASIOLAS ANASTASIOS;;UPADHYAY CHAITANYA D;;KALER CHRISTOPHER G;;CRITCHLEY CRAIG ANDREW;;LEVIN DAVID EDWIN;;DRIVER DAVID OWEN;;WORTENDYKE DAVID;;WALTER DOUGLAS A;;WAINGOLD ELLIOT LEE;;CHRISTENSEN ERIK BO;;HONEYCUTT ERIN P;;SHVETS EUGENE;;OSOVETSKY EVGENY;;DELLA-LIBERA GIOVANNI M;;RUIZ-SCOUGALL JESUS;;DOTY JOHN DAVID;;WHEELER JONATHAN T;;GUPTA KAPIL;;WOLF KENNETH DAVID;;SRINIVASAN KRISHNAN;;OLSON LANCE E;;TAVIS MATTHEW THOMAS;;OTTAVIANI MAURO;;FEINGOLD MAX ATTAR;;COULSON MICHAEL JAMES;;MARUCHECK MICHAEL JON;;VERNAL MICHAEL STEVEN;;DICE MICHAEL THOMAS;;RAMADAN MOHAMED-HANY ESSAM;;MAKARECHIAN MOHAMMAD;;JETHANANDANI NATASHA HARISH;;DIEVENDORFF RICHARD;;HILL RICHARD DOUGLAS;;STURGELL RYAN THOMAS;;NOG SAURAB;;SEELY SCOTT CHRISTOPHER;;SVERDLOV SERGE;;PURI SIDDHARTHA;;SRINIVASAN SOWMYANARAYANAN K;;BATRES STEFAN;;PHARIES STEFAN HARRINGTON;;VISHWANATH TIRUNELVELI;;JANCZUK TOMASZ;;HEGDE UDAY S;;MADAN UMESH;;BALAYOGAN VAITHIALINGAM B;;MODI VIPUL ARUNKANT;;PESSACH YANIV;;SHOHOUD YASSER,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2005-03-15),https://lens.org/093-230-441-237-167,Granted Patent,yes,5,56,8,8,0,G06F9/547;;H04L67/02;;G06F17/00;;G06F15/16;;G06F9/547;;H04L67/02,G06F3/00,719/328,0,0,,,,INACTIVE
554,JP,A,JP 2006164280 A,059-288-144-481-365,2006-06-22,2006,JP 2005349475 A,2005-12-02,US 330704 A,2004-12-03,INTERFACE INFRASTRUCTURE FOR CREATING WEB SERVICE AND PERFORMING CONVERSATION,"<P>PROBLEM TO BE SOLVED: To provide an interface infrastructure creating a Web Service and performing conversation. <P>SOLUTION: A web service name space relates to the infrastructure for realizing creation of various applications. The infrastructure provides a basis for constructing message base applications varied in scale and complication. The infrastructure or a framework provides an API for basic messaging, secure messaging, reliable messaging, and transaction type messaging. In some implementation forms, an associated API is factorized to layers in a name space by a method balancing utility, usability, extensibility, and a version property. <P>COPYRIGHT: (C)2006,JPO&NCIPI",MICROSOFT CORP,STERN AARON ABRAHAM;;DEJARNATT ALEXANDER MARTIN;;LEE IV ALFRED M;;KASIOLAS ANASTASIOS;;UPADHYAYA CHAITANYA D;;KALER CHRISTOPHER G;;CRITCHLEY CRAIG ANDREW;;WORTENDYKE DAVID;;LEVIN DAVID EDWIN;;DRIVER DAVID OWEN;;WALTER DOUGLAS A;;PURDY DOUGLAS M;;WAINGOLD ELLIOT LEE;;CHRISTENSEN ERIK BO;;HONEYCUTT ERIN P;;OSOVETSKY EVGENY;;EPPLEY GEARY L;;DELLA-LIBELA GIOVANNI M;;JOHNSON JAMES E;;RUIZ-SCOUGALL JESUS;;DOTY JOHN DAVID;;WHEELER JONATHAN T;;GUPTA KAPIL;;WOLF KENNETH DAVID;;SRINIVASAN SOWMYANARAYANAN;;OLSON LANCE E;;TAVIS MATTHEW THOMAS;;OTTAVIANI MAURO;;FEINGOLD MAX ATTAR;;COULSON MICHAEL JAMES;;MARUCHECK MICHAEL JON;;VERNAL MICHAEL STEVEN;;DICE MICHAEL THOMAS;;MAKARECHIAN MOHAMMAD;;JETHANANDANI NATASHA HARISH;;HILL RICHARD DOUGLAS;;DIEVENDORFF RICHARD;;STURGELL RYAN THOMAS;;NOG SAURAB;;SEELY SCOTT CHRISTOPER;;COHEN SHY;;MILLET STEPHEN J;;SWARTZ STEPHEN T;;VISHWANATH TIRUNELVELI;;JANCZUK TOMASZ;;HEGDE UDAY S;;MADAN UMESH;;GAJJALA VIJAY K;;MODI VIPUL ARUNKANT;;PESSACH YANIV;;SHOHOUD YASSER;;BALAYOGAN VAITHIALINGAM B;;PHARIES STEFAN HARRINGTON;;BATRES STEFAN;;PURI SIDDHARTHA;;SVERDOLOV SERGE;;RAMADAN MOHAMED-HANY ESSAM;;SRINIVASAN KRISHNAN;;SHVETS EUGENE;;RJAGOPALAN ANAND,,https://lens.org/059-288-144-481-365,Patent Application,no,1,11,8,8,0,G06F9/547;;H04L67/02;;G06F17/00;;G06F15/16;;G06F9/547;;H04L67/02,G06F9/44,,0,0,,,,PENDING
555,US,A1,US 2006/0150200 A1,010-930-464-562-057,2006-07-06,2006,US 330704 A,2004-12-03,US 330704 A,2004-12-03,Interface infrastructure for creating and interacting with web services,"A web services namespace pertains to an infrastructure for enabling creation of a wide variety of applications. The infrastructure provides a foundation for building message-based applications of various scale and complexity. The infrastructure or framework provides APIs for basic messaging, secure messaging, reliable messaging and transacted messaging. In some embodiments, the associated APIs are factored into a hierarchy of namespaces in a manner that balances utility, usability, extensibility and versionability.",MICROSOFT CORP,COHEN SHY;;EPPLEY GEARY L;;PURDY DOUGLAS M;;JOHNSON JAMES E;;MILLET STEPHEN J;;SWARTZ STEPHEN T;;GAJJALA VIJAY K;;STERN AARON A;;DEJARNATT ALEXANDER M;;LEE ALFRED M IV;;RJAGOPALAN ANAND;;KASIOLAS ANASTASIOS;;UPADHYAY CHAITANYA D;;KALER CHRISTOPHER G;;CRITCHLEY CRAIG A;;LEVIN DAVID E;;DRIVER DAVID O;;WORTENDYKE DAVID;;WALTER DOUGLAS A;;WAINGOLD ELLIOT L;;CHRISTENSEN ERIK B;;HONEYCUTT ERIN P;;SHVETS EUGENE;;OSOVETSKY EVGENY;;DELLA-LIBERA GIOVANNI M;;RUIZ-SCOUGALL JESUS;;DOTY JOHN D;;WHEELER JONATHAN T;;GUPTA KAPIL;;WOLF KENNETH D;;SRINIVASAN KRISHNAN;;OLSON LANCE E;;TAVIS MATTHEW T;;OTTAVIANI MAURO;;FEINGOLD MAX A;;COULSON MICHAEL J;;MARUCHECK MICHAEL J;;VERNAL MICHAEL S;;DICE MICHAEL T;;RAMADAN MOHAMED-HANY E;;MAKARECHIAN MOHAMMAD;;JETHANANDANI NATASHA H;;DIEVENDORFF RICHARD;;HILL RICHARD D;;STURGELL RYAN T;;NOG SAURAB;;SEELY SCOTT C;;SVERDLOV SERGE;;PURI SIDDHARTHA;;SRINIVASAN SOWMYANARAYANAN K;;BATRES STEFAN;;PHARIES STEFAN H;;VISHWANATH TIRUNELVELI;;JANCZUK TOMASZ;;HEGDE UDAY S;;MADAN UMESH;;BALAYOGAN VAITHIALINGAM B;;MODI VIPUL A;;PESSACH YANIV;;SHOHOUD YASSER,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2005-03-15),https://lens.org/010-930-464-562-057,Patent Application,yes,3,65,8,8,0,G06F9/547;;H04L67/02;;G06F17/00;;G06F15/16;;G06F9/547;;H04L67/02,G06F9/46,719/328,0,0,,,,INACTIVE
